Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,muscle contraction (GO:0006936),0.9031413136953921,2.6260757076948478,0.0,0.0,0.0,54/126,2.90%,MYH11;MYOM1;ACTA2;LMOD1;MYL1;TPM2;MYBPC1;MYLK2;DMD;MYLK;TRDN;RYR1;TPM1;MYOT;NEB;TTN;MYL9;MYH2;TCAP;TNNI2;SMTN;CACNA1S;SCN4A;TNNC2;ACTG2;EDNRA;MYOM2;CALD1;LMOD2;ACTA1;TNNT3;MYL2;VCL;MYOM3;ROCK1;HRC;LMOD3;SGCA;MYL6;CKMT2;SNTB1;KCNJ12;GJC1;CACNA1H;ITGA1;DTNA;DYSF;DES;MYL3;MYBPC2;VIM;SLC8A1;ASPH;SNTA1
prerank,actin-myosin filament sliding (GO:0033275),0.9471827980047648,2.3794338330884033,0.0,0.0,0.0,19/38,2.61%,MYL1;TPM2;MYBPC1;DMD;TPM1;NEB;TTN;MYH2;TCAP;TNNI2;TNNC2;ACTA1;TNNT3;MYL2;MYL6;DES;MYL3;MYBPC2;VIM
prerank,muscle filament sliding (GO:0030049),0.9471827980047648,2.3794338330884033,0.0,0.0,0.0,19/38,2.61%,MYL1;TPM2;MYBPC1;DMD;TPM1;NEB;TTN;MYH2;TCAP;TNNI2;TNNC2;ACTA1;TNNT3;MYL2;MYL6;DES;MYL3;MYBPC2;VIM
prerank,myofibril assembly (GO:0030239),0.9083697570871342,2.319962585856213,0.0,0.0,0.0,17/42,2.55%,LMOD1;TPM1;OBSCN;TTN;MYOZ2;TCAP;MYPN;MYOM2;LMOD2;TNNT3;MYL2;CASQ1;CSRP1;SYNPO2L;LMOD3;CSRP3;WDR1
prerank,sarcomere organization (GO:0045214),0.9437192482095351,2.25326743435814,0.0,0.0,0.0,14/27,2.55%,TPM1;OBSCN;TTN;MYOZ2;TCAP;MYPN;MYOM2;LMOD2;TNNT3;CASQ1;CSRP1;SYNPO2L;CSRP3;WDR1
prerank,striated muscle contraction (GO:0006941),0.8201494419952495,2.155245859218907,0.0,0.0,0.0,15/53,2.70%,MYLK2;DMD;TPM1;TTN;TCAP;RYR2;TNNI2;TNNC2;TNNT3;STAC;LMOD3;CSRP3;DTNA;MYL3;SLC8A1
prerank,actomyosin structure organization (GO:0031032),0.7778213315903132,2.1495820687464926,0.0,0.0,0.0,24/75,6.29%,LMOD1;TPM1;OBSCN;TTN;MYOZ2;TCAP;PDLIM1;MYPN;MYOM2;LMOD2;TNNT3;ROCK1;CASQ1;CSRP1;SYNPO2L;LMOD3;CSRP3;MYH9;WDR1;ITGB1;TNFAIP1;MYO18A;ITGB5;SORBS1
prerank,cardiac muscle cell differentiation (GO:0055007),0.9034246198818547,2.1065054151905898,0.0,0.0009164925708260929,0.008,8/21,2.70%,MYH11;MYOCD;TTN;TCAP;MEF2C;ALPK3;ALPK2;SLC8A1
prerank,skeletal muscle tissue development (GO:0007519),0.8546940158114669,2.0904790918331915,0.0,0.002138482665260884,0.019,9/32,1.72%,MYLK2;RYR1;MYOZ2;MEF2C;KLHL40;ACTA1;LMOD3;CSRP3;MYL6
prerank,heart contraction (GO:0060047),0.8288170958555736,2.0844536116027492,0.0,0.0019246343987347953,0.019,13/41,2.70%,MYLK2;DMD;TRDN;TPM1;TTN;TCAP;RYR2;TNNI2;SGCG;MYL2;CSRP3;MYL3;SLC8A1
prerank,cardiac muscle contraction (GO:0060048),0.8321342239551659,2.076011078292658,0.0,0.0021662551674071287,0.024,11/34,3.16%,MYLK2;DMD;TPM1;TTN;TCAP;RYR2;TNNI2;CSRP3;MYL3;SLC8A1;CAMK2D
prerank,cardiac muscle cell development (GO:0055013),0.9158102034843425,2.075159347717123,0.0,0.001985733903456535,0.024,11/20,2.70%,MYH11;SORBS2;TTN;TCAP;PDLIM5;HEY2;MYL2;ALPK3;CSRP3;ALPK2;SLC8A1
prerank,calcium ion transport into cytosol (GO:0060402),0.8790555484446249,2.0536867420637384,0.0,0.0038774685688796238,0.048,7/21,2.87%,JPH2;RYR2;CACNA1C;ATP2B4;CACNA2D1;SLC8A1;GRIN2C
prerank,smooth muscle contraction (GO:0006939),0.9478048660813132,2.038963227142806,0.0,0.006284520485664636,0.08,7/14,2.70%,MYH11;ACTA2;MYLK;SMTN;EDNRA;ROCK1;SLC8A1
prerank,regulation of heart contraction (GO:0008016),0.7213019723644343,2.0222710315093932,0.0,0.010325816297973979,0.133,23/90,3.43%,PLN;TRDN;RYR1;TPM1;ATP2A1;RYR2;ATP2B4;HSPB7;TNNI3K;TBX2;TMIGD3;CASQ1;HRC;ATP2A2;ITPR1;KCNJ12;CACNA1H;DES;SLC8A2;SLC8A1;ASPH;CAMK2D;STIM1
prerank,muscle cell differentiation (GO:0042692),0.8214374160669721,2.021016965870826,0.001466275659824047,0.0098522951363805,0.134,11/32,3.40%,MYOCD;DMD;NEB;MEF2C;NRAP;HEY2;SPEG;SYNE1;FBXO40;RORA;MRTFA
prerank,muscle organ development (GO:0007517),0.7583713870487875,2.018615854762377,0.0,0.01002750695139137,0.143,19/54,6.22%,SOX6;TAGLN;DMD;NEB;SMTN;MEF2C;SGCG;SGCA;ITGA7;CACNA1H;SPEG;LARGE1;FHL3;FHL1;ITGB1BP2;ANKRD2;UTRN;MEF2A;CHD2
prerank,regulation of cation channel activity (GO:2001257),0.7050034344941905,1.9929943921345392,0.0,0.018482600178326206,0.234,15/89,5.73%,JPH2;KCNAB1;CACNB2;DMD;FGF13;MEF2C;STAC;HRC;FGF14;CAMK2D;SHISA9;ITGB1;CACNB4;JPH1;CNIH2
prerank,actin filament organization (GO:0007015),0.6623532198430427,1.9841839033079134,0.0,0.02214053105311456,0.277,26/151,5.53%,LMOD1;TPM2;FLNA;TPM1;NEB;TTN;TCAP;ACTN1;ENAH;PLS3;NRAP;XIRP1;DSTN;LMOD2;ACTA1;MYO1E;MYO1D;LMOD3;HIP1;FAT1;LCP1;RHOBTB3;MYO1B;ERMN;ARHGEF2;MYO5C
prerank,regulation of blood circulation (GO:1903522),0.7855452821048439,1.9705586639758654,0.0029239766081871343,0.028594568209774098,0.34,10/34,3.16%,PLN;TPM1;AGTR1;HSPB7;TBX2;TMIGD3;KCNJ12;CACNA1H;DES;CAMK2D
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.8193711696429667,1.9612789218911826,0.001524390243902439,0.03377929761044742,0.394,8/27,5.30%,JPH2;PLN;CACNB2;DMD;HRC;CAMK2D;CACNB4;JPH1
prerank,mesonephric tubule development (GO:0072164),-0.7578876230553078,-1.9608501515917622,0.0,0.30515018955963835,0.203,8/15,10.87%,BMP7;BMP4;SLIT2;PKD2;OSR1;SALL1;FGFR2;SIX1
prerank,muscle cell development (GO:0055001),0.8139892164756599,1.9507228674856512,0.0,0.04095055441463861,0.463,12/30,2.70%,MYH11;DMD;NEB;TTN;TCAP;NRAP;HEY2;ALPK3;FER1L5;ALPK2;DYSF;SLC8A1
prerank,regulation of muscle contraction (GO:0006937),0.834048519183692,1.9393518797040028,0.0,0.05000861636464115,0.551,10/26,2.58%,MYLK2;TPM1;CNN1;MYL9;TNNC2;PPP1R12B;TNNT3;MYL2;PLCE1;MYL3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.8118734649348137,1.9388883832234798,0.0,0.048383170301527494,0.553,8/27,3.16%,PLN;CTNNA3;ATP2A1;FGF13;RYR2;CACNA1C;ATP2A2;CAMK2D
prerank,regulation of calcium ion transport (GO:0051924),0.7335643895944242,1.9353898246530283,0.0,0.04993051525860555,0.575,12/54,4.50%,PLN;CACNB2;MYLK;TRPC6;CAMK2G;CASQ1;CACNA2D1;HRC;PACSIN3;STIM1;CCL5;BCL2
prerank,cellular response to alkaloid (GO:0071312),0.8889238077488408,1.9326748366596982,0.0,0.050794838252323074,0.595,5/17,2.70%,RYR1;RYR2;CACNA1S;HTR1B;SLC8A1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.657550989278732,1.923045062941814,0.0,0.060013291304464166,0.654,19/140,7.67%,JPH2;AGTR1;RYR2;CACNA1C;GPR20;EDNRA;PTGER3;CACNA2D1;ADCY5;CD36;S1PR3;PLCE1;SLC8A1;ADRA1D;JPH1;CXCR6;CAV1;GPR17;C1QTNF1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.7281340378263776,1.9193223684669833,0.0013020833333333333,0.062485154203821835,0.683,11/54,7.03%,KCNAB1;FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;FHL1;KCNN2;KCNIP3;CAV1;NEDD4
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.8482731043837228,1.9147606764149447,0.0,0.06646151298094047,0.709,7/22,1.44%,JPH2;TRDN;ATP2A1;RYR2;AKAP6;STAC;CASQ1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.8255550495861192,1.913603348845345,0.001594896331738437,0.06632351237544824,0.719,6/24,3.16%,JPH2;DMD;TRDN;AKAP6;HRC;CAMK2D
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.8035056778202434,1.9135302595431694,0.001445086705202312,0.06433186561669607,0.719,6/29,2.58%,MYLK2;TPM1;TTN;TCAP;MYL2;MYL3
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.7016133681391241,1.9095695423718841,0.0,0.06770588866977761,0.744,10/76,4.00%,LMOD1;SYNPO2;NTF3;NTRK3;LMOD2;SYNPO2L;CDC42EP3;SEMA5A;WDR1;NUP62
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7807978441834159,1.9089195161855024,0.0068775790921595595,0.06665400515098857,0.748,4/32,1.44%,JPH2;TRDN;AKAP6;CASQ1
prerank,response to muscle stretch (GO:0035994),0.8574005031205385,1.9084416646204525,0.0,0.06552921881406565,0.751,6/15,2.70%,DMD;TTN;TCAP;RYR2;CSRP3;SLC8A1
prerank,cardiac cell development (GO:0055006),0.932100336437387,1.9003283816610355,0.0,0.07400022871870109,0.792,7/11,3.14%,MYH11;TTN;TCAP;ALPK3;ALPK2;SLC8A1;JAG1
prerank,striated muscle cell development (GO:0055002),0.8909535848591529,1.8990713210800398,0.0016835016835016834,0.07390494258633744,0.798,3/14,1.60%,LMOD1;LMOD2;LMOD3
prerank,divalent inorganic cation homeostasis (GO:0072507),0.8006953383092222,1.8955235037923335,0.004379562043795621,0.07626704393442,0.813,4/25,2.99%,JPH2;CNNM2;SLC8A1;FAM20A
prerank,cytosolic calcium ion transport (GO:0060401),0.8004465186684373,1.8950248068683362,0.001466275659824047,0.07495944500335518,0.815,10/28,7.87%,JPH2;RYR2;CACNA1C;CACNA2D1;ATP2A2;SLC8A2;SLC8A1;JPH1;AFG3L2;ATP2B1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.81872879506298,-1.887081629575002,0.0,0.49660542432195975,0.51,3/10,0.84%,PRKCB;PID1;APPL2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.8604121201860337,1.8849113606296037,0.006462035541195477,0.08791278737077983,0.861,3/17,4.10%,KCNAB1;AKAP6;KCNE4
prerank,skeletal muscle contraction (GO:0003009),0.8616145587730016,1.8820172327929106,0.0,0.09070985219751256,0.875,5/19,1.37%,TCAP;TNNI2;TNNC2;TNNT3;STAC
prerank,extracellular matrix assembly (GO:0085029),0.8081040815190423,1.8717775140094608,0.0030816640986132513,0.10631313821582677,0.916,6/23,6.93%,MYH11;NTN4;HAS2;EMILIN1;PXDN;LAMB2
prerank,protein kinase A signaling (GO:0010737),0.8910677170675635,1.8716820326821535,0.0,0.10393462178201619,0.916,3/12,3.35%,MYOM1;TTN;LCP1
prerank,vasoconstriction (GO:0042310),0.9283668933538044,1.8706320615786072,0.0,0.10309475732757702,0.918,4/11,2.70%,ACTA2;EDNRA;EDNRB;SLC8A1
prerank,muscle tissue morphogenesis (GO:0060415),0.8750351176962379,1.870323997881611,0.0,0.10120994094645422,0.918,5/16,1.06%,MYLK2;MYLK;TTN;TCAP;HEY2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.7200685631658997,1.8677026080384713,0.006747638326585695,0.10323779647816589,0.922,7/48,3.16%,JPH2;DMD;TRDN;AKAP6;CASQ1;HRC;CAMK2D
prerank,calcium ion import (GO:0070509),0.7974085130741032,1.8564253126305692,0.0015408320493066256,0.1198214417597418,0.951,7/28,2.70%,CACNB2;ATP2A1;CACNA1S;CACNA1C;ATP2A2;CACNA1H;SLC8A1
prerank,skeletal muscle organ development (GO:0060538),0.7778536238554788,1.8552652771009939,0.001445086705202312,0.1193975321525142,0.954,6/26,6.08%,MYOZ2;MEF2C;CSRP3;MYL6;LARGE1;CAV1
prerank,cellular response to copper ion (GO:0071280),-0.6957870010723877,-1.8543475761504085,0.0026041666666666665,0.4983727034120735,0.655,11/16,18.88%,SNCA;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;HSF1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.6368121968601348,1.8511779516365174,0.0,0.12481483198937851,0.957,26/142,8.90%,PLN;RYR1;AGTR1;RYR2;CACNA1C;EDNRA;HCRTR1;ATP2B4;TRPC6;PTGER3;HRC;ADCY5;CD36;S1PR3;PLCE1;SLC8A2;SLC8A1;ADRA1D;CXCR6;CAV1;CALB1;FZD9;C1QTNF1;ATP2B1;TRPM4;TRPC5
prerank,cardiac muscle tissue development (GO:0048738),0.7052875199356736,1.847011638867711,0.0039164490861618795,0.12965564287686684,0.964,8/50,1.66%,MYOCD;MYLK2;TTN;TCAP;HEY2;SGCG;TBX2;CSRP3
prerank,epithelial cell development (GO:0002064),0.8087678481423769,1.8429852688904516,0.0046801872074883,0.1341561825175235,0.966,2/20,3.53%,ACTA2;TMEM79
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.9115692888306475,1.8365594106045293,0.001718213058419244,0.14430265379869658,0.974,3/11,0.71%,MYOCD;SOX6;MEF2C
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.8020789051733458,1.8355989574637495,0.0,0.14351921161993988,0.974,6/23,1.60%,MYOCD;MEF2C;RBM24;AKAP6;SMYD1;LMOD3
prerank,actin nucleation (GO:0045010),0.7986961519588794,1.833274537259841,0.0030816640986132513,0.14553210332212071,0.976,7/21,8.93%,LMOD1;LMOD2;LMOD3;ACTR3;WHAMM;SPIRE1;WASHC1
prerank,positive regulation of heart rate (GO:0010460),0.8303507891928645,1.8307946373012634,0.0033333333333333335,0.14779291308802994,0.979,5/17,2.89%,TPM1;RYR2;HRC;ATP2A2;ADRA1D
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8012544799486946,1.8220001174540488,0.006568144499178982,0.16405217017787063,0.988,9/21,3.16%,DMD;TRDN;RYR2;CACNA1C;AKAP6;CASQ1;HRC;SLC8A1;CAMK2D
prerank,positive regulation of cation channel activity (GO:2001259),0.7352408287275337,1.8199033151715598,0.006906077348066298,0.16555783654422776,0.989,5/40,1.44%,JPH2;TRDN;AKAP6;STAC;CASQ1
prerank,calcium ion homeostasis (GO:0055074),0.635074491578773,1.8162730442284791,0.0011547344110854503,0.17067664279506978,0.99,12/95,3.64%,JPH2;TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;FAM20A;STIM1;CCL5
prerank,smooth muscle cell differentiation (GO:0051145),0.8656118356816331,1.815758702901819,0.007054673721340388,0.1689348633569269,0.99,6/12,5.24%,MYOCD;MEF2C;HEY2;EDNRB;MRTFA;TBX18
prerank,platelet aggregation (GO:0070527),0.7282247054564861,1.8151435800237645,0.009655172413793104,0.1673763974686636,0.99,11/33,7.52%,FLNA;MYL9;ACTN1;VCL;CSRP1;MYH9;ACTG1;ACTB;TLN1;ITGB3;PLEK
prerank,regulation of smooth muscle contraction (GO:0006940),0.8043035418037089,1.8149083144557847,0.0016129032258064516,0.1651825110152228,0.99,7/20,8.19%,MYOCD;CNN1;PLCE1;CAV1;ATP2B1;SETD3;DAPK3
prerank,embryonic skeletal system development (GO:0048706),-0.5595073015847221,-1.8143890010086965,0.0,0.6394604841061534,0.831,15/35,10.87%,PDGFRA;HOXB3;SULF1;COL1A1;PCSK5;HOXA3;KIAA1217;WNT5A;DSCAML1;RBP4;HOXB4;MEGF8;WNT9A;OSR1;SIX1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.842423472287391,1.8136819958078074,0.0067226890756302525,0.16507383402731612,0.992,5/17,3.63%,TPM1;CNN1;MEF2C;PRKG1;TGFB3
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.8439593784980208,1.812265415539367,0.0034965034965034965,0.16572255179889236,0.993,2/13,1.06%,RYR2;HEY2
prerank,modified amino acid transport (GO:0072337),-0.6853681355415632,-1.8116790211070135,0.0,0.5294768153980753,0.84,5/15,7.66%,SLC6A13;SLC16A12;PDPN;SLC25A32;CTNS
prerank,heart development (GO:0007507),0.6229901462571589,1.809853981417955,0.0,0.1681545654949017,0.994,21/150,2.23%,MYOCD;PDLIM3;LDB3;TCAP;CACNA1C;PDLIM1;MEF2C;NTRK3;PDLIM5;CRIP1;DLC1;SGCG;MYL2;TBX2;MICAL2;ALPK3;SYNPO2L;CSRP3;PLCE1;PDGFB;ALPK2
prerank,cellular response to purine-containing compound (GO:0071415),0.8938841937868289,1.805416076422822,0.012962962962962963,0.17505008102778374,0.998,4/10,2.70%,RYR1;RYR2;CACNA1S;SLC8A1
prerank,chordate embryonic development (GO:0043009),-0.49219256013180845,-1.8036698398224904,0.004672897196261682,0.49228540876834836,0.883,18/55,11.76%,ALDH1A2;CHD7;SULF1;COL1A1;BMP7;PCSK5;KIAA1217;PTCH1;WNT5A;RBP4;PKD2;ARNT2;ADAM10;FUT8;IGF2;TGFB1;FGFR2;TGFBR1
prerank,activation of adenylate cyclase activity (GO:0007190),0.7319157390382312,1.8022188693036922,0.00430416068866571,0.17912494799653358,0.999,8/35,4.27%,CAP2;LHCGR;EDNRA;TMIGD3;ADCY5;ADCY2;ADCY9;TSHR
prerank,regulation of cardiac conduction (GO:1903779),0.6922635845894032,1.798892930606813,0.0025412960609911056,0.18377064670170476,0.999,13/54,3.43%,TRDN;RYR1;ATP2A1;RYR2;ATP2B4;TNNI3K;CASQ1;ATP2A2;ITPR1;SLC8A2;SLC8A1;ASPH;STIM1
prerank,negative regulation of cell development (GO:0010721),-0.5989623178875101,-1.7954781734230383,0.0,0.4626904970212056,0.903,5/25,4.16%,IGF1;FBN1;APPL2;B2M;PCM1
prerank,calcium ion transport (GO:0006816),0.6195226203167219,1.7933838989401203,0.0045045045045045045,0.19405020313043214,0.999,17/113,3.64%,CACNB2;RYR1;ATP2A1;RYR2;CACNA1S;CACNA1C;ATP2B4;TRPC6;CACNA2D1;ATP2A2;ITPR1;CACNA1H;ANO6;SLC8A2;SLC8A1;STIM1;CCL5
prerank,calcium ion import across plasma membrane (GO:0098703),0.8129652723397464,1.790499056822834,0.010169491525423728,0.19754458250879478,0.999,5/14,6.56%,ATP2B4;CACNA2D1;SLC8A2;SLC8A1;TRPV2
prerank,negative regulation of reproductive process (GO:2000242),-0.653923520802199,-1.7883173811624888,0.005221932114882507,0.4468270632837562,0.927,6/17,15.49%,IGF1;SULF1;GJA1;ARHGDIB;CALR;DUSP1
prerank,calcium ion import into cytosol (GO:1902656),0.804771116571775,1.7871039518072167,0.011844331641285956,0.20249172814846067,1.0,5/15,6.56%,ATP2B4;CACNA2D1;SLC8A2;SLC8A1;TRPV2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.7104362090171601,1.7864755806519534,0.005405405405405406,0.20102609903519758,1.0,7/41,4.09%,FLNA;KCNMA1;AKAP6;STAC;KCNJ12;KCNMB1;KCNN2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.7157637357235195,1.7840453731741654,0.00823045267489712,0.20383569275936386,1.0,8/38,6.08%,CACNB2;CTNNA3;CACNA1C;CACNA2D1;CAMK2D;KCNA5;KCNE4;CAV1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.8928150076375185,1.7781587791493758,0.003616636528028933,0.2151466310014253,1.0,3/10,6.08%,KCNAB1;KCNE4;CAV1
prerank,anion transport (GO:0006820),-0.5519344212869297,-1.7772502961697623,0.00967741935483871,0.4581834678072648,0.947,8/33,8.17%,SLC13A4;SLC13A3;ABCG2;SLCO2B1;LRRC8B;SLC26A7;SLC22A6;SLC4A2
prerank,amino acid import (GO:0043090),-0.6018758128861249,-1.7766916282196565,0.005479452054794521,0.4148393117526976,0.949,8/21,9.92%,SLC6A13;SLC1A3;SLC47A1;SLC6A1;SLC6A6;SLC7A5;SLC22A4;SFXN2
prerank,heart morphogenesis (GO:0003007),0.6820201787360352,1.773239321799037,0.005076142131979695,0.22545717242321886,1.0,14/50,7.87%,MYLK2;TTN;TCAP;RYR2;DLC1;HEY2;TBX2;SYNPO2L;ALPK2;HEYL;BMPR1A;VEGFA;SOX9;TGFB2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5879186971839805,-1.771361023172632,0.005390835579514825,0.402189877780429,0.954,13/24,24.16%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;RNF34;TAB1;AAMP;UBB;CYLD
prerank,hepaticobiliary system development (GO:0061008),-0.6029197098628489,-1.7696432073277986,0.0026666666666666666,0.37544862447749583,0.957,6/20,6.56%,TGFBR3;NF1;COBL;WNT4;PKD2;LSR
prerank,ureteric bud development (GO:0001657),-0.6643034633438638,-1.7669244003474986,0.0024937655860349127,0.35762478408147697,0.962,8/17,10.87%,BMP7;BMP4;SLIT2;PKD2;OSR1;SALL1;FGFR2;SIX1
prerank,sensory perception of taste (GO:0050909),0.868384292991541,1.7628913096666348,0.0036036036036036037,0.24929836429943816,1.0,3/10,5.34%,ASIC3;CD36;PKD1L3
prerank,metal ion homeostasis (GO:0055065),0.6968435879482184,1.7592860626469484,0.00938337801608579,0.2557625267652016,1.0,4/40,2.99%,JPH2;CNNM2;SLC8A1;FAM20A
prerank,zinc ion homeostasis (GO:0055069),-0.5670808552222929,-1.758790581473984,0.009287925696594427,0.3660792400949881,0.969,15/28,17.79%,SLC39A10;SLC30A10;SLC39A8;PRKN;SLC30A1;SLC39A6;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.8371595255360856,1.7586187220604441,0.008756567425569177,0.2544472795319811,1.0,8/13,11.19%,TRDN;HRC;SLC8A1;CAMK2D;CAV1;CALM1;SRI;PDE4D
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.8488546621242752,1.754348835898345,0.009041591320072333,0.2628667328142112,1.0,8/12,11.19%,TRDN;HRC;GJD3;CAMK2D;CAV1;CALM1;SRI;PDE4D
prerank,response to purine-containing compound (GO:0014074),0.7920776968352385,1.7516846800509118,0.010238907849829351,0.26722808382433116,1.0,2/17,0.51%,RYR1;RYR2
prerank,homotypic cell-cell adhesion (GO:0034109),0.6844684437952743,1.749639177077853,0.01606425702811245,0.2691819888718713,1.0,11/39,7.52%,FLNA;MYL9;ACTN1;VCL;CSRP1;MYH9;ACTG1;ACTB;TLN1;ITGB3;PLEK
prerank,blood circulation (GO:0008015),0.6913699919997652,1.749308903717585,0.002600780234070221,0.26679098736747564,1.0,8/49,1.43%,PLN;GUCY1A1;TRDN;AGTR1;ELN;SGCG;MYL2;ROCK1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.7194524297457732,1.746144369871459,0.008486562942008486,0.2717230751652916,1.0,7/33,5.99%,TPM1;CNN1;MEF2C;PRKG1;IGFBP5;TGFB3;OGN
prerank,cellular response to cadmium ion (GO:0071276),-0.5620771312539918,-1.7421098984088108,0.0061162079510703364,0.4126793039758919,0.988,14/24,18.88%,EGFR;CHUK;MAPK9;AKT1;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;HSF1
prerank,focal adhesion assembly (GO:0048041),0.7475372551454919,1.741022694536552,0.0078125,0.28271560462251244,1.0,8/21,9.98%,ARHGEF7;ACTN1;DLC1;FERMT2;PEAK1;SORBS1;WHAMM;ACTN2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.628306129895229,-1.7389280859241056,0.005263157894736842,0.40006780402449693,0.989,9/19,11.86%,ROBO1;JCAD;DCN;SEMA6A;CCBE1;XDH;PIK3CB;CD63;SPRY2
prerank,cardiac myofibril assembly (GO:0055003),0.8188586214213716,1.7388516019119562,0.008361204013377926,0.2854708726935781,1.0,6/15,1.66%,NEB;TTN;TCAP;NRAP;MYL2;CSRP3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7383570647013802,1.7352530603739122,0.018433179723502304,0.292710270120505,1.0,10/25,8.74%,CTNNA3;FGF13;RYR2;CACNA1C;ATP2A2;CAMK2D;TBX18;CAV1;CALM1;TRPM4
prerank,regulation of glucose import (GO:0046324),-0.5464570559249557,-1.7347738781438544,0.006060606060606061,0.3951081604995454,0.991,14/30,16.74%,IGF1;OSBPL8;PID1;PRKAG2;APPL2;PTPN11;OCLN;CREBL2;ENPP1;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,striated muscle cell differentiation (GO:0051146),0.7863460072730847,1.7328411591775905,0.019230769230769232,0.2962643102186889,1.0,3/16,3.56%,MYOCD;MEF2C;SORT1
prerank,dendrite self-avoidance (GO:0070593),0.8113194227662831,1.7313817392691575,0.010452961672473868,0.29657060178510863,1.0,4/16,1.61%,NEXN;PALLD;MYPN;ROBO3
prerank,cellular calcium ion homeostasis (GO:0006874),0.591490908315671,1.7309333000574523,0.002171552660152009,0.29444694077195543,1.0,33/133,12.68%,PLN;TRDN;RYR1;ATP2A1;RYR2;HCRTR1;ATP2B4;TRPC6;HRC;ATP2A2;CSRP3;SLC8A2;SLC8A1;CAMK2D;STIM1;CCL5;BCL2;ATP1B1;CAV1;AFG3L2;CALB1;RMDN3;FZD9;ATP2B1;TRPC5;PTH1R;ATP2A3;CCL14;GPER1;HTR2B;DMPK;CHRNA7;CALB2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.709971335141742,1.730735036498605,0.014245014245014245,0.2916008578472702,1.0,11/35,7.69%,PDE3A;CAP2;AKAP6;CD36;IRAG1;ADCY2;GUCY1B1;NUDT4;KSR1;CAP1;SOX9
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.8529065086091911,1.729533603839562,0.009380863039399626,0.2916608885787351,1.0,1/10,0.03%,MYOCD
prerank,response to cadmium ion (GO:0046686),-0.5496564319585523,-1.7290231737218233,0.006430868167202572,0.39698324746443725,0.993,14/26,18.88%,EGFR;CHUK;MAPK9;AKT1;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;HSF1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.746443044246844,1.7276200082418514,0.014331210191082803,0.29421448173674974,1.0,3/20,6.72%,MYOCD;NR2F2;HEXIM1
prerank,negative regulation of neurogenesis (GO:0050768),-0.5385208870672615,-1.723673271209906,0.003289473684210526,0.39797884913508613,0.994,6/34,5.75%,PTN;NF1;APPL2;B2M;PCM1;RUFY3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.7966439094705612,1.7230031960186127,0.021848739495798318,0.3043762469835844,1.0,9/16,12.41%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1;AOAH;PHKA1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.69365102372146,1.7225092316062594,0.02,0.302352891490682,1.0,9/37,5.14%,TPM1;CNN1;MEF2C;PRKG1;HTR1B;PDGFB;IGFBP5;TGFB3;BMPR1A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.7554528168302804,1.7216725725736681,0.010852713178294573,0.30169358670182805,1.0,5/22,6.30%,CACNB2;DMD;STAC;CACNB4;STAC3
prerank,positive regulation of ion transport (GO:0043270),0.6512572232341706,1.720752859685339,0.013531799729364006,0.30125305801473,1.0,15/48,11.10%,CACNB2;MYLK;TRPC6;PLA2G3;ANO6;CCL5;FHL1;GDNF;PRSS8;KIF5B;ATP2B1;CNKSR3;AHCYL1;ACTN2;GPD1L
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.8322054404562785,1.7188752495038473,0.02054794520547945,0.3006000164333457,1.0,3/12,1.59%,MYOZ2;ATP2B4;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.8322054404562785,1.7188752495038473,0.02054794520547945,0.3006000164333457,1.0,3/12,1.59%,MYOZ2;ATP2B4;DYRK2
prerank,negative regulation of cation channel activity (GO:2001258),0.7305384958376497,1.7174100376176828,0.009077155824508321,0.30188509412849995,1.0,2/26,0.28%,KCNAB1;TRDN
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6198937109742062,-1.7147009610125814,0.008021390374331552,0.4154284047827355,0.997,6/18,11.66%,PTN;SLIT2;CAMK1D;PTK2B;IL6R;LYN
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5614249302622666,-1.7146846185210287,0.017595307917888565,0.39570220389118027,0.997,14/26,17.79%,SLC39A10;SLC30A10;SLC39A8;SLC30A1;SLC39A6;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,positive regulation of ATPase activity (GO:0032781),0.67369192542698,1.7144075983934173,0.008310249307479225,0.3073803858970614,1.0,6/41,2.58%,TPM1;ATP2A1;RYR2;DYNLL1;TNNT3;MYL3
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7557920145479415,1.7130317062609315,0.011475409836065573,0.30808036630829844,1.0,9/20,7.03%,DMD;RYR2;CACNA1C;HRC;ATP2A2;SLC8A1;CAMK2D;ATP1B1;CALM1
prerank,positive regulation of calcium ion transport (GO:0051928),0.6873256564885841,1.709576940320685,0.02112676056338028,0.315695030946756,1.0,7/36,7.87%,CACNB2;MYLK;TRPC6;PDGFB;CCL5;CAV1;ATP2B1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.49760462075466094,-1.70829894881094,0.0,0.404064264694186,0.999,10/37,11.18%,ALCAM;HMCN1;CADM1;CXADR;NLGN1;VCAM1;NECTIN1;TENM3;PTPRD;CADM3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.6832898077081542,1.7079980658273748,0.015647226173541962,0.3166980912316977,1.0,8/41,2.87%,RYR1;RYR2;ATP2B4;CACNA2D1;ITPR1;SLC8A2;SLC8A1;GRIN2C
prerank,peptidyl-arginine modification (GO:0018195),0.7871546124913024,1.7076301336338284,0.014657980456026058,0.3146085379892629,1.0,6/15,10.66%,ART1;PADI3;PADI2;ART4;PRMT7;KRTCAP2
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.5140827474158087,-1.707103703743069,0.006993006993006993,0.3909016445408092,0.999,9/36,13.45%,AFDN;SPTBN1;VAMP5;GOLGA4;OPTN;GCC2;GOLPH3;BLZF1;RILPL2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.8507662561584562,1.7055314871590823,0.0049833887043189366,0.3173021852005677,1.0,2/11,0.71%,MYOCD;MEF2C
prerank,glucan catabolic process (GO:0009251),0.7958117306744705,1.7046303915224863,0.02249134948096886,0.31695661822021237,1.0,7/15,8.26%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1
prerank,striated muscle tissue development (GO:0014706),0.7071329484153768,1.7009591782098783,0.014705882352941176,0.32475259609672014,1.0,6/29,1.72%,MYOZ2;MEF2C;SGCG;TBX2;CSRP3;MYL6
prerank,positive regulation of potassium ion transport (GO:0043268),0.6822664311533592,1.7005829622954922,0.018030513176144243,0.32274372343204144,1.0,7/38,4.09%,FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;FHL1;KCNN2
prerank,sulfur compound transport (GO:0072348),-0.5538623367006836,-1.6981245778860017,0.006153846153846154,0.4132978516574317,0.999,16/27,30.53%,SLC6A13;SLC13A4;ABCG2;SLC6A6;SLC26A7;SLC25A14;SLC35F3;SLC25A30;SLC25A11;LRRC8D;SLC36A1;SLC26A6;SLC25A19;SLC5A6;SLC35B2;RACGAP1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7838242248108735,1.69575830475187,0.02027027027027027,0.33353477297166406,1.0,2/16,1.43%,MYOCD;ROCK1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7858286940009921,1.695507822094537,0.025,0.3311083993378935,1.0,6/16,7.87%,SOX6;SOX5;RBM24;SP7;SOX9;TGFB2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.8325812313328018,1.6954490468585404,0.016216216216216217,0.3281968304316962,1.0,3/11,3.16%,CACNB2;CACNA2D1;CAMK2D
prerank,cardiac ventricle morphogenesis (GO:0003208),0.6604159322532664,1.6937255859548872,0.017881705639614855,0.33033724952829935,1.0,8/41,5.14%,TPM1;MEF2C;HEY2;MYL2;MYL3;HEYL;JAG1;BMPR1A
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.8461385697092499,1.6884455684630764,0.014571948998178506,0.3429168419058495,1.0,5/10,9.22%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1
prerank,regulation of cation transmembrane transport (GO:1904062),0.708988011849166,1.6882410736589755,0.0239880059970015,0.3405260878781877,1.0,6/29,5.31%,KCNAB1;ATP2B4;HRC;SNTA1;KCNN2;KCNIP3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.7267907909913698,1.6874772966676594,0.01929260450160772,0.3396294371977225,1.0,3/22,6.72%,MYOCD;NR2F2;HEXIM1
prerank,metal ion transport (GO:0030001),0.6068593737074071,1.6842624347473905,0.005931198102016607,0.34583123613356176,1.0,20/86,12.49%,RYR1;ATP2A1;RYR2;CACNA1S;CACNA1C;CACNA2D1;ITPR1;SLC8A2;SLC8A1;CCL5;CAV1;RAMP1;TRPC5;SLC30A5;MRS2;ATP2A3;PANX1;CACNA1B;CHRNA7;TRPM2
prerank,cGMP-mediated signaling (GO:0019934),0.8096683470947843,1.6827539757498082,0.011945392491467578,0.34733474534185743,1.0,4/13,3.85%,PDE3A;CD36;IRAG1;GUCY1B1
prerank,regulation of histone modification (GO:0031056),0.7883480094050934,1.6823749754445427,0.025594149908592323,0.34541498882712035,1.0,1/13,0.03%,MYOCD
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7693883296559793,1.6786184043512697,0.0297723292469352,0.3537974654182164,1.0,4/15,6.51%,NTF3;NTRK3;CDH13;VEGFA
prerank,positive regulation of calcium ion import (GO:0090280),0.8174733662904827,1.6785297669376271,0.014035087719298246,0.3510321883987804,1.0,2/12,2.09%,ATP2A1;PDGFB
prerank,response to calcium ion (GO:0051592),0.593815625294758,1.6784652321341729,0.004555808656036446,0.34822866882270415,1.0,17/102,7.03%,KCNMA1;RYR1;TTN;RYR2;MEF2C;PPP3CA;RASGRP2;KCNMB1;CAMK2D;STIM1;D2HGDH;SYT10;MEF2A;KCNH1;CAV1;CALM1;NEDD4
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8173879188972416,1.6778908674398134,0.01592920353982301,0.34696881243857836,1.0,3/12,0.63%,CTNNA3;RYR2;CACNA1C
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.7169288816778685,1.6778495124442898,0.022354694485842028,0.34414674750458146,1.0,5/26,1.59%,MYOZ2;ATP2B4;AKAP6;LMCD1;DYRK2
prerank,negative regulation of catalytic activity (GO:0043086),0.7150664807961508,1.6752891867568513,0.03134328358208955,0.34875547213607677,1.0,2/24,0.41%,PLN;PPP1R12A
prerank,ether lipid metabolic process (GO:0046485),-0.6357882016570651,-1.6746748226254708,0.012987012987012988,0.5010589676290463,1.0,7/14,16.23%,AGMO;GNPAT;PAFAH1B1;PLA2G6;PLAAT3;PLA2G7;LIPE
prerank,positive regulation of reproductive process (GO:2000243),0.6800962619970436,1.6709861306571552,0.023088023088023088,0.35801329303294394,1.0,7/31,11.74%,PDE3A;CACNA1H;TACR3;VEGFA;PLCB1;SIRT2;ACVR1B
prerank,second-messenger-mediated signaling (GO:0019932),0.5947955333884879,1.6686862024357387,0.014234875444839857,0.36165240308944796,1.0,12/82,5.56%,GUCY1A1;AGTR1;RYR2;RCAN2;CD36;PLCE1;EDNRB;GUCY1B1;INPP5A;NUDT4;CAMKK2;CXCR6
prerank,renal system development (GO:0072001),0.6327266960171278,1.6682862156734215,0.011612903225806452,0.36002760958275576,1.0,8/52,7.87%,MYOCD;ITGA8;AGTR1;CEP290;TBX18;HAS2;VEGFA;TGFB2
prerank,supramolecular fiber organization (GO:0097435),0.5405439558737724,1.6674690060176967,0.0,0.35972333404924145,1.0,53/334,8.57%,MYH11;LMOD1;TPM2;TRDN;TPM1;TTR;FGF13;ACTN1;MFGE8;COL18A1;XIRP1;COL4A2;COL4A1;LMOD2;MYO1E;MYO1D;LMOD3;ADAMTS14;CD36;HIP1;P3H2;FAT1;DES;VIM;LOXL2;HOOK2;KIF2A;CRTAP;COL4A6;RHOBTB3;MYO1B;ERMN;DST;MAP7D3;ARHGEF2;EMILIN1;MYO5C;TUBGCP6;PXDN;MAPT;TPPP;CALB1;PIN1;HDGFL3;CORO1C;NAT8;TGFB2;ARHGAP17;WHAMM;COL27A1;RHOF;COL4A5;TPM4
prerank,response to metal ion (GO:0010038),0.6148368336570786,1.6636403397587032,0.013365735115431349,0.36872588902645054,1.0,17/67,9.58%,KCNMA1;TTN;CRIP1;PPP3CA;LOXL2;D2HGDH;FXN;BCL2;CAV1;MAPT;NDRG1;CALM1;NEDD4;PPP1CA;AHCYL1;SLC30A5;HIF1A
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.808565076421181,1.6604443181422475,0.03165735567970205,0.37548271020852453,1.0,2/11,2.32%,AGTR1;PLA2G3
prerank,negative regulation of macroautophagy (GO:0016242),-0.5400695630816769,-1.6600525492949054,0.008571428571428572,0.555424097628822,1.0,13/26,23.98%,PIK3CA;NUPR1;SMG1;NRBP2;AKT1;SCFD1;QSOX1;FEZ1;LZTS1;CHMP4B;CHMP4A;SMCR8;PHF23
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6040211570207146,-1.6599797481057323,0.012658227848101266,0.5352019269196289,1.0,9/18,17.35%,TSHZ3;NLGN1;PTK2B;SHANK3;CACNG4;NRXN1;NLGN2;NLGN3;CACNG8
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.6000987907713761,1.6599690698950988,0.01282051282051282,0.3740355378006303,1.0,7/86,2.55%,LMOD1;SYNPO2;LMOD2;SYNPO2L;CDC42EP3;SEMA5A;WDR1
prerank,circulatory system development (GO:0072359),0.5828607996159741,1.6590876057326707,0.003355704697986577,0.37361172146868304,1.0,21/118,7.87%,PDLIM3;LDB3;CACNA1C;PDLIM1;MEF2C;NTRK3;PDLIM5;CRIP1;HEY2;MYL2;MICAL2;ALPK3;PLCE1;PDGFB;HDAC9;PDLIM7;MEF2A;FBXW7;SMYD4;SOX9;TGFB2
prerank,cell-matrix adhesion (GO:0007160),0.5892945332184082,1.658806952383156,0.0069124423963133645,0.371697204545187,1.0,20/95,8.30%,ITGA8;ARHGEF7;ACTN1;ITGB6;DLC1;VCL;BCAM;ITGA7;ITGA1;FERMT2;ITGA3;ITGB1;PEAK1;EMILIN1;ITGB5;SORBS1;SGCE;ITGB3;ITGA4;WHAMM
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.7500360171537492,1.6582837538589164,0.03600654664484452,0.37044351987769214,1.0,3/18,1.89%,FLNA;POLR2L;RASL11A
prerank,glycerolipid metabolic process (GO:0046486),0.8285049186146167,1.6575320447973458,0.005338078291814947,0.36975996133802497,1.0,2/11,0.44%,DGKB;DGKG
prerank,actin filament-based transport (GO:0099515),0.7149807582377369,1.655274318213114,0.0372168284789644,0.3737443024835212,1.0,7/21,8.00%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C;SYNE2;SUN2
prerank,nerve growth factor signaling pathway (GO:0038180),0.8368743478779193,1.6526620217439412,0.015384615384615385,0.3788576622779329,1.0,2/10,0.72%,NTF3;RAP1A
prerank,B cell proliferation (GO:0042100),0.7532473327552821,1.6513925336028126,0.02631578947368421,0.37985921494356767,1.0,5/17,11.12%,MEF2C;CD79A;BCL2;RASGRP1;CD180
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5987636571394593,1.6491700871947383,0.01650943396226415,0.383803005645508,1.0,7/76,2.89%,AGTR1;LHCGR;GPR20;PTGER3;ANO1;PLCE1;ADRA1D
prerank,neurotransmitter uptake (GO:0001504),-0.6659512174196529,-1.6490633708560827,0.006864988558352402,0.5729350497854435,1.0,3/12,1.14%,ATP1A2;SLC1A3;GLUL
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.7095977703780372,1.6486971676184872,0.03215926493108729,0.3825493120632218,1.0,3/22,0.77%,NTF3;RAP1A;NTRK3
prerank,positive regulation of cartilage development (GO:0061036),0.7532583945689824,1.6486553710259346,0.027243589743589744,0.37988287387154923,1.0,5/17,7.69%,SOX6;SOX5;LOXL2;TAPT1;SOX9
prerank,mesenchyme development (GO:0060485),-0.6302462327961154,-1.6477493326654535,0.01201923076923077,0.5601259038022546,1.0,8/15,21.92%,BMP7;BMP4;PKD2;BMPR2;FGFR2;TGFBR1;HMGA2;CRELD1
prerank,negative regulation of cell junction assembly (GO:1901889),0.7073328617818223,1.6439949558407998,0.030721966205837174,0.39126377123667083,1.0,7/25,6.96%,SLIT1;DLC1;ROCK1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,vesicle transport along actin filament (GO:0030050),0.7167989074907508,1.6438616563730648,0.03758169934640523,0.38884634797538553,1.0,5/19,5.53%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C
prerank,cAMP-mediated signaling (GO:0019933),0.7168225520300863,1.6427545668355936,0.025236593059936908,0.389767509522449,1.0,7/24,7.69%,PDE3A;CAP2;AKAP6;ADCY2;KSR1;CAP1;SOX9
prerank,regulation of microtubule depolymerization (GO:0031114),0.6851952044558209,1.6426344042918188,0.026825633383010434,0.3873687235895097,1.0,7/25,7.13%,FGF13;TRIM54;CLASP2;MAP1B;ARHGEF2;HDGFL3;TPX2
prerank,diacylglycerol metabolic process (GO:0046339),0.7082727022441897,1.6426335227376005,0.02384500745156483,0.38468502754076883,1.0,3/23,1.83%,DGKB;DGKG;PLCE1
prerank,cellular response to zinc ion (GO:0071294),-0.6289429425171744,-1.6423600800682074,0.01674641148325359,0.5695351414406533,1.0,11/15,20.83%,GLRA2;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;GLRA1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5732544975021172,-1.6417399916632245,0.013513513513513514,0.5542415262608302,1.0,8/20,14.60%,NUPR1;CASP8;BIRC2;PELI1;SDCBP;OGT;STUB1;BIRC3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.5699731262125496,-1.641604255050549,0.01891891891891892,0.5376578448527267,1.0,8/20,22.29%,ST3GAL4;B4GALT1;ST3GAL6;FUT8;ST3GAL3;MPDU1;ST6GALNAC5;B3GALT2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.6556974226275424,1.6411842188404564,0.02661064425770308,0.38648807743657315,1.0,7/34,7.03%,PLN;RYR2;TNNI3K;ATP2A2;SLC8A1;ATP1B1;CALM1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.5695073677365048,-1.6404909223349693,0.022099447513812154,0.5276845444824447,1.0,8/21,22.29%,ST3GAL4;B4GALT1;ST3GAL6;FUT8;ST3GAL3;MPDU1;ST6GALNAC5;B3GALT2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.6870112737122533,1.6393930423309628,0.032640949554896145,0.3894716785228363,1.0,4/26,3.59%,SYNPO2;ROCK1;SYNPO2L;ACTG1
prerank,action potential (GO:0001508),0.6430832084587905,1.6382518181044827,0.022135416666666668,0.39025126515842484,1.0,15/44,16.59%,DMD;SCN4A;AKAP6;CACNA1H;KCNE4;KCNB1;SLC4A3;SRI;GPER1;KCNA2;GNAQ;CHRNA4;YWHAH;CACNA1I;KCNH2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5959688678052408,-1.6359602241308226,0.0075,0.5343073782443861,1.0,9/18,16.06%,PUM1;UFD1;BIRC2;SEC14L1;DDX60;RNF125;BIRC3;ANKRD17;NOP53
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.7897611731832408,1.6340807952870993,0.03773584905660377,0.3997827289186604,1.0,5/10,9.98%,SEMA5A;WDR1;PLEK;CFL2;ACTN2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.8358360034640712,1.633573576934121,0.02737226277372263,0.3984466829058567,1.0,3/10,2.95%,SOX6;SOX5;LOXL2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.6321815347506007,1.6322566658640831,0.023809523809523808,0.39974961959245303,1.0,4/44,1.71%,LMOD1;LMOD2;LMOD3;CDC42EP3
prerank,lipid modification (GO:0030258),0.641035579121554,1.631491624012946,0.029661016949152543,0.3992994254934238,1.0,6/37,9.51%,DGKB;DGKG;ALOX5;PLPPR1;LPCAT3;DGKD
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7700281842017702,1.631485142311462,0.032590051457975985,0.3967146624835709,1.0,5/13,4.09%,CACNB2;CACNA1C;GJC1;KCNA5;KCNN2
prerank,regulation of cartilage development (GO:0061035),0.7384733726477188,1.6314359268022365,0.030303030303030304,0.3942655197333504,1.0,4/18,7.69%,SOX6;SOX5;TAPT1;SOX9
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6862154666006229,1.6302066339588155,0.030257186081694403,0.3953058605490416,1.0,9/25,9.70%,CTNNA3;ITGA7;ITGB1;JAM3;CD200R1;CD200;ITGB3;ITGA4;PARVA
prerank,actin filament depolymerization (GO:0030042),0.794411822991887,1.6293908703632378,0.015901060070671377,0.395026036591933,1.0,5/11,12.34%,DSTN;MICAL2;WDR1;CFL2;MICAL3
prerank,regulation of striated muscle contraction (GO:0006942),0.6903702562375535,1.62931543898101,0.03076923076923077,0.3927229415513579,1.0,6/27,2.58%,DMD;RYR2;TNNI3K;TNNT3;MYL2;MYL3
prerank,cellular response to organonitrogen compound (GO:0071417),0.5778753300812152,1.6290041030789526,0.011587485515643106,0.391190551902987,1.0,26/99,13.21%,PDE3A;MEF2C;RAP1A;AKAP6;NR1H4;HTR1B;P2RY2;IGFBP5;TSHR;ACTB;LARS1;TAF1;CPEB1;SOX9;RELA;IMPACT;GABRB2;CAPN2;RRAGB;SH3BP4;GABRB3;TRPM2;CPEB3;HCN2;DMTN;ZFP36L1
prerank,embryonic hemopoiesis (GO:0035162),-0.6449414136106971,-1.6279449836603814,0.014767932489451477,0.5598403532891721,1.0,8/12,27.63%,KIT;FLT3LG;THOC5;KDR;ATF4;TAL1;ZFPM1;KMT2A
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.7205471574023115,1.627291718728055,0.021212121212121213,0.3941440107282417,1.0,8/21,10.00%,GUCY1A1;ADCY5;ADCY2;ADCY9;GUCY1B1;AMPD2;ADCY6;NPR2
prerank,regulation of cell communication (GO:0010646),0.6635612697738285,1.6255682679606749,0.03076923076923077,0.3970660832322405,1.0,12/35,10.89%,TRDN;RYR2;IGFBP7;SLC8A1;ANXA1;CAMK2D;NUP62;TBX18;PTPN1;MGLL;SRI;CDC42SE2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7555595088662768,1.625441867900609,0.027422303473491772,0.3949682014760724,1.0,6/16,3.16%,DMD;RYR2;CACNA1C;HRC;SLC8A1;CAMK2D
prerank,metanephros development (GO:0001656),-0.5265714301829308,-1.624254438966831,0.011976047904191617,0.5633693010595897,1.0,10/26,14.30%,NF1;FOXD1;BMP7;BMP4;PTCH1;PKD2;CTSH;OSR1;SIX1;SOX17
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.695523855977443,1.6228535453452502,0.0343213728549142,0.4001429334228481,1.0,6/21,7.13%,FGF13;TRIM54;CLASP2;ARHGEF2;HDGFL3;TPX2
prerank,heart trabecula morphogenesis (GO:0061384),-0.5800498524415612,-1.6218719765040641,0.013227513227513227,0.5596383785360163,1.0,8/18,11.76%,TGFBR3;BMP7;TEK;ENG;ADGRG6;RBP4;FKBP1A;TGFBR1
prerank,lipid phosphorylation (GO:0046834),0.8141777993698618,1.6218444082086014,0.01967799642218247,0.4008636672285461,1.0,2/10,0.44%,DGKB;DGKG
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6138509165361192,-1.6217369113277058,0.022388059701492536,0.5459032094672376,1.0,6/15,13.79%,ADGRV1;KIT;COL11A1;WHRN;PIEZO2;TMEM120A
prerank,sympathetic nervous system development (GO:0048485),-0.614535534203736,-1.620411658320651,0.011876484560570071,0.5386122888485093,1.0,6/15,12.07%,NF1;NRP2;NRP1;CTNNB1;SEMA3A;SOX4
prerank,filopodium assembly (GO:0046847),-0.607857944667254,-1.61704680532881,0.02099737532808399,0.5414648585593468,1.0,5/16,4.55%,DNM3;FGD6;FGD5;FGD4;SRGAP2
prerank,mesoderm formation (GO:0001707),0.7281445122107827,1.6170238379862247,0.03600654664484452,0.41320320575115793,1.0,4/17,7.49%,ITGA8;ITGA3;ITGB1;ITGB3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6312871080706948,-1.6155344102770504,0.004975124378109453,0.5352700424642042,1.0,4/14,6.43%,KIT;WNT5A;SEMA7A;PLCG2
prerank,artery development (GO:0060840),-0.5404760532078979,-1.615176400821075,0.017391304347826087,0.5239561721451486,1.0,9/23,11.76%,ROBO1;NF1;NRP1;ENG;ACVRL1;PKD2;BMPR2;HES1;TGFBR1
prerank,epiboly involved in wound healing (GO:0090505),0.7206082992200362,1.6139608932291725,0.04576271186440678,0.42026772741710666,1.0,4/16,3.40%,FLNA;CCN1;LCP1;MRTFA
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7549202843743265,1.6133747769891897,0.03872053872053872,0.4193814459095909,1.0,4/15,3.34%,AGTR1;CD36;PLA2G3;LPL
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.7609223761294832,1.6131830884552583,0.0313588850174216,0.41753413952586815,1.0,4/14,6.46%,FLNA;LIMS1;LIMS2;SLC2A10
prerank,ganglioside biosynthetic process (GO:0001574),-0.6076365039953983,-1.6123501240352844,0.01485148514851485,0.5245667934918988,1.0,6/15,10.99%,ST8SIA4;ST3GAL1;ST3GAL5;ST6GALNAC3;B4GALT6;ST8SIA2
prerank,cell-substrate junction assembly (GO:0007044),0.6560564122569456,1.6118320106513788,0.02130681818181818,0.4192761432248064,1.0,10/33,9.98%,ARHGEF7;ACTN1;DLC1;FERMT2;PEAK1;DST;SORBS1;LAMC1;WHAMM;ACTN2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.7373970009653412,1.609647360229113,0.035541195476575124,0.42341411240873333,1.0,4/17,1.77%,PPP1R12A;VCL;ROCK1;S1PR3
prerank,neurotrophin signaling pathway (GO:0038179),0.7048655125820822,1.6094311192149735,0.03627760252365931,0.4215106601185142,1.0,3/21,3.56%,NTF3;RAP1A;SORT1
prerank,bicellular tight junction assembly (GO:0070830),-0.4618871414297953,-1.6078339885098054,0.008298755186721992,0.5343073782443861,1.0,8/46,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;CLDN11
prerank,regulation of receptor recycling (GO:0001919),-0.606854454498144,-1.6062590289873682,0.026634382566585957,0.5303408185087974,1.0,9/16,24.72%,ANXA2;TBC1D16;LAMTOR1;ECE1;OPTN;SNCA;RAB29;SCRIB;INPP5F
prerank,relaxation of muscle (GO:0090075),0.7589207193448773,1.6061749879711493,0.03208556149732621,0.42895626107599844,1.0,5/13,5.83%,PLN;ATP2A1;SLC8A1;CAMK2D;ATP1B1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5992927900781442,1.6056766775389055,0.023225806451612905,0.42789483846223847,1.0,12/59,6.21%,NEXN;PALLD;MYOT;MYPN;IGFN1;ROBO3;CDH13;ITGB1;CDH4;KIRREL3;IGSF21;DSCAM
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.545654328391078,-1.6050935761571257,0.014204545454545454,0.5241135075506866,1.0,11/23,17.37%,TGFBR3;SMAD3;DKK3;ENG;LTBP4;LATS2;SMURF2;TGFB1;TRIM33;SMAD2;SMAD4
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6690268958687234,1.6033293706761467,0.02608695652173913,0.43287222946959386,1.0,7/30,4.10%,RYR2;CACNA1C;CACNA2D1;GJC1;SNTA1;KCNA5;KCNE4
prerank,osteoclast differentiation (GO:0030316),-0.5596951332192037,-1.6025978558464775,0.021212121212121213,0.5243429323107661,1.0,5/22,2.87%,GAB2;FOXP1;MAPK14;ANXA2;SBNO2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6901418185403708,1.6011408526298738,0.04434250764525994,0.43714046805945594,1.0,6/24,7.72%,SOX6;SOX5;CHADL;LOXL2;SOX9;SNAI2
prerank,negative regulation of ATPase activity (GO:0032780),0.7341695605861343,1.6007690646999897,0.04074702886247878,0.43594496618961154,1.0,2/16,6.43%,PLN;TP53
prerank,aorta morphogenesis (GO:0035909),0.7142084383851403,1.6006608139864686,0.04508856682769726,0.4337837894225969,1.0,5/17,5.14%,MYLK;HEY2;TBX2;JAG1;BMPR1A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6964783655912536,1.5975690259914852,0.03333333333333333,0.4408329265673507,1.0,5/21,4.10%,FLNA;CACNA2D1;SNTA1;KCNA5;KCNE4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.7124582380868634,1.5974702382374577,0.05098684210526316,0.4386374867366713,1.0,1/18,0.10%,SOX6
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.6406050350567118,1.5962740494074008,0.033093525179856115,0.4398340526418435,1.0,4/34,2.33%,FLNA;ARHGEF7;LIMS1;FERMT2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.6131645474401055,1.5960875031740254,0.03062583222370173,0.4379656872396266,1.0,6/51,3.75%,SYNPO2;TPM1;SYNPO2L;FERMT2;TGFB3;PPM1E
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.555823622493166,-1.595486863762555,0.019390581717451522,0.5454265091863517,1.0,12/20,31.50%,SULF1;SPRY2;DSTYK;CREB3L1;FGF2;GPC1;SULF2;PRKD2;SPRY4;SPRY1;FGFBP3;SMOC2
prerank,regulation of metal ion transport (GO:0010959),0.7345720650502686,1.5953419440728758,0.039383561643835614,0.4379714330962159,1.0,5/16,4.50%,PLN;CAMK2G;CACNA2D1;STIM1;BCL2
prerank,response to cholesterol (GO:0070723),-0.5861394222556339,-1.5927131762649238,0.02295918367346939,0.5472794472119556,1.0,10/17,26.83%,PTCH1;GRAMD1C;TGFB1;TGFBR1;GRAMD1A;SMAD2;PMVK;ABCA2;SMO;OSBPL7
prerank,cardiocyte differentiation (GO:0035051),0.783692429425317,1.5908255548070935,0.03838771593090211,0.4495522647273647,1.0,1/10,0.03%,MYOCD
prerank,regulation of multicellular organism growth (GO:0040014),-0.6054931211579911,-1.588680108307139,0.038860103626943004,0.5552790901137358,1.0,4/15,3.57%,IGF1;GHR;APP;PTCH1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5561064931210599,-1.5871447625738633,0.024193548387096774,0.5512524659907707,1.0,9/20,18.19%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;PKDCC;NUMB;TMBIM1
prerank,negative regulation of vascular permeability (GO:0043116),0.7553658647023757,1.5863900309779204,0.048576214405360134,0.4611770473703035,1.0,3/12,2.33%,PDE3A;ANGPT1;FERMT2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.6452329592095849,-1.5862951942671546,0.03587443946188341,0.5440953855127084,1.0,6/11,23.12%,CRY1;SIK1;EP300;C1QTNF3;CLK2;PGP
prerank,superoxide anion generation (GO:0042554),0.7536692254815288,1.5861436415765875,0.03945111492281304,0.4594682755074813,1.0,1/13,0.36%,NCF2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6834070643742282,1.585816576514091,0.049079754601226995,0.4580271241461098,1.0,2/24,0.71%,MYOCD;MEF2C
prerank,neuron remodeling (GO:0016322),-0.6680521048096846,-1.5849878707304919,0.013605442176870748,0.5400315841023018,1.0,6/10,13.29%,APP;ADGRB3;ANKS1A;SCARF1;CX3CL1;EPHA8
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.7571214952177692,1.5847596761484182,0.046875,0.45900920355308544,1.0,1/14,0.09%,CCDC3
prerank,Notch signaling pathway (GO:0007219),0.5787226808599367,1.584418759723528,0.04498714652956298,0.45760572608935074,1.0,12/59,8.66%,SUSD5;SORBS2;NOTCH3;HEY2;PLXND1;HEYL;JAG1;MAML2;NLE1;SNAI2;MAML3;ADAM17
prerank,morphogenesis of an epithelium (GO:0002009),0.6775307462578019,1.5840473377180562,0.03202328966521106,0.4562711704074694,1.0,8/25,10.08%,VCL;LAMA5;ACTG1;ACTB;TBX18;SOX9;LIN7C;ARHGAP12
prerank,histone lysine demethylation (GO:0070076),-0.5220225910361737,-1.583800503509441,0.014124293785310734,0.5358564747307821,1.0,9/25,21.48%,KDM7A;KDM5C;KDM5B;KDM2A;KDM3B;RIOX2;KDM4D;KDM1A;KDM6A
prerank,connective tissue development (GO:0061448),0.6427293519234589,1.5836954951914695,0.03851640513552068,0.45493618724500967,1.0,6/35,7.69%,SOX6;SOX5;SNORC;ARID5B;DYRK1B;SOX9
prerank,negative regulation of viral life cycle (GO:1903901),-0.6169999288724811,-1.5832839067118278,0.028350515463917526,0.5282986293379995,1.0,10/15,30.44%,LY6E;TRIM5;BST2;IFITM1;MID2;SNX3;IFITM3;IFITM2;GSN;PPIA
prerank,endodermal cell fate commitment (GO:0001711),-0.6830960637584362,-1.583064741269867,0.012320328542094456,0.5198956380452443,1.0,4/10,14.30%,CTR9;RTF1;LEO1;SOX17
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7232390334330571,1.5816667346580162,0.04222972972972973,0.45891062129771937,1.0,6/17,5.83%,RYR2;CACNA1C;GJD3;GJC1;SLC8A1;ATP1B1
prerank,atrioventricular valve development (GO:0003171),0.7400390710551499,1.5812073426381725,0.047619047619047616,0.45794239577114093,1.0,4/14,7.87%,SLIT3;HEYL;BMPR1A;TGFB2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6148530975631332,-1.5786319622162064,0.01647058823529412,0.5314239228868322,1.0,4/14,8.31%,IL18;LGALS9;CD55;PTPN22
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6973747825186326,1.577275605944176,0.055900621118012424,0.4682461310549395,1.0,5/19,7.87%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,protein autoubiquitination (GO:0051865),-0.42489866791003006,-1.577263054513441,0.009389671361502348,0.5280914310998481,1.0,20/61,15.21%,RNF220;SH3RF1;RNF146;ITCH;CUL3;RNF185;UBE2D3;RNF13;RNF213;MDM2;SH3RF3;PRKN;UBE3A;RNF181;STUB1;DTX3L;SH3RF2;RNF115;RNF10;OBI1
prerank,endothelial tube morphogenesis (GO:0061154),-0.6899919397816807,-1.5771481540820023,0.017167381974248927,0.5198396528117601,1.0,4/10,7.10%,STARD13;BMP4;ACVRL1;CTNNB1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5776554814237861,1.5752539917543906,0.03201970443349754,0.47261898921907436,1.0,11/67,6.37%,FLNA;ARHGEF7;CD36;LIMS1;PDGFB;CDK6;FERMT2;CDH13;RSU1;UTRN;LIMS2
prerank,myotube cell development (GO:0014904),0.8048109253497107,1.5751605659934904,0.040152963671128104,0.47044560880399067,1.0,4/10,1.60%,RYR1;KLHL40;ACTA1;LMOD3
prerank,regulation of epithelial cell migration (GO:0010632),-0.44656060974805356,-1.5746356220905726,0.004081632653061225,0.5227611548556431,1.0,18/51,13.51%,PTN;MCC;SASH1;DOCK5;GLUL;PTPRG;PTK2;RAB11A;BMPR2;CTSH;PLCG2;ENPP2;PRKCE;BMPER;RTN4;PPM1F;PFN2;PFN1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.7732293503718405,1.5740237717586543,0.04639175257731959,0.4717007742878543,1.0,5/12,3.49%,TPM1;MEF2C;PRKG1;PDGFB;IGFBP5
prerank,primary alcohol metabolic process (GO:0034308),-0.5178481737985692,-1.5738317427730237,0.028901734104046242,0.5174361401546119,1.0,12/25,24.48%,IGF1;GPD2;RBP4;ALDH3A2;NAAA;NAPEPLD;CYP1B1;GDPD1;GDE1;PECR;ADH1A;RDH10
prerank,regulation of actin filament-based movement (GO:1903115),0.7675816669059851,1.5728604959612928,0.057245080500894455,0.47293836631767394,1.0,2/10,0.21%,PLN;MYLK2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6312925667025838,-1.5686683712632112,0.024553571428571428,0.5324260811484586,1.0,4/12,17.84%,NUPR1;IL18;IL33;TTBK1
prerank,microtubule polymerization (GO:0046785),0.6526712552791961,1.5679261764170778,0.042682926829268296,0.48672301886371433,1.0,9/29,7.13%,FGF13;CLASP2;MAP7D3;TUBGCP6;MAPT;TPPP;PIN1;HDGFL3;TPX2
prerank,mitochondrion localization (GO:0051646),0.7038431869959241,1.5670159123470189,0.0421875,0.48713208425700183,1.0,9/19,14.40%,ATP2A1;MARK1;MEF2A;TRAK1;ATCAY;MFN2;NECTIN2;MUL1;LRRK2
prerank,platelet degranulation (GO:0002576),0.5467177303151006,1.5670132356995201,0.013407821229050279,0.4846718212051988,1.0,22/118,7.87%,FLNA;TTN;STXBP2;ACTN1;ACTN4;VCL;ITIH4;CD36;PDGFB;ENDOD1;WDR1;LGALS3BP;TGFB3;TAGLN2;RARRES2;VEGFA;PCDH7;CALM1;TLN1;ITGB3;PLEK;TGFB2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6169559413616574,1.563860659693603,0.03480589022757698,0.492695352899374,1.0,8/44,5.83%,FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;ANO6;KCNN2;ATP1B1
prerank,spinal cord development (GO:0021510),-0.6435045537067782,-1.5636964100697293,0.030303030303030304,0.5466596305091493,1.0,9/12,29.12%,NF1;VIT;GLI2;PKD2;SOX4;LOXL3;SOX11;RELN;SOX12
prerank,regulation of muscle cell differentiation (GO:0051147),0.6518639360065639,1.563643017563864,0.055152394775036286,0.49096507019153796,1.0,4/31,5.32%,MYOCD;MEF2C;HDAC9;MEF2A
prerank,embryonic heart tube morphogenesis (GO:0003143),0.6100426841587582,1.5618657144600903,0.03204272363150868,0.49418100158558587,1.0,4/44,1.52%,RYR2;MEF2C;TBX2;MICAL2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.49618138816241664,-1.5612332235119093,0.02416918429003021,0.5489242490522018,1.0,11/28,17.14%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;IRGM;TAB1;AAMP
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5841234950972435,1.5603575181761455,0.025510204081632654,0.49695675380061194,1.0,6/57,3.81%,FLNA;ADCY5;HTR1B;NPY1R;ADCY2;ADCY9
prerank,detection of mechanical stimulus (GO:0050982),0.6968531099926445,1.55978596117394,0.04487179487179487,0.4963507055991165,1.0,4/19,5.34%,TTN;TCAP;CSRP3;PKD1L3
prerank,regulation of DNA binding (GO:0051101),-0.4440861163571802,-1.5596867589801728,0.01556420233463035,0.5472946138142989,1.0,22/44,27.55%,IGF1;LEF1;HMGB1;HJURP;NFKBIA;ILRUN;PRKN;TGFB1;HES1;SP100;PPARG;KDM1A;MDFI;BCL3;SUMO3;HMGA2;NME1;SMO;TFAP4;MAPK8;HMGB2;EGF
prerank,heart process (GO:0003015),0.7505731775775771,1.5584446646950112,0.05723905723905724,0.49826646100578587,1.0,3/14,1.34%,TRDN;SGCG;MYL2
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5499922418414378,-1.5573146588575957,0.02425876010781671,0.5491239605150366,1.0,9/20,32.39%,WNT4;CRY1;SIK1;EP300;C1QTNF3;CLK2;PGP;NCOR1;CDA
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.593298401607469,1.5566861405706462,0.041499330655957165,0.501513676146973,1.0,8/47,6.96%,FLNA;ARHGEF7;ACTN4;LIMS1;FERMT2;KANK1;LIMS2;CORO1C
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5932806783141923,-1.554319622908855,0.038860103626943004,0.5545211823646422,1.0,6/15,13.93%,GRM3;GRM7;HOMER3;DAGLA;GRIK3;GRM5
prerank,negative regulation of biomineral tissue development (GO:0070168),0.6673702533680245,1.5536832738764177,0.04084720121028744,0.5090448881979606,1.0,6/21,10.88%,ASPN;HEY2;ROCK1;SOX9;TRPM4;ROCK2
prerank,detection of calcium ion (GO:0005513),0.7395222876420023,1.553676407635599,0.0586145648312611,0.5065990166497216,1.0,4/13,7.03%,RYR2;KCNMB1;STIM1;CALM1
prerank,regulation of protein secretion (GO:0050708),0.5364137234157847,1.5528244141006917,0.016741071428571428,0.5070318899524046,1.0,15/119,8.38%,MYOM1;TTN;CACNA1C;RAP1A;ITPR1;KCNA5;TGFB3;CCL5;ALOX5;KCNB1;MYO18A;ENSA;TGFB2;FRMD4A;DPH3
prerank,cellular response to catecholamine stimulus (GO:0071870),0.6598376109372446,1.5527426708070013,0.046546546546546545,0.504864622831478,1.0,8/23,14.88%,RYR2;ATP2B4;GABPA;ADCY6;SIRT2;MAPK1;LRRK2;PRKACA
prerank,lymphocyte proliferation (GO:0046651),0.6713365839614095,1.5525118601143582,0.06041335453100159,0.5032635276419567,1.0,6/22,13.13%,MEF2C;CD79A;BCL2;RASGRP1;LMBR1L;PPP3CB
prerank,UV protection (GO:0009650),-0.6721245373531152,-1.5523810999696315,0.03218390804597701,0.5550469181548384,1.0,7/10,22.59%,SCARA3;ERCC5;CAT;XPA;GPX1;MFAP4;ERCC2
prerank,ceramide biosynthetic process (GO:0046513),-0.458601103557562,-1.5515810456150059,0.014925373134328358,0.5511007983905394,1.0,12/40,10.99%,SGMS1;SGMS2;CERS5;ST8SIA4;ST3GAL5;SPTLC2;ST6GALNAC3;SPTSSA;B4GALT6;CERS6;ASAH2;ST8SIA2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7321293553353205,1.5509309643624127,0.04317789291882556,0.5060255189632219,1.0,5/14,8.13%,DMD;ACTN4;TESC;ATP1B1;WNK2
prerank,aortic valve morphogenesis (GO:0003180),0.6325853770869051,1.5505548547668497,0.03597122302158273,0.504827452633099,1.0,9/30,7.72%,SLIT3;HEY2;ELN;ROCK1;HEYL;JAG1;EMILIN1;SOX9;SNAI2
prerank,calcium-mediated signaling (GO:0019722),0.5470116994529424,1.5496970978581008,0.027315914489311165,0.5055166487139641,1.0,24/93,14.88%,AGTR1;RYR2;CACNA1C;RCAN2;ATP2A2;PLCE1;PPP3CA;EDNRB;SLC8A1;NUDT4;CAMKK2;CXCR6;ATP1B1;RCAN3;TRPM4;SAMD14;HTR2B;DMPK;TRPM2;DMTN;PPP3CB;LRRK2;PPP1R9A;PRKACA
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.7441992038110243,1.5494223071334035,0.05490848585690516,0.5039895431186235,1.0,5/14,5.14%,TPM1;MEF2C;PRKG1;IGFBP5;BMPR1A
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7608456385749394,1.54888023237809,0.06306306306306306,0.5033334571415468,1.0,3/12,1.44%,TRDN;RYR2;CASQ1
prerank,cell differentiation in spinal cord (GO:0021515),0.7747720563398693,1.5479365325327847,0.058823529411764705,0.5039011931079018,1.0,1/10,0.10%,SOX6
prerank,actin filament network formation (GO:0051639),0.7465406240473721,1.5470460853136074,0.07307692307692308,0.5044130148678853,1.0,3/11,3.35%,ACTN1;PLS3;LCP1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5067341966922433,-1.5457349717950004,0.020833333333333332,0.5692826729992084,1.0,13/26,24.31%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;TAB1;AAMP;UBB;CYLD;ALPK1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6748017127343768,1.5446231148812626,0.051696284329563816,0.5101836671560994,1.0,5/23,3.16%,TRDN;CASQ1;CACNA2D1;HRC;CAMK2D
prerank,glycogen catabolic process (GO:0005980),0.7280345961357565,1.5416205305494337,0.06206896551724138,0.5177011253843994,1.0,7/15,8.26%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1
prerank,nucleosome disassembly (GO:0006337),0.7017352061514925,1.5414613242426471,0.07521367521367521,0.5135966308556522,1.0,4/14,6.19%,SMARCD3;ARID1A;SET;SMARCB1
prerank,chromatin disassembly (GO:0031498),0.7017352061514925,1.5414613242426471,0.07521367521367521,0.5135966308556522,1.0,4/14,6.19%,SMARCD3;ARID1A;SET;SMARCB1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.7730370358539571,1.5412093730164766,0.07034220532319392,0.5120592613622272,1.0,1/10,0.08%,PDE3A
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6229407706147344,-1.5405031790729966,0.037914691943127965,0.585525283517964,1.0,8/12,28.39%,LY6E;TRIM5;IFITM1;MID2;SNX3;IFITM3;IFITM2;GSN
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.49862387063338576,-1.5404730501188446,0.0223463687150838,0.5775402611710573,1.0,12/29,13.51%,TJP1;PIK3CA;PLEKHH2;SLIT2;KANK3;SHANK3;CYRIB;PRKN;SSH2;PFN2;PFN1;SSH1
prerank,cation transport (GO:0006812),0.5188014014646496,1.5404331568429717,0.013641133263378805,0.5123398962525668,1.0,27/167,11.35%,KCNAB1;KCNMA1;FGF13;SCN4A;TRPC6;ANO1;KCNJ12;SLC6A17;KCNMB1;ANO6;SLC8A2;SLC8A1;KCNA5;KCNQ4;KCNN2;PKD1L3;KCNH1;ATP1B1;SLC25A29;SLC23A1;ANO10;TRPM4;ABCC8;SLC7A8;PANX1;KCNK3;KCNA2
prerank,regulation of cellular respiration (GO:0043457),0.6821717814467925,1.5399326535002926,0.07401315789473684,0.5117751796278579,1.0,1/17,0.27%,PRDM16
prerank,protein-DNA complex disassembly (GO:0032986),0.6854742813778817,1.5385229378122294,0.07744107744107744,0.5142582380416225,1.0,4/16,6.19%,SMARCD3;ARID1A;SET;SMARCB1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.562420242422804,-1.5380932604480646,0.028350515463917526,0.5804260997055734,1.0,3/19,0.54%,AFDN;BMP6;TJP1
prerank,positive regulation of protein transport (GO:0051222),0.5691964704436265,1.5347249343669798,0.038177339901477834,0.5246676651367658,1.0,9/67,8.37%,MYOM1;TTN;OAZ2;TGFB3;CEP290;MYO18A;CNST;TGFB2;FRMD4A
prerank,cGMP biosynthetic process (GO:0006182),0.7829154127387011,1.5337109528938564,0.05486725663716814,0.5256831814945805,1.0,2/10,3.85%,GUCY1A1;GUCY1B1
prerank,regulation of histone acetylation (GO:0035065),0.6111765422462672,1.5322917909556586,0.04741379310344827,0.5281167848257621,1.0,5/33,9.42%,MYOCD;SET;PPARGC1A;CHEK1;PAXIP1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.6625605068025886,1.5317573056854004,0.07774390243902439,0.5276035616244709,1.0,9/21,13.01%,VCL;ROCK1;ACTG1;PEAK1;DUSP3;CORO1C;DAPK3;ROCK2;CLASP1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6588689038838302,1.5314828315701514,0.05354330708661417,0.5262101866652631,1.0,10/21,15.35%,DMD;CAV1;CNKSR3;GPD1L;PDE4D;DMTN;NCK2;MLXIPL;INPP5J;PTEN
prerank,membrane lipid metabolic process (GO:0006643),-0.5171806598546986,-1.5307161827490092,0.036619718309859155,0.6067021352060722,1.0,7/22,13.95%,AGMO;ST3GAL6;CERK;SERINC1;CYP1B1;ARV1;B4GALT4
prerank,dopamine metabolic process (GO:0042417),-0.5616353831485307,-1.530683229512532,0.04040404040404041,0.5987855740254691,1.0,6/18,14.68%,SNCAIP;MOXD1;MAOA;PRKN;SNCA;GCH1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.4817844237968569,-1.5297474571613263,0.027692307692307693,0.5950769750272443,1.0,7/30,10.97%,SPTBN1;VAMP5;GOLGA4;OPTN;GCC2;GOLPH3;BLZF1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6801883935574364,1.5279560592768624,0.06,0.5359180389154812,1.0,5/17,10.07%,PPP1R12A;ITGA1;CALM1;CD300A;PDGFRB
prerank,epithelial cell-cell adhesion (GO:0090136),0.7443869459613041,1.5268435775617415,0.06434782608695652,0.5374438848092599,1.0,3/11,6.25%,SERPINB8;VCL;ITGB5
prerank,regulation of adenylate cyclase activity (GO:0045761),0.6674757126389711,1.526149374478675,0.07255520504731862,0.5374461906215589,1.0,4/22,3.43%,CAP2;CACNA1C;EDNRB;STIM1
prerank,tight junction assembly (GO:0120192),-0.4349896907825812,-1.524914175392912,0.01276595744680851,0.6102085724132968,1.0,9/49,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;LSR;CLDN11
prerank,regulation of calcium-mediated signaling (GO:0050848),0.6569216982872911,1.5235906435101683,0.06511627906976744,0.5438130084679083,1.0,5/25,7.52%,ITPR1;CDH13;SLC8A2;MAPT;PLEK
prerank,cartilage development (GO:0051216),0.5770692378125281,1.5232279343904118,0.05483028720626632,0.5427274006012797,1.0,5/49,4.91%,SOX6;SOX5;MEF2C;SNORC;OSR2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6517902594346684,1.5186346347350788,0.07142857142857142,0.5565012792031777,1.0,3/25,1.44%,CACNB2;AKAP6;CASQ1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6879207427289998,1.517615369281202,0.08376068376068375,0.557776605193308,1.0,4/17,2.70%,CACNB2;CACNA1C;CACNA2D1;SLC8A1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.508455311477468,-1.5168782740498172,0.04878048780487805,0.641114476075106,1.0,15/23,29.51%,PTCH1;IFT122;MEGF8;TULP3;HERC4;MGRN1;ENPP1;GLIS2;GPR161;BTRC;GPC3;RFX4;RACK1;ULK3;PTCH2
prerank,negative regulation of defense response to virus (GO:0050687),-0.6489107750522036,-1.5156784024910408,0.04666666666666667,0.6383233108519663,1.0,4/10,7.41%,ITCH;PPM1B;ILRUN;PCBP2
prerank,myeloid leukocyte differentiation (GO:0002573),-0.39797318935423764,-1.5142869572134814,0.026881720430107527,0.6369421114027414,1.0,13/65,7.12%,LEF1;GAB2;FOXP1;IL31RA;PIR;IL15;MAPK14;BMP4;KIT;SBNO2;LGALS9;PML;CASP8
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6856319352274183,1.5138178443661867,0.08609271523178808,0.5687452531435285,1.0,5/17,8.52%,NOTCH3;PLXND1;HEYL;MAML2;MAML3
prerank,N-glycan processing (GO:0006491),-0.5636857946030296,-1.511825771146316,0.04834605597964377,0.6410350352296498,1.0,9/18,12.18%,MAN1C1;ST8SIA4;ST8SIA1;FUT8;MGAT4B;GANAB;MAN2A1;ST8SIA2;GNPTAB
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.47435065897605505,-1.5112816068071535,0.0231023102310231,0.6359618462326356,1.0,15/30,18.96%,TGFBR3;SMAD3;FSTL1;DKK3;ENG;LTBP4;LATS2;FKBP1A;SMURF2;SFRP4;TGFB1;TRIM33;SMAD2;SMAD4;TWSG1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5343634178179731,-1.5109913304248086,0.043243243243243246,0.6298753017318618,1.0,8/20,18.19%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;NUMB;TMBIM1
prerank,cytoskeleton organization (GO:0007010),0.5236841975470804,1.5106816181270315,0.026845637583892617,0.5775513768922992,1.0,15/114,4.93%,PALLD;TPM1;WTIP;MAST4;MICAL2;PLCE1;LIMD1;CNN2;DES;PACSIN3;PACSIN2;RHOBTB3;ARHGAP10;DST;MARK1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6888514239690917,1.5095386104886988,0.07777777777777778,0.5793111353001281,1.0,2/17,0.77%,NTF3;NTRK3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6191401291812633,1.5075395479222524,0.06906474820143885,0.5839768969344252,1.0,6/31,7.87%,TPM1;RYR2;MYL2;MYL3;BMPR1A;TGFB2
prerank,ganglion development (GO:0061548),-0.6229304004991129,-1.5075124738070915,0.048458149779735685,0.6390958074685109,1.0,4/11,7.31%,NRP2;NRP1;CTNNB1;SEMA3A
prerank,positive regulation of glucose import (GO:0046326),-0.5296447179177435,-1.5070659911298019,0.04619565217391304,0.6339334053831506,1.0,10/21,16.74%,IGF1;OSBPL8;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,microtubule polymerization or depolymerization (GO:0031109),0.6236846798139469,1.5069253338750919,0.0830860534124629,0.5837489602254675,1.0,7/25,6.90%,FGF13;KIF2A;MAP7D3;MAPT;TPPP;PIN1;HDGFL3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6320439416900417,1.5068114347218418,0.060514372163388806,0.581693685971519,1.0,5/28,6.25%,ATP2A1;MAP3K5;ITPR1;BCL2;DAB2IP
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.6708110875836764,1.5067181294303078,0.07223113964686999,0.5795388185979489,1.0,4/20,4.50%,ATP2A1;ATP2A2;CAMK2D;BCL2
prerank,positive regulation of phosphatase activity (GO:0010922),0.6566190877491388,1.5057997128868876,0.06732348111658457,0.58044280099919,1.0,6/21,10.07%,MEF2C;ITGA1;CALM1;PLEK;CD300A;PDGFRB
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6267211622871537,1.5051469555054002,0.07396449704142012,0.5804192157996321,1.0,2/27,0.65%,AGTR1;GPR20
prerank,cardiac muscle cell contraction (GO:0086003),0.667618671533583,1.5048313254446377,0.07037643207855974,0.5791416738448512,1.0,3/19,3.16%,CACNA1C;CACNA2D1;CAMK2D
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.49658212486020115,-1.504149856883407,0.04451038575667656,0.6402893242995789,1.0,9/24,18.86%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;NUMB;TMBIM1;ITGB1BP1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5897093505189686,-1.5039543833574165,0.04578313253012048,0.6338505579522865,1.0,8/14,29.18%,SULF1;SPRY2;CREB3L1;FGF2;GPC1;SULF2;SPRY4;SPRY1
prerank,cellular metal ion homeostasis (GO:0006875),0.5236485297045076,1.5035672665805653,0.0362400906002265,0.5811930246824548,1.0,15/102,7.87%,TRDN;KCNMA1;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;STIM1;CCL5;ATP1B1;CAV1;RMDN3;ATP2B1
prerank,glycogen metabolic process (GO:0005977),0.6327146842345127,1.5024830691690678,0.06800618238021638,0.5825727354426198,1.0,11/27,12.41%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1;NR1D1;NHLRC1;GYS1;PHKA1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.6745333061930494,1.502134689603939,0.07911392405063292,0.5791429747359625,1.0,5/20,6.01%,BCAT2;MCCC2;HSD17B10;HIBADH;DLD
prerank,branched-chain amino acid metabolic process (GO:0009081),0.6745333061930494,1.502134689603939,0.07911392405063292,0.5791429747359625,1.0,5/20,6.01%,BCAT2;MCCC2;HSD17B10;HIBADH;DLD
prerank,regulation of calcium ion import (GO:0090279),0.6588390987136405,1.5019539350015065,0.0746031746031746,0.5774339621238112,1.0,2/21,2.09%,PLN;PDGFB
prerank,cardiac muscle cell action potential (GO:0086001),0.6216601081064314,1.5018811821918145,0.07153502235469449,0.5753943219661888,1.0,6/30,5.83%,DMD;CACNA1C;CACNA2D1;SLC8A1;SLC4A3;ATP1B1
prerank,RNA stabilization (GO:0043489),0.612275202489994,1.5017391246181648,0.062326869806094184,0.5736197104215673,1.0,9/33,10.29%,RBM24;TENT5B;TRDMT1;PARN;CIRBP;GDNF;NAF1;FUS;HNRNPU
prerank,positive regulation of ruffle assembly (GO:1900029),-0.6011449375768939,-1.5012696347287235,0.035629453681710214,0.6396211458416183,1.0,11/13,37.24%,EPS8;NLGN1;PLEKHM1;PFN1;EPS8L2;EPS8L1;NDEL1;DEF8;HRAS;FAM98A;P2RY12
prerank,inhibitory synapse assembly (GO:1904862),0.7294910510365856,1.5006110368443168,0.09330985915492958,0.5752518369551777,1.0,5/11,11.99%,FGF13;PLXNB1;GABRB2;CBLN4;GABRB3
prerank,positive regulation of dendrite development (GO:1900006),-0.6349687986973799,-1.4993349194263603,0.05172413793103448,0.6417142613727592,1.0,6/10,13.61%,PTN;COBL;BMP7;ZDHHC15;ALK;LRP8
prerank,regulation of focal adhesion assembly (GO:0051893),0.567335699429265,1.4990357584405785,0.05754475703324808,0.5783927333697796,1.0,14/54,8.19%,DLC1;VCL;ROCK1;LIMS1;FERMT2;PHLDB2;CLASP2;ACTG1;PEAK1;ARHGAP6;DUSP3;VEGFA;CORO1C;DAPK3
prerank,positive regulation of vasoconstriction (GO:0045907),0.7110614348376647,1.4979558769583137,0.09739130434782609,0.5800363798832905,1.0,5/13,19.22%,ADRA1D;CAV1;TRPM4;TBXA2R;ADRA1A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.6436052425865466,1.497673396433892,0.06614173228346457,0.5787650584766776,1.0,5/24,11.19%,PDE3A;CGAS;PEX5L;PRKAR1B;PDE4D
prerank,cGMP metabolic process (GO:0046068),0.7317984369428219,1.4973256271026192,0.07082630691399663,0.5777371005931835,1.0,2/12,3.85%,GUCY1A1;GUCY1B1
prerank,dicarboxylic acid transport (GO:0006835),-0.48327523969617764,-1.49607585751699,0.03614457831325301,0.6494947020511325,1.0,7/28,7.83%,SLC1A3;SLC13A3;PDPN;GJA1;SLC26A7;SLC25A32;SLC22A6
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5497930898585708,1.495960867848516,0.04140526976160602,0.5800833977900968,1.0,16/70,11.20%,NTN4;ITGA8;ACTN1;MEF2C;LAMA5;FERMT2;PEAK1;LAMC1;LAMB2;YTHDF2;ITGB3;ITGA4;EPHA2;PARVA;TBCD;RB1
prerank,protein autoprocessing (GO:0016540),0.6829047609031729,1.495683751942193,0.085,0.5787913944700922,1.0,3/17,6.32%,HJV;FXN;AFG3L2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6491414069687506,1.494939399877119,0.0734375,0.5790484015997194,1.0,1/22,0.09%,CCDC3
prerank,skeletal system morphogenesis (GO:0048705),-0.4400330449059945,-1.4947772765793448,0.041379310344827586,0.6480282272408256,1.0,13/42,11.76%,PDGFRA;HOXB3;FBN2;HOXA3;CYP26B1;DSCAML1;WWOX;HOXB4;MEGF8;SFRP4;FGFR2;SIX1;TGFBR1
prerank,myotube differentiation (GO:0014902),0.6850187559975418,1.494654930441733,0.07792207792207792,0.5777840977972573,1.0,6/17,5.58%,MEF2C;KLHL40;CACNA1H;ADAMTS5;SORT1;KCNH1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6250661431128437,1.4932473048731751,0.0911854103343465,0.580438351730989,1.0,5/26,7.03%,KCNAB1;ITGB1;FHL1;ATP1B1;NEDD4
prerank,chondrocyte differentiation (GO:0002062),0.6085959506675882,1.4932073166943034,0.08211143695014662,0.5783690645168302,1.0,3/32,0.71%,SOX6;SOX5;MEF2C
prerank,positive regulation of cytokinesis (GO:0032467),-0.46682434615650287,-1.4923327069452315,0.03594771241830065,0.6521003715115321,1.0,12/32,21.43%,PKP4;CDC14B;CUL3;SPAST;PRKCE;CDC25B;GIPC1;CIT;CDC42;SVIL;CSPP1;DRD2
prerank,aortic valve development (GO:0003176),0.6022183853868731,1.4913872331679314,0.04892086330935252,0.5826722110154626,1.0,9/34,7.72%,SLIT3;HEY2;ELN;ROCK1;HEYL;JAG1;EMILIN1;SOX9;SNAI2
prerank,regulated exocytosis (GO:0045055),0.5030920707741375,1.4907316784237072,0.01689545934530095,0.5826730239893575,1.0,28/173,7.97%,FLNA;TTN;STXBP2;ACTN1;ACTN4;VCL;ITIH4;CD36;PDGFB;ENDOD1;MYH9;WDR1;LGALS3BP;TMEM79;TGFB3;TAGLN2;RIMS3;SYT10;RARRES2;VEGFA;PCDH7;CALM1;TLN1;RAB3A;ITGB3;PLEK;TGFB2;ARHGAP17
prerank,regulation of potassium ion transport (GO:0043266),0.616771705014128,1.490017983684289,0.07981927710843373,0.5828790158001992,1.0,6/31,7.79%,KCNAB1;KCNA5;FHL1;KCNN2;KCNIP3;KIF5B
prerank,protein localization to cilium (GO:0061512),-0.47165351888319507,-1.4895961053722768,0.012012012012012012,0.657985242884066,1.0,18/32,37.14%,BBS9;ZNF423;RABEP1;IFT122;TULP3;RAB29;EHD1;TCTN2;BBS1;TCTN1;BBS4;ARL6;TULP1;CSNK1D;ATP6V1D;IFT20;TMEM107;INVS
prerank,granulocyte differentiation (GO:0030851),-0.541498465002279,-1.489220750689786,0.059850374064837904,0.6527150772820064,1.0,11/18,30.44%,LEF1;LBR;PML;EP300;RARA;CBFA2T3;CDK2;TAL1;CDKN1A;RXRA;E2F1
prerank,BMP signaling pathway (GO:0030509),-0.3904977536212058,-1.4886061298034317,0.009708737864077669,0.6487836564289113,1.0,17/62,10.60%,BMP6;TGFBR3;SMAD3;DDX5;BMP7;BMP4;SMAD6;ENG;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;SMAD9;TMEM100;TGFB1;PDCD4
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.39378524540896426,-1.4885786468206696,0.015151515151515152,0.642209584912997,1.0,20/67,14.90%,FLT1;PDGFRA;EFEMP1;IL15;KIT;GHR;EPHA4;TEK;EGFR;PTK2;ABI1;EPHA3;PTK2B;ABL2;FGFR2;LYN;PRLR;KDR;INSR;PKDCC
prerank,neural tube development (GO:0021915),-0.5614632225721128,-1.4878629731114306,0.05426356589147287,0.6385646983130545,1.0,5/15,12.07%,ALDH1A2;PTCH1;PKD2;TGFB1;SOX4
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.7522297006689465,1.4872853043876868,0.0686456400742115,0.5899486527656616,1.0,4/10,10.25%,CACNB2;CACNA2D1;CALM1;SRI
prerank,peripheral nervous system development (GO:0007422),0.6383272828196308,1.4868909618297053,0.07378335949764521,0.5889822534329241,1.0,2/23,0.99%,NTF3;SERPINI1
prerank,response to fatty acid (GO:0070542),0.6692844900095872,1.4860127642840018,0.08460236886632826,0.589757896489483,1.0,6/17,7.69%,NR1H4;CD36;PDK4;LPL;IRS1;SOX9
prerank,sensory perception of sound (GO:0007605),-0.3801351968893806,-1.4836693221337272,0.02564102564102564,0.6513084673939566,1.0,17/88,9.93%,EYA1;COL1A1;CEMIP;ADGRV1;KIT;COL11A1;USP53;GRM7;GSDME;COL4A3;DCDC2;ATP6V0A4;ALDH7A1;EML2;WHRN;RIPOR2;CLIC5
prerank,macrophage chemotaxis (GO:0048246),0.7323211310923037,1.483519785516632,0.11846689895470383,0.5962727621458408,1.0,2/10,3.64%,EDNRB;CCL5
prerank,positive regulation of wound healing (GO:0090303),0.5863896615428711,1.4822797242300358,0.06740027510316368,0.5984662916337946,1.0,6/36,3.63%,MYLK;FERMT2;ANXA1;KANK1;ACTG1;ITGB1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6227418799092372,1.4822135323528787,0.08244274809160305,0.5965463522960628,1.0,8/26,13.13%,ANO1;ADCY5;NR1H4;KLF7;TRPM4;NR1D1;LRP5;PPP3CB
prerank,thyroid hormone generation (GO:0006590),0.7395342883550375,1.4821320817737114,0.09578544061302682,0.5946437088537719,1.0,2/10,7.66%,TG;DIO2
prerank,cellular response to drug (GO:0035690),0.6262487228672693,1.480162676809541,0.08181818181818182,0.5991869038048678,1.0,6/25,9.86%,MEF2C;HTR1B;PPM1E;TP53;CERS1;RAP2A
prerank,positive regulation of heart contraction (GO:0045823),0.6625601390120028,1.479592712833995,0.07890499194847021,0.5989361666284513,1.0,5/19,8.74%,RYR2;HRC;ATP2A2;TGFB2;TRPM4
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4550935508867333,-1.4790576140487157,0.028368794326241134,0.6663772752311684,1.0,10/33,13.19%,MCC;DCN;PTPRG;SLIT2;APOE;ACVRL1;PTPRM;ADAMTS9;SP100;PFN2
prerank,negative regulation of complement activation (GO:0045916),-0.6337153494294003,-1.4786263885144761,0.07158836689038031,0.6617399825021872,1.0,6/10,32.51%,CD55;CD46;SERPING1;A2M;CR1L;CR2
prerank,positive regulation of phospholipase activity (GO:0010518),0.6535002375116602,1.4782939595995213,0.0911854103343465,0.6013872599910973,1.0,4/22,3.64%,NTF3;AGTR1;NTRK3;CCL5
prerank,V(D)J recombination (GO:0033151),-0.6183870088336927,-1.4780572192362456,0.049217002237136466,0.6575328083989501,1.0,8/11,35.64%,HMGB1;PRKDC;LIG3;DCAF1;LIG1;HMGB2;TCF3;LIG4
prerank,positive regulation of secretion by cell (GO:1903532),0.554284217150097,1.4780090108429205,0.04797047970479705,0.6003059188106996,1.0,10/70,8.37%,MYOM1;TTN;CLASP2;TGFB3;UNC13D;KCNB1;MYO18A;RAB3A;TGFB2;FRMD4A
prerank,acidic amino acid transport (GO:0015800),-0.5336922514336127,-1.4777665735876426,0.05759162303664921,0.6525187129386604,1.0,5/17,3.81%,SLC6A13;SLC1A3;GJA1;SLC6A1;SLC6A6
prerank,regulation of interleukin-13 production (GO:0032656),-0.5829195562972831,-1.477504059841715,0.055944055944055944,0.6472702562665104,1.0,3/13,5.31%,LEF1;IL18;LGALS9
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5172815120373792,-1.4766954326220083,0.059431524547803614,0.644705677815914,1.0,8/21,12.95%,PRKCB;FOXP1;ELF1;PRKCH;SLC39A10;PTPN22;LYN;ELF2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3842826423028819,-1.476057162525928,0.01098901098901099,0.6412473996306017,1.0,24/74,19.26%,EYA2;IGF1;EYA1;EYA4;SH3RF1;TCF7L2;BMP4;DDX3X;ITGA6;BIRC6;TNFSF10;ITGAV;CASP8;BCL2L1;NOS3;RNF34;TGFBR1;FAIM;AKT1;GPX1;SERPINE1;SIAH2;TMBIM1;PARK7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6340993791106981,1.475491460646212,0.07313195548489666,0.6067540869521559,1.0,11/23,12.26%,TUBA1C;HOOK2;KIF1A;F8A1;KIF5B;HOOK1;KIF1C;DYNC1I2;KIF5C;MYO10;KIF5A
prerank,peptidyl-tyrosine modification (GO:0018212),-0.4049027266936701,-1.4733496599873772,0.01282051282051282,0.6471687108293853,1.0,23/56,22.00%,FLT1;PDGFRA;EFEMP1;KIT;EPHA4;TEK;EGFR;PTK2;ABI1;EPHA3;PTK2B;TPST1;ABL2;FGFR2;LYN;KDR;INSR;PKDCC;TTBK1;ABI2;FGFR4;FLT4;EPHB2
prerank,amide transport (GO:0042886),-0.48363760654926485,-1.4723907411292876,0.05504587155963303,0.6450954066878711,1.0,9/26,21.79%,ABCG2;PDPN;PLTP;SLC25A32;CERT1;PLEKHA3;SLC38A5;ABCB9;TAP1
prerank,negative regulation of developmental process (GO:0051093),0.5353752257031502,1.4700839246627506,0.0647921760391198,0.6236356867440797,1.0,17/69,14.01%,HEY2;TBX2;ROCK1;ALPK2;CDK6;LOXL2;KANK1;PTPRS;KLF7;MAPT;SOX9;ROCK2;MUL1;FOXJ1;GAS6;ADCK1;HOPX
prerank,blood vessel diameter maintenance (GO:0097746),0.6032528356236134,1.4699955641297844,0.06862745098039216,0.6217004604383213,1.0,4/34,2.26%,AGTR1;EDNRA;ROCK1;EDNRB
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.6740040707334859,1.4693629372470067,0.06788079470198675,0.6216896195367995,1.0,6/17,7.06%,CACNA1H;SLC4A8;UNC13D;SYT10;KCNB1;RAB3A
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5716043999149897,1.4686912907369971,0.07104557640750671,0.6217821217481981,1.0,10/42,8.34%,ROCK1;CD36;LIMS1;CDK6;FERMT2;CDH13;UTRN;RRAS;VEGFA;RIN2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5802530539447692,-1.4686590753880846,0.08120649651972157,0.6563150902433492,1.0,7/13,23.98%,NUPR1;SCFD1;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6361747136597766,1.4678802745541382,0.0891238670694864,0.6224045757833284,1.0,3/23,2.58%,TPM1;MYL2;MYL3
prerank,sulfate transport (GO:0008272),-0.5714148944501942,-1.467263208083834,0.07142857142857142,0.656509052576379,1.0,6/14,17.15%,SLC13A4;SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11
prerank,SNARE complex assembly (GO:0035493),-0.6100374306686275,-1.4668142192316649,0.07207207207207207,0.6525437047641772,1.0,5/10,20.20%,STXBP1;SNCA;VAMP8;UVRAG;VAMP1
prerank,positive regulation of cell development (GO:0010720),0.6046397857740352,1.4663234364639743,0.0830945558739255,0.6258554722119555,1.0,2/31,1.60%,PDE3A;LMOD3
prerank,cellular response to organic cyclic compound (GO:0071407),0.5102025725585503,1.465735407258137,0.03271537622682661,0.6256993775000801,1.0,28/141,13.21%,PDE3A;MEF2C;RAP1A;AKAP6;ADCY5;NR1H4;PDGFB;ADCY2;ABCB4;RORA;P2RY2;IGFBP5;CCL5;ACTB;TAF1;ARL6IP5;AR;MED1;IMPACT;GABRB2;ADCY6;GPER1;ROCK2;GABRB3;TRPM2;HCN2;DMTN;ZFP36L1
prerank,T-helper cell differentiation (GO:0042093),-0.5747651402672457,-1.4646125578774005,0.07398568019093078,0.6562390211734044,1.0,3/14,1.71%,LEF1;FOXP1;HMGB1
prerank,phasic smooth muscle contraction (GO:0014821),0.7367777797798761,1.4638368782965867,0.11151736745886655,0.6301109183040353,1.0,4/10,11.69%,PTGER3;EDNRB;GDNF;HTR2B
prerank,negative regulation of ion transport (GO:0043271),0.6307652201395839,1.4629052603454604,0.08761329305135952,0.631235050970114,1.0,7/24,9.98%,PLN;HTR1B;PACSIN3;NEDD4;WNK2;HRH3;ACTN2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7475354469736545,1.4604612352960058,0.0944741532976827,0.6377397752497319,1.0,4/10,11.24%,PFKP;HK2;GFPT1;PFKM
prerank,glucose transmembrane transport (GO:1904659),0.6638368104756279,1.4602153911772517,0.0782312925170068,0.6363670889719486,1.0,4/18,6.46%,SLC2A4;SLC5A3;SORT1;SLC2A10
prerank,embryonic digit morphogenesis (GO:0042733),0.6372627952341023,1.4590402855518652,0.11844331641285956,0.6384751772006352,1.0,3/18,4.91%,MAP3K20;TBX2;OSR2
prerank,xenobiotic transport (GO:0042908),-0.5311634647654078,-1.4589925012618765,0.05432098765432099,0.6758054201558139,1.0,6/17,13.69%,ABCG2;SLC47A1;GJA1;SLC7A5;SLC22A4;SLC22A18
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6467916580154158,-1.4586931535017102,0.04962779156327544,0.6713783785876323,1.0,6/10,20.21%,LRP1;APOD;SNCA;HGS;NDRG4;PTPN2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5489069575572162,1.4583890777831263,0.060075093867334166,0.6385638527523358,1.0,5/53,4.27%,LHCGR;HTR1B;NPY1R;ANXA1;TSHR
prerank,neuromuscular junction development (GO:0007528),0.6167913701678984,1.4579014621820772,0.07828655834564253,0.6382497905736284,1.0,7/24,7.03%,CACNB2;PDZRN3;MUSK;CACNB4;DOK7;PPFIBP2;NEDD4
prerank,membrane depolarization during action potential (GO:0086010),0.6250532483627704,1.4577299211571133,0.09662576687116564,0.6366858355756481,1.0,4/26,2.70%,SCN4A;CACNA1C;CACNA1H;SLC8A1
prerank,mitotic spindle assembly (GO:0090307),0.5648031108524821,1.4573026622779266,0.0850480109739369,0.6360737104814755,1.0,11/42,10.70%,FLNA;CLASP2;KIF2A;TOGARAM2;KIF3B;TPX2;PIBF1;TOGARAM1;CEP192;WRAP73;AAAS
prerank,protein monoubiquitination (GO:0006513),-0.44611966515979706,-1.457006435559115,0.04276315789473684,0.6731783088517445,1.0,13/36,15.21%,CUL3;RNF20;KLHL12;UBE2D3;CTR9;TOPORS;TRIM25;PRKN;MGRN1;KLHL22;DTX3L;LEO1;OBI1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.7158038596614981,1.4567548560583337,0.1146384479717813,0.6358390933039976,1.0,4/11,13.98%,TRDN;LPCAT3;STX18;BNIP1
prerank,amino acid import across plasma membrane (GO:0089718),-0.48808778730441177,-1.456320782179708,0.046012269938650305,0.6706644857798572,1.0,8/24,9.67%,SLC6A13;SLC1A3;SLC47A1;SLC6A6;SLC3A2;SLC7A5;SLC6A9;SLC22A4
prerank,negative regulation of organelle assembly (GO:1902116),-0.44530713628894236,-1.4558787228196166,0.0498220640569395,0.6671275429651754,1.0,19/35,29.36%,NUPR1;LIMK2;CEP97;TBC1D30;MDM1;SMAD4;SCFD1;ODF2L;NBDY;TBC1D7;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23;CCP110;KAT2A;TESK1;STYXL1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4786598493557748,-1.4554531885030526,0.07763975155279502,0.6632079821931091,1.0,9/24,5.55%,ROBO1;SEMA3C;NRP2;BMP4;SMAD6;NRP1;ENG;ZFPM2;BMPR2
prerank,regulation of acrosome reaction (GO:0060046),0.7269361112267049,1.4550089775163046,0.10948905109489052,0.6399086450558508,1.0,2/10,8.05%,CACNA1H;PLCB1
prerank,positive regulation of protein depolymerization (GO:1901881),0.6962781067567952,1.4526199534336257,0.08950086058519793,0.646038371848603,1.0,4/11,8.02%,SEMA5A;WDR1;PLEK;CFL2
prerank,vasodilation (GO:0042311),0.6936186345496054,1.45233364167346,0.100169779286927,0.644954151941738,1.0,1/13,0.29%,KCNMA1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.49129990025623677,-1.4503397771704893,0.06301369863013699,0.6801827878859775,1.0,5/21,9.32%,PRKCB;FOXP1;PRKCH;SLC39A10;IKBKG
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6219282083084587,1.4500488116075896,0.0898021308980213,0.6508345631450105,1.0,2/26,0.28%,PLN;TRDN
prerank,regulation of microtubule nucleation (GO:0010968),0.7259011948312387,1.4500252346695237,0.11327433628318584,0.6487614198876175,1.0,1/10,0.35%,ARHGEF7
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5040907720739798,-1.4497736981352225,0.0653950953678474,0.6770906577854239,1.0,7/18,20.93%,UNC13C;UNC13B;GRIK3;SLC17A6;GRID2;GRIK1;SLC1A4
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6775547299059939,1.4489853618819908,0.10638297872340426,0.6503074364683086,1.0,6/13,18.01%,HEY2;TAF1;TMSB4X;SIN3A;MAD2L2;DDIT3
prerank,negative regulation of transmembrane transport (GO:0034763),-0.6056651398642214,-1.4484954454634122,0.07789473684210527,0.6767598911247206,1.0,3/10,15.79%,PRKCB;CTTNBP2NL;AKT1
prerank,ceramide metabolic process (GO:0006672),-0.4107135453935228,-1.4484617107074746,0.037815126050420166,0.6713128902964265,1.0,11/49,9.94%,SGMS1;SGMS2;CERS5;CERK;SPTLC2;ST6GALNAC3;PPP2CA;SPTSSA;ACER2;CERS6;ASAH2
prerank,acetyl-CoA metabolic process (GO:0006084),0.660056874998874,1.447701637978327,0.12333333333333334,0.6527507301235301,1.0,4/15,8.58%,ACSS1;NUDT7;ACACB;MVD
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5787565787281107,1.4466533809285655,0.10112359550561797,0.65438170535718,1.0,11/32,14.27%,FGF13;TRIM54;CLASP2;ARHGEF2;DYRK1A;HDGFL3;TPX2;TBCD;CLIP3;CLASP1;STMN2
prerank,regulation of monooxygenase activity (GO:0032768),-0.4849257414097077,-1.4462424665224651,0.056338028169014086,0.6761435968044979,1.0,13/23,21.38%,POR;EGFR;NOS1AP;LYPLA1;NOSTRIN;NOS3;DDAH1;SNCA;AKT1;NOSIP;DDAH2;CYGB;SPR
prerank,protein localization to cell surface (GO:0034394),0.603426691733187,1.4461165726977752,0.10413476263399694,0.6542199517342652,1.0,4/26,4.90%,FLNA;ANGPT1;VCL;JAM3
prerank,purine ribonucleotide transport (GO:0015868),-0.5377697108431954,-1.4451201592942746,0.055825242718446605,0.6755603923493303,1.0,10/16,36.42%,SLC25A17;ABCC4;LRRC8D;LRRC8A;ABCC5;SLC25A24;SLC35B2;SLC17A9;SLC25A4;SLC19A1
prerank,negative regulation of calcium ion transport (GO:0051926),0.6741086780467971,1.4444521362809992,0.10552763819095477,0.6580416658531347,1.0,2/15,2.84%,PLN;PACSIN3
prerank,peptidyl-threonine modification (GO:0018210),0.5282627154601482,1.4440177272782515,0.06265356265356266,0.6574762970594433,1.0,27/66,18.88%,MYLK2;ROCK1;DYRK2;CAMK2D;GALNT16;DYRK1A;TAF1;DYRK1B;CHEK1;MAP3K10;MAP2K1;ROCK2;PRKCD;GALNT3;ACVR1B;GALNT2;CDC42BPB;MAPK1;GALNT1;LRRK2;PRKCA;HIPK2;MARK2;GALNT11;GALNTL6;PRKD1;ULK1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6297189467079654,1.4438116112742867,0.07739938080495357,0.6561315648317367,1.0,6/22,6.59%,LMCD1;ROCK1;MLIP;CAMK2D;MEF2A;PARP1
prerank,negative regulation of protein depolymerization (GO:1901880),0.6042560290426159,1.4424585661258018,0.10076335877862595,0.6588665091668783,1.0,6/24,7.13%,FGF13;TRIM54;CLASP2;ARHGEF2;HDGFL3;TPX2
prerank,acylglycerol metabolic process (GO:0006639),0.5860925596388173,1.4423836562478232,0.09115646258503401,0.6569955087385261,1.0,9/37,13.68%,DGKB;DGKG;LPL;CAV1;MGLL;DGKD;DGAT1;PNPLA3;DGKZ
prerank,regulation of wound healing (GO:0061041),0.5587868719484064,1.4421113179632163,0.07402597402597402,0.6558620585212341,1.0,8/42,6.77%,MYLK;ANXA1;KANK1;ACTG1;ITGB1;ALOX5;CAV1;AJAP1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.45668878008380476,-1.4416351643391117,0.058823529411764705,0.6863693919980433,1.0,11/29,18.54%,IL31RA;IFNAR2;IL15;GHR;PKD2;SOCS2;CTR9;STAT2;IFNAR1;STAT5A;STAT6
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6235964570135566,1.44089546160639,0.09437086092715231,0.658111940043869,1.0,5/20,11.08%,PLN;CAMK2D;NEDD4;ACTN2;GOPC
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7035502958423956,1.4406810916169595,0.1146384479717813,0.6566815208276412,1.0,5/11,11.60%,DLC1;PTGIS;TP53;SIRT2;BOK
prerank,relaxation of cardiac muscle (GO:0055119),0.6765935429057732,1.4404464742912333,0.11170212765957446,0.6554754866548216,1.0,4/13,5.83%,PLN;SLC8A1;CAMK2D;ATP1B1
prerank,cellular response to growth factor stimulus (GO:0071363),0.4949088680432504,1.4403862475573546,0.03763440860215054,0.6536245196969064,1.0,26/151,7.90%,PDE3A;SOX6;SOX5;HJV;MEF2C;RAP1A;NTRK3;LIMS1;PDGFB;NR4A1;ANXA1;CCL5;ACVR2A;BMPR1A;MTSS2;HAS2;MAPT;DAB2IP;MAPKAPK2;DUSP3;VEGFA;MED1;GAREM1;SOX9;SNAI2;RELA
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.6241743637960825,-1.4397992200441752,0.06818181818181818,0.6891163137941091,1.0,3/10,16.13%,IL18;LGALS9;RARA
prerank,response to glucocorticoid (GO:0051384),0.61548795346993,1.4393270549247068,0.09431137724550898,0.6555466087912327,1.0,6/26,14.27%,SLIT3;ANXA1;GOT1;HNRNPU;ZFP36L1;PDCD7
prerank,positive regulation of protein secretion (GO:0050714),0.5253973041176329,1.4383265808357772,0.06947890818858561,0.6572404553666893,1.0,2/69,0.37%,MYOM1;TTN
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.609895216713402,-1.4370052083442655,0.08237986270022883,0.6961489998935319,1.0,5/11,24.68%,DAB2;RDX;PRKN;EIPR1;MTMR2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.40631194831643797,-1.4368067359254877,0.036101083032490974,0.6914746155418235,1.0,23/47,22.34%,BMP7;CARM1;MEDAG;ASXL2;SOX13;NOCT;TMEM64;NAPEPLD;SIX1;CREBL2;AAMDC;CREB1;PTGS2;CEBPB;AKT1;TFE3;PPARG;LMO3;CDS1;ZC3H12A;METRNL;SYAP1;CCDC71L
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.4984244128723415,1.4367944340600725,0.05821917808219178,0.6605383180288334,1.0,22/107,12.39%,TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;STIM1;CCL5;ATP1B1;CAV1;RMDN3;ATP2B1;PTH1R;SLC30A5;ATP2A3;CCL14;SLC39A14;HTR2B;DMPK;CHRNA7
prerank,oligodendrocyte differentiation (GO:0048709),0.6395842646764512,1.435971538527556,0.07570977917981073,0.6614126400902045,1.0,3/19,7.69%,SOX6;TPPP;SOX9
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.37939477049394355,-1.4339160142651615,0.0375,0.699078539661709,1.0,17/85,9.93%,EYA1;COL1A1;CEMIP;ADGRV1;COL11A1;USP53;GRM7;GSDME;COL4A3;DCDC2;ATP6V0A4;ALDH7A1;EML2;WHRN;RIPOR2;PIEZO2;CLIC5
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.6059179842258837,1.432657558673459,0.09465648854961832,0.671146653080835,1.0,5/25,5.28%,NDST3;CSGALNACT1;EXT2;HS2ST1;HAS2
prerank,cellular response to BMP stimulus (GO:0071773),-0.3707700784361727,-1.4309394437281187,0.014925373134328358,0.7074413631112649,1.0,17/66,10.60%,BMP6;TGFBR3;SMAD3;DDX5;BMP7;BMP4;SMAD6;ENG;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;SMAD9;TMEM100;TGFB1;PDCD4
prerank,embryonic heart tube development (GO:0035050),0.6708833149766871,1.4300883551157875,0.11754966887417219,0.6783980474262657,1.0,2/14,1.35%,RYR2;TBX2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5477429772108432,1.429701108374076,0.092,0.6776937635173499,1.0,5/48,2.58%,FLNA;ARHGEF7;LIMS1;FERMT2;SS18L2
prerank,calcium ion transmembrane transport (GO:0070588),0.5117461137662852,1.4296687957277527,0.06855791962174941,0.6757237493723751,1.0,15/86,8.90%,ATP2A1;CACNA1C;ATP2B4;TRPC6;CACNA2D1;ATP2A2;ANO6;SLC8A2;SLC8A1;GRIN2C;AFG3L2;TRPV2;ATP2B1;TRPM4;TRPC5
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6674495130170218,1.42960942887952,0.11056105610561057,0.6738278978884715,1.0,3/16,3.85%,GUCY1A1;CD36;GUCY1B1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6898714680495788,1.42932912075479,0.12477064220183487,0.6726493204482646,1.0,2/11,2.43%,ATP2B4;MLIP
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6550858740833431,1.4289750543477913,0.1111111111111111,0.6718843472210555,1.0,5/16,6.59%,AKAP6;ROCK1;CAMK2D;MEF2A;PARP1
prerank,telomere capping (GO:0016233),-0.5478409216504219,-1.4277954559515433,0.0775,0.7164549431321084,1.0,14/16,35.55%,PRKDC;STN1;MRE11;RAD50;NBN;CTC1;TERF2IP;DCLRE1A;DCLRE1B;TINF2;TEN1;ACD;TFIP11;DCLRE1C
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.45806154170630875,-1.4273705930177147,0.06267029972752043,0.7130633861606993,1.0,10/25,11.27%,ATXN3;CUL3;RNF185;NGLY1;DERL1;UFD1;ZER1;UGGT2;ZYG11B;STUB1
prerank,modification-dependent protein catabolic process (GO:0019941),-0.3108429984284961,-1.42582226736497,0.0,0.7142306706611169,1.0,64/193,19.45%,TTC3;NEDD4L;ARRB1;FBXL7;TRIP12;RNF146;ATXN3;AREL1;ITCH;FBXO10;CUL3;RNF185;ANAPC1;RNF20;UBQLN1;BIRC6;RC3H2;RNF144B;RNF217;UBL7;RNF6;UFD1;RNF13;WDR91;PSMD9;PSMD13;RNF213;MDM2;TOPORS;CDC23;FBXO7;TRIM25;SMURF2;RNF144A;PRKN;DDB1;UBE4B;UBC;RNF34;STUB1;RNF125;DTX3L;RNF166;SIAH1;OS9;BUB3;PSMC2;UBE2H;CDC26;TOLLIP;RNF43;KLHL3;UBQLN2;UBE2S;ANAPC4;SIAH2;SYVN1;RNF130;HERPUD1;CHFR;ARRDC1;ARIH1;SPSB4;BTRC
prerank,adenine nucleotide transport (GO:0051503),-0.5218472849301029,-1.4241749935724106,0.06281407035175879,0.7162928318170755,1.0,10/17,36.42%,SLC25A17;ABCC4;LRRC8D;LRRC8A;ABCC5;SLC25A24;SLC35B2;SLC17A9;SLC25A4;SLC19A1
prerank,regulation of cellular localization (GO:0060341),0.5474058601161953,1.4228316634303424,0.09226594301221167,0.6917814457090038,1.0,12/46,14.52%,STXBP2;ADCY5;NR1H4;CAMK2D;UNC13D;PARP1;BRSK1;NR1D1;LRP5;CSNK1E;LRRK2;DVL1
prerank,receptor-mediated endocytosis (GO:0006898),-0.3232200130872153,-1.4226160360304048,0.012195121951219513,0.7183154220150342,1.0,39/132,19.14%,DAB2;DNM3;LRP1;SPARC;GRB2;FCHO2;DNAJC6;CALCRL;APOE;LDLR;FNBP1L;CTSL;SCARB2;CXCL16;CANX;DNM1;TMEM108;PPT1;EPS15;SCARF1;ARHGAP27;DNAJC13;RAMP2;RABEPK;HSP90B1;AP2S1;GRK2;CALR;SNCA;INSR;NLGN3;CLN3;LMBRD1;STAB1;CLTB;M6PR;AP2A2;CUBN;CLTA
prerank,diol metabolic process (GO:0034311),-0.5008173882343021,-1.422311647481153,0.08093994778067885,0.7143385718760463,1.0,10/19,22.93%,NAAA;SGPP1;NOS3;ASAH2;GCH1;PRKG2;AKT1;PTS;SPR;SPHK1
prerank,positive regulation of protein polymerization (GO:0032273),0.5254568702311021,1.4223035049164707,0.07439024390243902,0.6916008938189157,1.0,6/65,7.53%,LMOD1;LMOD2;CDC42EP3;MAPT;TPPP;TOGARAM1
prerank,liver development (GO:0001889),-0.4349790346386593,-1.4222004662932664,0.05660377358490566,0.7095972072118436,1.0,9/32,13.44%,TGFBR3;NF1;COBL;WNT4;PKD2;LSR;PCK2;CEBPB;CCDC39
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.43340709974660246,-1.4212150083349608,0.06007067137809187,0.70863161569524,1.0,21/35,38.59%,ACSS3;PAM;FAR2;HMGCL;HMGCLL1;PPT1;HMGCS2;ACLY;BDH2;AACS;GGT7;HPGD;ALOX12;HSD17B8;BDH1;GCDH;SLC25A1;SCD;ACACA;AWAT2;GGT1
prerank,Notch signaling involved in heart development (GO:0061314),0.6813548082383631,1.4207452186199399,0.12007168458781362,0.6950874064660113,1.0,4/11,7.72%,HEY2;HEYL;JAG1;SNAI2
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.4165795200168793,-1.4206210395001357,0.0429042904290429,0.7060066525500738,1.0,15/39,27.17%,TCF7L2;MYRIP;RBP4;MCU;PSMD9;NNAT;SOX4;NLGN2;CAPN10;ACSL4;AACS;DRD2;HFE;ADCYAP1;LRRC8A
prerank,sodium ion homeostasis (GO:0055078),-0.4836590312909177,-1.4204816929494173,0.0653950953678474,0.7015207991087445,1.0,4/21,3.00%,ATP1A2;ATP1B3;NEDD4L;SLC12A2
prerank,regulation of activated T cell proliferation (GO:0046006),-0.43810774379628437,-1.4199826692573894,0.07570977917981073,0.6986979960838228,1.0,6/30,8.49%,IGF1;IGFBP2;HMGB1;IL18;LGALS9;IGF2
prerank,protein depolymerization (GO:0051261),0.5832501787282628,1.4194672392569698,0.11722141823444283,0.6974148512221591,1.0,8/27,14.27%,DSTN;MICAL2;WDR1;KIF2A;CFL2;MICAL3;KIF18A;STMN2
prerank,epithelial structure maintenance (GO:0010669),-0.590517420974667,-1.419015832447145,0.07488986784140969,0.6981880456432308,1.0,2/11,4.18%,CXADR;RBP4
prerank,"wound healing, spreading of cells (GO:0044319)",0.5960517912632612,1.4175222032281232,0.11265432098765432,0.702447387221534,1.0,4/24,3.40%,FLNA;CCN1;LCP1;MRTFA
prerank,apoptotic mitochondrial changes (GO:0008637),0.5757974471278937,1.4165841938398918,0.11080711354309165,0.7039048256136332,1.0,10/32,12.48%,ATP2A1;HK2;BCL2;NDUFS1;FZD9;THEM4;DNM1L;GGCT;BOK;CLU
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7040217528866517,1.4153362297065668,0.12920353982300886,0.7061794777393686,1.0,2/11,2.79%,MEF2C;ANXA1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5743174205804908,-1.4146697508307686,0.08714596949891068,0.7121470966363945,1.0,4/12,5.38%,EPHA4;GLI2;MYCBP2;PAFAH1B1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5121173481601072,1.4146640161478652,0.07551766138855055,0.7064133230017202,1.0,11/78,9.53%,MYOCD;PDGFB;CCNA2;CCND2;NR2F2;ACTB;HEXIM1;CCND1;ADAM17;CCNT1;CDK7
prerank,negative regulation of nervous system development (GO:0051961),0.6402976036856968,1.4144007485791585,0.12186978297161936,0.7052928587234335,1.0,1/17,0.19%,SLIT1
prerank,spindle assembly (GO:0051225),0.514883159528499,1.4142419275214215,0.07028360049321825,0.703749353205877,1.0,22/67,17.28%,FLNA;CLASP2;KIF2A;TOGARAM2;HAUS8;KIF3B;MAPRE2;TUBGCP6;TPX2;PIBF1;TOGARAM1;CEP192;WRAP73;AAAS;CLASP1;HAUS7;HAUS2;MAPRE3;ABRAXAS2;MAP9;INO80;STARD9
prerank,inorganic cation transmembrane transport (GO:0098662),0.46736024422441796,1.413973195225224,0.018575851393188854,0.702738303538038,1.0,28/268,5.83%,KCNAB1;ATP2A1;SCN4A;CACNA1C;ASIC3;ATP2B4;TRPC6;ATP2A2;KCNJ12;CACNA1H;SLC6A17;ANO6;SLC8A2;SLC8A1;KCNQ5;ATP5MF;KCNA5;SLC4A8;SLC6A2;SLC6A5;KCNQ4;KCNN2;UCP3;KCNB1;CCDC51;ATP6V1H;KCNH1;ATP1B1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6611943189964823,1.413351780185521,0.11187607573149742,0.7029768370026938,1.0,4/14,8.73%,ATP2B4;PKIB;PKIA;PRKAR1B
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5833621756135464,1.4130405257815977,0.10110803324099724,0.7020063535889394,1.0,11/33,10.85%,HIP1;BCAR3;NUP62;FBXW7;DOK1;NEU3;AREG;ADAM17;DGKD;HBEGF;GPER1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.46102961558567834,1.4127678306700058,0.005030181086519115,0.7009555569920797,1.0,39/348,7.69%,MYOM1;ACTA2;NTF3;MYLK2;TTN;ACTG2;MEF2C;NTRK3;HEY2;ACTA1;ANGPT1;ROCK1;FGF1;CD36;LIMS1;MYD88;PDGFB;GABPA;HINFP;ACTG1;MUSK;RBMS3;UBR5;OSR2;SLC38A2;EMILIN1;TESC;TP53;SLC2A10;VEGFA;PTPN1;AR;PPARGC1A;MED1;CELF1;YAP1;NAT8;C1QTNF1;SOX9
prerank,protein N-linked glycosylation (GO:0006487),-0.36898242366176814,-1.4126690315860668,0.03636363636363636,0.7163206463993866,1.0,28/66,25.72%,MAN1C1;TUSC3;MGAT4C;B4GALT1;ST3GAL1;MGAT1;PGM3;SLC39A8;FUT8;MGAT4B;UGGT2;ENTPD5;OSTC;MGAT5;MCFD2;PMM2;MPDU1;LMAN1;ALG14;B4GALT7;ALG1;ALG12;GFPT2;RPN2;MGAT2;DPM3;MGAT4A;STT3B
prerank,mitochondrion distribution (GO:0048311),0.695420655260685,1.4125845199351408,0.14310344827586208,0.699594688669595,1.0,6/12,14.40%,MEF2A;MAPT;TRAK1;ATCAY;DNM1L;LRRK2
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.387422070195063,-1.4119078899643853,0.015463917525773196,0.7148971193415637,1.0,16/63,11.76%,IGF1;SH3RF1;TCF7L2;DEPTOR;BMP4;ITGA6;WWOX;BIRC6;TNFSF10;ITGAV;PML;CASP8;STX4;MADD;SP100;TGFBR1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.425400511748277,-1.411026603092546,0.06666666666666667,0.7140213795114692,1.0,12/36,15.49%,MECOM;DLG1;ITCH;FOXO1;PTPN22;PRKN;SIRPA;SH3RF2;PER1;IGBP1;AIDA;DUSP1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7101650689310811,1.4101356888284675,0.12407407407407407,0.706271085396607,1.0,2/10,1.91%,CD36;MYD88
prerank,import into cell (GO:0098657),-0.41274980119030036,-1.409941768977351,0.0749063670411985,0.7140211012436231,1.0,8/41,5.98%,ATP1A2;SLC6A13;SLC1A3;GLUL;SLC47A1;SLC12A7;SLC6A6;SLC7A5
prerank,regulation of protein acetylation (GO:1901983),-0.5731490275839426,-1.409046284715595,0.08783783783783784,0.7133075032287631,1.0,5/12,19.26%,DDX3X;CAMK1;TAOK1;TERF2IP;PARK7
prerank,glucose import (GO:0046323),0.6636949624520929,1.4077672307109308,0.13333333333333333,0.7127621336211497,1.0,3/13,6.46%,SLC2A4;SORT1;SLC2A10
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.575905904284947,1.4075251519322611,0.10984308131241084,0.7115090454850673,1.0,7/29,10.29%,RBM24;TENT5B;CIRBP;GDNF;NBAS;FUS;HNRNPU
prerank,ketone body metabolic process (GO:1902224),-0.6234055955218769,-1.406481773338518,0.0915032679738562,0.7201423470714808,1.0,6/10,17.28%,ACSS3;HMGCL;HMGCLL1;HMGCS2;BDH2;AACS
prerank,oligosaccharide metabolic process (GO:0009311),-0.40181413544612943,-1.4064351553994066,0.044715447154471545,0.7154673227367832,1.0,12/46,10.99%,ST3GAL4;B4GALT1;ST3GAL6;ST8SIA4;ST6GALNAC3;ST8SIA1;AMY1A;AMY1C;AMY1B;FUT8;ST3GAL3;ST8SIA2
prerank,response to ketone (GO:1901654),0.6050052500873209,1.4063311159571157,0.10425844346549193,0.7138814921120505,1.0,6/24,7.87%,SLIT3;ABCB4;TGFB3;CAV1;YAP1;TGFB2
prerank,positive regulation of transporter activity (GO:0032411),0.6704504206732533,1.4054798969476683,0.14188034188034188,0.7149909823146684,1.0,2/13,2.04%,TRPC6;KCTD7
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.6767878607406622,1.4049768251130499,0.13381555153707053,0.7148168004562062,1.0,3/12,4.69%,LAMA5;ACTG1;ACTB
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4739068673635695,1.4045152915623011,0.03858520900321544,0.7144204022516029,1.0,19/159,6.21%,NEXN;PALLD;MYOT;CDH6;MYPN;IGFN1;ROBO3;CDH13;MILR1;ITGB1;CDH4;KIRREL3;PTPRS;IGSF21;GPC4;CDHR3;PCDHB14;PTPRF;DSCAM
prerank,protein K48-linked ubiquitination (GO:0070936),-0.38299558151944185,-1.404442869831534,0.05660377358490566,0.7192982988237582,1.0,19/54,15.66%,TTC3;NEDD4L;RNF146;ITCH;CUL3;UBE2D3;RNF6;PELI1;TOPORS;UBE2E2;UBE2E3;PRKN;UBE3A;RNF34;SKP2;DTX3L;UBE2H;RNF115;KLHL3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5773304106999934,-1.404130346170068,0.09557109557109557,0.7161030478254236,1.0,3/11,11.76%,TGFBR3;TGFB1;TGFBR1
prerank,regulation of cell junction assembly (GO:1901888),0.6010310893857721,1.4037835621816148,0.11791044776119403,0.7149925142042681,1.0,8/27,11.12%,MEF2C;RAP1A;PDLIM5;ROCK1;CBFB;SNAI2;ROCK2;RUNX1
prerank,regulation of membrane repolarization (GO:0060306),0.6676067974224111,1.4035744840788784,0.12374581939799331,0.7137858250969132,1.0,3/13,6.08%,AKAP6;CACNA2D1;CAV1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3214130753033617,-1.4035707736575291,0.0,0.7139730011818697,1.0,35/128,13.66%,BMP6;TGFBR3;SMAD3;APPL2;DDX5;BMP7;BMP4;COL1A2;CDH5;PXN;SMAD6;ENG;PTK2;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;ID1;SMAD9;CLDN5;ZMIZ1;FURIN;FKBP1A;SMURF2;ZMIZ2;TMEM100;TGFB1;PDCD4;UBC;STUB1;TGFBR1;ZYX;ARHGEF18;APPL1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.41351397634043513,-1.4029605910111749,0.05747126436781609,0.7121172162847835,1.0,9/39,10.29%,AFDN;EPHA7;PTPRG;NF2;PTK2;PODXL;CDH1;TENM3;TGFB1
prerank,activation of protein kinase B activity (GO:0032148),0.5901909611452146,1.4029056558350734,0.12445095168374817,0.714215890897376,1.0,4/29,2.09%,NTF3;NTRK3;FGF1;PDGFB
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.561312085431196,-1.401628554572407,0.1024390243902439,0.7131009381403083,1.0,6/12,10.29%,PTPN14;BMP4;KHDRBS1;UHMK1;SIRT7;TGFB1
prerank,regulation of cellular component organization (GO:0051128),0.4745050690876778,1.4012205993483389,0.04632768361581921,0.7181822718322157,1.0,22/135,7.03%,AGTR1;RAP1A;PAPPA2;STK38L;ROCK1;CD36;PLCE1;HIP1;RASGRP2;CDH13;PACSIN3;PACSIN2;CAMK2D;NET1;ERMN;ATAD3A;PRKCQ;SLITRK4;DAB2IP;SLC2A10;PTPN1;NEDD4
prerank,positive regulation of behavior (GO:0048520),0.6999258811206058,1.4008630141470406,0.12727272727272726,0.7174195108019948,1.0,1/10,0.71%,MEF2C
prerank,positive regulation of vascular permeability (GO:0043117),0.6597357238967037,1.3995455427457049,0.13798977853492334,0.7202314955394157,1.0,2/12,1.26%,PDE3A;ANGPT1
prerank,mesenchymal cell development (GO:0014031),0.6341938456957668,1.3993206396937103,0.13122923588039867,0.7190502078290806,1.0,5/18,8.71%,HEY2;HEYL;TAPT1;SNAI2;CDH2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5544993711629518,1.3990560241555485,0.11468531468531469,0.7179833606324579,1.0,7/39,8.13%,DMD;FGF13;FGF14;CAMK2D;UTRN;NEDD4;WNK2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.4666399709359285,-1.3986862172231904,0.06907894736842106,0.7218099888051629,1.0,6/25,6.43%,KIT;B2M;WNT5A;CD55;SLC7A5;PLCG2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.676424605653966,1.3981663751533568,0.14754098360655737,0.7192137049031053,1.0,2/11,1.88%,WTIP;LIMD1
prerank,neural crest cell migration (GO:0001755),-0.42001045241650836,-1.3979388491560476,0.06319702602230483,0.7204532232616222,1.0,10/36,7.78%,SEMA3D;SEMA3C;SEMA6A;FN1;NRP1;RADIL;ANXA6;SEMA7A;SEMA3A;SEMA4D
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.446169802993667,-1.3977464026495465,0.06441717791411043,0.716584768729811,1.0,16/26,36.50%,ITCH;PPM1B;MAPKBP1;ILRUN;PCBP2;IRAK3;TRIB1;TRIM21;NLRC3;NFKBIL1;TNFAIP3;NMI;SIGIRR;TYRO3;LYAR;DHX58
prerank,triglyceride homeostasis (GO:0070328),0.5891823581738558,1.397230070946335,0.11596385542168675,0.7205520755724877,1.0,4/26,3.34%,NR1H4;ANGPTL8;RORA;LPL
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.46452325067667893,-1.3970357585901894,0.07926829268292683,0.7151589384660251,1.0,9/25,19.67%,SDF2;DNAJB12;HSPA5;BAG1;HSPA13;HSPA9;HSPE1;DNAJB4;ST13
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.6495393821035369,1.396918183106601,0.1292517006802721,0.7197063409935504,1.0,2/15,2.63%,RYR2;ZFAND2B
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.3472565173811414,-1.3965676623371024,0.04225352112676056,0.7126099069901377,1.0,39/91,25.37%,SEC62;RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;SEC63;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SSR1;SEC61A1;RPS7;RPL27;RPL11;SRPRA;SRP9;RPL18A;RPL37A;SSR2;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27
prerank,polyol biosynthetic process (GO:0046173),-0.5159630118516617,-1.3956743638411482,0.09359605911330049,0.7119041994750657,1.0,9/16,25.05%,CYP27A1;IP6K1;ISYNA1;IP6K2;PPIP5K2;FGF2;ITPKB;IPPK;CYP2R1
prerank,microvillus organization (GO:0032528),0.6571910695494125,1.3952001255615674,0.15053763440860216,0.7237650998518768,1.0,6/13,12.22%,RAP1A;RAP2C;STK26;RAPGEF6;RAP2A;TNIK
prerank,retinoic acid metabolic process (GO:0042573),-0.5504733874233949,-1.395148392773457,0.10922330097087378,0.7097875809002135,1.0,2/14,2.97%,ALDH1A2;CYP26B1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.36445037604957253,-1.3949676173303922,0.020618556701030927,0.7062570882343411,1.0,12/66,5.39%,TGFBR3;ROBO1;MCC;NF1;SULF1;SPARC;NUPR1;APOE;B2M;XDH;MTSS1;PTPRM
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6745272024311579,1.394745916137324,0.1407942238267148,0.7233303686610444,1.0,5/12,17.11%,IRS1;PPARGC1A;PPARA;IRS2;MTLN
prerank,protein localization to synapse (GO:0035418),-0.5667454633029632,-1.3938855909039167,0.0979020979020979,0.7064562635192073,1.0,5/12,15.28%,NLGN1;ZDHHC15;NRXN1;NLGN2;PCLO
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5334415479131764,1.3931660768388423,0.11342894393741851,0.7266927663857305,1.0,3/48,3.36%,CCDC3;SLIT3;PADI2
prerank,regulation of ossification (GO:0030278),-0.4130778481768079,-1.392691980380245,0.05592105263157895,0.7072636550512487,1.0,9/36,5.55%,PTN;SGMS2;BMP4;CHSY1;SMAD6;PTPN11;BMP2K;WNT5A;BMPR2
prerank,basement membrane organization (GO:0071711),0.661246080962013,1.392566303474062,0.13139931740614336,0.7268717686242141,1.0,4/14,6.93%,NTN4;COL4A1;PXDN;LAMB2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6161631867846804,-1.3924274573748492,0.08584686774941995,0.7041268326307696,1.0,5/10,11.86%,DCN;SEMA6A;XDH;PIK3CB;SPRY2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.44105820736227563,-1.3921648987780728,0.07333333333333333,0.7010419982642733,1.0,8/30,11.66%,IGF1;NOTCH2;GRB2;RASGRF1;RAPGEF1;ITGAV;RASGEF1A;LYN
prerank,ruffle organization (GO:0031529),0.658401513349549,1.3917153115897436,0.11594202898550725,0.7280616982642483,1.0,3/16,7.52%,TPM1;CYFIP1;PLEK
prerank,microvillus assembly (GO:0030033),0.6444043723860924,1.391604792665925,0.15734265734265734,0.7264806233756701,1.0,6/14,12.22%,RAP1A;RAP2C;STK26;RAPGEF6;RAP2A;TNIK
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5373176620627123,1.389812296125662,0.10554803788903924,0.7308915875864828,1.0,10/46,9.70%,NTN4;ITGA8;LAMA5;FERMT2;PEAK1;LAMC1;LAMB2;ITGB3;ITGA4;PARVA
prerank,entry into host (GO:0044409),-0.5570333936778527,-1.389539758199738,0.08333333333333333,0.7082520872515686,1.0,5/13,7.10%,GRB2;CDH1;ITGAV;CTNND1;CTNNB1
prerank,regulation of synapse assembly (GO:0051963),0.5359468942656136,1.3895245300687646,0.11096256684491979,0.7299738803182706,1.0,5/46,5.68%,SLIT1;MEF2C;PDLIM5;MUSK;GPC4
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.48995007173864796,1.3893358496783619,0.07514450867052024,0.7286662356402348,1.0,22/93,16.17%,NTF3;DMD;NTRK3;ATP2B4;HRC;BCAR3;CAV1;VEGFA;CNKSR3;GPD1L;PDE4D;PDCD10;FNIP2;DMTN;NCK2;GAS6;MLXIPL;INPP5J;PTEN;RAF1;NOS1;MAD2L2
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5424309929253854,-1.3892278859073925,0.0954653937947494,0.7052635781638407,1.0,3/13,9.72%,ATP1A2;ATP1B3;ATP1B2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6946355316294572,1.389117532928236,0.13774597495527727,0.7275514348329234,1.0,1/10,0.53%,AOC3
prerank,positive regulation of B cell proliferation (GO:0030890),0.5808829036340054,1.389111508385642,0.12960235640648013,0.7256076720651683,1.0,4/29,4.50%,MEF2C;IL2;TNFSF13B;BCL2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.6004962964840377,-1.388866816560962,0.07922912205567452,0.7023522651384554,1.0,3/10,18.63%,RC3H2;NFKBIZ;ZC3H12A
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6367724129778445,1.3887863426256521,0.13020833333333334,0.7248938860396025,1.0,4/13,3.63%,CD36;CDH13;LPL;ITGB1
prerank,positive regulation of viral life cycle (GO:1903902),0.6016034113107308,1.3882192184349709,0.13075780089153047,0.7249431664387992,1.0,6/22,13.44%,TMPRSS4;AXL;CHMP2B;TSG101;KPNA2;CHMP2A
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5650441912089724,1.3878349199658508,0.13056379821958458,0.7243231927400443,1.0,9/34,15.31%,MEF2C;GABRE;GRIN2C;GABRA4;GABRA5;GABRG1;INSYN2A;LRRK2;CHRNA4
prerank,axon extension (GO:0048675),0.5912311932005451,1.3877053341157148,0.12460567823343849,0.7228853482242225,1.0,4/23,3.78%,SLIT1;SLIT3;SEMA5A;MAP1B
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6516163417430524,1.387657687855875,0.1546572934973638,0.7211285294651585,1.0,4/13,11.08%,FLNA;NFKBIE;GET4;GOPC
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.687341812074957,1.3871540162616278,0.1601489757914339,0.720987931466928,1.0,4/10,11.29%,PRKG1;SERPINE2;C1QTNF1;PRKCD
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5060400419642939,-1.3863409705683223,0.09695290858725762,0.708969996397509,1.0,5/17,8.82%,ATP1A2;BMP7;BMP4;TFPI;NR3C1
prerank,RNA destabilization (GO:0050779),0.6247590620132806,1.3859789399027955,0.125,0.7232096217226156,1.0,8/18,14.01%,RBM24;ROCK1;YTHDF2;CELF1;FTO;ROCK2;DXO;GIGYF2
prerank,androgen metabolic process (GO:0008209),0.6469609941410226,1.3856936577242795,0.10929853181076672,0.722304964190083,1.0,5/18,11.05%,HSD17B10;HSD17B7;HSD17B4;MED1;SRD5A3
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6084437537655102,1.3848092082708867,0.1273006134969325,0.7235901792476388,1.0,3/26,1.66%,RYR1;RYR2;ITPR1
prerank,vasculature development (GO:0001944),-0.5144334156622438,-1.384235547989973,0.10772833723653395,0.7135397938805408,1.0,6/16,9.23%,PIK3CA;PDGFRA;CDH5;ACVRL1;BMPR2;STK11
prerank,negative regulation of protein catabolic process (GO:0042177),0.5366528670849106,1.3840631061252462,0.12552891396332863,0.7242793021530488,1.0,12/40,16.29%,FLNA;ROCK1;DAB2IP;PIN1;TIMP4;SF3B3;SIRT2;ADGRB1;CTSA;AZIN2;MAD2L2;AGAP2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5637326427311614,-1.3824657040059607,0.10874704491725769,0.7169536172319545,1.0,6/12,19.75%,SLIT2;NBL1;CCN3;DUSP1;AKT1;MIA3
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.615223727059867,1.381678943681588,0.13559322033898305,0.7308764340864816,1.0,3/24,1.66%,RYR1;RYR2;ITPR1
prerank,positive regulation of GTPase activity (GO:0043547),0.4616859438460309,1.381300126251282,0.05157894736842105,0.7302340010208955,1.0,36/188,10.65%,NTF3;ARHGEF7;RAP1A;NTRK3;RALGAPA2;TBC1D1;RGS6;ABR;LIMS1;RASGRP2;FERMT2;DOCK8;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;ARHGEF16;LARS1;MTSS2;MAPRE2;RABGAP1;PIN1;CORO1C;RAPGEF6;RASGRP1;RALGAPA1;EVI5;RALGAPB;EPHA2;AGRN;CCL14;SNX18
prerank,positive regulation of phospholipase C activity (GO:0010863),0.557644725147115,1.3812733186025794,0.14190093708165996,0.7284325913515044,1.0,3/40,0.77%,NTF3;EDNRA;NTRK3
prerank,heart looping (GO:0001947),0.5490501864256292,1.3798200503622142,0.10926694329183956,0.7315776970359629,1.0,3/40,1.52%,MEF2C;TBX2;MICAL2
prerank,positive regulation of receptor internalization (GO:0002092),0.5940090791799727,1.3795701588270082,0.12125984251968504,0.7305704186019032,1.0,5/22,10.44%,NTF3;ANGPT1;VEGFA;ATAD1;SCYL2
prerank,mitotic chromosome condensation (GO:0007076),0.5773214604746489,1.379450108571475,0.1336405529953917,0.7291302291375215,1.0,6/26,11.64%,TTN;SET;NCAPD3;TENT4A;RB1;NCAPD2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5135596864989209,1.3783188985602228,0.09331651954602774,0.731313829634128,1.0,17/59,14.87%,MYLK2;ROCK1;DYRK2;CAMK2D;DYRK1A;TAF1;DYRK1B;CHEK1;MAP3K10;MAP2K1;ROCK2;PRKCD;ACVR1B;CDC42BPB;MAPK1;LRRK2;PRKCA
prerank,proteoglycan metabolic process (GO:0006029),-0.43680356800120357,-1.3777560592783482,0.09217877094972067,0.733117762977123,1.0,10/26,19.99%,IGF1;CHST11;SULF1;BMPR2;CHST9;CANT1;XYLT1;FOXL1;CHST12;B4GALT7
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.47828399159146484,1.3761748429667175,0.07314410480349345,0.7370579327949484,1.0,17/117,9.47%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;CYSLTR2;RAMP1;PRKACB;ADAM17;PRKAR1B;PTH1R;ADCY6
prerank,regulation of cell motility (GO:2000145),0.47873630719714894,1.3760396510406994,0.05915178571428571,0.7355863372688255,1.0,12/121,3.95%,NEXN;FLNA;ROCK1;FGF1;CAVIN1;CDK6;PLXND1;PLXNB1;KIF2A;SERPINE2;DOCK10;NTN1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.48136960025594316,1.3757702716979952,0.07032967032967033,0.7347223256025076,1.0,17/116,9.47%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;CYSLTR2;RAMP1;PRKACB;ADAM17;PRKAR1B;PTH1R;ADCY6
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.48648654112315604,1.3752658356577248,0.08990011098779134,0.7346365972634246,1.0,14/112,7.87%,PDE3A;SOX6;SOX5;MEF2C;LIMS1;FERMT2;LRRC32;TGFB3;ITGB1;GCNT2;BMPR1A;ITGB5;SOX9;TGFB2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5255722076060606,-1.3749576527570415,0.0985576923076923,0.741139972445973,1.0,6/14,17.37%,KMT2E;AUTS2;CTR9;CTNNB1;SNW1;SMAD4
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4568742368164831,-1.3745419514222692,0.08875739644970414,0.7389650293713286,1.0,10/26,16.74%,IGF1;OSBPL8;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,sensory organ development (GO:0007423),-0.38045901355579625,-1.374055834718893,0.04878048780487805,0.7369486863384501,1.0,8/51,9.45%,SHROOM2;SMOC1;CHD7;PBX3;RBP4;ECE1;SMCHD1;MEIS2
prerank,renal filtration (GO:0097205),0.7014203521928689,1.373058297241659,0.16489361702127658,0.7401971792822248,1.0,3/10,2.73%,MCAM;MYO1E;ITGA3
prerank,potassium ion transport (GO:0006813),0.4702428453598363,1.3723258157165128,0.08021978021978023,0.7409679606499626,1.0,11/120,5.58%,KCNAB1;KCNMA1;KCNJ12;KCNMB1;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNB1;CCDC51;KCNH1
prerank,response to interferon-beta (GO:0035456),-0.48151012564685797,-1.3721062922042355,0.10684931506849316,0.7414717604743852,1.0,16/22,37.75%,IFNAR2;IRGM;BST2;IFITM1;SHFL;IFITM3;PNPT1;IFITM2;IKBKE;HTRA2;CDC34;XAF1;NDUFA13;TRIM6;PLSCR1;IRF1
prerank,negative regulation of cell cycle (GO:0045786),0.4988882495469634,1.371426333899277,0.09696969696969697,0.7423172181507178,1.0,14/73,11.39%,MYOCD;CDK6;NR4A1;GMNN;BTG2;NR2F2;RPS6KA2;HEXIM1;HECA;BTG1;BRINP1;GPER1;RB1;TRIM35
prerank,cellular response to misfolded protein (GO:0071218),-0.4829680289706878,-1.3709356689407994,0.07901907356948229,0.7420718852091055,1.0,8/20,11.27%,ATXN3;CUL3;RNF185;DNAJB12;DERL1;UFD1;UGGT2;STUB1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.631260665839681,1.3707093401556816,0.12824675324675325,0.7430671811738645,1.0,4/17,4.11%,ANGPTL8;LPL;SORT1;HDAC9
prerank,eye morphogenesis (GO:0048592),-0.4968829850840312,-1.3701469048703079,0.10410958904109589,0.7414805365344229,1.0,9/19,9.34%,SHROOM2;FBN1;NF1;EFEMP1;FBN2;MFAP5;IFT122;COL5A1;TENM3
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5210906795204115,-1.3687210590364345,0.11604938271604938,0.7436579501636369,1.0,8/14,18.54%,PXN;GHR;PTK2;SOCS2;LYN;PRLR;STAT5A;STAT6
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5329013272453252,1.3687092034057966,0.13096862210095497,0.7484512339923344,1.0,9/39,8.65%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C;KIF1A;F8A1;KIF5B;TRAK1
prerank,regulation of actin filament polymerization (GO:0030833),0.49783353414452275,1.3683836649207466,0.10501193317422435,0.7478164883813408,1.0,4/69,3.29%,LMOD1;LMOD2;CDC42EP3;KANK1
prerank,protein targeting to ER (GO:0045047),-0.33476128385921466,-1.3672440009223017,0.015748031496062992,0.74570064561451,1.0,44/99,25.37%,SEC62;RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;SRPRB;RPS13;SEC63;RPLP0;SGTA;RPS29;RPL28;RPS10;RPLP1;SGTB;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SEC61A1;RPS7;RPL27;RPL11;SRPRA;SRP9;RPL18A;RPL37A;RPL38;ZFAND2A;RPL29;RPL10A;CHMP4B;CHMP4A;RPL32;SPCS1;RPS4X;RPS27
prerank,metanephric mesenchyme development (GO:0072075),-0.5973228336224676,-1.3666879164974923,0.11422413793103449,0.7439856556391989,1.0,4/10,10.87%,WNT4;PKD2;OSR1;SIX1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5733622815414388,1.3665873321428952,0.14523449319213314,0.7523554126153388,1.0,2/27,1.23%,MAP3K20;MAP3K5
prerank,lamellipodium organization (GO:0097581),0.5744804600715593,1.3663276682315177,0.12063953488372094,0.7512993673975439,1.0,7/29,9.05%,ARHGEF7;VCL;CDH13;ITGB1;CYFIP1;WHAMM;ARHGEF4
prerank,eye photoreceptor cell differentiation (GO:0001754),0.6620325716023621,1.365760557634677,0.17391304347826086,0.7514987673834332,1.0,4/12,6.51%,NKD1;CEP290;DSCAM;VEGFA
prerank,regulation of tube diameter (GO:0035296),0.6463338752219123,1.365682253677327,0.16885245901639345,0.7480307751027339,1.0,2/13,1.43%,AGTR1;ROCK1
prerank,vascular process in circulatory system (GO:0003018),0.6463338752219123,1.365682253677327,0.16885245901639345,0.7480307751027339,1.0,2/13,1.43%,AGTR1;ROCK1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5338713294779694,-1.3654052810853345,0.11138014527845036,0.7453024747134296,1.0,7/13,19.05%,BMP7;SOX13;NAPEPLD;SIX1;PTGS2;TFE3;METRNL
prerank,regulation of chemotaxis (GO:0050920),-0.4287189948349806,-1.3649549990404763,0.0781758957654723,0.7432176956141352,1.0,12/30,12.71%,PDGFRA;EFNB2;ADGRA2;MYCBP2;STX3;ZSWIM6;CYRIB;STX4;TGFB1;ZSWIM5;ZSWIM4;PPM1F
prerank,transepithelial transport (GO:0070633),-0.5256334710984528,-1.3633115281951163,0.11735941320293398,0.7458554617609736,1.0,4/15,4.08%,SLC1A3;ABCG2;SLC12A2;CXADR
prerank,positive regulation of DNA repair (GO:0045739),-0.3930536468315507,-1.3631174246789863,0.0603448275862069,0.742630943533492,1.0,13/46,17.41%,EYA2;EYA1;EYA4;HMGB1;EGFR;SLF2;SMCHD1;XRCC1;BRCC3;SLF1;NPAS2;FAM168A;WRAP53
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4982712924121588,-1.362631940599387,0.112,0.7406316991124773,1.0,6/16,18.63%,APPL2;APOD;ADCY7;PDCD4;SIRPA;ZC3H12A
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.5342800720205919,-1.3622018204629394,0.13170731707317074,0.7384155792582664,1.0,9/13,39.19%,GAB2;STX4;LAMP1;SYK;AP1G1;ITGB2;ITGAM;FGR;SPHK2
prerank,positive regulation of intracellular transport (GO:0032388),0.5371156431278663,1.3610462049396481,0.1251700680272109,0.7629823337586897,1.0,10/38,12.64%,ATP2A1;OAZ2;EHD2;TBC1D20;CEP290;NEDD4;ACTN2;STX18;KIF20B;PDCD10
prerank,mRNA splice site selection (GO:0006376),-0.43411719728801906,-1.3606227534937998,0.07467532467532467,0.741241110293312,1.0,8/30,11.13%,CELF2;KHDC4;SRSF6;SRSF5;CELF4;SETX;SFSWAP;ISY1
prerank,pharyngeal system development (GO:0060037),-0.5169800332916976,-1.3604993722271241,0.11764705882352941,0.7378359196328529,1.0,6/15,11.76%,BMP7;BMP4;PTCH1;BMPR2;HES1;TGFBR1
prerank,cellular response to fatty acid (GO:0071398),0.6720874834582982,1.3599859955760445,0.1596330275229358,0.764791552380491,1.0,4/12,5.88%,NR1H4;PDK4;LPL;IRS1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5062583841425281,-1.3596420045709003,0.12376237623762376,0.7375506421208693,1.0,7/16,17.72%,AUTS2;CTR9;CTNNB1;SNW1;BCOR;SMAD4;KDM1A
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.572303434404992,-1.3595740884012335,0.1118421052631579,0.7340221881986975,1.0,3/11,1.66%,AFDN;TJP1;TJP2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5160042686968086,1.359239671661566,0.1310615989515072,0.7656008727859467,1.0,11/47,11.29%,AGTR1;CD36;PDGFB;SLC5A3;DHRS4;MAPT;TP53;CBR1;GSTP1;PDGFRB;PRKCD
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6299836859247181,1.3592392204425345,0.16225749559082892,0.7637197895604283,1.0,6/14,14.92%,PMAIP1;IRS1;PPARGC1A;ARPP19;NNMT;IRS2
prerank,regulation of vasculogenesis (GO:2001212),0.6246590114544422,1.3583459608429844,0.16666666666666666,0.76510731635138,1.0,4/14,8.34%,RAP1A;HEY2;RRAS;RIN2
prerank,lamellipodium assembly (GO:0030032),0.5762289429962802,1.3580029756136052,0.12859304084720122,0.7644377141548309,1.0,7/26,9.05%,ARHGEF7;VCL;CDH13;ITGB1;CYFIP1;WHAMM;ARHGEF4
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5033650343801256,1.3570359218922743,0.11677018633540373,0.7659731958281764,1.0,13/65,9.19%,ASPN;PRDM16;LTBP1;VASN;TGFB1I1;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5668874829533911,-1.356854389296591,0.11990950226244344,0.7414025751098903,1.0,5/11,11.07%,DDX5;BMP4;EGFR;TGFB1;MAP2K2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5161392012820647,-1.3564492174928269,0.12026726057906459,0.7391356321009702,1.0,7/14,21.86%,PIK3CA;NRP1;GAB1;KDR;VEGFC;VEGFB;FLT4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5500355245321848,-1.356437857078927,0.12589073634204276,0.7353874868205577,1.0,8/12,23.56%,SEC62;HSPA5;SEC63;SGTA;SGTB;SEC61A1;CHMP4B;CHMP4A
prerank,positive regulation of lyase activity (GO:0051349),0.6308514127834898,1.3563543741383974,0.1546218487394958,0.7665914027272063,1.0,3/14,4.46%,CACNA1C;STIM1;FXN
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.33770029222560727,-1.3559734646808856,0.04827586206896552,0.7334148112438326,1.0,32/88,22.18%,VPS13A;ARRB1;DNAJC6;APP;RABEP1;MON2;SCAMP2;GBF1;PUM1;STX4;COMMD1;SORCS1;DTNBP1;FTL;AP1M1;EPS15;FTH1;EXOC2;HGS;STEAP2;VAMP8;EXOC1;SCFD1;SH3GL2;CLINT1;CLTA;ACBD3;SCAMP3;AP1B1;VAMP7;SCAMP1;SYS1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5741406905687927,1.355325247494381,0.14285714285714285,0.7684345307070561,1.0,6/24,6.51%,ROCK1;LIMS1;FERMT2;MAPRE2;DUSP3;VEGFA
prerank,protein glycosylation (GO:0006486),-0.32102919653037526,-1.3551612958655517,0.0,0.7329573228050386,1.0,45/125,25.72%,MAN1C1;ST3GAL4;TUSC3;MGAT4C;B4GALT1;ST3GAL6;ST8SIA4;ST3GAL1;GALNT10;ST3GAL5;ST8SIA1;TET3;MGAT1;PGM3;SLC39A8;SERP2;FUT8;MGAT4B;TET2;ENTPD5;ST3GAL3;FUT10;OGT;ST8SIA2;B3GALNT1;PLOD2;MGAT5;PMM2;COG7;B4GALT7;ALG1;PLOD3;ALG12;B3GNT2;POMT1;B3GALT2;GFPT2;RPN2;NPC1;EOGT;MGAT2;DPM3;MGAT4A;SERP1;STT3B
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.49502547151192383,1.3550489729974495,0.11014851485148515,0.7675591994013413,1.0,10/69,7.63%,NTF3;MEF2C;PLA2G3;CRLF1;TGFB3;SET;BCL2;GDNF;PPARGC1A;FZD9
prerank,positive regulation of interferon-beta production (GO:0032728),-0.422056618951245,-1.3548446114714225,0.07120743034055728,0.730582465070654,1.0,13/33,25.14%,DDX3X;PTPN11;RNF135;POLR3F;RIOK3;POLR3B;POLR3A;TRIM56;TLR3;OAS2;POLR3C;TOMM70;POLR3D
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.41169617126804636,-1.354587707731976,0.07666666666666666,0.7279946539345898,1.0,22/33,37.58%,STN1;MRE11;HSP90AB1;RAD50;ANKRD28;CTC1;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;DCLRE1B;GAR1;TINF2;PPP6C;NOP10;ZBTB48;ACD;RAD51;RPA1;RFC1;NHP2
prerank,Rho protein signal transduction (GO:0007266),0.5107348398449417,1.3533334339433727,0.12692307692307692,0.7717221646383075,1.0,13/53,11.25%,AGTR1;ROCK1;CDC42EP3;CDH13;MYO9B;NTN1;ARHGAP6;ARHGDIG;RHOJ;GNA12;ARHGAP1;ROCK2;ARHGAP5
prerank,heterochromatin organization (GO:0070828),0.6271459518059964,1.3531097985675824,0.1681109185441941,0.7706333302830786,1.0,2/14,2.95%,PRDM16;LOXL2
prerank,modulation by symbiont of host process (GO:0044003),-0.5749399159206134,-1.353013439219606,0.14864864864864866,0.7307463400408283,1.0,7/10,30.61%,B2M;UBC;PGK1;HGS;UBB;ENO1;MRC1
prerank,motor neuron axon guidance (GO:0008045),0.6307510757829742,1.352828713561881,0.1527777777777778,0.7697524165654133,1.0,3/15,4.73%,SLIT1;NTN1;CHN1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5766220995268192,1.3524403815480248,0.13848396501457727,0.7692867209249177,1.0,7/25,10.85%,HIP1;BCAR3;NUP62;DOK1;NEU3;DGKD;GPER1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.43976817608700236,-1.3520399882259335,0.12101910828025478,0.7312139216428792,1.0,12/27,22.42%,VPS13A;GBF1;ZDHHC15;OPTN;ARL5B;GCC2;TMED10;GOLPH3;COG7;OBSL1;SYS1;GBP5
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.65771958250744,1.3511190564807176,0.1773049645390071,0.7722743523125591,1.0,4/11,7.87%,HEY2;JAG1;BMPR1A;TGFB2
prerank,actin crosslink formation (GO:0051764),0.6505344051525177,1.3508785096182032,0.1660839160839161,0.7713498953374623,1.0,2/12,3.35%,FLNA;LCP1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5868733586753374,-1.3506941036111484,0.12134831460674157,0.7332283464566929,1.0,8/10,34.77%,FN1;HSP90AB1;FURIN;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,cellular response to oxygen-containing compound (GO:1901701),0.44825770870669435,1.3492241239036764,0.03979591836734694,0.775178144905384,1.0,49/291,11.29%,PDE3A;TPM1;MEF2C;RAP1A;ATP2B4;AKAP6;NR1H4;MYD88;PDGFB;ABCB4;PDK4;RORA;VIM;FZD4;LPL;P2RY2;IGFBP5;GUCY1B1;TSHR;CAMKK2;ACTB;UPF1;CD14;LARS1;TESC;IRS1;TAF1;MAPT;DAB2IP;CHMP5;CPEB1;SOX9;NFKBIB;RELA;ADNP2;IMPACT;GSTP1;CAPN2;NR1D1;ADCY6;RRAGB;CERS1;AXL;BRINP1;SH3BP4;GPER1;ROCK2;CD180;PRKCD
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.39212432731837316,-1.3488316911372094,0.054945054945054944,0.7372368683799583,1.0,11/45,5.65%,PIK3CA;EFEMP1;GRB2;TGFA;PDPK1;PTPN11;EGFR;PTK2;SLC30A10;GAB1;PTK2B
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5845929358481199,-1.348673133926023,0.1111111111111111,0.7342524831454891,1.0,5/10,21.43%,APP;RAB5A;SHANK3;SYP;DRD2
prerank,ERAD pathway (GO:0036503),-0.35192633628398956,-1.3477038546096138,0.04819277108433735,0.734400728364239,1.0,28/83,18.62%,ECPAS;ATXN3;SEL1L;RNF185;UBXN4;UBQLN1;DNAJB12;DERL1;UFD1;HSPA5;DNAJC10;USP19;UGGT2;TRIM25;PRKN;SGTA;UBE4B;STUB1;RCN3;DNAJB2;HSP90B1;SGTB;OS9;UBQLN2;SYVN1;UBXN8;DNAJB9;HERPUD1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6612253921921046,1.3463588245690299,0.16304347826086957,0.7834748854218488,1.0,3/11,6.96%,ARHGEF7;KANK1;CORO1C
prerank,embryonic limb morphogenesis (GO:0030326),0.5430371864696083,1.3460888336961194,0.1339155749636099,0.7825586920515784,1.0,7/34,10.16%,MAP3K20;CACNA1C;TBX2;OSR2;TGFB2;SKI;MBNL1
prerank,regulation of endothelial cell migration (GO:0010594),-0.34820682251310986,-1.345540764388889,0.060810810810810814,0.7394147009940909,1.0,24/85,10.07%,PTN;SASH1;NF1;DCN;FOXP1;GLUL;NRP2;SPARC;BMP4;SLIT2;APOE;TEK;NRP1;PTK2;WNT5A;ACVRL1;PTPRM;BMPR2;PTK2B;FOXC2;PIK3CB;BMPER;ANXA3;ADAMTS9
prerank,barbed-end actin filament capping (GO:0051016),-0.4853745076141737,-1.3447940780149346,0.10804020100502512,0.7354203400856943,1.0,3/18,3.49%,ADD3;EPS8;CAPZA1
prerank,actin filament capping (GO:0051693),-0.4853745076141737,-1.3447940780149346,0.10804020100502512,0.7354203400856943,1.0,3/18,3.49%,ADD3;EPS8;CAPZA1
prerank,negative regulation of heart contraction (GO:0045822),0.6554937852350889,1.3447444525102472,0.17565217391304347,0.7853908002158896,1.0,1/11,0.13%,PLN
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3368082201411722,-1.344648719519774,0.0364963503649635,0.7324596706113491,1.0,24/87,13.66%,TGFBR3;SMAD3;APPL2;COL1A2;CDH5;PXN;SMAD6;ENG;PTK2;ACVRL1;ID1;SMAD9;CLDN5;ZMIZ1;FURIN;FKBP1A;ZMIZ2;TGFB1;UBC;TGFBR1;ZYX;ARHGEF18;FMOD;APPL1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.43842915407081623,-1.343888717004838,0.11452513966480447,0.732169701009596,1.0,8/25,5.55%,FOXD1;SULF1;ZNF423;BMP4;CDH5;ENG;ACVRL1;BMPR2
prerank,estrogen metabolic process (GO:0008210),0.6196993873267204,1.3436038641613746,0.18632478632478633,0.7877383338595195,1.0,3/15,5.63%,HSD17B10;HSD17B7;HSD17B4
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.35760551866639406,-1.3433526698294556,0.04455445544554455,0.7308997275814457,1.0,24/69,18.62%,ECPAS;SEL1L;RNF185;UBXN4;UBQLN1;DNAJB12;DERL1;UFD1;HSPA5;DNAJC10;USP19;TRIM25;SGTA;UBE4B;STUB1;DNAJB2;HSP90B1;SGTB;OS9;UBQLN2;SYVN1;UBXN8;DNAJB9;HERPUD1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4654829075697593,-1.3414933754574325,0.09970674486803519,0.734976917193527,1.0,5/21,4.90%,LRP1;PLTP;APOE;PTCH1;NFKBIA
prerank,sphingoid metabolic process (GO:0046519),-0.5455503660066685,-1.3410503667152607,0.13863636363636364,0.7333295544629691,1.0,9/12,43.91%,NAAA;SGPP1;ASAH2;SPHK1;DEGS2;PLPP2;SPHK2;PLPP1;SPTLC3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4964558729387326,1.3393848568923894,0.11830635118306351,0.8010317585268678,1.0,13/64,8.19%,VCL;ROCK1;CD36;CDK6;CDH13;JAG1;ACTG1;PEAK1;UTRN;DUSP3;AJAP1;CORO1C;DAPK3
prerank,negative regulation of inflammatory response (GO:0050728),0.4541261742801398,1.339281616282088,0.0547945205479452,0.7995451068412676,1.0,34/182,11.29%,LHCGR;GPR20;ADCY5;CRHR2;NR1H4;FCGR3A;ADCY2;VIPR2;MYH9;RORA;FEM1A;ADCY9;PTGIS;TSHR;ALOX5;MFHAS1;CYSLTR2;CD200R1;TNFAIP6;CD200;RAMP1;LPCAT3;PRKACB;PPARA;ADAM17;PRKAR1B;GSTP1;NR1D1;PTH1R;ADCY6;AOAH;GPER1;RB1;PRKCD
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6043882638019248,1.3390972035809496,0.14802631578947367,0.798357322352397,1.0,2/16,6.51%,AGTR1;VEGFA
prerank,determination of heart left/right asymmetry (GO:0061371),0.5181690905225462,1.339095970493715,0.13581890812250333,0.7965027081946907,1.0,3/43,1.52%,MEF2C;TBX2;MICAL2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.43787145099753133,-1.3390222391923696,0.09375,0.7379794114520731,1.0,11/26,22.93%,SPTLC2;ACER2;CYP1B1;NOS3;ASAH2;GCH1;AKT1;DDAH2;SPR;ABCA2;SPHK1
prerank,regulation of cytoskeleton organization (GO:0051493),0.4679656543606794,1.3384813066302148,0.11538461538461539,0.7968507679263873,1.0,30/108,17.16%,NEXN;DLC1;ROCK1;PHLDB2;PLXNB1;RHOBTB3;BICD2;MAPT;TPPP;ARHGAP17;RHOF;CAPN2;PAK2;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;DMTN;CLASP1;MAPK1;PRKAA2;RHOG;CDK2AP2;CLIC4;S100A8;S100A9;MARK2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3879781853298448,-1.3373996716300862,0.076,0.7415393463413973,1.0,13/44,15.49%,NF1;BMP7;BMP4;APOE;STK38;PIK3CB;PTPN22;IRAK3;PDCD4;LYN;SPRY2;AIDA;DUSP1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.48810550189434654,-1.3373935144104299,0.13246753246753246,0.7381281120724107,1.0,4/18,5.53%,PRKCB;PRKAG2;SLC2A1;OCLN
prerank,negative regulation of endopeptidase activity (GO:0010951),0.5095250339638602,1.3372182308784226,0.12920592193808883,0.799503359849178,1.0,4/47,6.82%,SERPINB8;SERPINI1;SERPINE2;TIMP4
prerank,reticulophagy (GO:0061709),-0.5421780013025065,-1.3371799175158248,0.12383177570093458,0.7356604617971141,1.0,5/12,13.02%,RB1CC1;RETREG1;TEX264;ATG2B;ATG2A
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6263747454807772,1.3368277098920103,0.16722972972972974,0.797259433174315,1.0,5/16,6.96%,DLC1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6263747454807772,1.3368277098920103,0.16722972972972974,0.797259433174315,1.0,5/16,6.96%,DLC1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,chromosome condensation (GO:0030261),0.5368518272677554,1.336811199033353,0.1473533619456366,0.7954753358677052,1.0,8/36,11.64%,TTN;H1-0;SET;NCAPD3;TENT4A;GPER1;RB1;NCAPD2
prerank,phosphatidic acid metabolic process (GO:0046473),0.5163851128701522,1.3365456816368166,0.15678524374176547,0.7946328466507693,1.0,3/48,2.32%,DGKB;DGKG;PLA2G3
prerank,regulation of telomere maintenance (GO:0032204),-0.4365922244470664,-1.3364816284171734,0.12202380952380952,0.7352043150569482,1.0,15/26,25.43%,XRCC5;SMG1;MRE11;PML;RAD50;USP7;GNL3;NBN;HNRNPD;TERF2IP;SMG6;YLPM1;ERCC1;ERCC4;TINF2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.6567480428053156,1.336444693260484,0.19891500904159132,0.7913261714457266,1.0,3/11,10.25%,TRDN;CALM1;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.6567480428053156,1.336444693260484,0.19891500904159132,0.7913261714457266,1.0,3/11,10.25%,TRDN;CALM1;SRI
prerank,positive regulation of protein binding (GO:0032092),-0.3661398931737116,-1.336248669932149,0.08597285067873303,0.7328209696771161,1.0,15/56,10.06%,LRP1;TCF7L2;BMP4;APOE;APP;VTN;B2M;PPP2CA;NVL;CLDN5;PPP2CB;DERL1;NMD3;FKBP1A;PRKN
prerank,excitatory postsynaptic potential (GO:0060079),0.593228892845236,1.3361340325530606,0.1839080459770115,0.7904863771410281,1.0,2/19,2.87%,MEF2C;GRIN2C
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.42407848187269187,-1.336132787621061,0.0851063829787234,0.7299183965640659,1.0,11/29,20.81%,SMAD3;AGO3;SRRT;PUM1;METTL3;ADAR;SMAD2;ZC3H7A;TUT4;TUT7;ZC3H7B
prerank,protein localization to cell periphery (GO:1990778),0.4535632884176011,1.335521751110578,0.11272321428571429,0.7910188790233836,1.0,40/133,16.60%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;CAV1;TTC7A;RAB3A;RAMP1;RAPGEF6;LIN7C;EPHA2;RAP2A;ACTN2;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;TSPAN17;RAB34;RAB8B;FLOT1;PRAM1;ANK1;LIN7A;SMURF1;RAB8A
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6467538637749943,1.3350676850018524,0.15575221238938053,0.7889980395358785,1.0,2/12,1.15%,AKAP6;LMCD1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6467538637749943,1.3350676850018524,0.15575221238938053,0.7889980395358785,1.0,2/12,1.15%,AKAP6;LMCD1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.44194227362393423,-1.3347217935169366,0.10946745562130178,0.7320107309361593,1.0,12/24,31.52%,APOE;EPHA4;PTK2B;UBE3A;GPX1;NUB1;PSME3;UBB;PSME1;CTSC;USP14;PSME2
prerank,regulation of DNA repair (GO:0006282),-0.38655680032408224,-1.3342685636969658,0.0873015873015873,0.7306133430017945,1.0,9/44,9.53%,EYA2;EYA1;EYA4;TRIP12;EGFR;PML;SIRT7;SMCHD1;BRCC3
prerank,respiratory chain complex IV assembly (GO:0008535),-0.4540057124044194,-1.3342362740985236,0.13297872340425532,0.7274691336228711,1.0,14/21,35.37%,COA8;COX10;COX20;SMIM20;COX14;TIMM21;BCS1L;COX17;COX16;COA3;SURF1;COA6;COX18;FASTKD3
prerank,protein localization to cell junction (GO:1902414),-0.45122587599132824,-1.3341753905220854,0.11815561959654179,0.7244318939299255,1.0,9/22,15.28%,TJP1;CGNL1;TJP2;HEG1;NLGN1;NECTIN1;ARHGEF18;NLGN2;PCLO
prerank,regulation of stress fiber assembly (GO:0051492),0.4828208648478406,1.3340408608511172,0.1386861313868613,0.7908686639750824,1.0,11/74,4.86%,TPM1;DLC1;ROCK1;SYNPO2L;FERMT2;PHLDB2;CLASP2;ACTG1;TGFB3;PPM1E;ARHGAP6
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5142673952332371,-1.3339094891817813,0.11578947368421053,0.72222805482648,1.0,4/15,3.00%,ATP1A2;ATP1B3;NEDD4L;SLC12A2
prerank,intestinal lipid absorption (GO:0098856),0.6400940944223615,1.333637609405555,0.18484288354898337,0.7904603277492793,1.0,1/11,1.73%,CD36
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5492101205913231,1.3328441023198883,0.13908205841446453,0.7914751226038582,1.0,3/33,3.36%,NTF3;ABR;SLC4A8
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.4243415886539485,-1.331790188960847,0.0970873786407767,0.7270502765325426,1.0,17/29,28.64%,DCPS;LSM1;DIS3;EXOSC1;DCP2;EXOSC9;EDC4;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;EXOSC5;LSM3;LSM6
prerank,positive regulation of response to wounding (GO:1903036),0.5675605263440122,1.3314264892379328,0.15639810426540285,0.7944958502833818,1.0,5/24,3.63%,MYLK;ANXA1;KANK1;ACTG1;ITGB1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.5322420618731617,1.331388821313035,0.16807909604519775,0.7928340383821821,1.0,12/36,14.24%,MAP3K20;HINFP;BRIP1;TIPIN;CHEK1;RAD9A;ERCC6;HUS1B;FBXO6;RHNO1;CLOCK;INTS7
prerank,keratan sulfate metabolic process (GO:0042339),-0.4176801961751881,-1.3313024792241808,0.10847457627118644,0.7256276665857297,1.0,15/31,23.35%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL1;B4GALT6;ST3GAL3;HEXA;FMOD;B4GALT4;GALNS;CHST2;SLC35D2;OMD;B3GNT2;B4GALT3
prerank,positive regulation of gene expression (GO:0010628),0.4349756942347348,1.3311149458763487,0.02208835341365462,0.7921495989411447,1.0,52/442,8.44%,MYOM1;ACTA2;MYLK2;TTN;ACTG2;MEF2C;NTRK3;RBM24;HEY2;ACTA1;ANGPT1;ROCK1;FGF1;CD36;POLR2L;LIMS1;MYD88;PDGFB;VIM;GABPA;HINFP;SAMD4A;ACTG1;NAT10;MUSK;RBMS3;UBR5;ACTB;OSR2;SLC38A2;EMILIN1;DYRK1A;TESC;U2AF2;MYBBP1A;TP53;SLC2A10;VEGFA;RPS27L;CIRBP;AR;PPARGC1A;MED1;CELF1;YAP1;NAT8;ERCC6;C1QTNF1;SOX9;PYM1;CUX2;TENT4A
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4832177984774662,-1.330428978206321,0.11369509043927649,0.7259021350401376,1.0,5/18,8.49%,IGF1;IGFBP2;HMGB1;IL18;IGF2
prerank,positive regulation of hydrolase activity (GO:0051345),0.4511009070750099,1.3303357647255407,0.09219088937093275,0.7928849922636931,1.0,23/137,8.17%,ARHGEF7;RAP1A;RGS6;LIMS1;RASGRP2;FERMT2;DOCK8;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;LARS1;MAPRE2;PIN1;CD200;CALM1;RAPGEF6;RASGRP1;EVI5
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5249780927264293,-1.3298562956469415,0.1513647642679901,0.725119498345094,1.0,6/14,17.21%,SPRED2;XDH;ZEB1;OSR1;SPRY2;NOTCH4
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5222883081306195,1.3293974003019617,0.13820078226857888,0.7943883474446263,1.0,10/48,10.00%,GUCY1A1;AMPD1;ADCY5;ADCY2;ADCY9;GUCY1B1;AMPD2;NUDT2;ADCY6;NPR2
prerank,C4-dicarboxylate transport (GO:0015740),-0.5094687130833857,-1.3293523545021608,0.1486810551558753,0.7239850888204191,1.0,10/14,31.79%,SLC25A14;SLC25A30;SLC25A11;LRRC8D;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC13A5;SLC1A6
prerank,neural crest cell differentiation (GO:0014033),0.604767270335876,1.3285261940056565,0.1819620253164557,0.7956665992504142,1.0,5/18,11.69%,MEF2C;TAPT1;SNAI2;CDH2;HTR2B
prerank,positive regulation of filopodium assembly (GO:0051491),-0.45094703512572964,-1.3282684078733618,0.12666666666666668,0.7248241444566904,1.0,14/24,28.38%,PALM;DOCK11;NRP1;NLGN1;FNBP1L;RIPOR2;DPYSL3;RHOQ;CDC42;FMR1;GPM6A;FSCN1;ARAP1;TENM1
prerank,regulation of vasoconstriction (GO:0019229),0.5608726855783336,1.3281319612764508,0.1593984962406015,0.7952141272537547,1.0,5/27,8.74%,AGTR1;ADRA1D;CAV1;ATP2B1;TRPM4
prerank,negative regulation of hemostasis (GO:1900047),-0.5385197872826498,-1.3277573407600345,0.15575620767494355,0.7236652386842449,1.0,5/12,8.26%,APOE;VTN;TFPI;CD34;THBD
prerank,sphingosine metabolic process (GO:0006670),-0.4847111828641133,-1.3275227799701734,0.1189873417721519,0.7213380945407575,1.0,5/17,9.94%,SPTLC2;ACER2;NAAA;SGPP1;ASAH2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5214286984026236,1.3270463260744283,0.15512465373961218,0.7974440469309598,1.0,15/37,18.38%,ROCK1;PHLDB2;CLASP2;BICD2;MAPRE2;MAPT;TPPP;CLASP1;STMN2;PRKAA2;MAPRE3;CDK2AP2;MARK2;BICD1;MAP6
prerank,DNA damage checkpoint signaling (GO:0000077),0.5600455430240121,1.326726987295531,0.17293233082706766,0.7968335164572189,1.0,11/28,14.24%,MAP3K20;HINFP;BRIP1;CHEK1;RAD9A;ERCC6;STK33;FBXO6;RHNO1;CLOCK;INTS7
prerank,cellular protein catabolic process (GO:0044257),-0.3679120100603072,-1.3251049885517803,0.09859154929577464,0.7274392623998923,1.0,20/59,20.62%,DENND3;RAB12;CTSL;CTSH;CASP8;MDM2;AFG1L;PRKN;AP2S1;CTSB;TCIRG1;YME1L1;CLPX;CHEK2;SIAH2;AP2A2;CLTA;BNIP3L;CLPP;CTSS
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5970782866616914,1.3244843104208006,0.16401273885350318,0.8030619472589059,1.0,4/18,6.87%,AGTR1;SIRT3;FXN;GDNF
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6117911550326468,1.3244705340056893,0.1718213058419244,0.8013415372907141,1.0,4/16,5.14%,MEF2C;AKAP6;TBX2;BMPR1A
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4645963120368105,-1.3239607470017236,0.13850415512465375,0.7286353815702116,1.0,5/19,18.63%,IGF1;PYDC1;CX3CL1;GIT1;ZC3H12A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6473428226120531,1.3229444940497408,0.17770034843205576,0.8051578590298938,1.0,2/11,3.06%,ANXA1;SOCS5
prerank,cell junction organization (GO:0034330),0.48565806470113143,1.3227807202133288,0.1361963190184049,0.803970999383771,1.0,14/71,7.87%,FLNA;MYOT;LIMS1;FERMT2;SLC8A2;ACTG1;TGFB3;FLNC;ACTB;PPFIBP2;MAPT;LIMS2;PIN1;TGFB2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6214825626658487,1.3223107901601108,0.19859402460456943,0.8039184045881237,1.0,6/13,7.03%,MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4
prerank,regulation of endocytic recycling (GO:2001135),0.6479847981906699,1.321713243322599,0.18971631205673758,0.8042722577869503,1.0,4/11,9.98%,PLA2G3;EHD2;ARHGAP1;ACTN2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.500038245597741,-1.3216952023482564,0.12378640776699029,0.7345341083776958,1.0,4/16,24.30%,CLDN5;CLDN11;CLDN1;CLDN14
prerank,vascular transport (GO:0010232),-0.33815890226128886,-1.3213640672539126,0.06358381502890173,0.7326925343896008,1.0,25/81,10.47%,SLC24A3;ATP1A2;SLC6A13;LEPR;SLC16A12;SLC1A3;SLC13A3;LRP1;SLC22A8;ABCG2;SLC2A13;ATP8A1;SLC2A1;SLC12A2;SLCO2B1;SLC6A1;SLC6A6;SLC16A1;SLCO1C1;SLC7A5;SLC6A9;SLCO3A1;ABCC4;ATP1B2;SLC5A5
prerank,negative regulation of leukocyte migration (GO:0002686),0.6531891926026884,1.3208797002456145,0.1970260223048327,0.8053633540027878,1.0,4/10,8.35%,EMILIN1;CD200R1;CD200;CD300A
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.5140021375529219,-1.3208671735215225,0.13592233009708737,0.7314654295664023,1.0,9/15,30.52%,USP46;STXBP1;NLGN1;SYN3;NLGN2;CLN3;DRD2;BAIAP3;CNTNAP4
prerank,triglyceride biosynthetic process (GO:0019432),-0.4749867421199181,-1.32053083515624,0.13802816901408452,0.7297211209826108,1.0,6/18,18.52%,AGMO;LPGAT1;LPIN2;PCK2;GPAM;LPIN3
prerank,dorsal/ventral pattern formation (GO:0009953),-0.46161370368251814,-1.3198356140830607,0.13803680981595093,0.7296555361135413,1.0,5/20,4.12%,NBL1;GLI2;PTCH1;DSCAML1;ACVRL1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5334553603666055,1.319552030146967,0.1782312925170068,0.8083823102213853,1.0,6/33,6.52%,ATP2B4;TCIM;FAM83D;MN1;TAF1;FBXW7
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.634167408793874,1.319461965617634,0.1837837837837838,0.8068931805070654,1.0,2/12,2.86%,CD36;SLC5A3
prerank,cellular defense response (GO:0006968),0.5227407380411113,1.3192267568144742,0.1584553928095872,0.8059957035369496,1.0,5/40,7.90%,NCF2;LGALS3BP;ITGB1;VEZF1;RELA
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5462250796550195,-1.3186859615217206,0.15434782608695652,0.731037562213437,1.0,10/11,44.03%,PARP11;PARP10;PARP3;PARP14;PARP12;PARP4;PARP16;PARP6;PARP8;PARP9
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6255264158902011,1.3182975809393536,0.2016949152542373,0.8075962300078298,1.0,3/13,4.75%,CACNA1H;SYT10;KCNB1
prerank,regulation of cell adhesion (GO:0030155),0.4493067655662619,1.3181381065473792,0.11399548532731377,0.8064719831373339,1.0,20/129,6.98%,TPM1;PPP1R12A;ZFHX3;ANGPT1;ROCK1;PPP3CA;SEMA5A;PLXND1;PLXNB1;CDH13;CYTIP;CCL5;RSU1;ARHGDIG;TESC;CBLL1;ZDHHC2;DSCAM;VEGFA;YTHDF2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.47296045456383,1.3176280493971533,0.13048933500627352,0.8065627361210922,1.0,14/75,11.29%,MYOCD;SLC8A1;NR2F2;DAB2IP;PKIB;HEXIM1;PTPN1;PKIA;CD300A;PRKAR1B;GSTP1;RB1;LRP5;PRKCD
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5633954658539023,1.3171290810841378,0.16718266253869968,0.8065488633275517,1.0,6/27,8.61%,AGTR1;CD36;PLA2G3;LPL;ITGB3;PPARA
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4669051825113561,1.315862394275201,0.11945392491467577,0.8091824770942498,1.0,19/104,10.68%,ASPN;PRDM16;RBPMS2;VASN;CRIM1;FST;ACVR2A;TGFB1I1;BMPR1A;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI;VWC2L;UBE2D1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.5142190318006308,-1.3153129355851672,0.13551401869158877,0.7408648161404068,1.0,8/14,27.37%,ERN1;NCBP2;CPSF2;CPSF6;CSTF2T;CPSF4;CSTF2;CPSF1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4803351544662304,1.3145240719254356,0.13711583924349882,0.812120125212165,1.0,16/75,11.24%,MEF2C;SDC2;MAP1B;CDHR1;SLITRK5;ACTB;KLF7;MEF2A;SLITRK4;AFG3L2;RAB3A;BRSK1;S100A6;TBCD;RB1;ZDHHC17
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5399079175540215,1.314362860813886,0.15877437325905291,0.8109083275546545,1.0,5/33,5.38%,MEF2C;ATP2B4;ANGPT2;ANGPT4;MMRN2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.484560973003044,-1.3142411902512898,0.13959390862944163,0.7419178226864304,1.0,10/17,19.75%,ROBO1;EFNB2;SLIT2;NRP1;PIK3R3;KDR;AKT1;FGF2;EPHB4;MIA3
prerank,cellular response to glucagon stimulus (GO:0071377),0.6061445336125658,1.3137087643169547,0.17609046849757673,0.8115034718774807,1.0,7/17,9.47%,ADCY5;ADCY2;ADCY9;CYSLTR2;PRKACB;PRKAR1B;ADCY6
prerank,protein import into mitochondrial matrix (GO:0030150),-0.4810520381104917,-1.3135000394864864,0.1220159151193634,0.7417019252374873,1.0,12/18,40.29%,TIMM44;DNAJC19;TIMM17B;TOMM70;TIMM21;TIMM23;GRPEL1;DNLZ;TOMM40L;TOMM40;TIMM50;GRPEL2
prerank,cAMP metabolic process (GO:0046058),0.6311974460669297,1.3134260969076872,0.21291448516579406,0.8108001568779806,1.0,6/13,11.19%,ADCY5;ADCY2;ADCY9;ADCY6;EPHA2;PDE4D
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5115063856918404,1.312591160510159,0.1690885072655218,0.811827954204824,1.0,2/46,0.44%,DGKB;DGKG
prerank,axon guidance (GO:0007411),0.4378842005196528,1.3119257325992704,0.07194994786235662,0.8124600071469729,1.0,26/201,7.09%,NTN4;NEXN;SLIT1;SLIT3;NOTCH3;PALLD;ENAH;MYPN;ROBO3;LAMA5;SEMA5A;PLXND1;PLXNB1;NTN1;PDLIM7;CHN1;SEMA6C;KLF7;PRKCQ;DOK4;DSCAM;DOK2;VEGFA;DOK1;GDNF;CYFIP1
prerank,regulation of hemopoiesis (GO:1903706),-0.5597334103115914,-1.3111575889917193,0.125,0.7475566506567631,1.0,2/10,0.40%,PTN;PRKCB
prerank,cell junction assembly (GO:0034329),0.4658781026063396,1.3108087043160568,0.12977983777520277,0.8145762767158748,1.0,19/100,8.71%,FLNA;CDH6;IGFN1;LIMS1;GJC1;FERMT2;FZD5;PLXND1;ACTG1;FLNC;KIRREL3;ACTB;CDHR3;PCDHB14;DSCAM;LIMS2;TLN1;PCDHB11;CDH2
prerank,synapse organization (GO:0050808),0.4566394701364256,1.3103851998017215,0.11123470522803114,0.8143084728240931,1.0,24/125,8.71%,CACNB2;MYOT;IGFN1;FZD5;PLXND1;SLC8A2;PDZRN3;MUSK;CACNB4;KIRREL3;PTPRS;DOK7;GPC4;PPFIBP2;PCDHB14;PTPRF;MAPT;DSCAM;PIN1;NEDD4;CYFIP1;PCDHB11;ARHGAP39;CDH2
prerank,negative regulation of peptidase activity (GO:0010466),0.49824623424033915,1.3069528169788482,0.14555256064690028,0.8247739991793035,1.0,4/47,6.82%,SERPINB8;SERPINI1;SERPINE2;TIMP4
prerank,regulation of phospholipase C activity (GO:1900274),0.6210816255775107,1.3067470137482475,0.19759450171821305,0.8237346843653565,1.0,2/15,0.77%,NTF3;NTRK3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.589488719818798,1.306463766416392,0.2023217247097844,0.8230410061774239,1.0,5/17,7.72%,HEY2;HEYL;JAG1;BMPR1A;SNAI2
prerank,synaptic vesicle recycling (GO:0036465),-0.4229010718129917,-1.306073631259448,0.14285714285714285,0.7644320205231798,1.0,13/31,16.00%,FCHO2;RAB5A;NLGN1;SYT1;CANX;STON2;OPHN1;TBC1D24;SNCA;NLGN2;NLGN3;PLD2;STX1A
prerank,mesenchyme morphogenesis (GO:0072132),0.5844297280644225,1.305842804474319,0.1875968992248062,0.8235958123735909,1.0,5/17,7.87%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.6158752096044349,1.3058033874191226,0.18858131487889274,0.8220212803691482,1.0,2/15,2.51%,FGF1;SEMA5A
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5545860903912248,-1.3056484875828063,0.17819706498951782,0.7630066484604403,1.0,4/10,12.70%,UFD1;SEC14L1;RIOK3;RNF125
prerank,catecholamine biosynthetic process (GO:0042423),-0.5323791908065694,-1.30553782555914,0.15945330296127563,0.7604193360238573,1.0,4/11,18.30%,MOXD1;SNCA;GCH1;DDC
prerank,macrophage migration (GO:1905517),0.6333918315758453,1.305515987120664,0.2111692844677138,0.821367882456193,1.0,2/13,3.64%,EDNRB;CCL5
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5354394079787614,1.305407408033673,0.16161616161616163,0.8200288755913432,1.0,13/33,19.08%,MAP3K5;ANXA1;NET1;FXN;RELA;IMPACT;PRKCD;TRPM2;PLEKHA1;ANKZF1;SIGMAR1;HDAC6;ABL1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3764186185778832,-1.3052525368857504,0.07806691449814127,0.7584631907624667,1.0,13/46,10.72%,LGR4;ALDH1A1;ZNF423;IL15;NRDC;NPR3;IP6K1;ID1;FOXC2;NOVA1;STK11;LAMA4;RHEB
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5102919242159316,1.3045957890925692,0.15567282321899736,0.8212494484657514,1.0,8/49,8.05%,MYL9;MEF2C;THPO;CBFB;CNOT4;PRKCQ;TESC;KMT2D
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.487990543077918,1.3027479631865528,0.13309352517985612,0.8260911827603729,1.0,16/65,12.04%,ARHGEF7;HIP1;ITGA1;CDH13;BCAR3;NUP62;DAB2IP;DUSP3;DOK1;NEU3;AREG;DGKD;HBEGF;STAM2;GPER1;TSG101
prerank,cellular response to nitrogen compound (GO:1901699),0.5749940464536184,1.3022794479171096,0.21085271317829457,0.8259620015825125,1.0,2/20,1.64%,ATP2B4;NR1H4
prerank,peptidyl-amino acid modification (GO:0018193),-0.5559042190954443,-1.3015140079725946,0.1552511415525114,0.7700435578885972,1.0,3/10,11.02%,METAP1D;TTLL4;FKBP10
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.46779939439281903,-1.301460222341538,0.14772727272727273,0.7672291295593363,1.0,6/17,4.01%,DOCK4;IGF1;DOCK5;VTN;NRP1;ADAMTS1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5342182391065748,-1.3013528511145667,0.18604651162790697,0.7646334023061931,1.0,5/12,16.53%,F3;APOD;SNCA;HGS;NDRG4
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.49546371266383765,-1.3002075008924807,0.13615023474178403,0.7658721645301584,1.0,7/15,18.62%,SEL1L;DERL1;UFD1;HSP90B1;OS9;SYVN1;HERPUD1
prerank,negative regulation of axon extension (GO:0030517),-0.3958500849986415,-1.2984947325455531,0.11041009463722397,0.7694529063132199,1.0,10/30,12.46%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;RNF6;SEMA3A;SEMA4D;CDKL3;SEMA6D;RTN4
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.38163958307884777,-1.2967961718047347,0.08487084870848709,0.7731210722842651,1.0,14/39,11.12%,PIK3CA;PI4KA;PIK3R3;IP6K1;EFR3A;SMG1;SOCS7;PIP4K2B;PI4K2A;SOCS2;EFR3B;PIK3CB;TTC7B;IP6K2
prerank,epithelial tube morphogenesis (GO:0060562),0.5367982397103598,1.2966245411465815,0.19368723098995697,0.8440840003692832,1.0,3/32,0.87%,RYR2;MEF2C;COL4A1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4393390794399198,-1.2966203661261702,0.1111111111111111,0.7707637977544474,1.0,7/23,11.45%,PRKAG2;CEMIP;BMP7;APP;WNK3;TGFB1;IRGM
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.45572160885276825,1.2965722855209874,0.12993039443155452,0.8425220225942851,1.0,23/102,11.29%,LHCGR;SLC2A4;ADCY5;ADCY2;NR4A1;ADCY9;HDAC9;TSHR;CYSLTR2;IRS1;CAV1;SORBS1;CPEB1;PARP1;GOT1;RELA;PRKACB;PRKAR1B;NR4A2;ADCY6;SLC39A14;GPER1;PRKCD
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.368679318877389,-1.2959802268815503,0.09163346613545817,0.7700706607523606,1.0,17/46,15.10%,ATP1A2;TSHZ3;GRM3;GRM7;NLGN1;PTK2B;SHANK3;SYT1;DGKI;CACNG4;NRXN1;GRIK3;OPHN1;GRM5;NLGN2;NLGN3;CLN3
prerank,neuronal action potential (GO:0019228),0.567725524186125,1.2959493661828645,0.1838006230529595,0.8430041398907958,1.0,2/22,1.95%,SCN4A;CACNA1H
prerank,negative regulation of neuron death (GO:1901215),0.45421961971091357,1.2957060907420073,0.13986013986013987,0.8421385968591957,1.0,13/93,7.63%,NTF3;MEF2C;PLA2G3;CRLF1;TGFB3;INPP5A;SET;BCL2;CD200R1;GDNF;CD200;PPARGC1A;FZD9
prerank,regulation of receptor binding (GO:1900120),0.6429824534313837,1.295235895931502,0.23642732049036777,0.8421294858650648,1.0,4/10,10.33%,ATP2A2;GREM2;PTPRF;ATP2A3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.35285642403695433,-1.2939524390670392,0.09268292682926829,0.7748399990052923,1.0,24/58,25.04%,HMGB1;KDM2A;PRKDC;XRCC5;MRE11;RAD50;HERC2;BRCC3;LIG3;MDC1;POLM;XRCC6;NBN;SMC5;ATM;DCLRE1A;IFFO1;UVRAG;NSMCE2;PRPF19;SMARCAL1;ERCC1;ERCC4;DCLRE1B
prerank,regulation of mast cell degranulation (GO:0043304),0.5963835955971112,1.2933687706010113,0.20209059233449478,0.8469679297149737,1.0,3/14,8.35%,STXBP2;UNC13D;CD300A
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.4239288745473904,-1.292876519608314,0.1373134328358209,0.7762062625054751,1.0,13/26,23.35%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL1;B4GALT6;ST3GAL3;FMOD;B4GALT4;CHST2;SLC35D2;OMD;B3GNT2;B4GALT3
prerank,oogenesis (GO:0048477),-0.49131051522665053,-1.2926585424389305,0.1618798955613577,0.7741407452273594,1.0,3/15,8.81%,PTN;MARF1;METTL3
prerank,phospholipid transport (GO:0015914),-0.36099647925493383,-1.2922426399280753,0.08181818181818182,0.7727636599703454,1.0,13/52,8.33%,OSBPL8;PITPNA;ATP8A1;PLTP;APOE;ABCA1;ABCA4;LDLR;ATP11C;ATP8A2;SCARB2;PITPNC1;TMEM30A
prerank,positive regulation of acute inflammatory response (GO:0002675),0.612459466251124,1.292018753876843,0.19759450171821305,0.8500952919754318,1.0,1/14,1.47%,PTGER3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5087350988852264,-1.2919722653645973,0.15897435897435896,0.7707630248509013,1.0,10/13,44.76%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;GAL3ST3;B3GNT6;B4GAT1
prerank,neuromuscular process controlling balance (GO:0050885),-0.5172026964757048,-1.290671949525528,0.1686746987951807,0.772979651307845,1.0,8/12,38.99%,PAFAH1B1;NRXN1;CLN3;TPP1;PCDH15;CDH23;MYO7A;SHANK1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5907720634198199,1.2906248056051277,0.22727272727272727,0.8532806095972904,1.0,5/16,8.05%,MEF2C;RBM24;SMYD1;BTG1;PLCB1
prerank,sterol metabolic process (GO:0016125),-0.3500782979502798,-1.2904179852751445,0.09292035398230089,0.7710156684959835,1.0,33/60,36.85%,PRKAG2;CYP27A1;APOE;ABCA1;LBR;CYP26B1;CYP1B1;CYP51A1;HMGCR;SOAT1;ARV1;INSIG1;PIP4P1;SQLE;GBA2;PMVK;LIPA;FDXR;CLN8;RXRA;INSIG2;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;SC5D;TM7SF2;SCAP;DHCR7;CH25H;LCAT
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6486732503179928,1.2903955781065486,0.2246376811594203,0.8523158278908374,1.0,1/11,0.93%,AKAP6
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.4421521294123563,-1.2901987722624086,0.1523545706371191,0.7689020067460121,1.0,7/20,11.10%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5011997798302793,-1.2895248064772782,0.15571776155717762,0.7685183650289328,1.0,2/14,0.77%,ANK2;ATP1B3
prerank,plasma membrane tubulation (GO:0097320),0.6035149308505074,1.2894283860054014,0.21232876712328766,0.8540488770004752,1.0,6/13,12.60%,PACSIN3;PACSIN2;EHD2;WHAMM;PACSIN1;SNX9
prerank,negative regulation of hippo signaling (GO:0035331),0.625441441206945,1.2893521155905543,0.21808510638297873,0.8526115604256903,1.0,2/12,1.88%,WTIP;LIMD1
prerank,positive regulation of axonogenesis (GO:0050772),-0.3811415921230918,-1.2893152153063623,0.13924050632911392,0.766399000374641,1.0,9/43,8.23%,PLXNA2;ROBO1;SLIT2;SEMA7A;RUFY3;TIAM2;GOLGA4;SEMA4D;PLXNA4
prerank,neuromuscular process (GO:0050905),-0.47955102901911506,-1.2892349866707196,0.13550135501355012,0.7638602264269205,1.0,7/16,25.86%,MYCBP2;PAFAH1B1;NRXN1;GCH1;CLN3;TPP1;UBA5
prerank,actin polymerization or depolymerization (GO:0008154),0.49436336764692873,1.2892178188079888,0.16996047430830039,0.851353368468224,1.0,7/50,8.54%,ENAH;DSTN;MICAL2;WDR1;ARHGAP6;CFL2;SPIRE1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3480117258048993,-1.2884234177539244,0.08121827411167512,0.7639813920409887,1.0,18/61,17.41%,EYA2;EYA1;EYA4;HMGB1;EGFR;MRE11;PML;RAD50;PARP3;USP7;SMCHD1;BRCC3;RGCC;GNL3;NBN;FGF2;NPAS2;WRAP53
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.44500316896855957,1.2883984332959426,0.11160220994475138,0.8525570921050702,1.0,33/140,11.61%,OBSCN;ARHGEF7;DLC1;KALRN;ABR;PLCE1;ARHGEF17;MYO9B;DEPDC1B;ITSN1;NET1;NUP62;ARHGAP21;ARHGAP10;ARHGEF16;CHN1;ARHGAP6;ARHGEF2;ARHGDIG;RHOJ;ARHGAP17;RHOF;ARHGAP39;ARHGAP30;ARHGEF4;ARHGAP1;ARHGAP12;VAV1;INPP5B;ARHGAP15;ARHGAP5;RHOH;ARHGAP35
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.34803720594457316,-1.2882946230735477,0.07589285714285714,0.7615838328850869,1.0,14/57,12.17%,IGF1;IL31RA;IL15;KIT;GHR;NF2;IL18;PPP2CA;ARL2BP;TNFRSF1A;IL6R;HES1;LYN;PARP14
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5734842415905805,1.2881078066010223,0.20454545454545456,0.851836683109077,1.0,4/16,13.21%,RBM24;UPF1;CPEB3;ZFP36L1
prerank,regulation of protein export from nucleus (GO:0046825),-0.42818921504025215,-1.2876562281156225,0.15895953757225434,0.7611038472589451,1.0,8/23,14.80%,PTPN14;TCF7L2;CAMK1;UHMK1;SIRT7;RANGAP1;SP100;EMD
prerank,B cell homeostasis (GO:0001782),0.6597917553980415,1.287434379534884,0.23290203327171904,0.8524425710213406,1.0,2/10,3.54%,MEF2C;DOCK10
prerank,positive regulation of mitochondrial translation (GO:0070131),0.6046864456462083,1.286905183471452,0.23407917383820998,0.852548463414464,1.0,9/14,20.38%,RPUSD3;TRMT10C;RCC1L;RPUSD4;FASTKD2;TRUB2;RMND1;UQCC2;C1QBP
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.4107611218995464,-1.2868613409081684,0.1340782122905028,0.7613420993944384,1.0,11/30,19.26%,DDX3X;TNFSF10;CASP8;BCL2L1;NOS3;RNF34;FAIM;GPX1;SERPINE1;TMBIM1;PARK7
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.399212012536655,-1.286672900179308,0.14655172413793102,0.7593128636698191,1.0,16/32,26.50%,CDC14B;MRE11;RINT1;BRCC3;BLM;NBN;TAOK1;FOXN3;NOP53;ATM;HMGA2;TAOK2;TRIM39;CLSPN;CDKN1A;DONSON
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.49273223625265594,1.286368778426728,0.16973684210526316,0.8528456305788036,1.0,6/54,2.09%,MEF2C;ATP2B4;ANGPT2;ANGPT1;ANGPT4;PDGFB
prerank,hexose transmembrane transport (GO:0008645),0.562579087175295,1.2859624360997726,0.1951219512195122,0.8525931782637248,1.0,3/21,6.46%,SLC2A4;SLC5A3;SLC2A10
prerank,mitochondrion disassembly (GO:0061726),-0.39087707327392407,-1.285793570700839,0.1299638989169675,0.7595989126663304,1.0,20/34,28.27%,RB1CC1;CISD2;ATG3;FBXO7;ATG5;PRKN;ATG2B;AMBRA1;WIPI2;ATG2A;FIS1;GABARAPL2;WDR45B;MAP1LC3A;ULK2;GABARAPL1;WIPI1;SQSTM1;MAP1LC3B;ATG12
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.38691975550032515,-1.285553537423162,0.125,0.757697881704181,1.0,15/39,21.39%,BMP6;WNK1;NF2;PTK2;PODXL;CDH1;FXYD5;RDX;TGFB1;RGCC;PPM1F;AKT1;NOTCH4;MIA3;ASS1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4091976363331984,-1.2853892208626023,0.12861736334405144,0.7555587677144221,1.0,10/31,11.76%,PDGFRA;HOXB3;HOXA3;DSCAML1;HOXB4;MEGF8;OSR1;FGFR2;SIX1;TGFBR1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6321230569578173,1.2847009571120744,0.22527472527472528,0.8555112645509877,1.0,4/10,14.21%,GALNT16;GALNT3;GALNT2;GALNT1
prerank,polyol metabolic process (GO:0019751),0.5004717052586498,1.2841393813385849,0.18392370572207084,0.8558135032903098,1.0,13/46,12.09%,ITPK1;PLCE1;INPP4B;PLCB4;SLC5A3;INPP5A;NUDT4;CALM1;PLCB1;INPPL1;PLCD1;INPP5B;ITPKC
prerank,regulation of lipid metabolic process (GO:0019216),0.45451437503117775,1.283868029788874,0.1548311990686845,0.8550549660782252,1.0,19/88,15.95%,CCDC3;SMARCD3;ANGPTL8;RORA;RARRES2;CAV1;ACACB;IDI1;MED1;MVD;PPARA;NR1D1;SREBF2;TGS1;ZFP69;EDF1;IRS2;SIN3A;SP1
prerank,regulation of neuron differentiation (GO:0045664),0.47062719286680504,1.2835994770968855,0.1552723059096176,0.8543012288010419,1.0,7/76,5.09%,NTF3;MEF2C;ZFHX3;ROCK1;HEYL;MMD;ARHGEF2
prerank,regulation of gastrulation (GO:0010470),0.6057057266926547,1.283425902744283,0.2157190635451505,0.8532708205121976,1.0,2/14,2.63%,PHLDB2;CLASP2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.4444268744546169,-1.2832977294767864,0.1875,0.7579974445640338,1.0,10/20,21.63%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C;PFKFB3;PRKAA1
prerank,positive regulation of glycolytic process (GO:0045821),-0.4444268744546169,-1.2832977294767864,0.1875,0.7579974445640338,1.0,10/20,21.63%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C;PFKFB3;PRKAA1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.42005728320636443,-1.2823292243719528,0.15030674846625766,0.759076985149855,1.0,9/24,11.10%,SEMA3D;SEMA3C;SEMA6A;NRP1;SEMA7A;MEGF8;SEMA3A;SEMA4D;SEMA6D
prerank,positive regulation of peptidase activity (GO:0010952),-0.4569369994798797,-1.2823130444386974,0.1575,0.756437528642253,1.0,11/20,35.22%,CTSH;APH1A;RCN3;NCSTN;APH1B;GRN;PSME3;PSENEN;PSME1;PSME2;NDUFA13
prerank,regulation of innate immune response (GO:0045088),-0.3520152735854078,-1.2816344319501405,0.0970873786407767,0.7561019522618984,1.0,37/57,38.57%,APPL2;IFNAR2;PTPN11;RNF135;POLR3F;CASP8;HSP90AB1;BIRC2;PTPN22;IRAK3;SAMHD1;RIOK3;POLR3B;LRP8;APPL1;BIRC3;TIRAP;SLC15A4;GBP5;RNASEL;TRIM21;POLR3C;NLRC3;POLR3D;USP18;TNFAIP3;NMI;TYRO3;LYAR;PTPN6;PLSCR1;DHX58;ADAM8;XIAP;IRF1;FGR;FCGR2B
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.537664090148866,1.2815994802047872,0.1976225854383358,0.8579450807809431,1.0,15/28,20.87%,CLASP2;MAP1B;PRUNE1;MAPRE2;MAPT;CLASP1;STMN2;MAPRE3;FKBP4;MAP1A;MAP1S;ABL1;CAMSAP1;STMN3;MAPRE1
prerank,sodium ion transport (GO:0006814),0.4634051168379041,1.2814480574266471,0.13849765258215962,0.8568396867308534,1.0,10/85,3.95%,FGF13;SCN4A;ASIC3;SLC6A17;ANO6;SLC8A2;SLC8A1;SLC4A8;SLC6A2;SLC6A5
prerank,membrane assembly (GO:0071709),-0.3948103791655956,-1.2811072645579848,0.132013201320132,0.7554512305347174,1.0,10/34,15.06%,SPTBN1;ANXA2;SPAST;NLGN1;STX4;PTPRD;NRXN1;NLGN2;NLGN3;S100A10
prerank,gliogenesis (GO:0042063),0.5903228594667121,1.2810607177793503,0.21869782971619364,0.8565241841369711,1.0,5/15,11.80%,CDK6;ANXA1;TGFB2;CDH2;NDUFS2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.49386360716775135,-1.28035540727402,0.1643835616438356,0.7556627270825541,1.0,4/15,6.93%,APOE;APP;LDLR;IAPP
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.5724340684466936,1.2798518197395397,0.19141914191419143,0.8590757432834801,1.0,5/18,13.52%,PMAIP1;BCL2;HEBP2;THEM4;MUL1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6005297169971199,1.279810386406751,0.23202614379084968,0.8575440545161948,1.0,2/14,7.41%,AGTR1;ENPEP
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5201449172593604,1.2794987787101888,0.17307692307692307,0.8570186219935941,1.0,6/36,6.25%,MEF2C;ATP2B4;ANGPT2;ANGPT4;NR2F2;DAB2IP
prerank,Golgi inheritance (GO:0048313),-0.5379740558874184,-1.2794065939988795,0.18303571428571427,0.7564327874508645,1.0,6/11,23.79%,GBF1;STX5;VCPIP1;STK25;YWHAZ;PLK5
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6189205642916837,1.2793135411572654,0.2208029197080292,0.8559827059848718,1.0,9/13,19.54%,UBA2;ATG7;SAE1;UBA3;SENP6;UBA1;DESI2;DESI1;ATG10
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5408642735410103,-1.279008881563314,0.19461697722567287,0.7553206141629958,1.0,3/10,9.30%,ADGRV1;WHRN;IFT88
prerank,histone monoubiquitination (GO:0010390),-0.42888243913863433,-1.2789277202270584,0.16758241758241757,0.7529474025537019,1.0,7/24,16.64%,RNF20;RYBP;CTR9;DDB1;DTX3L;LEO1;BCOR
prerank,positive regulation of interleukin-17 production (GO:0032740),0.549065513800101,1.2787613505951108,0.1984,0.8562385127394565,1.0,4/22,5.51%,NR1H4;MYD88;IL2;PRKCQ
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6414343715163986,1.278596471240608,0.23539823008849559,0.8551194774129979,1.0,1/10,0.13%,PLN
prerank,triglyceride catabolic process (GO:0019433),0.5644525111818601,1.2773103195533606,0.1918238993710692,0.8580971320227816,1.0,3/19,13.34%,LPL;FABP4;PNPLA3
prerank,presynapse organization (GO:0099172),-0.5579880240556916,-1.2770829016953735,0.18693693693693694,0.7569701754760328,1.0,4/10,14.46%,WNT5A;NLGN1;NLGN2;NLGN3
prerank,blood vessel morphogenesis (GO:0048514),-0.35229122431846643,-1.2764076571286656,0.10047846889952153,0.7567145426266161,1.0,20/54,14.30%,TGFBR3;FLT1;NF1;EFNB2;LAMA1;CCBE1;RASA1;NRP1;ENG;ID1;CYP1B1;RASIP1;CUL7;TGFB1;HES1;ITGB8;TGFBR1;RAMP2;KDR;SOX17
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4529712924010292,-1.2758485962308386,0.15521628498727735,0.756142690929493,1.0,6/19,12.30%,IGF1;NUPR1;IL18;DAGLA;PTGS2;IL33
prerank,cAMP biosynthetic process (GO:0006171),0.6426962427947811,1.2750061731576703,0.2509025270758123,0.8647345799765499,1.0,4/10,9.47%,ADCY5;ADCY2;ADCY9;ADCY6
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.45583379217378306,1.2746561262589298,0.1501787842669845,0.8643388560889489,1.0,13/90,7.66%,PRDM16;PRKAB2;CD36;PDGFC;EBF2;TSHR;CAV1;VEGFA;TRPV2;FABP4;PPARGC1A;PPARGC1B;DIO2
prerank,protein deacetylation (GO:0006476),0.49342791098548977,1.2735206819951919,0.18353576248313092,0.8666536696425136,1.0,16/41,18.91%,FLNA;HDAC9;SIRT3;MSL3;MTA3;SIRT2;MIDEAS;BAZ2A;MORF4L1;SIRT4;MTA1;SIN3A;SIRT6;HDAC1;RBM14;HDAC6
prerank,cell-cell junction assembly (GO:0007043),0.47315073139025365,1.2723044671716017,0.1811320754716981,0.8692370199759314,1.0,15/63,11.43%,CDH6;VCL;GJD3;GJC1;WDR1;ACTG1;ACTB;JAM3;CDHR3;TLN1;CDH2;PKN2;PAK2;TBCD;GJA4
prerank,axonogenesis (GO:0007409),0.42274079819831767,1.2718747431220827,0.09342915811088295,0.8690504993729862,1.0,27/237,7.09%,NTN4;NEXN;SLIT1;SLIT3;NOTCH3;PALLD;ENAH;MYPN;ROBO3;LAMA5;SEMA5A;MAP1B;PDLIM7;SLITRK5;ACTB;SEMA6C;KLF7;PRKCQ;SLITRK4;DOK4;DSCAM;DOK2;AFG3L2;DOK1;GDNF;RAB3A;CYFIP1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.40210036950280686,-1.2696991029533324,0.13622291021671826,0.7762742932995444,1.0,13/28,14.60%,APPL2;FOXP1;RNF135;CD55;CASP8;BIRC2;PTPN22;SAMHD1;TRIM5;CX3CL1;LRP8;APPL1;BIRC3
prerank,neuron migration (GO:0001764),0.48514463595384855,1.2689372159786547,0.18872870249017037,0.877651825558278,1.0,10/48,9.10%,FGF13;MEF2C;ASTN2;MAP1B;MARK1;VEGFA;TUBB2B;CEP85L;ASTN1;NR4A2
prerank,negative regulation of developmental growth (GO:0048640),0.5422147325432867,1.2685995623813588,0.1919191919191919,0.8771567096862369,1.0,3/30,4.99%,FGF13;NKD1;PTPRS
prerank,necroptotic process (GO:0070266),0.5894417381032425,1.2683670941283005,0.23865546218487396,0.8763376510784538,1.0,3/16,10.73%,ITPK1;CD14;DNM1L
prerank,somite development (GO:0061053),-0.5246042442644073,-1.2681149925521007,0.19550561797752808,0.7793518593680945,1.0,5/11,26.29%,PTCH1;MEOX2;SMO;LOXL3;SOX11
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4107819586807947,-1.2675782072953263,0.1317365269461078,0.7787930903614216,1.0,11/27,16.02%,FLT1;PDGFRA;KIT;TEK;PTK2;PTK2B;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,protein localization to plasma membrane (GO:0072659),0.43441696041873196,1.266683352511634,0.16095890410958905,0.8806067564067448,1.0,18/129,7.20%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;TTC7A;RAB3A;RAMP1;RAPGEF6
prerank,Golgi to plasma membrane transport (GO:0006893),-0.36497381248637284,-1.2665506691401869,0.13675213675213677,0.7801280585091823,1.0,12/47,17.49%,SPTBN1;VAMP5;RABEP1;GOLGA4;COMMD1;OPTN;GCC2;GOLPH3;BLZF1;EXOC2;STEAP2;EXOC1
prerank,negative regulation of JNK cascade (GO:0046329),-0.40259065630732227,-1.2662907755624904,0.13953488372093023,0.7784283313792125,1.0,13/31,24.16%,MECOM;ITCH;PTPN22;PRKN;PDCD4;SIRPA;SH3RF2;PER1;AIDA;HIPK3;DACT1;MAPK8IP1;CYLD
prerank,regulation of synapse organization (GO:0050807),0.534554550204421,1.26592734972513,0.2275449101796407,0.8815391410936592,1.0,6/26,11.34%,MEF2C;PDLIM5;SLITRK4;NEDD4;ABHD17B;IL1RAPL1
prerank,amino sugar metabolic process (GO:0006040),0.6391194280284587,1.2658079098107644,0.2568306010928962,0.8803474205328136,1.0,4/10,10.22%,CSGALNACT1;GNE;GFPT1;ST6GAL1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4250709064590832,-1.2657928674396213,0.1457142857142857,0.7776027996500438,1.0,6/23,9.36%,UACA;BMP7;DDX3X;PPM1B;HDAC7;CCN3
prerank,cellular response to virus (GO:0098586),-0.4081318249571363,-1.2656991080265427,0.13793103448275862,0.7752742900380695,1.0,12/30,18.66%,MAPK14;DDX3X;GSDME;LGALS9;GBF1;RIOK3;CHUK;IRGM;LGALS8;BAX;ZC3H12A;FMR1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5859095789555738,1.2649693698480258,0.2071307300509338,0.8816762285222957,1.0,4/16,8.04%,SLC5A3;SLC2A10;SLC23A2;SLC23A1
prerank,regulation of platelet aggregation (GO:0090330),0.5713306780965475,1.2647180972365113,0.22553897180762852,0.8809720113014206,1.0,7/17,14.87%,PRKG1;SERPINE2;PRKCQ;C1QTNF1;PRKCD;DMTN;PRKCA
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.350360738711759,-1.2640837322843386,0.10236220472440945,0.7786580100607514,1.0,17/49,21.01%,LDLRAD4;HMGB1;DDX3X;SMAD6;HSPA5;IAPP;PYDC1;PEX5;RIOK3;EP300;AIDA;NOP53;CDC42;PMEPA1;HSF1;PARK7;DACT1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3808015598732631,-1.263346088154369,0.14285714285714285,0.7787019128201816,1.0,10/37,14.55%,PRKAG2;CEMIP;BMP7;APP;SPRED2;WNK3;TGFB1;IRGM;SPRY2;DGKQ
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5528585342284176,-1.263039410254922,0.17286652078774617,0.7772245191759056,1.0,2/10,7.10%,WNT5A;CTNNB1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5196099765455421,1.2628226328042425,0.2040520984081042,0.8858796516840258,1.0,4/30,3.96%,ABRA;GPR20;SYNPO2L;NET1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.44755272862230666,1.2626829065235425,0.17018779342723006,0.8847145235438472,1.0,21/88,15.52%,SYNPO2;SYNPO2L;EMILIN1;MPP7;TPPP;DAB2IP;VEGFA;TRABD2B;PLEK;SLX4;SYNPO;HRK;STX18;TSG101;CLU;FNIP2;CHMP2A;HYAL1;PRKCA;STAM;FLOT1
prerank,ear morphogenesis (GO:0042471),-0.4449324500083144,-1.262290065823816,0.138328530259366,0.7774574900359678,1.0,9/20,26.20%,ZIC1;CHD7;OSR1;FGFR2;SIX1;MYO6;EPHB2;PAX8;TWIST1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6077533505647568,1.2619951828248976,0.21981981981981982,0.885424502442022,1.0,3/13,5.14%,MEF2C;TBX2;BMPR1A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.46189601691955817,1.2618776056846897,0.19128329297820823,0.8841909186475942,1.0,7/63,4.50%,MEF2C;ANXA1;IL2;TNFSF13B;CCL5;CD276;BCL2
prerank,T cell migration (GO:0072678),-0.4946934352387979,-1.2611969174596012,0.1905829596412556,0.7790040973560476,1.0,2/13,6.66%,SLC12A2;CXCL16
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.402882878571946,-1.261013881417289,0.13448275862068965,0.7771424488053784,1.0,10/30,19.67%,SDF2;DNAJB12;HSPA5;ENTPD5;BAG1;HSPA13;HSPA9;HSPE1;DNAJB4;ST13
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.49934557719385836,-1.2607613399088065,0.17804878048780487,0.7755147273257509,1.0,2/13,5.80%,NFAT5;IRAK1
prerank,cellular response to hormone stimulus (GO:0032870),0.4696655663699405,1.260437178598661,0.17556346381969157,0.8876435733354625,1.0,9/69,7.30%,SLIT3;LHCGR;MEF2C;CACNA1H;CAV1;ARID5A;AR;RAMP1;MED1
prerank,activation of protein kinase activity (GO:0032147),0.4405329505227154,1.2602280510800026,0.17406143344709898,0.8867398427307274,1.0,25/106,13.74%,NTF3;NTRK3;ANGPT1;FGF1;ADCY5;PDGFB;ADCY2;ADCY9;VEGFA;TPX2;PIBF1;ITGB3;TGFB2;PRKACB;PRKAR1B;PAK2;ADCY6;PRR5;PRKCD;COPS8;RICTOR;TNIK;TAOK3;GAS6;TNFRSF10B
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5060953349074938,-1.260199929462979,0.19070904645476772,0.7752425519178523,1.0,9/12,44.76%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.5257679439749835,-1.2591329663595392,0.18620689655172415,0.774256905250678,1.0,5/11,27.83%,AGO3;TNRC6A;NOTCH4;AGO4;ZFP36
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5257679439749835,-1.2591329663595392,0.18620689655172415,0.774256905250678,1.0,5/11,27.83%,AGO3;TNRC6A;NOTCH4;AGO4;ZFP36
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.46327703445381296,1.2569914866393126,0.17733990147783252,0.8964915684579345,1.0,6/73,6.51%,NTF3;NTRK3;ATP2B4;BCAR3;CAV1;VEGFA
prerank,positive regulation of stress fiber assembly (GO:0051496),0.48954022933317254,1.2568633692420836,0.19119669876203577,0.8953027184742659,1.0,5/44,3.75%,TPM1;SYNPO2L;FERMT2;TGFB3;PPM1E
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6101053817891574,1.2555212619587486,0.23550087873462214,0.8983171653798399,1.0,4/12,9.39%,GMNN;TIPIN;WRNIP1;KAT7
prerank,negative regulation of histone methylation (GO:0031061),-0.5296166192548158,-1.2554477737251326,0.2013274336283186,0.7854548148908096,1.0,6/10,37.69%,BCOR;KDM1A;JARID2;BRCA1;DNMT3B;AASS
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5004240119014358,1.2545541314281687,0.209366391184573,0.8999736816243826,1.0,5/35,8.09%,CDH6;CDH13;CDHR3;PCDHB14;PCDHB11
prerank,protein homotetramerization (GO:0051289),0.48305364678294704,1.2543942856775527,0.19079837618403248,0.8988424795820288,1.0,10/49,12.49%,RYR1;KCNJ12;HSD17B10;CRYZ;ACACB;TRPM4;ALDOA;GLS;OSBPL2;TRPM2
prerank,regulation of protein kinase C signaling (GO:0090036),0.5866941419932967,1.2541466273651307,0.23776223776223776,0.8981171479557731,1.0,4/14,11.10%,DGKG;VEGFA;DGKD;GPD1L
prerank,inorganic ion transmembrane transport (GO:0098660),0.5982844818575831,1.2540274618251361,0.253448275862069,0.8968772711898279,1.0,3/12,9.37%,CACNA1H;TRPM4;ABCC8
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6157289484657877,1.2539052711583838,0.25359712230215825,0.8956587608078096,1.0,6/11,12.64%,MAP3K5;ARL6IP5;STK24;PRKCD;DIABLO;PDCD10
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5278937091680043,1.2535163667049494,0.22782874617737003,0.8953393851529237,1.0,8/25,15.83%,CHMP4C;SORT1;LYST;CHMP5;DENND10;CHMP2B;CHMP2A;LEPROT
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5595089713191578,1.2532803382598605,0.2247191011235955,0.8945553912468863,1.0,3/17,4.10%,RYR2;SNTA1;KCNE4
prerank,negative regulation of secretion (GO:0051048),0.622127330154553,1.253017501992617,0.2476894639556377,0.8938194142883387,1.0,1/10,1.47%,PTGER3
prerank,lipoprotein catabolic process (GO:0042159),-0.5221553861904551,-1.2529747958407025,0.19602977667493796,0.7921235603125367,1.0,8/11,31.34%,APOE;LYPLA1;PPT1;NOTUM;ABHD17C;LYPLA2;CTSD;ABHD10
prerank,activin receptor signaling pathway (GO:0032924),0.5732319453868575,1.2528368959051535,0.21926910299003322,0.8927772821901084,1.0,2/15,4.04%,HJV;ACVR2A
prerank,positive regulation of metabolic process (GO:0009893),0.43996801084377957,1.2527518611161488,0.16724336793540945,0.8914489947407377,1.0,15/103,7.66%,PRDM16;PRKAB2;CD36;PDGFC;EBF2;TSHR;PIGA;CAV1;VEGFA;TRPV2;ACACB;FABP4;PPARGC1A;PPARGC1B;DIO2
prerank,female gonad development (GO:0008585),0.5577627116337662,1.2526768333687177,0.2387820512820513,0.8900772922103231,1.0,4/19,10.61%,LHCGR;NR2F2;VEGFA;NUP107
prerank,regulation of glycogen metabolic process (GO:0070873),0.6049069688000829,1.2523380079136648,0.2646048109965636,0.889622071249554,1.0,1/12,1.10%,PPP1R3A
prerank,gastrulation (GO:0007369),-0.4870153090495801,-1.251081298879705,0.18733509234828497,0.7964270863121614,1.0,6/15,25.07%,MEGF8;UGDH;LMBRD1;SMAD2;GPC3;MKKS
prerank,negative regulation of hormone secretion (GO:0046888),-0.5341013878309733,-1.2503057055403648,0.2151029748283753,0.7966970150236597,1.0,3/10,13.39%,GJA1;RAB11FIP5;RAB11FIP1
prerank,regulation of myoblast differentiation (GO:0045661),0.5154728874886751,1.249944280005407,0.2145922746781116,0.8962501833756953,1.0,7/32,8.05%,MEF2C;RBM24;SMYD1;ANKRD2;BTG1;SOX9;PLCB1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3934521905658103,-1.2485487418707624,0.1641337386018237,0.8011703092311746,1.0,11/29,16.02%,FLT1;PDGFRA;KIT;TEK;PTK2;PTK2B;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,macrophage differentiation (GO:0030225),-0.5076851114491686,-1.2481530237153045,0.18872549019607843,0.7999128100440436,1.0,4/13,7.12%,IL31RA;IL15;BMP4;CASP8
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5751476890127379,1.248122592636619,0.2482758620689655,0.9009403205402877,1.0,1/16,0.89%,ACSS1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.6154439801202056,1.2466726490195492,0.23497267759562843,0.9043403747383286,1.0,5/12,14.27%,ARHGEF7;DYRK1A;TBCD;CLIP3;STMN2
prerank,synaptic vesicle endocytosis (GO:0048488),-0.39971034847572134,-1.2465763057572248,0.1553398058252427,0.8031201264911109,1.0,13/33,16.00%,DNM3;FCHO2;DNAJC6;NLGN1;SYT1;CANX;DNM1;STON2;OPHN1;SNCA;NLGN2;NLGN3;STX1A
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4168835115609757,1.2459714530242978,0.13833157338965152,0.9051517994460866,1.0,22/199,7.87%,MYOCD;MEF2C;ATP2B4;HEY2;VASN;ROCK1;NR1H4;ALPK2;ADAMTS5;LOXL2;PLCL1;HDAC9;ASB1;KLF7;TBX18;LNPEP;PROCR;SDHAF2;DAB2IP;CORO1C;SOX9;ATP2B1
prerank,protein localization to chromosome (GO:0034502),-0.3733669891441921,-1.2453471968461303,0.14982578397212543,0.8050875540769717,1.0,18/34,34.05%,ATR;TNKS2;XRCC5;PARP3;SLF2;ESR1;SLF1;LEMD2;TERF2IP;IFFO1;TPP1;TINF2;CHMP7;BOD1;ATRX;ACD;MCM8;RPA2
prerank,positive regulation of cellular component movement (GO:0051272),0.5318325555108345,1.2452042843988336,0.22033898305084745,0.9060985249196146,1.0,6/24,8.66%,ACTN4;CAVIN1;NTN1;VEGFA;TUBB2B;ADAM17
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.43795072784432226,1.2449951171835523,0.1696113074204947,0.9052794977418103,1.0,22/94,14.20%,ATP2A1;CRIP1;MAP3K5;PMAIP1;ITPR1;BCL2;CUL2;MYBBP1A;DAB2IP;ARL6IP5;TP53;BCL2L2;EPHA2;STK24;ATP2A3;PRKCD;BOK;DIABLO;FNIP2;PDK2;TNFRSF10B;MCL1
prerank,fatty acid transmembrane transport (GO:1902001),0.5516908769783982,1.2449667334812207,0.23752151462994836,0.9037272556982718,1.0,7/19,14.42%,PRKAB2;CD36;ACACB;CPT1B;ABCD4;CPT1A;PRKAA2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3590329878734717,-1.2444761648319396,0.15810276679841898,0.8056772903387076,1.0,6/41,9.04%,AFDN;TJP1;BMP7;PODXL;CD44;PIEZO1
prerank,water transport (GO:0006833),-0.49967121497972067,-1.2444158064069766,0.21830985915492956,0.8033401995636622,1.0,1/12,1.63%,PDPN
prerank,cellular response to reactive oxygen species (GO:0034614),0.46889204781510957,1.2436109115722058,0.1951219512195122,0.9069004941160719,1.0,14/59,14.25%,TPM1;MAP3K5;ANXA1;NET1;FXN;CAMKK2;MAPT;RELA;IMPACT;PRKCD;TRPM2;PDK2;MAPK1;PLEKHA1
prerank,regulation of insulin secretion (GO:0050796),0.42812868403285886,1.2434692864810595,0.17391304347826086,0.9058426330913062,1.0,23/101,15.88%,CACNA1C;RAP1A;ADCY5;NR1H4;ITPR1;KCNA5;CCL5;ALOX5;KCNB1;IRS1;ENSA;NR1D1;ABCC8;GPER1;LRP5;PPP3CB;SIRT4;CLOCK;PRKCA;IRS2;GIPR;HADH;RFX3
prerank,acylglycerol homeostasis (GO:0055090),0.5547636003358358,1.2434405199244132,0.2564935064935065,0.9043302904111089,1.0,3/20,3.34%,ANGPTL8;RORA;LPL
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.42296964832628864,1.2431225462134068,0.15384615384615385,0.903848880244199,1.0,35/166,13.04%,NOTCH3;NR1H4;CAVIN1;POLR2L;POLR2I;RORA;NR4A1;TEAD3;HDAC9;GTF2H4;NR2C1;POLR2G;TAF1;RXRG;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;MAML3;PPARA;NR4A2;NR1D1;CDK7;POLR1E;NAT14;NR2C2;TEAD1;TFB2M;ESRRA;POLR1H;NR6A1;SMARCA5;POLR2J
prerank,membrane depolarization (GO:0051899),0.5061178296039309,1.2421869661046114,0.2335243553008596,0.9055954091594975,1.0,11/32,19.08%,SCN4A;CACNA1H;CACNB4;CAV1;CACNA1B;CHRNA4;YWHAH;CACNA1I;KCNH2;P2RX4;ABL1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5477822978560342,1.2419653895098386,0.23993558776167473,0.9047387563690913,1.0,4/19,6.51%,ROCK1;LIMS1;FERMT2;VEGFA
prerank,regulation of gluconeogenesis (GO:0006111),-0.4047086776004432,-1.2418616780163134,0.17777777777777778,0.8101571583257666,1.0,12/27,23.12%,CRY1;USP7;SIRT7;SIK1;DDB1;OGT;EP300;DGKQ;C1QTNF3;PTPN2;CLK2;PGP
prerank,response to hydrogen peroxide (GO:0042542),0.4805027587740803,1.2416743371437444,0.20080321285140562,0.9041587829957354,1.0,12/45,14.25%,MAP3K5;ANXA1;NET1;FXN;STK26;RELA;IMPACT;STK24;PRKCD;TRPM2;PDCD10;PLEKHA1
prerank,C-terminal protein amino acid modification (GO:0018410),0.615025625052619,1.241601803672375,0.24500907441016334,0.9028324672704469,1.0,2/11,5.48%,AGBL1;ATG7
prerank,regulation of protein localization to cell surface (GO:2000008),-0.39071166280348,-1.2414851186241675,0.1598639455782313,0.8090803743871638,1.0,16/33,28.22%,NEDD4L;STX3;GBF1;CTNNB1;HSP90AB1;STX4;COMMD1;RAB11FIP5;ABCA2;RIC3;LEPROTL1;KCNAB2;TOR1A;HFE;EGF;TAX1BP3
prerank,organic acid transport (GO:0015849),-0.3114013455106839,-1.2411841925314595,0.0847457627118644,0.8078072059174422,1.0,19/94,9.38%,SLC7A11;SLC6A13;SLC13A3;ABCG2;PDPN;SLCO2B1;SLC6A12;SLC6A6;SLC26A7;SLC16A1;SLCO1C1;NCOA1;SLC25A17;SLC7A14;SLC3A2;SLC25A32;SLC22A6;SLC25A14;ABCC4
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.4820073388920953,-1.2402506782032696,0.21779859484777517,0.8089977763196268,1.0,5/15,23.37%,EDA;GLI2;HDAC2;WNT6;ANKRD11
prerank,early endosome to Golgi transport (GO:0034498),-0.5132361268103309,-1.240090053526629,0.2239819004524887,0.8070684622366129,1.0,5/11,19.15%,STX5;SURF4;RBSN;LMAN1;EHD3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.325837625680933,-1.2396306217110091,0.13903743315508021,0.8062158896804565,1.0,19/67,8.27%,ELMO1;FLT1;PIK3CA;SULF1;NRP2;MAPK14;CYFIP2;PXN;NRP1;PTK2;ABI1;BAIAP2;PTK2B;VAV2;WASF2;ITGAV;NCK1;PIK3CB;CLEC14A
prerank,regulation of myotube differentiation (GO:0010830),0.5335311800067742,1.239389338936056,0.2332814930015552,0.9089750727847571,1.0,3/24,4.11%,RBM24;SMYD1;HDAC9
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.42670488522029504,1.2391644499037302,0.1673866090712743,0.9081249453332255,1.0,20/152,9.66%,LHCGR;PTGER3;ADCY5;CRHR2;S1PR3;HTR1B;NPY1R;ADCY2;VIPR2;ADRA1D;ADCY9;TSHR;GNAO1;GNAZ;RAMP1;PRKACB;GNA12;PTH1R;ADCY6;ADGRL2
prerank,negative regulation of protein transport (GO:0051224),-0.4159261436861552,-1.2387030277264788,0.16467065868263472,0.8072142994509587,1.0,10/25,29.15%,APOE;ERP29;CYP51A1;HMGCR;PPM1F;PKDCC;SNX3;DRD2;SNX12;RHBDF2
prerank,positive regulation of protein acetylation (GO:1901985),-0.5046860593440221,-1.2386751461653838,0.21889400921658986,0.8048356249707469,1.0,6/12,27.99%,DDX3X;CAMK1;TAOK1;TERF2IP;PRKAA1;RAPGEF3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5641587807732558,1.2383121777505761,0.23848684210526316,0.9096944469849477,1.0,6/16,10.75%,PDGFB;PDGFC;PDGFD;PTPN1;PDGFRB;PDGFA
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4200029747041096,-1.2381518107709595,0.18018018018018017,0.8042334297956346,1.0,11/24,24.62%,NIBAN2;DACH1;XRCC5;ACVRL1;BMPR2;BLM;TERF2IP;MSH6;CDKN1A;ERCC1;ERCC4
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3964367154746692,-1.237123681477886,0.1686046511627907,0.805586525610679,1.0,6/28,8.37%,PTN;APOE;APP;EPHA4;SHANK3;ADCY1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5085774971407978,1.2369132552804174,0.21727019498607242,0.9129517956750555,1.0,5/32,7.09%,ARHGEF7;PLCE1;ACTR3;CORO1C;CYFIP1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4218345866753414,1.2362794099918477,0.17121046892039257,0.9135780603604764,1.0,26/138,10.70%,NOTCH3;NR1H4;POLR2L;POLR2I;RORA;NR4A1;TEAD3;HDAC9;GTF2H4;NR2C1;POLR2G;TAF1;RXRG;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;MAML3;PPARA;NR4A2;NR1D1;CDK7;NR2C2;TEAD1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5170001643341806,1.2357903879384093,0.2198473282442748,0.9136951092093828,1.0,11/27,18.85%,CAMK2G;MARK1;NCS1;BRSK1;IL1RAPL1;FRMD7;HOMER1;PTEN;VPS35;ULK4;BRSK2
prerank,regulation of peptide hormone secretion (GO:0090276),0.4559819726262651,1.2354719279882362,0.20075757575757575,0.9131778694723734,1.0,7/67,4.75%,CACNA1C;RAP1A;ITPR1;KCNA5;CCL5;ALOX5;KCNB1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.46024241759927403,-1.2352016699101367,0.20596205962059622,0.8101272203359902,1.0,3/16,5.80%,NFAT5;ST3GAL4;IRAK1
prerank,wound healing (GO:0042060),0.45619647535274344,1.235039079413958,0.20358514724711907,0.9130624977610184,1.0,10/62,7.87%,TPM1;FGF1;FER1L5;PPP3CA;DYSF;MYH9;DST;RAB3A;ITGB3;TGFB2
prerank,glycoprotein biosynthetic process (GO:0009101),-0.31587411693684514,-1.2349369136771988,0.10126582278481013,0.8086271685551502,1.0,24/79,20.01%,IGF1;CHST11;ST3GAL4;ST3GAL6;ST8SIA4;ST3GAL5;ST8SIA1;BMPR2;MGAT1;CHST9;SERP2;GOLPH3;ST3GAL3;FUT10;ST8SIA2;B3GALNT1;PMM2;CANT1;XYLT1;FOXL1;COG7;CHST12;B4GALT7;ALG1
prerank,positive regulation of vasculogenesis (GO:2001214),0.6033288692751977,1.2345899790631956,0.24242424242424243,0.9130684527489787,1.0,3/10,8.34%,RAP1A;RRAS;RIN2
prerank,negative regulation of immune response (GO:0050777),0.42003971366157283,1.2341002836305952,0.15732758620689655,0.9131681012407566,1.0,21/154,9.92%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;HAVCR2;CYSLTR2;RAMP1;PRKACB;CD300A;ADAM17;PRKAR1B;PTH1R;ADCY6;SAMSN1;SIRT2
prerank,cellular response to cAMP (GO:0071320),0.5208729158702611,1.2339683180628942,0.21669106881405564,0.9120575713094828,1.0,3/30,3.49%,RAP1A;AKAP6;IGFBP5
prerank,protein polymerization (GO:0051258),0.45678079091516666,1.2336057043902233,0.20614596670934698,0.9116837548845218,1.0,9/56,8.54%,FGF13;CASQ1;ARHGAP6;MAP7D3;MAPT;TPPP;PIN1;HDGFL3;SPIRE1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5341769729110148,1.2327871329261721,0.25656877897990726,0.9129498529919686,1.0,6/25,9.98%,DMD;TRPC6;STAC;ATP1B1;WNK2;ACTN2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.49881337489951394,-1.2327030351024681,0.23429951690821257,0.8145455576918132,1.0,7/12,20.86%,CTSL;CTSH;RDX;CTSB;THRB;CTSS;LMO2
prerank,endocardial cushion morphogenesis (GO:0003203),0.5475215596696151,1.2321984334812353,0.24841772151898733,0.913394478899927,1.0,5/18,7.87%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,digestive tract development (GO:0048565),-0.3806277395151078,-1.231871994005828,0.18439716312056736,0.8149263059289306,1.0,10/33,14.90%,CLMP;COBL;KIT;PCSK5;GLI2;MEGF8;SALL1;FGFR2;CCDC39;PKDCC
prerank,neuron projection extension (GO:1990138),-0.38362832422789594,-1.231751781797427,0.17791411042944785,0.8128985488092941,1.0,9/32,9.10%,ALCAM;NRP2;AUTS2;NRP1;CTNNB1;HSP90AB1;SEMA3A;TMEM108;CDKL3
prerank,cellular macromolecule catabolic process (GO:0044265),-0.34793031063282864,-1.2313161233760928,0.1522633744855967,0.8120221568689456,1.0,19/49,27.90%,NGLY1;DENND3;RAB12;RNASEH2B;PRKN;ADAMTS9;HNRNPD;CHEK2;SIAH2;PNPT1;FBXO17;PABPC4;MAGEC2;PPP1R8;EXOSC7;STT3B;SND1;HTRA2;FBXO44
prerank,response to glucagon (GO:0033762),0.5506996554073078,1.2312813637447348,0.25585023400936036,0.9150217734701623,1.0,7/19,9.47%,ADCY5;ADCY2;ADCY9;CYSLTR2;PRKACB;PRKAR1B;ADCY6
prerank,defense response to tumor cell (GO:0002357),0.6119161394139265,1.2308645095910178,0.2512998266897747,0.9149787074543853,1.0,2/10,4.20%,DLEC1;RBMS3
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.45255996680256805,1.2305251778456534,0.22289156626506024,0.9146140749232181,1.0,15/72,10.85%,NTF3;NTRK3;PDGFB;PDGFC;ROR1;PLXNB1;CCL5;PDGFD;PIK3AP1;NEDD4;SOX9;TGFB2;PDGFRB;PDGFA;GPER1
prerank,replication fork processing (GO:0031297),-0.36456805248295493,-1.230414382054473,0.1388888888888889,0.8129979148001896,1.0,18/38,37.91%,ATR;MRE11;FBH1;SAMHD1;BLM;MMS22L;PRIMPOL;SMARCAL1;NUCKS1;ALYREF;DNA2;ATRX;BOD1L1;RFWD3;TRAIP;RAD51;CENPX;GEN1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3762196217916417,-1.2297716280742885,0.1643835616438356,0.8128143363317111,1.0,13/34,16.02%,FLT1;PDGFRA;KIT;TEK;PIK3R3;PTK2;PTK2B;WDR91;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,regulation of autophagosome assembly (GO:2000785),-0.3795885992401416,-1.2294921667164342,0.15699658703071673,0.8114220150341904,1.0,17/33,24.87%,NUPR1;RAB5A;PIP4K2B;NPRL3;IFT88;RAB3GAP2;UBQLN2;SCFD1;RAB1B;RALB;TBC1D14;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23;LRSAM1
prerank,response to thyroid hormone (GO:0097066),-0.4800674241003786,-1.2294521830192384,0.25,0.8091297962754657,1.0,7/13,20.86%,CTSL;CTSH;RDX;CTSB;THRB;CTSS;LMO2
prerank,gonad development (GO:0008406),0.4789651279966695,1.2294514128479515,0.20457604306864063,0.9167589020005209,1.0,8/41,10.61%,LHCGR;IRX5;NR2F2;CSDE1;AR;SOX9;TGFB2;NUP107
prerank,positive regulation of developmental process (GO:0051094),0.4192907729940838,1.2291213946017014,0.15555555555555556,0.9163596324839082,1.0,33/164,13.01%,SOX6;ARHGEF7;SOX5;PDGFB;PHLDB2;CLASP2;FST;FZD4;TMEM79;BMPR1A;TAPT1;DAB2IP;VEGFA;GDNF;CORO1C;PA2G4;AR;SOX9;MIEF2;PLCB1;MIEF1;SPIRE1;TRPM4;RBM19;PAXIP1;RIF1;NR2C2;DNM1L;ACVR1B;BMPR1B;PACSIN1;CPEB3;CLASP1
prerank,ovarian follicle development (GO:0001541),0.5846208201140697,1.2290952304213238,0.25426621160409557,0.9148734859948379,1.0,2/13,6.51%,LHCGR;VEGFA
prerank,presynaptic endocytosis (GO:0140238),-0.42996720922531373,-1.22902748320917,0.1894150417827298,0.8082601099194945,1.0,10/24,16.00%,FCHO2;NLGN1;SYT1;CANX;STON2;OPHN1;SNCA;NLGN2;NLGN3;STX1A
prerank,endothelial cell differentiation (GO:0045446),-0.4992046640622949,-1.228340684328967,0.22975929978118162,0.8082809520604796,1.0,5/12,6.39%,FSTL1;ACVRL1;BMPR2;SCUBE1;TIE1
prerank,organic substance transport (GO:0071702),-0.28921084625804405,-1.2280344815775035,0.04,0.8070365983013186,1.0,38/121,23.07%,ABCG2;SLC47A1;ATP8A1;ABCA9;PLTP;CALCRL;ABCA1;SLCO2B1;CHKA;ABCA4;SLCO2A1;SCAMP2;SLC22A6;PPT1;SLC22A4;SLC35F3;SPNS2;RCN3;RAMP2;HSP90B1;TOM1;ABCA6;ABCD3;SLC22A18;NDC1;PICK1;ABCB9;SLC50A1;ARRDC1;CUBN;SCAMP3;MIA3;TAP1;SCAMP1;ABCA2;MFSD2A;TXNIP;ARRDC4
prerank,protein ADP-ribosylation (GO:0006471),0.5088489838948536,1.2278969453064477,0.2412280701754386,0.9174059460752495,1.0,7/28,13.72%,ART1;SIRT3;PARP1;ART4;SIRT2;HPF1;SIRT4
prerank,negative regulation of signaling receptor activity (GO:2000272),0.516859570424854,1.2275959199918307,0.23546099290780143,0.916974935337054,1.0,5/25,12.04%,CNRIP1;SOCS5;SOCS4;PPARA;TSG101
prerank,positive chemotaxis (GO:0050918),0.5505786826227351,1.2268905348426176,0.25,0.9179372116580731,1.0,3/17,6.51%,ANGPT1;SEMA5A;VEGFA
prerank,regulation of interleukin-17 production (GO:0032660),0.49492299400323425,1.2267206191125617,0.2374821173104435,0.9169826074629475,1.0,4/31,5.51%,NR1H4;MYD88;IL2;PRKCQ
prerank,histone H2B ubiquitination (GO:0033523),-0.5243926634606746,-1.2261752963848127,0.22755741127348644,0.8114306005866914,1.0,4/10,13.86%,RNF20;CTR9;DTX3L;LEO1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.46381163304073136,-1.2257537169647745,0.21641791044776118,0.8106127398786784,1.0,4/15,7.38%,DAB2;AAK1;BMP2K;PIK3CB
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.34364432540499706,-1.22465056189086,0.13247863247863248,0.8123041686066045,1.0,12/49,12.17%,IGF1;IL31RA;IL15;KIT;GHR;IL18;ARL2BP;TNFRSF1A;IL6R;HES1;LYN;PARP14
prerank,substrate-dependent cell migration (GO:0006929),-0.47822464579901053,-1.2245552772088946,0.2202970297029703,0.8102553847435737,1.0,8/14,18.86%,NRP1;ANKS1A;CD2AP;SDCBP;OPHN1;EPHA8;VEGFC;ITGB1BP1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.4091491743665713,1.2243490096099783,0.15417106652587118,0.9236820834931814,1.0,47/190,15.39%,PDE3A;DGKG;WTIP;ATP2B4;NR1H4;ITPR1;LIMD1;RORA;BCL2;CARD19;CAV1;DAB2IP;DUSP3;PPM1A;PHLDA3;PLEK;BCL2L2;RELA;TNIP1;OTUD7A;PPARA;GSTP1;NR1D1;NDUFS3;DGKD;EPHA2;THEM4;EPM2A;NPRL2;ARHGAP12;RTKN2;SH3BP4;GPER1;GPD1L;PDE4D;RHOH;SHANK2;MUL1;MAP2K3;TMSB4X;MCL1;PLEKHA1;PRKAA2;VGLL4;URI1;PTEN;STAT1
prerank,regulation of receptor internalization (GO:0002090),0.48719564695083106,1.2243212954673282,0.21782178217821782,0.9222140809394119,1.0,6/35,10.44%,NTF3;ANGPT1;ATXN2;VEGFA;ATAD1;SCYL2
prerank,mRNA stabilization (GO:0048255),0.4805489129049878,1.2241361965256585,0.2321187584345479,0.9212864132798921,1.0,9/40,11.71%,RBM24;TENT5B;MYD88;MAPKAPK2;CIRBP;GDNF;FUS;HNRNPU;HNRNPC
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5553505457491015,1.2239402466992486,0.24757281553398058,0.9204542832498993,1.0,6/18,9.58%,LTBP1;ITGB6;LRRC32;CD200;TGFB2;HIF1A
prerank,aminoglycan metabolic process (GO:0006022),-0.5262169927353881,-1.223898837477686,0.2149321266968326,0.8103659620066872,1.0,9/10,44.72%,CHST9;XYLT1;B4GALT7;B3GAT1;CLN6;B3GAT3;B3GALT6;B3GAT2;GAL3ST3
prerank,endothelial cell development (GO:0001885),0.5127015399142404,1.222393092499849,0.2534992223950233,0.9241428234097504,1.0,2/25,0.72%,COL18A1;RAP1A
prerank,mitotic nuclear division (GO:0140014),0.4448314306946702,1.221867829157264,0.19559902200489,0.9243541427778524,1.0,22/71,17.21%,FLNA;CLASP2;KIF2A;TOGARAM2;NUP62;KIF3B;TPX2;PIBF1;TOGARAM1;ZWINT;CEP192;WRAP73;AAAS;CLASP1;CHMP2A;KIF18A;KNSTRN;ABRAXAS2;MAP9;INO80;DSN1;CENPK
prerank,acute inflammatory response (GO:0002526),0.5176359151782609,1.221576229116114,0.2601246105919003,0.9238168484113403,1.0,4/23,7.83%,ITIH4;ANO6;MBL2;IL22
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3810465325100884,-1.2204752381090858,0.1875,0.8209327264043685,1.0,10/32,16.28%,IGF1;ZBTB20;PID1;NUPR1;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C
prerank,protein mannosylation (GO:0035268),-0.4189578107395291,-1.220322868438252,0.19337016574585636,0.819084483418378,1.0,6/22,7.46%,TMTC1;TMTC2;DPY19L4;RXYLT1;TMTC4;DPY19L1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.41912854043392217,-1.2198648265271232,0.2154255319148936,0.8183809396543972,1.0,3/21,5.05%,OSBPL8;OSBPL10;PLA1A
prerank,regulation of store-operated calcium entry (GO:2001256),0.6083844516306235,1.2198602566860977,0.26595744680851063,0.9281545180294927,1.0,4/10,12.69%,CASQ1;STIM1;GRAMD2A;HOMER1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4705943793047055,-1.219691176085313,0.2073170731707317,0.8143189933159023,1.0,3/14,11.21%,ABCG2;SLCO2B1;BLVRB
prerank,heme catabolic process (GO:0042167),-0.4705943793047055,-1.219691176085313,0.2073170731707317,0.8143189933159023,1.0,3/14,11.21%,ABCG2;SLCO2B1;BLVRB
prerank,regulation of ion transmembrane transport (GO:0034765),0.4976543776634977,1.219120489103861,0.25035360678925034,0.9290973986501877,1.0,5/33,9.42%,AKAP6;KCNJ12;ANO6;NEDD4;AHCYL1
prerank,negative regulation of platelet activation (GO:0010544),0.5655870015183535,1.218031524936042,0.26903553299492383,0.9313607947288456,1.0,6/16,11.29%,PRKG1;PDGFB;SERPINE2;C1QTNF1;PDGFA;PRKCD
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2879371550577874,-1.2179121497172365,0.05084745762711865,0.8185060534099904,1.0,49/173,19.75%,SPTBN1;ANK2;SPTAN1;TGFA;DCTN4;CUL3;SPAST;PROS1;CAPZA1;DYNC1I1;KLHL12;DYNC1LI2;USO1;CD55;GBF1;VTI1A;TMED5;KDELR1;NRBP2;STX5;ERGIC3;TMED7;TMED10;COPB2;COG6;ARFGAP2;SEC24B;RAB2A;ACTR10;MCFD2;ARFGAP1;COPE;TRAPPC11;ARFGAP3;RAB1A;RAB29;F8;YKT6;LMAN1;COG7;COG2;TMED3;SCFD1;TRIP11;RAB1B;TRAPPC3;TFG;TMED4;MIA3
prerank,regulation of interferon-beta production (GO:0032648),-0.3530566123073061,-1.2170304239669878,0.17073170731707318,0.819242110405715,1.0,18/46,25.14%,DDX3X;PTPN11;PPM1B;RNF135;POLR3F;RIOK3;POLR3B;POLR3A;SIRPA;RELB;TRIM56;TLR3;OAS2;TIRAP;POLR3C;TOMM70;NLRC3;POLR3D
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.43794840947915076,-1.216535152590994,0.23017902813299232,0.8186518730613219,1.0,12/18,35.37%,COA8;COX20;SMIM20;COX14;TIMM21;BCS1L;COX17;COX16;COA3;SURF1;COX18;FASTKD3
prerank,activation of GTPase activity (GO:0090630),0.43289521756357946,1.2164264341699984,0.21288837744533948,0.9353172064378281,1.0,14/89,9.52%,NTF3;NTRK3;RALGAPA2;TBC1D1;ABR;ARHGEF16;MTSS2;RABGAP1;CORO1C;RASGRP1;RALGAPA1;EVI5;RALGAPB;EPHA2
prerank,protein insertion into membrane (GO:0051205),-0.3844465404605242,-1.2162968690000748,0.2138364779874214,0.8171504671453368,1.0,10/32,16.38%,APP;EGFR;ALDH3A2;CYB5A;STX5;SGTA;MAIP1;EMD;STX1A;TRAM2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5201413457921065,-1.2160970399490412,0.23296703296703297,0.815551041053955,1.0,3/10,23.32%,BMP4;SALL1;PAX8
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5394869829338388,1.2155455341130808,0.2616822429906542,0.9368423536300573,1.0,4/22,7.52%,DYNLL1;ROCK1;TP53;PLEK
prerank,regulation of cholesterol esterification (GO:0010872),0.6194034819268132,1.2153054946455573,0.26258992805755393,0.9361030840468817,1.0,1/10,0.46%,AGTR1
prerank,regulation of lymphocyte migration (GO:2000401),-0.5168482689325231,-1.214538601656132,0.22522522522522523,0.8187497032354524,1.0,4/10,19.75%,JAM2;AKT1;SLC8B1;MIA3
prerank,leukocyte tethering or rolling (GO:0050901),0.5521654085465753,1.2143979070187705,0.28180354267310787,0.9378688132507657,1.0,4/17,8.27%,ROCK1;ITGB1;ADD2;ITGA4
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5673836590595983,1.214291482234181,0.2627257799671593,0.9366735557520061,1.0,5/15,10.88%,ROCK1;CAMK2D;MEF2A;PARP1;ROCK2
prerank,generation of neurons (GO:0048699),0.40701149703611766,1.2142513632043708,0.16597510373443983,0.9352542457603351,1.0,28/190,9.13%,FGF13;MEF2C;HEY2;CDK6;FZD5;ASTN2;HEYL;IRX5;FZD4;MAP1B;PRUNE1;MARK1;FZD8;ITM2C;MAPT;EML1;TUBB2B;PIN1;YTHDF2;CEP85L;YAP1;ERCC6;TGFB2;ADNP2;ASTN1;MAP2K1;NR4A2;BRSK1
prerank,positive regulation of cell adhesion (GO:0045785),0.4385269757328745,1.2140879758885093,0.22565320665083136,0.9342827769459771,1.0,10/74,9.27%,TPM1;ZFHX3;LIMS1;PDGFB;PPP3CA;CCL5;RSU1;VEGFA;TGFB2;MAGI1
prerank,T cell mediated immunity (GO:0002456),-0.4824741535629352,-1.2139837982187112,0.20871559633027523,0.8183693611332291,1.0,5/13,12.25%,CADM1;CD55;CTSH;CD46;GNL1
prerank,positive regulation of endocytosis (GO:0045807),-0.3517960425700539,-1.2139171786398815,0.15163934426229508,0.8163146273382493,1.0,9/45,4.36%,DAB2;APPL2;LRP1;NEDD4L;APOE;VTN;B2M;HNRNPK;NLGN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5912379371039692,1.2135061848641875,0.2651646447140381,0.9332148041265755,1.0,3/12,6.96%,ACTN4;KANK1;CORO1C
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5912379371039692,1.2135061848641875,0.2651646447140381,0.9332148041265755,1.0,3/12,6.96%,ACTN4;KANK1;CORO1C
prerank,reverse cholesterol transport (GO:0043691),-0.47467564866218803,-1.2133005343659724,0.23459715639810427,0.8162723141916385,1.0,2/13,2.39%,APOE;ABCA1
prerank,response to muramyl dipeptide (GO:0032495),0.5719870706180887,1.212996005578603,0.27845884413309985,0.9334619332708647,1.0,3/12,6.34%,VIM;ARHGEF2;CHMP5
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5417603450379714,1.2126491871911993,0.2534562211981567,0.9331691415266148,1.0,3/20,7.57%,WTIP;LIMD1;CELF1
prerank,regulation of kinase activity (GO:0043549),0.4281867353800084,1.211657704130708,0.2138728323699422,0.9350093089821797,1.0,17/89,11.20%,TTN;NTRK3;MERTK;PLCE1;MST1R;ROR1;SMG8;MUSK;CAMKK2;MAPT;ANKRD54;EPHA2;AXL;NPRL2;PDGFRB;HNRNPU;RB1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5193034493771316,1.2116253349844057,0.27246376811594203,0.9336014272541201,1.0,6/25,11.24%,PFKP;ENO3;HK2;ADPGK;ALDOA;PFKM
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5060869361889729,-1.2115000042601602,0.2725225225225225,0.8204277297278416,1.0,6/11,30.77%,LGALS9;PARK7;PIH1D1;HTRA2;GSN;PLAUR
prerank,sodium-independent organic anion transport (GO:0043252),-0.5295203158681563,-1.2107482121962732,0.24153498871331827,0.8208291370986033,1.0,4/10,8.85%,SLCO2B1;SLCO1C1;SLCO2A1;SLCO3A1
prerank,L-serine metabolic process (GO:0006563),-0.5256947013420401,-1.210673205375202,0.2376470588235294,0.8187968839998417,1.0,5/10,26.80%,SERINC5;SRR;PSPH;PSAT1;CBS
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.44002370697039145,-1.2106261802804403,0.22015915119363394,0.816753076215381,1.0,6/17,19.37%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,hyaluronan catabolic process (GO:0030214),-0.4356127010871503,-1.2105383097394071,0.2236503856041131,0.8148016713705094,1.0,6/18,16.02%,CEMIP;CD44;TGFB1;HEXA;CEMIP2;FGF2
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4157402567177911,-1.2105292601866824,0.23351648351648352,0.812598809764164,1.0,7/22,5.65%,ROBO1;EFNB2;CDH5;SLIT2;NRP1;PIK3R3;ID1
prerank,regulation of microtubule-based process (GO:0032886),0.4860519742058325,1.2097756589010857,0.2517985611510791,0.9384496464985347,1.0,13/36,18.91%,ROCK1;PHLDB2;CLASP2;BICD2;MAPT;TPPP;CLASP1;PRKAA2;CDK2AP2;MARK2;BICD1;MAP6;HDAC6
prerank,myoblast fusion (GO:0007520),0.5769775789498653,1.2096394217883073,0.2912966252220249,0.9374290699440553,1.0,3/12,5.58%,CACNA1H;ADAMTS5;KCNH1
prerank,secondary palate development (GO:0062009),-0.4619176263436523,-1.2094913647908172,0.23809523809523808,0.814000679138852,1.0,4/14,3.75%,TGFBR3;LEF1;CHD7;WNT5A
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.42806741868181986,-1.2089005133178183,0.21367521367521367,0.8138465068915566,1.0,6/19,19.37%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,regulation of cellular amide metabolic process (GO:0034248),0.49960421624155993,1.2088588242195368,0.25464949928469244,0.9385567209833876,1.0,8/32,11.39%,ROCK1;NR1H4;ATXN2;CYFIP1;SAMD8;PRKCD;DDX25;RBM3
prerank,intermediate filament organization (GO:0045109),0.5451590085172324,1.2082010862576524,0.2696629213483146,0.9393114562424377,1.0,2/17,2.61%,DES;VIM
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4948559516400248,-1.208061997121549,0.24622030237580994,0.8145021745124729,1.0,3/12,6.93%,APOE;LDLR;IAPP
prerank,negative regulation of cell differentiation (GO:0045596),0.40364571319649634,1.2079792704782129,0.1944739638682253,0.9386053600753461,1.0,32/181,11.57%,MYOCD;VASN;CHADL;CRIM1;LIMD1;CDK6;FERMT2;RORA;RUNX1T1;JAG1;ANKRD2;ASXL1;SDHAF2;CAV1;DAB2IP;BBS12;YTHDF2;MED1;ITGB3;YAP1;SOX9;SNAI2;PPARA;TRPM4;IQCB1;SKI;SIRT2;HNRNPU;GPER1;RB1;LRP5;ABCG1
prerank,negative regulation of protein metabolic process (GO:0051248),0.454762198662872,1.20748770514769,0.22119205298013245,0.9387929045736454,1.0,12/48,16.29%,FLNA;ROCK1;EDNRB;PIN1;ITGB3;SF3B3;SIRT2;CLU;ADGRB1;AZIN2;MAD2L2;AGAP2
prerank,regulation of hydrolase activity (GO:0051336),-0.3194290424306373,-1.2074457517955786,0.14136125654450263,0.8144787426933953,1.0,20/71,12.33%,PLXNA2;NF1;FGD6;FGD5;EPHA4;PTK2;FGD4;CHN2;TBC1D15;SIPA1L1;EPHA3;PAFAH1B1;VAV2;SCARB2;PLXNA4;RDX;RASIP1;RAB3GAP2;ARHGAP27;RALBP1
prerank,glycoprotein metabolic process (GO:0009100),-0.3337371386976963,-1.2073371030048672,0.14601769911504425,0.8127121056570729,1.0,13/53,10.99%,MAN1C1;ST3GAL4;ST8SIA4;NGLY1;ST6GALNAC3;ST8SIA1;FUT8;MGAT4B;GANAB;GOLPH3;MAN2A1;ADAMTS9;ST8SIA2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.49548126337000425,-1.2072818755451171,0.24829157175398633,0.8107130122248233,1.0,6/12,15.43%,KDELR1;HSPA5;ANKRD13C;OS9;RER1;INSIG1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.40957910984860135,-1.2070772389803845,0.20118343195266272,0.8092486866814603,1.0,6/23,20.36%,IGF1;PYDC1;CX3CL1;GIT1;ZC3H12A;CEACAM1
prerank,regulation of neuron apoptotic process (GO:0043523),0.4233003269859407,1.206546369204141,0.21554770318021202,0.9403833626723613,1.0,13/96,7.87%,NTF3;MEF2C;TRIM2;PLA2G3;CRLF1;TGFB3;SET;BCL2;KCNB1;GDNF;PPARGC1A;FZD9;TGFB2
prerank,RNA catabolic process (GO:0006401),-0.34681800351891895,-1.2062530691298754,0.1394422310756972,0.8100155849694416,1.0,20/46,28.64%,AGO3;RNASEH2B;METTL3;ERN1;DCP2;HNRNPD;PNPT1;METTL16;PABPC4;LSM2;LSM5;PPP1R8;EXOSC7;CNOT10;SND1;NUDT12;AGO4;DNA2;ZFP36;LSM6
prerank,programmed necrotic cell death (GO:0097300),0.5535634987037655,1.2058356487663604,0.2823920265780731,0.941402897839575,1.0,3/18,10.73%,ITPK1;CD14;DNM1L
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5542651289663578,1.2051110681058799,0.28376068376068375,0.9423073567536311,1.0,3/15,7.17%,ENTPD1;AK7;ENTPD7
prerank,negative regulation of transposition (GO:0010529),-0.4444252720431341,-1.2039403916777405,0.25392670157068065,0.8159333300495615,1.0,7/16,30.97%,UBR2;SIRT7;TUT4;TEX15;TUT7;MOV10;SMYD5
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.48135582541289396,-1.203728538361973,0.22790697674418606,0.814567599727396,1.0,7/13,27.37%,NCBP2;CPSF2;CPSF6;CSTF2T;CPSF4;CSTF2;CPSF1
prerank,nucleic acid-templated transcription (GO:0097659),0.47045802919792334,1.2033402602095495,0.2613784135240572,0.9470144171631714,1.0,11/42,13.04%,POLR2L;POLR2I;MLF1;PWP1;MEF2A;POLR2G;TERT;NFKBIB;NR4A2;BAZ2A;POLR2J
prerank,histone H3-K36 demethylation (GO:0070544),-0.5194865595132385,-1.2028741113808548,0.2543478260869565,0.8154618450471468,1.0,3/10,12.76%,KDM7A;KDM2A;RIOX2
prerank,inositol phosphate metabolic process (GO:0043647),0.4680307519155026,1.2028433434713202,0.2371967654986523,0.9471826076498037,1.0,12/46,12.09%,ITPK1;PLCE1;INPP4B;PLCB4;INPP5A;NUDT4;CALM1;PLCB1;INPPL1;PLCD1;INPP5B;ITPKC
prerank,postsynaptic membrane organization (GO:0001941),-0.44046477702623477,-1.2027770449192101,0.23002421307506055,0.8136314786892773,1.0,10/17,28.35%,APOE;NLGN1;SHANK3;NRXN1;NLGN2;NLGN3;DNAJA3;CHRNB1;SHISA7;LHFPL4
prerank,membrane lipid catabolic process (GO:0046466),-0.5198575097430935,-1.2019582116780732,0.28348214285714285,0.8144484591945901,1.0,4/10,20.44%,ENPP2;CYP1B1;PPT1;NAGA
prerank,positive regulation of cell differentiation (GO:0045597),0.3984288337346812,1.201589754096785,0.16427104722792607,0.9499474777525257,1.0,38/237,8.82%,SOX6;AGTR1;SOX5;MEF2C;RAP1A;RBM24;SMYD1;CD36;CCN1;PLA2G3;FERMT2;LOXL2;HEYL;LPL;TGFB3;GCNT2;MMD;ACVR2A;TGFB1I1;SP7;ARHGEF2;BMPR1A;MEF2A;RARRES2;RRAS;GDNF;PA2G4;AR;BTG1;YAP1;SOX9;TGFB2;PLCB1;RIN2;CDH2;TRPM4;SUCO;IMPACT
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5197824002083361,1.201517464978655,0.2730210016155089,0.9486765156816732,1.0,8/22,10.75%,PDGFB;PDGFC;PDGFD;RAP2C;VEGFA;CALM1;RAP2A;PDGFA
prerank,regulation of intracellular transport (GO:0032386),0.48026121612034195,1.2012501142309244,0.253077975376197,0.9480750799427289,1.0,4/38,6.83%,MYLK2;PLA2G3;LCP1;PTPN1
prerank,regulation of neutrophil migration (GO:1902622),0.587771684603441,1.2011443840571314,0.32437275985663083,0.9468883602060659,1.0,4/10,15.31%,JAM3;RHOH;MPP1;RHOG
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5857418076243114,1.2010391554331672,0.28324697754749567,0.9457010435833091,1.0,3/12,5.71%,MYO1E;JAG1;KLF15
prerank,neuron maturation (GO:0042551),-0.41999012927242996,-1.1998744472018477,0.23218997361477572,0.8199208740882697,1.0,10/18,21.21%,APP;ADGRB3;B4GALT6;ANKS1A;SCARF1;CX3CL1;EPHA8;PICK1;LGI4;MTCH1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.48238137529897507,-1.199573579563913,0.24941176470588236,0.8187460516424013,1.0,4/12,7.33%,TNKS2;PARP11;PARP10;PARP3
prerank,histone H3-K9 demethylation (GO:0033169),-0.4998431216858312,-1.199466128517345,0.25217391304347825,0.8170162238492118,1.0,4/11,17.72%,KDM7A;KDM3B;KDM4D;KDM1A
prerank,odontogenesis (GO:0042476),-0.3716686597861471,-1.1993730300774041,0.16783216783216784,0.8151965212572401,1.0,10/35,16.64%,EDA;BMP4;COL1A2;GLI2;OSR1;LAMB1;FGFR2;HDAC2;WNT6;BCOR
prerank,regulation of actin filament-based process (GO:0032970),0.44357011835700727,1.198785538463006,0.22832722832722832,0.9518625028146144,1.0,15/70,12.99%,DLC1;ROCK1;CNN2;ABRACL;RHOBTB3;ARHGAP17;RHOF;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;DMTN
prerank,positive regulation of cell motility (GO:2000147),0.4003993610155854,1.198587347991009,0.1638655462184874,0.9510321595158648,1.0,34/205,10.88%,NTF3;MYLK;NTRK3;ACTN4;FGF1;CAVIN1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;SEMA5A;CDH13;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;NTN1;SEMA6C;HAS2;SYNE2;CBLL1;CAV1;VEGFA;SNAI2;SUN2;ADAM17;WASHC1;PDGFRB;HBEGF;PDGFA;GPER1;ROCK2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5164346168614913,-1.198549716848199,0.26018099547511314,0.8159925428169646,1.0,8/10,44.86%,KIT;LYN;CD24;BTLA;FGR;BAG6;CD40;LILRB1
prerank,angiogenesis involved in wound healing (GO:0060055),0.5756818023014838,1.1979357615450357,0.29887218045112784,0.9517044180970101,1.0,3/11,7.49%,MCAM;VEGFA;ITGB3
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.496653814234504,1.1969004446853186,0.26608187134502925,0.9537015909728809,1.0,7/32,6.96%,DLC1;PHLDB2;CLASP2;JAG1;ARHGAP6;AJAP1;CORO1C
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4407929661257101,-1.1966115503668944,0.22058823529411764,0.8206081289447174,1.0,7/17,18.62%,SEL1L;DERL1;UFD1;HSP90B1;OS9;SYVN1;HERPUD1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4725766773550581,1.196600456041275,0.25675675675675674,0.9532085621792346,1.0,13/44,14.01%,RBM24;ROCK1;BTG2;UPF1;POLR2G;YTHDF2;CELF1;FTO;ROCK2;CNOT7;CPEB3;ZFP36L1;GIGYF2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.5810330097846139,1.196543572852499,0.2898550724637681,0.9519129912520448,1.0,2/11,6.74%,PRKCQ;IL12RB1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5413776484814555,1.19630492533739,0.3101694915254237,0.9512905132405355,1.0,4/17,8.61%,PRKAB2;PDK4;CAV1;PPARA
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4419529657752405,1.1962765247078044,0.22771084337349398,0.9498842162945138,1.0,14/75,10.88%,RGS6;ROCK1;PLCE1;RGS4;CCL5;SAG;RPGRIP1L;CALM1;PLEK;PLCB1;MGLL;SLC39A14;GPER1;ROCK2
prerank,mesenchymal cell differentiation (GO:0048762),0.45221112398596386,1.1962689138221252,0.24621212121212122,0.9484392930836524,1.0,14/51,11.69%,MEF2C;HEY2;ROCK1;LIMS1;FAM83D;LOXL2;HEYL;SOX9;SNAI2;TGFB2;AKNA;HIF1A;ROCK2;HTR2B
prerank,mRNA destabilization (GO:0061157),0.4731990582186409,1.1958078696526098,0.26805555555555555,0.9484881856854169,1.0,11/38,14.01%,RBM24;ROCK1;UPF1;YTHDF2;CELF1;FTO;DIS3L2;ROCK2;CPEB3;ZFP36L1;GIGYF2
prerank,pentose-phosphate shunt (GO:0006098),-0.5073231598518921,-1.1949869070651298,0.26036866359447003,0.8242853540876836,1.0,5/11,26.78%,PGD;TKT;SHPK;DERA;PGLS
prerank,positive regulation of cyclase activity (GO:0031281),0.5606687553087446,1.1945893042661746,0.28888888888888886,0.9511248376756244,1.0,2/14,3.43%,CACNA1C;STIM1
prerank,regulation of coagulation (GO:0050818),0.5726808184320646,1.1941211757675922,0.2983050847457627,0.9511751051068094,1.0,2/11,6.08%,PROCR;CAV1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4428594751044883,1.193859593190471,0.24847746650426308,0.9506237233937471,1.0,18/66,14.42%,MAP3K5;FGF1;MST1R;PDGFB;PDGFC;PDGFD;TNFRSF11A;DAB2IP;VEGFA;RASGRP1;MAP3K10;PDGFRB;PDGFA;HTR2B;PDCD10;TAOK3;LRRK2;DIRAS2
prerank,regulation of macrophage migration (GO:1905521),0.5969392233248262,1.193677241741283,0.3088235294117647,0.9497751977731579,1.0,3/10,7.00%,EMILIN1;CD200R1;CD200
prerank,telomere maintenance (GO:0000723),-0.3388261068856305,-1.193530690381766,0.18518518518518517,0.8272855287028514,1.0,25/50,28.37%,ATR;PRKDC;XRCC5;STN1;MRE11;RAD50;PARP3;SP100;BLM;XRCC6;NBN;CTC1;SMC5;TPRKB;TERF2IP;LTO1;HUS1;ATM;NSMCE2;ERCC4;DCLRE1B;TINF2;RPA3;DNA2;TEN1
prerank,autophagy of mitochondrion (GO:0000422),-0.35711168875566446,-1.193289536013475,0.2217741935483871,0.8259603171365238,1.0,20/38,28.27%,RB1CC1;CISD2;ATG3;FBXO7;ATG5;PRKN;ATG2B;AMBRA1;WIPI2;ATG2A;FIS1;GABARAPL2;WDR45B;MAP1LC3A;ULK2;GABARAPL1;WIPI1;SQSTM1;MAP1LC3B;ATG12
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5332765657780587,1.1931760783268497,0.2809364548494983,0.9499750994136061,1.0,5/19,9.35%,NDST3;CSGALNACT1;EXT2;HS2ST1;HS6ST1
prerank,skin development (GO:0043588),0.4448381634795978,1.193169730999509,0.23636363636363636,0.9485300866688092,1.0,12/65,12.43%,RYR1;ITGA3;ANXA1;JAG1;TMEM79;FA2H;SLC2A10;MED1;EPHA2;PDGFA;BCR;COL3A1
prerank,negative regulation of protein modification process (GO:0031400),0.4252753444911356,1.1929400208455445,0.22576832151300236,0.9478077196100997,1.0,13/79,9.38%,DMD;NTRK3;ATP2B4;SNTA1;CRTAP;MFHAS1;MAPT;TPPP;DAB2IP;CORO1C;ENSA;IMPACT;CDYL
prerank,smooth muscle tissue development (GO:0048745),0.6031385214810343,1.1926367212821574,0.31970260223048325,0.9474425815165055,1.0,1/10,0.26%,MYLK
prerank,insulin secretion (GO:0030073),0.5203880098074876,1.1926193453929474,0.28440366972477066,0.9460363937448181,1.0,2/19,2.79%,CAMK2G;ANXA1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5436105499109599,1.1922025640674088,0.29152542372881357,0.9460882309209232,1.0,5/17,10.29%,FERMT2;THPO;TERT;KAT7;HNRNPU
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4993206926979665,1.19167034757552,0.27203647416413373,0.9463750152321677,1.0,5/28,7.30%,PRKAB2;NR1H4;PDK4;CCL5;MED1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.563831179050565,1.191262941242993,0.270979020979021,0.9463348059160284,1.0,4/13,7.86%,D2HGDH;DLST;GOT1;GOT2
prerank,zinc ion transmembrane transport (GO:0071577),-0.397757053663222,-1.1906702972081835,0.2275132275132275,0.8329866776988794,1.0,7/22,15.27%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,negative regulation of blood coagulation (GO:0030195),-0.36243773226405096,-1.1906003133682046,0.1947565543071161,0.8311191685231786,1.0,9/38,9.32%,PDGFRA;APOE;VTN;TFPI;PLAT;F3;CD34;THBD;NOS3
prerank,positive regulation of bone mineralization (GO:0030501),0.47826822695319354,1.1903563952280356,0.26483357452966716,0.9479171782698851,1.0,11/35,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1
prerank,substantia nigra development (GO:0021762),0.48347141302623314,1.1903550056548822,0.2703862660944206,0.9464677636242125,1.0,8/37,9.92%,DYNLL1;SYPL2;PADI2;ACTB;CALM1;MBP;NDUFS3;SIRT2
prerank,positive regulation of protein sumoylation (GO:0033235),0.5948339622278733,1.190194484857909,0.3041958041958042,0.9455306934556409,1.0,3/10,6.08%,UBA2;PIAS4;SAE1
prerank,presynapse assembly (GO:0099054),-0.45339148591668693,-1.1901667967225693,0.2603092783505155,0.830342526807114,1.0,6/16,15.28%,WNT5A;NLGN1;PTPRD;NLGN2;NLGN3;PCLO
prerank,positive regulation of macrophage activation (GO:0043032),-0.43702068754903123,-1.1898725644138348,0.2518891687657431,0.8292858948187033,1.0,5/17,21.36%,LBP;WNT5A;IL33;TTBK1;HSPD1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.492555447581846,-1.189780422684279,0.2482758620689655,0.8275446302375034,1.0,5/11,22.30%,RASA1;PCBP2;NOVA1;NOVA2;PCBP4
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.39730570449982117,-1.1897728193531907,0.20221606648199447,0.8254575916105724,1.0,5/24,16.44%,RBBP4;PPHLN1;AEBP2;PPM1D;MPHOSPH8
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.584611069777516,1.1897674548298263,0.2775800711743772,0.9455255466101433,1.0,2/10,6.45%,ACTN4;RXRG
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.42701331872834924,-1.1897165354283041,0.232620320855615,0.8235730414953432,1.0,6/18,11.07%,DDX5;BMP4;EGFR;ESR1;TGFB1;MAP2K2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.41759002511888244,-1.1891914598060767,0.2112676056338028,0.8234264625551246,1.0,8/20,12.36%,ITCH;DCUN1D3;UBQLN1;ZMIZ1;HSP90AB1;PRKN;TGFBR1;DNAJB2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.49229341185852465,1.189060765433304,0.26917293233082706,0.9463462352222104,1.0,7/30,12.99%,NTF3;CAV1;PIBF1;CD300A;SAMSN1;PRKCD;DMTN
prerank,positive regulation of nervous system development (GO:0051962),-0.35379377095059106,-1.1880978971162663,0.19776119402985073,0.8252820507141249,1.0,20/42,28.54%,NLGN1;SPEN;PTPRD;SNW1;NRXN1;FAIM;NLGN2;NLGN3;NUMB;LRRC4B;GRID2;NAP1L1;IL1RAP;EPHB2;SRPX2;MME;TRIM32;SOX11;EPHB3;SYNDIG1
prerank,regulation of blood coagulation (GO:0030193),-0.39147027587316185,-1.1878718814428773,0.2247557003257329,0.8238733794639306,1.0,6/27,8.26%,ST3GAL4;APOE;VTN;TFPI;CD34;THBD
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4273198502173327,-1.1873909881702611,0.2423469387755102,0.8234333470700713,1.0,14/19,33.54%,PGM3;RENBP;UGDH;PMM2;SLC35D1;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1;PMM1;NANS;GNPNAT1;MPI
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.485589891224834,-1.1873735760123418,0.27790432801822323,0.8214147435925618,1.0,3/12,6.83%,UNC13C;UNC13B;SYT1
prerank,activation of protein kinase A activity (GO:0034199),0.5506531114443168,1.1870891339850431,0.3021702838063439,0.9514571802568641,1.0,6/16,9.47%,ADCY5;ADCY2;ADCY9;PRKACB;PRKAR1B;ADCY6
prerank,long-term synaptic potentiation (GO:0060291),0.5152506660996599,1.186723845593515,0.29545454545454547,0.9511955133447931,1.0,3/21,2.87%,CRHR2;SLC8A2;GRIN2C
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4894112238063666,1.1866863413655104,0.28029197080291973,0.9498945591573821,1.0,4/28,6.98%,NOTCH3;TCIM;FBXW7;YTHDF2
prerank,carnitine shuttle (GO:0006853),0.5729454812221242,1.186591311890333,0.29310344827586204,0.9488082929868248,1.0,5/11,14.42%,PRKAB2;ACACB;CPT1B;CPT1A;PRKAA2
prerank,camera-type eye development (GO:0043010),-0.40142652491610914,-1.1864230474684863,0.2063953488372093,0.8227606929250804,1.0,9/25,9.34%,SHROOM2;FBN1;NF1;EFEMP1;LAMA1;FBN2;IFT122;CYP1B1;TENM3
prerank,regulation of necroptotic process (GO:0060544),-0.40125347174952425,-1.1854985501297046,0.2361111111111111,0.8239938757655294,1.0,8/23,14.60%,YBX3;CASP8;BIRC2;PELI1;SDCBP;OGT;STUB1;BIRC3
prerank,regulation of cell migration (GO:0030334),0.3878382095480916,1.1852272959620487,0.15166835187057634,0.9518675227441418,1.0,44/382,7.06%,NTF3;NEXN;FLNA;MYLK;TPM1;NTRK3;DLC1;ACTN4;VCL;TMIGD3;ROCK1;FGF1;NKD1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;SEMA5A;PLXND1;PLXNB1;CDH13;ANXA1;JAG1;KIF2A;KANK1;SERPINE2;IGFBP5;DOCK10;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;SEMA6C;HAS2;SYNE2;CBLL1;CAV1;RAP2C;DUSP3;VEGFA;CORO1C;STK26
prerank,histone ubiquitination (GO:0016574),-0.41674079047814877,-1.1844045948468542,0.25984251968503935,0.8258907993940491,1.0,6/21,13.86%,RNF20;UBR2;CTR9;PHC1;DTX3L;LEO1
prerank,telomere organization (GO:0032200),-0.3487205829890687,-1.183884742565725,0.23046875,0.8255743156483549,1.0,16/43,18.11%,ATR;PRKDC;XRCC5;STN1;MRE11;RAD50;PARP3;SP100;BLM;XRCC6;NBN;CTC1;TERF2IP;LTO1;HUS1;ATM
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5874517862864245,1.183628878313769,0.3125,0.9558340166265615,1.0,3/11,13.58%,MERTK;AXL;GAS6
prerank,negative chemotaxis (GO:0050919),0.48504646928403966,1.183432749112307,0.26573426573426573,0.955047370496101,1.0,4/33,4.74%,SLIT1;SLIT3;NTN1;SEMA6C
prerank,nuclear membrane disassembly (GO:0051081),-0.45526690682776333,-1.1829688499513513,0.23820754716981132,0.8267474836943975,1.0,4/14,16.57%,PRKCB;AKAP8L;NEK9;NEK6
prerank,protein neddylation (GO:0045116),0.55541350964911,1.182907904443084,0.3076923076923077,0.9553146448525593,1.0,5/13,12.10%,DCUN1D2;RNF7;UBE2F;DCUN1D1;UBA3
prerank,response to cAMP (GO:0051591),0.47806660643429355,1.182619939739478,0.25874125874125875,0.9548627845683509,1.0,3/37,3.49%,RAP1A;AKAP6;IGFBP5
prerank,cell chemotaxis (GO:0060326),0.4440861716986386,1.1823570720016578,0.24719101123595505,0.9543023550411177,1.0,13/60,11.29%,AGTR1;PDGFB;SEMA5A;NR4A1;ARHGEF16;PRKCQ;CXCR6;VEGFA;EPHA2;PARVA;PDGFRB;HBEGF;PRKCD
prerank,organelle organization (GO:0006996),0.3848648081865861,1.1822274023838042,0.1347517730496454,0.9532853571611877,1.0,71/388,14.15%,PALLD;TPM1;ARHGEF7;WTIP;MAST4;MICAL2;CHMP4C;PLCE1;LIMD1;SYNE1;ATP8B1;CNN2;DES;CLASP2;HSD17B10;PACSIN3;GABPA;PACSIN2;ARMC2;SORT1;GEM;TBC1D20;ARHGAP21;ARHGAP10;SIRT3;ATAD3A;DST;MARK1;LNPK;MYO18A;PEX2;CAV1;PITPNB;SEC31B;CHMP5;TERT;PARP1;ABCA3;YTHDF2;PPARGC1A;OPA1;MREG;MTX1;AUP1;MIEF2;ABCD4;LONP1;NSFL1C;DNM1L;TFB2M;PEX19;LONP2;KIF5C;KIFAP3;ESRRA;NECTIN2;CHMP2B;TNIK;PACSIN1;MICAL3;CDC42BPB;DMTN;CLASP1;MAST1;CAPZB;PNPLA3;CHMP2A;SIRT4;ADCK1;BNIP1;RAB14
prerank,bile acid and bile salt transport (GO:0015721),0.5005203307898826,1.1822014933623324,0.2834890965732087,0.9519494627814307,1.0,3/24,2.91%,NR1H4;ATP8B1;SLC10A1
prerank,positive regulation of cellular respiration (GO:1901857),-0.49534004579312374,-1.1820648948896513,0.2642369020501139,0.8281860600758238,1.0,4/11,22.46%,NUPR1;IFNAR1;PARK7;ISCU
prerank,cellular response to calcium ion (GO:0071277),0.4404838989709358,1.1820623918044295,0.2669962917181706,0.9509732099795455,1.0,7/67,5.58%,RYR1;MEF2C;RASGRP2;CAMK2D;SYT10;MEF2A;KCNH1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4426568508967778,-1.1817948715639532,0.24932975871313673,0.8270284321455702,1.0,7/16,19.05%,BMP7;SOX13;NAPEPLD;SIX1;PTGS2;TFE3;METRNL
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3963687893284735,-1.1811032383405478,0.24362606232294617,0.8273855135924102,1.0,9/23,18.62%,SEL1L;DERL1;UFD1;SURF4;HSP90B1;OS9;LMAN1;SYVN1;HERPUD1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.48826824550392467,1.1810036348569095,0.279887482419128,0.9529788093424526,1.0,3/32,6.08%,AKAP6;CASQ1;CAV1
prerank,sulfur amino acid catabolic process (GO:0000098),0.5900051982501651,1.1809156921705704,0.32922535211267606,0.9518443623861869,1.0,2/10,5.95%,TXN2;BLMH
prerank,regulation of axon guidance (GO:1902667),-0.5029323589142777,-1.1805199055361306,0.2802690582959641,0.8274195168683358,1.0,5/10,12.46%,NRP1;MYCBP2;ZSWIM6;ZSWIM5;ZSWIM4
prerank,response to interleukin-6 (GO:0070741),-0.5122671803032985,-1.1803924517660316,0.24019607843137256,0.8258737755819737,1.0,3/10,2.87%,PID1;ST3GAL6;SBNO2
prerank,negative regulation of bone remodeling (GO:0046851),-0.5041253242129168,-1.1799297710580556,0.2923076923076923,0.8253409399619669,1.0,9/11,44.89%,GPR137B;TMEM119;GPR137;TNFAIP3;UBASH3B;GREM1;CALCA;SFRP1;CARTPT
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5280571176912247,1.1799237801185594,0.28175895765472314,0.9536997179585007,1.0,3/18,4.35%,RAP1A;SLC4A8;RIMS3
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4133855078907078,1.1796523184389187,0.2376126126126126,0.9532012257845813,1.0,26/118,13.34%,WTIP;MEF2C;PDLIM5;SDC2;INF2;FERMT2;PLXND1;PHLDB2;CLASP2;CHN1;KIF1A;MAPT;GDNF;NEDD4;CDH2;BRSK1;PAK2;EPHA2;RAP2A;TSPAN12;ARHGAP35;TNIK;SARM1;CLASP1;BCL6;CAPZB
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3713693191300673,-1.1789196122017416,0.2159090909090909,0.8266929276116908,1.0,7/29,13.86%,LEF1;TLE1;TCF7L2;BCL9L;CTNNB1;EP300;LEO1
prerank,regulation of pseudopodium assembly (GO:0031272),0.5797040576720671,1.1786349179190463,0.32035398230088497,0.9536593272412208,1.0,2/10,8.93%,CDC42EP3;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5797040576720671,1.1786349179190463,0.32035398230088497,0.9536593272412208,1.0,2/10,8.93%,CDC42EP3;WASHC1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5049431514411503,-1.1778787456117659,0.26327433628318586,0.8281214685958254,1.0,6/11,14.60%,YBX3;NUPR1;CASP8;BIRC2;PELI1;BIRC3
prerank,response to laminar fluid shear stress (GO:0034616),-0.5105104680703241,-1.1778109524784315,0.275626423690205,0.8263430986984233,1.0,5/10,24.58%,ABCA1;SMAD6;KLF2;ASS1;MAPK7
prerank,stabilization of membrane potential (GO:0030322),-0.4348093084559692,-1.1777428930365692,0.26968973747016706,0.8245790462632849,1.0,2/16,6.55%,KCNK2;KCNK5
prerank,positive regulation of histone methylation (GO:0031062),-0.3961155883815072,-1.1771255875753883,0.2208955223880597,0.8246562496918158,1.0,7/24,17.37%,AUTS2;CTR9;CTNNB1;OGT;SNW1;CHTOP;SMAD4
prerank,cellular response to heat (GO:0034605),0.4825054123655451,1.1759839449342286,0.2979942693409742,0.9610433153066186,1.0,5/35,9.67%,FGF1;ANO1;TCIM;MAPT;BAG3
prerank,regulation of interleukin-12 production (GO:0032655),-0.3339760628568345,-1.1752117468505192,0.19313304721030042,0.8291193400021786,1.0,6/47,8.66%,FOXP1;HMGB1;MAPK14;LGALS9;PLCG2;IRAK3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4972957250245508,1.1750350488310257,0.2988871224165342,0.9627119129819717,1.0,2/25,2.87%,MEF2C;GRIN2C
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3504081017251161,-1.1742097853404272,0.20846905537459284,0.8305050530542657,1.0,8/32,14.00%,OSBPL8;OSBPL10;PLA1A;SERINC1;PTDSS2;SERINC5;PLAAT3;ABHD12
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.3707851667267503,-1.1741347491786995,0.21604938271604937,0.8287196874171703,1.0,18/29,37.58%,MRE11;HSP90AB1;RAD50;ANKRD28;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;GAR1;TINF2;PPP6C;NOP10;PPIA;ACD;RPA1;RFC1;NHP2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.4895530936773069,-1.1739991314491716,0.2727272727272727,0.8271937219968716,1.0,4/11,16.29%,SCARA3;CASP8;UNC93B1;TLR3
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3734936072076623,-1.1736881030294197,0.23859649122807017,0.826268351300956,1.0,9/31,26.68%,HMGB1;MAPK14;LGALS9;PLCG2;TLR3;TIRAP;HSPD1;SYK;LAPTM5
prerank,regulation of B cell proliferation (GO:0030888),0.4591726444648422,1.1731647054994485,0.28005464480874315,0.9674814122922586,1.0,6/44,10.87%,MEF2C;IL2;TNFSF13B;BCL2;CD300A;TNFRSF21
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4536542265392904,1.172964634199235,0.2574123989218329,0.9667487105039801,1.0,7/43,5.14%,RBPMS2;HTR1B;PDGFB;CDH13;IGFBP5;CCL5;BMPR1A
prerank,kidney development (GO:0001822),0.4344685954445721,1.1729478473373225,0.27,0.9653789036238284,1.0,8/65,7.87%,ITGA8;AGTR1;OSR2;CEP290;HAS2;VEGFA;GDNF;TGFB2
prerank,regulation of gene expression (GO:0010468),0.37992450780132847,1.1729073435894755,0.061,0.9641246517248184,1.0,120/903,11.82%,MYOM1;ACTA2;CCDC3;SOX6;MLF2;MYLK2;TMPRSS4;TTN;WTIP;ACTG2;MEF2C;NTRK3;CRIP1;ATP2B4;HEY2;ZFHX3;ACTA1;ANGPT1;PTP4A3;ROCK1;FGF1;CD36;LIMS1;LIMD1;MYD88;PDGFB;NAB1;ALPK2;CDK6;PLA2G3;RORA;SLC8A2;SLC8A1;MLF1;GABPA;HINFP;RBM38;SORT1;ACTG1;GCNT2;RBAK;PRDM1;CD276;MUSK;RBMS3;UBR5;ATXN1;OSR2;HAVCR2;BMPR1A;SLC38A2;EMILIN1;PRKCQ;TESC;ATP1B1;MYBBP1A;TAF1;MAPT;TERT;TP53;SLC2A10;VEGFA;FBXW7;PIN1;ZBTB38;GDNF;SFPQ;YTHDF2;AR;PPARGC1A;TRAF3;MED1;PPARGC1B;ZNF431;CELF1;REXO4;BTG1;YAP1;NAT8;C1QTNF1;SOX9;SNAI2;DICER1;TGFB2;RELA;KMT2D;ADNP2;DAPK3;CUX2;TRIM68;MBNL2;MAP2K1;MSL3;FUS;NSD3;PPIE;KAT7;RPL5;HIF1A;PTBP2;MBNL1;NR2C2;NUP107;TOB2;GPER1;ROCK2;SRSF10;RUNX1;ANKRA2;RB1;RHOH;TERF2;BAZ2A;AFF1;NFX1;ACVR1B;ESRRA;CNOT7;PSPC1;USP13
prerank,ganglioside metabolic process (GO:0001573),-0.4079093202454892,-1.1728412820317382,0.24571428571428572,0.8270501465094642,1.0,10/20,29.50%,ST8SIA4;ST3GAL5;ST6GALNAC3;ST8SIA2;HEXA;ST6GALNAC5;ABCA2;NEU1;ST6GALNAC4;ST8SIA3
prerank,renal water homeostasis (GO:0003091),0.5080393172794626,1.172485586428243,0.2834890965732087,0.9641555519618804,1.0,9/23,15.26%,ADCY5;ADCY2;ADCY9;PRKACB;PRKAR1B;ADCY6;MYO5B;PRKACA;RAB11FIP2
prerank,epithelial cell migration (GO:0010631),0.47596166353006963,1.1720028922882069,0.28804347826086957,0.9643324111020795,1.0,7/37,3.29%,PTP4A3;ROCK1;ZEB2;PLXND1;CDH13;LOXL2;KANK1
prerank,cytoplasmic translation (GO:0002181),-0.2964316856119751,-1.1718031938088356,0.15328467153284672,0.8286062223219721,1.0,40/91,29.90%,RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;RPLP0;ZC3H15;RPS29;RPL28;RWDD1;EIF2B3;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;RPS7;RPL27;RPL11;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27;GSPT2;RPL4;RPS5;RPS15;RPL35A
prerank,cellular response to osmotic stress (GO:0071470),0.5206036330927846,1.1715850241837684,0.3116279069767442,0.9642652478099126,1.0,3/21,8.15%,MYLK;ARHGEF2;RCSD1
prerank,Ras protein signal transduction (GO:0007265),0.3981472109285856,1.1714423260805331,0.23710208562019758,0.9633632834533404,1.0,27/137,11.37%,AGTR1;RAP1A;ROCK1;CDC42EP3;PLCE1;CCNA2;RASGRP2;CDH13;MYO9B;RERG;NTN1;KSR1;ARHGAP6;ARHGDIG;RAP2C;TP53;RRAS;CYFIP1;RAPGEF6;RASGRP1;GNA12;ARHGAP1;RAP2A;ROCK2;RB1;ARHGAP5;RHOH
prerank,vesicle transport along microtubule (GO:0047496),0.5055454614768274,1.1712618190634816,0.2961832061068702,0.9625346495697915,1.0,9/23,12.26%,KIF3B;KIF1A;KIF5B;TRAK1;FYCO1;KIF1C;KIFAP3;FBXW11;KIF5A
prerank,positive regulation of tissue remodeling (GO:0034105),0.5653399214280321,1.1711356676524634,0.3128390596745027,0.9615858702665495,1.0,2/10,3.19%,ROCK1;IL2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5339323714262855,1.170867311195921,0.3003194888178914,0.9610708226781898,1.0,3/15,5.83%,KCNA5;KCNN2;ATP1B1
prerank,organic hydroxy compound transport (GO:0015850),0.46197746286884456,1.1708245692133485,0.2830188679245283,0.9598280586750378,1.0,4/36,2.91%,NR1H4;ATP8B1;SLC5A3;SLC10A1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5860411186250328,1.170666120356081,0.2956204379562044,0.9589523055147409,1.0,4/10,14.92%,PMAIP1;IRS1;PTH1R;IRS2
prerank,response to UV-B (GO:0010224),0.5635386175396776,1.169874855151676,0.3264957264957265,0.9601398673060708,1.0,4/12,16.74%,CRIP1;RELA;HYAL1;MSH2
prerank,positive regulation of cell killing (GO:0031343),-0.47446929838790863,-1.1698429809386404,0.27699530516431925,0.8334102905383273,1.0,6/13,37.65%,WNT5A;SYK;DVL2;MAPK8;NOXO1;NOX1
prerank,fluid transport (GO:0042044),-0.4710480632271081,-1.1695311595468576,0.2768878718535469,0.8325096124213788,1.0,1/12,1.63%,PDPN
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.534957142654948,1.1688395583004494,0.3109375,0.9621148568517606,1.0,4/18,4.36%,DLC1;ITGA3;KANK1;TNFAIP1
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3503484684575905,-1.1683088529764096,0.23104693140794225,0.8347503810451367,1.0,8/36,8.59%,RBBP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,negative regulation of coagulation (GO:0050819),-0.4487515103343377,-1.1678431743038453,0.2748267898383372,0.8344301785806185,1.0,5/14,8.26%,APOE;VTN;TFPI;CD34;THBD
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3853067454959515,-1.1672202189064333,0.22058823529411764,0.8345816475600957,1.0,11/25,21.39%,SMAD3;PKD2;NOS1AP;HSP90AB1;DDAH1;PTGS2;KLF2;INSR;AKT1;DDAH2;ASS1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3408760060184449,-1.1669079902471615,0.22336769759450173,0.8337280517530937,1.0,13/39,18.86%,TSPAN5;ROBO1;AAK1;BMP2K;ZMIZ1;NOS3;CCN3;SNW1;EP300;JAG2;MAML1;NOTCH4;ITGB1BP1
prerank,fatty acid elongation (GO:0030497),-0.4659725387856478,-1.1666360766302775,0.2818181818181818,0.8326802451874201,1.0,7/13,22.83%,ELOVL7;HACD4;ELOVL4;ELOVL6;HACD2;ELOVL1;HACD3
prerank,histone H3-K4 trimethylation (GO:0080182),-0.4916821022418099,-1.1658729709440594,0.2971698113207547,0.8332274627287752,1.0,8/11,30.90%,TET3;CTR9;TET2;OGT;SETD1A;PRDM9;KMT2A;BEND3
prerank,regulation of histone methylation (GO:0031060),-0.46150056806746764,-1.1655708204429172,0.2837209302325581,0.8323281721567749,1.0,8/13,37.73%,NSD1;CTR9;CHTOP;PIH1D1;JARID2;PAF1;AASS;TTLL12
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5252830255061117,1.16530829671019,0.3015151515151515,0.9723972970520021,1.0,6/21,15.27%,FZD5;CAV1;AMER1;PPP1CA;DVL1;CSNK1A1
prerank,carboxylic acid catabolic process (GO:0046395),-0.4729694766872633,-1.1647658198917712,0.2866817155756208,0.8332017005221602,1.0,10/12,48.05%,RENBP;ACOT8;AMDHD2;NPL;GNPDA1;PON3;NAGK;IL4I1;BCKDK;GNPDA2
prerank,plasma membrane repair (GO:0001778),0.5694634746606426,1.1640088087559262,0.31443298969072164,0.9752100739932488,1.0,4/13,7.06%,FER1L5;DYSF;MYH9;RAB3A
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5303374284317938,1.1632837966781082,0.3245469522240527,0.9761646647047643,1.0,6/19,11.09%,FZD5;CAMKK2;FBXW7;VDAC1;DNM1L;SREBF2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.47212903108934196,-1.163054534540701,0.2853717026378897,0.8371066502489658,1.0,5/12,27.46%,PPHLN1;SETDB1;MPHOSPH8;RESF1;SETDB2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5022562228287644,1.1629530547297586,0.29753265602322204,0.9758173847686478,1.0,5/24,8.27%,ROCK1;ITGB1;CCL5;TNIP1;ITGA4
prerank,chloride transmembrane transport (GO:1902476),0.45120602688169364,1.1624191776556811,0.28835978835978837,0.9761656909784332,1.0,10/48,11.99%,ANO1;GABRE;ANO6;SLC4A8;GABRA4;GABRA5;GABRB2;GABRG1;ANO3;GABRB3
prerank,maintenance of blood-brain barrier (GO:0035633),0.47326015288819634,1.1620017695600786,0.2894736842105263,0.9761983250431283,1.0,8/30,7.75%,DMD;VCL;ACTG1;ITGB1;ACTB;JAM3;LAMC1;MBP
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.37048180484829857,-1.1617178185958732,0.2643312101910828,0.8397255847253119,1.0,12/29,26.97%,VTI1A;COPB2;COG6;COPE;GABARAPL2;COG2;NAPG;TRAPPC3;COPB1;GOLGA5;COPG2;GOSR1
prerank,external encapsulating structure organization (GO:0045229),0.38936467865862034,1.1614523080085428,0.24710830704521555,0.9765608031931362,1.0,28/205,8.54%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;PDGFB;ITGA1;ITGA3;ADAMTS5;ADAMTS19;COL4A6;ITGB1;BGN;JAM3;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;ITGA4;COL27A1;COL4A5
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.46119386085147984,-1.1613869450571952,0.2777777777777778,0.8388874777749555,1.0,6/14,33.15%,MOXD1;DAGLA;SLC5A7;DAGLB;ALDH9A1;SLC22A2
prerank,regulation of phospholipase activity (GO:0010517),-0.5033018626519583,-1.1613382682405151,0.2916666666666667,0.8371215092366328,1.0,4/10,14.14%,LRP1;PDPK1;FGFR2;SNCA
prerank,protein localization to membrane (GO:0072657),0.38984709735296535,1.160760294167359,0.24312896405919662,0.9773576138250057,1.0,48/187,16.95%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;FERMT2;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;CAV1;TTC7A;RAB3A;RAMP1;RAPGEF6;SAV1;ITGA4;LIN7C;EPHA2;RAP2A;ACTN2;AGRN;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;DVL1;TSPAN17;RAB34;RAB8B;FLOT1;PRAM1;RFTN1;ANK1;LIN7A;SMURF1;RAB8A;TM9SF2;RAB38
prerank,regulation of multicellular organismal development (GO:2000026),-0.3865593805563585,-1.1604476777686035,0.26239067055393583,0.8380983302163681,1.0,11/25,30.53%,PTN;TRIP12;INSR;SOX17;OAS2;SPAAR;DUSP6;KAT2A;CD24;TDG;RACGAP1
prerank,eye development (GO:0001654),-0.32238214494402784,-1.1595570015063346,0.1888412017167382,0.8392594060753846,1.0,9/54,6.52%,SHROOM2;FBN1;SMOC1;EFEMP1;LAMA1;PBX3;FBN2;RBP4;COL5A1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3730590228005515,-1.1590077821848768,0.2608695652173913,0.8391240174125876,1.0,12/27,30.49%,ENPP2;PLA2G6;GDPD1;ABHD12;PLA2G7;GDE1;GPCPD1;PNPLA6;INPP5F;ENPP6;PNPLA8;SMPD4
prerank,secretion (GO:0046903),-0.44973991915984723,-1.1587603479872761,0.2980769230769231,0.8380364982850947,1.0,4/14,15.78%,SLC22A6;NPR1;SLC22A4;FBLN5
prerank,negative regulation of chemotaxis (GO:0050922),-0.3581287979810605,-1.15853856442079,0.24285714285714285,0.8368441369071291,1.0,8/31,7.78%,ROBO1;SEMA3D;SEMA3C;SEMA6A;SLIT2;SEMA7A;SEMA3A;SEMA4D
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4158842996698424,-1.1585263973586835,0.25405405405405407,0.834978590639133,1.0,6/18,19.37%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4556932851364465,1.1583383251559827,0.2603626943005181,0.9839096076706636,1.0,10/43,12.04%,ARHGEF7;ITGA1;SOCS5;SOCS4;DAB2IP;DUSP3;AREG;HBEGF;STAM2;TSG101
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.4865907900873775,-1.1582855077860428,0.29493087557603687,0.8339078316567894,1.0,6/11,22.98%,IP6K1;IP6K2;PPIP5K2;FGF2;ITPKB;IPPK
prerank,negative regulation of cytokine production (GO:0001818),-0.2620543203783919,-1.1580265407091588,0.13636363636363635,0.833033395280067,1.0,43/163,21.00%,LGR4;LEF1;APPL2;ARRB1;HMGB1;FN1;ITCH;APOD;RNF135;OTUD7B;MAPKBP1;LGALS9;HDAC7;ADCY7;ILRUN;UFD1;SRGN;PCBP2;CD34;NAV3;PTPN22;IRAK3;TRIM25;HOMER3;PDCD4;RGCC;SIRPA;RNF125;CX3CL1;ANXA4;SYT11;C1QTNF3;SSC5D;RARA;NLRC5;UBA7;NCKAP1L;ZC3H12A;TWSG1;BCL3;CEACAM1;CD274;PPP1R11
prerank,regulation of leukocyte migration (GO:0002685),0.5306482727659476,1.158006182422366,0.30948419301164726,0.9834656239533733,1.0,4/16,15.31%,ANXA1;VEGFA;RHOH;RHOG
prerank,T cell homeostasis (GO:0043029),0.5643000248514753,1.1569130267130656,0.31993006993006995,0.9856708360549675,1.0,1/10,1.50%,PMAIP1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.40362291365608016,1.1568631080391831,0.2779069767441861,0.9844378200555916,1.0,14/98,10.44%,NTF3;AGTR1;ANGPT1;PDGFB;DHRS4;CCL5;TP53;VEGFA;ACACB;CBR1;PPARA;ATAD1;PDGFRB;SCYL2
prerank,synaptic vesicle membrane organization (GO:0048499),-0.42314789145046894,-1.156388357916112,0.2868020304568528,0.8366872384195219,1.0,8/17,26.77%,STX3;STX4;SNAP29;STX1A;SYP;STX2;TOR1A;SYNGR2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2508424081063638,-1.156110657581125,0.11538461538461539,0.8357760673174282,1.0,57/248,14.80%,RNF220;BICC1;MCC;DAB2;MLLT3;LRRK1;LGR4;TLE1;IGFBP2;COL1A1;TCF7L2;ADGRA2;DKK3;APOE;WNK1;RNF146;FZD6;DDX3X;PTK7;CUL3;EGFR;LYPD6;TNKS2;WNT5A;KLHL12;SOX13;PPM1B;CTNND1;TMEM64;CTNNB1;LATS2;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;STK11;SMURF2;KREMEN1;PRKN;SFRP4;TGFB1;IGFBP6;FGFR2;PSMB3;CCNY;SOX4;WWTR1;ZBED3;PSMC5;PSMA5;NOTUM;PSMA1;PSMC2;SOX17;HECW1;EMD
prerank,protein tetramerization (GO:0051262),0.42365574431680675,1.1559236310479506,0.2678132678132678,0.9861226395427642,1.0,11/67,12.69%,RYR1;KCNJ12;HSD17B10;CRYZ;ACACB;TRPM4;ALDOA;GLS;OSBPL2;TRPM2;HOMER1
prerank,response to copper ion (GO:0046688),-0.4054030522818058,-1.1559190692204975,0.2840909090909091,0.8345361314140665,1.0,11/20,18.88%,SNCA;MT2A;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X;HSF1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.460494403946752,-1.1553684567269755,0.2811791383219955,0.8344562075154476,1.0,4/13,8.49%,AKT3;HMGB1;PDPK1;IGF2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.36619871702997964,-1.1551760785233014,0.2433234421364985,0.8332773507478233,1.0,6/29,11.57%,ZBTB20;APOE;LDLR;LPGAT1;CREBL2;CREB1
prerank,purine nucleotide metabolic process (GO:0006163),-0.3923723597230506,-1.154900725206874,0.2563291139240506,0.8322952986481739,1.0,10/24,23.51%,XDH;NT5E;GART;HPRT1;PRPSAP2;ITPA;GPX1;PNP;GUK1;PRPS2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5551103288081913,1.1548877086749192,0.32149200710479575,0.9881526971560313,1.0,2/12,6.74%,PRKCQ;IL12RB1
prerank,peptide hormone secretion (GO:0030072),0.48869011136882423,1.1548688313290671,0.3084795321637427,0.9868126639404796,1.0,2/26,2.79%,CAMK2G;ANXA1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.46387888363427277,1.1547395213440652,0.2918454935622318,0.9858486955018378,1.0,8/32,11.29%,DLC1;ITGA1;PPP2R5A;PIN1;CALM1;CD300A;PDGFRB;PRKCD
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3241461924970846,-1.1544442901423266,0.2,0.8319276497845176,1.0,10/53,9.53%,EYA2;EYA1;EYA4;DDX5;SPRED2;ATR;EGFR;FBH1;SMCHD1;BRCC3
prerank,anion transmembrane transport (GO:0098656),-0.30561276260805326,-1.1543951633631202,0.21965317919075145,0.8302319268480205,1.0,34/67,33.12%,SLC6A13;SLC13A4;SLC16A12;SLC1A3;SLC13A3;LRRC8B;SLC3A2;SLC7A5;SLC39A8;SLC6A9;SLC25A14;SFXN2;SLC35A2;SLC25A30;SLC38A5;SLC25A11;SLC25A38;LRRC8D;SLC1A1;SLC6A8;SLC25A22;LRRC8A;ABCC5;SLC25A19;SLC25A21;SLC1A2;SLC5A6;SLC35C2;SLC25A18;SFXN3;SLC13A5;SLC1A6;SLC35B1;PRAF2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.40315261559707094,-1.1542273869052768,0.27595628415300544,0.8270814124687689,1.0,3/21,1.39%,EYA2;EYA1;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.40315261559707094,-1.1542273869052768,0.27595628415300544,0.8270814124687689,1.0,3/21,1.39%,EYA2;EYA1;EYA4
prerank,extracellular structure organization (GO:0043062),0.3883108292897453,1.1540059795143665,0.2529100529100529,0.9867088100974397,1.0,28/204,8.54%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;PDGFB;ITGA1;ITGA3;ADAMTS5;ADAMTS19;COL4A6;ITGB1;BGN;JAM3;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;ITGA4;COL27A1;COL4A5
prerank,positive regulation of chemotaxis (GO:0050921),0.4473383268823245,1.15330224048542,0.27906976744186046,0.9876038867962238,1.0,9/43,10.07%,NTRK3;PDGFB;SEMA5A;CDH13;RARRES2;DSCAM;VEGFA;ADAM17;PDGFRB
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4111657877100469,1.153219642425271,0.2684331797235023,0.9865012758009377,1.0,15/100,7.87%,NTF3;NTRK3;PIP5K1B;PDGFB;PDGFC;ROR1;PIP4K2A;PLXNB1;CCL5;PDGFD;PIK3AP1;DAB2IP;NEDD4;SOX9;TGFB2
prerank,lipid transport (GO:0006869),-0.2796702548657312,-1.1526517903516607,0.1746031746031746,0.8305017966733601,1.0,26/97,15.19%,OSBPL8;PITPNA;ATP8A1;ABCA9;PLTP;APOE;ABCA1;SLCO2B1;LBP;CHKA;ABCA4;LDLR;SLCO1C1;NCOA1;SLC25A17;SLCO2A1;PITPNC1;SLCO3A1;ABCC4;CERT1;SPNS2;PLEKHA3;ABCA6;ABCD3;CLN3;TNFAIP8L3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4716237125581424,1.1525496859841238,0.2933151432469304,0.9874249825173921,1.0,2/35,0.77%,NTF3;NTRK3
prerank,nitrogen compound transport (GO:0071705),-0.27966648250021275,-1.1524620152130514,0.17105263157894737,0.8293394094968899,1.0,43/141,23.07%,SLC7A11;SLC6A13;ABCG2;PDPN;CALCRL;SLC12A2;SLC6A12;SLC6A6;SLC7A14;SCAMP2;SLC3A2;SCARB2;SLC52A1;SLC7A5;SEC14L1;TMEM30A;CERT1;PPT1;SLC22A4;SLC35F3;RCN3;RALBP1;SLC43A2;RAMP2;HSP90B1;TOM1;NDC1;SLC38A5;PICK1;SLC7A7;ARRDC1;CUBN;SLC15A4;LRRC8D;SCAMP3;MIA3;SLC1A4;SLC36A1;SLC43A1;SCAMP1;SLC5A7;TXNIP;ARRDC4
prerank,negative regulation of lipid storage (GO:0010888),-0.42500619742866025,-1.1514121147209624,0.2864321608040201,0.8310862457982227,1.0,5/19,6.77%,OSBPL8;ABCA1;NFKBIA;ITGAV;ABHD5
prerank,regulation of osteoblast proliferation (GO:0033688),0.5085485947272919,1.150733349319468,0.3322314049586777,0.992039027767227,1.0,4/17,10.62%,CCN1;PLXNB1;MN1;EIF2AK2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5499859055446237,1.1506106076843208,0.3229706390328152,0.9910809662056318,1.0,3/12,8.13%,DMD;ATP1B1;WNK2
prerank,protein localization to organelle (GO:0033365),-0.27127867400453554,-1.1503998373786162,0.1485148514851485,0.8325134886950218,1.0,39/133,17.25%,ANK2;COL1A1;BBS9;ZNF423;BMP7;BMP4;APP;DDX3X;RAB11A;CEP68;IFT122;GBF1;ALDH3A2;CEP250;CYB5A;TULP3;STX5;CNTLN;OPTN;TMEM30A;MDM2;GCC2;TOPORS;SSB;TOR1AIP1;SCG3;SGTA;SIX1;CALR;EMD;TOLLIP;EHD1;STX1A;LMBRD1;TRAM2;XPA;GABARAPL2;COG7;OBSL1
prerank,magnesium ion transport (GO:0015693),-0.46397852996049194,-1.1500642619732686,0.28641975308641976,0.8318096482481173,1.0,5/12,19.05%,TUSC3;SLC41A1;NIPAL2;NIPAL3;MMGT1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2917923916933022,-1.1499207643841858,0.1518987341772152,0.8304902627912253,1.0,28/91,17.79%,BMP6;ABCG2;CP;FBXL5;APP;SLC39A10;SLC30A10;SCARA5;ABCB7;SLC39A8;ATOX1;FTL;ATP6AP1;ATP6V1G1;FTH1;SLC30A1;ACO1;SLC39A6;MT2A;SMAD4;MT1B;MT1G;MT1E;MT1A;MT1F;MT1H;MT1M;MT1X
prerank,regulation of cholesterol efflux (GO:0010874),-0.36936874260453145,-1.149220318489317,0.28013029315960913,0.8309438928829548,1.0,6/30,4.90%,LRP1;PLTP;APOE;PTCH1;LAMTOR1;NFKBIA
prerank,regulation of actin filament depolymerization (GO:0030834),0.552433711024543,1.1487920225286237,0.3333333333333333,0.9957640581323217,1.0,4/12,8.02%,SEMA5A;WDR1;PLEK;CFL2
prerank,positive regulation of ossification (GO:0045778),0.4578504648962202,1.1485869302202834,0.3061516452074392,0.9950565636861823,1.0,12/39,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;TGFB2;ATP2B1
prerank,regulation of axonogenesis (GO:0050770),-0.32203759525186665,-1.1484468254068492,0.2191780821917808,0.8315054508280464,1.0,9/51,8.23%,PLXNA2;ROBO1;SLIT2;KIF13B;EPHA4;SIPA1L1;RUFY3;TIAM2;PLXNA4
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4598464981895399,-1.1484059769363884,0.29195402298850576,0.8298867187056164,1.0,9/13,31.06%,ELOVL7;HACD4;ELOVL4;ELOVL6;HACD2;ELOVL1;HACD3;ELOVL5;TECRL
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.32002712592208293,-1.1483347022018973,0.25136612021857924,0.8283487746177157,1.0,21/59,19.26%,LEF1;AGO3;MED13;TCF7L2;CDK8;RUNX2;MED15;MED17;CTNNB1;MED25;MED27;SETX;TNRC6A;MED6;CEBPB;MED7;PPM1D;BAX;TNRC6B;MED24;MECP2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5089024772524514,1.1479936528027797,0.32507739938080493,0.995622386216972,1.0,3/20,5.83%,KCNMA1;SLC8A1;ATP1B1
prerank,cellular response to interleukin-4 (GO:0071353),-0.49436571010975566,-1.147830191283798,0.3021276595744681,0.8282749570096842,1.0,3/10,20.33%,LEF1;STAT6;SHPK
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.50405693909459,1.147601908048456,0.3145539906103286,0.9955824380612063,1.0,4/24,6.29%,PPP1R3A;DYRK2;IRS1;SORBS1
prerank,autophagy of peroxisome (GO:0030242),-0.459449012510638,-1.147463053670061,0.29646017699115046,0.8276896427373102,1.0,6/12,28.26%,RB1CC1;PEX5;ACBD5;ATM;SQSTM1;MAP1LC3B
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4579923510055027,-1.1472817539483462,0.2946859903381642,0.8265405021797168,1.0,7/13,21.38%,NOS3;GCH1;PRKG2;AKT1;PTS;FPGS;SPR
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4432609604991774,-1.1471255738310588,0.3014354066985646,0.8252449100536237,1.0,4/14,24.59%,IL18;DENND1B;RARA;CD86
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2702513710435728,-1.1469990097867746,0.14018691588785046,0.8238466025080199,1.0,35/128,17.44%,PTN;BMP6;SASH1;IL15;APP;IL18;WNT5A;STX3;NFKBIA;PUM1;POLR3F;GPR4;STX4;NAPEPLD;TNFRSF1A;THBD;OPTN;TGFB1;RIOK3;PDCD4;SCARF1;POLR3B;DDX60;IL33;NFKBIZ;PPM1F;CX3CL1;SNCA;ANKRD17;PLA2G7;TLR3;GRN;SERPINE1;PDE2A;CCN4
prerank,positive regulation of cell migration (GO:0030335),0.37949347755225293,1.1466981562494103,0.21721311475409835,0.9970573594270998,1.0,48/253,13.37%,NTF3;MYLK;ARHGEF7;NTRK3;ACTN4;FGF1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;SEMA5A;CLASP2;CDH13;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;SEMA6C;ARHGEF2;HAS2;SYNE2;CBLL1;CAV1;DAB2IP;VEGFA;SOX9;SNAI2;TGFB2;SUN2;ADAM17;WASHC1;HIF1A;PDGFRB;DOCK1;HBEGF;PDGFA;GPER1;ROCK2;ACVR1B;KIF20B;PDCD10;DMTN;CLASP1;CPNE3;FGF10;CEP43
prerank,cellular response to interleukin-6 (GO:0071354),-0.3688541715813929,-1.146475470435871,0.27492447129909364,0.823722880411093,1.0,6/26,8.49%,PID1;ST3GAL6;SBNO2;PTPN11;CTR9;IL6R
prerank,regulation of endopeptidase activity (GO:0052548),0.42000168254599096,1.1462410044897682,0.2920353982300885,0.9971617130310381,1.0,3/59,3.37%,SERPINB8;SERPINI1;SERPINE2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.44715730955796634,1.1459392104940198,0.30842391304347827,0.9968240332252043,1.0,13/48,12.81%,POLR2L;PADI2;H1-0;ARID1A;ACTB;MYBBP1A;CHEK1;ERCC6;POLR1E;SERTAD2;POLR1H;SMARCA5;SF3B1
prerank,superoxide metabolic process (GO:0006801),0.4808011284133091,1.1456901774711932,0.3163265306122449,0.996266720849921,1.0,1/29,0.36%,NCF2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.37653003312302774,-1.1456692318181534,0.22822822822822822,0.8246299708990278,1.0,10/26,18.17%,SMAD3;PKD2;NOS1AP;HSP90AB1;DDAH1;PTGS2;KLF2;INSR;AKT1;DDAH2
prerank,peptidyl-proline hydroxylation (GO:0019511),0.5568397254688024,1.1454728076419147,0.3424908424908425,0.9955387891861268,1.0,4/11,10.30%,P3H2;CRTAP;P4HTM;P4HA2
prerank,genitalia development (GO:0048806),0.5492821494676109,1.1454169721336642,0.338768115942029,0.9943135351745412,1.0,1/12,0.60%,LHCGR
prerank,adherens junction organization (GO:0034332),0.4422702657898342,1.145289772646669,0.29806451612903223,0.9933466585835206,1.0,13/48,12.74%,CDH6;VCL;FERMT2;CDH13;CDH4;ACTB;JAM3;CDHR3;CDH2;PAK2;TBCD;NECTIN2;CDH10
prerank,potassium ion transmembrane transport (GO:0071805),0.38775593568452316,1.1452641503044465,0.26058631921824105,0.9920761039436297,1.0,17/135,11.35%,KCNAB1;KCNJ12;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNE4;KCNB1;CCDC51;KCNH1;ATP1B1;KCNT2;SLC9A8;ABCC8;KCNH8;KCNK3;KCNA2
prerank,Rap protein signal transduction (GO:0032486),0.5678581796992059,1.1451311829442166,0.35619047619047617,0.9910948143076636,1.0,3/10,9.86%,RAP1A;RAP2C;RAP2A
prerank,protein polyubiquitination (GO:0000209),-0.24486759293494034,-1.1450475578834307,0.1111111111111111,0.8249828891699932,1.0,72/297,14.52%,TTC3;SASH1;NEDD4L;FBXL7;TRIP12;FBXL5;RNF146;AREL1;ITCH;FBXO10;CUL3;TNKS2;ANAPC1;RNF20;PPIL2;UBE2D3;NPEPPS;RNF135;RC3H2;RNF144B;SHPRH;RNF217;UNKL;RNF6;UBR2;CTNNB1;BIRC2;FBXO9;PSMD7;PSMD9;PSMD13;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;WWP1;SMURF2;RNF144A;RNF31;PRKN;UBE3A;UBE4B;PSMB3;UBC;TRIM5;RNF34;STUB1;HECTD2;RMND5A;SKP2;DZIP3;LONRF1;TRIM14;RNF125;DTX3L;RNF166;PSMC5;FBXW8;SIAH1;PSMA5;PSMA1;PSMC2;UBE2H;RNF115;HECW1;CDC26
prerank,protein localization to cell-cell junction (GO:0150105),-0.4275777862659313,-1.1445076473335236,0.2987012987012987,0.8248924922520279,1.0,5/15,6.56%,TJP1;CGNL1;TJP2;CDH5;LSR
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4548414629562604,1.1442574244672237,0.3194630872483222,0.9926394000748798,1.0,7/39,6.96%,ACTN4;JAG1;KANK1;FZD4;GCNT2;AJAP1;CORO1C
prerank,positive regulation of telomerase activity (GO:0051973),0.46508869175286366,1.144002732034547,0.3059163059163059,0.9920868868186692,1.0,5/33,8.20%,PARM1;PARN;PRKCQ;PKIB;NAF1
prerank,nucleotide catabolic process (GO:0009166),-0.43299629275180834,-1.14356801807474,0.28865979381443296,0.826167479593592,1.0,7/16,19.76%,XDH;NT5E;SAMHD1;NUDT3;ITPA;GPX1;PNP
prerank,histone H2A ubiquitination (GO:0033522),-0.42316325364343643,-1.1435371784091113,0.27543424317617865,0.8245164783375356,1.0,6/17,22.77%,RYBP;UBR2;DDB1;DTX3L;BCOR;UBE2B
prerank,myeloid cell development (GO:0061515),-0.4099380238807908,-1.1432180452643417,0.30684931506849317,0.8237827324216052,1.0,5/18,7.97%,FOXP1;KIT;ANXA2;APP;ALAS1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5514275640430251,1.1431353006794598,0.325497287522604,0.9935431418694423,1.0,2/10,6.51%,SMARCD3;VEGFA
prerank,membrane lipid biosynthetic process (GO:0046467),-0.31111985356662114,-1.1430804871704952,0.23931623931623933,0.8224728771648641,1.0,13/58,9.47%,SGMS1;ST3GAL4;SGMS2;ELOVL7;CERS5;HACD4;SPTLC2;SPTSSA;ACER2;ALDH3A2;CERS6;SGPP1;CERT1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4231461623211235,1.1427381772364793,0.28102189781021897,0.9934278652142374,1.0,10/72,5.09%,ABRA;GPR20;DLC1;SYNPO2L;ITGA3;MYO9B;KANK1;NET1;TNFAIP1;ARHGEF2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.39100154991147734,1.1426740236830404,0.2897297297297297,0.9922926330549622,1.0,22/151,10.85%,RAP1A;NTRK3;ANGPT1;CD36;PDGFB;PDGFC;FERMT2;ROR1;THPO;CCL5;GCNT2;PDGFD;MFHAS1;TNFRSF11A;FBXW7;GAREM1;RASGRP1;MAP2K1;PDGFRB;CCL14;PDGFA;GPER1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.2915159286220808,-1.1422978078674988,0.22818791946308725,0.8233248167529025,1.0,35/87,25.37%,RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;SEC63;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SEC61A1;RPS7;RPL27;RPL11;SRP9;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27
prerank,regulation of microglial cell activation (GO:1903978),-0.4366538651592604,-1.1422909543701971,0.2860520094562648,0.8216220984929186,1.0,6/15,22.93%,LDLR;CX3CL1;SYT11;GRN;TTBK1;SPHK1
prerank,sodium ion transmembrane transport (GO:0035725),0.4135279636395742,1.1419350316356673,0.28150765606595995,0.9933618244197806,1.0,10/84,5.83%,SCN4A;ASIC3;SLC6A17;ANO6;SLC8A2;SLC8A1;SLC4A8;SLC6A2;SLC6A5;ATP1B1
prerank,regulation of cell growth (GO:0001558),0.37966895072850243,1.1418581586628347,0.2555438225976769,0.99226717903906,1.0,41/204,14.70%,SLIT3;AGTR1;AKAP6;PAPPA2;MYL2;PLCE1;RASGRP2;CAMK2D;IL2;RERG;FHL1;NET1;PABIR1;ATAD3A;FXN;BCL2;JADE1;PRKCQ;NDRG3;TP53;BTG1;TGFB2;ADNP2;ADAM17;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;HDGFL2;BCL6;CEP43;MUL1;SGK1;N6AMT1;HYAL1;NUBP1;VGLL4
prerank,negative regulation of leukocyte activation (GO:0002695),0.525038898716613,1.141758206532234,0.3105175292153589,0.9912427508996248,1.0,5/15,10.85%,MILR1;HAVCR2;CD200;CD300A;GPER1
prerank,regulation of GTPase activity (GO:0043087),0.38247657125566675,1.1417423907852837,0.2608236536430834,0.98996866314608,1.0,33/177,11.21%,ARHGEF7;RAP1A;PRKG1;RGS6;LIMS1;RASGRP2;FERMT2;DOCK8;PLXND1;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;CHN1;LARS1;MAPRE2;RABGAP1;DAB2IP;PIN1;RAPGEF6;RASGRP1;EVI5;AGRN;ARHGAP12;CCL14;SNX18;VAV1;SH3BP4;ARHGAP15
prerank,negative regulation of GTPase activity (GO:0034260),-0.4001338367853027,-1.1414993556746782,0.29829545454545453,0.8224550393274606,1.0,8/22,18.41%,CPEB2;WNK1;GMIP;GPSM1;RDX;RCC2;LRCH1;ARL2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5092858721754836,1.1409176778889987,0.32385466034755134,0.9911022688784789,1.0,3/19,5.14%,MEF2C;TBX2;BMPR1A
prerank,cellular potassium ion homeostasis (GO:0030007),0.5400416600593367,1.1408074404526514,0.3406408094435076,0.9901269820577958,1.0,2/13,5.83%,KCNMA1;ATP1B1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.4079626475020229,-1.140626613415784,0.31025641025641026,0.8235913288616701,1.0,4/18,11.40%,PTN;NF1;PTPRZ1;HES1
prerank,pyroptosis (GO:0070269),-0.44111180889485013,-1.1405053513819066,0.291358024691358,0.8222611951745811,1.0,4/15,18.81%,GSDME;CASP8;GSDMD;CASP4
prerank,embryonic axis specification (GO:0000578),-0.42842474979063905,-1.1403990387468965,0.2898550724637681,0.8208901376954437,1.0,3/15,3.57%,COBL;SMAD6;PTCH1
prerank,cellular response to fluid shear stress (GO:0071498),0.5476665642732012,1.1401570795069675,0.3350970017636684,0.9908622274382081,1.0,3/12,11.09%,MEF2C;HAS2;SREBF2
prerank,positive regulation of apoptotic process (GO:0043065),0.37290631512969685,1.1398767530139502,0.23210633946830267,0.9904489450130649,1.0,45/293,12.53%,KCNMA1;OBSCN;ARHGEF7;MAP3K20;DLC1;MAP3K5;PMAIP1;KALRN;ABR;ARHGEF17;ANO6;ITSN1;TGFB3;ITGB1;NET1;PTGIS;ARHGEF16;ARHGEF2;ATG7;MYBBP1A;DAB2IP;RPS6KA2;ARL6IP5;TP53;PHLDA3;BTG1;FZD9;TGFB2;MAP3K10;DAPK3;TNFAIP8;ARHGEF4;HRK;SIRT2;PAWR;DNM1L;VAV1;GPER1;TRIM35;BOK;CLIP3;CSRNP3;DIABLO;CLU;ITGB3BP
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.49882091391888655,1.1397490550483351,0.32098765432098764,0.9895328291592872,1.0,5/22,13.15%,IL2;LAG3;CBFB;RUNX1;BCL6
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5544506935880059,1.1392874791520164,0.3278985507246377,0.9896516211298554,1.0,5/13,15.38%,RNF152;KPTN;CASTOR1;CASTOR2;ITFG2
prerank,manganese ion transport (GO:0006828),0.524067164868817,1.1388960019731882,0.3333333333333333,0.989602562867126,1.0,3/14,10.71%,TRPC6;TRPC5;SLC39A14
prerank,regulation of osteoclast differentiation (GO:0045670),-0.3565158790558998,-1.138753014559741,0.2694610778443114,0.8246131552396531,1.0,11/33,33.67%,FBN1;TCTA;CEBPB;PRXL2A;TLR3;GPR137B;MAFB;GPR137;CAMK4;FSTL3;UBASH3B
prerank,telomere maintenance via telomerase (GO:0007004),-0.36296407111118134,-1.1386932639812284,0.28,0.823050596636853,1.0,17/28,37.58%,MRE11;HSP90AB1;RAD50;ANKRD28;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;GAR1;TINF2;PPP6C;NOP10;ACD;RPA1;RFC1;NHP2
prerank,response to prostaglandin E (GO:0034695),-0.4902838600226129,-1.138656306223833,0.3235294117647059,0.821465330579382,1.0,1/10,0.16%,TGFBR3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5680073494132842,1.138494536610348,0.35,0.9895782401318355,1.0,2/10,5.45%,CHADL;EMILIN1
prerank,vitamin D metabolic process (GO:0042359),0.541788764001095,1.1384531056937948,0.3373287671232877,0.9884138953318584,1.0,2/13,5.64%,PIAS4;GC
prerank,positive regulation of biomineral tissue development (GO:0070169),0.45514086211820093,1.1384177743639101,0.3091168091168091,0.9871851885482196,1.0,11/40,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1
prerank,acute-phase response (GO:0006953),0.5440805298160445,1.1382041342934175,0.3460837887067395,0.9865552421963838,1.0,3/12,7.83%,ITIH4;MBL2;IL22
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3209948188107772,-1.1381806985073244,0.1939655172413793,0.8213023509235557,1.0,29/52,29.69%,DCPS;RC3H2;SAMD4B;LSM1;DIS3;EXOSC1;DCP2;PAN2;EXOSC9;PAN3;EDC4;CNOT11;TUT4;TUT7;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;CNOT10;EXOSC5;LSM3;ZFP36;LSM6;PNLDC1;PDE12;POLR2D
prerank,cellular component assembly (GO:0022607),0.3815263060972933,1.1381659520587926,0.25696594427244585,0.9853702301208871,1.0,47/253,13.58%,FLNA;TCAP;PLS3;CALD1;LIMS1;FERMT2;LCP1;SH3BGR;ACTG1;MYO1B;SKAP2;FLNC;RSPH1;ACTB;CEP290;HAS2;CHAF1B;AFG3L2;LIMS2;TP53;ABCA3;LAMC1;RHOJ;YTHDF2;CYFIP1;PPARGC1A;MDN1;TOGARAM1;YAP1;SOX9;ADD2;MAGI1;PARVA;PAWR;SYCP2;TEAD1;DNM1L;PDGFA;TLCD2;RHOH;KIFAP3;SNX9;PDCD10;DMTN;KPNA3;FOXJ1;GAS6
prerank,positive regulation of JUN kinase activity (GO:0043507),0.49270778799459763,1.1379581477398426,0.3231240428790199,0.9847284976993317,1.0,4/23,8.12%,MAP3K5;TNFRSF11A;DAB2IP;MAP3K10
prerank,male gonad development (GO:0008584),0.45593411147072926,1.137297054887485,0.31361760660247595,0.9854735862268186,1.0,5/34,7.87%,LHCGR;CSDE1;AR;SOX9;TGFB2
prerank,diol biosynthetic process (GO:0034312),-0.4315185816389448,-1.1371280478623198,0.28028503562945367,0.8229883653318146,1.0,7/15,22.93%,SPTLC2;ACER2;ASAH2;GCH1;SPR;ABCA2;SPHK1
prerank,ventricular septum morphogenesis (GO:0060412),0.484682607793961,1.1370196679342517,0.34310850439882695,0.985030858998363,1.0,5/27,7.87%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5290277872326582,1.136649590345235,0.3305227655986509,0.9849167133847933,1.0,5/14,9.33%,RAD51AP1;PARP1;ERCC6;FUS;FANCB
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5517010045417488,1.1365495482321113,0.33835845896147404,0.983919196673394,1.0,2/12,7.15%,CACNA1H;AKR1B1
prerank,primary miRNA processing (GO:0031053),-0.48760794398259305,-1.136097727503281,0.30493273542600896,0.8245274395345391,1.0,4/10,16.32%,SMAD3;SRRT;METTL3;SMAD2
prerank,neuron projection morphogenesis (GO:0048812),0.39232859535856607,1.1358475700218724,0.2686084142394822,0.984902975225398,1.0,33/137,15.43%,NTF3;SDC2;ROCK1;PLXNB1;DOCK10;MAP1B;SLITRK5;ACTB;KLF7;MEF2A;SLITRK4;DAB2IP;AFG3L2;RAB3A;DICER1;IMPACT;BRSK1;FLRT1;S100A6;ZDHHC17;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;EPHB1;LRRK2;ADGRB1;DVL1;ANKRD27;CNTNAP1;PTEN;DNM2
prerank,negative regulation of receptor binding (GO:1900121),0.5644945424899361,1.135533365313095,0.3527272727272727,0.9845385073346494,1.0,3/10,10.33%,ATP2A2;PTPRF;ATP2A3
prerank,digestive tract morphogenesis (GO:0048546),0.5416138405872473,1.1353885099217251,0.3404255319148936,0.9836677231276592,1.0,1/14,0.81%,RBPMS2
prerank,regulation of protein import into nucleus (GO:0042306),0.4524056208370439,1.1353038320844542,0.30997304582210244,0.9826493089597611,1.0,3/36,4.55%,FLNA;CABP1;UBR5
prerank,synapse assembly (GO:0007416),0.4225678351338805,1.134719581649803,0.3075980392156863,0.9832286859834268,1.0,17/67,15.35%,FGF13;IGFN1;FZD5;PLXND1;PLXNB1;KIRREL3;PCDHB14;DSCAM;PCDHB11;CDH2;GABRB2;CBLN4;GABRB3;SHANK2;PLXNB2;DVL1;PTEN
prerank,sprouting angiogenesis (GO:0002040),-0.3213525403083169,-1.1345302435172222,0.2727272727272727,0.8278455683837066,1.0,25/51,19.75%,ROBO1;EFNB2;ADGRA2;BMP4;SLIT2;CCBE1;TEK;NRP1;ENG;PIK3R3;ACVRL1;RECK;PTK2B;JMJD6;RNF213;BMPER;RAMP2;KDR;VEGFC;AKT1;FGF2;VEGFB;ITGB1BP1;EPHB4;MIA3
prerank,positive regulation of B cell activation (GO:0050871),0.4378576334740773,1.1344952372313133,0.31175693527080584,0.9826488635044079,1.0,11/50,17.15%,MEF2C;IL2;TNFSF13B;BCL2;PAXIP1;RIF1;IRS2;KMT5B;MAD2L2;VAV3;MIF
prerank,negative regulation of immune system process (GO:0002683),0.5265524166218505,1.1340319620192552,0.3557692307692308,0.9828220646905054,1.0,4/16,12.43%,CD200;SOX9;GPER1;COL3A1
prerank,response to interleukin-1 (GO:0070555),0.41365990144348097,1.133900319605164,0.2836710369487485,0.981952030363114,1.0,17/73,14.87%,MYD88;ANXA1;CCL5;PTGIS;UPF1;HAS2;TNFRSF11A;DAB2IP;SOX9;RELA;NR1D1;HIF1A;CCL14;YTHDC2;GBP2;HYAL1;PRKCA
prerank,positive regulation of locomotion (GO:0040017),0.4781343896150061,1.1338751531092923,0.3244444444444444,0.9807395408598742,1.0,4/27,5.41%,CAVIN1;PDGFB;NTN1;RARRES2
prerank,actin filament bundle organization (GO:0061572),0.4682592237176341,1.1335399544672893,0.3265602322206096,0.9805042986688299,1.0,6/33,10.17%,PLS3;CALD1;LCP1;MYO1B;ADD2;PAWR
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5125928381769213,1.1334080165408424,0.34299516908212563,0.9796586764428324,1.0,4/18,8.27%,ROCK1;ITGB1;ADD2;ITGA4
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.33764833971085695,-1.1334009219798475,0.24573378839590443,0.8297603751911964,1.0,13/40,12.15%,DAB2;SMAD3;LEF1;COL1A1;PDPN;TCF7L2;BCL9L;CTNNB1;SDCBP;TGFB1;TGFBR1;RGCC;WWTR1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.42448747688695876,1.1333803019589865,0.2880710659898477,0.9784730729755761,1.0,20/62,19.66%,WTIP;POLR2L;LIMD1;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;STAT3;DHX9;NUP54;NUP160;NUP133;AGO1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5573046078079273,1.1332966918012624,0.3611111111111111,0.9761839228999486,1.0,5/11,15.35%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5573046078079273,1.1332966918012624,0.3611111111111111,0.9761839228999486,1.0,5/11,15.35%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5323917252859623,1.1326199269599952,0.35374149659863946,0.9770323278095169,1.0,4/15,12.13%,CD36;MYD88;EIF2AK2;USP50
prerank,response to organic cyclic compound (GO:0014070),0.4333358312299684,1.1325052919915874,0.30250990752972257,0.9761336224351239,1.0,7/52,6.40%,PMAIP1;ABCB4;ANXA1;IGFBP5;CCL5;STRN3;ARL6IP5
prerank,actin filament bundle assembly (GO:0051017),0.46793612884973795,1.1324719291314613,0.3275862068965517,0.9749888087124121,1.0,6/33,10.17%,PLS3;CALD1;LCP1;MYO1B;ADD2;PAWR
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4508122325428514,-1.1324469407372293,0.32589285714285715,0.8311970677799695,1.0,5/13,8.23%,PLXNA2;NRP2;NRP1;SEMA3A;PLXNA4
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.4809040525415085,-1.132376967167646,0.33698030634573306,0.8297159806243731,1.0,2/10,2.39%,APOE;ABCA1
prerank,regulation of inclusion body assembly (GO:0090083),-0.47451823418143435,-1.1318017776652074,0.317351598173516,0.8298635963269974,1.0,6/11,35.63%,SNCAIP;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A
prerank,Golgi ribbon formation (GO:0090161),-0.45294730632841257,-1.131598405273484,0.2956730769230769,0.8288872831516843,1.0,7/13,20.66%,VTI1A;TMED5;OPTN;GCC2;GOLPH3;TRIP11;STX6
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.44962422155532394,1.1315017967359524,0.3159379407616361,0.9769169735073189,1.0,5/35,4.74%,FLNA;SEMA5A;PLXND1;PLXNB1;SEMA6C
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5405280890744261,1.1310465413541448,0.3583617747440273,0.9770960866835001,1.0,3/14,10.85%,ANO6;ITGA4;GPER1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3405037953354767,-1.1305049711907638,0.254416961130742,0.8309020328687872,1.0,13/38,25.14%,BMP6;SASH1;PUM1;POLR3F;RIOK3;POLR3B;DDX60;ANKRD17;GRN;SLC15A4;GBP5;POLR3C;POLR3D
prerank,epithelial to mesenchymal transition (GO:0001837),0.43207610121366813,1.1305021505142108,0.32945736434108525,0.9775601048767572,1.0,12/47,10.88%,HEY2;ROCK1;LIMS1;FAM83D;LOXL2;HEYL;SOX9;SNAI2;TGFB2;AKNA;HIF1A;ROCK2
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.39609173736779874,-1.1304564738307943,0.2904040404040404,0.829383601915352,1.0,4/20,7.18%,B2M;IL18;CD55;DENND1B
prerank,ephrin receptor signaling pathway (GO:0048013),0.4046377407228868,1.1301735657641483,0.2914691943127962,0.9773039223997576,1.0,9/82,4.73%,ARHGEF7;SDC2;ROCK1;KALRN;ITSN1;ACTG1;ACTB;ACTR3;CHN1
prerank,regulation of cellular component movement (GO:0051270),0.4371030748194433,1.1297440498750393,0.32483221476510066,0.977408619560717,1.0,10/49,10.88%,ACTN1;ACTN4;ROCK1;CDK6;VEGFA;DAPK3;ADAM17;PKN2;HBEGF;ROCK2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.33385078125461676,-1.1297193575884572,0.25448028673835127,0.8301399414275094,1.0,19/43,24.01%,CDC14B;NAE1;MRE11;RINT1;INTS3;BRCC3;BLM;NBN;TAOK1;FOXN3;NOP53;HUS1;ATM;CHFR;HMGA2;TAOK2;TRIM39;CLSPN;CDKN1A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4579524850579545,-1.1295515998523877,0.30295566502463056,0.829021867581144,1.0,4/14,5.71%,WNK1;WNT5A;PTK2B;ADAM10
prerank,negative regulation of phagocytosis (GO:0050765),0.5130529798444206,1.1293980020247425,0.3333333333333333,0.9771886772734149,1.0,4/17,8.35%,FER1L5;DYSF;PIP4P2;CD300A
prerank,diterpenoid metabolic process (GO:0016101),0.4286916702972984,1.1290693873645077,0.33081761006289306,0.9769940386217963,1.0,7/55,7.15%,TTR;SDC2;LPL;DHRS3;RARRES2;GPC4;AKR1B1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2984583531727891,-1.1288080356465209,0.23076923076923078,0.8296177072722289,1.0,18/71,7.70%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,alpha-amino acid catabolic process (GO:1901606),0.46383914894466427,1.128501159792308,0.3273809523809524,0.97745756251754,1.0,6/29,10.71%,HSD17B10;BLMH;HGD;KMO;GOT2;SARDH
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.4482422408713864,-1.12829020572215,0.3184855233853007,0.829582012248469,1.0,2/13,2.34%,DKK3;APOE
prerank,peptidyl-lysine methylation (GO:0018022),0.47551650506908905,1.1277784072594323,0.32664756446991405,0.9785085681186585,1.0,8/26,15.17%,SMYD1;SETD6;SUV39H2;SETD3;ATPSCKMT;VCPKMT;N6AMT1;EEF1AKMT2
prerank,response to lipid (GO:0033993),-0.28543100481285594,-1.1277363175891295,0.24,0.8297087248658122,1.0,32/105,17.23%,FOXP1;SMAD6;LBP;RBP4;FOXO1;LGALS9;SOCS2;ACER2;CTSH;IRAK1;NOCT;RPS6KA3;CTNNB1;PAQR7;PTPN22;IRAK3;PELI1;SPP1;NOS3;TAB2;ESR1;TGFB1;PAQR8;VPS4B;PCK2;SNCA;GCH1;IFNAR1;RARA;SRR;PPARG;TRIM16
prerank,hippo signaling (GO:0035329),-0.3778896345919267,-1.1276679840448542,0.2898550724637681,0.828229595470553,1.0,9/26,12.99%,TJP1;TJP2;AMOTL1;TEAD4;LATS2;WWC1;TEAD2;WWTR1;MOB1B
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.29925693971460027,-1.1273358859661489,0.23333333333333334,0.8276862476352153,1.0,18/70,7.70%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.2712123545981143,-1.1270307087993146,0.23893805309734514,0.8270047956968342,1.0,29/113,17.13%,PTN;BMP6;IGF1;NRP2;AKT3;NOTCH2;TCF7L2;TGFA;BMP4;TEK;NRP1;EGFR;WNT5A;F3;BMPR2;SRSF6;OSR1;LAMB1;FGFR2;TGFBR1;RTN4;KDR;ARNT;VEGFC;AKT1;FGF2;GRN;STAT5A;VEGFB
prerank,extracellular matrix organization (GO:0030198),0.3709811666072547,1.1264315571447066,0.28307692307692306,0.9813593567896701,1.0,45/276,10.80%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;P3H2;PDGFB;ITGA1;ITGA3;ADAMTS5;LOXL2;HTRA1;KLK2;CRTAP;ADAMTS19;LCP1;COL4A6;ITGB1;BGN;DST;JAM3;HAS2;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;TGFB2;ITGA4;COL27A1;COL4A5;WASHC1;CAPN2;ITGA9;AGRN;P4HA2;COL19A1;PDGFA;THSD4
prerank,ureteric bud morphogenesis (GO:0060675),-0.4246493963207313,-1.1263667980745447,0.30952380952380953,0.8275182268883056,1.0,5/16,16.02%,BMP4;PKD2;SALL1;SIX1;FGF2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5423833640595502,1.1261964430237819,0.3527397260273973,0.9808451163139317,1.0,1/13,1.50%,PMAIP1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.45230290248307525,-1.1261094401243235,0.31910112359550563,0.8267047514976308,1.0,3/12,16.57%,PRKCB;NEK9;NEK6
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4764351311140522,-1.1260521290756769,0.32272727272727275,0.8252600772043535,1.0,4/10,14.01%,PRKCB;VTN;ITGA5;ARNT
prerank,negative regulation of lyase activity (GO:0051350),-0.42256175152749503,-1.1257323149206808,0.3200992555831266,0.8245910862192094,1.0,3/16,2.20%,ADGRV1;PALM;GRM3
prerank,protein insertion into ER membrane (GO:0045048),-0.3435638753430369,-1.1249698486916258,0.2913907284768212,0.8252325335560953,1.0,12/37,19.05%,APP;EMC2;ALDH3A2;CYB5A;STX5;SGTA;EMC3;EMC8;EMD;STX1A;TRAM2;MMGT1
prerank,alcohol catabolic process (GO:0046164),-0.4995421111316641,-1.1244534859994684,0.33905579399141633,0.8252731317082096,1.0,3/10,10.71%,CYP27A1;APOE;SCARF1
prerank,membrane repolarization (GO:0086009),-0.4292255926539433,-1.1243939313702087,0.3147208121827411,0.8238771523422586,1.0,4/15,9.85%,ATP1A2;ATP1B3;ATP1B2;KCND3
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.48386055851268006,-1.1242161237976902,0.35147392290249435,0.8227604622338873,1.0,4/10,14.55%,USP7;SIRT7;OGT;DGKQ
prerank,histone H3 acetylation (GO:0043966),-0.34186609310086946,-1.1241613387793752,0.28174603174603174,0.8213426700479854,1.0,13/40,18.18%,LEF1;MBIP;TADA2A;YEATS2;TADA1;DR1;BRPF1;PER1;NAA60;TAF12;MEAF6;TRIM16;TAF6L
prerank,negative regulation of protein binding (GO:0032091),0.4107193356287703,1.1240666345546548,0.29647630619684084,0.9861541996290493,1.0,17/71,14.52%,XIRP1;ROCK1;ATP2A2;PDGFB;ACTB;CAV1;PTPRF;PIN1;ITGA4;PPP1CA;PSME3IP1;ATP2A3;PRKCD;BAG2;CSNK1E;LRRK2;DVL1
prerank,regulation of organelle organization (GO:0033043),0.4030447931554579,1.1239703028362025,0.29537366548042704,0.9852423725899363,1.0,20/80,17.16%,NEXN;PDE4DIP;ZEB2;PLXNB1;MAPT;MIEF2;CAPN2;PAK2;STX18;DNM1L;PDCD10;MUL1;MAPK1;RHOT1;VPS35;CLIC4;PREB;S100A8;S100A9;MARK2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.45380501595053246,1.1237552565494957,0.31713900134952766,0.9846434253953049,1.0,9/39,12.04%,ARHGEF7;ITGA1;PTPN18;DAB2IP;DUSP3;AREG;HBEGF;STAM2;TSG101
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4523962792949763,-1.1234174267581092,0.3256880733944954,0.8221240211380841,1.0,5/12,22.46%,STX3;STX4;SNAP29;STX1A;STX2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.45895996894856395,-1.12329640199186,0.3101123595505618,0.8208959899430048,1.0,4/12,21.35%,HDAC4;CCN3;BHLHE41;TMEM119
prerank,endocardial cushion development (GO:0003197),0.4896946227732784,1.1224973898842017,0.34087481146304677,0.9872968690172798,1.0,5/21,7.87%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.41247614176354197,-1.1222835494636527,0.30423280423280424,0.8226022005647228,1.0,7/17,19.65%,ARRB1;OTUD7B;MAPKBP1;PTPN22;ANXA4;SSC5D;BCL3
prerank,limb morphogenesis (GO:0035108),-0.3985176054281998,-1.1207693508834649,0.30833333333333335,0.8256281246597882,1.0,4/20,5.56%,PCSK5;CYP26B1;PTCH1;MEGF8
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5453942078716446,1.120680051654365,0.35567970204841715,0.9916472907127927,1.0,4/11,10.02%,PADI2;ARID1A;CHEK1;SERTAD2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.29708823380076,-1.1200389019825436,0.21468926553672316,0.8263792476390902,1.0,18/73,7.70%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,epithelial cell morphogenesis (GO:0003382),0.5001867895057163,1.1200369653878082,0.348993288590604,0.9924835290749056,1.0,1/17,0.72%,COL18A1
prerank,positive regulation of secretion (GO:0051047),-0.47925631925825213,-1.119882353284846,0.34557235421166305,0.8252886886249045,1.0,2/11,9.94%,NPR1;ACSL3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4971122110978201,-1.1195964609830873,0.34101382488479265,0.8246962559167283,1.0,4/10,17.21%,BMP6;RGCC;PPM1F;NOTCH4
prerank,response to interleukin-4 (GO:0070670),-0.4809341056554308,-1.1195701455238436,0.3261802575107296,0.823187971625108,1.0,1/10,0.83%,LEF1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4159228782731178,1.119542007842092,0.31402831402831405,0.9928181650514933,1.0,8/55,10.07%,AGTR1;PDGFB;DHRS4;ALOX5;TP53;CBR1;SIRT2;PDGFRB
prerank,synaptic vesicle exocytosis (GO:0016079),-0.324866653597612,-1.1193122822678574,0.2490566037735849,0.8224077258541916,1.0,13/40,22.46%,UNC13C;UNC13B;STX3;SYT1;STX4;SNAP29;SNCA;PCLO;SNPH;STX1A;RIMS2;SYT2;STX2
prerank,regulation of fibroblast migration (GO:0010762),0.49091091996537917,1.1192254417234793,0.3338509316770186,0.9925115691659935,1.0,4/20,8.68%,ARHGEF7;ITGB1;CORO1C;GNA12
prerank,transport along microtubule (GO:0010970),0.5255980486857225,1.1190814229366723,0.35456110154905335,0.9916565481391527,1.0,5/13,11.85%,APBA1;ARHGAP21;BAG3;DYNC1I2;CLIP3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.35280784847384417,-1.119016512000253,0.31456953642384106,0.8216912879516574,1.0,8/32,8.41%,DAPK1;DLG1;APP;NLGN1;PTK2B;LRRC7;SLC6A9;NEFL
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.45945855626866733,-1.1186289591836702,0.33849557522123896,0.8213620689271348,1.0,4/11,13.02%,NECAB1;ITM2A;BACE2;SOAT1
prerank,cranial nerve development (GO:0021545),-0.4627886704610922,-1.1183428182765742,0.32860520094562645,0.8207042119735034,1.0,3/11,21.55%,CHD7;SALL1;TMEM126A
prerank,negative regulation of type I interferon production (GO:0032480),-0.32979688835830545,-1.11805881344392,0.2786259541984733,0.8200354169923942,1.0,17/40,27.45%,ITCH;PPM1B;RNF135;ILRUN;UFD1;PCBP2;TRIM25;SIRPA;RNF125;RELB;NLRC5;UBA7;NLRX1;CYLD;NLRC3;IKBKE;GPATCH3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.40958480803894337,-1.117637967935718,0.2992874109263658,0.8198274678030837,1.0,6/16,17.71%,PRKDC;PARP3;SMCHD1;DTX3L;WRAP53;KDM4D
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3663977608153498,1.1173991326562989,0.2399193548387097,0.9956685028822698,1.0,55/390,10.88%,NTF3;ARHGEF7;NCF2;NTRK3;COL4A2;SDC2;ANGPT2;ANGPT1;ROCK1;FGF1;KALRN;MERTK;POLR2L;MST1R;PDGFB;POLR2I;PDGFC;PDK4;ROR1;FRK;ITSN1;COL4A6;BCAR3;SORT1;ACTG1;PDGFD;MUSK;ACTB;ACTR3;CHN1;RARRES2;POLR2G;ATP6V1H;IRS1;SORBS1;ATP6V0A2;MAPKAPK2;VEGFA;CYFIP1;LCP2;ITGB3;PLCB1;PAK2;SLA;EPHA2;ATP6V1C1;AXL;SIRT2;PDGFRB;DOCK1;FLRT1;SLC39A14;PDGFA;VAV1;ROCK2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.44533145630946336,1.1173118345649666,0.3342736248236953,0.9947053302688231,1.0,6/35,10.07%,PPP1R12A;ITGA1;CALM1;NUAK1;CD300A;PDGFRB
prerank,positive regulation of binding (GO:0051099),-0.2779952764037762,-1.117302110108305,0.2236842105263158,0.8194217105437578,1.0,29/84,22.24%,IGF1;LRP1;TCF7L2;HMGB1;BMP4;APOE;APP;VTN;B2M;NVL;CLDN5;DERL1;NMD3;GPSM1;MED25;FKBP1A;PRKN;HES1;DTX3L;SPPL3;RARA;PPARG;KDM4D;RALB;RPL11;DACT1;NME1;RAN;STMN1
prerank,ERBB signaling pathway (GO:0038127),-0.30208475487909475,-1.1171424413781257,0.2681818181818182,0.8184629158280231,1.0,14/64,11.27%,PIK3CA;EFEMP1;GRB2;TGFA;PDPK1;PTPN11;EGFR;PTK2;SLC30A10;GAB1;PTK2B;NRG2;TGFB1;STUB1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4422348640207713,-1.1165715977309725,0.325,0.8185925595778515,1.0,3/13,2.20%,ADGRV1;PALM;GRM3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2303591741062949,-1.1153927898564884,0.09090909090909091,0.8206032626336021,1.0,120/341,26.03%,TTC3;NEDD4L;ARRB1;FBXL7;TRIP12;RNF146;ATXN3;AREL1;ITCH;FBXO10;CUL3;RNF185;ANAPC1;RNF20;UBQLN1;UBE2D3;OTUD7B;BIRC6;RC3H2;RNF144B;RNF217;UBL7;RNF6;PML;UFD1;CTNNB1;BIRC2;PCBP2;UBAP1;RNF13;PSMD7;WDR91;PSMD9;PSMD13;RNF213;MDM2;PELI1;TOPORS;CDC23;FBXO7;RBCK1;TRIM25;WWP1;ARMC8;SMURF2;RNF144A;PRKN;KCTD2;RMND5B;DDB1;UBE4B;PSMB3;KLHL22;RNF34;STUB1;RMND5A;SKP2;VPS4B;RNF125;DTX3L;RNF166;PSMC5;SIAH1;PSMA5;OS9;PSMA1;BUB3;PSMC2;UBE2H;RNF115;HECW1;CDC26;TOLLIP;NHLRC3;UBXN1;RNF43;KLHL3;UBQLN2;UBE2S;ANAPC4;MVB12B;SIAH2;SYVN1;FBXW5;RNF130;HERPUD1;CHFR;SPOPL;ARRDC1;ARIH1;SPSB4;BTRC;UBAP1L;PPP1R11;NUB1;ZFAND2A;WDR81;SHARPIN;KCTD17;PSME3;PSMC4;ZNRF3;KEAP1;IFI27;UBE2B;PSMB6;MVB12A;UBR4;FBXL19;RAD23B;TBL1XR1;VPS37C;SIAH3;UCHL1;PSMB10;ANAPC15;HECTD3;SPSB1;TRIM32;RNF19B
prerank,stress fiber assembly (GO:0043149),0.5201763694243786,1.1151327603099075,0.37375415282392027,0.9991290745518238,1.0,7/15,12.64%,PDLIM1;ITGB1;TNFAIP1;ITGB5;SORBS1;FHDC1;PDCD10
prerank,contractile actin filament bundle assembly (GO:0030038),0.5201763694243786,1.1151327603099075,0.37375415282392027,0.9991290745518238,1.0,7/15,12.64%,PDLIM1;ITGB1;TNFAIP1;ITGB5;SORBS1;FHDC1;PDCD10
prerank,nitric oxide biosynthetic process (GO:0006809),-0.44797127857811564,-1.114750979394268,0.3460620525059666,0.8212001131437517,1.0,6/13,21.38%,CYP1B1;NOS3;GCH1;AKT1;DDAH2;SPR
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5543636933391471,1.1146604674083016,0.35751295336787564,0.9992635939719685,1.0,3/11,19.41%,PKD1L3;LPO;RTP4
prerank,toxin transport (GO:1901998),-0.4727548078557807,-1.1146298927802785,0.3412322274881517,0.8199843406065799,1.0,7/10,45.86%,ADAM10;RAB29;RAB40B;ANTXR2;SLC22A2;SLC22A3;SLC29A4
prerank,apical junction assembly (GO:0043297),-0.30933437962841426,-1.1145475503450955,0.23873873873873874,0.8186981059327634,1.0,8/53,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;CLDN11
prerank,nitric oxide metabolic process (GO:0046209),-0.4404782975409185,-1.1137866155797704,0.3234567901234568,0.8196034810290458,1.0,6/14,21.38%,CYP1B1;NOS3;GCH1;AKT1;DDAH2;SPR
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5372464377841614,1.1136442394843615,0.3783303730017762,1.0,1.0,4/12,12.35%,JAG1;YTHDF2;HNRNPU;NELFB
prerank,negative regulation of cyclase activity (GO:0031280),-0.4387006970617121,-1.113499976375369,0.3422330097087379,0.8189338304105023,1.0,3/14,2.20%,ADGRV1;PALM;GRM3
prerank,sphingosine biosynthetic process (GO:0046512),-0.459620111228611,-1.113290827914353,0.3243847874720358,0.8164785597587167,1.0,5/11,22.93%,SPTLC2;ACER2;ASAH2;ABCA2;SPHK1
prerank,sphingoid biosynthetic process (GO:0046520),-0.459620111228611,-1.113290827914353,0.3243847874720358,0.8164785597587167,1.0,5/11,22.93%,SPTLC2;ACER2;ASAH2;ABCA2;SPHK1
prerank,catecholamine metabolic process (GO:0006584),-0.4310675864439163,-1.1132564785556998,0.3421686746987952,0.8150774226814721,1.0,4/14,21.43%,SNCAIP;PRKN;DDC;DRD2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3103227642340829,-1.1132312092190344,0.24651162790697675,0.8136422021321409,1.0,20/56,17.58%,KMT2E;DDX3X;CUL3;CCND3;EGFR;RAB11A;ADAMTS1;TFDP1;RDX;UBE2E2;CDC23;RGCC;VPS4B;RCC2;CDC25B;ANKRD17;AKT1;CDC25A;KLHL18;ANAPC4
prerank,glycine transport (GO:0015816),0.5639348458498163,1.112830882851106,0.34594594594594597,1.0,1.0,3/10,10.38%,SLC6A17;SLC6A5;SLC7A8
prerank,regulation of centrosome cycle (GO:0046605),0.48192748589271095,1.1127802015750081,0.35714285714285715,1.0,1.0,5/21,13.44%,CHMP4C;NAT10;CHMP5;CHMP2B;CHMP2A
prerank,long-chain fatty acid transport (GO:0015909),0.447274470468245,1.11266420497395,0.3397058823529412,1.0,1.0,6/30,8.96%,PRKAB2;CD36;ACACB;FABP4;CPT1B;ABCD4
prerank,negative regulation of DNA recombination (GO:0045910),0.4330563268604128,1.1122262092867437,0.344559585492228,1.0,1.0,13/43,16.74%,POLR2L;POLR2I;CGAS;H1-0;POLR2G;FANCB;RIF1;TERF2;RMI2;POLR2J;ZRANB3;MAD2L2;MSH2
prerank,negative regulation of dephosphorylation (GO:0035305),0.49778899216152017,1.1119304738956266,0.35218093699515346,1.0,1.0,5/18,15.30%,PPP1R26;MFHAS1;ENSA;ARPP19;URI1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.48777253208436067,1.1117803627724265,0.34330708661417325,0.9993820763755884,1.0,6/21,13.53%,LAX1;DUSP3;PIBF1;SAMSN1;PAG1;FOXJ1
prerank,regulation of hippo signaling (GO:0035330),0.5078811455390092,1.1117182413606077,0.34206219312602293,0.9983066315143146,1.0,2/17,1.88%,WTIP;LIMD1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.49114683301509765,1.1117177694748306,0.33553719008264465,0.9970664990528062,1.0,4/19,6.81%,DYRK2;TP53;PHLDA3;RPS27L
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3697965025311963,-1.1113751223465191,0.33048433048433046,0.8177634819677114,1.0,18/24,46.26%,XRCC1;LIG3;UBC;UBB;LIG1;RPA3;RFC3;RPA2;POLD3;LIG4;RPA1;RFC1;POLE;RFC4;RFC5;POLB;POLD2;RFC2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4644297230228146,1.1112401422088496,0.3389592123769339,0.9973770200079445,1.0,6/27,9.07%,FBXL22;CRTC1;USP2;TP53;PPP1CB;PPP1CA
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.34293897375263604,-1.1108603062348579,0.3238095238095238,0.8178132899439231,1.0,7/30,21.36%,HMGB1;LGALS9;PLCG2;CD34;CD46;CD274;HSPD1
prerank,ethanol metabolic process (GO:0006067),0.5549947440000474,1.1106674237428533,0.37251356238698013,0.9979014146359154,1.0,1/12,0.89%,ACSS1
prerank,mitochondrion morphogenesis (GO:0070584),-0.4675550017994441,-1.1105775000451175,0.36253041362530414,0.8171772665924433,1.0,5/11,22.16%,PID1;FIS1;PNPT1;NUBPL;SLIRP
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4811366290883481,1.1102129759134276,0.373546511627907,0.9968674965553508,1.0,5/24,11.24%,PFKP;ENO3;HK2;ALDOA;PFKM
prerank,canonical glycolysis (GO:0061621),0.4811366290883481,1.1102129759134276,0.373546511627907,0.9968674965553508,1.0,5/24,11.24%,PFKP;ENO3;HK2;ALDOA;PFKM
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.39149625114719216,1.1101646592347956,0.3253968253968254,0.9958053853164591,1.0,19/101,10.75%,ATP2B4;FGF1;MST1R;TCIM;PDGFB;PDGFC;FERMT2;CCND2;SLC8A2;PDGFD;DAB2IP;VEGFA;CALM1;RASGRP1;CCND1;ADAM17;MAP2K1;PDGFRB;PDGFA
prerank,establishment of protein localization to membrane (GO:0090150),-0.28818013152855315,-1.1098855206399358,0.265,0.8177260991885817,1.0,13/66,13.37%,AFDN;EGFR;RAB11A;ZDHHC18;ATG3;SYNE3;ZDHHC15;SDCBP;SEC63;RAB3GAP2;FRMPD1;ZDHHC9;ZDHHC20
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3824526727717048,-1.109797163777921,0.3123209169054441,0.8165153667718141,1.0,3/22,1.84%,ALDH1A2;RBP1;VKORC1L1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4674187756825883,1.1097399895769284,0.35251798561151076,0.9958861411878526,1.0,5/28,13.54%,FLNA;UBR5;BAG3;PRKCD;TRIM28
prerank,neuromuscular synaptic transmission (GO:0007274),0.4944323009999433,1.1095359425715268,0.35833333333333334,0.9953425351092344,1.0,4/18,9.77%,DTNA;STAC3;RIMBP2;FCHSD2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3809273803035106,-1.1093907377796044,0.32571428571428573,0.8161873141925635,1.0,9/20,18.08%,MCU;LETM1;SPG7;MCUB;MICU2;MAIP1;STOML2;YME1L1;SLC8B1
prerank,peptidyl-asparagine modification (GO:0018196),-0.3450845019259372,-1.1090678630059805,0.2831541218637993,0.815690302575676,1.0,14/31,28.11%,TUSC3;MGAT1;FUT8;UGGT2;OSTC;MGAT5;MCFD2;LMAN1;HIF1AN;RPN2;MGAT2;DPM3;STT3B;ASGR1
prerank,peptide catabolic process (GO:0043171),-0.38380714457112053,-1.1088476647143777,0.3037974683544304,0.8148382090924766,1.0,6/23,10.14%,ANPEP;XPNPEP1;NPEPPS;CTSH;ECE1;ACE
prerank,positive regulation of multicellular organismal process (GO:0051240),0.363789313536858,1.1081596464605077,0.26802030456852793,0.9983974714730063,1.0,44/308,11.74%,SOX6;PRDM16;SOX5;ROCK1;PRKAB2;CD36;PDGFB;PDGFC;PLA2G3;FERMT2;FST;EBF2;ADRA1D;LOXL2;IL2;TGFB3;GCNT2;TSHR;TGFB1I1;BMPR1A;TAPT1;CAV1;TERT;VEGFA;TRPV2;FABP4;GDNF;PPARGC1A;MED1;PPARGC1B;DIO2;SOX9;TGFB2;PLCB1;TRPM4;RBM19;PAXIP1;RIF1;NR2C2;EIF2AK2;MFN2;NKX6-1;HTR2B;ACVR1B
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4917546332898007,1.1074111689922315,0.36486486486486486,0.9995274732902864,1.0,1/19,0.51%,RYR2
prerank,regulation of mitochondrial translation (GO:0070129),0.48867833859379073,1.1074065085974867,0.3617021276595745,0.9983213007663412,1.0,11/21,20.38%,RPUSD3;TRMT10C;RCC1L;TSFM;RPUSD4;FASTKD2;TRUB2;RMND1;MALSU1;UQCC2;C1QBP
prerank,protein ubiquitination (GO:0016567),-0.23416769829719702,-1.1065871517622363,0.0,0.8203608671563292,1.0,112/471,15.37%,RNF220;SASH1;NEDD4L;ARRB1;SH3RF1;FBXL7;TRIP12;FBXL5;RNF146;AREL1;ITCH;RNF38;FBXO10;CUL3;RNF185;TNKS2;PRKDC;MYCBP2;RNF20;PPIL2;KLHL12;PEX14;UBE2D3;NPEPPS;RNF135;BIRC6;RC3H2;ATG3;RNF144B;SHPRH;RNF217;UNKL;TRIM24;RNF6;DERL1;UBR2;CTR9;CTNNB1;BIRC2;FBH1;PHC1;RNF25;RNF13;FBXO9;PSMD7;USP7;HERC2;PSMD9;PSMD13;COMMD1;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;TRIM25;WWP1;PEX5;SH3RF3;KLHL2;SMURF2;CUL7;RNF144A;RNF31;PRKN;UBE3A;MGRN1;FBXO25;MKRN2;RNF181;DDB1;UBE4B;PSMB3;UBC;TRIM5;KLHL22;RNF34;STUB1;HECTD2;RMND5A;SKP2;DZIP3;LONRF1;DTX1;TRIM33;VPS18;TRIM14;RNF125;DTX3L;RNF166;RTF1;PSMC5;FBXW8;SH3RF2;SIAH1;PSMA5;LEO1;OS9;PSMA1;PSMC2;UBE2H;RNF115;HECW1;RNF10;OBI1;NHLRC3;RNF43
prerank,positive regulation of protein processing (GO:0010954),0.49814524732185333,1.1064031061278978,0.3611111111111111,1.0,1.0,4/19,13.18%,ANGPTL8;MYH9;LPCAT3;BAG2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.47557493430954784,-1.1060943793762081,0.34968017057569295,0.8204502134202922,1.0,4/10,19.05%,EMC2;EMC3;EMC8;MMGT1
prerank,positive regulation of insulin secretion (GO:0032024),-0.33093248281118626,-1.1059510284521654,0.30793650793650795,0.8193931233489945,1.0,13/36,17.28%,TCF7L2;MYRIP;RBP4;MCU;PSMD9;STX4;NNAT;SOX4;PLA2G6;NLGN2;CAPN10;ACSL4;AACS
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.44261701244561,-1.1046062256235827,0.3574660633484163,0.8218338679887236,1.0,2/12,1.03%,DAB2;FOXP1
prerank,cochlea morphogenesis (GO:0090103),0.5559244097353964,1.1044942698800022,0.36936936936936937,1.0,1.0,2/10,7.69%,TBX18;SOX9
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.4036147308601679,-1.1044933012808262,0.3375,0.8206566584240261,1.0,7/18,18.03%,NLGN1;PTK2B;SHANK3;NRXN1;NLGN2;NLGN3;RIMS2
prerank,cellular response to leucine starvation (GO:1990253),0.5521860424823173,1.1044172491256408,0.3726937269372694,1.0,1.0,3/10,9.52%,LARS1;IMPACT;RRAGB
prerank,photoperiodism (GO:0009648),0.4591191341013732,1.104228727876492,0.3474576271186441,1.0,1.0,8/28,14.13%,FBXL22;CRTC1;USP2;TP53;PPP1CB;PPP1CA;CLOCK;MTA1
prerank,regulation of protein kinase A signaling (GO:0010738),0.49307605020686357,1.103848220849011,0.3572593800978793,1.0,1.0,2/20,2.08%,AKAP6;TCIM
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4973925761177777,1.1037946056796137,0.35453100158982515,1.0,1.0,3/17,4.10%,CACNA2D1;SNTA1;KCNE4
prerank,negative regulation of translation (GO:0017148),0.39902564634524257,1.103741278486204,0.32752613240418116,1.0,1.0,20/87,14.33%,RBM24;ROCK1;IGFBP5;SAMD4A;MRPL13;BTG2;EIF4EBP1;CPEB1;YTHDF2;CELF1;FTO;DAPK3;EIF3E;EIF2AK2;ROCK2;CNOT7;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,protein polyglutamylation (GO:0018095),0.5405552582631976,1.1037257691047833,0.3739130434782609,0.9998622139790644,1.0,2/11,3.99%,TTLL7;CEP41
prerank,organophosphate ester transport (GO:0015748),-0.3721653043599034,-1.103642737008099,0.3323943661971831,0.8218145505578349,1.0,5/24,6.15%,OSBPL8;PITPNA;PLTP;LDLR;PITPNC1
prerank,B cell receptor signaling pathway (GO:0050853),0.4541017608005351,1.1028621965591112,0.34442836468885674,1.0,1.0,3/32,4.50%,MEF2C;CD79A;BCL2
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.41779643177223214,-1.1027366145482926,0.3213429256594724,0.8231062558621615,1.0,4/16,10.82%,POGZ;PDS5A;MAU2;NAA50
prerank,positive regulation of programmed cell death (GO:0043068),0.36174924974645833,1.1026650533379319,0.2882051282051282,1.0,1.0,39/272,12.53%,KCNMA1;OBSCN;ARHGEF7;MAP3K20;MAP3K5;PMAIP1;KALRN;ABR;ARHGEF17;ANO6;ITSN1;TGFB3;ITGB1;NET1;ARHGEF16;ARHGEF2;ATG7;DAB2IP;RPS6KA2;ARL6IP5;TP53;PHLDA3;FZD9;MAP3K10;DAPK3;TNFAIP8;ARHGEF4;HRK;PAWR;DNM1L;VAV1;GPER1;TRIM35;BOK;CLIP3;CSRNP3;DIABLO;CLU;ITGB3BP
prerank,regulation of T cell migration (GO:2000404),0.5026910651008231,1.1025468413456208,0.3700159489633174,0.9997480430439328,1.0,4/18,7.00%,DOCK8;CCL5;CD200R1;CD200
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.38092168585323505,-1.1023351128833596,0.34560906515580736,0.8227722493920875,1.0,4/22,2.34%,AKAP13;AEBP1;PIK3CA;APOE
prerank,defense response to symbiont (GO:0140546),0.39550792801591794,1.102330675527191,0.3212192262602579,0.9992373323747388,1.0,9/92,7.90%,FLNA;PMAIP1;MYD88;CGAS;BCL2;ATG7;LYST;ABCE1;RELA
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.25647670321854665,-1.1020912173156354,0.21428571428571427,0.8220692760502484,1.0,29/129,14.21%,RNF220;LRRK1;LGR4;COL1A1;ADGRA2;WNK1;RNF146;DDX3X;PTK7;EGFR;LYPD6;TNKS2;PPM1B;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;SMURF2;SFRP4;TGFB1;FGFR2;PSMB3;SOX4;ZBED3;PSMC5;PSMA5;PSMA1;PSMC2
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3276996895614557,-1.1020644026250912,0.30970149253731344,0.8206530426229577,1.0,8/38,8.59%,RBBP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4776737145134272,-1.101857774682629,0.3498964803312629,0.8197983004062477,1.0,5/10,14.44%,ATP1A2;NEDD4L;PRKCE;OSR1;HECW1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4492924336026245,1.1011993451055262,0.36363636363636365,1.0,1.0,9/35,12.19%,DLC1;ITGA3;KANK1;TNFAIP1;DAB2IP;TGFB2;MFN2;ARHGAP35;SCAI
prerank,cellular response to lipid (GO:0071396),0.37411446769663015,1.1011850946215824,0.3159541188738269,1.0,1.0,31/191,11.12%,MEF2C;ADCY5;NR1H4;MYD88;ADCY2;ABCB4;PDK4;RORA;VIM;FZD4;LPL;UPF1;CD14;TESC;IRS1;DAB2IP;CHMP5;AR;MED1;SOX9;NFKBIB;RELA;ADNP2;GSTP1;NR1D1;ADCY6;AXL;BRINP1;GPER1;ROCK2;CD180
prerank,regulation of lipase activity (GO:0060191),0.5218983799909872,1.101002565450811,0.38823529411764707,0.9996548858612692,1.0,2/13,3.34%,ANGPTL8;LPL
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3999646337003105,-1.1007754581040337,0.3282442748091603,0.8216459192600924,1.0,10/17,26.20%,CD44;MDM2;PRKN;RNF34;PTTG1IP;KDM1A;ARMC10;SNAI1;YJU2;TWIST1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5198466442554184,1.1006884617034443,0.3685152057245081,0.9994356999254276,1.0,4/13,10.02%,PADI2;ARID1A;CHEK1;SERTAD2
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3687418704634764,-1.0998532575189197,0.3081395348837209,0.8229976154941416,1.0,9/24,16.92%,HMGB1;SLIT2;NBL1;MOSPD2;CCN3;LYN;PLA2G7;DUSP1;SERPINE1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.36737667216422676,-1.0996145577721896,0.3135593220338983,0.822317266688046,1.0,10/25,18.54%,IL31RA;IFNAR2;GHR;PKD2;SOCS2;CTR9;STAT2;IFNAR1;STAT5A;STAT6
prerank,cellular response to type I interferon (GO:0071357),-0.3215761086336549,-1.0991908500658767,0.2872727272727273,0.8206045018604353,1.0,18/41,22.74%,IFNAR2;IRAK1;SAMHD1;IP6K2;SP100;STAT2;IRF9;IFIT1;IFIT3;IFNAR1;ADAR;BST2;IFITM1;OAS2;IFITM3;IFIT2;RNASEL;IFI27
prerank,type I interferon signaling pathway (GO:0060337),-0.3215761086336549,-1.0991908500658767,0.2872727272727273,0.8206045018604353,1.0,18/41,22.74%,IFNAR2;IRAK1;SAMHD1;IP6K2;SP100;STAT2;IRF9;IFIT1;IFIT3;IFNAR1;ADAR;BST2;IFITM1;OAS2;IFITM3;IFIT2;RNASEL;IFI27
prerank,iron ion transmembrane transport (GO:0034755),-0.46930438736622204,-1.0989283155951028,0.35881104033970274,0.8199924743920285,1.0,4/10,14.03%,SCARA5;ABCB7;SLC39A8;SLC25A28
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4920651952552537,1.098805741932823,0.3598673300165838,1.0,1.0,6/18,14.08%,NAT8L;GOT1;GOT2;ADI1;SMS;SLC25A12
prerank,apical protein localization (GO:0045176),0.5463036090064337,1.098700819533466,0.3838771593090211,1.0,1.0,5/10,11.08%,ATP8B1;ACTB;JAM3;INSC;GOPC
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.530432683241999,1.098474009324091,0.3532608695652174,1.0,1.0,5/11,18.31%,TP53;RPS27L;MAD2L2;HIPK2;RPS6KA6
prerank,ventricular septum development (GO:0003281),0.44370081801957106,1.0982154916336095,0.35911602209944754,1.0,1.0,5/37,7.87%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,purine nucleotide catabolic process (GO:0006195),-0.44234692549271937,-1.0982068176586521,0.361244019138756,0.8207772821094654,1.0,6/13,19.76%,XDH;NT5E;HINT1;ITPA;GPX1;PNP
prerank,regulation of protein kinase activity (GO:0045859),0.38700063203605034,1.0974364474866194,0.33069082672706684,1.0,1.0,23/106,14.59%,TTN;RAP1A;PLCE1;CCN1;SMG8;PPM1E;MMD;CAMKK2;RAP2C;LCP2;ANKRD54;GSTP1;PAK2;CENPE;RB1;CEP85;SNX9;CEP43;GAS6;MAP2K3;GNAQ;DVL1;MAPRE3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3289999165086007,-1.097363330621269,0.2765957446808511,0.8218045172336997,1.0,15/34,18.86%,FLT1;PIK3CA;SEMA6A;MAPK14;NRP1;GAS1;GAB1;SPRY2;ERN1;RAMP2;KDR;VEGFC;VEGFB;MT1G;ITGB1BP1
prerank,negative regulation of cellular process (GO:0048523),0.3582540236957728,1.0972014178023664,0.2702702702702703,1.0,1.0,74/521,11.81%,MYOCD;SLIT3;ACTN1;IGFBP7;COL18A1;DLC1;ANGPT1;MYL2;TMIGD3;FER1L5;P3H2;SPEG;CCN1;ITGA1;CDK6;FERMT2;DYSF;MYH9;SEMA5A;PLXND1;PLXNB1;CDH13;NR4A1;FRK;RERG;TGFB3;GMNN;BTG2;FHL1;NACC2;NUP62;ALOX5;PIP4P2;TGFB1I1;BCL2;JADE1;ARHGDIG;EMILIN1;TESC;CBLL1;DSCAM;DAB2IP;NDRG3;TMEM98;RPS6KA2;TP53;CD200;AR;BNIPL;CELF1;BTG1;TGFB2;ADNP2;WNK2;LPCAT3;DIS3L2;IMPACT;MAP2K1;SKI;NDUFS3;CRLF3;SIRT2;SERTAD2;BRINP1;EIF2AK2;SH3BP4;GPER1;TNFRSF21;RB1;COPS8;TCHP;HTR2B;ACVR1B;CNOT7
prerank,autophagy of nucleus (GO:0044804),-0.4132755867593835,-1.097129734322854,0.32663316582914576,0.8210546334290374,1.0,10/16,28.27%,RB1CC1;ATG3;ATG5;ATG2B;WIPI2;ATG2A;WDR45B;ULK2;WIPI1;ATG12
prerank,cellular response to gamma radiation (GO:0071480),0.5039703354814977,1.0967050923058665,0.3762541806020067,1.0,1.0,3/17,7.60%,MAP3K20;TP53;YAP1
prerank,regulation of lymphocyte activation (GO:0051249),0.5336424477597149,1.0960325101656014,0.38035714285714284,1.0,1.0,2/12,9.75%,CCL5;PAG1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3416281833126226,-1.0960095534825314,0.3184931506849315,0.8230261170487843,1.0,13/33,16.02%,TJP1;GLUL;SEMA6A;PDPK1;EPN1;PIK3CB;ITGA5;BMPER;ADAMTS9;CEMIP2;KLF2;CREB3L1;FGF2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3802427070272086,-1.0959718291315155,0.33156498673740054,0.8217124321448123,1.0,15/19,49.58%,OFD1;CCDC39;SPEF2;NEK10;CFAP53;ROPN1L;ADCY10;SPAG17;AQP4;SPA17;DNAAF2;ODAD4;NPHP3;CCDC40;DNAAF4
prerank,protein localization to nucleus (GO:0034504),-0.26929528541622805,-1.0957740586671314,0.23134328358208955,0.820836656947362,1.0,35/102,22.21%,APPL2;COL1A1;BMP7;BMP4;E2F3;FAM53A;NUP88;PML;ARL2BP;TOR1AIP2;MDM2;TOPORS;NUTF2;IPO8;TOR1AIP1;SIX1;PTTG1IP;APPL1;NUP50;CALR;AKT1;EIF4ENIF1;NOP53;XPA;TBRG1;ARL2;RPL11;NUP85;BCL3;TAF3;IPO11;RPF2;NXT2;NUP214;RAN
prerank,P-body assembly (GO:0033962),0.5305966946084564,1.0955000677597593,0.38917975567190227,1.0,1.0,2/12,5.77%,LIMD1;ATXN2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.42188811516808633,1.0951150677106665,0.35621761658031087,1.0,1.0,7/46,5.99%,RBPMS2;ELN;PDGFB;CDH13;IGFBP5;CCL5;OGN
prerank,methylguanosine-cap decapping (GO:0110156),-0.46938454966593485,-1.0947868920998214,0.3682983682983683,0.8224068261863537,1.0,6/10,22.60%,DCPS;LSM1;DCP2;EDC4;PNRC2;EDC3
prerank,response to alcohol (GO:0097305),0.46055599619206644,1.0946193874163717,0.3776119402985075,1.0,1.0,1/27,0.19%,SLIT3
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.39143663726819167,1.0945598190587817,0.3429895712630359,1.0,1.0,14/95,9.19%,ASPN;PRDM16;VASN;ZEB2;ITGA3;TGFB1I1;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.2841328249017114,-1.094319746063218,0.23809523809523808,0.8223759261040595,1.0,18/76,10.60%,NFAT5;SASH1;UACA;BMP7;DLG1;APP;DDX3X;EGFR;NOD1;PPM1B;NFKBIA;LGALS9;IRAK1;HDAC7;RASSF2;PTPN22;CCN3;PDCD4
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36725168383464074,1.0941800760293032,0.321390937829294,1.0,1.0,37/214,11.76%,RAP1A;NTRK3;ANGPT1;CD36;PDGFB;CCN1;PDGFC;FERMT2;ROR1;FAM83D;THPO;CCL5;GCNT2;PDGFD;MFHAS1;EMILIN1;DAB2IP;DUSP3;RRAS;FBXW7;PIN1;PTPN1;GAREM1;RASGRP1;WNK2;TNIP1;MAP2K1;GSTP1;CNKSR3;EPHA2;PDGFRB;CCL14;PDGFA;GPER1;ZDHHC17;HTR2B;DUSP29
prerank,natural killer cell mediated immunity (GO:0002228),0.5166172538393949,1.0938888568554732,0.4010152284263959,1.0,1.0,2/15,7.79%,LYST;KIF5B
prerank,regulation of cellular component size (GO:0032535),0.442366936765998,1.0938543024779261,0.37648809523809523,1.0,1.0,4/30,10.79%,NEB;LARS1;PPP1CA;VAV1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.36032609027410956,-1.0937978969496442,0.31384615384615383,0.8225565503499054,1.0,10/27,17.58%,ANAPC1;UBE2D3;UBE2E2;CDC23;UBE2E3;PRKN;UBE2H;CDC26;UBE2S;ANAPC4
prerank,dermatan sulfate metabolic process (GO:0030205),-0.436400108004522,-1.0936945186065383,0.3642691415313225,0.8214292720656294,1.0,3/13,1.18%,UST;DCN;DSE
prerank,organophosphate catabolic process (GO:0046434),-0.4451665841880086,-1.0936880503354154,0.3492063492063492,0.8200154523508635,1.0,2/11,14.00%,ENPP2;ABHD12
prerank,signal transduction in response to DNA damage (GO:0042770),0.4225988297672732,1.0936045131851058,0.34048257372654156,1.0,1.0,12/49,10.63%,MAP3K20;HINFP;BRIP1;NDRG1;TP53;CHEK1;RAD9A;ERCC6;PAXIP1;STK33;FBXO6;RHNO1
prerank,ion homeostasis (GO:0050801),0.4483159417641398,1.093584858418779,0.3573487031700288,1.0,1.0,7/30,8.13%,CAMK2D;SLC4A8;P2RY2;FHL1;SLC4A3;SLC4A7;WNK2
prerank,defense response to virus (GO:0051607),0.3872318051508723,1.0935102870072257,0.3302857142857143,0.9996613030130486,1.0,10/100,7.90%,FLNA;PMAIP1;MYD88;CGAS;ATAD3A;BCL2;ATG7;LYST;ABCE1;RELA
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.362578902500287,-1.0929551240557192,0.2922636103151863,0.820793426240553,1.0,8/26,19.26%,POR;APOE;NPR3;NOS1AP;PIK3CB;GCH1;AKT1;PARK7
prerank,regulation of biosynthetic process (GO:0009889),0.5327726926942095,1.0926499976831434,0.3807829181494662,1.0,1.0,6/11,22.88%,ALOX5;GSTP1;SLC25A33;THRSP;PIKFYVE;MID1IP1
prerank,neuron projection regeneration (GO:0031102),-0.47394726398716724,-1.092097865820543,0.3663157894736842,0.8219458092536587,1.0,2/10,10.38%,PTN;MAPK8IP3
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4635762929161895,-1.0920092687830687,0.3829787234042553,0.8208192340954502,1.0,5/11,15.49%,RIN3;SLIT2;NBL1;CCN3;DUSP1
prerank,neurogenesis (GO:0022008),0.43413881465338167,1.0917938984329154,0.36136662286465177,1.0,1.0,8/43,8.65%,CLN5;CDK6;ANXA1;BTBD2;MAPT;ERCC6;TGFB2;TRAK1
prerank,dephosphorylation (GO:0016311),0.3734906668199723,1.0913653625604487,0.3482532751091703,1.0,1.0,29/147,13.13%,PPP1R12A;PPM1L;PPM1J;PPP3CA;MTMR7;DUSP5;PPP2R1B;ACP3;PPM1E;PTPN18;PTPRS;LHPP;SDHAF2;PTPRF;DUSP3;PPP2R5A;PPM1A;PTPN1;PLPPR1;PPP1CB;PPP1CA;CTDSP2;DUSP29;FBXW11;SBF1;CTDSP1;TPTE;DUSP16;PPP3CB
prerank,protein heterooligomerization (GO:0051291),-0.39558401291785183,-1.0912745001947814,0.35142118863049093,0.8216222684808077,1.0,4/17,13.79%,PKD2;KCNC2;FARSB;TMEM120A
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.46145166829941237,1.0911830131703386,0.38222222222222224,1.0,1.0,4/27,4.89%,ATP2B4;SNTA1;CAMK2D;UTRN
prerank,regulation of viral entry into host cell (GO:0046596),0.45969343274943214,1.0906697320737282,0.3734087694483734,1.0,1.0,1/30,0.21%,TMPRSS4
prerank,carboxylic acid transport (GO:0046942),-0.2990610280456,-1.0903649880284028,0.23809523809523808,0.8227307731111926,1.0,21/55,22.83%,SLC6A13;SLC16A12;SLC13A3;SLC16A9;SLC6A12;SLC6A6;SLC16A1;SLC3A2;SLC7A5;SLC16A11;SLC6A9;SLC6A11;CLN3;SLC66A1;SLC38A5;SLC38A6;SLC15A4;SLC1A4;PSAP;SLC36A1;SLC1A1
prerank,regulation of Golgi organization (GO:1903358),0.4898285760466532,1.0901620619704422,0.3679092382495948,1.0,1.0,5/17,14.05%,PDE4DIP;MAP2K1;STX18;PDCD10;MAPK1
prerank,potassium ion export across plasma membrane (GO:0097623),0.5259503717767788,1.090079290041035,0.37603993344425957,1.0,1.0,3/13,7.76%,KCNA5;KCNE4;KCNT2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4493369512435953,1.0898381695462622,0.37183098591549296,1.0,1.0,7/32,11.78%,CAVIN1;POLR2L;GTF2H4;TAF1;CDK7;POLR1E;POLR1H
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.33836244636982554,-1.0897491801761043,0.33003300330033003,0.8232443510426031,1.0,6/30,6.47%,DAB2;FOXP1;DDX5;SAFB2;RNF6;PRMT2
prerank,regulation of cell population proliferation (GO:0042127),0.3537147100918867,1.0890546239767525,0.243,1.0,1.0,77/691,8.83%,MYOCD;NTF3;AGTR1;IGFBP7;COL18A1;NTRK3;DLC1;LIFR;ELN;TBX2;TMIGD3;FGF1;S1PR3;LIMS1;P3H2;MST1R;SPEG;PDGFB;ITGA1;PDGFC;CDK6;TRNP1;CCND2;CDH13;CRLF1;FRK;ADRA1D;THPO;JAG1;IL2;RERG;TGFB3;GCNT2;BTG2;PDGFD;NACC2;NUP62;IL12RB2;TSHR;TGFB1I1;FXN;BCL2;KSR1;OSR2;ARHGEF2;BMPR1A;HAS2;TESC;KCNH1;JUND;IRS1;TNFRSF11A;DAB2IP;RPS6KA2;TIPIN;TP53;VEGFA;GDNF;CD200;AR;AREG;BNIPL;GAREM1;CELF1;BTG1;YAP1;SOX9;TGFB2;RELA;NUAK1;KMT2D;WNK2;DIS3L2;MVD;ADAM17;TRPM4;MAP2K1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3860989216365801,-1.0890504328044777,0.3351063829787234,0.8239279438269186,1.0,4/20,13.38%,IGF1;NIBAN2;TGFB1;EP300
prerank,triglyceride metabolic process (GO:0006641),-0.30508641509037243,-1.0889034871974541,0.3222748815165877,0.8229811199399162,1.0,5/48,4.77%,AGMO;APOE;SEL1L;LPGAT1;LPIN2
prerank,negative regulation of autophagy (GO:0010507),-0.29717189141902267,-1.0888656403503358,0.3013698630136986,0.821701196182386,1.0,21/54,23.81%,LEPR;PIK3CA;NUPR1;FOXK2;SMG1;DAP;NRBP2;PTPN22;RASIP1;TAB2;KLHL22;EIF4G3;SNCA;DAPL1;AKT1;ZKSCAN3;QSOX1;TLK2;TBC1D14;LZTS1;SMCR8
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.44478265100897,-1.0885450846741354,0.37327188940092165,0.8212399161140125,1.0,3/12,1.18%,UST;DCN;DSE
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.36491056540697403,-1.088500517216551,0.35240963855421686,0.8199552767431613,1.0,12/22,29.55%,URB1;ERI3;EXOSC9;RPS21;FTSJ3;NOP9;EXOSC2;UTP20;EXOSC7;EXOSC3;PES1;RRS1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.42231182672252193,1.087798664680817,0.3486750348675035,1.0,1.0,13/48,16.74%,CRIP1;DYRK2;BCL2;TP53;PHLDA3;RPS27L;BCL2L2;EPHA2;BOK;FNIP2;MCL1;HIPK2;MSH2
prerank,bone development (GO:0060348),-0.32924771393156504,-1.087336893720772,0.3125,0.8218348698476183,1.0,9/39,10.56%,RANBP3L;AKAP13;SULF1;GJA1;GNAS;CYP26B1;SLC10A7;SFRP4;FGFR2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.32240469750377304,-1.0871369320158002,0.3288135593220339,0.8210956680782757,1.0,14/39,17.21%,BMP4;SLIT2;GLI2;NRP1;ENG;PKD2;TIE1;CTNNB1;RASIP1;SALL1;SIX1;KDR;FGF2;NOTCH4
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.39335016313117044,1.0871359314428934,0.3606755126658625,1.0,1.0,14/79,10.68%,RBPMS2;ATP2B4;CRIM1;ACVR2A;BMPR1A;MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4;SKI;VWC2L;UBE2D1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.450096639406679,-1.0863702466613692,0.3837471783295711,0.8220303987425301,1.0,4/11,19.26%,SLC30A10;ABCB7;COA8;PARK7
prerank,B cell activation (GO:0042113),0.4003882240552919,1.0859928127664187,0.3594936708860759,1.0,1.0,10/68,9.74%,MEF2C;CD79A;ITGB1;LAX1;HDAC9;BCL2;RASGRP1;ITGA4;ADAM17;TPD52
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.46884589299490187,1.085311952395803,0.3865814696485623,1.0,1.0,9/23,17.86%,MTMR7;PIP4P2;SYNJ2;SACM1L;INPP5B;TPTE;INPP5J;PTEN;MTMR3
prerank,regulation of type I interferon production (GO:0032479),-0.2727699439260271,-1.08482993964451,0.22929936305732485,0.8252146738848845,1.0,42/84,27.70%,ITCH;PRKDC;XRCC5;RNF135;MRE11;IRAK1;ILRUN;POLR3F;UFD1;CTNNB1;PCBP2;PTPN22;TRIM25;POLR3B;POLR3A;XRCC6;RNF125;EP300;NLRP4;TRIM56;POLR3H;NLRC5;POLR3E;UBA7;STAT6;POLR2K;TIRAP;POLR2F;POLR2H;POLR3GL;TRIM21;NLRX1;POLR3C;CYLD;DDX41;POLR3D;TRIM32;NFKB2;POLR2E;IKBKE;GPATCH3;PQBP1
prerank,regulation of cell differentiation (GO:0045595),0.3719729572538899,1.0847196469074762,0.351931330472103,1.0,1.0,24/148,13.31%,NTF3;HEY2;ZFHX3;ROCK1;CDK6;PHLDB2;CLASP2;ALOX5;CBFB;TAF8;GDNF;PA2G4;AR;SNAI2;NR1D1;EIF2AK2;RUNX1;BMPR1B;MOSMO;CLASP1;BCL6;NSUN2;ZFP36L1;CASZ1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4691859032658295,1.0845028489586663,0.36037441497659906,1.0,1.0,3/22,6.19%,RASL11A;PWP1;SMARCB1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5077325884188921,1.0844308189482799,0.38487394957983195,1.0,1.0,5/15,14.92%,PMAIP1;IRS1;PPARA;LDLRAP1;IRS2
prerank,positive regulation of rRNA processing (GO:2000234),-0.4587289245819236,-1.0834483378535567,0.37104072398190047,0.8279065679853082,1.0,6/10,35.66%,SIRT7;DIMT1;BUD23;HEATR1;RIOK2;TRMT112
prerank,embryonic eye morphogenesis (GO:0048048),-0.4541029995622705,-1.083313036669024,0.34934497816593885,0.8269534970298471,1.0,4/11,3.63%,FBN1;EFEMP1;FBN2;MFAP5
prerank,cardiac ventricle development (GO:0003231),0.47076019947050957,1.083252993569038,0.3941267387944359,1.0,1.0,2/20,3.09%,HEY2;HEYL
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4770399915100892,1.0831952246299046,0.3878504672897196,1.0,1.0,4/20,10.85%,ANO6;PIAS4;ITGA4;GPER1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.393331933670002,1.082451992997973,0.34993773349937735,1.0,1.0,10/72,7.13%,FGF13;TRIM54;CHADL;CLASP2;KANK1;ARHGEF2;EMILIN1;DYRK1A;HDGFL3;TPX2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4119941044504929,-1.0823040755904416,0.3604060913705584,0.8286396776160555,1.0,6/16,15.79%,APOE;NPR3;NOS1AP;PIK3CB;GCH1;AKT1
prerank,telomere maintenance via recombination (GO:0000722),-0.4535412038304458,-1.0820941840941458,0.3404255319148936,0.8278529301484374,1.0,6/11,24.62%,RAD50;SMC5;TPRKB;NSMCE2;ERCC1;ERCC4
prerank,purine-containing compound catabolic process (GO:0072523),-0.4343780228968187,-1.0820864906418322,0.3634085213032581,0.8264975211431904,1.0,6/13,19.76%,XDH;NT5E;ITPA;DPYD;GPX1;PNP
prerank,anterior/posterior axis specification (GO:0009948),0.49937976935050665,1.081880676299977,0.38190954773869346,1.0,1.0,2/15,9.19%,FZD5;SKI
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.38111083978527427,1.081399940105637,0.3568181818181818,1.0,1.0,15/95,11.12%,MEF2C;MYD88;FZD5;VIM;UPF1;CD14;DAB2IP;CHMP5;NFKBIB;RELA;GSTP1;NR1D1;AXL;SIRT2;CD180
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.36924698553868757,1.0812968023779186,0.3449048152295633,1.0,1.0,39/129,20.36%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;FBXL22;CEP41;HAUS8;CEP290;ENSA;PLCB1;PPP1CB;BRSK1;CDK7;CEP192;DYNC1I2;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;DNM2;PLK4;CDK14;DCTN1;MASTL;MNAT1;HAUS4;BRSK2;CEP135;CKAP5;ACTR1A;KDM8;SFI1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.41395784461379254,1.081123538832899,0.3588456712672522,1.0,1.0,14/51,15.43%,NTF3;PLXNB1;DAB2IP;DICER1;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;LRRK2;ANKRD27;SNX1;CNTNAP1;DNM2
prerank,urogenital system development (GO:0001655),0.5363154247589499,1.080382036669325,0.39568345323741005,1.0,1.0,3/11,7.69%,ANXA1;OSR2;SOX9
prerank,positive regulation of chromosome organization (GO:2001252),-0.4233779452553228,-1.080096693016438,0.3545232273838631,0.8309744308203797,1.0,5/15,12.83%,MRE11;PML;RAD50;GNL3;NBN
prerank,regulation of signal transduction (GO:0009966),0.3649178620526086,1.0800758058013396,0.36163522012578614,1.0,1.0,40/190,14.48%,IGFBP7;LIFR;RGS6;CD36;PLCE1;SEMA5A;RORA;RGS4;ZFAND2B;SLC8A2;ITGA3;SOCS5;IGFBP5;NUP62;DHRS3;CBFB;CASTOR1;IFT81;RFNG;PTPN1;IGFBP4;GDNF;YJEFN3;ANKRD54;PLCB1;MGLL;AMFR;CDC42SE2;SREBF2;RUNX1;ZDHHC17;TSPAN12;CHRNA7;CLU;HOMER1;NCK2;USP20;RGS5;LRRK2;CASTOR2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.505223736717988,1.0800419005330568,0.3976510067114094,1.0,1.0,2/14,7.17%,ENTPD1;ENTPD7
prerank,photoreceptor cell development (GO:0042461),0.4915055901208665,1.0788903044283877,0.3931034482758621,1.0,1.0,3/14,6.51%,CDHR1;CEP290;VEGFA
prerank,carboxylic acid metabolic process (GO:0019752),0.44599904617026986,1.0787244537285754,0.37110481586402266,1.0,1.0,10/33,14.48%,CSGALNACT1;PTGIS;GNE;TBXAS1;SLC23A2;SLC23A1;ST6GAL1;SIRT4;PLA2G4A;CYB5R3
prerank,response to molecule of bacterial origin (GO:0002237),-0.2830523881981164,-1.0786501083399174,0.2925531914893617,0.8340828327339795,1.0,17/69,16.13%,FOXP1;SMAD6;LBP;LGALS9;IRAK1;NOCT;RPS6KA3;CYRIB;PTPN22;IRAK3;PELI1;NOS3;TAB2;SNCA;GCH1;IFNAR1;SRR
prerank,rRNA transcription (GO:0009303),0.5000898768088614,1.0784255336056445,0.38118022328548645,1.0,1.0,6/17,19.13%,CAVIN1;GTF3C4;POLR1E;SPIN1;GTF3A;NIFK
prerank,positive regulation of DNA recombination (GO:0045911),0.4500365520587936,1.077994703811378,0.38323353293413176,1.0,1.0,10/27,16.17%,RAD51AP1;ZCWPW1;PARP1;ERCC6;FUS;FANCB;PAXIP1;RIF1;KMT5B;MAD2L2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3785575523419805,-1.077917141457789,0.33695652173913043,0.8348716900092552,1.0,7/20,11.66%,LBP;IL18;IRAK1;PRKCE;PTPN22;TGFB1;LYN
prerank,regulation of nervous system development (GO:0051960),0.4236934789068516,1.0778318864032523,0.38186813186813184,1.0,1.0,7/37,9.92%,HEY2;HEYL;PRUNE1;GBX1;YTHDF2;YAP1;SIRT2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.33579187750855277,-1.0773503875243888,0.34055727554179566,0.8352318071352192,1.0,15/31,21.49%,IGF1;CHST11;EXTL3;BMPR2;CHST9;UGDH;HS3ST3B1;GLCE;CANT1;XYLT1;PXYLP1;FOXL1;CHST12;B4GALT7;B3GAT1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4365608119773941,1.0772542927195503,0.37746478873239436,1.0,1.0,8/34,10.85%,FERMT2;RORA;RUNX1T1;ASXL1;BBS12;YAP1;SIRT2;GPER1
prerank,protein transport (GO:0015031),-0.22445579362781123,-1.0771259116636467,0.2222222222222222,0.8344870341013252,1.0,91/332,19.77%,SPTBN1;PRKCB;LRP1;VAMP5;CALCRL;APOE;TBC1D16;ABCA1;SNX27;SEL1L;RABGAP1L;RAB5A;STXBP1;STX3;TBC1D15;RAB12;USO1;SCAMP2;ERP29;TBC1D8B;ATP6V0A4;GOLGA4;TMED5;SEC23IP;TBC1D2B;SCG5;TBC1D13;SLC10A7;CANX;STEAP3;STX5;HERC2;TBC1D5;STX4;OPTN;ARL5B;GCC2;TMED7;TMED10;WLS;COPB2;GOLPH3;TBC1D8;PPT1;ATP6AP1;ATP6V1G1;RAB3GAP2;SNX6;PDIA4;ARF3;BLZF1;UNC93B1;SNX15;ARFIP2;RCN3;RAMP2;TBC1D25;HSP90B1;TOM1;TBC1D9B;SGSM1;GRTP1;MYO6;ARFGAP3;RAB1A;TBC1D30;RAB29;TBC1D22A;TBC1D9;MON1A;EHD1;STX1A;TCIRG1;SGSM3;PPARG;NDC1;COG7;PICK1;TMED3;RAB13;SCFD1;STX8;RAB1B;NAPG;ARRDC1;TBC1D10A;TMED4;MCOLN1;SCAMP3;MIA3;PPY
prerank,adipose tissue development (GO:0060612),0.5139414795886514,1.0769762629368624,0.3926056338028169,1.0,1.0,5/11,17.90%,ARID5B;DYRK1B;LRP5;NAMPT;SH3PXD2B
prerank,muscle tissue development (GO:0060537),0.5147024610294799,1.0768051255577713,0.40472175379426645,1.0,1.0,2/13,1.66%,CSRP1;CSRP3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3561917733194797,1.0767166551487144,0.3494845360824742,1.0,1.0,33/260,10.53%,FLNA;MYLK;ARHGEF7;RAP1A;DYNLL1;VCL;PLA2G3;KIF27;ANO6;CDH13;EHD2;ITGB1;NTN1;CEP41;KIF3B;ACTR3;CEP290;IFT43;RAP2C;IFT81;STK26;CYFIP1;RAPGEF6;PIBF1;BBIP1;WHAMM;ARHGEF4;IQCB1;PARVA;RAP2A;ACTN2;EXOC6;RAB11FIP3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.43808765718843495,-1.076433568004804,0.37819025522041766,0.8351969182146806,1.0,4/12,19.45%,CDC14B;RAB1A;UBE2S;BTRC
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.42781020452601404,1.0754512262724691,0.3774104683195592,1.0,1.0,9/40,13.27%,NTF3;ANGPT1;HIP1;VEGFA;DGKD;ATAD1;SCYL2;CLU;LDLRAP1
prerank,organophosphate biosynthetic process (GO:0090407),-0.3277458926090087,-1.0754184698574047,0.35833333333333334,0.8368755232295797,1.0,17/37,30.29%,AGPAT4;IP6K1;GNPAT;IP6K2;TKT;PPIP5K2;GPAM;FGF2;AGPAT5;ITPKB;GK5;IPPK;FADS1;GK;NFS1;TPI1;PPIP5K1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.32289218149649096,-1.0754087878855052,0.33557046979865773,0.8355192273151286,1.0,16/39,26.32%,ABCA1;SEL1L;RAB12;CANX;STEAP3;GOLPH3;PDIA4;RCN3;ARFGAP3;MON1A;RAB13;MIA3;PPY;SVBP;RAB3D;COPG2
prerank,negative regulation of axonogenesis (GO:0050771),0.46240018323719184,1.0753185229949067,0.3892128279883382,1.0,1.0,2/27,4.99%,FGF13;PTPRS
prerank,sterol transport (GO:0015918),0.4884749591586307,1.0751973167398403,0.38898163606010017,1.0,1.0,5/19,13.97%,CD36;CAV1;OSBPL2;LDLRAP1;OSBPL5
prerank,cation transmembrane transport (GO:0098655),-0.3101247411348849,-1.0745191877597988,0.3046875,0.8368314787097894,1.0,8/44,9.92%,TRPM3;ATP1A2;TRPM6;PKD2;SLC3A2;SLC7A5;SLC6A9;SFXN2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4088283310310185,-1.0741511360630793,0.37965260545905705,0.836519879459512,1.0,14/15,59.16%,CD55;PNP;SYK;CCR2;HSPH1;NKAP;SHH;GLI3;IL12A;IL23A;EBI3;IHH;IL23R;IL12B
prerank,regulation of glycolytic process (GO:0006110),-0.2836514043592943,-1.073877301797535,0.3404255319148936,0.8359123341323136,1.0,22/68,21.67%,IGF1;ZBTB20;PRKAG2;NUPR1;APP;NUP88;HDAC4;ENTPD5;OGT;PFKFB2;EP300;NUP50;ARNT;INSR;PRXL2C;NDC1;GIT1;NUP85;PFKFB3;PRKAA1;NUP214;CBFA2T3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2653360006954604,-1.073783915529936,0.2980769230769231,0.8348417138647143,1.0,40/110,25.37%,UPF2;PPP2CA;RPL27A;SMG1;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;PABPC1;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;NCBP2;RPL36A;RPS8;RPS21;RPL9;SMG6;RPS7;RPL27;RPL11;PNRC2;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RNPS1;RPS4X;RPS27
prerank,sulfation (GO:0051923),-0.4519616596837175,-1.0734038809441944,0.3627906976744186,0.8346316480554873,1.0,1/11,0.11%,UST
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5000266132448823,1.0733721320646046,0.39558573853989815,1.0,1.0,5/16,15.83%,CHMP4C;CHMP5;VPS36;STAM;LEPROT
prerank,T cell proliferation (GO:0042098),0.5079440844779369,1.0732019457745754,0.3881118881118881,1.0,1.0,4/13,13.13%,DOCK8;RASGRP1;LMBR1L;PPP3CB
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.43449981981864383,-1.0730089000327927,0.3859223300970874,0.834381710482911,1.0,7/12,29.14%,SETX;IRGM;INSR;UVRAG;SMCR8;JMJD4;ADRB2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3354689843556587,-1.0730059699043395,0.33976833976833976,0.8330180385935119,1.0,8/35,5.39%,FLT1;NF1;SULF1;SPARC;APOE;XDH;COL4A3;PTPRM
prerank,global genome nucleotide-excision repair (GO:0070911),-0.35268585450171724,-1.0730056598467927,0.3582554517133956,0.8316568980075747,1.0,13/26,24.62%,USP45;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;RAD23B;ERCC4
prerank,cytoplasmic translational initiation (GO:0002183),0.4931852016717311,1.0729057471660912,0.4028436018957346,1.0,1.0,4/17,8.83%,DENR;EIF3M;EIF2D;EIF4A1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.42211031076138716,1.0728287770001554,0.3800841514726508,1.0,1.0,6/40,7.23%,PMAIP1;BCL2;NDUFS1;MAPT;ARL6IP5;HEBP2
prerank,regulation of protein neddylation (GO:2000434),0.5537762436404081,1.0728045784609779,0.4074766355140187,1.0,1.0,4/10,9.58%,DCUN1D2;DCUN1D1;RPL5;HIF1A
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.31439335728521706,-1.072692828320458,0.32751091703056767,0.8311670203812886,1.0,12/45,11.98%,DDX5;BMP4;POLR2A;EGFR;NMD3;SIRT7;RBM20;SETX;TGFB1;DIMT1;MAP2K2;ERN1
prerank,visual perception (GO:0007601),-0.2758558545660769,-1.0724144841737644,0.2916666666666667,0.8306230912232605,1.0,12/84,9.55%,PITPNA;COL1A1;EYA4;EFEMP1;ABLIM1;ADGRV1;COL11A1;SLC4A10;ZIC2;CEP250;EML2;MYO9A
prerank,histone lysine methylation (GO:0034968),0.43574579792213747,1.0722911841601088,0.3746556473829201,1.0,1.0,9/33,16.57%,SMYD1;SETD6;SUV39H2;KMT2D;SETD3;PAXIP1;N6AMT1;WDR5B;ASH2L
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3675617379169947,-1.0720993342168776,0.34806629834254144,0.8302150334189257,1.0,9/22,22.70%,MAN1C1;SEL1L;RNF185;UGGT2;UBC;OS9;SYVN1;UBB;MAN1A2
prerank,cell projection organization (GO:0030030),0.4441868668690396,1.071684847934174,0.37446808510638296,1.0,1.0,8/30,11.37%,PACSIN2;ITGB1;RHOJ;CYFIP1;PLEK;PARVA;PDGFA;RHOH
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5054588925954497,1.0715058525798407,0.3975481611208406,1.0,1.0,5/13,16.03%,CRLF1;OASL;STAT1;JAK2;STAT3
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.34950624694184157,-1.071007804579776,0.35782747603833864,0.8321761484359909,1.0,9/27,18.63%,ARRB1;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;C1QTNF3;NCKAP1L;ZC3H12A
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3875489949269157,1.0707721831254478,0.36910377358490565,1.0,1.0,16/87,12.99%,NEB;DLC1;ROCK1;RHOBTB3;ARHGAP17;DAPK3;RHOF;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;TRPM2;DMTN
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.48978607440809396,1.0705586168767744,0.39344262295081966,1.0,1.0,5/17,11.57%,FGF1;LPCAT3;MBTPS1;SREBF2;ABCG1
prerank,cellular response to glucose stimulus (GO:0071333),-0.34671787281792477,-1.0703626486127222,0.3449367088607595,0.8326586513260666,1.0,8/30,12.73%,ZBTB20;UNC13B;PTPRN2;TRA2B;RAB11FIP5;ERN1;SOX4;PCK2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.495686069168372,1.0701623776732248,0.40441176470588236,1.0,1.0,2/13,6.51%,COL4A1;VEGFA
prerank,myeloid dendritic cell activation (GO:0001773),-0.43309326895834555,-1.0701442208536636,0.36538461538461536,0.8319728453576528,1.0,9/12,52.81%,HMGB1;DOCK2;CAMK4;BATF;PYCARD;BATF2;TGFBR2;IL4;BATF3
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4177541345331459,-1.0700795979868203,0.38734177215189874,0.8308077026182175,1.0,5/13,10.29%,WNT5A;SEMA7A;PLCG2;IRAK3;TGFB1
prerank,positive regulation of protein import (GO:1904591),0.44842338037216245,1.0698152460356523,0.39111747851002865,1.0,1.0,5/30,13.54%,FLNA;UBR5;BAG3;PRKCD;TRIM28
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.4665174800848142,-1.069634175277422,0.41139240506329117,0.8307902990620796,1.0,3/10,7.84%,ANXA2;EPHA4;FURIN
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4457527668887123,1.0696192410772305,0.3888888888888889,1.0,1.0,10/28,13.74%,SORT1;BCL2;GABARAP;DAB2IP;BAG3;DEDD2;CASP8AP2;DIABLO;DEDD;TNFRSF10B
prerank,ribosomal small subunit assembly (GO:0000028),-0.4024388129346326,-1.0694711372419046,0.3838120104438642,0.8300083638230138,1.0,10/16,29.78%,PRKDC;XRCC5;RPS19;RPSA;ERAL1;RRP7A;RPS27;MRPS11;RPS5;RPS15
prerank,regulation of establishment of protein localization (GO:0070201),0.49521842356552803,1.0694478916292915,0.4193011647254576,1.0,1.0,2/14,5.22%,PTP4A3;CEP290
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.45092226785674355,1.069264483836413,0.38968481375358166,1.0,1.0,6/29,10.85%,PMAIP1;PPP2R1B;CAV1;PAK2;DEDD2;GPER1
prerank,defense response to protozoan (GO:0042832),0.5232424760550085,1.0691867491221538,0.40394973070017953,1.0,1.0,3/12,12.30%,MYD88;LYST;GBP2
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.301220119460987,-1.0683502433141154,0.31981981981981983,0.831850501538326,1.0,17/50,20.78%,ZIC1;PTCH1;GAS1;DCDC2;IFT122;MEGF8;TULP3;INTU;HERC4;MGRN1;FGFR2;EVC;GLIS2;TXNDC15;BTRC;GPC3;PDCL
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.400559083101507,-1.068281900056301,0.36633663366336633,0.8307478793615217,1.0,5/16,11.91%,DDX5;SRSF6;CELF4;HNRNPM;DDX17
prerank,regulation of telomerase activity (GO:0051972),0.4173797329967583,1.0680592527327766,0.38140161725067384,1.0,1.0,7/45,9.60%,PARM1;PARN;PRKCQ;TP53;PKIB;NAF1;CERS1
prerank,histone mRNA metabolic process (GO:0008334),-0.3524098260577313,-1.0679861834357793,0.3465045592705167,0.8302605416844261,1.0,9/27,18.83%,SSB;SLBP;LSM1;DCP2;NCBP2;TUT4;ATM;CPSF2;TUT7
prerank,post-translational protein modification (GO:0043687),0.34813335952811886,1.067929088883067,0.3556231003039514,1.0,1.0,53/332,12.46%,IGFBP7;MFGE8;LTBP1;SPARCL1;SDC2;ASB15;HRC;ASB10;KCTD7;CCN1;ASB18;FBXL22;FBXO40;SOCS5;IGFBP5;FEM1C;FEM1A;LMO7;ASB2;ASB1;CUL2;SOCS6;RNF7;NUCB1;ASB8;PSMC6;ELOC;FBXW7;FBXO30;FBXL18;KTN1;IGFBP4;LAMC1;LAMB2;RAB3A;UBE2F;CUL9;DCUN1D1;CDH2;HIF1A;PSME4;FBXO6;SUMF1;PSMB1;MBTPS1;PSMD5;FBXO32;COPS8;FBXW11;UBA3;WSB1;PSMB2;DCAF11
prerank,cellular component maintenance (GO:0043954),0.5124325731096886,1.0674933229573575,0.40974729241877256,1.0,1.0,2/12,4.94%,ITGA3;LNPK
prerank,positive regulation of signaling (GO:0023056),-0.3206265540056343,-1.0674258621612935,0.3076923076923077,0.8304929857101196,1.0,13/37,26.30%,ANXA2;SYT1;ECE1;WLS;SNCA;RAB29;RIMS2;CD80;NMU;SCRIB;INPP5F;SOX11;EDN3
prerank,negative regulation of anoikis (GO:2000811),0.49132695361435574,1.0665558830576873,0.3953098827470687,1.0,1.0,5/14,7.72%,PDK4;ITGB1;BCL2;CAV1;SNAI2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.40596492974766196,1.0665199013281255,0.39299610894941633,1.0,1.0,14/52,11.85%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;ZDHHC2;CNST;SORBS1;STAC3;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.4216066588457087,1.0665186288575437,0.3713527851458886,1.0,1.0,11/48,15.56%,PRDM16;NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210
prerank,negative regulation of macrophage activation (GO:0043031),-0.4039556451420171,-1.0663813787626142,0.38481675392670156,0.8321626010806157,1.0,6/16,18.63%,IL31RA;LDLR;CX3CL1;SYT11;GRN;ZC3H12A
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.526576082453018,1.0661762369076193,0.41397849462365593,1.0,1.0,2/11,9.92%,MST1R;SIRT2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2367878979311994,-1.0660338876976572,0.2,0.8318970708140483,1.0,32/152,14.21%,RNF220;LRRK1;LGR4;SULF1;COL1A1;ADGRA2;WNK1;RNF146;DDX3X;PTK7;EGFR;LYPD6;TNKS2;PPM1B;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;SMURF2;SALL1;SFRP4;RSPO2;TGFB1;FGFR2;PSMB3;SOX4;ZBED3;PSMC5;PSMA5;PSMA1;PSMC2
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2825260544624272,-1.0658896527547526,0.3005464480874317,0.8310057713061876,1.0,16/71,9.94%,SGMS1;SGMS2;ELOVL7;CERS5;HACD4;ST3GAL5;SPTLC2;ST8SIA1;SPTSSA;B4GALT6;ACER2;ALDH3A2;CERS6;SGPP1;CERT1;ASAH2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.39512986280115214,1.0656144509967225,0.3784764207980653,1.0,1.0,10/66,11.29%,FLNA;FERMT2;MCRS1;UBR5;TERT;YAP1;KAT7;BAG3;CCT3;PRKCD
prerank,amyloid fibril formation (GO:1990000),0.40446673459730037,1.0654087711601345,0.39276139410187666,1.0,1.0,6/51,7.64%,TTR;MFGE8;CD36;MAPT;CALB1;NAT8
prerank,histone H4-K8 acetylation (GO:0043982),0.4987015271259201,1.0645767256304863,0.40594059405940597,1.0,1.0,6/15,12.60%,MCRS1;JADE1;KAT7;KANSL3;JADE3;KANSL1
prerank,histone H4-K5 acetylation (GO:0043981),0.4987015271259201,1.0645767256304863,0.40594059405940597,1.0,1.0,6/15,12.60%,MCRS1;JADE1;KAT7;KANSL3;JADE3;KANSL1
prerank,cytoplasmic microtubule organization (GO:0031122),0.3980477711772107,1.0644805404894215,0.3778337531486146,1.0,1.0,6/54,6.20%,TRDN;HOOK2;DST;TUBGCP6;MAPT;TPPP
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3562658035981386,1.063933172613085,0.36926360725720386,1.0,1.0,32/182,12.64%,CCDC3;MEF2C;ATP2B4;HEY2;PDGFB;PLA2G3;HINFP;RBMS3;HAVCR2;BMPR1A;EMILIN1;ATXN2;TAF1;MAPT;TERT;SLC2A10;VEGFA;FBXW7;CELF1;YAP1;DICER1;TGFB2;MAP2K1;HIF1A;GPER1;ROCK2;RUNX1;RB1;TERF2;CNOT7;CITED2;PDCD10
prerank,monocarboxylic acid transport (GO:0015718),0.40182157550823727,1.063868887448842,0.380764163372859,1.0,1.0,6/51,2.91%,NR1H4;CD36;ATP8B1;ABCB4;SLC16A7;SLC10A1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.4927345800635734,1.063357050931183,0.38235294117647056,1.0,1.0,4/15,11.74%,FST;ACVR2A;SKI;ACVR1B
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4748005890683431,1.0631270567864102,0.4205607476635514,1.0,1.0,5/19,13.44%,CHMP4C;CHMP5;HNRNPU;CHMP2B;CHMP2A
prerank,positive regulation of embryonic development (GO:0040019),-0.3785422041691564,-1.062690234617305,0.40437158469945356,0.838954637824485,1.0,4/19,12.53%,NIBAN2;WNT4;OSR1;ZBED3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.41336348981179916,1.0626232571917245,0.38337801608579086,1.0,1.0,4/45,3.34%,CD36;MYD88;FZD5;LPL
prerank,regulation of AMPA receptor activity (GO:2000311),0.45360610191945827,1.0620180721322205,0.401854714064915,1.0,1.0,4/25,7.45%,MEF2C;SHISA9;CNIH2;GSG1L
prerank,endoderm development (GO:0007492),0.5078261703732712,1.0619215525692471,0.41455160744500846,1.0,1.0,2/13,6.91%,DUSP5;LAMC1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5065596381030886,1.0618570767061384,0.42357274401473294,1.0,1.0,5/13,14.85%,SLC8A2;SHISA9;RAB3A;PPFIA3;SHISA6
prerank,artery morphogenesis (GO:0048844),0.4409305965687087,1.0618112279060101,0.39355742296918766,1.0,1.0,7/30,10.07%,HEY2;TBX2;JAG1;BMPR1A;VEGFA;TGFB2;PDGFRB
prerank,hexose biosynthetic process (GO:0019319),0.41850354639192056,1.0616208073961986,0.3814713896457766,1.0,1.0,12/42,15.44%,ENO3;PFKFB1;MDH1;AKR1B1;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;CRTC2;SLC25A12;GAPDHS
prerank,histone H4-K16 acetylation (GO:0043984),0.47507044532593945,1.060894406003847,0.4170692431561997,1.0,1.0,8/19,15.24%,MCRS1;JADE1;MSL3;KAT7;KANSL3;JADE3;KANSL1;MSL1
prerank,regulation of cilium assembly (GO:1902017),-0.28740892636007015,-1.0608770786273287,0.3763440860215054,0.8428350345095752,1.0,31/62,26.17%,TBC1D16;LIMK2;TBC1D15;DCDC2;CEP97;ATG3;TBC1D2B;TBC1D13;TBC1D5;TBC1D8;IFT88;ATG5;TBC1D9B;RABEP2;TBC1D24;TBC1D30;TBC1D22A;SGSM3;DYNLT2B;ODF2L;TBC1D10A;TBC1D7;SDCCAG8;KCTD17;TBC1D14;CYLD;CCP110;CROCC;TBC1D2;CDKL1;BBS4
prerank,regulation of neurotransmitter transport (GO:0051588),0.4830738336282826,1.0606886876914445,0.40468227424749165,1.0,1.0,1/16,0.71%,MEF2C
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.43637107320764124,1.0606630727602178,0.37574850299401197,1.0,1.0,6/32,6.81%,PMAIP1;DYRK2;MYBBP1A;TP53;PHLDA3;RPS27L
prerank,leukotriene metabolic process (GO:0006691),0.4762133336920895,1.0605959311872923,0.40224358974358976,1.0,1.0,4/19,14.19%,ALOX5;MAPKAPK2;PTGR1;PLA2G4A
prerank,phosphorylation (GO:0016310),0.34545221876689197,1.0589683546985615,0.36879432624113473,1.0,1.0,90/385,17.24%,DGKB;DGKG;MAP3K20;STK38L;TNNI3K;PRKG1;MAP3K5;ROCK1;DYRK2;MERTK;LIMD1;PDGFB;CDK6;PDK4;FRK;FAM20A;CAMK2D;ACVR2A;CAMKK2;PEAK1;MARK1;BMPR1A;DYRK1A;MAP4K3;MAP4K5;TAF1;COQ8A;MAPKAPK2;DYRK1B;STK26;CHEK1;FGGY;TGFB2;NUAK1;WNK2;DAPK3;PRKACB;PRKAR1B;MAP2K1;CCNT1;BRSK1;PKN2;PAK2;DGKD;CDK7;STK24;CDK18;EIF2AK2;ROCK2;PRKCD;COPS8;HTR2B;ACVR1B;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;GAS6;CSNK1E;PDK2;DGKZ;SGK1;STK10;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;CSNK1A1;JAK2;STAT3;PLK4;HIPK2;STRADB;RYK;MAP3K13;EIF2AK3;NADK;CDK14;MARK2;POMK
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.36287917916895096,-1.0588823020071652,0.335423197492163,0.8471960656265035,1.0,8/23,19.37%,SLIT2;CAMK1D;MOSPD2;MCU;RIPOR2;DPP4;NCKAP1L;TIRAP
prerank,positive regulation of cell population proliferation (GO:0008284),0.34106338856007373,1.0579868906296763,0.3631790744466801,1.0,1.0,81/423,15.39%,NTF3;MEF2C;NTRK3;RBPMS2;LIFR;TBX2;FGF1;S1PR3;MST1R;PDGFB;CCN1;PDGFC;CDK6;CCND2;CDH13;CRLF1;ADRA1D;THPO;IL2;TGFB3;CCL5;GCNT2;PDGFD;IL12RB2;TSHR;FXN;BCL2;OSR2;BMPR1A;HAS2;IRS1;TNFRSF11A;TERT;TIPIN;VEGFA;GDNF;LAMC1;AR;AREG;GAREM1;YAP1;FZD9;SOX9;TGFB2;RELA;KMT2D;SAAL1;MVD;ADAM17;TRPM4;PDGFRB;RTKN2;HNRNPU;IL13RA1;CCL14;HBEGF;S100A6;PDGFA;GPER1;LRP5;HTR2B;CNOT7;CHRNA7;KIF20B;PDCD10;POU3F3;SHANK2;FGF10;CEP43;GAS6;S1PR2;HYAL1;UFL1;MLXIPL;IRS2;FBXO5;SRPK2;RHOG;PTEN;CIAO1;STAT1
prerank,regulation of inflammatory response (GO:0050727),0.35439089481840647,1.057919285794796,0.3833157338965153,1.0,1.0,30/190,11.29%,AGTR1;NR1H4;MYD88;RORA;ANXA1;IL2;LPL;FEM1A;CCL5;PTGIS;ALOX5;MFHAS1;SETD6;CD200R1;PIK3AP1;TNFAIP6;CD200;CELF1;RELA;TNIP1;LPCAT3;PPARA;NR1D1;MGLL;AKNA;AOAH;GPSM3;GPER1;RB1;PRKCD
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.33144712362596446,-1.057555566023473,0.3356401384083045,0.8497387325529456,1.0,13/30,28.11%,TUSC3;MGAT1;FUT8;UGGT2;OSTC;MGAT5;MCFD2;LMAN1;RPN2;MGAT2;DPM3;STT3B;ASGR1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4546420546350941,1.0573524841838977,0.40644171779141103,1.0,1.0,4/23,9.45%,CHMP4C;PABIR1;CHEK1;ZWINT
prerank,gluconeogenesis (GO:0006094),0.420118048535006,1.0572670735783265,0.3904494382022472,1.0,1.0,11/39,15.44%,ENO3;PFKFB1;MDH1;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;CRTC2;SLC25A12;GAPDHS
prerank,negative regulation of catabolic process (GO:0009895),0.4018486341672988,1.0571141032529778,0.3945666235446313,1.0,1.0,6/47,9.92%,FLNA;PFKFB1;PIN1;SF3B3;PPARA;SIRT2
prerank,regulation of feeding behavior (GO:0060259),-0.44465808026730375,-1.0571084961038095,0.42789598108747046,0.8496396639203669,1.0,1/11,0.87%,LEPR
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35525680761300715,1.0570163337275595,0.38075742067553736,1.0,1.0,24/234,8.37%,MYOCD;ABRA;CD36;MYD88;ROR1;CRTC1;ARID5B;FZD4;CRTC3;ARHGEF2;PRKCQ;MTDH;TNFRSF11A;CAV1;TAF1;SMARCB1;VEGFA;CD200;AR;PPARGC1A;PPARGC1B;NFKBIB;RELA;TRIM68
prerank,negative regulation of cell activation (GO:0050866),0.5018496292914981,1.0567875990773778,0.42016806722689076,1.0,1.0,7/14,10.85%,PDGFB;EMILIN1;CD200;C1QTNF1;NR1D1;PDGFA;GPER1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4373509297728923,1.0567345642521968,0.4153400868306802,1.0,1.0,13/32,20.77%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,tRNA export from nucleus (GO:0006409),0.4373509297728923,1.0567345642521968,0.4153400868306802,1.0,1.0,13/32,20.77%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.39047917050127084,-1.05655509891159,0.4014251781472684,0.8500389422930967,1.0,5/16,26.90%,LDLR;ABHD5;MFSD2A;DAGLB;PNPLA2
prerank,mitotic sister chromatid segregation (GO:0000070),0.37022571001082893,1.0563893587283333,0.37986270022883295,1.0,1.0,24/98,17.61%,TTN;CHMP4C;NUP62;SET;NCAPD3;CHMP5;PIBF1;DIS3L2;TENT4A;ZWINT;CENPE;WRAP73;RB1;NCAPD2;CHMP2B;CHMP2A;KIF18A;KNSTRN;TEX14;RAD21;INO80;DSN1;CENPK;VPS4A
prerank,phospholipid translocation (GO:0045332),-0.33500997243652986,-1.055722828312873,0.3824451410658307,0.8510585258207554,1.0,8/28,8.33%,PLSCR4;ATP8A1;ABCA1;PLSCR2;ABCA4;ATP11C;ATP8A2;TMEM30A
prerank,organelle assembly (GO:0070925),0.3466138729706247,1.0556530455835713,0.36016096579476864,1.0,1.0,89/385,18.91%,LMOD1;FLNA;DYNLL1;LMOD2;LMOD3;ATP2A2;CHMP4C;LIMD1;PLA2G3;KIF27;EHD2;CEP41;NUP62;HAUS8;KIF3B;ACTR3;CSDE1;CEP290;ATG16L2;ATG7;GABARAP;MAPRE2;ATXN2;IFT43;TUBGCP6;MAPT;IFT81;CHMP5;ABCA3;CIRBP;YTHDF2;PIBF1;AUP1;BBIP1;SYNPO;IQCB1;ANLN;PARVA;IST1;CENPE;EXOC6;NSFL1C;RPS23;RAB11FIP3;STX12;STAM2;FHDC1;WDR45;CHMP2B;TSG101;HPS4;STK36;VPS36;PIK3C3;CHMP2A;FOXJ1;TTC39C;G3BP1;HAUS7;HAUS2;MAPRE3;PLA2G4C;STAM;RAB8B;STX7;CCDC66;ATG13;CFAP43;RFX3;PLK4;PRRC2C;RAB8A;CENPW;INO80;RAB38;STARD9;DZIP1L;UBXN2B;VPS4A;GALNT11;BICD1;SH3PXD2B;DHX29;FARP2;RBM14;MRPL22;HAUS4;ULK1;HDAC6
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3814968241190458,1.0555528790159272,0.39382716049382716,1.0,1.0,11/75,12.68%,ATP2B4;CACNA2D1;KCNJ12;SLC8A2;SLC8A1;ATP1B1;TRPV2;TRPM4;SLC39A14;TRPM2;HCN2
prerank,cell cycle G2/M phase transition (GO:0044839),0.360353218814908,1.0555049668368965,0.38626126126126126,1.0,1.0,39/130,20.36%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;FBXL22;CEP41;HAUS8;CEP290;ENSA;PLCB1;PPP1CB;BRSK1;CDK7;CEP192;DYNC1I2;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;DNM2;PLK4;CDK14;DCTN1;MASTL;MNAT1;HAUS4;BRSK2;CEP135;CKAP5;ACTR1A;KDM8;SFI1
prerank,peptide metabolic process (GO:0006518),0.3795882277454779,1.0552468655294218,0.3923444976076555,1.0,1.0,12/75,12.12%,DMD;CLN5;ETHE1;LNPEP;APEH;GSTT1;ENPEP;NAT8;GSTP1;MIPEP;OPLAH;GSTA4
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4445371957109782,-1.0551182131581933,0.4105960264900662,0.8514061528472464,1.0,4/11,9.08%,RNF185;DERL1;UFD1;UGGT2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.35608968410630154,1.0550376453130699,0.39556962025316456,1.0,1.0,37/198,13.22%,ITPK1;PLCE1;LIMD1;PFKP;INPP4B;PPP3CA;PLA2G3;PLCB4;PIP4K2A;DUSP5;HK2;LPL;ACP3;PFKFB1;INPP5A;NUDT4;GFPT1;LHPP;COQ8A;DUSP3;PPM1A;CALM1;PLPPR1;PLCB1;PPP1CA;PAK2;INPPL1;PLCD1;ALDOA;INPP5B;PFKM;HTR2B;ITPKC;TPTE;DUSP16;PPP3CB;PLB1
prerank,regulation of leukocyte activation (GO:0002694),0.5088406658487069,1.054965829036855,0.41408934707903783,1.0,1.0,4/14,10.85%,MFHAS1;MYO18A;CD200;GPER1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.402170681954089,-1.054607420310152,0.382051282051282,0.851599172814021,1.0,2/15,2.55%,CPEB2;DDX3X
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3929043531950864,-1.0545528170848657,0.40601503759398494,0.8504324263542292,1.0,5/16,4.96%,ST8SIA4;ST3GAL5;ST6GALNAC3;ST8SIA1;B4GALT6
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.479204046123041,1.0545044261275731,0.4035656401944895,1.0,1.0,4/16,14.87%,ACP3;SLC39A14;GPER1;PRKCA
prerank,spliceosomal complex assembly (GO:0000245),-0.30621928043595065,-1.054116116349615,0.36231884057971014,0.8504143294033993,1.0,13/46,19.06%,CELF2;KHDC4;RBM5;SNRNP200;SRSF6;SRSF5;CELF4;SETX;CRNKL1;SNRPD1;SMN1;SRPK1;SCAF11
prerank,regulation of biomineral tissue development (GO:0070167),0.43912989643324696,1.0540581383476526,0.4243759177679883,1.0,1.0,7/26,16.47%,HEY2;ROCK1;SOX9;ROCK2;GAS6;FBXO5;ANKH
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5039743020670238,1.0538239559882092,0.41594454072790293,1.0,1.0,5/12,16.81%,CGAS;CAV1;MUL1;FLOT1;DHX9
prerank,fatty acid transport (GO:0015908),0.4801455984225146,1.0537408580187486,0.410958904109589,1.0,1.0,4/17,7.86%,CD36;FABP4;CPT1B;GOT2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3637497131573311,1.0530243600187494,0.4066666666666667,1.0,1.0,15/121,7.49%,NTF3;ANGPT1;ANGPT4;PDGFB;CRLF1;CSPG4;IL2;CCL5;ARHGEF2;DOK7;TP53;VEGFA;PTPN1;PIBF1;ITGB3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4902872474903047,1.0528344697625798,0.3935599284436494,1.0,1.0,2/14,3.06%,ANXA1;SOCS5
prerank,positive regulation of cellular process (GO:0048522),0.3418928668959394,1.0528050621136256,0.3533533533533533,1.0,1.0,114/565,17.55%,NTF3;TPM1;RYR2;NTRK3;AKAP6;LIFR;ACTN4;ZFHX3;TBX2;FGF1;MERTK;CD36;S1PR3;MST1R;PDGFB;PPP3CA;PDGFC;CCND2;CRLF1;ADRA1D;THPO;IL2;TGFB3;CCL5;GCNT2;PDGFD;PABIR1;IL12RB2;TSHR;FXN;BCL2;OSR2;HAS2;IRS1;TNFRSF11A;CAV1;MAPT;TPPP;TIPIN;VEGFA;ACACB;GDNF;PA2G4;AR;AREG;GAREM1;CHEK1;CELF1;SOX9;DICER1;TGFB2;RELA;KMT2D;ADNP2;CCND1;MVD;ADAM17;TRPM4;SIRT2;PDGFRB;RTKN2;IL13RA1;CCL14;HBEGF;PDGFA;GPER1;LRP5;PRKCD;HTR2B;CNOT7;BMPR1B;HDGFL2;CHRNA7;CITED2;KIF20B;PDCD10;POU3F3;NSMCE4A;SHANK2;ZFP36L1;FGF10;CEP43;GAS6;N6AMT1;S1PR2;HYAL1;PRKAA2;UFL1;PRKCA;MLXIPL;IRS2;FBXO5;SRPK2;RHOG;PTEN;CIAO1;FLOT1;NAMPT;TUB;ASH2L;MT3;INO80;DDX49;RPS6;MTLN;S100A8;S100A9;FGFR3;FAF1;EIF4G2;DNAJA2;ADRA2A;MAP1A;HDAC1
prerank,thymus development (GO:0048538),-0.4191947721144128,-1.052646241196242,0.38004750593824227,0.8536731189851269,1.0,6/13,27.21%,SIX1;HES1;TGFBR1;ZBTB1;FOXE1;EPHB3
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3500799276237765,-1.052267400694936,0.3835978835978836,0.8535709869339656,1.0,9/24,25.11%,NF1;EPHA7;NUPR1;CTNNB1;GRN;BAX;ATF4;FOXO3;CDK5R1
prerank,sensory perception of chemical stimulus (GO:0007606),0.4791591287044664,1.0521712607364135,0.4091680814940577,1.0,1.0,2/15,4.63%,CD36;SYT10
prerank,regulation of dendrite development (GO:0050773),-0.3107006671282533,-1.0521572504778371,0.3885135135135135,0.8525570882040575,1.0,9/37,10.01%,PTN;COBL;NEDD4L;BMP7;ADGRB3;CAMK1D;ZDHHC15;SEMA4D;ALK
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5225933495035109,1.0521177978982532,0.41544117647058826,1.0,1.0,4/10,15.39%,SOX9;PDGFA;LRP5;STAT1
prerank,response to retinoic acid (GO:0032526),-0.28836967729087515,-1.0518578568896053,0.358974358974359,0.8521400169716992,1.0,18/59,18.27%,PTK7;WNT5A;RBP4;EPHA3;ACER2;PTK2B;CTSH;WNT9A;SETX;ABL2;SNW1;CREB1;LYN;RARA;WNT6;TRIM16;ATM;RORB
prerank,cellular amino acid catabolic process (GO:0009063),0.375567878848514,1.0517675108808953,0.38686987104337633,1.0,1.0,15/87,11.00%,BCAT2;MCCC2;HSD17B10;CARNS1;HIBADH;BLMH;DLD;HGD;KMO;DLST;GOT1;GOT2;SARDH;GLS2;GLS
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.39376973808974,1.0517423900167753,0.4118404118404118,1.0,1.0,1/54,0.09%,CCDC3
prerank,epithelial cell differentiation (GO:0030855),0.3705926667098894,1.0517127412242868,0.4025670945157526,0.9998082508894266,1.0,9/88,8.76%,TAGLN;ANXA1;JAG1;TAGLN2;DMBT1;VEGFA;CNN3;CBR1;VDAC1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3127209804725205,-1.0516667505603303,0.39636363636363636,0.8513327319592296,1.0,6/41,10.17%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B2;KCNJ13
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.47221515429760064,1.0514933546865814,0.4003215434083601,0.9993983549884854,1.0,4/18,7.00%,CRTC1;CRTC3;VEGFA;CD200
prerank,endochondral bone morphogenesis (GO:0060350),0.5085823879932881,1.0514304786123374,0.40794223826714804,0.9985186559150281,1.0,3/11,12.20%,MEF2C;INPPL1;BMPR1B
prerank,lipid translocation (GO:0034204),-0.36325843054421514,-1.051214322122193,0.37771739130434784,0.8513408072053009,1.0,7/21,8.33%,ATP8A1;ABCA1;ABCA4;ATP11C;ATP8A2;RFT1;TMEM30A
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.45071145936600004,-1.051197246484704,0.4017467248908297,0.8487473918928604,1.0,4/10,41.33%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.45071145936600004,-1.051197246484704,0.4017467248908297,0.8487473918928604,1.0,4/10,41.33%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5318197572535442,1.051088792532647,0.4336917562724014,0.9984018293386221,1.0,4/10,12.85%,DGKD;GAP43;HTR2B;PRKD3
prerank,regulation of autophagosome maturation (GO:1901096),-0.4206537201306028,-1.0508162201781162,0.3944020356234097,0.8485721460743333,1.0,7/13,29.14%,IRGM;TBC1D25;CLN3;UVRAG;SMCR8;PHF23;ADRB2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.37615585358419,-1.050797465781279,0.3829787234042553,0.8473100235865484,1.0,8/19,24.97%,TPST1;BPNT2;SLC26A2;ENPP1;PAPSS1;PAPSS2;SLC35B3;BPNT1
prerank,regulation of neuron death (GO:1901214),0.38347111183656946,1.0507460595237608,0.40094899169632264,0.9983786097529581,1.0,17/82,14.97%,MEF2C;MAP3K5;TRIM2;CCL5;INPP5A;CD200R1;MAPT;CD200;PPARGC1A;FAIM2;CHRNA7;CLU;SARM1;EPHB1;LRRK2;SNCG;DHCR24
prerank,peptide cross-linking (GO:0018149),0.4581488381354186,1.050549730137235,0.4203338391502276,0.997896716252479,1.0,2/25,2.79%,FCGR3A;ANXA1
prerank,negative regulation of metabolic process (GO:0009892),0.39318040445502916,1.0505273975486213,0.3970976253298153,0.9969281039741651,1.0,7/54,9.23%,CCDC3;ADAMTS5;PLCL1;LNPEP;ADAM17;GSTP1;NR1D1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4167570502542162,1.0500008749631062,0.40109140518417463,0.9973908476996334,1.0,10/38,11.37%,NR1H4;RORA;CARD19;DAB2IP;PPM1A;TNIP1;OTUD7A;GSTP1;NR1D1;RHOH
prerank,chemical synaptic transmission (GO:0007268),0.3453906242466645,1.049995459717701,0.4,0.9963687882488875,1.0,44/284,12.69%,CACNB2;STXBP2;HCRTR1;APBA1;HTR1B;DTNA;GABRE;KCNMB1;GRIN2C;SLC6A2;SLC6A5;CACNB4;CAMKK2;SYT10;GABARAP;PCDHB14;STAC3;RPS6KA2;GABRA4;CALM1;RAB3A;GABRA5;MBP;PCDHB11;PRKACB;PRKAR1B;RAPSN;GRIK5;LIN7C;GABRB2;RIMBP2;BRSK1;GABRG1;HRH3;FCHSD2;CBLN2;KCNK3;CACNA1B;HTR2B;GABRB3;KIF5A;CHRNA7;CHRFAM7A;HOMER1
prerank,development of primary male sexual characteristics (GO:0046546),0.4208226034116163,1.0498263832331949,0.426027397260274,0.9958577945990051,1.0,5/34,7.87%,LHCGR;CSDE1;AR;SOX9;TGFB2
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.2434655246081473,-1.0498035848473788,0.35294117647058826,0.8490153756421472,1.0,31/132,14.50%,IGF1;ZBTB20;DAPK1;DCN;HMGB1;APOE;APP;NRDC;ITCH;TPCN1;FOXO1;ABHD5;PRR5L;PIK3CB;TFEB;FURIN;OPTN;RDX;STK11;ENTPD5;TRIM5;IRGM;GTPBP1;PTTG1IP;TRIM14;DTX3L;PFKFB2;ARNT;SNCA;INSR;TMEM59
prerank,regulation of intracellular signal transduction (GO:1902531),0.3421179181966706,1.049546620186282,0.3853118712273642,0.9955741394942956,1.0,84/420,14.62%,OBSCN;ARHGEF7;NTRK3;AKAP6;DLC1;FGF1;KALRN;PRKAB2;DYRK2;LBH;ABR;PIP5K1B;ARHGEF17;PIP4K2A;FAM83D;MYO9B;DEPDC1B;ITSN1;BRIP1;NET1;PRDM1;ARHGAP21;ARHGAP10;ARHGEF16;USP2;CHN1;ARHGAP6;ARHGEF2;ARHGDIG;TAF1;MAPT;CASTOR1;DAB2IP;TP53;RRAS;VEGFA;PIN1;RHOJ;TPX2;TRAF3;CHEK1;RAD9A;ANKRD54;RELA;PEX5L;NUAK1;ARHGAP17;RHOF;ARHGAP39;GNA12;ARHGAP30;PRKAR1B;ARHGEF4;PAK2;ARHGAP1;RRAGB;RPL5;ARHGAP12;TRAF5;PRR5;RHNO1;VAV1;INPP5B;ARHGAP15;ARHGAP5;RHOH;ZFAND6;ARHGAP35;RICTOR;TNIK;BCR;ARHGAP32;TPTE;RMI2;TAOK3;CHD4;SGK1;TMSB4X;MAPK1;LRRK2;PRKAA2;CASTOR2;ARHGAP24;UFL1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.27183378558396254,-1.0485773950330843,0.3392857142857143,0.8513181551230827,1.0,27/72,25.44%,CARM1;TFDP1;ACER2;PML;ARID3A;MDM2;SP100;RGCC;SOX4;NBN;EP300;MYO6;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;USP10;BCL3;PCBP4;PLAGL1;CDKN1A;SESN2;TFAP4;CNOT10
prerank,inorganic anion transmembrane transport (GO:0098661),0.3940234740780671,1.0484897910119462,0.3934010152284264,0.9974531978334641,1.0,11/63,9.83%,ANO1;GABRE;ANO6;SLC4A8;SLC20A2;GABRA4;GABRA5;GABRB2;XPR1;GABRG1;ANO3
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3953803531887255,1.0484156472347004,0.41060419235511714,0.9966365392128782,1.0,6/62,5.51%,MYL9;MEF2C;CDK6;CBFB;CNOT4;PRKCQ
prerank,stress granule assembly (GO:0034063),0.4699729679237214,1.048412190874152,0.41930379746835444,0.9956214633855218,1.0,9/20,17.74%,CSDE1;ATXN2;MAPT;CIRBP;YTHDF2;RPS23;G3BP1;PRRC2C;BICD1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5099321525965094,1.0483483848421025,0.4102079395085066,0.9947725396764561,1.0,3/10,8.98%,ACAD11;ETFA;ACADS
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.4488795183056331,-1.0482337447548695,0.45021645021645024,0.8509828296002877,1.0,3/10,19.37%,LBP;PTPN22;TIRAP
prerank,regulation of protein autophosphorylation (GO:0031952),0.42114264004875773,1.048189956376484,0.40660919540229884,0.9941994609679337,1.0,10/36,10.75%,PDGFB;PDGFC;PDGFD;RAP2C;VEGFA;PPP2R5A;CALM1;IMPACT;RAP2A;PDGFA
prerank,regulation of small molecule metabolic process (GO:0062012),0.4301969203417603,1.048054261826935,0.4149560117302053,0.9935202898614058,1.0,3/28,2.57%,NR1H4;PDK4;RORA
prerank,negative regulation of protein polymerization (GO:0032272),-0.349312546193016,-1.0476946544649186,0.3958333333333333,0.8512024409404159,1.0,10/27,14.14%,CDH5;SLIT2;KANK3;CYRIB;EML2;SSH2;PFN2;PFN1;SSH1;SNCA
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3693299753553947,-1.0473023010216878,0.36795252225519287,0.8510881017548648,1.0,7/20,18.66%,APOE;NLGN1;SHANK3;CAMK1;LRP8;DBN1;FMR1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.43009242068306586,-1.0467446551196893,0.40825688073394495,0.8513860271282884,1.0,3/12,5.65%,NOTCH2;DOCK11;PTK2B
prerank,positive regulation of hemostasis (GO:1900048),-0.4458097205963698,-1.0462932467319448,0.44419642857142855,0.8500370330421027,1.0,3/10,19.33%,ST3GAL4;SERPINE1;ENPP4
prerank,positive regulation of coagulation (GO:0050820),-0.4458097205963698,-1.0462932467319448,0.44419642857142855,0.8500370330421027,1.0,3/10,19.33%,ST3GAL4;SERPINE1;ENPP4
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3648330310455953,-1.0458392203893219,0.37960339943342775,0.8499788767538808,1.0,6/22,16.40%,ZBTB20;APOE;CREBL2;CREB1;AKT1;PPARG
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5012449762037003,1.045698449527694,0.4381443298969072,0.9989402424976083,1.0,2/12,3.64%,DOCK8;CCL5
prerank,monocyte chemotaxis (GO:0002548),0.4330330909795684,1.0454129870129034,0.4253521126760563,0.9986867421549646,1.0,5/32,10.44%,PDGFB;ANXA1;CCL5;TNFRSF11A;CCL14
prerank,aerobic electron transport chain (GO:0019646),0.3871651620976589,1.0454027214154318,0.4099756690997567,0.9976908107832432,1.0,24/68,18.71%,NDUFS1;COX7A2L;NDUFA11;NDUFA2;SDHC;SDHAF2;COX8A;NDUFC1;NDUFB6;NDUFS3;COX7B;NDUFV2;NDUFB8;NDUFS2;SDHA;NDUFAB1;NDUFA1;UQCRFS1;NDUFAF1;COX6C;UQCRH;COX5B;NDUFV3;UQCRQ
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.45653418473562013,1.0448790032498179,0.43057722308892354,0.9981466236546828,1.0,3/22,6.82%,ROCK1;PACSIN3;TIMP4
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.41662502994775863,1.0447951745187884,0.39295392953929537,0.9973601681148268,1.0,13/38,18.24%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFA1;NDUFAF1;NDUFV3
prerank,hemopoiesis (GO:0030097),-0.26532648307439777,-1.0447798214529214,0.34375,0.8517212510803372,1.0,17/87,11.02%,TGFBR3;FLT1;MECOM;NOTCH2;BMP4;KIT;TEK;RUNX2;MFAP5;WNT5A;PGM3;CD34;TET2;FUT10;TGFB1;FGFR2;FLT3LG
prerank,negative regulation of binding (GO:0051100),0.3735389497767141,1.0442796435656894,0.3931924882629108,0.9977246740858126,1.0,15/81,14.52%,PLN;XIRP1;ROCK1;PDGFB;ACTB;CAV1;PIN1;PPP1CA;PSME3IP1;PEX19;PRKCD;BAG2;CSNK1E;LRRK2;DVL1
prerank,positive regulation of MAPK cascade (GO:0043410),0.34648386291236566,1.0442766788145619,0.42535787321063395,0.9967235076226303,1.0,34/245,10.88%,RAP1A;NTRK3;ANGPT1;ROCK1;FGF1;CD36;MST1R;PDGFB;PDGFC;FERMT2;ROR1;ADRA1D;THPO;BCAR3;CCL5;GCNT2;PDGFD;MFHAS1;KSR1;DAB2IP;ARL6IP5;VEGFA;FBXW7;GAREM1;RASGRP1;TGFB2;MAP2K1;PDGFRB;CCL14;PELI2;EIF2AK2;PDGFA;GPER1;ROCK2
prerank,regulation of glucose metabolic process (GO:0010906),0.4261129465724751,1.0438501373547804,0.41168289290681503,0.9968853952236374,1.0,4/34,5.88%,PMAIP1;PDK4;RORA;IRS1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3664945010087806,-1.0438496300566265,0.3795811518324607,0.8531031045361753,1.0,7/22,13.51%,SLIT2;KANK3;CYRIB;SSH2;PFN2;PFN1;SSH1
prerank,receptor clustering (GO:0043113),0.4448896084961282,1.0435678395108368,0.40702781844802344,0.9966590990152188,1.0,5/27,10.07%,FLNA;MUSK;SAV1;ITGA4;AGRN
prerank,activation of phospholipase C activity (GO:0007202),0.43661120470119663,1.0435355043579568,0.41134751773049644,0.9957458933303237,1.0,2/29,4.86%,EDNRA;ARHGAP6
prerank,sensory perception of light stimulus (GO:0050953),-0.2670361268198396,-1.0432483760373679,0.3625,0.8535610431449473,1.0,12/87,9.55%,PITPNA;COL1A1;EYA4;EFEMP1;ABLIM1;ADGRV1;COL11A1;SLC4A10;ZIC2;EML2;WHRN;MYO9A
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5107629188636069,1.042419604746732,0.43523316062176165,0.9977412655161193,1.0,8/12,20.20%,CDYL;LRIF1;HNRNPU;PCGF5;PCGF3;RBM15;RLIM;YTHDC1
prerank,positive regulation of DNA binding (GO:0043388),-0.32837604241959145,-1.042361797646461,0.3754152823920266,0.854914585827829,1.0,12/31,27.55%,IGF1;NIBAN2;HMGB1;PRKN;TGFB1;HES1;PPARG;PARK7;NME1;TWIST1;HMGB2;EGF
prerank,positive regulation of axon extension (GO:0045773),0.4599288821794981,1.0418978413610787,0.42989214175654855,0.9981821748697552,1.0,5/22,6.51%,SEMA5A;NTN1;MAPT;DSCAM;VEGFA
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2607462736787512,-1.0412329220306478,0.3567251461988304,0.8570743815394117,1.0,24/87,22.00%,NF1;FBLN1;SEMA6A;BMP7;DLG1;BMP4;APOE;SPRED2;FOXO1;STK38;PIK3CB;IRAK3;LYN;SPRY2;SIRPA;IGBP1;DUSP1;LMO3;SMAD4;ITGB1BP1;QARS1;PTPN2;PEBP1;EPHB2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4392629938948709,-1.0409849426467277,0.44844124700239807,0.8565111012729835,1.0,6/11,14.78%,SEMA6A;EPN1;PIK3CB;ADAMTS9;KLF2;CREB3L1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.42628495297434377,-1.0409596014835774,0.41531322505800466,0.8552833527388024,1.0,3/12,5.56%,CYP26B1;PTCH1;MEGF8
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3859069791680628,-1.040310093424957,0.4044665012406948,0.8558690273825882,1.0,4/17,11.40%,PTN;PTPRZ1;TGFB1;HES1
prerank,metal ion export (GO:0070839),0.4339257420133732,1.0402890207126776,0.4387186629526462,1.0,1.0,5/31,7.76%,ATP2B4;KCNA5;KCNE4;ATP1B1;KCNT2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4885726237737449,1.0402446212848262,0.43042071197411,1.0,1.0,4/13,15.40%,SOCS5;SOCS4;TSG101;CBLB
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4689530907429533,1.0400981897284312,0.44684129429892144,0.9990935467094555,1.0,5/19,13.04%,POLR2L;POLR2I;POLR2G;TERF2;POLR2J
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4689530907429533,1.0400981897284312,0.44684129429892144,0.9990935467094555,1.0,5/19,13.04%,POLR2L;POLR2I;POLR2G;TERF2;POLR2J
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4999128642756624,1.0400908865552816,0.4355400696864111,0.9981038759775755,1.0,4/11,16.03%,IL12RB2;STAT1;JAK2;STAT3
prerank,anterograde trans-synaptic signaling (GO:0098916),0.34444860609139943,1.0400109102817603,0.41243523316062175,0.9973111399976192,1.0,34/224,12.69%,CACNB2;HCRTR1;APBA1;HTR1B;DTNA;GABRE;KCNMB1;SLC6A2;SLC6A5;CACNB4;CAMKK2;SYT10;GABARAP;PCDHB14;RPS6KA2;GABRA4;CALM1;GABRA5;MBP;PCDHB11;PRKACB;PRKAR1B;RAPSN;GABRB2;GABRG1;HRH3;KCNK3;CACNA1B;HTR2B;GABRB3;KIF5A;CHRNA7;CHRFAM7A;HOMER1
prerank,negative regulation of cell growth (GO:0030308),0.3622766809072235,1.0397347766964213,0.41202672605790647,0.9970451610617312,1.0,23/121,14.70%,SLIT3;FGF13;MYL2;RERG;FHL1;JADE1;PTPRS;NDRG3;TP53;BTG1;TGFB2;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6;MUL1;HYAL1;VGLL4
prerank,regulation of mitochondrial fusion (GO:0010635),-0.4431924562108158,-1.039244394791952,0.43544857768052514,0.8577000213803859,1.0,2/11,10.06%,PID1;PRKN
prerank,histone H3-K4 methylation (GO:0051568),-0.34298173417147837,-1.03910095508911,0.38613861386138615,0.8568411034449037,1.0,13/26,30.90%,TET3;CTR9;TET2;OGT;KMT2C;DPY30;SETD1A;KDM6A;PRDM9;CXXC1;KMT2A;RBBP5;BEND3
prerank,neural crest cell development (GO:0014032),-0.2995234163620249,-1.038576999286084,0.41975308641975306,0.8571171503412597,1.0,9/44,7.78%,SEMA3D;SEMA3C;SEMA6A;KLHL12;RADIL;ANXA6;SEMA7A;SEMA3A;SEMA4D
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3251417310458979,-1.03848693660993,0.35789473684210527,0.8561350552573964,1.0,3/33,1.02%,IGF1;NF1;PIK3CA
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.36488868092156446,-1.0383877116257978,0.3803191489361702,0.8551400846379548,1.0,13/21,42.48%,EPHA7;BIRC2;DELE1;BIRC3;TTBK1;PSMB9;PYCARD;NGF;GRIN1;AIM2;FYN;BEX3;GRIN2B
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4557084546995709,1.0381644751981256,0.43457943925233644,1.0,1.0,3/19,4.05%,PLCE1;PPP3CA;INPP5A
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3781510169796047,-1.0380487404589833,0.41818181818181815,0.8548634024913553,1.0,7/18,17.30%,APOE;ADAM10;APH1A;NCSTN;CLN3;APH1B;PSEN2
prerank,transcription by RNA polymerase I (GO:0006360),0.4246415538744005,1.0373006069490003,0.4200278164116829,1.0,1.0,7/34,11.78%,CAVIN1;POLR2L;GTF2H4;TAF1;CDK7;POLR1E;POLR1H
prerank,macrophage activation involved in immune response (GO:0002281),0.49561511301184674,1.0367495463890855,0.4300341296928328,1.0,1.0,2/13,2.43%,FER1L5;DYSF
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5079460987381147,1.0365578743360928,0.43672014260249553,1.0,1.0,2/10,5.71%,SET;KLF15
prerank,COPII vesicle coating (GO:0048208),-0.2850332338456061,-1.0365167586861739,0.39408866995073893,0.8555638076104685,1.0,18/61,19.22%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,vesicle coating (GO:0006901),-0.2850332338456061,-1.0365167586861739,0.39408866995073893,0.8555638076104685,1.0,18/61,19.22%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2850332338456061,-1.0365167586861739,0.39408866995073893,0.8555638076104685,1.0,18/61,19.22%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,protein destabilization (GO:0031648),-0.32091511842934894,-1.0364797760294717,0.3881578947368421,0.8543975247669978,1.0,9/32,14.30%,CUL3;CTSH;DERL1;MDM2;PRKN;IRGM;EP300;SNCA;SOX17
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3760736943014509,-1.0362295351619026,0.40568475452196384,0.8538873015073017,1.0,7/17,34.97%,PDE3B;ALK;AKT1;PRKAA1;MFSD2A;BSCL2;GPLD1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.22847139792458965,-1.0356757089350965,0.35714285714285715,0.8541883690300758,1.0,83/314,19.49%,ECPAS;NEDD4L;ARRB1;FBXL7;FBXL5;ATXN3;AREL1;ITCH;CUL3;SEL1L;RNF185;ANAPC1;UBXN4;UBQLN1;UBE2D3;DNAJB12;PML;DERL1;UFD1;UBR2;HSPA5;DNAJC10;CTNNB1;USP19;BIRC2;PCBP2;FBXO9;PSMD7;PSMD9;PSMD13;LTN1;MDM2;PELI1;FBXO4;TOPORS;CDC23;RBCK1;TRIM25;WWP1;ARMC8;SMURF2;PRKN;KCTD2;RMND5B;DDB1;SGTA;UBE4B;PSMB3;UBC;KLHL22;RNF34;STUB1;RMND5A;SKP2;DNAJB2;HSP90B1;PSMC5;SGTB;SIAH1;NEMF;PSMA5;OS9;PSMA1;BUB3;PSMC2;HECW1;CDC26;NHLRC3;UBXN1;UBQLN2;AMN1;UBE2S;ANAPC4;SIAH2;SYVN1;UBXN8;FBXW5;DNAJB9;HERPUD1;SPOPL;SPSB4;BTRC;FBXO31
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.382100528698075,1.0355250055643135,0.4218181818181818,1.0,1.0,24/69,18.71%,NDUFS1;COX7A2L;NDUFA11;NDUFA2;SDHC;SDHAF2;COX8A;NDUFC1;NDUFB6;NDUFS3;COX7B;NDUFV2;NDUFB8;NDUFS2;SDHA;NDUFAB1;NDUFA1;UQCRFS1;NDUFAF1;COX6C;UQCRH;COX5B;NDUFV3;UQCRQ
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5180953919402416,1.0352389339209624,0.4270650263620387,1.0,1.0,3/10,15.17%,SETD6;SETD3;EEF1AKMT2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4970810387478899,1.034891583520415,0.4239316239316239,1.0,1.0,4/13,11.96%,LARGE1;CHST5;CHST3;CHST1
prerank,bicarbonate transport (GO:0015701),0.4483576418798306,1.034733512499387,0.438953488372093,1.0,1.0,4/25,8.08%,CA3;SLC4A8;SLC4A3;SLC4A7
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4718793852814511,1.034706993254016,0.4336134453781513,1.0,1.0,5/14,18.41%,NMNAT2;AK7;NMNAT1;CMPK1;CMPK2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4264822951177467,-1.0345798654333014,0.4579646017699115,0.8561282932416953,1.0,5/11,12.04%,LGALS9;CD34;ATP6AP2;PTGS2;CD46
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.2873158570320499,-1.0338612557763447,0.4069264069264069,0.8569397697836789,1.0,19/54,25.44%,CARM1;TFDP1;PML;ARID3A;MDM2;RGCC;SOX4;EP300;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;PCBP4;PLAGL1;CDKN1A;CNOT10
prerank,negative regulation of receptor internalization (GO:0002091),-0.42454959572612855,-1.033507925777066,0.4469026548672566,0.8567211942364278,1.0,4/12,16.12%,RIN3;ANKRD13A;SDCBP;UBQLN2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.4369064886810978,-1.0332784037957394,0.41284403669724773,0.856093831379582,1.0,6/10,30.64%,PTPN22;PDCD4;AIDA;HIPK3;MAPK8IP1;DUSP19
prerank,response to progesterone (GO:0032570),0.4666832672971054,1.0331589242922237,0.4416403785488959,1.0,1.0,4/18,7.87%,TGFB3;CAV1;YAP1;TGFB2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.43603762548008485,1.0328025602823743,0.4277198211624441,1.0,1.0,4/27,8.83%,WTIP;LIMD1;TP53;MAP2K1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3210771657683009,-1.0327845363500976,0.43288590604026844,0.8563221886185651,1.0,11/31,18.88%,ATXN3;DNAJB12;HSPA5;OPTN;PRKN;STUB1;ERN1;HSPA13;BAX;HSPA9;HSF1
prerank,positive regulation of defense response (GO:0031349),0.3646043842330918,1.032456503633672,0.42123687281213534,1.0,1.0,6/89,3.64%,AGTR1;MEF2C;IL2;LPL;FEM1A;CCL5
prerank,positive regulation of biosynthetic process (GO:0009891),0.4061755604275891,1.032294139870948,0.4109396914446003,1.0,1.0,12/40,14.90%,CD36;VIM;SLC5A3;TGFB3;CCL5;SORBS1;PPARA;SUCO;RUNX1;SIRT4;ADGRB1;MLXIPL
prerank,cellular response to retinoic acid (GO:0071300),-0.29996391209386236,-1.0319538027701782,0.3836734693877551,0.8574731350588974,1.0,13/42,18.27%,PTK7;WNT5A;EPHA3;PTK2B;WNT9A;SETX;ABL2;SNW1;CREB1;LYN;WNT6;ATM;RORB
prerank,potassium ion homeostasis (GO:0055075),0.4420300416427453,1.0319363052030863,0.4362519201228879,1.0,1.0,2/23,5.83%,KCNMA1;ATP1B1
prerank,tRNA transport (GO:0051031),0.41921645293486653,1.0313852258773777,0.44600280504908835,1.0,1.0,13/35,20.77%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.482326377344782,1.0313403499021907,0.4271523178807947,1.0,1.0,4/15,11.96%,LARGE1;CHST5;CHST3;CHST1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.32333391691846325,-1.0312801453606408,0.4025974025974026,0.8581391267697377,1.0,19/31,40.29%,PEX14;PEX5;TIMM44;DNAJC19;AIFM1;TIMM17B;HSPD1;TOMM70;TIMM21;TIMM23;GRPEL1;PEX6;PEX16;DNLZ;TOMM40L;TOMM40;TIMM50;PEX12;GRPEL2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.45757032284948224,1.031156775415782,0.4473684210526316,1.0,1.0,2/21,6.32%,ATP2A1;AFG3L2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.49351434346597545,1.0308055041119766,0.43137254901960786,1.0,1.0,3/12,13.13%,ANO1;TRPM4;PPP3CB
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4146556327517109,1.0302696066229327,0.41632088520055327,1.0,1.0,14/37,18.02%,PMAIP1;NACC2;BCL2;CAV1;TP53;SFPQ;EIF5A;DNM1L;BOK;S100A8;S100A9;BCAP31;DDIT3;BBC3
prerank,regulation of bone mineralization (GO:0030500),0.38459475150551037,1.0301356224739737,0.42428198433420367,1.0,1.0,12/55,8.74%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1;TRPM4
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.41381363111102387,-1.0299556644674868,0.43478260869565216,0.8606322849099645,1.0,9/13,30.45%,SART3;PRPF19;LSM2;AAR2;PRPF31;PRPF8;SRSF12;PRPF3;DDX20
prerank,response to interferon-alpha (GO:0035455),-0.39791329723185487,-1.0298998946728317,0.4201474201474201,0.8595321775947342,1.0,10/16,30.00%,IFNAR2;IFNAR1;ADAR;BST2;IFITM1;IFITM3;RO60;IFITM2;PDE12;KLHL20
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.42882299882621616,-1.0289819585034787,0.4377880184331797,0.8608687019742688,1.0,4/13,9.74%,GLUL;ALDH4A1;NOS3;DDAH1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.30955172244083745,-1.0289737763997056,0.397212543554007,0.8596380653192419,1.0,7/35,9.60%,VTN;B2M;HNRNPK;AAK1;BMP2K;PIK3CB;PPT1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3380323495356224,1.028955167734878,0.435793731041456,1.0,1.0,58/348,14.05%,NTF3;RBPMS;RAP1A;NTRK3;ATP2B4;ANGPT1;FGF1;ANGPT4;PDGFB;CCN1;PDGFC;CCND2;CSPG4;THPO;FAM20A;BCAR3;TGFB3;MMD;PDGFD;ACVR2A;MUSK;CAMKK2;ARHGEF2;BMPR1A;RARRES2;CAV1;RAP2C;TP53;VEGFA;PIN1;CALM1;LCP2;RASGRP1;ITGB3;SOX9;TGFB2;CCND1;ADAM17;PAK2;GDF1;RAP2A;CENPE;PELI2;PDGFA;GPER1;ROCK2;CLIP3;TNIK;AKTIP;CHRNA7;SNX9;PDCD10;FNIP2;FGF10;GAS6;MAP2K3;S1PR2;MAPK1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.31006533974152795,-1.0285084934387758,0.40310077519379844,0.859689925232776,1.0,13/37,19.55%,GRM3;APP;GRM7;PTK2B;HOMER3;GRIN3A;DAGLA;GRIK3;GRM5;CLN3;GRID2;FMR1;GRIK1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3503535071251779,1.028496609289319,0.4336842105263158,1.0,1.0,35/172,15.73%,DGKB;DGKG;PIP5K1B;INPP4B;PIP4K2A;MTMR7;SLC44A5;PITPNM3;STARD7;SYNJ2;SACM1L;SLC44A1;LPCAT3;AGPAT3;INPPL1;DGKD;MTMR14;PCYT2;TAMM41;GPD1L;CDIPT;SBF1;CPNE3;PNPLA3;PIK3C3;DGKZ;RAB14;PLA2G4A;CHKB;PLEKHA1;PLA2G4C;INPP5J;PITPNM2;PTEN;VAC14
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.40200997305378683,-1.0284039428078187,0.43107769423558895,0.8587271333003297,1.0,10/14,28.87%,ADK;GMPS;ADSS2;PFAS;GART;ATIC;RFK;IMPDH1;IMPDH2;PAICS
prerank,NAD biosynthetic process (GO:0009435),0.4446016365624513,1.0283330874327894,0.4391025641025641,1.0,1.0,6/20,15.72%,NMNAT2;PTGIS;NAXE;NMNAT1;NNMT;NAMPT
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4734194502043016,1.0282492116295325,0.45394736842105265,1.0,1.0,8/17,18.02%,BCL2;FZD9;DNM1L;GGCT;BOK;CLU;MFF;BBC3
prerank,mitotic spindle organization (GO:0007052),0.34849505999221025,1.0282345152445564,0.44228694714131606,1.0,1.0,29/153,14.16%,FLNA;DYNLL1;CLASP2;KIF2A;CENPP;TOGARAM2;KIF3B;DCTN6;EFHC1;EML1;TPX2;PIBF1;TOGARAM1;SUN2;CENPO;SEC13;ZWINT;CEP192;CENPE;WRAP73;NUP107;AAAS;DYNC1I2;ITGB3BP;CLASP1;MAP4;NUP98;KIF18A;NUP37
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.436554418121264,1.0278928169050043,0.4258160237388724,1.0,1.0,12/26,20.46%,SOCS5;SOCS4;FBXW7;AREG;ADAM17;HBEGF;TSG101;NCK2;CBLB;ADRA2A;SHC1;ERRFI1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3369161760832649,1.0276899726894586,0.4174174174174174,1.0,1.0,46/476,9.80%,ACTA2;MYOCD;PRDM16;TNNI2;MEF2C;HEY2;MAP3K5;ZFHX3;SMARCD3;LBH;NR1H4;PDGFB;RORA;ETS2;FZD4;HINFP;TGFB3;NUP62;ARID1A;NR2F2;TGFB1I1;CAMKK2;OSR2;CEP290;DYRK1A;TESC;TP53;DYRK1B;PPM1A;AR;PPARGC1A;MED1;YAP1;MED12;SOX9;RELA;PLCB1;SETD3;ZXDC;PPARA;MAP2K1;NSD3;NR1D1;HIF1A;CRLF3;SFR1
prerank,regulation of anoikis (GO:2000209),0.45331528425349654,1.0275406841904033,0.45339652448657186,1.0,1.0,6/19,7.72%,PDK4;ITGB1;BCL2;MYBBP1A;CAV1;SNAI2
prerank,mitochondrial gene expression (GO:0140053),0.39803270808094204,1.027322164776189,0.42016806722689076,1.0,1.0,17/42,20.51%,FASTKD5;GATB;IARS2;MRPS28;MRPL51;MRPL23;GFM2;MRPL16;TFB2M;MRPL47;LARS2;FASTKD2;MRPS21;TEFM;GATC;MRPS14;SLC25A33
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3851826517850501,-1.0270876671610014,0.44819277108433736,0.8613714880052324,1.0,4/15,17.23%,BMP4;PRKCH;SFRP4;TRIM16
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.47658529023627316,1.0270273489068293,0.47191011235955055,1.0,1.0,6/17,12.48%,ROCK1;RTN2;PIN1;RTN1;CHRNA7;CLU
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.49555929695616485,1.0268018986100684,0.4496527777777778,1.0,1.0,2/12,4.48%,CCDC68;BICD2
prerank,protein complex oligomerization (GO:0051259),-0.2632429951388721,-1.0267143531278562,0.41875,0.8611605030852625,1.0,28/85,24.42%,SPAST;PKD2;RNF135;MCU;LETM1;WDCP;JMJD6;RNF213;UGDH;KCNC2;BLM;GSDMD;UPB1;TMEM120A;SNCA;STOML2;EHD1;G3BP2;YME1L1;PNPT1;ZC3H12A;EHD3;LRRC8D;CLDN1;RBMX;CPSF6;ALS2;ZBTB1
prerank,cellular protein modification process (GO:0006464),0.33117663056208324,1.0261965613897939,0.423,1.0,1.0,181/983,14.88%,ART1;PPP1R12A;MAP3K20;IGFBP7;MFGE8;LTBP1;SPARCL1;STK38L;SDC2;TNNI3K;PRKG1;MAP3K5;ASB15;PPM1L;ROCK1;HRC;DYRK2;MERTK;PPM1J;ASB10;FCGR3A;KCTD7;PDGFB;PPP3CA;CCN1;ASB18;CDK6;LARGE1;FBXL22;FBXO40;PDK4;ANXA1;FRK;MTMR7;LOXL2;FAM20A;DUSP5;SOCS5;CAMK2D;PPP2R1B;IGFBP5;FEM1C;FEM1A;PPM1E;GCNT2;ACVR2A;SIRT3;MCRS1;LMO7;ASB2;CAMKK2;PTPN18;ASB1;PEAK1;MARK1;SEPHS1;CUL2;PTPRS;SOCS6;RNF7;BMPR1A;LHPP;NUCB1;DYRK1A;ATG7;PHKA2;MAP4K3;CHST5;MAP4K5;SDHAF2;ASB8;PTPRF;TAF1;PSMC6;ELOC;COQ8A;MAPKAPK2;DYRK1B;FBXW7;FBXO30;PPP2R5A;FBXL18;PPM1A;PARP1;ART4;KTN1;PTPN1;IGFBP4;LAMC1;LAMB2;RAB3A;STK26;UBE2F;CUL9;CHEK1;TGFB2;NUAK1;DCUN1D1;SETD3;WNK2;DAPK3;PRKACB;DDOST;CDH2;PRKAR1B;MAP2K1;UBE2E1;CCNT1;PPP1CB;PPP1CA;BRSK1;PKN2;PAK2;CDK7;HIF1A;PSME4;SIRT2;STK24;FBXO6;CTDSP2;SUMF1;CDK18;PSMB1;MBTPS1;PSMD5;EIF2AK2;ROCK2;PHEX;FBXO32;ST8SIA5;PRKCD;COPS8;ACVR1B;DUSP29;WDR45;FBXW11;CDK12;UBA3;MAN2A2;DMPK;BMPR1B;TNIK;WSB1;BCR;PSMB2;SBF1;COL3A1;DCAF11;CDC42BPB;CTDSP1;STK36;MACROD1;TPTE;DUSP16;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;ST3GAL2;PRSS23;PIK3C3;GAS6;CSNK1E;DNAJC3;PDK2;SIRT4;SGK1;STK10;MAPK1;LRRK2;PRKAA2;UFL1;PIGH;PSMB7;FEM1B;PSMD3;TNC;KCTD6;PRKCA;PRKACA
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.4400935316138173,-1.0261134881848468,0.46543778801843316,0.8616156145707531,1.0,4/10,35.47%,LGALS9;CD274;SCRIB;PRKAR1A
prerank,regulation of protein localization to centrosome (GO:1904779),0.5027737843466853,1.0259638181857764,0.45985401459854014,1.0,1.0,5/10,17.74%,NUP62;NSFL1C;CEP72;UBXN2B;BICD1
prerank,establishment of protein localization to organelle (GO:0072594),0.3687728832606986,1.0257205712334805,0.4311594202898551,1.0,1.0,20/72,16.03%,RYR2;HK2;NUP62;RANBP17;IL10RA;SPRN;NEURL1B;SEC13;NUP153;PPP1R10;NUP107;PEX19;RANBP6;TNPO3;FAM53B;IPO4;TSPAN17;IPO7;FAM53C;STAT3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.48581664081177056,1.0250298631370343,0.45068027210884354,1.0,1.0,3/13,5.14%,RBPMS;TGFB3;BMPR1A
prerank,negative regulation of wound healing (GO:0061045),0.4181896445321564,1.0249677160595103,0.437410071942446,1.0,1.0,5/28,6.77%,PHLDB2;CLASP2;SERPINE2;ALOX5;AJAP1
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.24867281877598063,-1.024781173401884,0.4132231404958678,0.8640087614947413,1.0,47/108,28.22%,TLE1;LRP1;SULF1;NXN;APP;PTK7;APCDD1;WWOX;PPP2CA;DCDC2;CTNNB1;WLS;ATP6AP2;KREMEN1;ESR1;SALL1;PRKN;SFRP4;RSPO2;FGFR2;CCNY;NOTUM;TMEM237;EMD;RNF43;FOXL1;SNX3;DISC1;CTNND2;DACT3;BTRC;MDFI;GPC3;DACT1;RSPO3;NFATC1;AXIN1;CBY1;SULF2;CSNK2A1;SOX7;HHEX;MDFIC;TIAM1;HMGXB4;RACK1;TAX1BP3
prerank,mitotic cell cycle phase transition (GO:0044772),0.33904006428239264,1.024770626788412,0.43940990516332984,1.0,1.0,40/204,14.88%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;CDK6;FBXL22;CLASP2;CCND2;HINFP;CEP41;EIF4EBP1;HAUS8;CUL2;CEP290;ENSA;PLCB1;CCND1;PPP1CB;BRSK1;CDK7;CEP192;CRLF3;DYNC1I2;RB1;GSPT1;ACVR1B;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CHMP2A;CSNK1E;DCTN3;HAUS7;HAUS2;CCNJL;EIF4E;PRKACA
prerank,cellular response to interleukin-15 (GO:0071350),-0.40784946170452274,-1.0240969362171328,0.4238875878220141,0.8634988177888572,1.0,4/13,16.93%,GRB2;IL15;IL15RA;STAT5A
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.40784946170452274,-1.0240969362171328,0.4238875878220141,0.8634988177888572,1.0,4/13,16.93%,GRB2;IL15;IL15RA;STAT5A
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3477018589247307,-1.0240913853375315,0.41228070175438597,0.8622667773023119,1.0,6/23,11.84%,KIT;GHR;CENPJ;CYP1B1;HES1;MGAT5
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3566544762715271,-1.0240783247544691,0.4155844155844156,0.8610669159917241,1.0,6/22,19.43%,APPL2;PTPRZ1;TAFA1;NES;KDM1A;NAP1L1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.47461953274311497,1.0239711516114753,0.4354561101549053,1.0,1.0,6/15,20.59%,SEMA5A;VEGFA;TMSB4X;P2RX4;PRKD1;HSPB1
prerank,hexose metabolic process (GO:0019318),-0.29776629875512184,-1.0239176333517073,0.3969465648854962,0.8602895804691081,1.0,15/39,27.95%,APOD;BRAT1;SORD;PMM2;HECTD4;SLC35A2;FPGT;GALK2;FUCA2;PGM1;ALDOC;GALM;GALK1;PMM1;GDPGP1
prerank,negative regulation of chemokine production (GO:0032682),-0.39779180671567754,-1.023323063477696,0.44226044226044225,0.8607834077801616,1.0,4/14,15.24%,APOD;LGALS9;SIRPA;C1QTNF3
prerank,protein localization to kinetochore (GO:0034501),-0.40171460395719594,-1.0230893916910198,0.44341801385681295,0.860243656627442,1.0,8/14,41.78%,IK;RCC2;BUB3;ZWILCH;KNL1;TTK;CENPT;SPDL1
prerank,sphingolipid metabolic process (GO:0006665),-0.24724252637942523,-1.0230392313935985,0.390625,0.8591372972641103,1.0,23/108,11.73%,SGMS1;SGMS2;ELOVL7;CERS5;CERK;HACD4;SPTLC2;ST6GALNAC3;PPP2CA;SPTSSA;ACER2;ALDH3A2;ENPP2;SERINC1;SUMF2;CERS6;SGPP1;CERT1;PPT1;ASAH2;HEXA;B3GALNT1;SPNS2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.44843530155283373,1.022676724247647,0.44084278768233387,1.0,1.0,6/21,13.21%,ROCK1;CBFB;KLF7;ROCK2;RUNX1;ZFP36L1
prerank,regulation of cell development (GO:0060284),0.4028167556663882,1.0223649143324207,0.4353448275862069,1.0,1.0,6/36,7.60%,HEY2;HEYL;HDAC9;PRUNE1;YTHDF2;YAP1
prerank,polyamine metabolic process (GO:0006595),0.4907006361062636,1.0222256489932848,0.4444444444444444,1.0,1.0,4/13,14.99%,OAZ2;SAT2;SMS;PAOX
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.32964978596599365,-1.02219139608871,0.4380165289256198,0.8602498740687717,1.0,9/26,18.05%,LGR4;APPL2;BIRC2;IRAK3;APPL1;BIRC3;GPR108;TLR3;LRRC14
prerank,T cell activation involved in immune response (GO:0002286),0.49352317229820314,1.0220687680698202,0.4409722222222222,1.0,1.0,1/12,3.35%,LCP1
prerank,error-prone translesion synthesis (GO:0042276),-0.35582113771533574,-1.0219315420081954,0.41643835616438357,0.8598167900407248,1.0,12/21,37.17%,UBC;REV1;PRIMPOL;UBB;POLE2;POLI;RPA3;RFC3;RPA2;RPA1;RFC1;RFC4
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3613926277432263,1.0218457867507509,0.45598194130925507,1.0,1.0,19/98,11.85%,ATP2B4;STAC;PMAIP1;ITGA3;SLC5A3;ITGB1;BCL2;ARHGEF16;KCNB1;SORBS1;STAC3;TP53;KIF5B;MIEF2;MIEF1;EPHA2;GPER1;DPP10;CLIP3
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.33264977898126635,1.0218316864721146,0.4407630522088353,1.0,1.0,70/509,11.24%,NTF3;FLNA;NTRK3;ACTN4;ANGPT1;PTP4A3;ROCK1;FGF1;PMAIP1;LIMS1;HIP1;MYD88;MST1R;TCIM;PDGFB;PDGFC;FERMT2;SEMA5A;ROR1;PLXNB1;CDH13;ADRA1D;THPO;CGAS;BCAR3;ITGB1;CCL5;GCNT2;PDGFD;NUP62;MFHAS1;BCL2;KSR1;CD14;LARS1;MTDH;PIK3AP1;IRS1;CAV1;DAB2IP;TP53;VEGFA;PPM1A;HEXIM1;NEDD4;AREG;SOX9;GOLT1B;TIFA;TGFB2;RELA;TRIM68;SEC13;RRAGB;THEM4;EDAR;AXL;PDGFRB;RTKN2;TRAF5;HBEGF;PELI2;EIF2AK2;DNM1L;PDGFA;VAV1;GPER1;ROCK2;DDX1;ZDHHC17
prerank,regulation of sodium ion transport (GO:0002028),0.41156789318753306,1.0216536538615066,0.4407252440725244,1.0,1.0,11/34,15.60%,ATP2B4;SNTA1;NEDD4;PRSS8;WNK2;CNKSR3;AHCYL1;GPD1L;SLMAP;YWHAH;NOS1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3720615197657783,1.020880229859567,0.4223826714801444,1.0,1.0,13/76,10.68%,KLHL40;ANGPT1;UBA2;DCUN1D2;PIAS4;SAE1;CAV1;FBXW7;DCUN1D1;TNIP1;AMER1;PAXIP1;UBE2D1
prerank,regulation of vacuole organization (GO:0044088),-0.36214058899817725,-1.0208599900501487,0.4393530997304582,0.8616879027987413,1.0,10/20,24.07%,ANXA2;RAB5A;NPRL3;SCARB2;IFT88;UBQLN2;RAB1B;ENO2;TBC1D14;ENO1
prerank,endocrine system development (GO:0035270),0.44724918624492604,1.020684102181112,0.45794392523364486,1.0,1.0,1/21,0.40%,TG
prerank,regulation of protein metabolic process (GO:0051246),-0.30189127251324716,-1.0206432969020964,0.41700404858299595,0.8611290255384744,1.0,17/44,18.84%,NEDD4L;APOE;APP;LDLR;LTBP4;HSP90AB1;FURIN;FKBP1A;MDM2;ACE;KLF2;SSH1;HGS;GSAP;CHEK2;ODC1;SPOPL
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.42960709282612985,1.0204645095905205,0.4396423248882265,1.0,1.0,4/26,8.61%,CD36;SLC5A3;ALOX5;PPARA
prerank,negative regulation of cell adhesion (GO:0007162),0.36974039646171436,1.0204381957829565,0.43333333333333335,1.0,1.0,13/72,7.72%,ANGPT1;SEMA5A;PLXND1;PLXNB1;CDH13;JAG1;FZD4;GCNT2;JAM3;ARHGDIG;CBLL1;DSCAM;SNAI2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.4394176013640978,1.020283285581917,0.42452830188679247,0.9998705483601059,1.0,3/21,7.63%,SMARCD3;VEGFA;FZD9
prerank,organic anion transport (GO:0015711),-0.2625458283314277,-1.020033662161667,0.40625,0.8616317616606776,1.0,15/76,9.38%,ABCG2;SLC4A10;SLCO2B1;SLC26A7;SLCO1C1;SLC25A17;SLCO2A1;SLC52A1;CYB5R4;CA2;SLC39A8;SLC22A6;SLC4A2;SLCO3A1;ABCC4
prerank,endothelial cell migration (GO:0043542),0.40763437343575515,1.0196509182449314,0.44367176634214184,1.0,1.0,6/37,2.95%,PTP4A3;MYH9;PLXND1;CDH13;NR4A1;LOXL2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.48317706907637464,1.0194138925514986,0.45342706502636204,1.0,1.0,6/13,18.66%,GLRX5;ISCA1;ISCA2;GLRX3;CIAO1;NFU1
prerank,regulation of programmed cell death (GO:0043067),0.3430040841767863,1.0192842744635586,0.4439701173959445,0.9995823480574593,1.0,29/161,15.91%,NTF3;ACTN1;ACTN4;PMAIP1;HIP1;ALPK2;NUP62;NDRG1;TP53;STK26;SOX9;DAPK3;ACTN2;GLS2;ZBTB7A;TNFRSF25;CLU;TMEM219;PERP;BCL6;RBM25;SGK1;TNFRSF10B;LRRK2;USP42;STAT1;RAF1;MAGED1;JAK2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.335603489109269,-1.0191182270571373,0.4143302180685358,0.8631185018186783,1.0,8/26,19.44%,HMGB1;DDX3X;LBP;PTPN22;RTN4;TLR3;TIRAP;SLC15A4
prerank,positive regulation of neuron differentiation (GO:0045666),0.4080250717938339,1.0189187132486248,0.42724867724867727,0.999542378991992,1.0,6/40,10.57%,MEF2C;HEYL;MMD;ARHGEF2;IMPACT;BRINP1
prerank,gene silencing by miRNA (GO:0035195),0.4224614537713839,1.0188241900367239,0.4633093525179856,0.9988527209551576,1.0,2/32,1.88%,WTIP;LIMD1
prerank,regulation of macroautophagy (GO:0016241),-0.24582077663099242,-1.0188047506765572,0.408,0.8627972677124279,1.0,35/105,25.16%,PRKAG2;DCN;PIK3CA;RB1CC1;PAFAH1B2;CAPNS1;LAMTOR1;UBQLN1;SMG1;NRBP2;GPSM1;IKBKG;ATP6V1G1;SNX6;RHEB;ERN1;TBC1D25;KDR;CLN3;AKT1;UBQLN2;EXOC1;EXOC7;BNIP3L;QSOX1;PRKAG3;PRKAA1;LZTS1;SMCR8;ATP6V0D1;RRAGD;SESN2;UCHL1;CDK5R1;LAMTOR2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.44216567114993527,1.0187538039879742,0.44193548387096776,0.9980839990475487,1.0,2/20,2.65%,ENTPD1;ANO6
prerank,protein sumoylation (GO:0016925),0.3906599854374367,1.0183676386821854,0.439374185136897,0.9981581688371699,1.0,20/49,19.62%,UBA2;NUP62;PIAS4;SAE1;TRPM4;NUP153;NUP107;AAAS;PIAS2;TRIM28;NUP98;NUP37;NUP210;PIAS1;BCL11A;NUP54;SUMO1;UBE2I;NUP160;NUP133
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4330296731352784,1.0183502338049746,0.43605546995377503,0.9972494314270763,1.0,9/25,12.81%,DDX23;TXNL4A;SF3B3;SRSF4;PRPF4;SRSF10;SF3A3;SRRM1;SF3B1
prerank,regulation of protein modification process (GO:0031399),-0.2922718276565704,-1.0182778449051453,0.42543859649122806,0.8632342241795491,1.0,13/50,17.71%,CDH5;FN1;SPRED2;PTK2;PPP2CA;ASPSCR1;PML;IGF2;STAT2;LYN;GRM5;NOP53;KDM4D
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3705760048572163,-1.018229193670473,0.46112600536193027,0.8621541970175077,1.0,9/18,27.90%,NGLY1;SAMHD1;ADAMTS9;FBXO17;BPGM;NAGA;STT3B;DERA;FBXO44
prerank,inositol phosphate catabolic process (GO:0071545),0.49311014136860176,1.0180984371435,0.4550359712230216,0.996989716312557,1.0,5/12,15.35%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,negative regulation of cell population proliferation (GO:0008285),0.33246268945350005,1.0180965012648342,0.4484848484848485,0.9960472592817321,1.0,39/351,9.19%,MYOCD;IGFBP7;COL18A1;DLC1;TMIGD3;P3H2;SPEG;ITGA1;CDK6;PLXNB1;CDH13;FRK;RERG;IGFBP5;TGFB3;BTG2;NACC2;NUP62;TGFB1I1;PEX2;TESC;MN1;OGN;DAB2IP;RPS6KA2;TP53;CD200;AR;BNIPL;CELF1;BTG1;SOX9;TGFB2;WNK2;CD300A;DIS3L2;MAP2K1;GSTP1;SKI
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3063089766382327,-1.01790436847054,0.46835443037974683,0.8618075755958274,1.0,13/38,18.19%,DDX3X;TNFSF10;CASP8;BCL2L1;STX4;MADD;NOS3;RNF34;SP100;FAIM;GPX1;SERPINE1;TMBIM1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.50184498046193,1.017838287767946,0.4430147058823529,0.9957413530011586,1.0,4/10,18.31%,TP53;RPS27L;HIPK2;RPS6KA6
prerank,positive regulation of chemokine production (GO:0032722),-0.2965575114705855,-1.0173742859140376,0.42641509433962266,0.8620658692173282,1.0,7/44,8.49%,HMGB1;APP;DDX3X;IL18;WNT5A;LGALS9;IL6R
prerank,cellular glucan metabolic process (GO:0006073),0.49423256393500253,1.0169360511385854,0.45901639344262296,0.9971725845989191,1.0,1/11,1.09%,PYGM
prerank,COPII-coated vesicle budding (GO:0090114),-0.27290232999356584,-1.0168839357756447,0.4105263157894737,0.8622377540802738,1.0,34/68,35.42%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC23B;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG;MIA3;F5;TRAPPC2;SAR1A;PEF1;SEC16B;PPP6C;CTSC;PPP6R1;TRAPPC6A;SAR1B;CSNK1D;SCAP;TRAPPC5;CNIH3
prerank,C21-steroid hormone metabolic process (GO:0008207),0.45479106817932824,1.0168104721398992,0.4508320726172466,0.9965546192788733,1.0,2/20,7.15%,HSD17B10;AKR1B1
prerank,neuron development (GO:0048666),-0.23851392533607124,-1.0166790333447675,0.3950617283950617,0.8616456415946144,1.0,42/141,18.49%,PLP1;PBX3;HMGB1;APOE;WNK1;THOC2;APP;FRYL;GLI2;RASGRF1;RAB11A;STX3;NLGN1;B4GALT6;PTPRM;TDP2;ATP8A2;UHMK1;TMEM108;DTNBP1;TENM3;UGDH;PPT1;LAMB1;ALK;UNK;MANF;LYN;OPHN1;EPHA8;TBC1D24;STMN4;EHD1;VSX1;CNTN4;RAB13;SH3GL2;ATXN10;LGI4;RP1;CDK16;RAB35
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3391128402385453,-1.0162427612902338,0.42073170731707316,0.8615744370865775,1.0,7/24,12.67%,KIT;GHR;PTK2B;CENPJ;CYP1B1;HES1;PRLR
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3667467760668207,1.0161337090861846,0.4597839135654262,0.9973676210164741,1.0,17/86,13.32%,NTF3;ANGPT1;ANGPT4;PDGFB;CSPG4;ARHGEF2;RAP2C;TP53;VEGFA;ITGB3;PAK2;SAMSN1;PDGFA;PRKCD;CNOT7;DMTN;FGF10
prerank,atrial septum morphogenesis (GO:0060413),0.5099262321062408,1.0157665173926633,0.4843205574912892,0.9973630783257258,1.0,2/10,7.87%,HEY2;TGFB2
prerank,positive regulation of dephosphorylation (GO:0035306),0.4258417613208309,1.0151408368106125,0.441726618705036,0.9980958923448219,1.0,4/27,7.03%,DLC1;PPP2R5A;PIN1;CALM1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.44008494654913094,-1.015017420130679,0.45,0.8638745713888828,1.0,4/10,15.41%,NT5E;UPP2;UPB1;DPYD
prerank,regulation of membrane depolarization (GO:0003254),0.44739923966505696,1.014907926316904,0.4453507340946166,0.9977707633926087,1.0,5/18,16.10%,CAMK2D;FHL1;GPD1L;LRRK2;GJA5
prerank,cellular response to amino acid starvation (GO:0034198),0.37184519027315177,1.0147127086058894,0.44569288389513106,0.9973322256171681,1.0,22/71,20.44%,MAP3K5;RNF152;LARS1;KPTN;ATP6V1H;CASTOR1;IMPACT;SEC13;RRAGB;ATP6V1C1;NPRL2;EIF2AK2;ATP6V0D2;MAPK1;CASTOR2;ITFG2;EIF2AK3;EIF2AK4;PRKD1;ATP6V0C;LAMTOR3;EIF2S1
prerank,regulation of interleukin-1 production (GO:0032652),-0.3876817155472062,-1.0146985733801606,0.4317617866004963,0.863530088409788,1.0,4/15,12.14%,FOXP1;HMGB1;TMED10;SIRPA
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3701011665656488,1.0146757517284712,0.43899521531100477,0.9964975395300237,1.0,11/74,7.87%,VASN;FERMT2;PHLDB2;CLASP2;LOXL2;TGFB3;GCNT2;TGFB1I1;SDHAF2;DAB2IP;TGFB2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4736158085778501,1.014384998529409,0.48700173310225303,0.9963041581086625,1.0,5/14,17.11%,IRS1;PPARA;LONP2;IRS2;MTLN
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.338024278095531,-1.0143761581293356,0.44879518072289154,0.8631767441106898,1.0,3/26,1.39%,EYA2;EYA1;EYA4
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3748630909706541,1.014362432246535,0.45499383477188654,0.9954134343757162,1.0,12/65,9.92%,PMAIP1;ANGPT4;RORA;PTGIS;SUV39H2;NDRG1;TERT;TP53;CPEB1;VEGFA;HIF1A;SIRT2
prerank,ESCRT complex disassembly (GO:1904896),0.5150408587557542,1.0141773886441237,0.4517857142857143,0.994026466719375,1.0,5/10,17.61%,CHMP5;IST1;CHMP2B;CHMP2A;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),0.5150408587557542,1.0141773886441237,0.4517857142857143,0.994026466719375,1.0,5/10,17.61%,CHMP5;IST1;CHMP2B;CHMP2A;VPS4A
prerank,T cell differentiation in thymus (GO:0033077),0.4763156852158691,1.0141742050035436,0.43119266055045874,0.9931034474681931,1.0,5/14,21.71%,ADAM17;ZFP36L1;MR1;PTPRC;ZFP36L2
prerank,secretory granule organization (GO:0033363),-0.4401928139719721,-1.0139925266847167,0.4449648711943794,0.8630417152548489,1.0,3/10,8.93%,ABCA1;SRGN;DTNBP1
prerank,regulation of apoptotic process (GO:0042981),0.3293902932059773,1.013643548859375,0.4724724724724725,0.9935817816079472,1.0,100/676,13.74%,NTF3;FLNA;KCNMA1;OBSCN;ARHGEF7;MAP3K20;ACTN1;MEF2C;NAA38;ACTN4;MAP3K5;ANGPT1;PMAIP1;KALRN;NR1H4;ABR;HIP1;ANGPT4;MYD88;TCIM;TRIM2;ARHGEF17;ALPK2;ANO6;CCND2;ANXA1;IL2;ITSN1;TGFB3;ITGB1;NET1;NUP62;ARHGAP10;ATAD3A;FXN;BCL2;ARHGEF16;ARHGEF2;MYO18A;ATG7;MTDH;NDRG1;DAB2IP;RPS6KA2;ARL6IP5;TP53;VEGFA;PHLDA3;GDNF;STK26;PA2G4;MED1;BCL2L2;FZD9;NAT8;OPA1;SOX9;RELA;MAP3K10;DAPK3;API5;CBX4;VDAC1;TNFAIP8;GSTP1;ARHGEF4;PAK2;HRK;BAG3;AXL;ACTN2;FAIM2;PAWR;DNM1L;VAV1;GPER1;GLS2;TRIM35;ZFAND6;BOK;HTR2B;ZBTB7A;CLIP3;TNFRSF25;CSRNP3;DIABLO;CLU;CITED2;ITGB3BP;PDCD10;POU3F3;TMEM219;PERP;BCL6;RBM25;GAS6;DNAJC3;SON;SGK1;TNFRSF10B
prerank,regulation of mRNA stability (GO:0043488),0.3421278846356135,1.0136377783844828,0.43769968051118213,0.9926686212498909,1.0,29/145,14.87%,RBM24;TENT5B;ROCK1;VIM;SAMD4A;PARN;SET;PSMC6;MAPKAPK2;CIRBP;GDNF;YTHDF2;CELF1;FTO;FASTKD1;FUS;PSME4;HNRNPU;PSMB1;PSMD5;ROCK2;PRKCD;DCP1A;PSMB2;ZFP36L1;GIGYF2;PSMB7;PSMD3;PRKCA
prerank,protein export from nucleus (GO:0006611),-0.3245196376708661,-1.0136293988213274,0.41194029850746267,0.8628548416674139,1.0,8/27,22.21%,RANBP3L;NUTF2;RANBP3;TGFB1;CALR;CCHCR1;NUP214;RAN
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4055875125486049,1.0135246707595855,0.43802816901408453,0.9920329720399861,1.0,5/37,6.30%,DYNLL1;DYNLRB1;KIF3B;IFT43;IFT81
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.44351358522828244,1.0134603505368094,0.46831530139103555,0.9912855527825283,1.0,4/21,6.46%,RBPMS;TGFB3;BMPR1A;SLC2A10
prerank,rRNA pseudouridine synthesis (GO:0031118),0.507891497478005,1.0132584266847091,0.4732142857142857,0.9908712435586482,1.0,3/10,13.51%,RPUSD3;NAF1;RPUSD4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.33227501371186446,1.0132414337504911,0.4676113360323887,0.9899922001011685,1.0,45/327,11.82%,SOX6;MLF2;WTIP;MEF2C;ACTN4;ZFHX3;PTP4A3;LIMD1;NAB1;RORA;MLF1;HINFP;RBAK;ATXN1;PRKCQ;MYBBP1A;TP53;ZBTB38;SFPQ;PPARGC1A;PPARGC1B;ZNF431;REXO4;BTG1;SNAI2;RELA;KMT2D;DAPK3;MSL3;FUS;NSD3;PPIE;KAT7;HIF1A;NR2C2;NUP107;SRSF10;RB1;RHOH;BAZ2A;NFX1;ACVR1B;ESRRA;PSPC1;USP13
prerank,ribosomal large subunit assembly (GO:0000027),0.4293999271422355,1.0131641959775555,0.45592705167173253,0.98927095573808,1.0,7/24,17.34%,RPL3L;NLE1;MDN1;RPL5;DHX30;FASTKD2;BOP1
prerank,positive regulation of neurogenesis (GO:0050769),-0.2607622922769694,-1.0125715608342736,0.39893617021276595,0.8646060551790179,1.0,21/68,19.43%,PLXNA2;ROBO1;SLIT2;CUX1;TIAM2;SHANK3;CTNNB1;PLXNA4;CDKL3;SPEN;CUL7;PTPRD;SNW1;CX3CL1;FBXW8;FAIM;NUMB;OBSL1;KDM1A;DISC1;NAP1L1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3739911908450082,-1.0119503669820586,0.4308093994778068,0.8652279468749647,1.0,5/17,13.12%,BMP6;SASH1;CD55;TRIM5;CX3CL1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4267538945543631,1.0118746439631894,0.4631578947368421,0.9916722432731501,1.0,4/27,8.19%,CD36;MYD88;CD14;TNIP1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4197282690801102,1.0115466905181967,0.44695898161244696,0.9916228159025672,1.0,6/30,11.78%,CAVIN1;POLR2L;GTF2H4;CDK7;POLR1E;POLR1H
prerank,peptidyl-serine modification (GO:0018209),0.3405404067508029,1.0115301577705793,0.46129374337221635,0.9907531471359441,1.0,44/166,17.53%,STK38L;ROCK1;MAST4;DYRK2;PDGFB;CAMK2D;GALNT16;MARK1;DYRK1A;PRKCQ;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;PARP1;MAP3K10;BRSK1;PKN2;PAK2;ROCK2;PRKCD;GALNT3;RICTOR;GALNT2;DMPK;HPF1;MAST1;GAS6;CSNK1E;SGK1;MAPK1;GALNT1;LRRK2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;HIPK2;MAST3;MAP3K13;EIF2AK3;MARK2;MASTL
prerank,establishment of endothelial barrier (GO:0061028),-0.3287965521012625,-1.011360460476238,0.4161676646706587,0.8656856145855332,1.0,7/29,8.64%,AFDN;TJP1;TJP2;PECAM1;RAPGEF1;RAP1B;RDX
prerank,regulation of developmental growth (GO:0048638),-0.3221867964549441,-1.0111882005638102,0.41304347826086957,0.8649573440601835,1.0,11/29,24.01%,IGF1;APOE;GHR;APP;LATS2;SIX1;INSR;STAT5A;SPAAR;MFSD2A;OLFM1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.31307369027040277,-1.0110413864544359,0.4253246753246753,0.8641840792367712,1.0,11/32,16.02%,JCAD;STARD13;AKT3;MEOX2;HDAC7;FOXC2;MAP3K3;CARD10;PTGS2;KDR;FGF2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3900302288630293,-1.0109632258471033,0.44761904761904764,0.8632203506612954,1.0,9/14,35.19%,NT5E;UPP2;UPB1;DPYD;DHODH;NT5C1A;UMPS;CAD;ERH
prerank,negative regulation of blood pressure (GO:0045776),-0.40946068690522325,-1.0109521404131148,0.431980906921241,0.8620701744700752,1.0,4/13,21.43%,BMPR2;NOS3;SCPEP1;DRD2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3040461559869122,-1.0107408217072709,0.4402730375426621,0.8614476843362617,1.0,13/35,24.16%,SASH1;DLG1;XDH;LGALS9;RELL1;PTPN22;MAP3K4;PER1;DUSP1;ZC3H12A;GADD45B;SPHK1;CYLD
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.29537692953564193,-1.01063939355951,0.4043321299638989,0.8605545123093082,1.0,20/39,32.75%,RPS19;RPSA;RPS24;RIOK3;WDR3;RRP36;DDX52;RPS7;ERAL1;RRP7A;EMG1;SURF6;NOL11;RPS27;LSM6;MRPS11;RPS5;RPS15;RIOK2;TSR3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.46730414261717645,1.0105349886831978,0.4576547231270358,0.9924050213354266,1.0,4/15,17.17%,MYD88;HIF1A;STAT3;TICAM1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4193806336583941,-1.0099427759499806,0.4566744730679157,0.8612958580541731,1.0,3/12,15.16%,PTK2;LYN;BST2
prerank,regulation of phagocytosis (GO:0050764),0.3785775106896321,1.0098917417679487,0.4440104166666667,0.9930906246139493,1.0,4/53,4.33%,MERTK;FER1L5;DYSF;PIP4P2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4431163385276639,1.0098285164061618,0.46537842190016104,0.9923187533942361,1.0,4/21,5.14%,HTR1B;PDGFB;IGFBP5;BMPR1A
prerank,regulation of extracellular matrix organization (GO:1903053),-0.386778532392367,-1.0093586415416687,0.43301435406698563,0.861773183308885,1.0,3/15,6.39%,AEBP1;LRP1;TIE1
prerank,mesonephros development (GO:0001823),0.4902325330923629,1.0091625755498603,0.47653429602888087,0.993130340897558,1.0,2/11,4.91%,FGF1;OSR2
prerank,response to amino acid starvation (GO:1990928),0.3706640499394183,1.0089782998274963,0.46375,0.9926876625161679,1.0,23/72,20.85%,MAP3K5;RNF152;LARS1;KPTN;ATP6V1H;CASTOR1;IMPACT;SEC13;RRAGB;ATP6V1C1;NPRL2;EIF2AK2;ATP6V0D2;MAPK1;CASTOR2;ITFG2;EIF2AK3;EIF2AK4;PRKD1;ATP6V0C;LAMTOR3;EIF2S1;LARP1
prerank,plasma membrane organization (GO:0007009),0.37834924238434325,1.0088662337664611,0.46875,0.9920689346513615,1.0,16/61,12.67%,FER1L5;DYSF;MYH9;ANO6;PACSIN3;PACSIN2;EHD2;FA2H;RAB3A;WHAMM;TLCD2;OSBPL2;NSF;PACSIN1;SNX9;A4GALT
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4618496620358733,1.0085859738552203,0.46909667194928684,0.991847029645297,1.0,6/19,12.48%,ROCK1;RTN2;PIN1;RTN1;CHRNA7;CLU
prerank,regulation of protein localization to nucleus (GO:1900180),-0.2941694553969295,-1.0083536453810624,0.44534412955465585,0.8633696083175796,1.0,11/43,12.73%,GLUL;BMP4;LIMK2;OTUD7B;NVL;ILRUN;LATS2;CARD10;TGFB1;WWTR1;DTX3L
prerank,positive regulation of immune effector process (GO:0002699),-0.32406445560137975,-1.0083494323768618,0.41389728096676737,0.862201367686182,1.0,7/27,15.15%,APPL2;LBP;LGALS9;RPS19;DDX60;CD46;ANKRD17
prerank,regulation of protein ubiquitination (GO:0031396),-0.24673506524207126,-1.0077535967994848,0.45901639344262296,0.8626787186022037,1.0,29/108,15.79%,SASH1;ARRB1;NXN;CUL3;MYCBP2;UBQLN1;CRY1;DERL1;HSP90AB1;BIRC2;PRMT3;COMMD1;FKBP1A;SIRT7;FBXO4;PRKN;UBE3A;OGT;STUB1;TGFBR1;SPRY2;SOX4;DNAJB2;PTTG1IP;SH3RF2;FANCI;BIRC3;UBXN1;AKT1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3888441396910369,1.0074579060195619,0.4544235924932976,0.9937364230212661,1.0,9/48,9.58%,ANGPT1;ANGPT4;PDGFB;ANXA1;HDAC9;VEGFA;RHOJ;ADAM17;HIF1A
prerank,nucleoside phosphate catabolic process (GO:1901292),0.48176142622490575,1.0069399091245468,0.4657534246575342,0.9941210106235229,1.0,2/13,7.17%,ENTPD1;ENTPD7
prerank,response to unfolded protein (GO:0006986),-0.2845661409779004,-1.006915610090827,0.43089430894308944,0.8637142926107553,1.0,19/48,21.36%,HSPA4L;HSPA4;SERPINH1;DERL1;HSPA5;HSP90AB1;OPTN;PRKN;ERN1;DNAJB2;HSPA13;BAX;HSPA9;HSPE1;HERPUD1;DNAJB4;HSF1;DNAJC4;HSPD1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3996914703048202,-1.0068257609424816,0.4532710280373832,0.8628089600814352,1.0,4/14,16.29%,PUM1;DDX60;ANKRD17;TLR3
prerank,negative regulation of innate immune response (GO:0045824),-0.31221312662848055,-1.0067973262972838,0.4794520547945205,0.861711573378542,1.0,20/34,37.73%,RPS19;IRAK3;METTL3;SAMHD1;STAT2;GRN;SERPING1;NLRC5;YTHDF3;PTPN2;TRIM21;A2M;NLRC3;USP18;TNFAIP3;NMI;TYRO3;LYAR;DHX58;TTLL12
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.4020492218283984,-1.0067288375524057,0.45154185022026433,0.8607047204685,1.0,2/13,3.17%,BMP4;GLI2
prerank,nervous system development (GO:0007399),0.32886268911559075,1.00656934835175,0.4799196787148594,0.9941608897215465,1.0,47/429,10.77%,SOX6;NTF3;FGF13;MEF2C;SERPINI1;IGFN1;KALRN;MERTK;CRIM1;APBA1;MST1R;ZEB2;PDGFC;NAB1;CLN5;EDNRB;FZD5;SEMA5A;PLXND1;DPYSL4;JAG1;KIRREL3;ATXN1;DYRK1A;BTBD2;MBD5;PCDHB14;DSCAM;VEGFA;GDNF;YAP1;FZD9;ERCC6;MBP;PCDHB11;TRAK1;CDH2;TRPC5;GSTP1;AXL;MBNL1;COX7B;HAPLN2;NR2C2;TEAD1;GFRA1;NDUFV2
prerank,fatty acid beta-oxidation (GO:0006635),0.38666998014064147,1.0065619330345421,0.44342105263157894,0.9932631438291973,1.0,12/51,10.21%,HSD17B10;PEX2;HSD17B4;ACAD11;CRAT;MECR;ETFA;ABCD4;ACADS;ACAD10;HADHB;SCP2
prerank,midbody abscission (GO:0061952),0.4645205299637643,1.006387859058515,0.46365105008077545,0.992786158994751,1.0,4/17,13.44%,CHMP4C;CHMP5;CHMP2B;CHMP2A
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.273348368820323,-1.0062248641617393,0.431924882629108,0.8610425406225931,1.0,29/57,35.84%,GLUL;RPS19;SDAD1;NVL;RPS24;NOC2L;RRP36;PAK1IP1;LTO1;RPS7;RPL11;DDX31;RPF2;RPL38;EMG1;SURF6;EBNA1BP2;BYSL;RBIS;PES1;NIP7;RRS1;RPS15;RPL35A;RIOK2;WDR74;URB2;RPL14;MRTO4
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.3472312849161477,-1.0058128992108462,0.45161290322580644,0.8610825219174647,1.0,6/20,4.19%,IGF1;LRP1;SLIT2;VTN;NRP1;IGFBP3
prerank,negative regulation of nuclear division (GO:0051784),-0.422645936190914,-1.0057147369292718,0.44941176470588234,0.8601947524616849,1.0,2/11,2.11%,BMP7;BMP4
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.384973151368057,-1.0056227474341108,0.4457831325301205,0.8592887828985536,1.0,6/15,16.76%,IGF1;GHITM;BCL2L1;PRKN;AKT1;GPX1
prerank,ERBB2 signaling pathway (GO:0038128),-0.3171521663756283,-1.0055933141142486,0.4263803680981595,0.8582191923996078,1.0,6/31,11.27%,PIK3CA;GRB2;EGFR;GAB1;NRG2;STUB1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.47460480037027064,1.0052749024320309,0.4635416666666667,0.9947189954310254,1.0,3/13,6.29%,DYRK2;IRS1;SORBS1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3534464137141694,1.0050359653134853,0.4423076923076923,0.994401999779984,1.0,15/101,11.12%,MEF2C;MYD88;VIM;CCL5;UPF1;CD14;MTDH;DAB2IP;CHMP5;NFKBIB;RELA;GSTP1;NR1D1;AXL;CD180
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.403199069057298,-1.0048319919518223,0.44559585492227977,0.8590650476107824,1.0,4/13,9.81%,BMP7;BMP4;NR3C1;ESR1
prerank,regulation of fatty acid oxidation (GO:0046320),0.45636040481481077,1.0045027264989732,0.44763513513513514,0.9948501677949908,1.0,6/16,13.72%,PDK4;PPARGC1A;SOX9;PPARA;LONP2;SIRT4
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5008087682615159,1.0040147735279898,0.46139705882352944,0.995138198642123,1.0,4/10,10.49%,FBXW7;AREG;ADAM17;HBEGF
prerank,retinoid metabolic process (GO:0001523),0.37002573335393063,1.0039218943456227,0.47158403869407495,0.9944514059777699,1.0,7/71,7.15%,TTR;SDC2;LPL;DHRS3;RARRES2;GPC4;AKR1B1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4296863178421914,1.003793889303047,0.45121951219512196,0.9938746750664176,1.0,6/24,13.21%,ROCK1;CBFB;MED1;ROCK2;RUNX1;ZFP36L1
prerank,plasma membrane invagination (GO:0099024),0.4170794885884049,1.0037000831115028,0.4685714285714286,0.9932078490561628,1.0,7/29,12.60%,CD36;MYH9;SPIRE1;ARHGAP12;DOCK1;SNX18;SNX9
prerank,base conversion or substitution editing (GO:0016553),-0.42378516999005456,-1.0036222883568746,0.4671361502347418,0.8612839771646126,1.0,4/11,33.90%,METTL3;ADAR;ADARB2;NUDT16
prerank,positive regulation of translation (GO:0045727),0.35546307085773965,1.0034559253412356,0.4661308840413318,0.9929190283343883,1.0,35/94,20.85%,VIM;SAMD4A;CCL5;NAT10;RPUSD3;POLR2G;TRMT10C;RCC1L;RPS27L;CIRBP;YTHDF2;PYM1;RPL5;EIF3E;EIF5AL1;EIF5A;RBM3;ZCCHC4;CPEB3;PLXNB2;RPUSD4;FASTKD2;PIWIL2;DHX9;EEF2;TRUB2;RMND1;UPF3A;HABP4;PKM;NSUN5;UQCC2;C1QBP;ERBB2;LARP1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4547306318293208,1.0027936646791966,0.4696485623003195,0.9936699260935995,1.0,4/18,8.09%,SUV39H2;ASH1L;KMT2D;SETD3
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.46007394902869325,1.0023714302161173,0.44549763033175355,0.9938106861164853,1.0,6/16,12.89%,AMPD1;LHPP;AMPD2;NUDT2;PPAT;ADSS1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.454716759767263,1.002294487052747,0.46178861788617886,0.9930921867206733,1.0,4/17,7.69%,KLF7;CAV1;AJAP1;SOX9
prerank,glycolytic process (GO:0006096),0.42370666970336096,1.002202794883646,0.4876632801161103,0.9924016298871303,1.0,8/28,19.38%,ENO3;HK2;PFKFB1;ALDOA;PFKM;GAPDHS;LDHA;PKM
prerank,epithelium development (GO:0060429),0.354328693059656,1.0020059899288731,0.4603174603174603,0.9919543402512075,1.0,11/107,8.76%,TAGLN;TBX2;VCL;TAGLN2;DMBT1;VEGFA;CNN3;SOX9;SNAI2;CBR1;VDAC1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.47468250958128055,1.0019799750756953,0.4802065404475043,0.991128967176459,1.0,4/15,13.21%,ANXA1;HNRNPU;GPER1;ZFP36L1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.30337398888880707,-1.0019672887370017,0.42391304347826086,0.8647743920601726,1.0,20/36,33.91%,SGMS1;DEPTOR;MADD;ASAH2;TGFBR1;MAZ;CX3CL1;CRADD;BCL2L12;QARS1;TRIM39;TMBIM6;CYLD;CSNK2A1;CSNK2A2;STYXL1;PPIA;TRAF1;TPD52L1;ING5
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.4223272953834001,-1.001918472079766,0.48148148148148145,0.8637724022814904,1.0,3/12,7.19%,MYCBP2;B4GALT6;HSP90AB1
prerank,regulation of interferon-gamma production (GO:0032649),0.3631393828338299,1.0019107199840578,0.4576470588235294,0.9904105191946855,1.0,10/71,11.19%,NR1H4;FZD5;IL12RB2;CD276;HAVCR2;CD14;IL12RB1;RASGRP1;AXL;PDE4D
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3567147263118074,1.0017841090311623,0.489216799091941,0.9898368586434244,1.0,12/110,9.66%,LHCGR;PTGER3;ADCY5;S1PR3;ADCY2;ADRA1D;ADCY9;TSHR;RAMP1;PTH1R;ADCY6;ADGRL2
prerank,regulation of fibrinolysis (GO:0051917),-0.3997990959316926,-1.0015870414324608,0.46190476190476193,0.863569538252163,1.0,11/13,60.05%,THBD;SERPINE1;USF1;HRG;FAP;KLKB1;APOH;PLG;THBS1;F11;F2
prerank,histone deubiquitination (GO:0016578),-0.36250253837510915,-1.001521248083031,0.4730077120822622,0.8626079041495757,1.0,4/18,14.69%,USP7;BRCC3;USP3;ATXN7
prerank,negative regulation of cell division (GO:0051782),0.49108864143762143,1.0013124673611757,0.47007042253521125,0.9901856999546058,1.0,1/11,1.79%,CHMP4C
prerank,secondary alcohol metabolic process (GO:1902652),-0.29774264919784027,-1.0010791465284075,0.4790874524714829,0.8625747690226664,1.0,20/42,37.25%,CYP27A1;APOE;ABCA1;SOAT1;PIP4P1;SQLE;GBA2;IDH3G;CLN8;RXRA;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;SCAP;CH25H;LCAT;IDH1
prerank,negative regulation of ossification (GO:0030279),0.42542536174641277,1.0005185722530763,0.4588938714499253,0.9912359757892182,1.0,3/23,8.74%,MEF2C;SOX9;TRPM4
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3916897981708848,-1.0003206192850087,0.45566502463054187,0.8635321492294649,1.0,5/14,19.37%,IRAK1;CARD10;CARD14;TLR3;TIRAP
prerank,neutrophil activation (GO:0042119),-0.40386851148503694,-1.000101784779901,0.4613686534216336,0.8630150386816149,1.0,2/12,2.05%,KMT2E;IL15
prerank,chloride transport (GO:0006821),0.3678225955587189,0.999883892227073,0.4684466019417476,0.9919352945691755,1.0,12/74,9.83%,ANO1;GABRE;ANO6;SLC4A8;CLCN6;GABRA4;TTYH1;GABRA5;ANO10;GABRB2;GABRG1;ANO3
prerank,mitotic cytokinetic process (GO:1902410),0.4501163361289367,0.9997060782040719,0.4691358024691358,0.9914829845879517,1.0,6/20,17.61%,CHMP4C;CHMP5;CHMP2B;CHMP2A;CNTROB;VPS4A
prerank,regulation of interleukin-4 production (GO:0032673),-0.3482639972434477,-0.9996757143999994,0.4659090909090909,0.8630501584652912,1.0,8/21,26.06%,LEF1;LGALS9;SLC7A5;CEBPB;RARA;CD86;SYK;ZFPM1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.22799738388278068,-0.9995924559028306,0.46296296296296297,0.8621423248019924,1.0,40/186,14.80%,BICC1;MCC;DAB2;MLLT3;TLE1;LRP1;IGFBP2;TCF7L2;NXN;DKK3;APOE;FZD6;CUL3;WNT5A;APCDD1;WWOX;KLHL12;SOX13;CTNND1;TMEM64;LATS2;PSMD7;PSMD9;PSMD13;RNF213;STK11;KREMEN1;PRKN;SFRP4;IGFBP6;PSMB3;WWTR1;PSMC5;PSMA5;NOTUM;PSMA1;PSMC2;SOX17;HECW1;EMD
prerank,cellular response to starvation (GO:0009267),0.3394855645504168,0.9994068686152009,0.486870897155361,0.991332858758362,1.0,32/147,14.48%,MAP3K5;PMAIP1;RNF152;PDK4;LARS1;KPTN;ATG7;GABARAP;ATP6V1H;MYBBP1A;CASTOR1;TP53;STK26;NUAK1;PPARA;IMPACT;SEC13;XPR1;BRSK1;RRAGB;ATP6V1C1;STK24;NPRL2;EIF2AK2;SREBF2;WDR45;ATP6V0D2;PIK3C3;MAPK1;LRRK2;PRKAA2;CASTOR2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4192525881235676,-0.9990349053072779,0.48699763593380613,0.8626065114824099,1.0,6/11,21.38%,NOS3;GCH1;PRKG2;AKT1;PTS;SPR
prerank,chemical homeostasis (GO:0048878),-0.2716416622890259,-0.9989352552436533,0.4528301886792453,0.8617342994834529,1.0,10/61,8.17%,ZBTB20;RBP1;NEDD4L;WNK1;DDX3X;SLC4A10;WNK4;ABHD5;WNK3;SLC4A2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3509519855479347,0.9985255012723572,0.4696969696969697,0.9926893177046389,1.0,8/107,6.43%,ATP2A1;MAP3K5;ATP2A2;ITPR1;TMEM259;BCL2;DAB2IP;TP53
prerank,regulation of interleukin-8 production (GO:0032677),-0.2659218144129956,-0.998374339266875,0.4521276595744681,0.8621558888362494,1.0,17/69,19.65%,ARRB1;HMGB1;LBP;F3;NOD1;OTUD7B;MAPKBP1;LGALS9;PTPN22;ANXA4;RAB1A;SSC5D;TLR3;SERPINE1;PARK7;TIRAP;BCL3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.42487904102904817,-0.9983374365110995,0.4857142857142857,0.8611129376371813,1.0,2/10,1.71%,SH3RF1;HMGB1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4926622127444795,0.9983118634955827,0.46830985915492956,0.9923620016847486,1.0,3/10,7.00%,PADI2;CD200R1;CD200
prerank,signal release from synapse (GO:0099643),0.391548130963695,0.9982766595732161,0.4745308310991957,0.9915617938443865,1.0,6/43,9.43%,STXBP2;SYT10;RAB3A;LIN7C;BRSK1;HRH3
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.34321242674062746,0.9979764296066271,0.47811816192560175,0.9914327039289196,1.0,16/138,10.07%,NTF3;NTRK3;LIFR;MERTK;MST1R;ROR1;FRK;ACVR2A;MUSK;PTPRF;LCP2;SLA;EPHA2;AXL;NPR2;PDGFRB
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.333036460029899,-0.9978297805715812,0.4536082474226804,0.8613716737006648,1.0,10/24,26.55%,B2M;CANX;SEC24B;ACE;CALR;ABCB9;TAP1;TAPBP;HFE;TAPBPL
prerank,miRNA metabolic process (GO:0010586),0.4426085006819725,0.9975270581337883,0.4611801242236025,0.9916630448953196,1.0,6/20,13.83%,PARN;DICER1;DIS3L2;XPO5;DROSHA;DGCR8
prerank,mitochondrial membrane organization (GO:0007006),0.40243013845751885,0.9974932451610937,0.4419970631424376,0.9908590446174522,1.0,7/32,11.31%,PMAIP1;BCL2;RCC1L;OPA1;MTX1;DNAJC11;MFN2
prerank,retrograde axonal transport (GO:0008090),0.4523777161441468,0.9973439580282125,0.4858569051580699,0.9903797588189589,1.0,6/16,12.26%,DST;KIF1A;KIF5B;KIF1C;FBXW11;KIF5A
prerank,collagen fibril organization (GO:0030199),0.35721904183873915,0.9968217480352042,0.46265060240963857,0.9907530618869105,1.0,19/88,13.26%,COL18A1;COL4A2;COL4A1;ADAMTS14;P3H2;LOXL2;CRTAP;COL4A6;DST;PXDN;TGFB2;COL27A1;COL4A5;P4HA2;COL19A1;COL6A3;COL3A1;COL14A1;COL8A1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4802854405690008,0.9965724749924925,0.4752650176678445,0.9904925889375391,1.0,3/12,6.29%,DYRK2;IRS1;SORBS1
prerank,negative regulation of defense response (GO:0031348),0.3586148023548151,0.9961226125795309,0.47285886610373945,0.9907088299364887,1.0,15/77,11.29%,NR1H4;RORA;FEM1A;PTGIS;ALOX5;MFHAS1;TNFAIP6;LPCAT3;PPARA;NR1D1;SIRT2;AOAH;GPER1;RB1;PRKCD
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.38252927174006923,0.995615792755804,0.4588688946015424,0.99114869848442,1.0,7/47,7.72%,ATP2B4;PTGIS;CAV1;FBXW7;PLEK;GLA;SNAI2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.38339858825180867,0.9954688118908221,0.4682230869001297,0.9906394336884787,1.0,8/50,10.62%,ACTN4;PTP4A3;LIMS1;TCIM;CD14;RELA;RTKN2;EIF2AK2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.42228699989207075,-0.9953550131215961,0.4689507494646681,0.8669764070392338,1.0,2/11,0.31%,DAB2;MLLT3
prerank,cellular response to hexose stimulus (GO:0071331),-0.3417557045786196,-0.9952127755675935,0.45429362880886426,0.8661721260377621,1.0,6/23,12.73%,ZBTB20;UNC13B;TRA2B;ERN1;SOX4;PCK2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.42222269964632675,0.9951840046693966,0.4602446483180428,0.9904673135664219,1.0,12/25,20.32%,ELL;HEXIM1;HNRNPU;CDK12;NELFB;NELFCD;ZMYND11;BRD4;CDK13;EAPP;WDR43;NELFA
prerank,regulation of telomere capping (GO:1904353),-0.3419867574528981,-0.9949998363402539,0.42857142857142855,0.8655966433515183,1.0,8/23,18.11%,TNKS2;RAD50;USP7;NBN;MAP3K4;HNRNPD;SMG6;ATM
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3945664918073948,0.9949489464149218,0.4647137150466045,0.9901682996714072,1.0,6/40,10.38%,SLC38A11;SLC16A7;SLC38A2;SLC23A2;SLC23A1;SLC7A8
prerank,regulation of neuron migration (GO:2001222),-0.325805284439837,-0.9948885041985676,0.4269340974212034,0.8647516053957308,1.0,4/26,7.31%,PHACTR1;SEMA6A;SRGAP2;SEMA3A
prerank,ncRNA 3'-end processing (GO:0043628),-0.3866092545246185,-0.9947828455943085,0.47126436781609193,0.8639318453339546,1.0,8/14,28.47%,INTS6;TRNT1;SSB;INTS2;PTCD1;ELAC2;INTS14;TOE1
prerank,T cell receptor signaling pathway (GO:0050852),-0.23431151506475467,-0.9943782651773153,0.47126436781609193,0.8638991681885049,1.0,29/138,15.97%,PIK3CA;WNK1;PDPK1;KHDRBS1;RC3H2;FYB1;PLCG2;NCK1;DENND1B;PIK3CB;PSMD7;PSMD9;PSMD13;PTPN22;IKBKG;RBCK1;TAB2;RNF31;PSMB3;CHUK;EIF2B3;NFKBIZ;PSMC5;PSMA5;PSMA1;PSMC2;STOML2;SPPL3;THEMIS
prerank,positive regulation of protein modification process (GO:0031401),0.3321301234903834,0.9943742914671025,0.5073529411764706,0.9907235811026287,1.0,34/203,12.39%,NTRK3;DLC1;ANGPT1;FGF1;CCN1;CCND2;THPO;FAM20A;ACVR2A;MUSK;CAMKK2;RARRES2;DYRK1A;ATG7;VEGFA;PPP2R5A;PIN1;TRABD2B;CALM1;RAMP1;RASGRP1;ITGB3;SOX9;CCND1;ADAM17;RAP2A;PELI2;GPER1;ROCK2;PRKCD;CLIP3;TNIK;AKTIP;CHRNA7
prerank,cardiac atrium morphogenesis (GO:0003209),0.459314420033484,0.9942129973441187,0.47495961227786754,0.9902319677590953,1.0,2/16,7.87%,HEY2;TGFB2
prerank,positive regulation of type I interferon production (GO:0032481),-0.2570270555875673,-0.9938977463982686,0.4491017964071856,0.864098224701079,1.0,33/73,26.58%,DDX3X;PTPN11;PRKDC;XRCC5;RNF135;MRE11;IRAK1;POLR3F;CTNNB1;PTPN22;RIOK3;POLR3B;CHUK;POLR3A;XRCC6;EP300;TRIM56;TLR3;POLR3H;OAS2;POLR3E;STAT6;POLR2K;HSPD1;POLR2F;POLR2H;POLR3GL;POLR3C;DDX41;TOMM70;POLR3D;NFKB2;POLR2E
prerank,regulation of spindle assembly (GO:0090169),0.42363082716143285,0.9936482831030483,0.48391812865497075,0.990736601206492,1.0,6/25,13.44%,CHMP4C;CHMP5;HNRNPU;CHMP2B;SENP6;CHMP2A
prerank,regulation of cytoplasmic translation (GO:2000765),0.463990820745924,0.993302505343868,0.46536412078152756,0.9906894693791415,1.0,2/14,6.44%,RBM24;CPEB1
prerank,negative regulation of growth (GO:0045926),0.345741450427687,0.9929550873791367,0.48106904231625836,0.990593714619466,1.0,22/121,14.70%,SLIT3;TMPRSS4;MYL2;RERG;FHL1;JADE1;NDRG3;TP53;BTG1;TGFB2;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6;MUL1;HYAL1;VGLL4
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.2894214931898886,-0.992596360462309,0.4562043795620438,0.8666470072255273,1.0,10/43,12.78%,PRKCB;PID1;GKAP1;PTPN11;PIP4K2B;NCK1;IGF2;OGT;GRB14;ENPP1
prerank,regulation of transposition (GO:0010528),-0.3871015083823586,-0.9923776181091439,0.47277227722772275,0.8660386694087481,1.0,3/13,18.06%,UBR2;SIRT7;TEX15
prerank,negative regulation of stress fiber assembly (GO:0051497),0.418501009445739,0.9922721733768735,0.4486404833836858,0.9914211103510467,1.0,4/24,4.86%,DLC1;PHLDB2;CLASP2;ARHGAP6
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3652527894694924,-0.9919167798466682,0.4597156398104265,0.8661302637645867,1.0,8/18,24.27%,RAB11A;VPS4B;RCC2;CDC25B;CDC25A;MECP2;CDC7;RAD51C
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3168975947719211,-0.991844740132036,0.4894366197183099,0.8651701050322078,1.0,17/31,28.64%,DCPS;LSM1;DIS3;EXOSC1;DCP2;EXOSC9;EDC4;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;EXOSC5;LSM3;LSM6
prerank,cellular lipid catabolic process (GO:0044242),-0.3248153412550417,-0.991545564988295,0.45454545454545453,0.8648891635419226,1.0,8/27,18.52%,LPIN2;ENPP2;CYP1B1;ACOT8;ACBD5;ABHD12;ACOX1;LPIN3
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.33088587281804305,-0.9914598603778404,0.4421364985163205,0.8640244215812385,1.0,5/25,9.37%,RIN3;APP;ANKRD13A;ITGAV;SDCBP
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2856087403212926,-0.9912666035562582,0.4505928853754941,0.8634689997083699,1.0,11/41,16.13%,IGF1;LBP;LGALS9;ILRUN;CD34;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;RARA
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4667345338215144,0.9912512930700551,0.4925124792013311,0.9931270703093771,1.0,2/13,5.63%,MYD88;PIK3AP1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.44346254053708933,0.99118796470276,0.4746317512274959,0.9924124836807787,1.0,5/19,12.92%,AMPD1;TERT;AMPD2;POLD1;GMPR
prerank,axon development (GO:0061564),0.3587516453072779,0.9909767800744907,0.4916864608076009,0.9920510333642427,1.0,24/78,19.87%,SEMA5A;MAP1B;SLITRK5;ACTB;KLF7;SLITRK4;MAPT;AFG3L2;RAB3A;BRSK1;GAP43;S100A6;ZDHHC17;ARHGAP35;ADGRB1;RTN4RL1;RAB8A;RYK;MARK2;MAP1A;MAP1S;BRSK2;NREP;PARD3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3393712853073639,-0.990768686543244,0.46511627906976744,0.8636392293746787,1.0,10/23,23.12%,NUPR1;CRY1;HDAC4;SIK1;EP300;C1QTNF3;GIT1;CBFA2T3;CLK2;PGP
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.25630658009162166,-0.990696649868035,0.43478260869565216,0.8627491083134127,1.0,23/76,18.63%,ARRB1;BMP7;ITCH;NFKBIA;IRAK1;PRMT2;PARP10;DAP;USP7;COMMD1;CYP1B1;IRAK3;PYDC1;RBCK1;IRAK2;CHUK;ANXA4;G3BP2;MTURN;NLRC5;LRRC14;NWD1;ZC3H12A
prerank,positive regulation of viral transcription (GO:0050434),0.4216121337217424,0.9904801769343046,0.47763347763347763,0.9923303105756849,1.0,9/25,18.19%,POLR2L;POLR2I;POLR2G;CCNT1;NELFB;POLR2J;NELFCD;DHX9;RSF1
prerank,protein heterotetramerization (GO:0051290),-0.38660146953354646,-0.9904414305228041,0.4569377990430622,0.862248956241224,1.0,6/13,42.48%,PKD2;FARSB;CPSF6;HSD17B8;GRIN1;GRIN2B
prerank,bile acid biosynthetic process (GO:0006699),0.4309886266169173,0.9903013299225846,0.4714285714285714,0.991879131541797,1.0,5/24,11.79%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,regulation of integrin activation (GO:0033623),0.45947586189345285,0.990274219159467,0.47783251231527096,0.9910737673203247,1.0,3/15,7.52%,FERMT2;JAM3;PLEK
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.3571331624054156,-0.9902449330108744,0.4845360824742268,0.8616850535959427,1.0,4/18,10.05%,HDAC7;CD34;NAV3;HOMER3
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.3628089649768397,-0.9898480498570562,0.4891304347826087,0.8615727243496273,1.0,10/18,33.90%,PTBP3;RPS13;ESR1;TGFB1;NRDE2;ZC3H12A;TMBIM6;ZC3H10;NCOR1;NUDT16
prerank,nucleosome organization (GO:0034728),0.36795827790656427,0.9890952390586373,0.4830729166666667,0.9930450914452001,1.0,15/55,19.31%,SMARCD3;H1-0;ARID1A;SET;CHAF1B;SMARCB1;SOX9;MCM3AP;SMARCA5;INO80;RSF1;NAP1L4;VPS72;NAP1L2;BRD2
prerank,regulation of stem cell proliferation (GO:0072091),-0.3646146378988848,-0.9890377143493343,0.4744897959183674,0.8627052454977485,1.0,3/17,1.74%,AGO3;FBLN1;GJA1
prerank,regulation of Notch signaling pathway (GO:0008593),0.3559008643626545,0.988811938909523,0.47342995169082125,0.9929222526859681,1.0,16/76,12.64%,NOTCH3;TCIM;JAG1;EPN2;FBXW7;RFNG;MAML2;YTHDF2;YJEFN3;YAP1;TGFB2;MAML3;SREBF2;ZBTB7A;TM2D3;PDCD10
prerank,histone mRNA catabolic process (GO:0071044),-0.37963853821041116,-0.9886696640427255,0.4766355140186916,0.8626717504301733,1.0,6/15,18.83%,SSB;LSM1;DCP2;TUT4;ATM;TUT7
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.40243258588139685,0.988590729606523,0.47493036211699163,0.992604100478806,1.0,9/35,10.85%,PADI2;ARID1A;UBR5;NEDD4;AR;MED1;PPARGC1B;YAP1;GPER1
prerank,regulation of defense response to virus (GO:0050688),-0.38919754842121845,-0.9885776536655843,0.5056179775280899,0.8617776481643499,1.0,4/14,7.41%,ITCH;PPM1B;ILRUN;PCBP2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.2497197090739245,-0.9885261714289559,0.4716981132075472,0.8607926538944536,1.0,19/80,17.92%,UACA;DAPK1;EPHA7;SH3RF1;HMGB1;DDX3X;NOD1;TNFSF10;RPS6KA3;CD44;DELE1;PDCD5;PPM1F;IGBP1;SNCA;FIS1;AKT1;GPX1;SIAH2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4394967558277481,0.9883565756807585,0.48058252427184467,0.9922824867291526,1.0,5/20,7.87%,HEY2;HEYL;HAS2;SNAI2;TGFB2
prerank,regulation of water loss via skin (GO:0033561),0.4592191954966218,0.9883081803859521,0.49122807017543857,0.9906578461678814,1.0,2/15,4.19%,TMEM79;FA2H
prerank,establishment of skin barrier (GO:0061436),0.4592191954966218,0.9883081803859521,0.49122807017543857,0.9906578461678814,1.0,2/15,4.19%,TMEM79;FA2H
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.34720747336429897,-0.9874626830430959,0.47262247838616717,0.8625867859935766,1.0,9/21,22.00%,CGNL1;SLIT2;CYRIB;CD2AP;SPRY2;ARHGAP25;SYNGAP1;MAPKAP1;EPHB2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.32327749115762866,-0.9874579547211829,0.44970414201183434,0.861501339050176,1.0,3/25,0.71%,IGF1;NSD1;NIBAN2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.4598807384986636,0.9871349360098448,0.49745331069609505,0.9926825306510232,1.0,5/16,16.17%,CGAS;FANCB;RIF1;RMI2;MAD2L2
prerank,nucleic acid metabolic process (GO:0090304),0.36723422293749836,0.9871084748077953,0.4870530209617756,0.9918636700882341,1.0,14/69,13.69%,LSM8;POLR2L;POLR2I;HNRNPR;POLR2G;ATXN2;HNRNPU;DDX1;HNRNPC;POLG;KPNA2;POLR2J;DXO;DNASE1L1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3632515979520558,-0.9869695777020173,0.4772727272727273,0.8616716895987325,1.0,8/15,21.43%,PTN;NF1;CTNNB1;TAFA1;CX3CL1;KDM1A;DISC1;DRD2
prerank,long-term memory (GO:0007616),0.43868456938409506,0.9867411102882592,0.4529505582137161,0.9919227109107553,1.0,4/19,13.74%,SLC2A4;CALB1;CPEB3;SGK1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4609106138186518,0.9867394560464251,0.4697754749568221,0.9910595580022054,1.0,2/13,3.01%,LTBP1;GREM2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3232300217541872,0.9864494655054099,0.5297679112008072,0.9909785668613225,1.0,51/366,11.82%,SOX6;MLF2;WTIP;MEF2C;ZFHX3;PTP4A3;LIMD1;CCNA2;NAB1;RORA;MLF1;HINFP;GMNN;RBAK;ATXN1;PRKCQ;ATXN2;MYBBP1A;TP53;ZBTB38;SFPQ;CYFIP1;PPARGC1A;PPARGC1B;ZNF431;REXO4;BTG1;SNAI2;RELA;KMT2D;DAPK3;MSL3;FUS;NSD3;PPIE;KAT7;HIF1A;NR2C2;NUP107;PDGFA;SRSF10;RB1;DDX25;RHOH;RBM3;BAZ2A;NFX1;ACVR1B;ESRRA;PSPC1;USP13
prerank,negative regulation of viral transcription (GO:0032897),-0.38848174720321466,-0.9857271799855816,0.4809843400447427,0.8640649106678924,1.0,8/13,31.19%,TRIM14;LARP7;MID2;IFITM3;TRIM21;TRIM32;ZFP36;TRIM13
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3805176038110817,-0.9856371820540016,0.4681372549019608,0.8632400523234132,1.0,3/14,3.92%,ATR;TNKS2;XRCC5
prerank,regulation of protein processing (GO:0070613),0.4331985129265335,0.985400310913317,0.47962382445141066,0.9926828016530607,1.0,5/21,14.40%,ANGPTL8;SERPINE2;RUNX1;BAG2;LRRK2
prerank,negative regulation of cellular component movement (GO:0051271),0.4565526606773213,0.9852241579781379,0.4863481228668942,0.9922830765656523,1.0,2/15,6.75%,ACTN1;PIN1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.3266755808293449,-0.9851966041432285,0.49032258064516127,0.8633061415846226,1.0,11/26,15.79%,KMT2E;DDX3X;CCND3;EGFR;ADAMTS1;TFDP1;RDX;UBE2E2;RGCC;ANKRD17;AKT1
prerank,actin cytoskeleton reorganization (GO:0031532),0.36431006199551774,0.9848686205166085,0.4707379134860051,0.9922697704821174,1.0,15/63,14.00%,FLNA;MYH9;ANXA1;PTPN1;PLEK;WHAMM;PARVA;RAP2A;RICTOR;TNIK;CDC42BPB;DMTN;FGF10;MKLN1;S1PR2
prerank,regulation of filopodium assembly (GO:0051489),-0.2946104286921431,-0.984825698572762,0.48638132295719844,0.8631814091085221,1.0,15/38,24.73%,PALM;DOCK11;NRP1;RAB5A;NLGN1;FNBP1L;RIPOR2;DPYSL3;RHOQ;CDC42;FMR1;GPM6A;FSCN1;FXR1;ABITRAM
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.22155287219431594,-0.9845443924556576,0.4915254237288136,0.862789222054314,1.0,49/168,20.29%,DDX5;UPF2;PPP2CA;RPL27A;DCPS;SMG1;RC3H2;RPS19;SAMD4B;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;PABPC1;LSM1;RPLP0;RPS29;RPL28;RPS10;DCP2;RPLP1;RPS20;RPL23A;RPL34;NCBP2;PAN2;EXOSC9;RPL36A;RPS8;PAN3;RPS21;CNOT11;TUT4;RPL9;SMG6;ATM;ZC3H12A;RPS7;RPL27;TUT7;RPL11;PNRC2;NBDY;RPL18A;RPL37A;RPL38
prerank,keratinocyte differentiation (GO:0030216),0.41440076721790714,0.984376429335944,0.48678720445062584,0.9926060446338213,1.0,5/29,12.31%,ANXA1;JAG1;MED1;EPHA2;BCR
prerank,positive regulation of interleukin-1 production (GO:0032732),0.37393406485977376,0.984365052616543,0.47631241997439183,0.9917698655692664,1.0,4/51,3.34%,CD36;MYD88;FZD5;LPL
prerank,mucosal immune response (GO:0002385),-0.37960714236428267,-0.9837110339403214,0.4784688995215311,0.8638896997900484,1.0,2/15,9.12%,OTUD7B;DEFA6
prerank,regulation of JUN kinase activity (GO:0043506),0.40123592140754005,0.983664030708327,0.46853146853146854,0.992598813398786,1.0,5/33,8.98%,MAP3K5;TNFRSF11A;DAB2IP;MAP3K10;GSTP1
prerank,positive regulation of growth (GO:0045927),0.36585480355070044,0.9836556417964455,0.4775,0.9917569420952593,1.0,25/64,21.29%,AKAP6;IL2;PABIR1;FXN;BCL2;TGFB2;PLCB1;ADNP2;ADAM17;HDGFL2;CEP43;N6AMT1;HYAL1;RFTN1;INO80;DDX49;S100A8;S100A9;EIF4G2;WFS1;SLC25A33;ERBB2;TAF9B;H3-3A;LGI1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.45009673208553647,0.9836308867254178,0.47796610169491527,0.9909649320812801,1.0,2/16,5.17%,RYR2;TAPT1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4139484075650275,-0.983296070910306,0.484375,0.8639160575121225,1.0,4/10,13.74%,WNK1;PODXL;PIEZO1;DPP4
prerank,sulfur compound catabolic process (GO:0044273),0.3934006452355855,0.9830737807998603,0.497907949790795,0.9914911557871714,1.0,5/38,5.99%,CSPG4;NUDT7;BGN;TXN2;OGN
prerank,regulation of intracellular protein transport (GO:0033157),-0.3072939225427574,-0.9830688652681645,0.48771929824561405,0.863439952605505,1.0,10/32,10.29%,PTPN14;BMP4;PCM1;RUFY3;PRR5L;UHMK1;SIRT7;GCC2;ICE1;TGFB1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3449955985333638,0.9830408880426947,0.4813979706877114,0.9906936154129491,1.0,28/109,15.73%,PIP5K1B;INPP4B;PLA2G3;PIP4K2A;MTMR7;PITPNM3;PIP4P2;SYNJ2;SACM1L;PLEK;PLCB1;INPPL1;PLCD1;MTMR14;PDGFRB;INPP5B;CDIPT;SBF1;TPTE;PIK3C3;RAB14;PLA2G4A;PLEKHA1;PLA2G4C;INPP5J;PITPNM2;PTEN;VAC14
prerank,regulation of chemokine production (GO:0032642),-0.2979644784846094,-0.9828563291140496,0.47540983606557374,0.862898437946513,1.0,6/36,8.49%,FOXP1;APP;IL18;WNT5A;LGALS9;IL6R
prerank,regulation of sensory perception of pain (GO:0051930),0.464186609591864,0.982717145724841,0.48312611012433393,0.9906271641847113,1.0,3/11,11.93%,ACP3;MGLL;ATPSCKMT
prerank,inner ear morphogenesis (GO:0042472),-0.33156511380305537,-0.9826093087352119,0.4887640449438202,0.8625046315049181,1.0,5/22,13.53%,ZIC1;CHD7;FGFR2;SIX1;MYO6
prerank,steroid metabolic process (GO:0008202),0.35883261341070766,0.9818981058398157,0.4855072463768116,0.9918268367773098,1.0,7/72,5.64%,HSD17B10;CYP7B1;DHRS4;HSD17B7;PIAS4;HSD17B4;GC
prerank,regulation of ERAD pathway (GO:1904292),-0.4091709659714553,-0.9816386941555978,0.4868995633187773,0.8640178749586127,1.0,7/11,23.52%,ATXN3;RNF185;USP19;UBXN1;HERPUD1;RNFT1;USP25
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3257989510243403,-0.9813668865764892,0.4666666666666667,0.8637121277654227,1.0,11/26,33.54%,PDE8A;FBXO7;PRKN;AKT1;PARK7;ATF4;MAPK7;BAG5;HTRA2;PPIA;GPR37
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3648228416271036,0.981361813381671,0.47761194029850745,0.9923370715407668,1.0,9/60,10.92%,PARM1;PDGFB;PARN;PRKCQ;PKIB;CHTF18;NAF1;PDGFRB;CCT3
prerank,regulation of fat cell differentiation (GO:0045598),0.3551071649239158,0.9812065420883535,0.4919053549190536,0.9918486266495716,1.0,16/74,11.25%,FERMT2;RORA;RUNX1T1;LPL;ALOX5;RARRES2;ASXL1;BBS12;TAF8;YAP1;FTO;TRPM4;NR1D1;SIRT2;GPER1;LRP5
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.34296521353220133,-0.9811321189858924,0.4913294797687861,0.8632348352289297,1.0,7/21,18.52%,CYP26B1;LPIN2;ACOT8;ACBD5;HOGA1;ACOX1;LPIN3
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2788289317759847,-0.9811199103685978,0.44642857142857145,0.8621968529422794,1.0,12/51,17.13%,PTN;HMGB1;PTK2;LGALS9;MOSPD2;IL6R;AKIRIN1;VEGFC;CALR;PLA2G7;SERPINE1;VEGFB
prerank,ncRNA export from nucleus (GO:0097064),0.4002189262286943,0.98078419761442,0.48575498575498577,0.9920464200835318,1.0,13/36,20.77%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.37195444508346903,-0.9804208664511866,0.4782608695652174,0.8629860315673341,1.0,3/15,1.18%,UST;DCN;DSE
prerank,neurotransmitter secretion (GO:0007269),0.3823525268866084,0.9804133653269864,0.488031914893617,0.992119362775395,1.0,6/44,9.43%,STXBP2;SYT10;RAB3A;LIN7C;BRSK1;HRH3
prerank,embryonic digestive tract development (GO:0048566),0.4455708282102322,0.980228417255347,0.49445324881141045,0.9917063760844549,1.0,3/18,7.87%,RBPMS2;RARRES2;TGFB2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4435717922785715,0.9800801788325318,0.48509933774834435,0.9911808151816545,1.0,2/16,2.57%,PDK4;RORA
prerank,myelination (GO:0042552),-0.28080191383319747,-0.9799685768893577,0.48698884758364314,0.8631408682881015,1.0,14/46,20.41%,NF1;PLP1;ADGRG6;B4GALT6;SBF2;PLLP;MAL;ARHGEF10;CMTM8;LGI4;MYOC;EIF2B5;PMP22;BCAS1
prerank,fibrinolysis (GO:0042730),-0.38322401317223653,-0.9795533163490007,0.47815533980582525,0.8631150749605718,1.0,9/13,57.01%,PLAT;SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA
prerank,positive regulation of autophagy (GO:0010508),-0.24758871891668893,-0.9793227383133167,0.503030303030303,0.8626941777205387,1.0,24/81,19.65%,DAPK1;DCN;HMGB1;PAFAH1B2;TPCN1;FOXO1;GPSM1;PIK3CB;TFEB;OPTN;STK11;FBXO7;IKBKG;PRKN;TRIM5;IRGM;TRIM14;KDR;TMEM59;PLK2;MID2;ZC3H12A;PARK7;BNIP3L
prerank,regulation of defense response (GO:0031347),0.3553329131026403,0.9790420857286002,0.4867149758454106,0.9928121927381864,1.0,12/76,9.50%,AGTR1;MYD88;ANXA1;ALOX5;ELMOD2;SETD6;PIK3AP1;TRAF3;CELF1;RELA;MGLL;AKNA
prerank,cellular response to oxidative stress (GO:0034599),0.3411934593630613,0.9785108544801738,0.5116796440489433,0.993199936175594,1.0,28/118,17.32%,TPM1;NCF2;ANKRD2;CAMKK2;MAPT;TP53;PARP1;PPARGC1A;ADNP2;SRXN1;NUDT2;GSTP1;LONP1;PYROXD1;HIF1A;SIRT2;PRKCD;TXNRD2;PDK2;MAPK1;LRRK2;PRKAA2;ZFAND1;RAD52;MT3;SOD3;PRDX5;PRDX6
prerank,response to organonitrogen compound (GO:0010243),-0.29939388083126844,-0.9784516337136487,0.4915254237288136,0.863912968281777,1.0,13/38,22.56%,SEL1L;RNF185;DNAJB12;DERL1;GLRB;IRAK3;PRKN;GLRA2;RCN3;SYVN1;GLRA1;DRD2;CCDC47
prerank,phospholipid catabolic process (GO:0009395),-0.329007443777774,-0.9777016622518102,0.47674418604651164,0.8648090075068581,1.0,10/24,32.71%,ENPP2;GDPD1;ABHD12;GDE1;GPCPD1;PNPLA6;ENPP6;SMPDL3A;SMPD4;ANGPTL3
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3180118432458364,0.9776774244483576,0.562,0.9943810999852628,1.0,106/834,11.37%,MYOCD;NOTCH3;PPP1R12A;FHL5;HJV;ABRA;MEF2C;HEY2;ZFHX3;SMARCD3;FGF1;MICAL2;NR1H4;CSRP3;PDGFB;PPP3CA;CCN1;ZEB2;MLIP;FZD5;PLXND1;RORA;SS18L2;CDH13;NR4A1;CRTC1;GABPA;HEYL;JAG1;HINFP;MRTFA;TGFB3;CRTC3;FOSL2;ACVR2A;MCRS1;NR2F2;LMO7;VEZF1;ACTR3;ELL;OSR2;SP7;ARHGEF2;BMPR1A;KLF7;MEF2A;NCOA7;DBP;FOXJ3;ASXL1;KLF15;JUND;SMARCB1;DAB2IP;TERT;TP53;RXRG;VEGFA;PARP1;GRHL1;PIN1;ZBTB38;GDNF;MAML2;SFPQ;HOXC4;AR;PPARGC1A;MED1;PPARGC1B;YAP1;MED12;SOX9;TGFB2;RELA;KMT2D;SETD3;TNIP1;MAML3;PPARA;CCNT1;NR4A2;SKI;NR1D1;KAT7;PAXIP1;AKNA;CDK7;HIF1A;CRLF3;KANSL3;SIRT2;AGRN;HNRNPU;MED14;NR2C2;TEAD1;EIF5A;GPER1;PCGF5;SREBF2;RUNX1;PFKM;LRP5;ATF3
prerank,endoderm formation (GO:0001706),0.3931072391168366,0.9776170253587259,0.4918032786885246,0.9936684580626625,1.0,5/35,8.27%,COL4A2;ITGA7;DUSP5;ITGB5;ITGA4
prerank,sphingolipid catabolic process (GO:0030149),-0.3741425577246502,-0.9774769738540715,0.49385749385749383,0.8642855059784194,1.0,4/15,9.94%,ACER2;ENPP2;PPT1;ASAH2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3976707353747161,-0.9774323344994881,0.4847161572052402,0.8633205686536813,1.0,3/12,8.49%,GKAP1;PTPN11;IGF2
prerank,positive regulation of TOR signaling (GO:0032008),-0.28529878754327676,-0.9768468108266748,0.46885245901639344,0.8636540185563224,1.0,19/40,30.26%,PIK3CA;LAMTOR1;GOLPH3;RHEB;KLHL22;PIP4P1;NCKAP1L;GPR137B;MIOS;TELO2;SMCR8;RRAGD;LAMTOR2;GPR137;SIK3;PIH1D1;RRAGA;RPTOR;SLC38A9
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.25678162000347177,-0.9765126321179031,0.5031847133757962,0.863449125990365,1.0,28/77,25.48%,IGF1;SH3RF1;TCF7L2;BMP4;DDX3X;ITGA6;BIRC6;ITGAV;GHITM;BCL2L1;ASAH2;PRKN;TGFBR1;MAZ;CX3CL1;NOC2L;AKT1;GPX1;SIAH2;HERPUD1;PARK7;QARS1;PSME3;TMBIM6;SLC35F6;PELI3;CSNK2A1;CSNK2A2
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.35491860422705,-0.9762138504762109,0.4720812182741117,0.8632041109803804,1.0,8/18,29.45%,DAB2;RDX;MAP2K2;DNAJC13;SNX3;MTMR2;SNX12;SRC
prerank,cellular response to organic substance (GO:0071310),0.34295221949589144,0.9762030292874451,0.5011185682326622,0.9962947906085535,1.0,12/116,7.16%,SLIT3;AKAP6;NR1H4;CACNA1H;PDGFB;IGFBP5;CCL5;ACVR2A;PTPN18;BMPR1A;ARL6IP5;RAMP1
prerank,translesion synthesis (GO:0019985),-0.2877388871427763,-0.9760639531339627,0.46747967479674796,0.8625205961595923,1.0,21/42,37.17%,UFD1;PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;POLE2;ZBTB1;POLI;RPA3;RFC3;USP43;RPA2;POLD3;PCLAF;RPA1;RFC1;RFC4
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2984978088597078,-0.975795629218589,0.4982698961937716,0.8621557419982617,1.0,5/34,8.31%,WNT5A;RBP4;SLC7A5;STX4;PTPN22
prerank,regulation of protein catabolic process (GO:0042176),0.3378288481262904,0.9754068658519288,0.497116493656286,0.9973630613114204,1.0,10/99,7.95%,FLNA;NKD1;OAZ2;FAM83D;ATG7;ZDHHC2;DAB2IP;PIN1;NEDD4;SF3B3
prerank,cellular respiration (GO:0045333),0.3794973724888606,0.9752341968048271,0.48846675712347354,0.9969101019745936,1.0,17/41,22.11%,SIRT3;ME3;NDUFS1;SDHC;PPARGC1A;ETFA;SDHA;LYRM7;UQCRFS1;UQCRH;MTLN;MDH2;ATP5F1D;NDUFS4;OXA1L;COQ10A;ETFRF1
prerank,response to peptide hormone (GO:0043434),0.38455812930508754,0.9750824191521278,0.5153129161118508,0.9964297872977191,1.0,11/43,16.03%,ROCK1;ANXA1;IGFBP5;SORT1;IRS1;CAV1;GPER1;ROCK2;ZFP36L1;STAT1;STAT3
prerank,positive regulation of viral process (GO:0048524),0.36734230437812626,0.9749108851607245,0.49815043156596794,0.9959627814032015,1.0,19/60,18.19%,POLR2L;POLR2I;CCL5;TBC1D20;POLR2G;PPARA;CCNT1;PPIE;PKN2;AXL;CNOT7;KPNA2;NELFB;POLR2J;SRPK2;NELFCD;DHX9;VPS4A;RSF1
prerank,regulation of organelle assembly (GO:1902115),-0.24990255773327572,-0.9748123676836605,0.5222222222222223,0.8634947318701727,1.0,31/73,25.60%,TBC1D16;RAB5A;TBC1D15;DCDC2;NPRL3;ATG3;CENPJ;TBC1D2B;TBC1D13;TBC1D5;RDX;TBC1D8;IFT88;ATG5;TBC1D9B;RABEP2;TBC1D24;TBC1D22A;PLK2;UBQLN2;SGSM3;DYNLT2B;RAB1B;TBC1D10A;SDCCAG8;KIF9;TBC1D14;CYLD;TBC1D2;CEP76;CDKL1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4094771213064438,-0.9745979029746711,0.5066079295154186,0.8629909680407596,1.0,5/10,24.72%,NF2;PPP2CA;PARP14;PTPN2;INPP5F
prerank,regulation of catabolic process (GO:0009894),0.42959356347317756,0.974168108358629,0.5032258064516129,0.9969450186710779,1.0,4/18,5.88%,FAM83D;ITGB1;RARRES2;ZDHHC2
prerank,intracellular lipid transport (GO:0032365),0.41952432333355194,0.974104636412631,0.5123558484349259,0.996269508330501,1.0,6/21,14.42%,PRKAB2;ACACB;CPT1B;ABCD4;CPT1A;PRKAA2
prerank,multivesicular body assembly (GO:0036258),0.4022631099786436,0.9736636696152956,0.492816091954023,0.9965108597435116,1.0,9/30,15.02%,CHMP4C;CHMP5;IST1;STAM2;CHMP2B;TSG101;VPS36;CHMP2A;STAM
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.33393906741440127,-0.973663643926167,0.5225988700564972,0.8644294881336487,1.0,6/21,13.82%,IGF1;LGALS9;CTSH;ITGAV;MAP2K2;KDR
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.41069823022713503,-0.9732624006077877,0.5252747252747253,0.8644212851551665,1.0,5/10,36.58%,IRAK3;MAPK7;SIGIRR;TLE5;KLF4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.31241930634305126,-0.973111396621113,0.4752186588921283,0.8637830100297293,1.0,9/28,20.05%,PRKDC;PARP3;SIRT7;SMCHD1;DTX3L;WRAP53;KDM4D;HSF1;HMGA2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3728568261969029,0.9726485501379951,0.49301143583227447,0.9981070900661599,1.0,6/48,7.38%,FZD5;IL12RB2;CD276;CD14;IL12RB1;RASGRP1
prerank,central nervous system myelination (GO:0022010),-0.397558669933651,-0.9719420445697597,0.496551724137931,0.8657943366835242,1.0,2/11,4.96%,PLP1;B4GALT6
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.37394727648419657,0.9717873495417998,0.5019607843137255,0.9992808450292734,1.0,12/52,11.85%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;SORBS1;STAC3;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4207002519937919,0.9713217166631278,0.5088757396449705,0.9995143707250275,1.0,5/25,10.85%,PMAIP1;TP53;HRK;DNM1L;GPER1
prerank,establishment of melanosome localization (GO:0032401),-0.3509310547846492,-0.97118936001745,0.5102564102564102,0.8667072462470815,1.0,2/19,3.88%,SHROOM2;RAB11A
prerank,carbohydrate derivative transport (GO:1901264),-0.34789199668031817,-0.9711253912932801,0.5074257425742574,0.8658277224673762,1.0,6/18,22.47%,PLTP;LBP;SLC10A7;CLN3;SLC15A4;MFSD2A
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.42922106089379786,0.9710012719844691,0.4938080495356037,0.9994293282536095,1.0,6/20,12.89%,AMPD1;NT5C2;LHPP;AMPD2;PPAT;ADSS1
prerank,inflammatory response (GO:0006954),0.3249312142790157,0.9705144225371637,0.5148305084745762,0.9997507258769932,1.0,13/195,7.90%,AGTR1;AOC3;TMIGD3;PTGER3;ANXA1;CCL5;HDAC9;MFHAS1;CD14;TNFAIP6;MAPKAPK2;IL22;RELA
prerank,autonomic nervous system development (GO:0048483),-0.35478820092310626,-0.969922170855489,0.5128205128205128,0.8678822012376036,1.0,5/17,12.07%,NF1;FN1;NRP1;SEMA3A;SOX4
prerank,glucose metabolic process (GO:0006006),0.3606603617650712,0.969572170557852,0.49232736572890023,1.0,1.0,14/58,15.44%,ENO3;PFKFB1;MDH1;ADPGK;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;LRP5;CRTC2;SLC25A12;IRS2;GAPDHS
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3371856223542573,-0.9691348401806112,0.49866666666666665,0.868925087842984,1.0,12/20,37.27%,FAR2;PPT1;ACSL3;ACLY;ACSL4;HSD17B8;DGAT2;FITM2;GCDH;SLC25A1;SCD;ACACA
prerank,regulation of mitotic spindle organization (GO:0060236),0.39446958899554,0.9690263818681829,0.4837340876944837,1.0,1.0,9/35,17.38%,CHMP4C;NUP62;CHMP5;TPX2;HNRNPU;CHMP2B;CHMP2A;MAP9;DCTN1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.40627517364744237,0.9690204517441626,0.5148514851485149,1.0,1.0,3/29,6.25%,VASN;SDHAF2;DAB2IP
prerank,Fc receptor signaling pathway (GO:0038093),-0.23539451207703407,-0.9688714751012395,0.5689655172413793,0.8685444824447449,1.0,22/110,14.21%,NFATC3;GAB2;PIK3CA;GRB2;KIT;PDPK1;VAV2;PLCG2;PIK3CB;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;PSMA5;PSMA1;PSMC2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.28615261002133763,-0.9684125667059836,0.49224806201550386,0.8687838455221346,1.0,23/39,38.27%,ERCC5;FAN1;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;OGG1;RPA3;RFC3;RPA2;ERCC3;POLD3;RPA1;RFC1;RFC4;NTHL1
prerank,multivesicular body organization (GO:0036257),0.3983059501333343,0.9678319173782537,0.51,1.0,1.0,9/31,15.02%,CHMP4C;CHMP5;IST1;STAM2;CHMP2B;TSG101;VPS36;CHMP2A;STAM
prerank,positive regulation of signal transduction (GO:0009967),0.3211390808705968,0.9677758291535329,0.5413223140495868,1.0,1.0,48/238,15.42%,NTF3;FLNA;NTRK3;SLC2A4;FGF1;LIMS1;JAG1;DEPDC1B;KANK1;PTGIS;MN1;ASXL1;IRS1;MBD5;EPN2;SMARCB1;DAB2IP;SORBS1;LIMS2;TERT;MAML2;ITGB3;YAP1;TGFB2;TTC23;CUX2;MAML3;SKI;HIF1A;AXL;SLC39A14;GPER1;CD180;TM2D3;CHRNA7;CITED2;PDCD10;HOMER1;STK36;DMTN;SPIN1;GAS6;TUBD1;LRRK2;RAB34;PRKCA;PTEN;CAV2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3764451749821675,0.9676681346751327,0.5139813581890812,1.0,1.0,11/42,16.52%,CGAS;RAD51AP1;PARP1;CHEK1;ERCC6;FUS;FANCB;RIF1;RMI2;MAD2L2;SIRT6
prerank,nucleus organization (GO:0006997),0.37774298842526627,0.9674721742664623,0.4973474801061008,1.0,1.0,14/47,19.62%,CHMP4C;SYNE1;PITPNB;CHMP5;SUN2;CHMP2B;DMPK;CHMP2A;NUP98;SUN1;USP36;VPS4A;NUP54;NUP133
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.39520501447199674,0.9671112291890857,0.5109170305676856,1.0,1.0,7/31,11.25%,CRIM1;LIMD1;CDK6;SOX9;TRPM4;SKI;LRP5
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.35892973152457563,0.9668203894930311,0.516728624535316,1.0,1.0,15/61,16.91%,NR1H4;OAZ2;PDK4;CAV1;PSMC6;PPARA;PSME4;PSMB1;PSMD5;PSMB2;PDK2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4313103946501055,0.9668027076251944,0.5069551777434312,1.0,1.0,5/19,14.05%,CCL5;JAM3;RARRES2;MPP1;MAPK1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.45284473114819357,0.9666234662969456,0.4850498338870432,0.9998334732117331,1.0,5/14,16.17%,PAXIP1;RIF1;NECTIN2;KMT5B;MAD2L2
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3427077467699823,0.9665882834347546,0.5120274914089347,0.999078222987166,1.0,7/107,4.35%,NTF3;MEF2C;ABR;SLC8A2;SLC4A8;ITGB1;RIMS3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.45150484497584453,0.9665765282803798,0.49222797927461137,0.9982697840830341,1.0,5/14,14.06%,TBC1D20;SEC31B;SEC13;SEC24A;SEC24C
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3722852161734408,0.9665332627295051,0.5116580310880829,0.997520169443635,1.0,8/46,13.58%,FLNA;UBR5;TP53;NEDD4;BAG3;PRKCD;TRIM28;GAS6
prerank,regulation of cellular component biogenesis (GO:0044087),0.3794537420776062,0.9664997517135131,0.5070821529745042,0.9967794638727294,1.0,3/39,1.73%,RAP1A;ROCK1;CD36
prerank,positive regulation of cholesterol transport (GO:0032376),-0.31174698214200497,-0.9664540815066269,0.5227272727272727,0.872800803164417,1.0,5/27,4.90%,LRP1;PLTP;APOE;PTCH1;NFKBIA
prerank,negative regulation of cellular component organization (GO:0051129),-0.25255673076555385,-0.9661798223636744,0.5276073619631901,0.8724780819466809,1.0,18/74,16.77%,BMP6;DDX3X;XRCC5;EPHA3;MCTP1;HSPA5;IAPP;RDX;IRAK3;PEX5;RIOK3;SPRY2;DNAJB2;EP300;SYT11;AIDA;NOP53;CDC42
prerank,nucleotide metabolic process (GO:0009117),0.4167018702487779,0.9654258275880703,0.49920255183413076,0.9985592019135705,1.0,12/23,22.84%,NMNAT2;DCTD;AK7;NMNAT1;CMPK1;REXO2;CMPK2;DCK;FHIT;CTPS2;NMNAT3;NUDT5
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.4754525723113645,0.9652498532158056,0.496309963099631,0.9981269107586074,1.0,1/11,2.68%,CDH13
prerank,homeostasis of number of cells (GO:0048872),-0.3880142428850293,-0.9652085007705642,0.4844559585492228,0.8739696078400334,1.0,3/12,9.36%,NAPEPLD;NOS3;CCN3
prerank,anterior/posterior pattern specification (GO:0009952),-0.275405600950169,-0.9644890167803954,0.5407725321888412,0.8748258616267344,1.0,12/53,12.16%,HOXB6;HOXB3;PCSK5;HOXA3;HOXB4;HOXA5;BMPR2;WLS;ATP6AP2;HES1;TGFBR1;BHLHE41
prerank,regulation of cellular protein metabolic process (GO:0032268),0.37162876533289557,0.9643096965033746,0.5092838196286472,0.9995581112391068,1.0,6/47,11.39%,AGTR1;EDNRB;ATXN2;CYFIP1;DDX25;RBM3
prerank,regulation of protein sumoylation (GO:0033233),0.44650243375866205,0.9639565812857239,0.5145631067961165,0.9995553379778651,1.0,3/17,6.08%,UBA2;PIAS4;SAE1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.4068930683650241,-0.9632067337589099,0.5035460992907801,0.8770751630374323,1.0,2/11,7.10%,WNT5A;CTNNB1
prerank,receptor catabolic process (GO:0032801),-0.32853955601035145,-0.9627990111870701,0.5096952908587258,0.8771127907889719,1.0,11/24,30.62%,GPRASP1;TGFB1;AP2S1;RNF43;AP2A2;CLTA;UVRAG;ZNRF3;MVB12A;AP2M1;SNX25
prerank,response to gamma radiation (GO:0010332),0.41670240091309607,0.9627645616188409,0.5091743119266054,1.0,1.0,3/24,7.60%,MAP3K20;TP53;YAP1
prerank,protein homotrimerization (GO:0070207),-0.3812682659811609,-0.9623709740819075,0.5242718446601942,0.8760816368777243,1.0,2/14,3.82%,CLYBL;SCARA5
prerank,protein trimerization (GO:0070206),-0.3812682659811609,-0.9623709740819075,0.5242718446601942,0.8760816368777243,1.0,2/14,3.82%,CLYBL;SCARA5
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.25850423585856097,-0.9618038034086128,0.5454545454545454,0.8765492636773696,1.0,22/63,25.44%,CARM1;PRKDC;TFDP1;PML;ARID3A;MDM2;RGCC;SOX4;EP300;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;FBXO31;PCBP4;PLAGL1;CDK2;CDKN1A;CNOT10
prerank,phospholipid dephosphorylation (GO:0046839),0.37998926160459406,0.9617996618974489,0.5136298421807748,1.0,1.0,9/37,15.35%,MTMR7;PIP4P2;SYNJ2;SACM1L;PLPPR1;INPP5B;TPTE;INPP5J;PTEN
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.420081146153958,-0.9617336304303797,0.5291479820627802,0.8756684680762592,1.0,3/10,5.71%,WNK1;WNT5A;ADAM10
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2761961460798058,-0.9611915106475167,0.5425101214574899,0.8759834471109273,1.0,13/43,20.39%,IGF1;LBP;LGALS9;ILRUN;CD34;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;RARA;ZC3H12A;CD274
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.38591522236280595,0.9611336738748777,0.501412429378531,1.0,1.0,3/39,2.65%,ANGPT1;SEMA5A;ANO6
prerank,myeloid cell activation involved in immune response (GO:0002275),0.43321992225486317,0.9609325976359908,0.47791798107255523,1.0,1.0,2/18,2.43%,FER1L5;DYSF
prerank,cholesterol metabolic process (GO:0008203),-0.2545617643679384,-0.9605517386931912,0.5333333333333333,0.8766308845443643,1.0,32/68,36.85%,CYP27A1;APOE;ABCA1;LBR;GGPS1;CYP51A1;SCARF1;HMGCR;ACLY;SOAT1;ARV1;INSIG1;PIP4P1;SQLE;GBA2;PMVK;LSS;MVK;CLN8;RXRA;INSIG2;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;TM7SF2;SCAP;DHCR7;CH25H;LCAT
prerank,nucleoside catabolic process (GO:0009164),-0.4012566360556792,-0.9605268179417468,0.5077262693156733,0.8756576504615509,1.0,6/11,29.43%,NT5E;UPP2;UPB1;DPYD;DERA;NT5C1A
prerank,regulation of MAPK cascade (GO:0043408),0.32943994806577237,0.9602036296173245,0.5497267759562842,1.0,1.0,30/157,14.05%,NTRK3;ROCK1;LBH;PDGFB;CCN1;ROR1;ADRA1D;FAM83D;THPO;BCAR3;KSR1;CAV1;DAB2IP;DUSP3;RRAS;RASGRP1;MAP2K1;GSTP1;PAK2;EPHA2;PELI2;PDGFA;GPER1;ROCK2;ZDHHC17;TNIK;TAOK3;FGF10;EPHB1;MAPK1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.29511693727478094,-0.959924613516099,0.5264797507788161,0.8761917260342457,1.0,7/34,8.78%,NEDD4L;ANKRD13A;OTUD7B;ILRUN;LATS2;COMMD1;RIPOR2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3663906316340728,-0.9597208915152227,0.5175,0.8756654248975912,1.0,4/15,11.76%,PDGFRA;FGFR2;SIX1;TGFBR1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3118861191370988,0.9594680739353463,0.664,1.0,1.0,128/1082,11.25%,ACTA2;MYOCD;PRDM16;PPP1R12A;FHL5;TNNI2;HJV;ABRA;MEF2C;HEY2;MAP3K5;ZFHX3;SMARCD3;FGF1;LBH;NR1H4;CSRP3;RASL11A;PDGFB;PPP3CA;CCN1;ZEB2;MLIP;FZD5;RORA;SS18L2;CDH13;NR4A1;CRTC1;GABPA;ETS2;HEYL;JAG1;FZD4;PADI2;HINFP;MRTFA;TGFB3;H1-0;CRTC3;FOSL2;NUP62;ACVR2A;MCRS1;ARID1A;NR2F2;LMO7;TGFB1I1;VEZF1;CAMKK2;ACTR3;ELL;OSR2;SP7;ARHGEF2;BMPR1A;KLF7;CEP290;MEF2A;DYRK1A;NCOA7;TESC;DBP;FOXJ3;ASXL1;KLF15;JUND;SMARCB1;DAB2IP;TP53;RXRG;VEGFA;DYRK1B;PPM1A;PARP1;GRHL1;PIN1;ZBTB38;GDNF;MAML2;SFPQ;HOXC4;AR;PPARGC1A;MED1;PPARGC1B;CHEK1;YAP1;ERCC6;MED12;SOX9;RELA;PLCB1;KMT2D;SETD3;TNIP1;ZXDC;MAML3;PPARA;MAP2K1;CCNT1;NSD3;NR4A2;SKI;NR1D1;KAT7;AKNA;CDK7;HIF1A;CRLF3;SFR1;KANSL3;SIRT2;SERTAD2;AGRN;HNRNPU;NAT14;MED14;NR2C2;TEAD1;EIF5A;RAI1;GPER1;PCGF5;SREBF2;RUNX1;PFKM;LRP5
prerank,regulation of T cell chemotaxis (GO:0010819),-0.40471194809469624,-0.959022596617841,0.5176470588235295,0.8763521424430022,1.0,3/11,5.71%,WNK1;WNT5A;ADAM10
prerank,protein processing (GO:0016485),0.3370332267906376,0.9589738437393941,0.5177142857142857,1.0,1.0,6/102,6.32%,TMPRSS4;HJV;CLN5;KLK2;FXN;AFG3L2
prerank,microtubule nucleation (GO:0007020),0.42493148589031965,0.9588008555833973,0.4934210526315789,1.0,1.0,4/20,7.13%,CLASP2;TUBGCP6;TPPP;TPX2
prerank,stem cell differentiation (GO:0048863),0.38295145328908325,0.9586443700697633,0.510148849797023,1.0,1.0,8/39,12.35%,MEF2C;SP7;SETD6;TP53;TGFB2;LMBR1L;HTR2B;NELFB
prerank,regulation of cell morphogenesis (GO:0022604),0.3902100759666966,0.9586428220442248,0.48917748917748916,1.0,1.0,2/30,2.33%,WTIP;FERMT2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3454224273243427,0.9583908976888236,0.5115995115995116,1.0,1.0,10/75,9.58%,AGTR1;PDGFB;SEMA5A;CDH13;NR4A1;VEGFA;ITGB3;ITGA4;ADAM17;HIF1A
prerank,respiratory tube development (GO:0030323),0.392325860455093,0.958331342749584,0.5125925925925926,1.0,1.0,5/28,7.58%,FGF1;ITGA3;VEGFA;ABCA3;HECA
prerank,positive regulation of innate immune response (GO:0045089),-0.30342013373410737,-0.958151274236988,0.51,0.8775012376122023,1.0,17/30,37.02%,LBP;WNT5A;RPS19;POLR3F;RIOK3;POLR3B;NLRC5;SLC15A4;GBP5;POLR3C;POLR3D;NMI;TRIM6;SPI1;PLSCR1;ADAM8;ZBP1
prerank,negative regulation of neuron differentiation (GO:0045665),-0.33450468680812767,-0.9581219657653239,0.5257452574525745,0.8765383217303209,1.0,6/22,16.84%,BMP7;B2M;HES1;DTX1;CALR;CNTN4
prerank,positive regulation of sodium ion transport (GO:0010765),0.45645192975686233,0.9575276546181257,0.5132275132275133,1.0,1.0,5/12,15.60%,PRSS8;CNKSR3;AHCYL1;GPD1L;NOS1
prerank,amino acid transport (GO:0006865),0.3767449798137158,0.9574359044573058,0.5278137128072445,1.0,1.0,8/49,11.03%,SLC38A11;SLC6A17;SLC38A2;SLC25A29;SLC1A5;SLC7A8;SH3BP4;SLC6A15
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3538759593739642,-0.9574225269390731,0.5303430079155673,0.8772815232415474,1.0,7/16,17.59%,IRAK3;OGFOD1;GLE1;TBC1D25;INSR;CLN3;SHFL
prerank,RNA modification (GO:0009451),0.358262856521346,0.9574073267495917,0.5232558139534884,1.0,1.0,7/54,5.50%,WDR4;TRDMT1;NAT10;PARN;CDKAL1;TYW5;FTSJ1
prerank,Golgi to endosome transport (GO:0006895),-0.35602293664136814,-0.9573987840884705,0.5216346153846154,0.8762905050580262,1.0,4/16,10.58%,VPS13A;MON2;GBF1;EPS15
prerank,regulation of protein kinase B signaling (GO:0051896),0.32012092890391924,0.9566896080566204,0.5544973544973545,1.0,1.0,37/193,15.44%,NTRK3;ANGPT1;FGF1;HIP1;MST1R;PDGFB;FERMT2;SEMA5A;THPO;ITGB1;GCNT2;MFHAS1;MTDH;PIK3AP1;IRS1;RRAS;PHLDA3;AREG;PPARA;EPHA2;THEM4;AXL;PDGFRB;HBEGF;PDGFA;VAV1;GPER1;RICTOR;TPTE;FGF10;MUL1;GAS6;PLEKHA1;IRS2;RHOG;PTEN;MYDGF
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3953783295381683,-0.956400329297364,0.5353075170842825,0.877926664125662,1.0,5/11,27.46%,PPHLN1;SETDB1;MPHOSPH8;RESF1;SETDB2
prerank,response to chemokine (GO:1990868),-0.38744084482540875,-0.9560321001069795,0.5343137254901961,0.8778194726445357,1.0,6/13,18.63%,WNK1;SLC12A2;RIPOR2;DUSP1;LRCH1;ZC3H12A
prerank,positive regulation of cellular component organization (GO:0051130),-0.23312504489453553,-0.9560279311600419,0.6311475409836066,0.8767924661164508,1.0,29/107,20.51%,DAB2;FRMPD4;LRP1;NEDD4L;BMP7;CDH5;APOE;ABCB7;SHANK3;SLF2;CAMK1;TMEM30A;SURF4;ICE1;TGFB1;SLF1;NRXN1;TGFBR1;SNCA;INSR;MMP1;GPX1;LMAN1;BAX;PARK7;TIRAP;AJUBA;BID;GPC3
prerank,defense response to fungus (GO:0050832),0.44015457611603803,0.9557971668192317,0.5207006369426752,1.0,1.0,4/17,17.14%,RARRES2;FAM3A;S100A8;S100A9
prerank,positive regulation of developmental growth (GO:0048639),-0.2723274230225806,-0.9557780030717083,0.5418502202643172,0.8763888494330366,1.0,7/49,7.78%,NEDD4L;GHR;SEMA7A;RUFY3;GOLGA4;SYT1;SEMA4D
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.39634535690883255,-0.9556663240009593,0.547945205479452,0.8756608302928057,1.0,2/11,2.36%,IGF1;GHR
prerank,regulation of protein dephosphorylation (GO:0035304),0.3804547112106856,0.9553655955409165,0.5302826379542396,1.0,1.0,8/37,12.79%,DLC1;MFHAS1;PPP2R5A;PIN1;CALM1;ENSA;PRKCD;ARPP19
prerank,response to reactive oxygen species (GO:0000302),0.3637841716101664,0.9549069019942665,0.5167525773195877,1.0,1.0,12/54,14.36%,TPM1;CAMKK2;MAPT;STK26;GSTP1;HIF1A;STK24;TXNRD2;PDCD10;PDK2;MAPK1;HYAL1
prerank,regulation of fibroblast proliferation (GO:0048145),0.37186420092981143,0.9548932444626206,0.5176151761517616,1.0,1.0,11/45,10.75%,PDGFB;PDGFC;CDK6;PEX2;DAB2IP;TP53;CD300A;GSTP1;SKI;S100A6;PDGFA
prerank,protein import (GO:0017038),-0.24777150582815638,-0.9548825873465169,0.5531914893617021,0.8766312739859003,1.0,28/84,22.21%,APPL2;APOE;HSPA4;E2F3;PEX14;FAM53A;SLC25A17;NUP88;ALDH3A2;NUTF2;IPO8;PEX5;ACBD5;PTTG1IP;ABCD3;APPL1;NUP50;FIS1;AKT1;EIF4ENIF1;SAMM50;NUP85;IPO11;NXT2;PXMP2;PEX13;NUP214;RAN
prerank,protein O-linked mannosylation (GO:0035269),-0.35076739754612385,-0.9548433726775337,0.5637755102040817,0.8756974936554188,1.0,4/18,7.11%,TMTC1;TMTC2;RXYLT1;TMTC4
prerank,negative regulation of transport (GO:0051051),0.3629246566217236,0.9548125387900126,0.5147058823529411,1.0,1.0,6/51,7.49%,FER1L5;DYSF;PACSIN3;PIP4P2;ARL6IP5;ITGB3
prerank,carbohydrate catabolic process (GO:0016052),0.39034196242658215,0.954781858154515,0.5352697095435685,1.0,1.0,7/38,11.57%,ENO3;HK2;PFKFB1;NEU3;ALDOA;PFKM;MAN2C1
prerank,protein dephosphorylation (GO:0006470),0.32880641869286376,0.9546817842512999,0.5366922234392114,1.0,1.0,27/135,13.13%,PPP1R12A;PPM1L;PPM1J;PPP3CA;MTMR7;DUSP5;PPP2R1B;PPM1E;PTPN18;PTPRS;LHPP;SDHAF2;PTPRF;DUSP3;PPP2R5A;PPM1A;PTPN1;PPP1CB;PPP1CA;CTDSP2;DUSP29;FBXW11;SBF1;CTDSP1;TPTE;DUSP16;PPP3CB
prerank,mitochondrial fusion (GO:0008053),0.4351661745960601,0.9543259345344368,0.5257234726688103,1.0,1.0,9/18,21.73%,AFG3L2;OPA1;MIEF2;MIEF1;MFN2;USP30;MFF;MFN1;GDAP1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.45276258073022635,0.9543011501943015,0.5150501672240803,1.0,1.0,4/13,8.61%,PDGFB;SOX9;RELA;PPARA
prerank,regulation of axon regeneration (GO:0048679),-0.39692577727581607,-0.9540328588707284,0.5125284738041003,0.8766890750678025,1.0,2/12,2.92%,PTN;EPHA4
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.43460893839557935,0.9533046737127133,0.5235772357723577,1.0,1.0,4/16,7.44%,PADI2;ARID1A;AR;PPARGC1B
prerank,regulation of actomyosin structure organization (GO:0110020),0.44501810268764014,0.9531759475062077,0.5163511187607573,1.0,1.0,2/13,3.59%,ROCK1;ACTG1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3484238747993343,0.9530319490957772,0.5042219541616405,1.0,1.0,14/70,16.91%,NCF2;CD36;LNPEP;PSMC6;ITGB5;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;MFSD6;PSMA2;PSMD14
prerank,tRNA 5'-end processing (GO:0099116),0.4494800029616879,0.9527273041710846,0.5157342657342657,1.0,1.0,2/15,5.56%,HSD17B10;TRMT10C
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3966968703814957,-0.9522426036763969,0.5533333333333333,0.8802772363006282,1.0,5/11,28.10%,FBXO7;PRKN;PARK7;ATF4;RACK1
prerank,positive regulation of myelination (GO:0031643),0.46588061057308616,0.9522198411191917,0.5046728971962616,1.0,1.0,2/11,7.82%,TPPP;DICER1
prerank,lipid oxidation (GO:0034440),0.4598658632033715,0.9519780736553559,0.5408695652173913,1.0,1.0,2/12,7.19%,ALOX5;PPARGC1A
prerank,regulation of dendrite morphogenesis (GO:0048814),0.3935400359932691,0.9518063499745145,0.508100147275405,1.0,1.0,8/32,12.90%,SDC2;SS18L2;NEDD4;CUX2;RAP2A;IL1RAPL1;TNIK;SARM1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.246325445103542,-0.9516695934207514,0.5176470588235295,0.8806486591823995,1.0,24/73,21.36%,ROBO1;SMAD3;XDH;F3;NOD1;COL4A3;SENP1;ACER2;TNFSF10;DAP;CASP8;EGLN3;SNCA;CASP9;PPARG;APAF1;BAX;HSPE1;CRADD;AIFM1;CASP4;BID;MTCH1;HSPD1
prerank,DNA packaging (GO:0006323),0.43246782881511003,0.951581181365265,0.5192629815745393,1.0,1.0,4/16,10.55%,H1-0;CHAF1B;TP53;HAT1
prerank,intestinal absorption (GO:0050892),0.4668618292591455,0.9509162907085217,0.5381882770870338,1.0,1.0,1/13,1.73%,CD36
prerank,zinc ion transport (GO:0006829),-0.3212819722524229,-0.9508642502472939,0.5406824146981627,0.8816639868674526,1.0,6/21,15.27%,SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3264292727026936,0.9506734299146423,0.5526881720430108,1.0,1.0,28/144,16.23%,FLNA;PMAIP1;OAZ2;FZD5;BCL2;UBR5;KCNB1;CEP290;ZDHHC2;SAE1;TP53;FBXW7;MIEF2;MIEF1;BAG3;SREBF2;PRKCD;KIF20B;PDCD10;HPS4;TRIM28;GAS6;MTCL1;ZFAND1;YWHAH;ATG13;LEPROT;SLC51B
prerank,regulation of chromatin organization (GO:1902275),-0.3788013219666032,-0.9505554781708817,0.5279069767441861,0.8814452078494074,1.0,5/14,22.35%,MLLT3;IGF2;SETD5;SETD1A;TLK2
prerank,protein palmitoylation (GO:0018345),0.39017147059661467,0.9504890872147452,0.5352941176470588,1.0,1.0,12/30,18.77%,GOLGA7B;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;CLIP3;ZDHHC13;ZDHHC4;ZDHHC5;ZDHHC8;ZDHHC3
prerank,zymogen activation (GO:0031638),-0.27695402864252217,-0.9504736466137744,0.5362318840579711,0.8806234436062198,1.0,6/39,7.84%,CYFIP2;PLAT;CTSL;CTSH;CASP8;FURIN
prerank,positive regulation of T cell proliferation (GO:0042102),-0.266577509917431,-0.9499971175288339,0.5700483091787439,0.8809434169566013,1.0,8/55,8.49%,IGF1;IGFBP2;HMGB1;IL15;IL18;VCAM1;NCK1;IGF2
prerank,proteasome assembly (GO:0043248),0.4619891758218062,0.9492796994940794,0.5026269702276708,1.0,1.0,3/11,10.54%,ADRM1;OTUD6B;PSMD5
prerank,monocarboxylic acid metabolic process (GO:0032787),0.32817475528292794,0.9492584814887671,0.5400890868596881,1.0,1.0,18/117,10.97%,CKM;CD36;CKMT2;MCCC2;LPL;FA2H;ME3;DLD;CPT1B;MECR;GOT2;PPARA;VDAC1;AASDHPPT;THEM4;SCP2;AOAH;PTGR1
prerank,proteasomal protein catabolic process (GO:0010498),-0.20903712778212516,-0.9489476555403638,0.6595744680851063,0.8826679862849122,1.0,70/201,25.74%,NEDD4L;ARRB1;ATXN3;AREL1;ITCH;CUL3;SEL1L;RNF185;UBE2D3;DNAJB12;PML;DERL1;CTNNB1;BIRC2;PCBP2;PSMD7;PSMD9;PSMD13;MDM2;PELI1;TOPORS;RBCK1;WWP1;ARMC8;SMURF2;PRKN;KCTD2;RMND5B;DDB1;UBE4B;PSMB3;KLHL22;RNF34;STUB1;RMND5A;SKP2;RCN3;PSMC5;SIAH1;PSMA5;PSMA1;PSMC2;HECW1;NHLRC3;UBXN1;SIAH2;SYVN1;FBXW5;SPOPL;SPSB4;RNF41;BTRC;ZFAND2A;SHARPIN;KCTD17;PSME3;PSMC4;PRPF19;CCDC47;IFI27;UBE2B;PSMB6;FBXL19;RAD23B;TBL1XR1;SIAH3;UCHL1;PSMB10;HECTD3;SPSB1
prerank,selective autophagy (GO:0061912),-0.2618901948406204,-0.9484924672880077,0.5374449339207048,0.8827798246023579,1.0,23/56,22.14%,RB1CC1;DYNC1I1;DYNC1LI2;UBQLN1;RETREG1;TEX264;IFT88;PEX5;ATG5;PRKN;ATG2B;AMBRA1;UBC;ACBD5;ATG2A;LGALS8;KLHL3;ATM;PARK7;PCNT;DYNLL2;WDR81;UBB
prerank,apoptotic process (GO:0006915),0.31680032493256066,0.9483792710458738,0.5861344537815126,1.0,1.0,31/203,12.40%,ATP2A1;DLC1;PMAIP1;RNF152;HIP1;MYD88;HK2;TNFAIP1;BCL2;JADE1;NDUFS1;CD14;PARP1;BNIPL;CHEK1;MAP3K10;DAPK3;NUDT2;VDAC1;TRPC5;ATCAY;AHCYL1;PAWR;TNFRSF21;PRKCD;RELT;TCHP;BOK;TNFRSF25;DMPK;DIABLO
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3415162799816927,-0.9483469508522842,0.525065963060686,0.8821487232983477,1.0,7/18,15.31%,DCN;MCU;PRKN;DDHD1;RALBP1;KDR;FIS1
prerank,UV-damage excision repair (GO:0070914),-0.3831953904382521,-0.9480655547907515,0.5542725173210161,0.8818422658587429,1.0,7/12,41.60%,DDB1;XPA;ACTR5;ERCC1;POLD3;XPC;POLA1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.40908039142134567,-0.947395756894109,0.5419501133786848,0.8814287455792429,1.0,2/10,0.85%,NFAT5;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.40908039142134567,-0.947395756894109,0.5419501133786848,0.8814287455792429,1.0,2/10,0.85%,NFAT5;NFATC3
prerank,lytic vacuole organization (GO:0080171),0.38533425338735344,0.947044577072581,0.5257142857142857,1.0,1.0,9/32,14.40%,CLN5;HOOK2;ACP3;CLVS1;HOOK1;MBTPS1;AKTIP;HPS4;LRRK2
prerank,mitochondrial genome maintenance (GO:0000002),0.4685294979882332,0.9470295525331771,0.5281306715063521,1.0,1.0,4/11,9.01%,MEF2A;PARP1;OPA1;LONP1
prerank,membrane repolarization during action potential (GO:0086011),0.44634232017803166,0.9468423012819397,0.5398671096345515,1.0,1.0,2/13,5.83%,KCNE4;ATP1B1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.39004936931141054,-0.9468076362363887,0.5398633257403189,0.8818851757332717,1.0,5/10,18.54%,GHR;LYN;PRLR;STAT5A;STAT6
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.41977356931999044,0.9467844144511277,0.5349922239502333,1.0,1.0,3/19,5.63%,NR1H4;CD14;PIK3AP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.30973298091106216,-0.9467151744385249,0.5552325581395349,0.8811175753568439,1.0,7/26,15.90%,DAB2;FOXP1;CRY1;VPS18;PER1;CALR;CRY2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.38243853863898875,-0.9465787446506406,0.55,0.8804412240951661,1.0,5/12,26.57%,WNK1;AKT1;MIA3;ASS1;SKAP1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.36843672361507784,-0.9462990746933211,0.5359628770301624,0.880174052956024,1.0,5/14,19.46%,GJA1;SMURF2;ARHGDIB;CALR;YTHDF3
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.46956084954553245,0.9461988265620203,0.4944649446494465,1.0,1.0,1/10,5.12%,SAG
prerank,"phagocytosis, engulfment (GO:0006911)",0.3811113342478931,0.9461914624532815,0.518467852257182,1.0,1.0,8/36,15.31%,CD36;MYH9;XKR4;ARHGAP12;DOCK1;RHOH;ADGRB1;RHOG
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.30698482311225067,0.9460150175432258,0.637,1.0,1.0,89/572,13.15%,PRDM16;MYOZ2;HJV;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;PDGFB;ZEB2;EDNRB;MLIP;ID4;FST;FRK;LOXL2;ETS2;ARID5B;ZNF436;H1-0;NACC2;PRDM1;HDAC9;NR2F2;ANKRD2;NR2C1;USP2;ATXN1;OSR2;CBFB;KLF7;KCNIP3;MEF2A;PEX2;MTDH;SUV39H2;CAV1;TAF1;DAB2IP;ARID5A;TP53;VEGFA;PPM1A;PARP1;HEXIM1;SFPQ;NEDD4;AR;MED1;ZNF431;YAP1;SOX9;SNAI2;HSF4;DICER1;RELA;CUX2;LIN37;CCND1;PPARA;CBX4;IMPACT;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;BAG3;SIRT2;RIF1;HNRNPU;ZNF3;NR2C2;UBE2D1;SREBF2;RUNX1;RB1;ATF3;NKX6-1;ZBTB7A;NFX1;ORC2;CITED2;CPEB3;NR6A1;FNIP2;ZFP69;MXD4;BCL6
prerank,regulation of interleukin-2 production (GO:0032663),-0.28168944583134686,-0.9448953780210972,0.5355805243445693,0.8827075471287481,1.0,6/43,10.05%,SPTBN1;HDAC7;PLCG2;CD34;NAV3;HOMER3
prerank,regulation of neuron projection development (GO:0010975),0.3205479847357746,0.9447754505221052,0.5672766415500539,1.0,1.0,19/163,9.47%,RAP1A;NTRK3;PDLIM5;CAMK2G;SERPINI1;PLA2G3;ROR1;KANK1;CHN1;MARK1;PTPRS;ITM2C;KIF1A;DAB2IP;NCS1;CDH2;BRSK1;PAK2;ADCY6
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.38386063547567817,-0.9439724241603699,0.5525114155251142,0.8840002969812261,1.0,6/11,37.27%,STX4;CAMK4;TYROBP;ITGB2;SPI1;ITGAM
prerank,muscle cell migration (GO:0014812),0.46748868982349656,0.9439356991717873,0.5341959334565619,1.0,1.0,2/10,7.49%,ROCK1;ITGB3
prerank,histone acetylation (GO:0016573),-0.25307526284182064,-0.9437148670660839,0.5906432748538012,0.8836354963075206,1.0,18/69,18.18%,LEF1;PHF20;MBIP;TADA2A;YEATS2;TADA1;ATF2;NAA50;DR1;BRPF1;EP300;PER1;NAA60;TAF12;MORF4L2;MEAF6;TRIM16;TAF6L
prerank,melanosome localization (GO:0032400),-0.3335786419729785,-0.9432285506253126,0.5549597855227882,0.8838943244222618,1.0,2/21,3.88%,SHROOM2;RAB11A
prerank,regulation of ruffle assembly (GO:1900027),-0.32521315177496135,-0.9429659403571703,0.5519287833827893,0.8835547156605424,1.0,8/23,16.14%,EPS8;NLGN1;RDX;PLEKHM1;PFN2;PFN1;EPS8L2;EVL
prerank,detection of visible light (GO:0009584),-0.3532078184262959,-0.9426189643393096,0.5323741007194245,0.8834082117208713,1.0,7/16,41.38%,ABCA4;CEP250;RP1;CACNA2D4;TULP1;CNGB1;GNA11
prerank,establishment of spindle localization (GO:0051293),0.44439087611638256,0.9426142791552121,0.5271739130434783,1.0,1.0,4/14,18.59%,CLASP2;CLASP1;MAP4;CFL1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.43286624546290475,0.9425106112423048,0.5384615384615384,1.0,1.0,5/13,18.85%,EDEM2;UBE2J1;SVIP;BCAP31;BRSK2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.41562302686191344,0.9424891984780287,0.530448717948718,1.0,1.0,4/21,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,melanocyte differentiation (GO:0030318),0.47367117934988334,0.9424467503304818,0.5433212996389891,1.0,1.0,3/11,11.82%,MEF2C;MREG;USP13
prerank,pore complex assembly (GO:0046931),-0.3493741271933557,-0.942375049459994,0.5831062670299727,0.8830041037724712,1.0,8/19,22.87%,AFDN;ADAM10;AHCTF1;GSDMD;RTN4;NDC1;PDZD11;PLEKHA7
prerank,positive regulation of cell division (GO:0051781),-0.2803436076984577,-0.9421644340703376,0.5687732342007435,0.8824949064358603,1.0,14/38,23.47%,PKP4;CDC14B;CUL3;SPAST;PRKCE;FGFR2;CDC25B;GIPC1;CIT;CDC42;SVIL;CSPP1;DRD2;TAL1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2936720569633212,-0.9418521210854849,0.5205479452054794,0.8823005144834711,1.0,13/29,30.91%,RPS19;RRP36;RPS8;RPS21;TSR2;NOP9;DCAF13;UTP20;HEATR1;UTP6;MRPS11;RRS1;TBL3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.40806370519831614,0.9416686399812907,0.5255023183925811,1.0,1.0,8/22,18.77%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;CLIP3;ZDHHC4;ZDHHC8;ZDHHC3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.40806370519831614,0.9416686399812907,0.5255023183925811,1.0,1.0,8/22,18.77%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;CLIP3;ZDHHC4;ZDHHC8;ZDHHC3
prerank,negative regulation of neuron projection development (GO:0010977),-0.2549734023335666,-0.941438155881163,0.5826086956521739,0.8823462180863756,1.0,19/56,27.08%,EFNB2;LPAR1;APOE;EPHA4;NLGN1;RUFY3;SEMA3A;DPYSL3;RTN4;RAB29;CBFA2T2;HDAC2;PRAG1;PTPRO;EFNB3;PTPN9;BAG5;THY1;DENND5A
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.40418364404722884,0.9412074462101351,0.5227629513343799,1.0,1.0,4/23,15.01%,PLA2G3;LPCAT3;PLA2G4A;PLA2G4C
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.30062454190867355,-0.9410949739261266,0.5501618122977346,0.8812497776402288,1.0,9/29,30.56%,ACSF2;ACOT8;DBI;ACOT9;ACLY;CROT;ACOT7;ACOT11;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.30062454190867355,-0.9410949739261266,0.5501618122977346,0.8812497776402288,1.0,9/29,30.56%,ACSF2;ACOT8;DBI;ACOT9;ACLY;CROT;ACOT7;ACOT11;OXSM
prerank,regulation of dendritic spine development (GO:0060998),0.4167678666117884,0.9408773827239445,0.5340557275541795,1.0,1.0,3/19,6.12%,MEF2C;PTPRS;KIF1A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.2910096141964701,-0.9405782369099376,0.5643564356435643,0.8815420269521802,1.0,12/33,18.86%,PTPN11;PTK2;ACER2;FOXC2;CYP1B1;PDE3B;LYN;EPHA8;DPP4;SERPINE1;NCKAP1L;ITGB1BP1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3781206839215172,0.9405754924367937,0.5372714486638537,1.0,1.0,7/38,12.48%,ATP2B4;CD36;PTGIS;CAV1;GLA;ROCK2;CLU
prerank,engulfment of apoptotic cell (GO:0043652),0.4367073652228327,0.9403522202335302,0.5192629815745393,1.0,1.0,4/15,15.31%,XKR4;RHOH;ADGRB1;RHOG
prerank,pulmonary valve morphogenesis (GO:0003184),0.4218000752962043,0.9403328368179981,0.5153473344103393,1.0,1.0,4/17,7.87%,HEY2;HEYL;JAG1;TGFB2
prerank,7-methylguanosine RNA capping (GO:0009452),0.37829324254307467,0.9397361166455903,0.5233516483516484,1.0,1.0,5/31,9.53%,POLR2L;POLR2I;GTF2H4;POLR2G;CDK7
prerank,7-methylguanosine mRNA capping (GO:0006370),0.37829324254307467,0.9397361166455903,0.5233516483516484,1.0,1.0,5/31,9.53%,POLR2L;POLR2I;GTF2H4;POLR2G;CDK7
prerank,mRNA catabolic process (GO:0006402),-0.2756672047808623,-0.9390370462181904,0.596,0.8844192270083886,1.0,20/44,29.76%,AGO3;DDX5;METTL3;ERN1;DCP2;EXOSC9;TUT4;PNPT1;TUT7;NBDY;METTL16;LSM2;LSM5;CNOT10;NUDT12;AGO4;ZFP36;LSM6;PDE12;THRAP3
prerank,positive regulation of protein maturation (GO:1903319),0.4633224471377872,0.9385221168834829,0.5379310344827586,1.0,1.0,1/11,1.92%,ANGPTL8
prerank,positive regulation of histone modification (GO:0031058),-0.2916981730540465,-0.9378633835761937,0.5666666666666667,0.8864139402537019,1.0,16/33,35.74%,ARRB1;TADA2A;AKAP8;AKAP8L;SART3;CHTOP;KDM1A;FMR1;RPS6KA4;ZBTB7B;TADA2B;RUVBL2;SAP30BP;APLNR;PAF1;BRCA1
prerank,regulation of DNA replication (GO:0006275),-0.2668943328570109,-0.9374696744026845,0.5807860262008734,0.8863443198268388,1.0,14/49,16.09%,ATR;GLI2;EGFR;ACVRL1;PPP2CA;STN1;PDS5A;ORC5;BLM;CTC1;TSPYL2;ANKRD17;OBI1;USP37
prerank,regulation of collagen biosynthetic process (GO:0032965),0.41432347434223765,0.9372528920389862,0.5307820299500832,1.0,1.0,5/19,11.12%,VIM;TGFB3;EMILIN1;SUCO;RUNX1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4529668026217837,0.9369504014331419,0.5220458553791887,1.0,1.0,3/12,12.39%,ROCK1;ROCK2;CHRNA7
prerank,icosanoid metabolic process (GO:0006690),0.36729664687469143,0.936863972010562,0.5182186234817814,1.0,1.0,12/40,19.50%,PTGIS;ALOX5;TBXAS1;MAPKAPK2;MGLL;PTGR1;PLA2G4A;PLA2G4C;EPHX1;PON2;FAAH;ABCC10
prerank,response to glucose (GO:0009749),-0.2713280019160107,-0.9367324042201876,0.5669291338582677,0.8872006688754286,1.0,9/46,12.73%,ZBTB20;UNC13B;TCF7L2;TRA2B;EIF2B3;ERN1;SOX4;ZBED3;PCK2
prerank,regulation of mitochondrion organization (GO:0010821),0.3619357171433932,0.9359664630995101,0.5587431693989071,1.0,1.0,16/47,18.91%,INF2;FZD5;MAPT;FBXW7;PPARGC1A;MIEF2;VDAC1;DNM1L;SREBF2;MUL1;LRRK2;RHOT1;VPS35;USP36;MFF;HDAC6
prerank,regulation of mast cell activation (GO:0033003),0.47462429321396965,0.9355096361907793,0.5236363636363637,1.0,1.0,2/10,11.86%,MILR1;NECTIN2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.31781930492143085,0.9353318309235034,0.5845986984815619,1.0,1.0,38/153,17.53%,STK38L;ROCK1;MAST4;DYRK2;PDGFB;CAMK2D;MARK1;DYRK1A;PRKCQ;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;MAP3K10;BRSK1;PKN2;PAK2;ROCK2;PRKCD;RICTOR;DMPK;MAST1;GAS6;CSNK1E;SGK1;MAPK1;LRRK2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;HIPK2;MAST3;MAP3K13;EIF2AK3;MARK2;MASTL
prerank,positive regulation of cell projection organization (GO:0031346),0.3259333967179424,0.935105584714102,0.5727069351230425,1.0,1.0,9/115,3.34%,RAP1A;NTRK3;SERPINI1;PLA2G3;PLXND1;ROR1;SS18L2;PLXNB1;FZD4
prerank,regulation of osteoblast differentiation (GO:0045667),0.3310541891995905,0.9346463670096952,0.557396449704142,1.0,1.0,14/82,9.19%,MEF2C;CRIM1;LIMD1;CCN1;CDK6;FERMT2;ACVR2A;BMPR1A;YAP1;SOX9;SNAI2;TRPM4;SUCO;SKI
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.40191721865779517,0.9346105494057734,0.5273865414710485,1.0,1.0,2/24,2.51%,ANGPT1;SEMA5A
prerank,female gamete generation (GO:0007292),-0.2967623008577861,-0.9344740980965093,0.5857605177993528,0.8915856670318612,1.0,2/29,1.34%,PTN;MARF1
prerank,eye photoreceptor cell development (GO:0042462),0.4260512549387452,0.9343741864019145,0.518918918918919,1.0,1.0,3/15,6.51%,CEP290;RPGRIP1L;VEGFA
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.31171407496868886,-0.9342565100831802,0.5574229691876751,0.8910929965775275,1.0,8/23,16.28%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C
prerank,defense response to Gram-positive bacterium (GO:0050830),0.36895568281647523,0.9334147586479292,0.5411436541143654,1.0,1.0,10/40,16.54%,MYD88;DMBT1;RARRES2;MBL2;ADAM17;GBP2;DROSHA;RNASE3;MR1;MPEG1
prerank,DNA recombination (GO:0006310),-0.27880708707362684,-0.9333050486723697,0.5724907063197026,0.8923634171196765,1.0,17/37,37.91%,HMGB1;MRE11;RAD50;FBH1;BLM;RAD51C;IGHMBP2;ERCC1;TSN;XRCC2;RAD54L;RPAIN;RAD51;LIG4;RPA1;HDAC10;GEN1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.4469437317667245,0.9332318976617818,0.5132275132275133,1.0,1.0,2/12,4.95%,SEPHS2;SEPHS1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.38572866798369365,0.9332307452464448,0.5269461077844312,1.0,1.0,4/27,4.86%,DLC1;PHLDB2;CLASP2;ARHGAP6
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3712656528360885,-0.9331880164714447,0.5647058823529412,0.8916475077727143,1.0,5/14,16.88%,IGF1;LDLR;CX3CL1;SYT11;GRN
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.390405084667646,0.9331370646249002,0.5305810397553516,1.0,1.0,2/26,2.53%,PRKAB2;PDK4
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.36034399909186965,0.933117702690002,0.5508365508365508,1.0,1.0,9/51,12.20%,RBPMS2;CRIM1;GREM2;ACVR2A;BMPR1A;SKI;VWC2L;UBE2D1;BMPR1B
prerank,regulation of peptidase activity (GO:0052547),-0.33531976737301183,-0.932982211683459,0.5475,0.8911247248802421,1.0,4/19,12.23%,NRDC;CTSH;FURIN;RCN3
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.32892626293094224,0.932871909497899,0.5672853828306265,1.0,1.0,19/101,13.37%,AGTR1;VIM;ASPH;SAMD4A;NAT10;ATG7;RPS27L;CIRBP;PYM1;AMER1;RPL5;IST1;EIF3E;RBM3;ZCCHC4;FBXW11;CPEB3;PERP;PLXNB2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3423926483814842,0.9321356245483755,0.5399515738498789,1.0,1.0,7/62,7.60%,ABRA;GPR20;SYNPO2L;NET1;MAPRE2;RASGRP1;GPR17
prerank,negative regulation of viral release from host cell (GO:1902187),-0.37079185409767,-0.9319458407994131,0.5800970873786407,0.8926613102066981,1.0,6/13,31.19%,PML;TRIM5;MID2;TRIM21;TRIM32;TRIM13
prerank,regulation of dephosphorylation (GO:0035303),-0.3561081286622613,-0.9316214550323387,0.533498759305211,0.8924878014409273,1.0,6/15,34.71%,MTMR4;IGBP1;SMG6;MTMR2;SRC;MTMR1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.368363387573996,-0.9314572715413975,0.5550122249388753,0.8919184412935347,1.0,3/13,7.95%,STX3;HSP90AB1;STX4
prerank,intracellular protein transport (GO:0006886),-0.2049700439139295,-0.9314325706263421,0.6666666666666666,0.8909703344373621,1.0,86/304,20.76%,RANBP3L;APPL2;TBC1D16;KIF13B;SNX27;E2F3;RABGAP1L;RAB5A;STXBP1;STX3;NLGN1;FAM53A;TBC1D15;USO1;ERP29;TBC1D8B;NUP88;TMED5;SEC23IP;RASSF9;TBC1D2B;SCG5;TBC1D13;STX5;HERC2;TBC1D5;STX4;ARL5B;TMED7;SURF4;TMED10;WLS;COPB2;NUTF2;IPO8;TBC1D8;FUT10;HOMER3;RANBP3;RAB3GAP2;TGFB1;SNX6;ARF3;UNC93B1;SNX15;ARFIP2;PTTG1IP;TBC1D25;TBC1D9B;SGSM1;GRTP1;MYO6;ARFGAP3;APPL1;NUP50;RAB1A;CALR;TBC1D30;MAIP1;GIPC1;RAB29;CCHCR1;TBC1D22A;TBC1D9;EHD1;AKT1;EIF4ENIF1;STX1A;SGSM3;LMAN1;COG7;PICK1;TMED3;SCFD1;STX8;RAB1B;NAPG;RPL11;TBC1D10A;SRPRA;TMED4;NUP85;IPO11;ARL4A;STX6;NXT2
prerank,regulation of nuclear division (GO:0051783),0.411505567214277,0.9313038747184441,0.5375,1.0,1.0,6/20,15.42%,PIN1;CUL9;DAPK3;KIF20B;FBXO5;CAV2
prerank,regulation of JNK cascade (GO:0046328),-0.2321713382933412,-0.9309285256581091,0.6031746031746031,0.8912327374908684,1.0,31/101,24.16%,TGFBR3;MECOM;SH3RF1;HMGB1;APP;ITCH;EGFR;PTK2B;MBIP;SEMA3A;RASSF2;SDCBP;SH3RF3;PRKN;MAPK8IP3;SIRPA;SH3RF2;TAOK1;PER1;AIDA;MTURN;TIRAP;GADD45B;DACT1;TAOK2;FLT4;MAP3K11;AXIN1;WNT16;MAPK8IP1;CYLD
prerank,positive regulation of immune system process (GO:0002684),0.4198711592849036,0.9308792063624842,0.5344,1.0,1.0,3/16,7.87%,ANXA1;VEGFA;TGFB2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3408583944028856,0.930748489435676,0.5423728813559322,1.0,1.0,9/75,7.87%,COL4A2;ATP2B4;ROCK1;ANGPT4;ALOX5;EMILIN1;DAB2IP;YJEFN3;TGFB2
prerank,positive regulation of transmembrane transport (GO:0034764),0.44787531087307675,0.9306822207983838,0.5477477477477477,1.0,1.0,4/13,15.65%,ANO6;ACSL5;CLIP3;AZIN2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.29666633714245727,-0.9306208054791905,0.5893416927899686,0.8909986158931322,1.0,5/30,5.55%,NIBAN2;DACH1;ACVRL1;STN1;BMPR2
prerank,cellular response to peptide (GO:1901653),0.3500523942900163,0.9302095368133293,0.5664160401002506,1.0,1.0,8/56,8.27%,CACNA2D1;CD36;VIM;ARHGEF2;CAV1;CHMP5;TP53;ITGA4
prerank,positive regulation of macroautophagy (GO:0016239),-0.26091281302522895,-0.9300060922320931,0.5535714285714286,0.8914740236632452,1.0,16/48,24.89%,DCN;PAFAH1B2;SPTLC2;PIP4K2B;GPSM1;OPTN;IKBKG;RAB3GAP2;IRGM;KDR;RALB;BNIP3L;UVRAG;SMCR8;LRSAM1;SESN2
prerank,negative regulation of apoptotic process (GO:0043066),0.30478527355562807,0.9298860604818276,0.6589769307923772,1.0,1.0,51/444,9.80%,NTF3;FLNA;MEF2C;NAA38;ANGPT1;NR1H4;MERTK;ANGPT4;MYD88;TCIM;PLA2G3;PDK4;CCND2;CRLF1;ANXA1;IL2;TGFB3;ITGB1;NUP62;ARHGAP10;SET;ATAD3A;FXN;BCL2;MYO18A;MTDH;CAV1;TP53;VEGFA;GDNF;SFPQ;PA2G4;PPARGC1A;MED1;BCL2L2;YAP1;FZD9;NAT8;OPA1;SOX9;SNAI2;RELA;API5;CBX4;VDAC1;TNFAIP8;GSTP1;NR4A2;PAK2;BAG3;AXL
prerank,actin filament polymerization (GO:0030041),-0.2954625778234412,-0.9298728086669091,0.5598705501618123,0.8908238618320858,1.0,2/29,0.74%,GAS7;COBL
prerank,cellular senescence (GO:0090398),0.3868926126346627,0.9292329005334442,0.5494011976047904,1.0,1.0,5/27,11.54%,TBX2;OPA1;MAP2K1;PRKCD;TERF2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3252583745625418,0.9292124071845858,0.5498812351543944,1.0,1.0,13/85,7.87%,ANGPT1;FGF1;LIMS1;CDK6;NR4A1;OSR2;PEX2;DAB2IP;VEGFA;LAMC1;YAP1;SOX9;TGFB2
prerank,ncRNA metabolic process (GO:0034660),0.3779579030809948,0.9286670396986912,0.5246575342465754,1.0,1.0,10/37,19.45%,PARN;DTD1;MAPT;DICER1;XPO5;DROSHA;DGCR8;PIWIL2;NIFK;PRKRA
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3271729624524824,-0.9285645503411115,0.5561497326203209,0.8930990322473101,1.0,8/20,28.96%,WNT4;PRMT3;SIK1;WDTC1;CEACAM1;ABCA2;ASXL3;ACADVL
prerank,negative regulation of RNA splicing (GO:0033119),-0.3398184988955725,-0.9285074047206158,0.5623188405797102,0.8922630310531212,1.0,10/19,26.25%,PTBP3;SRSF7;SRSF6;RPS13;SFSWAP;RBMX;PCBP4;TMBIM6;RNPS1;SRSF12
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.40479702407420814,0.9284969115190788,0.5321821036106751,1.0,1.0,4/21,9.35%,NDST3;EXT2;HS2ST1;HS6ST1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4105051700070086,0.92848308521985,0.5366242038216561,1.0,1.0,5/20,9.58%,CHD6;VEGFA;RELA;CARF;HIF1A
prerank,positive regulation of transferase activity (GO:0051347),0.3173526191772016,0.9277567483394352,0.5980284775465499,1.0,1.0,19/142,10.07%,PARM1;NTRK3;MERTK;MST1R;ROR1;DCUN1D2;MUSK;PARN;PRKCQ;FBXW7;PKIB;PIN1;CD200;CHTF18;DCUN1D1;NAF1;EPHA2;AXL;PDGFRB
prerank,protein import into peroxisome membrane (GO:0045046),-0.325868536856115,-0.9276699284095731,0.5751445086705202,0.8932907546763372,1.0,9/22,21.52%,PEX14;SLC25A17;ALDH3A2;PEX5;ACBD5;ABCD3;FIS1;PXMP2;PEX13
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.26146302519041525,-0.9272353440405521,0.591743119266055,0.8933608833556573,1.0,12/50,19.26%,SH3RF1;DDX3X;RPS6KA3;CD44;RNF34;IGBP1;SNCA;AKT1;GPX1;SIAH2;BCL2L12;PARK7
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.20941591666974657,-0.9271984733793509,0.765625,0.8924922137955593,1.0,28/149,13.38%,PRKCB;EDA;APP;PRKCH;IL18;WNT5A;NOD1;NFKBIA;LGALS9;IRAK1;RNF25;IRAK3;SLCO3A1;IKBKG;RBCK1;TRIM25;TAB2;RNF31;ALK;IRAK2;UBC;TRIM5;CHUK;CARD14;TRIM14;CX3CL1;TAB1;EP300
prerank,mRNA 3'-end processing (GO:0031124),-0.2337957980483907,-0.9269806153932278,0.6287425149700598,0.8920402977589537,1.0,35/78,32.17%,THOC2;APP;PABPN1;SRSF7;SRSF6;SRSF11;SRSF5;POLDIP3;SLBP;PABPC1;THOC5;SRSF2;LEO1;NCBP2;CHTOP;PAPOLG;SRSF3;CPSF2;SARNP;SCAF8;CPSF6;CSTF2T;SSU72;CPSF4;RNPS1;DHX38;ALYREF;CSTF2;CPSF1;LSM11;CLP1;POLR2D;PAPOLB;SLU7;DDX39A
prerank,cellular response to ionizing radiation (GO:0071479),0.3611963606744991,0.9268964222509988,0.5467914438502673,1.0,1.0,6/47,7.62%,MAP3K20;NET1;RAD51AP1;TP53;YAP1;RAD9A
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3957485809764054,-0.9267601337818304,0.5893271461716937,0.8915984711760351,1.0,4/10,9.35%,WNK1;ACER2;CYP1B1;PDE3B
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.39016139169390673,0.9266810434417114,0.5423476968796433,1.0,1.0,11/27,20.46%,PDGFB;PDGFC;CDK6;S100A6;PDGFA;GAS6;DHX9;MIF;AGT;NDUFS4;DDR2
prerank,establishment of mitotic spindle localization (GO:0040001),0.3852173975649221,0.9265796697546921,0.5544267053701016,1.0,1.0,8/28,17.51%,CLASP2;ITGB1;INSC;NSFL1C;FBXW11;CLASP1;DCTN1;UBXN2B
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3008062816002148,-0.9264148482456446,0.5859872611464968,0.8914236179361574,1.0,11/29,22.64%,IFNAR2;PTPN11;WNT5A;HSP90AB1;METTL3;SAMHD1;STAT2;NLRC5;YTHDF3;PTPN2;RNASEL
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.41783223156404575,0.9262268531631289,0.5356576862123613,1.0,1.0,6/19,11.12%,ROCK1;CBFB;SNAI2;EPHA2;ROCK2;RUNX1
prerank,negative regulation of response to external stimulus (GO:0032102),0.32310311492175514,0.9261992557969149,0.5845799769850403,1.0,1.0,18/105,11.29%,NR1H4;RORA;FEM1A;PTGIS;ALOX5;MFHAS1;PTPRS;TNFAIP6;DUSP3;AJAP1;LPCAT3;PPARA;NR1D1;SIRT2;AOAH;GPER1;RB1;PRKCD
prerank,negative regulation of cell cycle process (GO:0010948),-0.2494410886723426,-0.9255838992841782,0.5951219512195122,0.8924558504261041,1.0,10/61,8.59%,BMP7;RBBP4;BMP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,chromatin organization (GO:0006325),0.3175552312595092,0.9253356971065669,0.5909090909090909,1.0,1.0,18/132,12.72%,PRDM16;PADI3;SMARCD3;LOXL2;PADI2;CHRAC1;ARID1A;SUV39H2;SMARCB1;HMGN3;INO80C;SOX9;MCM3AP;RB1;BAZ2A;ZBTB7A;RUVBL1;SMARCA5
prerank,protein O-linked glycosylation (GO:0006493),-0.23678489324069124,-0.9252667918715769,0.616,0.8922208826460795,1.0,15/96,13.00%,GXYLT2;TMTC1;ST3GAL4;TMTC2;ST3GAL1;GALNT10;TET3;RXYLT1;PGM3;TMTC4;TET2;ST3GAL3;OGT;PLOD2;GALNT12
prerank,ATP transport (GO:0015867),-0.3951608607812781,-0.9251178318048741,0.5669642857142857,0.8915803380413525,1.0,4/10,35.74%,SLC25A17;SLC25A24;SLC17A9;SLC25A4
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.39644242986376926,0.9251062582243162,0.5519877675840978,1.0,1.0,8/24,9.58%,MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4;ITGB3;HIF1A
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.30553336371623874,-0.9251034395532536,0.5645161290322581,0.8906401922712878,1.0,3/24,3.53%,PID1;LEPR;COQ10B
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24889116849070048,-0.9248152232955198,0.6305418719211823,0.8903124915154134,1.0,19/59,16.92%,NFKBIA;BIRC2;TNFRSF1A;NKIRAS1;IKBKG;RBCK1;TAB2;RNF31;IRAK1BP1;IRAK2;UBC;CHUK;TAB1;FAIM;BIRC3;RELB;AKT1;TLR3;PRDX4
prerank,regulation of cytokinesis (GO:0032465),-0.23722825841853226,-0.9245779292526898,0.5987654320987654,0.8899184775498978,1.0,26/78,26.49%,PKP4;CDC14B;CUL3;SPAST;RAB11A;BIRC6;AHCTF1;BCL2L1;PRKCE;CDC25B;GIPC1;CIT;PLK2;CDC42;GIT1;SVIL;UVRAG;CSPP1;DRD2;ZFYVE26;PLK5;CCP110;PRPF40A;CALM3;BBS4;KIF23
prerank,bile acid metabolic process (GO:0008206),0.3916354895251188,0.9245757673979393,0.546969696969697,1.0,1.0,5/27,11.79%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,monocyte differentiation (GO:0030224),-0.39490758738543896,-0.92453515572671,0.5579868708971554,0.8890617762032933,1.0,6/10,17.75%,IL31RA;PIR;BMP4;THOC5;PPARG;MT1G
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3131889689799108,0.92445452057175,0.5865800865800865,1.0,1.0,21/150,10.79%,ANGPT1;FGF1;HIP1;MST1R;PDGFB;FERMT2;SEMA5A;THPO;ITGB1;GCNT2;MFHAS1;MTDH;PIK3AP1;IRS1;AREG;THEM4;AXL;PDGFRB;HBEGF;PDGFA;VAV1
prerank,proteolysis (GO:0006508),0.30895321983559115,0.9243367314970719,0.6286008230452675,1.0,1.0,34/252,14.96%,TMPRSS4;TINAGL1;MMP17;PAPPA2;PGPEP1L;HTRA1;LNPEP;RNPEP;APEH;AFG3L2;TRABD2B;CPA4;CPA3;ENPEP;ADAM17;LONP1;CAPN2;MIPEP;FBXO6;MBTPS1;ATG4D;LONP2;PHEX;RSPRY1;UBA3;DDI2;ATG4A;DPP8;SENP6;HM13;SPPL2B;ADAM19;PCSK4;CTSA
prerank,linoleic acid metabolic process (GO:0043651),0.42268738667527506,0.9242060875371025,0.5411184210526315,1.0,1.0,3/17,8.98%,ALOX5;FADS2;GSTP1
prerank,cholesterol efflux (GO:0033344),-0.3273126276489393,-0.9238971508374424,0.5706666666666667,0.889633373703105,1.0,2/20,2.39%,APOE;ABCA1
prerank,in utero embryonic development (GO:0001701),-0.307300263815567,-0.9237219914880885,0.5706214689265536,0.8890936342880804,1.0,7/25,11.76%,CHD7;ARNT2;ADAM10;FUT8;IGF2;FGFR2;TGFBR1
prerank,protein localization to condensed chromosome (GO:1903083),-0.3709937404588838,-0.9234825200010143,0.5648351648351648,0.8887283334318142,1.0,10/12,55.28%,IK;BUB3;ZWILCH;KNL1;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3355936731497353,-0.9231584802408441,0.547486033519553,0.8885484399687616,1.0,6/17,12.58%,FSTL1;SULF1;SLIT2;TMEM204;SFRP4;CASK
prerank,regulation of steroid biosynthetic process (GO:0050810),0.4505858665117707,0.9230530664198439,0.5505226480836237,1.0,1.0,1/11,1.64%,NR1H4
prerank,cellular response to interferon-beta (GO:0035458),-0.36333163080875724,-0.9225299918085345,0.5875299760191847,0.8891245134213295,1.0,9/14,40.51%,IRGM;PNPT1;IFITM2;HTRA2;CDC34;NDUFA13;TRIM6;IRF1;AIM2
prerank,endothelial cell proliferation (GO:0001935),0.4258229537119933,0.9224880544050643,0.5557432432432432,1.0,1.0,3/17,2.95%,ANGPT4;SEMA5A;LOXL2
prerank,alanine transport (GO:0032328),0.4627195388298272,0.9223828603313238,0.5465313028764806,1.0,1.0,1/10,2.28%,SLC6A17
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4022985184746879,-0.9219486203667244,0.5557894736842105,0.8895662942602678,1.0,5/10,14.44%,NEDD4L;PRKCE;COMMD1;OSR1;HECW1
prerank,mitochondrion organization (GO:0007005),0.3108411261092651,0.9219203344019695,0.6267379679144385,1.0,1.0,54/165,21.25%,ATP2A1;HSD17B10;GABPA;HK2;SIRT3;ATAD3A;NDUFS1;COX7A2L;MEF2A;AFG3L2;TERT;PARP1;PPARGC1A;OPA1;MTX1;MIEF2;MIEF1;TRAK1;ATCAY;LONP1;DNM1L;TFB2M;MFN2;ESRRA;MUL1;SIRT4;ADCK1;USP30;LRRK2;CAV2;DNM2;RHOT1;MGME1;TOMM5;ATP23;RAB38;BCAP31;MFF;TOMM7;ATP5F1D;GABPB1;AGTPBP1;VPS13C;PPRC1;HIGD2A;MTX3;PHB2;MFN1;SLC25A33;CLUH;BIK;TIMM9;TIMM22;OXA1L
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.34353944372489964,0.9217413035601253,0.5621890547263682,1.0,1.0,19/56,21.65%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;NDUFA1;NDUFAF2;NDUFAF1;NDUFV3;NDUFS4;OXA1L;NDUFA3;NDUFAF6
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.34353944372489964,0.9217413035601253,0.5621890547263682,1.0,1.0,19/56,21.65%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;NDUFA1;NDUFAF2;NDUFAF1;NDUFV3;NDUFS4;OXA1L;NDUFA3;NDUFAF6
prerank,retina homeostasis (GO:0001895),0.3988779317474019,0.921703193699268,0.5566037735849056,1.0,1.0,3/23,4.69%,ACTG1;POTEF;ACTB
prerank,regulation of lipid storage (GO:0010883),0.4007580160411743,0.9215922461769692,0.5518867924528302,1.0,1.0,4/22,8.01%,LPL;FBXW7;ITGB3;FTO
prerank,copper ion homeostasis (GO:0055070),-0.3478392623984268,-0.9214778839013928,0.5405405405405406,0.8897234320764136,1.0,5/17,22.58%,APP;COMMD1;ATOX1;MT2A;SLC31A1
prerank,negative regulation by host of viral process (GO:0044793),-0.3983371694157869,-0.9214493620409548,0.5656108597285068,0.8888296907993039,1.0,3/10,21.39%,PRKN;ZC3H12A;CCNK
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.35109328668955236,0.9209321988297481,0.5706874189364461,1.0,1.0,18/50,21.19%,POLR2L;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;AGO1;TPR;H3-3A
prerank,regulation of gene silencing by RNA (GO:0060966),0.35109328668955236,0.9209321988297481,0.5706874189364461,1.0,1.0,18/50,21.19%,POLR2L;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;AGO1;TPR;H3-3A
prerank,regulation of centrosome duplication (GO:0010824),0.38141057189100036,0.9207326821323149,0.5526315789473685,1.0,1.0,9/30,19.55%,CHMP4C;NAT10;CHMP5;CHMP2B;CEP120;CHMP2A;CCNF;CEP295;CENATAC
prerank,synaptic vesicle transport (GO:0048489),0.45827971107508625,0.9206969412098701,0.5512820512820513,1.0,1.0,6/11,21.96%,KIF5B;KIF5C;KIF5A;DNM2;SNAPIN;SYNJ1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35765236140384316,0.9205185899869042,0.5681233933161953,1.0,1.0,14/52,18.34%,PMAIP1;FZD5;BCL2;SAE1;TP53;FBXW7;SREBF2;HPS4;YWHAH;ATG13;LEPROT;USP36;BBC3;TOMM7
prerank,purine-containing compound salvage (GO:0043101),0.4468565843173902,0.9202956349374745,0.531021897810219,1.0,1.0,2/12,6.86%,AMPD1;AMPD2
prerank,placenta development (GO:0001890),-0.3877528071025813,-0.9202665333749868,0.580335731414868,0.8907303380006791,1.0,3/12,16.40%,PTK2;CUL7;PPARG
prerank,regulation of MAP kinase activity (GO:0043405),0.3300964231906371,0.9200289786034208,0.5819477434679335,1.0,1.0,21/92,14.42%,FGF1;MST1R;PDGFB;PDGFC;PDGFD;KSR1;DAB2IP;VEGFA;PTPN1;RASGRP1;CD300A;GSTP1;PDGFRB;PDGFA;PRKCD;HTR2B;CDK12;TSG101;PDCD10;LRRK2;DIRAS2
prerank,neutrophil degranulation (GO:0043312),0.29979638182981294,0.9199861102142074,0.6670010030090271,1.0,1.0,67/425,14.96%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,establishment of vesicle localization (GO:0051650),-0.32961987771825463,-0.9197399138405615,0.5684210526315789,0.8909888786424219,1.0,6/18,14.70%,LIMK2;RAB11A;TMEM230;CCDC186;IKBKG;SYT11
prerank,negative regulation of gene expression (GO:0010629),0.3012721243704139,0.9197397809209747,0.6562184024266936,1.0,1.0,44/302,12.64%,CCDC3;MEF2C;ATP2B4;HEY2;PDGFB;PLA2G3;HINFP;IGFBP5;SAMD4A;MRPL13;BTG2;HDAC9;RBMS3;ASB1;HAVCR2;BMPR1A;EMILIN1;TAF1;MAPT;TERT;SLC2A10;VEGFA;FBXW7;YTHDF2;CELF1;YAP1;DICER1;TGFB2;ATP2B1;DAPK3;DIS3L2;MAP2K1;HIF1A;PTBP2;EIF2AK2;GPER1;ROCK2;RUNX1;RB1;TERF2;CNOT7;CITED2;CPEB3;PDCD10
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.37828578093394694,-0.9196372220109293,0.592255125284738,0.8902646150512683,1.0,2/12,1.71%,FOXP1;HMGB1
prerank,cell cycle G1/S phase transition (GO:0044843),0.3390830475535465,0.91917377572544,0.5682102628285357,1.0,1.0,11/61,11.74%,CCNA2;CDK6;HINFP;EIF4EBP1;CUL2;CCND1;CDK7;CRLF3;RB1;GSPT1;ACVR1B
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.4397241324415435,0.9191732942502063,0.5668449197860963,1.0,1.0,3/12,7.69%,VEGFA;GDNF;SOX9
prerank,long-chain fatty acid import into cell (GO:0044539),0.452774461097694,0.9188235007137147,0.5386100386100386,1.0,1.0,1/10,1.73%,CD36
prerank,cellular response to unfolded protein (GO:0034620),-0.29467564280812863,-0.9188231180250169,0.5745341614906833,0.8912348415994926,1.0,12/26,29.35%,HSPA5;OPTN;PRKN;ERN1;HSPA13;BAX;HSPA9;HSF1;HSPD1;TMBIM6;PACRG;HSPA8
prerank,regulation of response to external stimulus (GO:0032101),0.3193108641036476,0.9188220817977878,0.5882352941176471,1.0,1.0,17/121,9.94%,AGTR1;CD36;MYD88;ANXA1;ALOX5;ELMOD2;SAG;SETD6;PIK3AP1;CAV1;CALM1;TRAF3;CELF1;RELA;MGLL;AKNA;STK24
prerank,positive regulation of phospholipid transport (GO:2001140),0.4510949928680234,0.918144332711931,0.5503597122302158,1.0,1.0,2/10,6.66%,ABCB4;ABCA3
prerank,neutrophil activation involved in immune response (GO:0002283),0.29885901981423874,0.9174373808832733,0.675025075225677,1.0,1.0,67/428,14.96%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,visual system development (GO:0150063),-0.2735737595821732,-0.917344740714523,0.6195652173913043,0.893753155137217,1.0,16/37,34.97%,SMOC1;PBX3;RBP4;MEIS2;MEIS3;PBX4;C1QA;SIPA1L3;PBX1;SMG9;ZDHHC16;MEIS1;ATF6;SALL2;C3;ADAMTS18
prerank,neurotransmitter transport (GO:0006836),0.3331100032927016,0.917314220285617,0.5783847980997625,1.0,1.0,15/73,14.52%,STXBP2;APBA1;SLC6A2;SLC38A2;RAB3A;LIN7C;BRSK1;HRH3;GLS2;GLS;SLC6A15;SLC29A1;PPFIA3;SLC38A1;DVL1
prerank,Wnt signaling pathway (GO:0016055),-0.2370147458749852,-0.9171827770097727,0.6030534351145038,0.8932134164966014,1.0,16/92,10.91%,LEF1;WNT4;TCF7L2;NXN;FZD6;DDX3X;WNT5A;KLHL12;BCL9L;DIXDC1;PLCG2;WNT9A;CTNNB1;WLS;SFRP4;UBC
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.43434123577413897,0.9170425075583352,0.5538461538461539,1.0,1.0,5/15,12.52%,BTG2;POLR2G;TENT4A;CNOT7;CPEB3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.32330234670847713,-0.9160681513125614,0.5911458333333334,0.8950527474388282,1.0,13/20,31.68%,HOXA5;PTK2B;CTR9;MEIS2;LEO1;HSPA9;HOXB8;HOXA9;MAFB;ZFP36;CIB1;LDB1;MEIS1
prerank,cyclooxygenase pathway (GO:0019371),0.45961054878932833,0.9159125580058273,0.5393053016453382,1.0,1.0,3/10,8.50%,PTGIS;TBXAS1;CBR1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3059812271227304,-0.9148765769094663,0.5955678670360111,0.8968881270793531,1.0,13/25,28.99%,EPHA4;PML;HSP90AB1;SGTA;OPHN1;GABARAPL2;RPS7;RPL11;TRIM39;CSNK2A1;CSNK2A2;HFE;PSMF1
prerank,small GTPase mediated signal transduction (GO:0007264),0.3231884297229267,0.914772702630887,0.608139534883721,1.0,1.0,22/103,14.17%,ABR;PLCE1;CCNA2;RASGRP2;RRAD;RERG;NTN1;KSR1;NUCB1;TP53;RRAS;RAPGEF6;RASGRP1;RIN2;ARHGAP30;ARHGAP1;RB1;USP50;BCR;ARHGAP32;TRIM28;G3BP1
prerank,cellular response to alcohol (GO:0097306),-0.2676934446928445,-0.913927883307887,0.6076923076923076,0.8982303428094378,1.0,14/42,18.12%,PTCH1;GRAMD1C;CDH1;ADCY7;CTNNB1;ADAM15;ADCY1;GOLPH3;AHR;GLRA2;BLM;GRAMD1A;ADCY3;PTGFR
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.45003521241558353,0.913770619161458,0.53584229390681,1.0,1.0,5/10,26.26%,FTO;MPG;ASCC1;ALKBH1;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.45003521241558353,0.913770619161458,0.53584229390681,1.0,1.0,5/10,26.26%,FTO;MPG;ASCC1;ALKBH1;ALKBH5
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.369459886531903,-0.9135490638230781,0.5683453237410072,0.8962392053934435,1.0,6/12,29.24%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.369459886531903,-0.9135490638230781,0.5683453237410072,0.8962392053934435,1.0,6/12,29.24%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.369459886531903,-0.9135490638230781,0.5683453237410072,0.8962392053934435,1.0,6/12,29.24%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.40047427584745277,-0.9132840654615327,0.5895196506550219,0.8959274214654792,1.0,3/10,15.22%,ENPP2;PLA2G6;PLA2G7
prerank,ncRNA processing (GO:0034470),-0.20082072662187925,-0.9130747677228657,0.7804878048780488,0.8954842757782278,1.0,77/200,30.27%,SMAD3;AGO3;INTS6;RPL27A;SRRT;RPS19;SENP3;NVL;RPL21;RPS24;RPL36;RPL18;METTL3;INTS3;SSB;POP1;RPLP0;DIS3;C1D;EXOSC1;RPL28;WDR3;RPLP1;INTS2;RPL23A;RPL34;RRP36;MPHOSPH10;FCF1;ADAR;EXOSC9;RPL36A;NOP53;SMAD2;AARS1;TUT4;RPL9;DDX52;RPS7;RPL27;TUT7;RPL11;RPL18A;RPL37A;RPL38;RRP7A;EMG1;DCAF13;RPL29;EXOSC2;EBNA1BP2;UTP20;RPL10A;INTS11;RPL32;BYSL;NOL11;NOP56;EXOSC7;EXOSC3;UTP18;RPS27;HEATR1;NOLC1;IMP3;WDR18;EXOSC5;PIH1D1;AGO4;PES1;RPL4;UTP6;FBL;RPS15;RPL35A;NOL8;POP4
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3102131504799151,0.9129971142486173,0.6008583690987125,1.0,1.0,38/175,17.40%,ACTN4;LIMS1;TNFSF13B;CCL5;ARHGEF2;HAS2;TNFRSF11A;PSMC6;DAB2IP;TP53;TRAF3;RELA;ADAM17;NR1D1;PSME4;EDAR;TRAF5;PSMB1;CCL14;PSMD5;EIF5A;GPER1;TNFRSF21;ZFAND6;TNFRSF25;GBP2;PSMB2;ZFP36L1;TMSB4X;HYAL1;PSMB7;PSMD3;STAT1;JAK2;PSMA2;DHX9;PSMD14;TNFSF12
prerank,clathrin-dependent endocytosis (GO:0072583),-0.30085272156807374,-0.9129244426869876,0.5977011494252874,0.8948951157224749,1.0,9/26,19.14%,FCHO2;DNAJC6;FNBP1L;CANX;AP2S1;LMBRD1;CLTB;AP2A2;CLTA
prerank,regulation of tissue remodeling (GO:0034103),-0.32926553864395314,-0.9126471666118793,0.6,0.8945732120723107,1.0,3/18,3.27%,LEPR;IL15;IL18
prerank,regulation of RNA metabolic process (GO:0051252),-0.25005851013410096,-0.9124525253748982,0.6213592233009708,0.8941316679386708,1.0,11/59,10.16%,PTBP3;RASA1;RC3H2;AHNAK2;TRA2B;PCBP2;NOVA1;BRDT;AHNAK;RBM20;CLK3
prerank,negative regulation of bone mineralization (GO:0030502),-0.36430481315575314,-0.9121733307765589,0.5943396226415094,0.8938350488689799,1.0,7/13,34.92%,PTK2B;SRGN;ENPP1;BCOR;RFLNA;RFLNB;GREM1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.36637874427364947,-0.9120203915824295,0.594272076372315,0.8932326311298845,1.0,4/12,17.41%,GNL3;CCT8;CCT4;WRAP53
prerank,positive regulation of lipid transport (GO:0032370),-0.37476771370079226,-0.9119793477013741,0.5789473684210527,0.8923841094624572,1.0,4/12,10.53%,LRP1;APOE;SPP1;DBI
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3118171130011026,-0.9119554596461709,0.6017441860465116,0.8915074316275438,1.0,10/23,27.31%,STXBP1;GRIK3;SLC30A1;PRRT1;SYT11;PLK2;PICK1;DRD2;MTMR2;SLC24A2
prerank,regulation of platelet activation (GO:0010543),0.4004435145436508,0.9119433755776686,0.5454545454545454,1.0,1.0,7/21,14.87%,PDGFB;PRKCQ;PLEK;C1QTNF1;PDGFA;PLA2G4A;PRKCA
prerank,protein hydroxylation (GO:0018126),0.4294339571426417,0.9117223580666922,0.5654362416107382,1.0,1.0,2/15,2.85%,P3H2;ASPH
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.23086837085231168,-0.911530013184718,0.6724137931034483,0.8915502228888055,1.0,29/80,24.04%,GBF1;RINT1;KDELR1;ERGIC3;TMED7;SURF4;TMED10;COPB2;GOLPH3;ARFGAP2;ARF3;ARFGAP1;COPE;ARFGAP3;RAB1A;RER1;KLC2;COG7;PICK1;TMED3;SCFD1;RAB1B;UVRAG;KIF26A;ARF5;ATP9A;USE1;COPB1;TAPBP
prerank,positive regulation of kinase activity (GO:0033674),0.3194502710535303,0.9112408428998502,0.5932584269662922,1.0,1.0,14/107,10.07%,RAP1A;NTRK3;MERTK;MST1R;CCN1;ROR1;MMD;MUSK;MAPT;LCP2;EPHA2;AXL;CENPE;PDGFRB
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3677005338473879,-0.9111924231992065,0.571753986332574,0.8914073531506236,1.0,3/13,8.49%,GKAP1;PTPN11;IGF2
prerank,mitochondrial protein processing (GO:0034982),0.45152865565864714,0.9111311323644914,0.5691768826619965,1.0,1.0,6/11,18.39%,AFG3L2;MIPEP;PMPCB;PMPCA;ATP23;IMMP1L
prerank,neuropeptide signaling pathway (GO:0007218),0.342285348719018,0.9110444647892614,0.577020202020202,1.0,1.0,3/58,5.49%,HCRTR1;SORT1;CYSLTR2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.35549323701904223,-0.9109213480739273,0.5919811320754716,0.891098072438235,1.0,7/14,23.71%,BCL2L1;PRKN;CREB3L1;SYVN1;HERPUD1;PARK7;TMBIM6
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.36491695005387215,-0.9108936270470034,0.5604395604395604,0.8902189933712576,1.0,4/12,12.95%,ELF1;PTPN22;LYN;ELF2
prerank,response to zinc ion (GO:0010043),0.38874384480504987,0.9108842526108687,0.5521936459909228,1.0,1.0,2/25,3.50%,CRIP1;D2HGDH
prerank,aminoglycan biosynthetic process (GO:0006023),0.3446365702597899,0.9108588657160201,0.5808538163001293,1.0,1.0,7/49,10.07%,SDC2;EXT2;GCNT2;HS2ST1;GPC4;HS6ST1;AGRN
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3281768200245833,-0.9107852675528568,0.6077922077922078,0.8895217848383633,1.0,4/18,12.57%,ATP1A2;NEDD4L;COMMD1;SLC43A2
prerank,neutrophil mediated immunity (GO:0002446),0.2966356547867026,0.9106173748307409,0.687374749498998,1.0,1.0,68/432,14.96%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;ADAM17;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,cellular response to ATP (GO:0071318),0.42719830817196824,0.9104112652255895,0.5714285714285714,1.0,1.0,2/14,6.16%,P2RY2;TAF1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.36694236780760003,-0.9101925006103424,0.5927601809954751,0.8899434605762,1.0,7/13,19.16%,ATXN3;RNF185;UBQLN1;SGTA;UBQLN2;HERPUD1;RNFT1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4122483337459785,0.9094546548302362,0.5584415584415584,1.0,1.0,2/17,3.64%,ANO6;CCL5
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3126267546178877,-0.9086818489502191,0.590027700831025,0.891547747708007,1.0,14/21,36.05%,ERCC5;DDB1;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;ERCC2;ERCC1;ERCC4;RPA3;RPA2;ERCC3;RPA1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3126267546178877,-0.9086818489502191,0.590027700831025,0.891547747708007,1.0,14/21,36.05%,ERCC5;DDB1;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;ERCC2;ERCC1;ERCC4;RPA3;RPA2;ERCC3;RPA1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.32093243364141155,-0.9086364650601103,0.5743589743589743,0.8907272057939242,1.0,8/21,24.27%,RAB11A;VPS4B;RCC2;CDC25B;CDC25A;MECP2;CDC7;RAD51C
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.27241593531252645,-0.9083207990911246,0.624113475177305,0.8905011821111459,1.0,7/37,10.06%,RIN3;APOE;ANKRD13A;ITGAV;OPTN;SDCBP;PRKN
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.435569444329863,0.9079810724292371,0.570446735395189,1.0,1.0,3/12,11.60%,DAB2IP;PTPN1;BOK
prerank,protein maturation (GO:0051604),0.3204648509746709,0.9076740873833546,0.6133486766398158,1.0,1.0,17/95,15.36%,TMPRSS4;TSPAN32;TESC;AFG3L2;ISCA1;ADAM17;LONP2;PHEX;NDUFAB1;GALNT2;DDI2;TSPAN17;ADAM19;PCSK4;NAA35;GLRX3;CIAO1
prerank,brain development (GO:0007420),0.3112943993194978,0.9073867801568727,0.6134636264929425,1.0,1.0,13/136,10.44%,SOX6;COL4A1;ZFHX3;CLN5;SLC6A17;GRIN2C;ATXN1;SYNJ2;EML1;SLC23A1;CDH2;ADGRL2;SCYL2
prerank,regulation of protein localization (GO:0032880),-0.2565185800792616,-0.9069794399177761,0.616580310880829,0.8928429670549471,1.0,25/58,29.67%,AFDN;DLG1;AAK1;RABGAP1L;HSP90AB1;CAMK1;FKBP1A;TRIM25;RSL1D1;TRIM5;TRIM14;PPM1F;TMEM231;KDM1A;RAB9A;STX6;TRIM21;TRIM17;MAPK8;ADCYAP1;WDPCP;RACK1;TESK1;CTSD;TRIM46
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.38933174534807585,-0.9066250346790101,0.6038543897216274,0.8927593953126849,1.0,3/11,7.48%,MECOM;WNT5A;CD34
prerank,histone methylation (GO:0016571),0.3773845821782787,0.9065738804116789,0.5779036827195467,1.0,1.0,5/26,9.03%,SMYD1;SETD6;SUV39H2;PRMT7;NSD3
prerank,coenzyme A biosynthetic process (GO:0015937),-0.3754534632222226,-0.9059822730512004,0.5967365967365967,0.8914789665890304,1.0,5/11,27.02%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.3754534632222226,-0.9059822730512004,0.5967365967365967,0.8914789665890304,1.0,5/11,27.02%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.3754534632222226,-0.9059822730512004,0.5967365967365967,0.8914789665890304,1.0,5/11,27.02%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.24189929517803102,-0.905761044598455,0.6310160427807486,0.8910743900068047,1.0,13/66,8.80%,APPL2;KMT2E;DLG1;DDX3X;CCND3;EGFR;DCUN1D3;ADAMTS1;PKD2;TFDP1;PRMT2;RDX;UBE2E2
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3363642358359529,-0.9057456143578008,0.5876288659793815,0.890188837390817,1.0,4/16,10.14%,BMPR2;PLCB3;DDAH1;ACE
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3392526632107689,-0.9056534510152757,0.601010101010101,0.8885553826367065,1.0,7/15,31.35%,DTNBP1;AP3M2;AP3S1;AP3M1;BLOC1S6;BLOC1S2;AP3S2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3392526632107689,-0.9056534510152757,0.601010101010101,0.8885553826367065,1.0,7/15,31.35%,DTNBP1;AP3M2;AP3S1;AP3M1;BLOC1S6;BLOC1S2;AP3S2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.45355071675230707,0.9055204423359453,0.5607985480943739,1.0,1.0,2/11,5.51%,CCL5;PRKCQ
prerank,transcription by RNA polymerase II (GO:0006366),0.29688278062082685,0.9052423784651562,0.6846938775510204,1.0,1.0,44/305,12.62%,NOTCH3;SOX5;NR1H4;POLR2L;POLR2I;RORA;NR4A1;ADRM1;PRRX1;TEAD3;HDAC9;GTF2H4;NR2C1;WDR33;ELL;PCF11;CBFB;POLR2G;TAF1;ELOC;RXRG;PARP1;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;ERCC6;PAPOLA;MAML3;PPARA;CCNT1;NR4A2;NR1D1;CDK7;NR2C2;TEAD1;NFX1;ESRRA;CDK12;NELFB;INTS5;NR6A1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2933597383903462,0.9033502099090593,0.7887887887887888,1.0,1.0,124/807,13.61%,FLNA;PRDM16;MYOZ2;HJV;MEF2C;HEY2;ZFHX3;TBX2;LBH;NR1H4;LIMS1;LIMD1;PDGFB;ZEB2;NAB1;EDNRB;ATP8B1;MLIP;ID4;FST;FRK;LOXL2;ETS2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;GMNN;ZNF436;H1-0;RBAK;NACC2;PRDM1;HDAC9;SET;NR2F2;ANKRD2;NR2C1;USP2;MTERF3;ATXN1;OSR2;PIAS4;CBFB;KLF7;KCNIP3;MEF2A;PEX2;MTDH;SUV39H2;MYBBP1A;CAV1;TAF1;DAB2IP;ARID5A;TP53;VEGFA;PPM1A;PARP1;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;AR;L3MBTL2;MED1;ZNF431;YAP1;SOX9;SNAI2;HSF4;DICER1;RELA;PLCB1;MAP3K10;CUX2;LIN37;CCND1;PPARA;CBX4;IMPACT;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;RIF1;PCGF6;SPINDOC;HNRNPU;ZNF3;NR2C2;UBE2D1;SREBF2;RUNX1;RB1;ATF3;NKX6-1;ZBTB7A;NFX1;CNOT7;PSPC1;FBXW11;ORC2;CITED2;CPEB3;NR6A1;POU3F3;FNIP2;ZFP69;MXD4;BCL6;IKZF1;FOXJ1;TRIM28;GAS6;ZBTB5
prerank,lysosome organization (GO:0007040),0.3608334577905069,0.9033152864569608,0.5774058577405857,1.0,1.0,9/36,14.40%,CLN5;HOOK2;ACP3;CLVS1;HOOK1;MBTPS1;AKTIP;HPS4;LRRK2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.22017548138626633,-0.9032876742398201,0.7166666666666667,0.8931615861295346,1.0,21/109,14.21%,NFATC3;GAB2;PIK3CA;GRB2;PDPK1;VAV2;PLCG2;PIK3CB;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;PSMA5;PSMA1;PSMC2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3528917013757583,-0.903118148372663,0.6148148148148148,0.8926218402319746,1.0,4/14,18.52%,CHKA;LPIN2;SELENOI;LPIN3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.38980088354650366,-0.9021709191923171,0.5859728506787331,0.8937651151094036,1.0,8/10,44.50%,DLGAP1;DLGAP2;NPTXR;DLGAP3;AKAP9;BEGAIN;NPTX2;CACNG5
prerank,double-strand break repair (GO:0006302),-0.20757508603216637,-0.9021024609935326,0.703125,0.8930114242441515,1.0,55/158,28.15%,EYA1;HMGB1;KDM2A;PRKDC;XRCC5;TDP2;MRE11;RAD50;PARP3;ACTR8;FBH1;HERC2;ERCC5;XRCC1;FAN1;SAMHD1;BRCC3;SETX;LIG3;MDC1;POLM;BLM;XRCC6;DTX3L;NBN;RMI1;SMC5;UBXN1;MMS22L;ZSWIM7;HUS1;POLN;KDM4D;CHEK2;ATM;DCLRE1A;IFFO1;ACTR5;NSMCE2;PRPF19;ZFYVE26;SMARCAL1;NSMCE1;NUCKS1;RAD51C;ERCC1;ERCC4;AP5Z1;DCLRE1B;MAPK8;HMGB2;RPA3;DNA2;CYREN;XRCC2
prerank,tRNA 5'-leader removal (GO:0001682),-0.36182204573086885,-0.9017407093148719,0.5866666666666667,0.8929956568789783,1.0,7/13,43.54%,SSB;POP1;POP4;RPP38;RPP21;RPP25L;POP7
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4328710535561261,0.9014627839703777,0.5817555938037866,1.0,1.0,6/12,20.32%,HEXIM1;HNRNPU;NELFB;NELFCD;EAPP;NELFA
prerank,response to iron ion (GO:0010039),-0.36435674476849783,-0.9013765737673708,0.6036866359447005,0.8929154805081769,1.0,4/12,14.14%,BMP6;B2M;ACO1;SNCA
prerank,DNA biosynthetic process (GO:0071897),0.409015972014633,0.9013671056418371,0.5697674418604651,1.0,1.0,3/16,11.22%,TERT;WRNIP1;POLD1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4248078894990479,0.9009392145481548,0.5874363327674024,1.0,1.0,2/16,7.79%,LYST;KIF5B
prerank,AMP metabolic process (GO:0046033),0.4361726666694502,0.9009241415986071,0.5971731448763251,1.0,1.0,4/13,12.89%,AMPD1;AMPD2;NUDT2;ADSS1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4010088578831556,0.9008985984431398,0.5612582781456954,1.0,1.0,6/18,9.19%,PEX2;DAB2IP;TP53;CD300A;GSTP1;SKI
prerank,RNA metabolic process (GO:0016070),0.31171163340229296,0.9004646340766072,0.6435754189944134,1.0,1.0,23/127,13.08%,RBPMS;LSM8;POLR2L;POLR2I;HNRNPR;PARN;ATXN1;POLR2G;ATXN2;DICER1;FTO;FASTKD1;PAPOLA;DEDD2;DHX8;HNRNPU;PRPF4;RBM3;HNRNPC;RBM6;DROSHA;POLR2J;PCBP3
prerank,natural killer cell activation (GO:0030101),0.39420979321586896,0.9000111733043074,0.5890850722311396,1.0,1.0,4/23,9.80%,IL2;RASGRP1;KAT7;AXL
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.36982694989266696,0.8999709622355001,0.5974930362116991,1.0,1.0,7/29,14.87%,STRN3;CBFB;YAP1;KMT2D;RUNX1;UFL1;KCTD6
prerank,regulation of angiogenesis (GO:0045765),0.30156496186548454,0.8998577646794366,0.6574761399787911,1.0,1.0,22/192,7.87%,COL4A2;ATP2B4;ROCK1;FGF1;ANGPT4;HSPB6;SEMA5A;PLXND1;HK2;STIM1;ITGB1;PTGIS;ALOX5;EMILIN1;MTDH;DAB2IP;RRAS;VEGFA;RHOJ;YJEFN3;BTG1;TGFB2
prerank,positive regulation of vasculature development (GO:1904018),0.31615422422117095,0.8996080364387975,0.6201641266119577,1.0,1.0,12/94,7.59%,FGF1;ANGPT4;HSPB6;SEMA5A;HK2;STIM1;ITGB1;PTGIS;MTDH;RRAS;VEGFA;BTG1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.44596632047893936,0.899444800051255,0.592391304347826,1.0,1.0,2/10,8.35%,ANO6;CD300A
prerank,transcription by RNA polymerase III (GO:0006383),0.3763518118315916,0.8985398669529434,0.5742128935532234,1.0,1.0,3/27,4.85%,POLR2L;GTF3C4;ELL
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3187305043592341,0.8984566394692866,0.62,1.0,1.0,13/95,5.99%,SDC2;ANGPT1;CSPG4;CHSY3;CSGALNACT1;BGN;EXT2;GCNT2;HS2ST1;HAS2;GPC4;CHST5;OGN
prerank,regulation of presynapse assembly (GO:1905606),-0.3338944606883969,-0.8983611966707906,0.5934959349593496,0.8980677741406594,1.0,5/18,17.29%,GPC6;APP;PTPRD;SNCA;LRRC4B
prerank,regulation of presynapse organization (GO:0099174),-0.3338944606883969,-0.8983611966707906,0.5934959349593496,0.8980677741406594,1.0,5/18,17.29%,GPC6;APP;PTPRD;SNCA;LRRC4B
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4544140283186936,0.8983146172031378,0.5594795539033457,1.0,1.0,3/10,12.37%,TERT;DICER1;DROSHA
prerank,glutathione biosynthetic process (GO:0006750),0.43748100667698436,0.8981730063496814,0.5881294964028777,1.0,1.0,5/11,20.64%,OPLAH;GGCT;CHAC2;CNDP2;HAGH
prerank,regulation of ERBB signaling pathway (GO:1901184),0.4111030727954491,0.8980103969052405,0.551433389544688,1.0,1.0,2/15,4.60%,CDH13;PTPN18
prerank,negative regulation of cell migration (GO:0030336),0.3079094533790031,0.8980085455686069,0.6383682469680264,1.0,1.0,15/137,7.06%,TPM1;DLC1;VCL;TMIGD3;PHLDB2;CLASP2;JAG1;KANK1;IGFBP5;BMPR1A;RAP2C;DAB2IP;DUSP3;CORO1C;STK26
prerank,tyrosine metabolic process (GO:0006570),0.4353606779395115,0.8979527126151807,0.5819112627986348,1.0,1.0,2/11,10.78%,HGD;THAP4
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.41257703265691614,0.8978651904325307,0.5742904841402338,1.0,1.0,6/16,17.31%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2
prerank,cellular response to hypoxia (GO:0071456),0.31156529043249864,0.8978148739114856,0.6347438752783965,1.0,1.0,19/126,10.54%,PMAIP1;LIMD1;ANGPT4;RORA;PTGIS;CUL2;SUV39H2;PSMC6;NDRG1;ELOC;TERT;TP53;CPEB1;VEGFA;HIF1A;PSME4;SIRT2;PSMB1;PSMD5
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.23479094103440473,-0.8977283114486008,0.6683937823834197,0.8986068716719052,1.0,15/72,11.24%,ELF1;IFNAR2;PTPN11;IRAK1;CASP8;HSP90AB1;BIRC2;MADD;TNFRSF1A;IRAK3;IKBKG;RBCK1;RNF31;IRAK2;CHUK
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.32432988090761855,-0.8975256588911353,0.6237113402061856,0.8981470961213781,1.0,14/18,47.11%,LIG3;GINS3;LIG1;RFC3;GINS4;POLD3;GINS1;POLE;RFC4;MCM3;POLE3;POLA1;POLD2;GINS2
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.2970245353134991,-0.897429907152743,0.6207865168539326,0.8974402891630333,1.0,12/27,26.04%,NIBAN2;DACH1;ACVRL1;BMPR2;RGCC;FGF2;SMG6;ATM;FGFR4;CDKN1A;PARP4;PRKD2
prerank,cellular protein-containing complex assembly (GO:0034622),0.3057929110661732,0.8971978032931449,0.6424759871931697,1.0,1.0,24/160,14.21%,DMD;ANGPT1;PDE4DIP;CASQ1;HIP1;ADRM1;COX7A2L;MAPT;BBS12;OTUD6B;LONP1;ANLN;NUP153;CENPE;NUP107;TBCD;CLU;SNX9;CHMP2A;NCK2;HOPX;NUP98;PTGES3L;SRP19
prerank,histone H4 deacetylation (GO:0070933),0.4363958303506031,0.8970491852277083,0.5860805860805861,1.0,1.0,4/10,19.60%,HDAC9;SIRT2;HDAC1;SMARCAD1
prerank,intracellular sterol transport (GO:0032366),-0.3574474922732864,-0.8968974419446168,0.6162790697674418,0.8978116128646312,1.0,6/13,23.58%,ABCA1;ARV1;STARD4;OSBP;RELCH;NPC1
prerank,regulation of amyloid-beta formation (GO:1902003),0.37112003530999493,0.8967472622856012,0.5994475138121547,1.0,1.0,9/34,12.48%,ROCK1;RTN2;PIN1;RTN1;RELA;ROCK2;ABCG1;CHRNA7;CLU
prerank,vitamin transport (GO:0051180),-0.28878845459570074,-0.8965440677272163,0.6277602523659306,0.8976908624126902,1.0,5/29,9.83%,ABCG2;PDPN;SLC25A32;SLC52A1;SLC35F3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4345294486797191,0.8964674809760127,0.5852372583479789,1.0,1.0,2/12,6.25%,ATP2B4;DAB2IP
prerank,fatty acid oxidation (GO:0019395),0.33779886346070265,0.8964120849920346,0.6060991105463787,1.0,1.0,11/57,10.21%,HSD17B10;PEX2;HSD17B4;PPARGC1A;ACAD11;MECR;ABCD4;ACADS;ACAD10;HADHB;SCP2
prerank,negative regulation of angiogenesis (GO:0016525),0.3253783900232209,0.8963121250852906,0.6146572104018913,1.0,1.0,10/84,7.87%,COL4A2;ATP2B4;ROCK1;ANGPT4;ALOX5;EMILIN1;EPN2;DAB2IP;YJEFN3;TGFB2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.3531186470632369,-0.8958309712000756,0.6102088167053364,0.8984060632816666,1.0,8/13,32.16%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1;GNPNAT1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.32248466920259505,0.8951857166285184,0.6065573770491803,1.0,1.0,25/80,18.44%,VIM;SAMD4A;NAT10;SIRT3;RPS27L;CIRBP;RELA;PYM1;RPL5;EIF3E;ROCK2;PRKCD;RBM3;ZCCHC4;ABCG1;CHRNA7;CLU;CPEB3;PLXNB2;SP1;PIWIL2;LRRTM3;SMPD2;EEF2;UPF3A
prerank,cellular protein metabolic process (GO:0044267),0.2911666392724361,0.894893947317507,0.7186234817813765,1.0,1.0,32/396,6.93%,IGFBP7;MFGE8;LTBP1;SPARCL1;PAPPA2;SDC2;LMCD1;MSRB3;RPL3L;HRC;CCN1;CLN5;LOXL2;IGFBP5;D2HGDH;MRPL36;MRPL13;MCRS1;HARS2;SEPHS1;DMBT1;NUCB1;PHKA2;ZDHHC2;DAB2IP;AFG3L2;ABCA3;KTN1;IGFBP4;LAMC1;LAMB2;RPL8
prerank,negative regulation of cell motility (GO:2000146),0.313213698886284,0.894546609381851,0.6184510250569476,1.0,1.0,11/108,7.06%,TPM1;DLC1;VCL;TMIGD3;JAG1;KANK1;IGFBP5;RAP2C;DUSP3;PIN1;STK26
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3620098739394338,0.8944146989818871,0.5951008645533141,1.0,1.0,8/34,12.90%,MFHAS1;PTPRS;CD14;DAB2IP;CD300A;NR1D1;OTUD4;SARM1
prerank,negative regulation of cartilage development (GO:0061037),0.41715927720024126,0.8943425470901067,0.5630397236614854,1.0,1.0,3/13,7.72%,CHADL;SOX9;SNAI2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.32027790330617056,-0.8943063614260047,0.6335078534031413,0.9009003322437455,1.0,3/18,12.30%,LBP;WNT5A;IL33
prerank,RNA splicing (GO:0008380),0.31535001364836385,0.8942818118016622,0.627039627039627,1.0,1.0,26/95,15.22%,DDX23;TXNL4A;SFPQ;PPARGC1A;SF3B3;SRSF4;SNRPN;PRPF18;FUS;ZMAT5;RBM8A;MBNL1;U2AF1;DHX8;PRPF4;SRSF10;SF3A3;HNRNPC;CDK12;SRRM1;SF3B1;SF3B2;ZCRB1;SYNCRIP;PDCD7;SRPK2
prerank,eosinophil chemotaxis (GO:0048245),0.41513284562525427,0.89410745189945,0.5752508361204013,1.0,1.0,1/14,3.64%,CCL5
prerank,eosinophil migration (GO:0072677),0.41513284562525427,0.89410745189945,0.5752508361204013,1.0,1.0,1/14,3.64%,CCL5
prerank,cellular protein localization (GO:0034613),0.29349152994951044,0.8937705593594831,0.6979591836734694,1.0,1.0,50/285,16.95%,FLNA;DMD;STXBP2;HEY2;TBC1D1;ANGPT1;VCL;CSRP3;FERMT2;ITSN1;BICD2;JAM3;ARHGEF2;RABGAP1;SEC31B;VPS26A;EVI5;EIF2D;SEC13;VPS26B;RRAGB;RAP2A;STX12;MFN2;WDR45;SNX13;NSF;PACSIN1;SNX9;FGF10;FOXJ1;RAB14;LRRK2;SNX17;CTSA;SNX1;CNTNAP1;USP4;STX7;YWHAH;GGA2;ATG13;RUNDC1;TBC1D22B;VPS35;SMURF1;TM9SF2;TBC1D12;ARL4D;RAB38
prerank,protein K63-linked ubiquitination (GO:0070534),-0.26773448426032337,-0.8932278476715245,0.6232394366197183,0.902420721413909,1.0,17/41,25.59%,ITCH;RNF135;PELI1;UBE2E2;UBE2E3;PRKN;TRIM5;STUB1;RNF115;TRIM56;UBE2S;PRPF19;UBE2B;HECTD1;TRIM21;PELI3;UBE2O
prerank,regulation of nervous system process (GO:0031644),-0.322857794707202,-0.893227337329919,0.6105263157894737,0.9014998839430786,1.0,6/18,12.37%,APP;DLGAP1;TMEM108;NOS3;DLGAP2;HTR2C
prerank,regulation of response to cytokine stimulus (GO:0060759),0.39874378957325995,0.8926845460838359,0.5780254777070064,1.0,1.0,2/19,5.01%,LIFR;CBFB
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.34243414291526425,0.8924477803874564,0.5893089960886571,1.0,1.0,6/45,9.59%,RBPMS;TGFB3;ACVR2A;BMPR1A;TGFB2;GDF1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.32705548927430567,0.8918660299715777,0.595438175270108,1.0,1.0,13/67,17.85%,NCF2;CD36;PSMC6;ITGB5;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14;SNAP23
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3728854077285644,0.8916689546968658,0.5828488372093024,1.0,1.0,5/29,7.97%,DCUN1D2;FEM1A;FBXW7;PIN1;DCUN1D1
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3753832915311267,-0.8907920208483026,0.6404761904761904,0.906077924425264,1.0,3/11,18.88%,CASP8;TGFB1;HSF1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.25545955759243155,-0.8905824661443452,0.6875,0.9056987394566174,1.0,9/44,17.92%,SH3RF1;DDX3X;RPS6KA3;CD44;IGBP1;SNCA;AKT1;GPX1;SIAH2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.2877371075308954,-0.8904843783772595,0.620253164556962,0.9049931186543358,1.0,7/30,10.29%,MLLT3;FLT1;BMP4;KIT;HOXB4;ACE;TGFB1
prerank,transport across blood-brain barrier (GO:0150104),0.3212110266341754,0.8904779630618173,0.6140979689366786,1.0,1.0,12/83,6.98%,ATP2B4;SLC2A4;CD36;SLC6A17;SLC16A7;SLC8A2;SLC5A3;SLC4A8;SLC38A2;SLC4A3;SLC2A10;SLC44A1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3968803138253535,0.8902466546336457,0.5674342105263158,1.0,1.0,1/17,2.32%,PLA2G3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3708467321323506,-0.8901124182115406,0.6387665198237885,0.904900774598297,1.0,8/11,32.16%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1;GNPNAT1
prerank,glucose homeostasis (GO:0042593),0.3139013418408822,0.8899066634292466,0.6158463385354142,1.0,1.0,19/83,17.44%,SLC2A4;PDK4;HK2;ALOX5;KCNB1;KLF7;IRS1;MBD5;PPARGC1A;NR1D1;HIF1A;CRTC2;PDK2;PRKAA2;MLXIPL;STAT3;SELENOT;RPS6;ADRA2A
prerank,regulation of vasculature development (GO:1901342),-0.2901022456305087,-0.8896984536344761,0.6470588235294118,0.9049712914481289,1.0,5/26,11.42%,NF1;ADGRA2;CTNNB1;BMPER;SP100
prerank,synaptic membrane adhesion (GO:0099560),0.43169800908706896,0.8896308400314964,0.6047297297297297,1.0,1.0,3/14,6.10%,PTPRS;GPC4;PTPRF
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.27229690085909164,-0.8892264536969554,0.6344086021505376,0.905174300812128,1.0,11/33,19.26%,DDX5;CARM1;SAFB2;RNF6;PRMT2;ESR1;EP300;GPAM;CALR;KDM1A;PARK7
prerank,peptidyl-lysine modification (GO:0018205),0.3122443380125358,0.8886606623043692,0.6383467278989667,1.0,1.0,33/99,19.62%,UBA2;LOXL2;NUP62;HDAC9;SIRT3;PIAS4;SAE1;TRPM4;NUP153;SIRT2;NUP107;AAAS;PIAS2;ATPSCKMT;NDUFAB1;SENP6;TRIM28;VCPKMT;SIRT4;NUP98;NUP37;EEF1AKMT2;NUP210;PIAS1;BCL11A;ESCO1;HDAC6;NUP54;SUMO1;SENP2;UBE2I;NUP160;NUP133
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4457081536710562,0.8883491289206842,0.5883424408014571,1.0,1.0,4/10,12.51%,IMPACT;BAG3;SIRT2;CITED2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.32132134391588496,0.8882987621487302,0.6299303944315545,1.0,1.0,17/84,14.33%,ROCK1;IGFBP5;SAMD4A;RTN2;MRPL13;BTG2;PIN1;RTN1;DAPK3;EIF2AK2;CNOT7;CHRNA7;CLU;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.31183167746026746,0.8882117235942404,0.6223463687150838,1.0,1.0,25/114,17.40%,ACTN4;LIMS1;TNFSF13B;TNFRSF11A;PSMC6;TP53;TRAF3;RELA;ADAM17;PSME4;EDAR;TRAF5;PSMB1;PSMD5;EIF5A;TNFRSF25;PSMB2;TMSB4X;PSMB7;PSMD3;STAT1;JAK2;PSMA2;PSMD14;TNFSF12
prerank,positive regulation of dendrite extension (GO:1903861),-0.3279303613656701,-0.8880122167954488,0.6222760290556901,0.9069943680207824,1.0,8/17,36.92%,NEDD4L;SYT1;RIMS2;SYT2;SYT3;PLAA;CPNE5;CPNE9
prerank,protein phosphorylation (GO:0006468),0.288320452636965,0.8875116937819363,0.7744209466263847,1.0,1.0,86/479,15.27%,MYLK2;MAP3K20;STK38L;TNNI3K;PRKG1;MAP3K5;ROCK1;MAST4;DYRK2;MERTK;PDGFB;CCNA2;CDK6;PDK4;FRK;FAM20A;CAMK2D;ACVR2A;MUSK;GTF2H4;CAMKK2;PEAK1;MARK1;BMPR1A;DYRK1A;PRKCQ;MAP4K3;MAP4K5;TAF1;DAB2IP;RPS6KA2;COQ8A;MAPKAPK2;DYRK1B;STK26;CHEK1;TGFB2;NUAK1;MAP3K10;WNK2;DAPK3;PRKACB;PRKAR1B;MAP2K1;CCNT1;BRSK1;PKN2;PAK2;CDK7;STK33;STK24;PDGFRB;CDK18;EIF2AK2;ROCK2;PRKCD;COPS8;ACVR1B;CDK12;RICTOR;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;EEF2K;GAS6;CSNK1E;PDK2;SGK1;STK10;EPHB1;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1
prerank,translational termination (GO:0006415),0.31037393034078914,0.8870741144642537,0.6425287356321839,1.0,1.0,33/95,22.05%,MRPL36;MRPS31;MRPL13;APEH;MRPL30;ABCE1;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;GSPT1;MRPL47;MRPL9;MRPL42;N6AMT1;ETF1;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,cellular response to increased oxygen levels (GO:0036295),0.4368510042626954,0.8870120612342821,0.5933682373472949,1.0,1.0,3/11,6.33%,ATG7;CAV1;ATP6V0A2
prerank,microtubule anchoring at centrosome (GO:0034454),0.4383530695810932,0.8868167188389894,0.5894736842105263,1.0,1.0,1/10,2.05%,CCDC68
prerank,response to interferon-gamma (GO:0034341),-0.24113811786768688,-0.8867213193306033,0.6842105263157895,0.9090301701491091,1.0,15/67,17.92%,DAPK1;WNT5A;LGALS9;GBP7;CXCL16;SP100;SIRPA;CX3CL1;GBP4;SNCA;GCH1;BST2;IFITM1;SHFL;IFITM3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.36535264579601506,0.8865213225836629,0.6020114942528736,1.0,1.0,7/33,10.70%,PDGFB;TERT;TP53;TGFB2;RELA;HIF1A;TEAD1
prerank,negative regulation of T cell proliferation (GO:0042130),-0.28768977624093256,-0.8864070679163372,0.6439628482972136,0.9088079342289831,1.0,7/28,24.61%,LGALS9;CEBPB;SDC4;CD80;CD274;CD86;SCRIB
prerank,cardiac conduction system development (GO:0003161),0.3777618866056947,0.8862274040077709,0.6012084592145015,1.0,1.0,3/24,5.24%,HEY2;BMPR1A;TBX18
prerank,aspartate family amino acid catabolic process (GO:0009068),0.39632343489663074,0.8855983408202696,0.5870253164556962,1.0,1.0,4/19,7.86%,DLD;DLST;GOT1;GOT2
prerank,brain morphogenesis (GO:0048854),-0.3590554798646796,-0.8853488248716977,0.6201923076923077,0.9103189138394737,1.0,6/12,30.51%,PAFAH1B1;SHANK3;SPEF2;MKKS;BBS4;CTNNA2
prerank,carbohydrate transport (GO:0008643),0.43591019067841114,0.885087737790635,0.5978062157221207,1.0,1.0,2/11,8.04%,SLC23A2;SLC23A1
prerank,protein targeting to membrane (GO:0006612),-0.22790300173195677,-0.8849246504818493,0.8053691275167785,0.9103181476684737,1.0,29/83,25.22%,SEC62;ZDHHC18;PEX14;SLC25A17;ATG3;ALDH3A2;ZDHHC15;SDCBP;PEX5;SEC63;SGTA;ACBD5;ZDHHC9;ZDHHC20;ABCD3;SGTB;FIS1;SSR1;SEC61A1;SRPRA;SSR2;CHM;PXMP2;PEX13;TAOK2;CHMP4B;CHMP4A;VPS37C;ZDHHC24
prerank,tRNA methylation (GO:0030488),0.35939267897198945,0.8845195338037214,0.6142857142857143,1.0,1.0,8/34,16.96%,HSD17B10;TRDMT1;FTSJ1;TRMT10C;METTL6;NSUN2;TRMT44;WDR6
prerank,negative regulation of transferase activity (GO:0051348),0.37312659430280504,0.8845087977858375,0.6005917159763313,1.0,1.0,9/28,19.08%,MAPT;TP53;CERS1;NPRL2;HNRNPU;IRS2;FBXO5;MEN1;ABL1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.35284535273852397,-0.8842984326221592,0.6266968325791855,0.9107722673778681,1.0,7/13,40.37%,DUSP1;ANAPC15;DYNC1LI1;MAD2L1;GEN1;NDC80;XRCC3
prerank,regulation of dendrite extension (GO:1903859),-0.32120372084220367,-0.8842494167915338,0.6347607052896725,0.9099582995227308,1.0,8/18,36.92%,NEDD4L;SYT1;RIMS2;SYT2;SYT3;PLAA;CPNE5;CPNE9
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.36955793751622446,0.8840769081790116,0.5821114369501467,1.0,1.0,14/26,23.24%,DAB2IP;DUSP3;MED1;GAREM1;SOX9;SNAI2;ZFP36L1;KNSTRN;PTPN12;ERBB2;ZFP36L2;DUSP22;ZPR1;PLCG1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.28958508483930817,-0.8840102369100101,0.6310679611650486,0.909603494398881,1.0,5/27,12.14%,NFAT5;IRAK1;CYRIB;CD44;SIRPA
prerank,autophagosome maturation (GO:0097352),0.3592284600714222,0.8839432314497413,0.607094133697135,1.0,1.0,5/32,7.52%,ATP2A2;LIX1L;GABARAP;CALM1;LIX1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.39335062333342846,0.8839250431382945,0.5781512605042017,1.0,1.0,2/17,3.81%,ADRA1D;ADCY9
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3592823909690557,0.8837749931903549,0.6022727272727273,1.0,1.0,8/36,11.69%,ATP2B4;CAV1;TERT;CALM1;GLA;HIF1A;TERF2;HTR2B
prerank,negative regulation of protein phosphorylation (GO:0001933),0.30050981957022255,0.8835442228279716,0.6468646864686468,1.0,1.0,30/150,15.35%,NTF3;DMD;NTRK3;PPM1E;EMILIN1;CAV1;DAB2IP;CORO1C;CALM1;IMPACT;GSTP1;PAK2;CNKSR3;SAMSN1;SIRT2;GPD1L;PDE4D;RB1;PRKCD;CEP85;DMTN;CEP43;NCK2;DNAJC3;GNAQ;LRRK2;DVL1;MLXIPL;INPP5J;PTEN
prerank,hyaluronan metabolic process (GO:0030212),-0.2979808581234789,-0.8835373715938248,0.6349206349206349,0.909731333834527,1.0,6/23,16.02%,CEMIP;CD44;TGFB1;HEXA;CEMIP2;FGF2
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.32068127191641677,-0.8832866834205733,0.6212121212121212,0.9093916640607341,1.0,7/17,23.41%,RNF20;CTR9;VIRMA;NCBP2;ZC3H3;HSF1;CPSF6
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.24952053150461856,-0.8829958198816692,0.676923076923077,0.9091105805020778,1.0,14/52,15.43%,CELF2;DDX5;KHDRBS1;RBM5;RBFOX3;SRSF6;TRA2B;NOVA1;CELF4;DDX17;SMU1;RBFOX1;NOVA2;KHDRBS2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.34276515393265267,0.8828372087074998,0.6016483516483516,1.0,1.0,9/43,12.20%,MEF2C;CCN1;FERMT2;ACVR2A;BMPR1A;YAP1;SUCO;LRP5;BMPR1B
prerank,regulation of T cell differentiation (GO:0045580),0.3690621434807055,0.8824538648822393,0.6162790697674418,1.0,1.0,5/33,11.37%,IL2;PRDM1;CBFB;RUNX1;RHOH
prerank,stress-activated MAPK cascade (GO:0051403),0.3257241737380645,0.8824269554861137,0.6306306306306306,1.0,1.0,8/61,14.05%,MAP3K20;MAP3K5;MAP4K3;MAP3K10;FBXW11;ZFP36L1;MAP2K3;MAPK1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3153827823762384,0.8823107862979392,0.625609756097561,1.0,1.0,32/83,23.07%,DYNLL1;CEP41;HAUS8;CEP290;TP53;TPX2;CEP192;DYNC1I2;NEDD1;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;PLK4;DCTN1;HAUS4;CEP135;CKAP5;ACTR1A;SFI1;MAPRE1;ODF2;PPP2R1A;NINL;TUBA4A;CEP63;YWHAG;NDE1
prerank,Rac protein signal transduction (GO:0016601),-0.32035161761409203,-0.8817354677700915,0.6162162162162163,0.9110270584914362,1.0,2/18,1.21%,ELMO1;EPS8
prerank,regulation of primary metabolic process (GO:0080090),0.30286518889156805,0.8816139831995263,0.6512141280353201,1.0,1.0,27/126,16.91%,SMARCD3;PRKAB2;ANGPTL8;OAZ2;PSMC6;ACACB;IDI1;MED1;MVD;PPARA;NR1D1;PSME4;PSMB1;PSMD5;ROCK2;SREBF2;TGS1;PSMB2;ZFP69;EDF1;PSMB7;PSMD3;IRS2;SIN3A;SP1;PSMA2;PSMD14
prerank,regulation of steroid metabolic process (GO:0019218),0.3870413874584234,0.881484019641238,0.6224328593996841,1.0,1.0,2/23,2.57%,NR1H4;RORA
prerank,transition metal ion homeostasis (GO:0055076),0.3691944424120346,0.8814817369102802,0.588495575221239,1.0,1.0,4/28,10.71%,HJV;HMOX2;NEO1;SLC39A14
prerank,regulation of T cell cytokine production (GO:0002724),0.41166206604022626,0.8813425211829715,0.606473594548552,1.0,1.0,2/15,8.74%,FZD5;TRPM4
prerank,regulation of stem cell differentiation (GO:2000736),0.3156058981895221,0.8810523180128994,0.6375291375291375,1.0,1.0,20/89,14.72%,RBM24;JAG1;CBFB;SP7;BMPR1A;PSMC6;GDNF;YTHDF2;YAP1;PSME4;HNRNPU;PSMB1;PSMD5;EIF2AK2;RUNX1;PSMB2;NELFB;NSUN2;PSMB7;PSMD3
prerank,regulation of myelination (GO:0031641),-0.29060787853431236,-0.88103219841986,0.6068376068376068,0.9117355675885859,1.0,3/25,5.83%,PTN;JAM2;PTPRZ1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3985201150110413,0.8809468889443292,0.5959595959595959,1.0,1.0,4/18,11.82%,PMAIP1;TMEM259;BOK;USP13
prerank,MAPK cascade (GO:0000165),0.2905934887555332,0.8805744631386107,0.7182377049180327,1.0,1.0,59/295,16.91%,MAP3K20;FGF13;MEF2C;MAP3K5;ANGPT1;FGF1;PDGFB;RASAL2;DUSP5;IL2;CCL5;KSR1;CAMKK2;MEF2A;PRKCQ;IRS1;PSMC6;DAB2IP;MAPKAPK2;GDNF;CALM1;AREG;RASGRP1;SOX9;MBP;MAP2K1;PPP1CB;PSME4;ACTN2;PDGFRB;PSMB1;HBEGF;PSMD5;PDGFA;GFRA1;ABHD17B;HTR2B;FBXW11;TNIK;PSMB2;SPTB;TAOK3;ZFP36L1;FGF10;MAPK1;LRRK2;PSMB7;PSMD3;CSF2RA;IRS2;KARS1;MAPK12;RAF1;JAK2;PSMA2;RASGRP3;MT3;SHOC2;PSMD14
prerank,snRNA 3'-end processing (GO:0034472),-0.31432486411786276,-0.8805579978087773,0.6233766233766234,0.9118394284047828,1.0,9/19,28.47%,INTS6;INTS2;EXOSC9;EXOSC2;EXOSC7;EXOSC3;EXOSC5;INTS14;TOE1
prerank,RNA processing (GO:0006396),0.2952127769554844,0.8801927298274431,0.6741452991452992,1.0,1.0,43/176,16.52%,RBPMS;HNRNPR;FASTKD5;DDX23;ATXN1;U2AF2;SFPQ;PPARGC1A;CELF1;DICER1;SF3B3;SRSF4;SNRPN;TENT4A;PRPF18;FUS;ZMAT5;DEDD2;RBM8A;MBNL1;U2AF1;DHX8;HNRNPU;PRPF4;RBM3;SF3A3;HNRNPC;RBM6;CDK12;SRRM1;DROSHA;SF3B1;SF3B2;ZCRB1;SON;SYNCRIP;PDCD7;PRKACA;FASTKD2;SRPK2;SF3A1;WBP4;PIWIL2
prerank,icosanoid biosynthetic process (GO:0046456),0.4378760024603745,0.8801390926070097,0.5952813067150635,1.0,1.0,2/10,14.19%,ALOX5;PLA2G4A
prerank,protein-containing complex subunit organization (GO:0043933),0.3098144619753008,0.879956160627509,0.6430180180180181,1.0,1.0,20/109,14.33%,TCAP;SH3BGR;SKAP2;AFG3L2;TP53;LAMC1;PPARGC1A;MDN1;YAP1;SOX9;ADD2;MAGI1;TEAD1;DNM1L;KIFAP3;SNX9;DMTN;KPNA3;NUP98;EPRS1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.36828380974250385,0.8794877570423295,0.6157337367624811,1.0,1.0,4/27,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,negative regulation of immune effector process (GO:0002698),-0.3596375857815781,-0.8794672957666326,0.644927536231884,0.9132966421155397,1.0,5/13,16.88%,RPS19;CD55;ENPP3;APPL1;GRN
prerank,carbohydrate homeostasis (GO:0033500),0.3185638032641171,0.8792212753519331,0.6317103620474407,1.0,1.0,7/67,5.93%,SLC2A4;PDK4;ALOX5;KCNB1;KLF7;IRS1;MBD5
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3576618334387669,0.8791147227586694,0.6025280898876404,1.0,1.0,4/33,4.59%,CDK6;FHL1;NACC2;JADE1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4084796682510461,0.8790721439265269,0.610738255033557,1.0,1.0,4/17,8.66%,PDGFB;CCND2;CCND1;ADAM17
prerank,axonal transport of mitochondrion (GO:0019896),0.4294308173250242,0.8790296240973052,0.5940766550522648,1.0,1.0,4/11,9.58%,MAPT;OPA1;TRAK1;HIF1A
prerank,regulation of ion transport (GO:0043269),-0.22513084027033825,-0.8786641680184194,0.7,0.9140807216130585,1.0,16/76,14.71%,NEDD4L;WNK1;B2M;NKAIN3;SYT1;CA2;NKAIN4;DTNBP1;SIK1;PRKN;KCNJ13;SNX6;PER1;SNCA;SYT11;SYT12
prerank,skeletal system development (GO:0001501),0.2973398484784112,0.8785058630507039,0.6822633297062024,1.0,1.0,6/148,3.03%,SOX6;SOX5;PLS3;SNORC;ALX4;ETS2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3313821531428751,0.8784953515721662,0.635,1.0,1.0,13/57,13.96%,PMAIP1;CAMKK2;TP53;PPARGC1A;MIEF2;MIEF1;SPIRE1;HRK;DNM1L;GPER1;BOK;MUL1;ADCK1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.21627281978560803,-0.878456526968794,0.7647058823529411,0.9136039998988162,1.0,30/110,21.01%,CDH5;APOE;ABCA1;DDX3X;HJURP;PTPN11;STXBP1;HSPA5;IAPP;SLF2;PEX5;HCFC1;ICE1;TGFB1;RIOK3;SLF1;IRGM;EP300;AIDA;NOP53;MMP1;CDC42;BAX;RALB;HSF1;PARK7;TIRAP;AJUBA;BID;KIF9
prerank,erythrocyte differentiation (GO:0030218),-0.2537293641102956,-0.8784119994346806,0.7177033492822966,0.9127914355991026,1.0,13/44,26.06%,TGFBR3;KMT2E;KIT;RPS19;ALAS1;LYN;HSPA9;SLC25A38;NCKAP1L;PTPN2;TAL1;UBA5;ZFPM1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3443156975488503,0.8781234497753027,0.625169147496617,1.0,1.0,6/42,6.96%,LIMS1;PDGFB;FZD4;GCNT2;RSU1;CORO1C
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.31652484146462395,0.8774758335561502,0.638755980861244,1.0,1.0,21/86,16.91%,LIMD1;ANKRD2;CUL2;PSMC6;ELOC;TP53;VEGFA;CHEK1;IMPACT;HIF1A;PSME4;BAG3;PSMB1;PSMD5;ATF3;PSMB2;PSMB7;PSMD3;PSMA2;INO80;PSMD14
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.38942092656005267,0.8774023741960638,0.6123680241327301,1.0,1.0,3/23,6.43%,PMAIP1;BCL2;TP53
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.38942092656005267,0.8774023741960638,0.6123680241327301,1.0,1.0,3/23,6.43%,PMAIP1;BCL2;TP53
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4165176082757212,0.8772326342512095,0.5963963963963964,1.0,1.0,5/13,19.15%,KPNA4;KPNA2;KPNA3;CBLB;NUP54
prerank,glycosphingolipid metabolic process (GO:0006687),0.34279371182180896,0.8772222260058178,0.6119205298013245,1.0,1.0,11/42,14.96%,ESYT2;LARGE1;NEU3;GLA;SUMF1;ST8SIA5;A4GALT;GM2A;GLTP;GLB1;CTSA
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3448461403836034,-0.8770480521158381,0.6326034063260341,0.9148855082998539,1.0,6/14,15.49%,PPP2R2B;PPP2CA;PPP2CB;NCK1;PPM1F;DUSP1
prerank,regulation of protein phosphorylation (GO:0001932),0.2881094082738635,0.8769396907965914,0.7254098360655737,1.0,1.0,41/256,13.58%,TTN;NTRK3;ANGPT1;FGF1;HRC;PLCE1;CCN1;CCND2;THPO;FAM20A;SMG8;ACVR2A;MUSK;CAMKK2;RARRES2;DAB2IP;VEGFA;PPP2R5A;PIN1;CORO1C;RASGRP1;ITGB3;SOX9;ANKRD54;CCND1;ADAM17;IMPACT;RAP2A;PELI2;PDGFA;GPER1;ROCK2;ATF3;CLIP3;TNIK;AKTIP;CHRNA7;FNIP2;FGF10;PLXNB2;GAS6
prerank,embryonic organ morphogenesis (GO:0048562),0.3451734466833976,0.8765722782562335,0.6389261744966444,1.0,1.0,4/42,6.97%,RYR2;RBPMS2;OSR2;HOXC4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.40076548116848276,0.8765358133276239,0.6461794019933554,1.0,1.0,5/19,17.11%,IRS1;PPARA;PRKCD;IRS2;MTLN
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.34503457469040655,0.8762089650699706,0.6185983827493261,1.0,1.0,11/41,16.24%,ALOX5;FADS3;HSD17B4;FADS2;GSTP1;MGLL;SCP2;PTGR1;PLA2G4A;PLA2G4C;EPHX1
prerank,regulation of endocytosis (GO:0030100),0.32626417880910724,0.8759646081351132,0.6551282051282051,1.0,1.0,7/61,6.83%,ROCK1;HIP1;CDH13;PACSIN3;PACSIN2;CBLL1;PTPN1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.318618240794591,0.8757144229945716,0.6450060168471721,1.0,1.0,16/78,11.85%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;ACTB;ZDHHC2;SORBS1;STAC3;PPP2R5A;AR;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,cellular response to acid chemical (GO:0071229),0.36267697205293903,0.8756459305583432,0.6123076923076923,1.0,1.0,7/27,12.52%,LARS1;CPEB1;VEGFA;CAPN2;RRAGB;SH3BP4;CPEB3
prerank,positive regulation of synapse assembly (GO:0051965),-0.2882388422007599,-0.8756035422069546,0.6579710144927536,0.9172073073370799,1.0,13/27,28.54%,NLGN1;SEMA4D;PTPRD;NRXN1;NLGN2;NLGN3;LRRC4B;GRID2;IL1RAP;EPHB2;SRPX2;EPHB3;SYNDIG1
prerank,cellular response to glucose starvation (GO:0042149),0.3456948520427419,0.8755031865628357,0.6024759284731774,1.0,1.0,13/41,18.85%,PMAIP1;KPTN;MYBBP1A;TP53;NUAK1;IMPACT;BRSK1;PIK3C3;PRKAA2;ITFG2;EIF2AK3;MTMR3;BRSK2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.29345242542250566,-0.8750536189136705,0.6331360946745562,0.9174536019806528,1.0,8/26,14.46%,APP;NLGN1;PTK2B;SHANK3;TMEM108;NRXN1;NLGN2;NLGN3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3109529666500569,0.8747527911134183,0.6182669789227166,1.0,1.0,14/86,12.51%,RBPMS;CCN1;ZEB2;TGFB3;ACVR2A;TGFB1I1;BMPR1A;SLC2A10;TGFB2;ADAM17;GDF1;ACVR1B;BMPR1B;CITED2
prerank,cortical cytoskeleton organization (GO:0030865),0.3400149198319692,0.8740897631106427,0.6135458167330677,1.0,1.0,7/41,11.37%,ROCK1;LCP1;RHOBTB3;PLEK;RHOF;ROCK2;RHOH
prerank,regulation of BMP signaling pathway (GO:0030510),0.3210337323377048,0.8737346868733419,0.6549636803874092,1.0,1.0,7/73,5.14%,RBPMS2;CRIM1;CCN1;ITGA3;FST;ACVR2A;BMPR1A
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.4014998012085166,0.8736669675679097,0.5909090909090909,1.0,1.0,3/14,7.72%,CHADL;SOX9;SNAI2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.37932926384520427,0.8736233152761959,0.5922330097087378,1.0,1.0,3/21,5.29%,SAMD4A;PARN;CNOT4
prerank,lung epithelium development (GO:0060428),-0.37353400148808935,-0.8735129036511254,0.6223628691983122,0.9200627930767914,1.0,2/10,12.23%,BMP4;RCN3
prerank,negative regulation of protein secretion (GO:0050709),-0.2620902197105144,-0.8732298531848361,0.6893939393939394,0.919763967396378,1.0,9/38,13.39%,APOE;ERP29;PSMD9;CCN3;RAB11FIP5;PRKN;CYP51A1;HMGCR;RAB11FIP1
prerank,pulmonary valve development (GO:0003177),0.3929327010637958,0.8728877769697092,0.6138933764135702,1.0,1.0,4/18,7.87%,HEY2;HEYL;JAG1;TGFB2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3063397158947392,0.8728877159326103,0.6478060046189377,1.0,1.0,17/104,12.64%,CCNA2;CCND2;SLC8A2;SLC8A1;KSR1;ACTB;DAB2IP;CALM1;CCND1;MAP2K1;CCNT1;CDK7;RB1;LRP5;CDK12;TSG101;PDCD10
prerank,regulation of cell cycle phase transition (GO:1901987),0.3116963161822155,0.8726961725068748,0.650887573964497,1.0,1.0,21/91,17.87%,ATP2B4;TCIM;ANAPC10;MN1;TAF1;PSMC6;TP53;FBXW7;UBE2E1;PSME4;PSMB1;PSMD5;UBE2D1;PSMB2;PSMB7;PSMD3;FBXO5;PSMA2;PSMD14;ANAPC16;ANAPC5
prerank,protein oxidation (GO:0018158),0.4321221985409939,0.872393418500835,0.5897887323943662,1.0,1.0,2/11,10.21%,LOXL2;SUMF1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.2863901603997785,-0.8721624295847487,0.6501457725947521,0.9211828521434821,1.0,9/24,24.50%,SULF1;CCBE1;CYP1B1;TGFB1;PTGS2;ARNT;ATF4;FLT4;SULF2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.21889497793391036,-0.871938314146706,0.7851851851851852,0.920711035419946,1.0,34/94,27.98%,NOD1;NFKBIA;IRAK1;PSMD7;PSMD9;PSMD13;IRAK3;PELI1;MAP3K3;IKBKG;TAB2;PSMB3;IRAK2;UBC;CHUK;PSMC5;TAB1;PSMA5;PSMA1;PSMC2;TOLLIP;BTRC;IL1RAP;PSME3;UBB;PSMC4;PSMB6;IRAK4;PSMB10;PELI3;RPS6KA4;PSMA4;SQSTM1;PSME1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.31546934055231896,-0.8711770861435553,0.6309226932668329,0.9214986680683361,1.0,7/18,22.14%,SEL1L;RNF185;UGGT2;UBC;OS9;SYVN1;UBB
prerank,positive regulation of T cell differentiation (GO:0045582),-0.26144986894618316,-0.8710742672563307,0.6875,0.9208262606529235,1.0,7/36,19.76%,LEF1;GLI2;ZMIZ1;CD46;SOX4;NCKAP1L;PNP
prerank,protein deubiquitination (GO:0016579),-0.18780814291944856,-0.8708475643229523,0.896551724137931,0.920449145040302,1.0,59/242,19.24%,SMAD3;ATXN3;USP46;FOXK2;USP11;ASXL2;NFKBIA;OTUD7B;WDR48;USP45;UFD1;USP19;BIRC2;ACTR8;PSMD7;USP7;USP12;PSMD9;PSMD13;MDM2;IKBKG;BRCC3;SMURF2;HCFC1;ESR1;SENP8;PRKN;OGT;PSMB3;UBC;TGFBR1;SKP2;USP3;IL33;SUDS3;PSMC5;TAB1;EP300;PSMA5;USP29;PSMA1;PSMC2;BIRC3;ATXN7;MINDY1;HGS;VCPIP1;USP37;OTUD3;SMAD2;CDC25A;EIF3F;USP24;SMAD4;SNX3;SIAH2;ZC3H12A;USP32;USP10
prerank,regulation of axon extension (GO:0030516),-0.26725160154972183,-0.8705764904236699,0.6842105263157895,0.9201447405281237,1.0,8/37,12.46%,APOE;SEMA7A;RUFY3;GOLGA4;RNF6;SEMA3A;CDKL3;RTN4
prerank,negative regulation of TOR signaling (GO:0032007),0.34228285818944304,0.8705459773063658,0.6321678321678321,1.0,1.0,9/36,15.38%,RNF152;KPTN;CASTOR1;EPM2A;NPRL2;SH3BP4;PRKAA2;CASTOR2;ITFG2
prerank,sterol biosynthetic process (GO:0016126),-0.271191764002491,-0.8704668960558952,0.6333333333333333,0.9194756511735245,1.0,12/33,24.99%,PRKAG2;LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3848209000495145,0.8703032108268483,0.5880503144654088,1.0,1.0,4/20,10.88%,ROCK1;LCP1;PLEK;ROCK2
prerank,negative regulation of telomere maintenance (GO:0032205),-0.34565024920598497,-0.8699821266341141,0.6327543424317618,0.9196373576868935,1.0,8/15,24.62%,TNKS2;RAD50;NBN;TERF2IP;SMG6;ATM;ERCC1;ERCC4
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3424754983207535,0.8699239848395172,0.6284224250325945,1.0,1.0,19/49,18.02%,PMAIP1;BCL2;CAV1;TP53;BCL2L2;NDUFS3;RTKN2;DNM1L;BOK;MCL1;URI1;PTPMT1;EIF2AK3;S100A8;S100A9;BCAP31;DAPK2;DDIT3;BBC3
prerank,regulation of cellular response to heat (GO:1900034),0.31683922287651456,0.8695666250419788,0.6448484848484849,1.0,1.0,24/77,20.94%,CAMK2G;CAMK2D;NUP62;MAPT;MAPKAPK2;SEC13;NUP153;BAG3;NUP107;AAAS;BAG2;NUP98;MAPK1;NUP37;NUP210;FKBP4;HSPB8;DNAJB6;NUP54;NUP160;NUP133;HIKESHI;TPR;PTGES3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.4065297584792054,0.869507064958814,0.6112956810631229,1.0,1.0,2/14,5.41%,CCL5;RARRES2
prerank,chromatin assembly or disassembly (GO:0006333),0.4321167449401071,0.8692037145156878,0.5925266903914591,1.0,1.0,3/11,6.43%,CHAF1B;SUV39H2;TP53
prerank,tRNA aminoacylation (GO:0043039),0.35413195468364084,0.8691241447424731,0.6187150837988827,1.0,1.0,14/37,19.51%,HARS2;LARS1;GATB;IARS2;AIMP1;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2;GARS1;GATC
prerank,cell projection assembly (GO:0030031),0.37812843525443046,0.8688350111411932,0.6075757575757575,1.0,1.0,6/22,15.31%,RHOJ;CYFIP1;PARVA;PDGFA;RHOH;RHOG
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.28231660637696454,-0.8685408326050456,0.6345029239766082,0.9218680949098782,1.0,8/27,18.52%,CHKA;LPIN2;NAAA;NAPEPLD;PLA2G6;PLAAT3;SELENOI;LPIN3
prerank,regulation of pH (GO:0006885),0.42349898579899975,0.8685048823618321,0.5968028419182948,1.0,1.0,1/11,2.53%,PDK4
prerank,megakaryocyte differentiation (GO:0030219),0.435843265226481,0.8679873814542655,0.6078066914498141,1.0,1.0,2/11,7.30%,THPO;MED1
prerank,negative regulation of insulin secretion (GO:0046676),0.38889400236074245,0.8676590638812129,0.6032786885245902,1.0,1.0,3/17,5.88%,KCNB1;KLF7;IRS1
prerank,regulation of defense response to virus by host (GO:0050691),0.361376107477308,0.8675745543742103,0.6124818577648766,1.0,1.0,8/30,17.63%,CGAS;IL12RB1;ZDHHC1;MUL1;STAT1;SIN3A;DHX9;EIF2AK4
prerank,positive regulation of neuron death (GO:1901216),-0.24714910403846888,-0.8674188609141156,0.7136563876651982,0.9233868484790727,1.0,5/46,3.75%,NF1;EPHA7;EFNB2;NUPR1;WNT5A
prerank,positive regulation of integrin activation (GO:0033625),0.432050060799534,0.8673060944356766,0.6010362694300518,1.0,1.0,2/11,7.52%,FERMT2;PLEK
prerank,myelin assembly (GO:0032288),0.4301574261538289,0.8671611351754638,0.5836653386454184,1.0,1.0,3/10,15.12%,TPPP;DICER1;CNTNAP1
prerank,mitochondrial fission (GO:0000266),-0.32163794568320514,-0.8671230877307269,0.6702127659574468,0.92305679927264,1.0,5/16,15.31%,DNM3;DNM1;MTFR1;PRKN;FIS1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.23804199558935069,-0.867006672972832,0.7679324894514767,0.9224227529834971,1.0,22/57,24.01%,CDC14B;PRKDC;MRE11;RINT1;BRCC3;ATF2;MDC1;BLM;NBN;TAOK1;FOXN3;NOP53;HUS1;CHEK2;ATM;FBXO31;HMGA2;TAOK2;TRIM39;CLSPN;CDK2;CDKN1A
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.28137228999474223,0.8670061995254134,0.962,1.0,1.0,261/1645,15.60%,ACTA2;MYOCD;SOX6;MLF2;PRDM16;SOX5;TNNI2;WTIP;MEF2C;ATP2B4;HEY2;MAP3K5;ZFHX3;TBX2;SMARCD3;PTP4A3;LBH;NR1H4;POLR2L;LIMS1;EBF1;LIMD1;TCIM;PDGFB;ZEB2;NAB1;ATP8B1;ALX4;RORA;MLF1;ID4;NR4A1;EBF2;SIM2;LOXL2;GABPA;PRRX1;ETS2;ARID5B;IFRD1;RUNX1T1;HEYL;TEAD3;PBXIP1;CAMK2D;IRX5;FZD4;HINFP;BRIP1;TGFB3;GMNN;ZNF436;FOSL2;RBAK;NACC2;NUP62;PRDM1;HDAC9;ARID1A;SET;NR2F2;TGFB1I1;ANKRD2;NR2C1;VEZF1;MTERF3;CAMKK2;ATXN1;OSR2;PIAS4;CBFB;SP7;KLF7;CCNQ;CEP290;TBX18;MEF2A;GBX1;DYRK1A;NCOA7;KLF16;PRKCQ;MTDH;TESC;DBP;FOXJ3;KLF15;SUV39H2;MYBBP1A;JUND;SMARCB1;CHD2;DAB2IP;ELOC;ARID5A;TP53;RXRG;VEGFA;DYRK1B;PPM1A;GRHL1;ZNF418;HEXIM1;ZBTB38;HDGFL3;SFPQ;HOXC4;BCL7A;PA2G4;AR;PPARGC1A;ZFP28;L3MBTL2;MED1;PPARGC1B;ZNF431;MED29;REXO4;BTG1;YAP1;ERCC6;MED12;SOX9;SNAI2;HSF4;RELA;ZFP62;PLCB1;KMT2D;SETD3;MAP3K10;DAPK3;CUX2;EPC2;ZXDC;ZKSCAN4;PPARA;TRAK1;CBX4;BBX;MAP2K1;MED13L;MSL3;CARF;CCNT1;FUS;NSD3;MTA3;NR4A2;PPIE;NR1D1;LRRFIP1;KAT7;ZBTB33;HIF1A;CRLF3;SFR1;ZBTB41;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC;CDK18;ZNF3;NAT14;MED14;NR2C2;NUP107;TEAD1;RAI1;SRSF10;PCGF5;SREBF2;RUNX1;RB1;LRP5;RHOH;ATF3;PIAS2;HOXC8;NKX6-1;ZKSCAN1;BAZ2A;ZBTB7A;NFX1;ACVR1B;ESRRA;CNOT7;PSPC1;LCORL;USP13;FBXW11;RUVBL1;LIN9;TSFM;CSRNP3;HDGFL2;TOX4;CITED2;CTDSP1;NR6A1;POU3F3;ZXDB;SMARCA5;MED8;ZBTB10;ZNF83;CDK15;ZFP69;MXD4;PPP3CB;BCL6;CHD4;IKZF1;CASZ1;MEF2B;HMG20A;FOXJ1;TRIM28;SPIN1;GAS6;ZBTB5;MAP2K3;RFX7;ZKSCAN7;CLOCK;ETV3;HOPX;ZNF276;ZBTB4;SP4;RFX1;EDF1;DVL1;MAPRE3;EBF3;VGLL4;UXT;IRF2BPL;PCGF3;MLXIPL;ZNF711;KLF6;KARS1;FBXO5;HOXB2;POFUT1;ZSCAN22;KDM2B;URI1;RHOG;RBM15;CIAO1;STAT1;DNM2;YWHAH;HOXC5;NR5A1;MAGED1;NOS1
prerank,regulation of TORC1 signaling (GO:1903432),0.3538021157089876,0.8669232832970575,0.6449787835926449,1.0,1.0,5/33,9.52%,RNF152;LARS1;KPTN;CASTOR1;RRAGB
prerank,apoptotic DNA fragmentation (GO:0006309),-0.32246882450813685,-0.8668230724969985,0.6333333333333333,0.9219040770588608,1.0,3/16,5.23%,HMGB1;CECR2;KPNA1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.28901855485246886,-0.8662578355645337,0.6267029972752044,0.9222732218752877,1.0,4/21,10.06%,SLC30A10;ABCB7;COA8;PRKN
prerank,positive regulation of actin nucleation (GO:0051127),0.431475866891189,0.8662166244061832,0.5920138888888888,1.0,1.0,3/11,9.77%,CYFIP1;WHAMM;FCHSD2
prerank,gland development (GO:0048732),0.3266290884671484,0.8659616812795807,0.6588380716934487,1.0,1.0,10/59,13.32%,TG;ANXA1;ARID5B;TGFB3;CAV1;SOX9;ARHGAP35;GFER;CITED2;FGF10
prerank,cognition (GO:0050890),0.3363632570995948,0.8656453351736243,0.674863387978142,1.0,1.0,7/42,12.39%,LHCGR;SLC8A2;CYFIP1;CUX2;HRH3;CHMP2B;CHRNA7
prerank,positive regulation of inflammatory response (GO:0050729),0.30865877928138286,0.8654428774184336,0.652744630071599,1.0,1.0,5/86,3.61%,AGTR1;PLA2G3;IL2;LPL;FEM1A
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3205552376899409,-0.8651927866532426,0.659846547314578,0.9237024733887431,1.0,1/18,0.13%,PTN
prerank,lipid homeostasis (GO:0055088),-0.2407707680176317,-0.8649286059031682,0.7545454545454545,0.923331196608554,1.0,5/57,2.55%,ZBTB20;RBP1;APOE;ABCA1;DDX3X
prerank,amino sugar biosynthetic process (GO:0046349),-0.34871499371869924,-0.8648823496180933,0.6681818181818182,0.9225587282421407,1.0,7/12,26.99%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.4139896577196861,0.8645706653408177,0.58578856152513,1.0,1.0,2/13,3.64%,CSPG4;BGN
prerank,dendritic cell migration (GO:0036336),0.3964039540468221,0.8632586595925869,0.6227045075125208,1.0,1.0,4/16,12.49%,CCL5;ALOX5;TRPM4;TRPM2
prerank,calcium import into the mitochondrion (GO:0036444),-0.35983573609451813,-0.8631049881412972,0.6430205949656751,0.9254083632275597,1.0,4/10,14.62%,MCU;MCUB;MICU2;MAIP1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3320629925631171,-0.8627986172799944,0.6561679790026247,0.9251236137635843,1.0,5/13,30.91%,RPS21;NOP9;UTP20;RRS1;TBL3
prerank,negative regulation of interferon-gamma production (GO:0032689),0.3672799460252197,0.8627063106863095,0.6327433628318584,1.0,1.0,4/23,13.58%,NR1H4;HAVCR2;AXL;GAS6
prerank,positive regulation of protein kinase activity (GO:0045860),0.29528169621502365,0.8626944009268218,0.6983606557377049,1.0,1.0,26/148,13.62%,RAP1A;PDGFB;CCN1;SLC8A2;CCL5;MMD;DOK7;DAB2IP;VEGFA;PTPN1;CALM1;TPX2;LCP2;ITGB3;TGFB2;MAP2K1;PAK2;CENPE;PRKCD;TNIK;CLU;SNX9;PDCD10;TAOK3;GAS6;MAP2K3
prerank,cellular response to metal ion (GO:0071248),0.29866019917029957,0.8624545462546997,0.6743169398907104,1.0,1.0,8/123,5.58%,RYR1;MEF2C;CACNA1H;RASGRP2;CAMK2D;SYT10;MEF2A;KCNH1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4070329686688967,0.8613795865379877,0.5887372013651877,1.0,1.0,4/13,15.77%,IL12RB1;NECTIN2;STX7;MR1
prerank,positive regulation of phosphorylation (GO:0042327),0.2833781731168501,0.8612745982253857,0.7384140061791967,1.0,1.0,47/240,15.73%,NTRK3;ANGPT1;FGF1;MERTK;MST1R;CCN1;ROR1;CCND2;THPO;FAM20A;CCL5;PFKFB1;ACVR2A;MUSK;CAMKK2;RARRES2;DSCAM;VEGFA;PIN1;AR;RASGRP1;ITGB3;SOX9;CCND1;ADAM17;EPHA2;HIF1A;AXL;RAP2A;PDGFRB;PELI2;GPER1;ROCK2;CLIP3;TNIK;AKTIP;CHRNA7;FGF10;GAS6;EPHB1;LRRK2;PRKAA2;MLXIPL;GAPDHS;MYDGF;FLOT1;VAC14
prerank,gas transport (GO:0015669),0.4273402805863909,0.8612211820563881,0.6090909090909091,1.0,1.0,1/10,2.97%,MB
prerank,cellular amide metabolic process (GO:0043603),-0.21105058926455278,-0.8611217697972949,0.7567567567567568,0.927879343880201,1.0,24/102,22.27%,AEBP1;CERK;ST3GAL1;PPP2CA;SLC25A32;PCCA;NAAA;NAPEPLD;ACSF2;ASAH2;ACOT8;DBI;ACOT9;PLAAT3;CPD;CPXM1;MTHFS;ALDH1L1;FPGS;ABCB9;MCCC1;ATF4;ABCA2;PDZD11
prerank,ribosome assembly (GO:0042255),0.329592482114554,0.8610678309522305,0.6223118279569892,1.0,1.0,7/47,9.57%,RPL3L;MTERF3;RPS27L;NLE1;MDN1;PWP2;RPL5
prerank,cellular response to UV (GO:0034644),0.31673474356688536,0.8609413949451631,0.6829558998808105,1.0,1.0,11/76,11.29%,CRIP1;TAF1;TP53;PARP1;NEDD4;CHEK1;IMPACT;CERS1;RHNO1;POLD1;PRKCD
prerank,regulation of keratinocyte migration (GO:0051547),0.4118244432123277,0.860881979772089,0.5925266903914591,1.0,1.0,5/12,24.12%,MAPRE2;FGF10;PTEN;ADAM9;IQSEC1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2603307197766108,-0.8607523904766988,0.6730769230769231,0.9277254372329673,1.0,21/37,38.27%,ERCC5;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;RPA3;RFC3;RPA2;ERCC3;POLD3;RPA1;RFC1;RFC4;NTHL1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.2229482970594763,-0.8607471900134686,0.7485029940119761,0.9268381769123347,1.0,27/72,28.99%,IRAK1;BIRC2;PSMD7;PSMD9;PSMD13;CARD10;PSMB3;CHUK;CARD14;PSMC5;PSMA5;PSMA1;PSMC2;BIRC3;RELB;AKT1;TLR3;TIRAP;BTRC;PSME3;PSMC4;PSMB6;PSMB10;NFKB2;PSMA4;PSME1;PSMF1
prerank,positive regulation of neuron projection development (GO:0010976),0.30848522310983306,0.8603891598093366,0.6515679442508711,1.0,1.0,5/85,2.57%,RAP1A;NTRK3;SERPINI1;PLA2G3;ROR1
prerank,intracellular cholesterol transport (GO:0032367),-0.3308838934952595,-0.8603247895778131,0.6474820143884892,0.9268180091829605,1.0,6/15,23.58%,ABCA1;LDLR;STARD4;OSBP;RELCH;NPC1
prerank,lipoprotein transport (GO:0042953),-0.3650805527958996,-0.8602351267851184,0.6740576496674058,0.9261238166461848,1.0,2/10,1.11%,PRKCB;LRP1
prerank,phosphate ion homeostasis (GO:0055062),-0.3661251713041591,-0.8601095476954962,0.6202247191011236,0.9254867996432747,1.0,3/10,21.25%,SFRP4;ENPP1;FGFR4
prerank,steroid hormone biosynthetic process (GO:0120178),0.3573681680789164,0.8600135236438113,0.6030640668523677,1.0,1.0,4/29,11.05%,HSD17B7;AKR1B1;MED1;SRD5A3
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2946455416342046,-0.8595495887706358,0.6769662921348315,0.9257787639669034,1.0,11/26,26.59%,FBN1;TCTA;RARA;TLR3;GPR137B;PTPN2;CEACAM1;C1QC;ZFPM1;MAFB;GPR137
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3123502031335296,-0.8594512257112117,0.6404494382022472,0.9250773495655386,1.0,8/19,17.73%,CUX1;CDKL3;CUL7;PTPRD;FBXW8;LRP8;OBSL1;DBN1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.38745596160909934,0.8594135332261982,0.6039933444259568,1.0,1.0,6/17,15.88%,VEZF1;BTG1;SOX9;NKX6-1;FOXJ1;RFX3
prerank,regulation of mitochondrial fission (GO:0090140),0.374709140061538,0.8592618422485224,0.6506955177743431,1.0,1.0,10/24,17.99%,INF2;MAPT;MIEF2;MIEF1;SPIRE1;DNM1L;MUL1;LRRK2;VPS35;MFF
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3279557030987828,-0.859190631936017,0.6674816625916871,0.9247431277776231,1.0,5/15,24.17%,ZC3H12B;POP1;ZC3H12C;ZC3H12A;KHNYN
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4002168134161812,0.8591747752368529,0.5973813420621932,1.0,1.0,2/15,7.87%,TGFB3;TGFB2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2775762619212645,-0.8591284297500499,0.6804733727810651,0.9239736892233364,1.0,15/29,37.27%,ELOVL7;PPT1;ACSL3;ACLY;ACSL4;ELOVL6;HACD2;ELOVL1;ACSL1;HSD17B8;ELOVL5;GCDH;SLC25A1;SCD;ACACA
prerank,camera-type eye morphogenesis (GO:0048593),0.42414999348869553,0.8589647417213141,0.6356589147286822,1.0,1.0,3/10,9.19%,TBX2;VEGFA;SKI
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.22476207397228556,-0.8589250501534296,0.8148148148148148,0.9235209730962006,1.0,29/72,30.18%,MRE11;RAD50;FBH1;ERCC5;FAN1;DDB1;UBC;RNASE4;ENPP1;CHD1L;XPA;EDC4;GTF2H5;GTF2H2;ZC3H12A;PNRC2;GTF2H3;UBB;ERCC2;EDC3;ERCC1;ERCC4;SPO11;MUS81;OGG1;RPA3;DNA2;PDE12;RFC3
prerank,aromatic amino acid family catabolic process (GO:0009074),0.39259572649890706,0.8585009572728008,0.6235294117647059,1.0,1.0,3/15,14.07%,HGD;KMO;QDPR
prerank,acylglycerol catabolic process (GO:0046464),0.3545132277569256,0.8584670854378627,0.6316546762589929,1.0,1.0,4/30,13.34%,LPL;FABP4;MGLL;PNPLA3
prerank,cell-cell junction organization (GO:0045216),0.31127280510769567,0.8580132030961604,0.6707168894289186,1.0,1.0,11/79,8.71%,CDH6;LIMS1;GJC1;CDH13;TGFB3;CDH4;CDHR3;LIMS2;TLN1;TGFB2;CDH2
prerank,transition metal ion transport (GO:0000041),0.34599034990110245,0.8579530676267516,0.6353111432706223,1.0,1.0,8/35,16.65%,TRPC6;TTYH1;TRPC5;SLC30A5;ATP7B;SLC31A2;IREB2;MT3
prerank,endomembrane system organization (GO:0010256),0.28980266399024895,0.8578392916631384,0.7175324675324676,1.0,1.0,36/178,17.68%,ARHGEF7;FER1L5;SYNE1;ATP8B1;DYSF;CLASP2;HOOK2;TBC1D20;ARHGAP21;LNPK;MYO18A;SEC31B;SUN2;HOOK1;NSFL1C;DNM1L;TLCD2;OSBPL2;CHMP2B;USP50;DMPK;AKTIP;PLEKHJ1;A4GALT;CLASP1;BNIP1;LRRK2;CSNK1A1;CAV2;SUN1;EIF2AK3;TRAPPC12;VPS51;UBXN2B;VPS4A;ARFGEF2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3432562534637342,0.8577432564268225,0.6479663394109397,1.0,1.0,7/39,12.69%,TRPC6;FHL1;UTRN;NEDD4;AHCYL1;GPD1L;HOMER1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3092556009580247,0.8577329216729158,0.654275092936803,1.0,1.0,18/79,15.70%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;MFSD6;DNM2;AP1S3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35850837885602943,0.8575207241588433,0.6437768240343348,1.0,1.0,9/30,18.34%,FZD5;SAE1;FBXW7;SREBF2;HPS4;ATG13;LEPROT;USP36;TOMM7
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.35175131285741323,-0.8570128506044852,0.6710526315789473,0.9266580635753865,1.0,3/12,6.39%,ABCA1;NFKBIA;ITGAV
prerank,neuron fate commitment (GO:0048663),-0.3425979387852238,-0.8569276202050425,0.6578947368421053,0.9259535145362673,1.0,10/14,54.71%,TGFBR1;POU3F2;DLL4;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1;MYT1L
prerank,fat cell differentiation (GO:0045444),0.31542169522794916,0.8566940871163111,0.6422018348623854,1.0,1.0,7/57,11.85%,PRDM16;NR4A1;PPARGC1A;MED1;NR4A2;ZBTB7A;CLIP3
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4257551185856984,0.8565555877136151,0.6204379562043796,1.0,1.0,1/10,2.16%,ZEB2
prerank,fatty acid metabolic process (GO:0006631),0.2950773080653069,0.8561604938430868,0.68140589569161,1.0,1.0,18/115,14.02%,CD36;LPL;FA2H;ALOX5;PEX2;ACSL5;PPARGC1A;CPT1B;CRAT;MECR;PPARA;THEM4;NUDT19;AOAH;NDUFAB1;PNPLA3;CPT1A;ACOT6
prerank,cellular response to dsRNA (GO:0071359),0.40051649131382944,0.8559219801704289,0.6162988115449916,1.0,1.0,5/15,16.81%,CGAS;CAV1;MUL1;FLOT1;DHX9
prerank,endocytic recycling (GO:0032456),0.32890072497973866,0.8557716799474803,0.6564171122994652,1.0,1.0,15/50,17.40%,EHD2;ANKRD50;VPS26A;WASHC1;RAB11FIP3;RAB11FIP4;DENND1A;VPS35L;VPS50;RAB14;ANKRD27;SNX17;VPS35;SNX4;VPS51
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2980370765011188,-0.8556317920299057,0.7134328358208956,0.92782604509689,1.0,10/22,24.54%,DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;RAD23B
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2971921536831958,0.8555483857472074,0.7154017857142857,1.0,1.0,35/119,19.45%,PIP5K1B;INPP4B;PIP4K2A;MTMR7;SOCS5;PITPNM3;PIGN;SOCS6;SOCS4;SYNJ2;PIGA;SACM1L;TTC7A;INPPL1;MTMR14;ITPKC;CDIPT;SBF1;PIK3C3;RAB14;PLEKHA1;PIGH;INPP5J;PIGB;PITPNM2;PTEN;VAC14;PIGP;DPM2;PLEKHA2;MTMR3;INPP4A;MBOAT7;PIK3R2;PGAP4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.31884020884615827,0.8555264674015876,0.6458852867830424,1.0,1.0,8/56,9.59%,RBPMS;TGFB3;ACVR2A;BMPR1A;EMILIN1;PIN1;TGFB2;GDF1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.38550731669948024,0.8554601835586437,0.6247960848287113,1.0,1.0,3/16,6.84%,ZFAND2B;IGFBP5;IGFBP4
prerank,lipoprotein localization (GO:0044872),-0.3520294856406219,-0.8550213455335922,0.6791569086651054,0.9281440267393869,1.0,2/11,1.11%,PRKCB;LRP1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.32307493725953534,0.8549778256561742,0.6458598726114649,1.0,1.0,16/55,18.02%,PMAIP1;BCL2;CAV1;DAB2IP;TP53;PAK2;DEDD2;DNM1L;GPER1;BOK;S100A8;S100A9;TNFSF12;BCAP31;DDIT3;BBC3
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.31562437790376846,-0.8549339340028109,0.6564102564102564,0.927432179215146,1.0,4/16,10.77%,AUTS2;RASGRF1;PIK3CB;OGT
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3199569466023825,0.8541889316462473,0.6666666666666666,1.0,1.0,13/64,13.04%,POLR2L;POLR2I;ADRM1;GTF2H4;ELL;POLR2G;ELOC;CCNT1;CDK7;POLR1E;CDK12;NELFB;POLR2J
prerank,DNA double-strand break processing (GO:0000729),-0.31203315733169185,-0.8541398589542925,0.6724137931034483,0.9281637036199821,1.0,5/18,18.11%,MRE11;RAD50;BLM;NBN;ATM
prerank,response to histamine (GO:0034776),0.42590317767531677,0.8541277882461482,0.6172607879924953,1.0,1.0,2/10,11.99%,GABRB2;GABRB3
prerank,cellular copper ion homeostasis (GO:0006878),-0.333506515582094,-0.8538917709967901,0.6432160804020101,0.9278068794619283,1.0,4/14,22.58%,APP;ATOX1;MT2A;SLC31A1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.29261348578147217,-0.8538567293939964,0.6630727762803235,0.926974736244566,1.0,6/23,20.21%,HSP90AB1;IRGM;PARP14;PPARG;NLRC5;PTPN2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.34007095354648864,-0.8537229135735853,0.6721311475409836,0.9263622804146937,1.0,5/13,21.18%,GLUL;ASPA;ACOT8;MTHFS;GAD1
prerank,arachidonate transport (GO:1903963),0.42385061681516717,0.8533723230963615,0.6061776061776062,1.0,1.0,1/10,2.79%,ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.42385061681516717,0.8533723230963615,0.6061776061776062,1.0,1.0,1/10,2.79%,ANXA1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.32481452123155724,-0.8529606753610762,0.672,0.9270482324123213,1.0,5/16,14.86%,DCPS;SNRNP200;CWC15;SFSWAP;NCBP2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.29280600210051283,0.8526668607544066,0.6950276243093922,1.0,1.0,16/124,11.50%,TPM1;ROCK1;FRY;ARMC2;BTG2;MAPT;GDNF;HDGFL3;NEDD4;CYFIP1;PLEK;ERCC6;ATCAY;SAMD14;RB1;KIFAP3
prerank,negative regulation of cilium assembly (GO:1902018),-0.3505776497172527,-0.8525072726479509,0.6751152073732719,0.9270910469524642,1.0,7/12,29.20%,LIMK2;CEP97;TBC1D30;ODF2L;TBC1D7;CCP110;TESK1
prerank,cellular response to nutrient levels (GO:0031669),0.3166919827895543,0.852355301409885,0.6508951406649617,1.0,1.0,13/62,14.42%,PDK4;LPL;KCNB1;ATG7;STK26;PPARA;RRAGB;STK24;SREBF2;WDR45;PDK2;LRRK2;PRKAA2
prerank,response to X-ray (GO:0010165),-0.3298648404514293,-0.8522053475968613,0.6517412935323383,0.9268714626656445,1.0,7/14,23.63%,XRCC5;BRCC3;BLM;XRCC6;ATM;IKBIP;NUCKS1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.4072149871662254,0.8521232956206808,0.6309523809523809,1.0,1.0,3/13,11.29%,MAPT;GSTP1;PRKCD
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.38571500329425634,0.8516944611260221,0.6330128205128205,1.0,1.0,4/18,9.75%,LAX1;DUSP3;PPARA;PAG1
prerank,regulation of establishment of cell polarity (GO:2000114),0.392551799583158,0.8514222569907606,0.631404958677686,1.0,1.0,4/16,12.58%,ROCK1;KANK1;ROCK2;KIF20B
prerank,lung development (GO:0030324),0.338749668423843,0.8514025163488723,0.6647482014388489,1.0,1.0,4/33,6.66%,FGF1;ITGA3;VEGFA;ABCA3
prerank,regulation of plasminogen activation (GO:0010755),0.4107621830048934,0.8513813819453407,0.656084656084656,1.0,1.0,2/12,11.12%,SERPINE2;RUNX1
prerank,snRNA metabolic process (GO:0016073),-0.32024760864116153,-0.851104110295601,0.6675531914893617,0.9283277391340023,1.0,5/17,23.69%,INTS6;INTS3;INTS2;RBM7;INTS11
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.36230338432139514,-0.8510051428765392,0.6681514476614699,0.9276430601287217,1.0,5/10,21.49%,DSE;DSEL;XYLT1;PXYLP1;B3GAT1
prerank,myoblast differentiation (GO:0045445),0.39560351750698475,0.8506023750513537,0.6146953405017921,1.0,1.0,5/14,11.20%,JAG1;HINFP;PLEKHM3;MBNL1;RB1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.34336899862565723,0.8501749705055541,0.6235632183908046,1.0,1.0,9/32,15.54%,PRKAB2;PDK4;SORBS1;PPARA;GPER1;SIRT4;PRKAA2;MLXIPL;NR5A1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.33995878224619364,0.8501084246068925,0.647945205479452,1.0,1.0,6/36,8.05%,PPP3CA;FZD5;FZD4;GNAO1;CALM1;PLCB1
prerank,response to exogenous dsRNA (GO:0043330),0.3778930266564134,0.8488034641707171,0.6025848142164781,1.0,1.0,7/18,17.17%,CGAS;CAV1;MUL1;FLOT1;RFTN1;DHX9;TICAM1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.3533905793802834,-0.848432668053628,0.6791208791208792,0.9320111251115748,1.0,1/10,1.71%,HMGB1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.21821850615094346,-0.848339918208319,0.7922077922077922,0.9313041509621725,1.0,32/80,28.65%,DENND2A;GBF1;VTI1A;TMEM87B;STX5;TBC1D5;GCC2;HEATR5A;SURF4;SNX6;RBSN;RAB29;YKT6;LMAN1;SNX3;VPS53;RAB9A;TBC1D10A;EHD3;VPS52;STX6;TBC1D14;BET1L;UBE2O;ARL1;ERC1;BAIAP3;GOSR1;PHETA1;DENND5A;RIC1;SNX12
prerank,body fluid secretion (GO:0007589),-0.31559285406646576,-0.8482301391006432,0.672544080604534,0.9306386812128281,1.0,3/15,12.67%,NPR1;SLC22A4;PRLR
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.24826790516553227,-0.8481839686391345,0.7391304347826086,0.9298618908839487,1.0,24/42,42.94%,PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;ZBTB1;POLI;RPA3;RFC3;USP43;RPA2;POLD3;PCLAF;RPA1;RFC1;POLE;RFC4;CDKN2D;DTL;POLA1;RFC5
prerank,protein homooligomerization (GO:0051260),0.29631175739150645,0.8481804547731789,0.6834285714285714,1.0,1.0,16/114,13.73%,RYR1;KCNJ12;HSD17B10;CRYZ;NACC2;ACACB;TIFA;TRPM4;FUS;SLC1A5;ALDOA;GLS;OSBPL2;TRPM2;CHMP2A;VSTM5
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.3596440750167935,0.8478210968961443,0.6318926974664679,1.0,1.0,5/27,6.83%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1
prerank,N-terminal protein amino acid modification (GO:0031365),-0.3205839659226538,-0.8473133553551906,0.6437054631828979,0.9307870322132858,1.0,6/14,35.62%,METAP1D;NAA50;NAA60;NAA40;NAA10;NTMT1
prerank,protein deacylation (GO:0035601),-0.2873850934098342,-0.8469735968089557,0.7109826589595376,0.930613456131959,1.0,7/23,15.13%,LYPLA1;HDAC7;HDAC4;SIRT7;PPT1;NOTUM;ABHD17C
prerank,regulation of interleukin-6 production (GO:0032675),-0.21227739835347598,-0.8464894221232574,0.8571428571428571,0.9307858828967133,1.0,20/96,19.37%,ARRB1;HMGB1;APP;PTPN11;LBP;WNT5A;LGALS9;PLCG2;PTPN22;IL6R;IRAK3;SIRPA;IL33;CX3CL1;SYT11;C1QTNF3;TLR3;NCKAP1L;ZC3H12A;TIRAP
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.21127336325398555,-0.8463349287741049,0.8344827586206897,0.9302073213201476,1.0,34/85,31.52%,FZD6;PRICKLE2;VANGL1;WNT5A;MAGI2;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2;CDC42;AP2A2;PSME3;PSMC4;CELSR1;VANGL2;PSMB6;PSMB10;DVL2;TIAM1;PSMA4;PSME1;WNT11;PSMF1;AP2M1;ARHGEF19;PSMB9;PSME2
prerank,regulation of spindle organization (GO:0090224),0.3793706940143986,0.8462524034293935,0.6203554119547657,1.0,1.0,6/18,19.28%,NUP62;TPX2;SENP6;MAP9;DCTN1;CLTC
prerank,microtubule anchoring (GO:0034453),0.41756343418374975,0.8452444828719557,0.6290909090909091,1.0,1.0,2/12,4.48%,CLASP2;BICD2
prerank,dendritic cell chemotaxis (GO:0002407),0.3948825152162,0.8446721911202661,0.6344827586206897,1.0,1.0,3/14,12.49%,CCL5;TRPM4;TRPM2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3796484244356705,0.8445025227591925,0.6418918918918919,1.0,1.0,5/20,13.27%,NR1H4;LPCAT3;MBTPS1;SREBF2;LDLRAP1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27529321203060925,0.8439765172958217,0.8165322580645161,1.0,1.0,50/417,10.28%,PRDM16;HEY2;TBX2;LBH;LIMS1;LIMD1;PDGFB;NAB1;ATP8B1;ID4;LOXL2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;GMNN;RBAK;NACC2;HDAC9;SET;NR2F2;MTERF3;ATXN1;PIAS4;SUV39H2;MYBBP1A;DAB2IP;ARID5A;TP53;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;L3MBTL2;SOX9;RELA;PLCB1;MAP3K10;CBX4;MTA3;NR1D1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3276061286861481,-0.8437157771668334,0.6825,0.9345567083461711,1.0,3/14,10.26%,STARD13;MEOX2;CARD10
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.270161831013394,-0.8431773613840516,0.729903536977492,0.9347803569081929,1.0,8/29,16.29%,UBE2D3;CASP8;BIRC2;IKBKG;UBC;CHUK;BIRC3;TLR3
prerank,isotype switching (GO:0045190),-0.35854314461476644,-0.8430800141650318,0.6536697247706422,0.9340856186836295,1.0,5/10,35.64%,MSH6;HSPD1;EXOSC3;BATF;LIG4
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.33483173661111454,0.8429429676962127,0.6575342465753424,1.0,1.0,7/41,10.49%,PDGFB;DOK7;FBXW7;PTPN1;AREG;ADAM17;HBEGF
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.3605642792310406,-0.8427893642119743,0.6924829157175398,0.9338092519342751,1.0,5/10,22.14%,UBC;TUT4;CHFR;TUT7;UBB
prerank,iron-sulfur cluster assembly (GO:0016226),0.3637743750258862,0.8426883091429279,0.6357927786499215,1.0,1.0,8/24,15.36%,FXN;GLRX5;ISCA1;ISCA2;NUBP2;NUBP1;GLRX3;CIAO1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.40978900708494953,0.8425956524627367,0.6448763250883393,1.0,1.0,2/11,6.19%,PWP1;SMARCB1
prerank,kinetochore organization (GO:0051383),-0.3379504326902776,-0.8419211662294942,0.6900726392251816,0.9346408543835084,1.0,2/13,5.53%,POGZ;CENPC
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.3571657671429701,-0.8418636847717463,0.6674528301886793,0.9338896774110671,1.0,4/11,20.39%,HMGB1;LGALS9;TWSG1;CD274
prerank,negative regulation of viral genome replication (GO:0045071),-0.24799793767586872,-0.8417058129805604,0.7242647058823529,0.9333120017301209,1.0,15/40,25.31%,PARP10;SETDB1;IFIT1;BST2;MPHOSPH8;IFITM1;OAS2;SHFL;IFITM3;SRPK1;HMGA2;RNASEL;RESF1;ZC3HAV1;IFITM2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3098421292418747,-0.8415787569760074,0.6899038461538461,0.9327045469487815,1.0,6/18,26.59%,FBN1;TCTA;TLR3;GPR137B;MAFB;GPR137
prerank,Golgi organization (GO:0007030),0.29358829235797673,0.8414990912241713,0.7045977011494253,1.0,1.0,7/112,5.29%,ARHGEF7;SYNE1;ATP8B1;CLASP2;TBC1D20;ARHGAP21;MYO18A
prerank,spermatid development (GO:0007286),0.3412782893045572,0.8412974444881809,0.6662030598052852,1.0,1.0,6/32,12.07%,RSPH1;ACRBP;CDYL;DDX25;NECTIN2;YTHDC2
prerank,positive regulation of cell junction assembly (GO:1901890),0.31774265009003794,0.841004137146371,0.6662303664921466,1.0,1.0,8/56,11.34%,ROCK1;LIMS1;FERMT2;CAV1;VEGFA;CUX2;EPHA2;IL1RAPL1
prerank,protein modification process (GO:0036211),-0.21774105350155715,-0.8409962661827401,0.8409090909090909,0.9330165520587185,1.0,25/76,27.40%,ST3GAL6;PLAT;ST8SIA4;ST3GAL1;PRKDC;UBE2D3;STK38;ATG3;CDKL3;ABL2;ST8SIA2;PLOD2;PPP4R2;NTAQ1;UBE2S;UBA7;CHRM3;B4GALT7;RPN2;FBXW2;USP25;SERP1;PARP4;LOX;QPCT
prerank,regulation of microtubule-based movement (GO:0060632),-0.3538214396174263,-0.8408304706498354,0.6891891891891891,0.9324743121706737,1.0,7/11,46.41%,IGBP1;DYNLT2B;LAMP1;DRC1;HAP1;CCDC65;CFAP298
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3626564856249438,0.8407793988467729,0.6563944530046225,1.0,1.0,9/22,20.17%,ELL;ERCC6;CCNT1;KAT7;CDK12;BRD4;HMGN1;CDK13;EAPP
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.37213333982301844,0.8406940981315013,0.6120826709062003,1.0,1.0,2/18,4.47%,CABP1;MFHAS1
prerank,phagosome maturation (GO:0090382),0.33920529283448386,0.8400237242569661,0.6605633802816901,1.0,1.0,16/35,25.66%,ATP6V1H;ATP6V0A2;MREG;ATP6V1C1;ATP6V0D2;RAB14;RAB34;RAB38;ATP6V0C;PIKFYVE;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,regulation of cholesterol storage (GO:0010885),0.3954643839037066,0.8399435545486557,0.6288135593220339,1.0,1.0,4/15,11.57%,LPL;PPARA;SREBF2;ABCG1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2965776074523186,-0.839527393508593,0.7193460490463215,0.934218017523929,1.0,7/22,22.93%,SASH1;XDH;RELL1;MAP3K4;ZC3H12A;GADD45B;SPHK1
prerank,macrophage activation (GO:0042116),0.34123691695106423,0.8393943687855082,0.6712707182320442,1.0,1.0,4/34,6.18%,FER1L5;DYSF;CRTC3;MAPT
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.33547760279317185,-0.8393008362062163,0.6708229426433915,0.9338063341647376,1.0,7/13,29.78%,SDAD1;NUP88;NMD3;NOP9;RAN;RRS1;RPS15
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2853220614631032,-0.8392842881136486,0.6942857142857143,0.9329697785293908,1.0,12/23,34.11%,ATXN3;OTUD7B;MINDY1;VCPIP1;USP37;OTUD3;USP25;TNFAIP3;YOD1;USP34;MINDY2;BAP1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3670607425728619,0.8391181799325088,0.6688206785137318,1.0,1.0,7/21,18.01%,PMAIP1;OPA1;BOK;LRRK2;EIF2AK3;CREB3;DDIT3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.2663435111601163,-0.8387561129046746,0.7443365695792881,0.9331956947242059,1.0,8/30,16.29%,UBE2D3;CASP8;BIRC2;IKBKG;UBC;CHUK;BIRC3;TLR3
prerank,protein localization to chromatin (GO:0071168),-0.29643221604293146,-0.8387444018905067,0.6994818652849741,0.932343742038441,1.0,7/18,33.86%,PPHLN1;ESR1;LEMD2;CHMP7;PIH1D1;RUVBL2;MCM8
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3302212823973285,-0.8384087138479895,0.6816143497757847,0.932113642093098,1.0,7/13,27.90%,APP;SHANK3;ADCY1;EPHB2;SHISA7;SQSTM1;RELN
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2833118173541523,0.8382842987371233,0.7433155080213903,1.0,1.0,42/166,18.78%,DYRK2;CD36;PDGFB;ZEB2;VIM;BCAR3;SAMD4A;CCL5;NAT10;IRS1;SORBS1;RPS27L;CIRBP;PPARGC1A;PYM1;NR1D1;KAT7;PTH1R;RPL5;HIF1A;PDGFRB;EIF3E;RBM3;ZCCHC4;CLU;CPEB3;ARPP19;PLXNB2;NNMT;MLXIPL;IRS2;PAOX;SP1;PIWIL2;DHX9;FAF1;NR1H3;P2RX4;EEF2;UPF3A;EGR1;CCL19
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3029661840162656,0.8382091639105547,0.681592039800995,1.0,1.0,17/78,15.70%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;DNM2;AP1S3
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3029661840162656,0.8382091639105547,0.681592039800995,1.0,1.0,17/78,15.70%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;DNM2;AP1S3
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3182480464394996,0.8381948637685371,0.666232073011734,1.0,1.0,7/54,10.07%,SDC2;EXT2;GCNT2;HS2ST1;GPC4;HS6ST1;AGRN
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.27114224470679227,-0.8380174388798137,0.7055214723926381,0.9320173073603895,1.0,14/30,31.40%,ELOVL7;HACD4;ABCD3;ACOX1;ELOVL4;ELOVL6;HACD2;SLC27A4;ELOVL1;HACD3;ACSL1;ELOVL5;TECRL;SLC27A2
prerank,retinal metabolic process (GO:0042574),-0.34396865587878767,-0.8375661819678301,0.6894977168949772,0.9320827559514591,1.0,2/12,8.42%,ABCA4;CYP1B1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.36168680338626846,-0.837432148056437,0.6831460674157304,0.9314706263568906,1.0,3/10,10.14%,MLLT3;HOXB4;ACE
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.3432676169028646,-0.8372698640411413,0.6868932038834952,0.9309370124602447,1.0,7/12,34.13%,ESR1;TGFB1;PPARG;ZC3H12A;ZC3H10;NCOR1;ELAVL1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.19606684820008194,-0.8372611982551615,0.8773584905660378,0.9300907827063823,1.0,23/124,14.21%,LEF1;AGO3;WNT4;TCF7L2;FZD6;PRICKLE2;VANGL1;WNT5A;PLCB3;CTNNB1;PSMD7;PSMD9;PSMD13;SMURF2;SFRP4;PSMB3;TNRC6A;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.319196400908873,-0.837016439607124,0.6809045226130653,0.9296834479254267,1.0,2/15,6.70%,GRB2;FRS2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.37746037794190235,0.8370039632662877,0.6197654941373534,1.0,1.0,4/16,11.12%,VIM;TGFB3;SUCO;RUNX1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.2830013005388704,-0.8367866051273406,0.7216828478964401,0.9292594744845085,1.0,4/25,3.37%,APP;ITGA6;NRP1;EGFR
prerank,intraciliary retrograde transport (GO:0035721),-0.3440725326876491,-0.8365134301994736,0.6831460674157304,0.9289579017676554,1.0,5/12,28.50%,IFT122;DYNC2H1;DYNLT2B;DYNC2I2;DYNC2I1
prerank,positive regulation of blood coagulation (GO:0030194),-0.3102944258332112,-0.8362013887359093,0.6683804627249358,0.9287111287270797,1.0,6/17,21.90%,ST3GAL4;F3;THBD;SERPINE1;ENPP4;USF1
prerank,aorta development (GO:0035904),0.38945779951860215,0.8360146782769028,0.626465661641541,1.0,1.0,2/14,3.14%,TBX2;JAG1
prerank,negative regulation of proteolysis (GO:0045861),0.335897676115749,0.8356241811979552,0.6275362318840579,1.0,1.0,3/34,6.82%,ROCK1;SERPINE2;TIMP4
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.34768113762056685,0.8351702495729776,0.6647058823529411,1.0,1.0,3/31,4.75%,CACNA1H;SYT10;KCNB1
prerank,endodermal cell differentiation (GO:0035987),0.34535113888723834,0.8347611443819536,0.6647398843930635,1.0,1.0,4/31,8.27%,COL4A2;ITGA7;ITGB5;ITGA4
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.22501329494471278,-0.8346855412232176,0.8341708542713567,0.930873208466237,1.0,8/68,8.49%,HMGB1;APP;PTPN11;LBP;WNT5A;LGALS9;PLCG2;IL6R
prerank,axonal fasciculation (GO:0007413),-0.3356662849895087,-0.8343306907450736,0.6972477064220184,0.9307095942051361,1.0,8/12,27.21%,EPHA4;EPHA3;MEGF8;RTN4;CNTN4;EPHB2;CDK5R1;EPHB3
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.34135331271791197,-0.834024507827174,0.6699751861042184,0.9304597286526818,1.0,8/12,28.87%,GMPS;ADSS2;PFAS;GART;ATIC;IMPDH1;IMPDH2;PAICS
prerank,positive regulation of telomere maintenance (GO:0032206),-0.26413729630967525,-0.8334374729706345,0.727810650887574,0.9307410457484864,1.0,8/31,13.56%,TNKS2;MRE11;PML;RAD50;GNL3;NBN;MAP3K4;HNRNPD
prerank,embryonic organ development (GO:0048568),0.31100411263084193,0.83338522502274,0.680503144654088,1.0,1.0,9/61,10.75%,HEY2;TBX2;TEAD3;BMPR1A;RARRES2;GDNF;TGFB2;TEAD1;PDGFA
prerank,nuclear membrane organization (GO:0071763),-0.2982735158681524,-0.8329373477913222,0.664,0.9308058643601416,1.0,9/19,26.54%,SPAST;TOR1AIP1;AKAP8L;TARDBP;EMD;TMEM43;CHMP4B;TOR1A;CHMP7
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.36521632444091934,0.8327921000178192,0.6459909228441755,1.0,1.0,6/22,10.59%,PSMC6;TP53;MED1;MED12;PAXIP1;MED14
prerank,cellular response to mechanical stimulus (GO:0071260),0.3186749170665567,0.8325145198323292,0.6832460732984293,1.0,1.0,8/46,17.09%,MYD88;CNN2;CHEK1;SOX9;CASP8AP2;TNFRSF10B;MAP2K4;MAP3K2
prerank,regulation of embryonic development (GO:0045995),0.3394013688635698,0.8322820765549389,0.6552706552706553,1.0,1.0,7/34,14.15%,PHLDB2;CLASP2;PLCB1;RBM19;NR2C2;CLASP1;RAB14
prerank,protein secretion (GO:0009306),-0.22935194778475385,-0.8321166934509389,0.8009049773755657,0.9316063910814566,1.0,18/56,19.77%,PCSK5;ABCA1;SEL1L;RAB12;CYB5R4;CANX;STEAP3;WLS;GOLPH3;PDIA4;RCN3;ARFGAP3;MON1A;RAB13;RIMS2;PARK7;MIA3;PPY
prerank,regulation of T cell activation (GO:0050863),0.3296352691197073,0.8320854357232963,0.6758530183727034,1.0,1.0,5/42,9.75%,CCL5;LAX1;PRKCQ;DUSP3;PAG1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3222523564134384,0.8318772601263441,0.6631716906946264,1.0,1.0,11/46,11.76%,EMILIN1;DAB2IP;DUSP3;PIN1;PTPN1;WNK2;TNIP1;GSTP1;CNKSR3;GPER1;DUSP29
prerank,integrin-mediated signaling pathway (GO:0007229),0.3031564589494583,0.8315406921051032,0.7087264150943396,1.0,1.0,10/73,7.52%,ITGB6;LAMA5;FERMT2;MYH9;ITGB1;DST;FYB2;ITGB5;ITGB3;PLEK
prerank,membrane fusion (GO:0061025),0.3460704956924656,0.8313972435420234,0.659634317862166,1.0,1.0,10/33,17.85%,FER1L5;DYSF;OPA1;GCA;NSFL1C;DNM1L;NSF;DNM2;UBXN2B;SNAP23
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.20620719257151937,-0.8312649820953472,0.8819875776397516,0.9323105944480332,1.0,33/84,31.52%,CUL3;ANAPC1;PSMD7;PSMD9;PSMD13;CDC23;PSMB3;UBC;SKP2;PSMC5;PSMA5;PSMA1;BUB3;PSMC2;CDC26;UBE2S;ANAPC4;FBXO31;PSME3;UBB;PSMC4;CDK2;PSMB6;PSMB10;ANAPC15;PSMA4;PSME1;CDC16;PSMF1;CDC27;FZR1;PSMB9;PSME2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.26854517376657094,-0.8311200722354057,0.7333333333333333,0.9317362447305301,1.0,17/29,36.05%,CCNH;ERCC5;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;RAD23B;RPA3;CETN2;RPA2;ERCC3;RPA1
prerank,positive regulation of organelle assembly (GO:1902117),0.323457561518557,0.8311017539964263,0.6719787516600265,1.0,1.0,9/44,16.22%,PIP4K2A;LCP1;NUP62;TAPT1;STX18;ARHGAP35;CEP120;G3BP1;PLK4
prerank,glutathione derivative metabolic process (GO:1901685),0.3685671349967264,0.8306552093564643,0.6565008025682183,1.0,1.0,4/20,12.12%,GSTT1;GSTP1;ESD;GSTA4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3685671349967264,0.8306552093564643,0.6565008025682183,1.0,1.0,4/20,12.12%,GSTT1;GSTP1;ESD;GSTA4
prerank,postreplication repair (GO:0006301),-0.23963794137994357,-0.830482434118214,0.7801724137931034,0.9320904293356024,1.0,23/45,37.17%,PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;UBE2B;NSMCE1;ZBTB1;POLI;RPA3;RFC3;USP43;RAD18;RPA2;POLD3;BRCA1;PCLAF;RPA1;RFC1;RFC4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.350475247177795,0.8304816172648687,0.6428571428571429,1.0,1.0,7/24,22.25%,PLA2G3;ABCA3;PLA2G4A;LPCAT1;PLA2G15;CRLS1;SERAC1
prerank,rRNA processing (GO:0006364),-0.18280352811427508,-0.8302300238993094,0.9215686274509803,0.9317140512545421,1.0,69/172,30.36%,NSA2;PRKDC;RPL27A;RPS19;SENP3;NVL;RPL21;RPS24;RPL36;RPL18;RSL1D1;RIOK3;RPLP0;DIS3;C1D;EXOSC1;RPL28;WDR3;RPLP1;RPL23A;MRPL1;RPL34;RRP36;MPHOSPH10;FCF1;EXOSC9;RPL36A;NOP53;RPL9;DDX52;RPS7;RPL27;RPL11;RPL18A;RPL37A;RPL38;RRP7A;EMG1;DCAF13;RPL29;EXOSC2;EBNA1BP2;UTP20;RPL10A;RPL32;BYSL;NOL11;THUMPD1;NOP56;EXOSC7;EXOSC3;UTP18;RPS27;HEATR1;NOLC1;IMP3;WDR18;EXOSC5;PIH1D1;PES1;RPL4;LSM6;UTP6;FBL;RPS15;RPL35A;NOL8;POP4;SART1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.35852530527005816,-0.8301293154492614,0.6917960088691796,0.931075227568599,1.0,5/10,44.86%,LGALS9;CEACAM1;ARRB2;FCGR2B;LILRB1
prerank,O-glycan processing (GO:0016266),-0.23108832469456886,-0.830082109025438,0.7922077922077922,0.9303098770212922,1.0,4/54,3.33%,GXYLT2;ST3GAL4;ST3GAL1;GALNT10
prerank,regulation of transport (GO:0051049),-0.24810267602880975,-0.8299736644776808,0.7410071942446043,0.929702438999796,1.0,8/36,14.45%,LEPR;NRP1;RAB11A;PRKN;WWC1;MYO6;SNCA;ICA1
prerank,regulation of monocyte differentiation (GO:0045655),0.3841733367112583,0.8298656635677502,0.6357504215851602,1.0,1.0,4/14,20.76%,CDK6;ZFP36L1;ACIN1;CTNNBIP1
prerank,mononuclear cell differentiation (GO:1903131),-0.27697678396009895,-0.8292412416608911,0.7337278106508875,0.930242159124049,1.0,8/24,17.75%,IL31RA;PIR;BMP4;LYN;THOC5;RELB;PPARG;MT1G
prerank,ion transport (GO:0006811),0.2854731026181466,0.8291705989921506,0.7271714922048997,1.0,1.0,13/111,10.90%,TRPC6;ANO1;ANO6;SLC8A2;SLC8A1;SLC20A2;KCNN2;PKD1L3;SLC9A8;ANO10;VDAC1;SLC25A26;PANX1
prerank,aerobic respiration (GO:0009060),0.36969668569126235,0.8291089524296391,0.6612377850162866,1.0,1.0,3/20,5.60%,SIRT3;ME3;SDHC
prerank,cellular response to estrogen stimulus (GO:0071391),0.3879414844564542,0.8290897503879489,0.6612641815235009,1.0,1.0,5/14,18.10%,ARID5A;AR;SFR1;PELP1;SERPINB9
prerank,sulfur amino acid metabolic process (GO:0000096),0.364358120036582,0.8287053481912626,0.6734375,1.0,1.0,4/24,10.82%,TXN2;ADI1;AHCY;SMS
prerank,cellular component disassembly (GO:0022411),0.3137582514738351,0.8286298557658972,0.6844850065189049,1.0,1.0,7/53,9.09%,ADAMTS5;HTRA1;KLK2;LCP1;LAMC1;WASHC1;CAPN2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.3029335923205594,-0.828540267226702,0.7101827676240209,0.9307466554570476,1.0,3/18,8.05%,THOC2;PABPN1;POLDIP3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.31116488802986486,0.82835852376353,0.705,1.0,1.0,12/62,13.04%,POLR2L;POLR2I;ADRM1;GTF2H4;ELL;POLR2G;ELOC;CCNT1;CDK7;CDK12;NELFB;POLR2J
prerank,protein lipidation (GO:0006497),0.3045241661279104,0.8279521041483808,0.6893081761006289,1.0,1.0,20/59,19.54%,PIGN;ATG7;ZDHHC2;PIGA;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;WDR45;PIK3C3;PIGH;PIGB;ZDHHC13;PIGP;DPM2;ZDHHC5;ZDHHC8;ZDHHC3;PGAP4;ATG10
prerank,positive regulation of defense response to virus by host (GO:0002230),0.35983055204774966,0.827860303787865,0.6610687022900763,1.0,1.0,6/24,17.63%,CGAS;IL12RB1;ZDHHC1;STAT1;SIN3A;EIF2AK4
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3245396571332769,-0.827076914927955,0.7012345679012346,0.9326625626727089,1.0,10/14,59.16%,ATP6AP1;TYROBP;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.262309363903276,-0.8269189704643579,0.7328990228013029,0.9321160799294165,1.0,15/27,33.15%,SLC1A3;SLC47A1;SLC3A2;SLC7A5;SLC6A9;SLC38A5;SLC25A38;SLC1A4;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2;SLC22A2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3410897937202861,0.8268613415117894,0.6767676767676768,1.0,1.0,8/29,20.63%,PLA2G3;LPCAT3;PLB1;PLA2G4A;PLA2G4C;NR1H3;MBOAT7;LPCAT1
prerank,steroid biosynthetic process (GO:0006694),-0.2262938174759448,-0.8267745188432958,0.815668202764977,0.9315503104382483,1.0,27/56,36.67%,PRKAG2;CYP27A1;LBR;CYP51A1;ACOT8;HMGCR;PRLR;INSIG1;SQLE;OSBP;AMACR;DHRS11;PMVK;LSS;FDXR;OSBPL7;OSBPL9;INSIG2;EBP;SLC27A2;SC5D;STAR;TM7SF2;HSD11B1;SRD5A1;DHCR7;CH25H
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.30638019584267173,-0.8266634601143469,0.7310704960835509,0.9309130612067157,1.0,8/19,25.86%,PRKDC;ZMIZ1;XRCC6;NCKAP1L;PPP2R3C;ZBTB1;MMP14;SYK
prerank,extracellular matrix disassembly (GO:0022617),0.31340957321837093,0.8259314271618642,0.6950261780104712,1.0,1.0,7/53,9.09%,ADAMTS5;HTRA1;KLK2;LCP1;LAMC1;WASHC1;CAPN2
prerank,positive regulation of cilium assembly (GO:0045724),0.37078363953233795,0.8259306933611916,0.67430441898527,1.0,1.0,4/18,12.25%,TAPT1;WRAP73;ARHGAP35;CEP120
prerank,organonitrogen compound catabolic process (GO:1901565),-0.22878933510749358,-0.8258346483172094,0.8053097345132744,0.9316213321436086,1.0,21/57,27.85%,GGACT;ANPEP;NPEPPS;TRIM24;RENBP;ENPP2;PPT1;ACE;PLA2G6;SIAH1;PLA2G7;CLPX;AMDHD2;USE1;TPP1;NPL;LRSAM1;GNPDA1;PNPLA8;CPQ;CLN8
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3708659820713895,0.8254652540658632,0.6405990016638935,1.0,1.0,4/17,11.12%,VIM;TGFB3;SUCO;RUNX1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2881210351206336,0.8254354113124389,0.7373167981961668,1.0,1.0,14/113,7.52%,CD36;MYD88;FERMT2;LCP1;GTF2H4;MPP7;PSMC6;TPPP;DAB2IP;TP53;VEGFA;PARP1;TRABD2B;PLEK
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3407554881120823,0.8251366877695019,0.6801112656467315,1.0,1.0,9/33,16.03%,THPO;ACVR2A;TESC;MED1;ANKRD54;HIF1A;ACVR1B;STAT1;STAT3
prerank,respiratory electron transport chain (GO:0022904),0.38155853405718354,0.8250856580937124,0.6345177664974619,1.0,1.0,5/14,16.07%,PPARGC1A;ETFA;SDHA;SLC25A12;UQCRFS1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.352960372523007,0.8248022079597257,0.6853252647503782,1.0,1.0,5/24,11.37%,CHD6;TP53;VEGFA;HIF1A;ATF3
prerank,aggrephagy (GO:0035973),0.3454311318393184,0.824493804262538,0.6676470588235294,1.0,1.0,2/27,2.61%,DYNLL1;VIM
prerank,respiratory system development (GO:0060541),0.3303619394668186,0.824367340506283,0.6598837209302325,1.0,1.0,4/32,6.66%,FGF1;ITGA3;VEGFA;ABCA3
prerank,covalent chromatin modification (GO:0016569),-0.32107023859995154,-0.8239880420676152,0.6908665105386417,0.9342823881432165,1.0,4/14,19.26%,SIRT7;CHD1;SETD5;PARK7
prerank,negative regulation of translational initiation (GO:0045947),0.40080075546234745,0.8238510415567671,0.6755407653910149,1.0,1.0,5/13,20.85%,EIF4EBP1;EIF3E;EIF2AK4;TPR;LARP1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.40251643207879867,0.8237369502337099,0.6460767946577629,1.0,1.0,1/12,2.54%,DPYSL4
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3436047305563579,-0.8236775316144368,0.7130620985010707,0.934025075987042,1.0,3/11,26.43%,AHR;CEACAM1;HFE
prerank,protein-DNA complex assembly (GO:0065004),-0.19661171068168407,-0.8232585024254979,0.8888888888888888,0.9339498958782841,1.0,53/116,36.05%,TCF4;CCNH;PSMD7;PSMD9;PSMD13;ERCC5;DDB1;PSMB3;ORC6;UBC;ORC5;PSMC5;PSMA5;NAA60;CHD1L;PSMA1;PSMC2;SART3;ASF1A;XPA;GTF2H5;GTF2H2;NAP1L1;GTF2H3;PSME3;UBB;PSMC4;ERCC2;PSMB6;ORC4;RAD23B;PSMB10;HMGB2;PSMA4;RPA3;PSME1;ORC1;SPTY2D1;PSMF1;ATRX;PSMB9;NAP1L3;PSME2;PSMA8;KAT6B;CETN2;MCM8;RPA2;ERCC3;RAD51;CHAF1A;PSMD8;RPA1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2851106556108443,0.8227400802259528,0.7418630751964085,1.0,1.0,30/122,18.78%,DYRK2;PDGFB;VIM;BCAR3;SAMD4A;NAT10;IRS1;SORBS1;RPS27L;CIRBP;AR;TGFB2;PYM1;KAT7;RPL5;PDGFRB;EIF3E;RBM3;ZCCHC4;CPEB3;PLXNB2;IRS2;NAMPT;JAK2;PIWIL2;DHX9;FAF1;EEF2;UPF3A;CCL19
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.26637131763321314,0.8227387335196201,0.984,1.0,1.0,224/1667,13.64%,MYOCD;SOX6;PRDM16;PPP1R12A;FHL5;MYOZ2;SOX5;HJV;ABRA;MEF2C;ATP2B4;HEY2;ZFHX3;TBX2;SMARCD3;FGF1;NR1H4;CSRP3;EBF1;PPP3CA;CCN1;ZEB2;EDNRB;ALX4;MLIP;FZD5;RORA;SS18L2;CDH13;ID4;NR4A1;FST;FRK;EBF2;SIM2;CRTC1;LOXL2;GABPA;PRRX1;ETS2;ARID5B;IFRD1;HEYL;TEAD3;JAG1;CAMK2D;IRX5;HINFP;MRTFA;BRIP1;TGFB3;ZNF436;H1-0;CRTC3;FOSL2;RBAK;NACC2;ACVR2A;PRDM1;HDAC9;GTF2H4;MCRS1;ARID1A;NR2F2;LMO7;ANKRD2;NR2C1;VEZF1;USP2;ACTR3;ATXN1;OSR2;PIAS4;CBFB;SP7;ARHGEF2;BMPR1A;KLF7;CCNQ;TBX18;KCNIP3;MEF2A;PEX2;GBX1;NCOA7;KLF16;MTDH;DBP;FOXJ3;ASXL1;KLF15;SUV39H2;JUND;CAV1;TAF1;SMARCB1;CHD2;DAB2IP;ELOC;ARID5A;TP53;RXRG;VEGFA;PPM1A;PARP1;GRHL1;ZNF418;HEXIM1;PIN1;ZBTB38;GDNF;MAML2;HDGFL3;SFPQ;HOXC4;AR;PPARGC1A;ZFP28;MED1;PPARGC1B;ZNF431;MED29;YAP1;MED12;SOX9;SNAI2;HSF4;DICER1;RELA;ZFP62;KMT2D;SETD3;TNIP1;CUX2;EPC2;LIN37;ZXDC;ZKSCAN4;CCND1;MAML3;PPARA;TRAK1;CBX4;BBX;IMPACT;MED13L;CARF;CCNT1;FUS;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;KAT7;ZBTB33;AKNA;CDK7;HIF1A;CRLF3;KANSL3;ZBTB41;SIRT2;MIDEAS;RIF1;AGRN;PCGF6;HNRNPU;ZNF3;MED14;NR2C2;UBE2D1;TEAD1;EIF5A;RAI1;GPER1;PCGF5;SREBF2;RUNX1;RB1;PFKM;LRP5;ATF3;PIAS2;HOXC8;NKX6-1;ZKSCAN1;ZBTB7A;NFX1;ESRRA;LCORL;CDK12;RUVBL1;LIN9;BMPR1B;CSRNP3;HDGFL2;TOX4;ORC2;CITED2;CPEB3;CTDSP1;NR6A1;POU3F3;ZXDB;SMARCA5;MED8;ZBTB10;FNIP2;CRTC2;ZNF83;ZFP69;MXD4;PPP3CB;BCL6;CHD4;IKZF1;CASZ1;MEF2B;NCK2;FOXJ1;TRIM28;ZBTB5;RFX7
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.37844626019498595,0.8224675884947994,0.6677740863787376,1.0,1.0,3/15,8.93%,ACTR3;WHAMM;WASHC1
prerank,apoptotic cell clearance (GO:0043277),0.33387320728329273,0.8222568382295176,0.6685472496473907,1.0,1.0,8/30,17.47%,XKR4;ANXA1;ITGB3;RHOH;GAS6;ADGRB1;RHOG;NR1H3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.30291012841259607,-0.8222556072410113,0.7023498694516971,0.9350339315693645,1.0,4/17,12.25%,IL18;CD55;CD46;GNL1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.35623440656101707,0.8221354256009257,0.6651718983557549,1.0,1.0,5/22,12.82%,DUSP5;PPM1E;PPM1A;PPP1CA;DUSP16
prerank,synaptic vesicle cycle (GO:0099504),-0.25445150214503826,-0.8221305636987232,0.7441860465116279,0.9343863835202417,1.0,7/30,16.00%,RAB5A;NLGN1;SNCA;SLC17A6;PLD2;PCLO;STX1A
prerank,endoplasmic reticulum organization (GO:0007029),0.301026530972355,0.8221079004293848,0.7139364303178484,1.0,1.0,13/72,17.02%,TRDN;LNPK;SEC31B;LPCAT3;STX18;DNM1L;GET4;TRAM1;BNIP1;LRRK2;CAV2;SEC61B;EIF2AK3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2510586594678759,-0.8220936771722183,0.7473684210526316,0.9336043815865943,1.0,19/37,26.43%,RYBP;PML;HSP90AB1;USP7;SDCBP;SGTA;OGT;GIPC1;UBXN1;NOP53;RPS7;RPL11;PARK7;TRIM39;TLK2;BAG5;CSNK2A1;CSNK2A2;HFE
prerank,fatty acid catabolic process (GO:0009062),0.305367996257793,0.8218229112545047,0.7142857142857143,1.0,1.0,12/67,10.21%,HSD17B10;NUDT7;PEX2;HSD17B4;ACAD11;MECR;ABCD4;ACADS;ACAD10;NUDT19;HADHB;SCP2
prerank,ncRNA transcription (GO:0098781),0.3993702148521488,0.8218046407311387,0.6573913043478261,1.0,1.0,1/13,1.68%,CAVIN1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.39410931062802973,0.8215334893736307,0.653448275862069,1.0,1.0,4/13,12.52%,BTG2;POLR2G;CNOT7;CPEB3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.351667838988705,0.8214203680835491,0.6565349544072948,1.0,1.0,6/24,11.71%,NAT10;PARP1;SLX4;HNRNPU;TERF2;HNRNPC
prerank,protein methylation (GO:0006479),-0.2420667348507738,-0.8211496488255791,0.7795918367346939,0.9345026735389732,1.0,6/40,9.39%,NSD1;CARM1;CAMKMT;PRMT2;PRMT3;EEF1AKMT1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3690069874726779,0.8203623543759792,0.6597110754414125,1.0,1.0,6/17,16.88%,ARL6IP5;TGFB2;EIF2AK2;PDCD10;TAOK3;SEMA4C
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.30960666928096137,-0.8203001058612218,0.7614457831325301,0.9352861876705866,1.0,3/15,7.84%,APOE;NRDC;FURIN
prerank,regulation of establishment of planar polarity (GO:0090175),-0.20333497542197762,-0.8201380340550095,0.8714285714285714,0.934739006652569,1.0,34/88,31.52%,FZD6;PRICKLE2;VANGL1;WNT5A;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2;CDC42;AP2A2;DACT1;PSME3;PSMC4;CELSR1;VANGL2;PSMB6;PSMB10;DVL2;TIAM1;PSMA4;PSME1;WNT11;PSMF1;AP2M1;ARHGEF19;PSMB9;PSME2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.23846934027055905,-0.819963439713671,0.7854406130268199,0.9342054749130074,1.0,7/42,11.94%,LBP;RPS19;OPTN;IL6R;DEFA6;IRGM;GSDMD
prerank,positive regulation of protein ubiquitination (GO:0031398),0.29462178544272766,0.8198600824352562,0.7016509433962265,1.0,1.0,10/80,10.68%,KLHL40;ANGPT1;DCUN1D2;CAV1;FBXW7;PIN1;DCUN1D1;AMER1;PAXIP1;UBE2D1
prerank,regulation of viral transcription (GO:0046782),0.326420087159972,0.8197593699965853,0.7133243606998654,1.0,1.0,10/39,18.19%,POLR2L;POLR2I;POLR2G;HEXIM1;CCNT1;NELFB;POLR2J;NELFCD;DHX9;RSF1
prerank,aminoglycan catabolic process (GO:0006026),0.3444531216384277,0.8197136236410516,0.6539589442815249,1.0,1.0,3/28,10.07%,SDC2;GPC4;AGRN
prerank,myelination in peripheral nervous system (GO:0022011),-0.32879591953948717,-0.819441907362918,0.7252252252252253,0.9343226411828334,1.0,5/13,19.28%,NF1;ADGRG6;ARHGEF10;LGI4;MYOC
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3871055764293659,0.818387799928249,0.6526315789473685,1.0,1.0,3/14,10.75%,FASTKD5;FASTKD1;TFB2M
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3518073689237619,-0.8180424220910667,0.6926406926406926,0.9360793630670943,1.0,7/10,33.12%,SLC1A3;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2
prerank,organic cation transport (GO:0015695),-0.278347611277711,-0.8179161983707454,0.754874651810585,0.935452356510247,1.0,5/20,13.69%,SLC47A1;SEC14L1;SLC22A4;RALBP1;SLC22A18
prerank,negative regulation of signal transduction (GO:0009968),0.2701157226127719,0.8177938787780007,0.808091286307054,1.0,1.0,27/249,7.72%,NOTCH3;NKD1;TCIM;PIP4K2A;SOCS5;KANK1;IGFBP5;CCL5;NTN1;BCL2;PTPN18;MMRN2;EMILIN1;PRKCQ;ASXL1;RPGRIP1L;IRS1;EPN2;DAB2IP;SLC2A10;FBXW7;PTPN1;YTHDF2;TRABD2B;NEDD4;PLEK;SNAI2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3046623568222692,-0.8177568632687157,0.7230392156862745,0.9349022101403991,1.0,7/16,24.72%,NF2;PPP2CA;PARP14;HGS;BCL3;PTPN2;INPP5F
prerank,positive regulation of nuclear division (GO:0051785),0.348223811985201,0.817587569577478,0.6625954198473283,1.0,1.0,5/25,11.25%,PDGFB;NUP62;SIRT2;PDGFRB;LRP5
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3574335603281189,0.8172306303860266,0.6672,1.0,1.0,7/22,15.36%,FXN;GLRX5;ISCA1;ISCA2;NUBP2;NUBP1;CIAO1
prerank,positive regulation of T cell migration (GO:2000406),0.35984086784896285,0.8171689417280088,0.6708074534161491,1.0,1.0,3/20,8.66%,DOCK8;CCL5;ADAM17
prerank,organelle fission (GO:0048285),-0.274927714516902,-0.8170404924459831,0.7614678899082569,0.9354355891359551,1.0,7/24,15.31%,DNM3;DNM1;MTFR1;PRKN;ACOT8;TMCC1;FIS1
prerank,regulation of exosomal secretion (GO:1903541),-0.28995286738523707,-0.8166740358851671,0.751269035532995,0.9352707664364296,1.0,7/19,26.34%,SDCBP;PRKN;VPS4B;SDC4;HGS;ATP9A;SDC1
prerank,regulation of translation (GO:0006417),0.27665956643121326,0.816374601178316,0.7734042553191489,1.0,1.0,44/173,18.44%,VIM;IGFBP5;SAMD4A;MRPL13;BTG2;NAT10;UPF1;CSDE1;ATXN2;EIF1;RPS27L;CIRBP;CYFIP1;DAPK3;PYM1;IMPACT;RPL5;EIF3E;EIF2AK2;DDX1;GSPT1;DDX25;RBM3;ZCCHC4;CNOT7;EIF3H;TSFM;CPEB3;PLXNB2;SYNCRIP;GIGYF2;EPRS1;EIF4E;CTIF;NANOS1;ETF1;PIWIL2;DHX9;EIF2AK3;EIF4G2;METAP1;EIF2AK4;EEF2;UPF3A
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3676840458349357,0.8163346569993237,0.6931637519872814,1.0,1.0,4/18,11.98%,PARN;NAF1;CCT3;RUVBL1
prerank,heterochromatin assembly (GO:0031507),-0.2818874390765201,-0.8161839484079493,0.7463414634146341,0.9353727192530734,1.0,6/20,20.69%,EZH1;SMCHD1;NRDE2;RRP8;HMGA2;SUV39H1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3628421278583022,0.8157769968914244,0.6588050314465409,1.0,1.0,3/19,12.25%,PTP4A3;CCT3;CEP120
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2929489121195892,0.8156410293481732,0.7188995215311005,1.0,1.0,10/88,7.49%,ANGPT1;PDGFB;SEMA5A;CDH13;NR4A1;ALOX5;NR2F2;CAV1;VEGFA;ITGB3
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.235532803787731,-0.8152762774824758,0.8137651821862348,0.9361694527211382,1.0,18/40,37.91%,ATR;FBH1;BLM;MMS22L;PRIMPOL;SMARCAL1;NUCKS1;DONSON;ALYREF;ATRX;BOD1L1;TIMELESS;RFWD3;TRAIP;RAD51;POLE;CENPX;GEN1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.37053041849566465,0.8151560489611482,0.6744548286604362,1.0,1.0,4/17,12.18%,DHDDS;MVD;SRD5A3;ALG13
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.22557905092708574,-0.8147648493543462,0.8071748878923767,0.936245290820129,1.0,17/54,20.41%,ARRB1;NXN;DCUN1D3;CRY1;CTNNB1;PRMT3;SIRT7;OGT;SPRY2;SOX4;SH3RF2;UBXN1;AKT1;SPOPL;RPL11;PARK7;PIAS3
prerank,regulation of myoblast fusion (GO:1901739),0.3979802194312538,0.81458099167893,0.647787610619469,1.0,1.0,4/11,15.52%,EHD2;CD53;ADGRB1;FLOT1
prerank,amide biosynthetic process (GO:0043604),0.31314852430114903,0.8141748050817708,0.7159383033419023,1.0,1.0,2/47,4.19%,DMD;FA2H
prerank,protein localization to mitochondrion (GO:0070585),0.39693736430667254,0.8139904476685026,0.6689655172413793,1.0,1.0,3/11,17.92%,HK2;LRRK2;ISG15
prerank,cellular response to ketone (GO:1901655),0.3321164685378358,0.8139475567875397,0.6953551912568307,1.0,1.0,5/35,10.88%,ADCY5;ADCY2;AR;ADCY6;ROCK2
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.22970356480925297,-0.8139078759739052,0.8177777777777778,0.9369937949585786,1.0,21/52,30.32%,EXTL3;HSPA5;SRPRB;CUL7;ERN1;ARFGAP1;TSPYL2;ZBTB17;SYVN1;DNAJB9;SSR1;SRPRA;TPP1;ATP6V0D1;CXXC1;SERP1;WIPI1;PPP2R5B;ACADVL;KLHDC3;PARP16
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2829331921712301,0.8137121784937468,0.7748917748917749,1.0,1.0,25/151,15.01%,DMD;PPM1L;LARGE1;SLC44A5;FA2H;STARD7;TYW5;HACD1;GSTT1;SLC44A1;TNIP1;LPCAT3;GSTP1;CERS1;MOCS1;SAMD8;ESD;GSTA4;SLC25A2;PRKD3;ST3GAL2;PLA2G4A;CHKB;SPTLC1;PLA2G4C
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.3099646520313131,-0.8135499573408974,0.7254901960784313,0.9367875495894276,1.0,5/15,17.72%,CD44;MDM2;PRKN;PTTG1IP;KDM1A
prerank,positive regulation of double-strand break repair (GO:2000781),0.32167008901995586,0.8134016325071035,0.6954102920723226,1.0,1.0,8/39,10.04%,RAD51AP1;ZCWPW1;PARP1;ERCC6;SPIRE1;FUS;FANCB;RIF1
prerank,protein-containing complex disassembly (GO:0032984),0.3099590481493489,0.8131831922301509,0.6967821782178217,1.0,1.0,11/54,15.27%,FZD5;LIX1L;GABARAP;CAV1;LIX1;PYM1;AMER1;PPP1CA;TSG101;DVL1;CSNK1A1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29789013446292295,0.8131383846730108,0.7013301088270859,1.0,1.0,11/68,14.40%,AMPD1;NT5C2;SULT4A1;AMPD2;ENTPD7;OPA1;EPHA2;THEM4;ADSS1;ACOT6;LRRK2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.2869513510452427,0.812617517419241,0.7171837708830548,1.0,1.0,11/84,9.58%,ANGPT1;FGF1;ANGPT4;PDGFB;SEMA5A;RRAS;VEGFA;ITGB3;RIN2;ADAM17;HIF1A
prerank,response to ethanol (GO:0045471),-0.31882342191718277,-0.8125042173254454,0.7119815668202765,0.9379081737123285,1.0,10/14,45.67%,ADCY7;GRIN3A;GLRA2;GLRA1;SDF4;GRIN2A;GRIN1;SOD1;GRIN2B;CHRNB2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3611310332080884,0.8123930719217081,0.677938808373591,1.0,1.0,2/18,3.29%,ROCK1;KANK1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.33776145182026834,-0.8116227474409392,0.7115384615384616,0.9386104298226376,1.0,5/12,17.23%,CYP26B1;SNW1;KLF2;CALR;TRIM16
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.2795179894812213,-0.8108669072766818,0.7610389610389611,0.9391508760519979,1.0,5/22,13.66%,APPL2;LBP;PTPN22;LYN;APPL1
prerank,pre-miRNA processing (GO:0031054),-0.3113081864326529,-0.8106857217770299,0.7407407407407407,0.9386351035622463,1.0,4/14,18.83%,AGO3;ADAR;TUT4;TUT7
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.27507327558052486,-0.8106129576793113,0.7320872274143302,0.9379433062622178,1.0,4/23,15.68%,CADM1;LGALS9;PIK3R6;PVR
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.27770264047192506,-0.8099731319239641,0.7613293051359517,0.938282213105239,1.0,8/22,19.26%,APOD;BAG4;RANGAP1;SP100;INSIG1;LMAN1;ITGB1BP1;PARK7
prerank,protein targeting to lysosome (GO:0006622),-0.28582865722266937,-0.8095504918391054,0.7371273712737128,0.938217403894472,1.0,10/20,30.76%,SCARB2;GCC2;GNPTAB;AP3M1;HGS;M6PR;NCOA4;LAPTM5;HSPA8;GGA3
prerank,lymphocyte differentiation (GO:0030098),0.29500946148352386,0.8093058845377574,0.732685297691373,1.0,1.0,13/68,13.27%,CD79A;IL2;ITGB1;HDAC9;ITGA4;ADAM17;KAT7;TPD52;AXL;LMBR1L;RHOH;ZBTB7A;IKZF1
prerank,dendritic spine organization (GO:0097061),0.33508327172815683,0.8091759699422291,0.6756352765321375,1.0,1.0,5/26,15.35%,ITGA3;DOCK10;CHRNA7;EPHB1;PTEN
prerank,regulation of humoral immune response (GO:0002920),-0.2362866234573253,-0.8083845295010179,0.8389830508474576,0.9395187818850104,1.0,19/44,40.49%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;GATA6;CR1L;C1QC;C1QA;CFHR2;C2;CR2;C3;C3AR1;C6;FCGR2B;C7;CD81
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.25038513271158247,-0.8082357036324455,0.7756410256410257,0.9389582845571535,1.0,9/32,18.11%,ATR;TNKS2;XRCC5;CTNNB1;FBXO4;MAP3K4;CCT8;CCT4;ATM
prerank,response to UV-A (GO:0070141),-0.3051253916493462,-0.8081879081195581,0.7036082474226805,0.9382122529318839,1.0,4/14,16.35%,EGFR;MMP2;AKT1;MMP1
prerank,meiosis I (GO:0007127),0.34971095682510145,0.808071413071535,0.6848484848484848,1.0,1.0,2/23,5.67%,ZCWPW1;FOXJ3
prerank,negative regulation of phosphorylation (GO:0042326),0.2891170653792595,0.8077487311854988,0.7511792452830188,1.0,1.0,11/85,10.29%,NTRK3;DYNLL1;ROCK1;PFKFB1;MAPT;DAB2IP;CORO1C;PPARA;IMPACT;NPRL2;HNRNPU
prerank,acyl-CoA metabolic process (GO:0006637),-0.24399440922749738,-0.8073195588580572,0.8169934640522876,0.9389573476719042,1.0,6/35,11.38%,SUCLG2;ACSF2;HMGCS2;ACOT8;DBI;ACOT9
prerank,regulation of catecholamine secretion (GO:0050433),-0.2627191242196413,-0.8072379964595406,0.7484276729559748,0.9382736566767317,1.0,16/29,31.37%,SYT1;DTNBP1;PRKN;GRK2;SNCA;SYT11;SYT12;STX1A;SYT6;SYT2;DRD2;SYT7;SYT9;CHGA;SYT13;SYT3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3512333114343473,0.8069088673811455,0.6806451612903226,1.0,1.0,6/21,14.57%,MYH9;PRKCQ;ADAM17;HM13;SPPL2B;ADAM19
prerank,establishment of spindle orientation (GO:0051294),0.33628967288838374,0.8068560497584458,0.6860119047619048,1.0,1.0,8/28,17.51%,ITGB1;INSC;NSFL1C;FBXW11;CLASP1;MAP4;DCTN1;UBXN2B
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3516609311761091,-0.8067772961576887,0.7193763919821826,0.9382608708999095,1.0,4/10,14.21%,HMGB1;ESR1;PSMC5;PSMC2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3434405443802807,-0.8066608212635983,0.7396313364055299,0.9376347486216574,1.0,4/11,19.26%,UBQLN1;PRKN;P4HB;PARK7
prerank,gene expression (GO:0010467),0.2654303573765437,0.8064987392510191,0.8664627930682977,1.0,1.0,67/348,16.42%,TSPAN32;RBPMS;ANGPT2;RPL3L;POLR2L;POLR2I;MLF1;MRPL36;MRPL13;NUP62;PWP1;HARS2;WDR33;UPF1;ATXN1;MEF2A;POLR2G;TESC;U2AF2;RPL8;NFKBIB;MRPL43;SRSF4;TNIP1;SEC13;NR4A2;ZC3H11A;MRPL51;NUP153;RPL5;MCM3AP;MRPL23;DEDD2;RBM8A;U2AF1;DHX8;HNRNPU;RPS23;NUP107;AAAS;PRPF4;GSPT1;DDX25;THOC7;RBM3;BAZ2A;RBM6;MRPL9;GALNT2;SRRM1;DROSHA;POLR2J;MRPL42;SYNCRIP;RPL15;NUP98;NUP37;TSPAN17;EIF4E;FASTKD2;NUP210;RPL22;SARS1;FIP1L1;XAB2;RPL31;DNAJB11
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.271155855463984,-0.8062334886117019,0.7652173913043478,0.9375142176112984,1.0,7/25,26.04%,SPTBN1;PLCG2;STOML2;PNP;CD80;CD86;PRKD2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3267424137114241,-0.8060936583261222,0.7427884615384616,0.936942414131742,1.0,8/13,40.49%,TMEM30A;GCC2;INSIG1;SAR1A;SEC16B;SAR1B;TM9SF4;CD81
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3539647120706918,0.8057208192070706,0.6716417910447762,1.0,1.0,4/18,6.96%,ANXA1;HDAC9;VEGFA;RHOJ
prerank,organelle transport along microtubule (GO:0072384),0.3339938232569394,0.8056243721474299,0.697054698457223,1.0,1.0,10/31,18.34%,ARHGAP21;BICD2;MAPT;KIF5B;TRAK1;FBXW11;UXT;RHOT1;BICD1;MAP1S
prerank,regulation of dopamine secretion (GO:0014059),-0.26789205290710194,-0.8054994675580555,0.7435897435897436,0.937173889103023,1.0,13/25,31.37%,SYT1;DTNBP1;PRKN;SNCA;SYT11;SYT12;SYT6;SYT2;DRD2;SYT7;SYT9;SYT13;SYT3
prerank,leukotriene biosynthetic process (GO:0019370),0.3816498774862752,0.805258741475886,0.6802721088435374,1.0,1.0,2/14,14.19%,ALOX5;PLA2G4A
prerank,cholesterol homeostasis (GO:0042632),0.29638208871248556,0.8052214626090738,0.7175283732660782,1.0,1.0,10/64,14.31%,RORA;CYP7B1;LPL;HDAC9;CAV1;NR1D1;LRP5;ABCG1;LDLRAP1;MTTP
prerank,response to estrogen (GO:0043627),0.33673214128697077,0.8050143785303961,0.7340720221606648,1.0,1.0,9/31,18.10%,CAV1;ARID5A;AR;KMT2D;SFR1;CITED2;PELP1;ASH2L;SERPINB9
prerank,cardiolipin metabolic process (GO:0032048),0.3864617381228865,0.8036763219951166,0.6881533101045296,1.0,1.0,5/13,16.84%,HADHB;TAMM41;PLA2G4A;HADHA;PTPMT1
prerank,signal transduction by p53 class mediator (GO:0072331),0.3342256510396644,0.8036758991877093,0.7001455604075691,1.0,1.0,7/30,13.66%,PMAIP1;MYBBP1A;NDRG1;TP53;PAXIP1;BOK;PDK2
prerank,positive regulation of T cell activation (GO:0050870),0.29564094685072667,0.8036213493843566,0.7380952380952381,1.0,1.0,5/62,5.51%,DOCK8;ANXA1;CCL5;CD276;PRKCQ
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2790782022328401,0.8035269938950327,0.7694013303769401,1.0,1.0,21/125,14.16%,DYNLL1;CLASP2;KIF2A;CENPP;KIF3B;DCTN6;EFHC1;EML1;SUN2;CENPO;SEC13;ZWINT;CENPE;NUP107;DYNC1I2;ITGB3BP;CLASP1;MAP4;NUP98;KIF18A;NUP37
prerank,positive regulation of angiogenesis (GO:0045766),0.27933763887878904,0.8031451625612387,0.7725714285714286,1.0,1.0,12/108,7.59%,FGF1;ANGPT4;HSPB6;SEMA5A;HK2;STIM1;ITGB1;PTGIS;MTDH;RRAS;VEGFA;BTG1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.29010794984832816,0.8029195890085327,0.7640845070422535,1.0,1.0,19/85,15.54%,KLHL40;SOCS5;TMEM259;PABIR1;GABARAP;TAF1;PSMC6;DAB2IP;FBXW7;RNF180;SIRT2;USP13;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;HSPBP1
prerank,positive regulation of vacuole organization (GO:0044090),-0.33931832508918053,-0.8024168904689162,0.7081545064377682,0.9418090089539389,1.0,5/10,18.53%,ANXA2;PIP4K2B;RAB3GAP2;GRN;RALB
prerank,regulation of translational initiation (GO:0006446),0.2970722565007531,0.802351129431012,0.7367119901112484,1.0,1.0,21/63,20.85%,CCL5;EIF4EBP1;CSDE1;POLR2G;EIF1;YTHDF2;IMPACT;EIF3E;DDX1;ATF3;EIF3H;NCK2;DNAJC3;CTIF;EIF2AK3;EIF4G2;EIF2AK4;HABP4;HSPB1;TPR;LARP1
prerank,membrane protein proteolysis (GO:0033619),0.3225622747372333,0.8023074169247482,0.7002801120448179,1.0,1.0,9/37,14.57%,MYH9;PRKCQ;AFG3L2;RELA;ADAM17;MBTPS1;HM13;SPPL2B;ADAM19
prerank,negative regulation of double-strand break repair (GO:2000780),0.3352758739643245,0.802274293144149,0.70254110612855,1.0,1.0,6/30,12.83%,CGAS;UBR5;ERCC6;FANCB;RIF1;RMI2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3500863702389908,-0.8022651895634889,0.715311004784689,0.9412380389624071,1.0,5/11,23.41%,KHDRBS1;AKAP8L;NCBP2;NRDE2;CPSF6
prerank,response to ATP (GO:0033198),0.36367980522278975,0.8021136347999516,0.69,1.0,1.0,2/18,6.16%,P2RY2;TAF1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2969889704227215,0.8019964930616513,0.7348951911220715,1.0,1.0,4/66,3.34%,CD36;MYD88;FZD5;LPL
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3055947071730344,0.8018897370119334,0.7072243346007605,1.0,1.0,8/52,8.66%,D2HGDH;MDH1;ME3;MTHFD2L;DLST;GOT1;GOT2;ALDH1L2
prerank,nuclear export (GO:0051168),-0.2039292224441386,-0.8018640608140564,0.8902439024390244,0.9411364628535064,1.0,16/80,14.96%,RANBP3L;THOC2;SRSF7;SRSF6;SRSF11;SRSF5;POLDIP3;NUTF2;RANBP3;TGFB1;THOC5;SRSF2;NEMF;CALR;NCBP2;CCHCR1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.30084609194289086,-0.8017605971817418,0.765625,0.9405239690567133,1.0,6/16,15.41%,NT5E;TET2;UPP2;DPYSL3;UPB1;DPYD
prerank,sterol homeostasis (GO:0055092),0.29458183855169073,0.8014659550497945,0.7216624685138538,1.0,1.0,10/65,14.31%,RORA;CYP7B1;LPL;HDAC9;CAV1;NR1D1;LRP5;ABCG1;LDLRAP1;MTTP
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3780233640616527,0.8014605793750965,0.7133220910623946,1.0,1.0,6/13,20.32%,HEXIM1;HNRNPU;NELFB;NELFCD;EAPP;NELFA
prerank,mitochondrial translation (GO:0032543),0.27827886915775907,0.8014103440226528,0.7548460661345496,1.0,1.0,34/104,22.05%,MRPL36;MRPS31;MRPL13;MRPL30;GATB;MRPL43;IARS2;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42;LARS2;FASTKD2;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;GATC;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,regulation of transmembrane transport (GO:0034762),0.32616819738562636,0.8011804508953618,0.6921944035346097,1.0,1.0,4/31,7.03%,KCNJ12;BCL2;ACTB;NEDD4
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.29893808073922457,0.8009756344541848,0.7222222222222222,1.0,1.0,8/59,11.98%,HSD17B10;CYP7B1;LPL;ALOX5;HSD17B4;SCP2;OSBPL2;NDUFAB1
prerank,mitochondrial translational elongation (GO:0070125),0.2829882915572262,0.8006732501289516,0.7540983606557377,1.0,1.0,17/88,13.17%,MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42
prerank,protein prenylation (GO:0018342),-0.3442748470685183,-0.7998834969066174,0.7342047930283224,0.9429077385054168,1.0,6/10,39.17%,CHM;RCE1;CHML;RABGGTA;FNTA;FNTB
prerank,cellular response to estradiol stimulus (GO:0071392),-0.29356222751274613,-0.7997700302950939,0.7521367521367521,0.9422937451659122,1.0,12/18,52.67%,EGFR;ESR1;CCDC62;RUVBL2;FAM210B;SFRP1;NCOA3;SSTR2;POU4F1;RAMP3;CRHBP;SSTR1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.26027016143697135,-0.799222891355923,0.7901234567901234,0.9424423916312518,1.0,6/26,14.01%,SULF1;CCBE1;CYP1B1;TGFB1;PTGS2;ARNT
prerank,response to peptide (GO:1901652),0.3219623871115564,0.7992213982515569,0.7130559540889526,1.0,1.0,7/33,16.03%,ANXA1;IRS1;KAT7;CACNA1B;CHRNA7;STAT1;STAT3
prerank,neural tube closure (GO:0001843),0.3228519541711463,0.7990330288809981,0.7262247838616714,1.0,1.0,7/34,16.88%,DLC1;TGFB2;SKI;PLXNB2;DVL1;KDM2B;SEMA4C
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3243969337244556,0.7987982585384161,0.7180925666199158,1.0,1.0,6/34,6.83%,DUSP5;PTPN18;PTPRS;PTPRF;DUSP3;PTPN1
prerank,ameboidal-type cell migration (GO:0001667),0.30666440533576494,0.798578666998536,0.714828897338403,1.0,1.0,7/51,9.22%,PDLIM1;SEMA5A;SEMA6C;GDNF;CORO1C;ITGA4;PKN2
prerank,regulation of interleukin-10 production (GO:0032653),-0.225941566414844,-0.7985129079937159,0.8571428571428571,0.9428812356210103,1.0,17/44,40.32%,HMGB1;LGALS9;PLCG2;CD34;CD46;CD274;HSPD1;SYK;TYROBP;NOD2;TRIB2;JAK3;PYCARD;FCGR2B;DLL1;AGER;TLR4
prerank,heterocycle biosynthetic process (GO:0018130),0.3831698219383384,0.7984236031946381,0.6760797342192691,1.0,1.0,2/14,9.62%,ALOX5;MOCS1
prerank,glycogen biosynthetic process (GO:0005978),0.37693303424068425,0.7979705191536225,0.6660447761194029,1.0,1.0,3/12,10.14%,NR1D1;NHLRC1;GYS1
prerank,glucan biosynthetic process (GO:0009250),0.37693303424068425,0.7979705191536225,0.6660447761194029,1.0,1.0,3/12,10.14%,NR1D1;NHLRC1;GYS1
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.30740172885201866,-0.7973860915435799,0.7723970944309927,0.944009063047518,1.0,6/15,23.17%,LRP1;PDPN;TGFB1;DPP4;FGFR4;FSCN1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.2433427083058559,-0.7972232385541239,0.781021897810219,0.9434483124618089,1.0,16/40,26.68%,PTK2;PTK2B;PML;COMMD1;UBE3A;SGTA;RPS7;RPL11;NUB1;TRIM39;AXIN1;RAD23B;CSNK2A1;CSNK2A2;HFE;LAPTM5
prerank,DNA replication checkpoint signaling (GO:0000076),0.3614584898588339,0.7964678347073257,0.6947723440134908,1.0,1.0,3/16,7.80%,TIPIN;RAD9A;HUS1B
prerank,negative regulation of response to wounding (GO:1903035),0.35681248199864823,0.7964109407911418,0.698051948051948,1.0,1.0,3/19,6.77%,ALOX5;PTPRS;AJAP1
prerank,early endosome to late endosome transport (GO:0045022),0.349671715804151,0.7962583711069209,0.6865671641791045,1.0,1.0,5/20,14.58%,HOOK2;HOOK1;AKTIP;PIK3C3;ANKRD27
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.35762198993369637,0.7962189970609838,0.697560975609756,1.0,1.0,4/20,8.66%,PDGFB;CCND2;CCND1;ADAM17
prerank,iron ion transport (GO:0006826),-0.22873269740307262,-0.7961269282144017,0.8326848249027238,0.9445053509725427,1.0,8/47,10.79%,CP;SCARA5;ABCB7;ATP6V0A4;STEAP3;ATP6AP1;ATP6V1G1;FTH1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.26868453470822223,-0.7960827688591785,0.7665706051873199,0.9437678018044746,1.0,4/23,7.39%,HMGB1;CECR2;KPNA1;FBH1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.28609904155072,0.7956744620425444,0.7397899649941657,1.0,1.0,15/88,14.33%,EDNRB;SERPINE2;IGFBP5;SAMD4A;MRPL13;BTG2;DAB2IP;DAPK3;EIF2AK2;CNOT7;DNAJC1;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,heme biosynthetic process (GO:0006783),-0.27606700007540147,-0.7947793346780913,0.7657142857142857,0.9451129556659063,1.0,6/22,20.85%,ABCG2;ALAS1;COX10;PPOX;SLC25A38;UROS
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2776096962986044,-0.7941953308405328,0.7708333333333334,0.9452826873900406,1.0,12/22,44.86%,WNT5A;SLC7A5;TRIL;LAPTM5;NOD2;TRIM6;BTK;SPHK2;CCR2;LACC1;TNFRSF14;LILRB1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.38899345828154397,0.7941496470346576,0.6514598540145985,1.0,1.0,2/10,13.32%,MAPRE2;FGF10
prerank,pyruvate metabolic process (GO:0006090),0.30450781287564826,0.7937596065757807,0.7528809218950064,1.0,1.0,8/52,11.24%,ENO3;HK2;PFKFB1;ME3;DLD;VDAC1;ALDOA;PFKM
prerank,regulation of autophagy (GO:0010506),0.2645591622184618,0.7936487612309577,0.8138801261829653,1.0,1.0,63/216,19.82%,ROCK1;PRKAB2;RNF152;ITPR1;FZD5;PIP4K2A;BCL2;MTDH;ATP6V1H;MAPT;ATP6V0A2;FBXW7;IL10RA;VPS26A;NEDD4;DAPK3;TRIM68;VDAC1;WASHC1;VPS26B;RRAGB;ATP6V1C1;SIRT2;NPRL2;DNM1L;SH3BP4;SREBF2;BOK;HTR2B;USP13;ATP6V0D2;MCL1;LRRK2;PRKAA2;UFL1;TRIM65;EIF4E;PRKACA;CTSA;ATG13;STAT3;VPS35;RAB8A;MT3;SVIP;WDR6;TICAM1;WDR41;EIF4G2;USP36;DAPK2;MTMR3;DDIT3;PRKD1;ULK1;HDAC6;KAT8;ABL1;PIK3R2;ATP6V0C;KDM4A;PRKAB1;DCAF12
prerank,positive regulation of organelle organization (GO:0010638),0.3255076222896029,0.7933661269709529,0.699859747545582,1.0,1.0,5/32,10.33%,ANXA1;LNPK;PPARGC1A;FYCO1;STX18
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.3797075941746352,0.7931542394010056,0.6583184257602862,1.0,1.0,3/12,8.49%,TP53;RPS27L;CCND1
prerank,regulation of superoxide anion generation (GO:0032928),0.37577812438491104,0.7931438803064939,0.6973684210526315,1.0,1.0,3/14,11.29%,MAPT;GSTP1;PRKCD
prerank,negative regulation of cell communication (GO:0010648),0.34522356581153546,0.7928971700847659,0.6977848101265823,1.0,1.0,2/21,6.83%,SOCS5;PTPN1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3610001087835758,0.7925541187829799,0.6815181518151815,1.0,1.0,5/16,13.91%,PARP1;PPARGC1A;PPARA;ATPSCKMT;TMSB4X
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.30723464035255,-0.7923416977404397,0.7251184834123223,0.9475726578181178,1.0,5/15,18.42%,OSBPL8;ABHD5;PLIN2;PPARG;PLIN3
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.36060691078284585,0.7918424739167187,0.6855753646677472,1.0,1.0,3/16,10.47%,SLX4;HFM1;TOP2B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.33482615731728016,0.7918175774500568,0.7,1.0,1.0,11/25,22.62%,ELL;ERCC6;CCNT1;KAT7;TSFM;ZMYND11;HMGN1;WDR43;HTATSF1;CCAR2;THOC1
prerank,positive regulation of leukocyte migration (GO:0002687),-0.25240241372964356,-0.7914683867014953,0.7823343848580442,0.9482203919912309,1.0,1/27,0.13%,PTN
prerank,pancreas development (GO:0031016),-0.31880092226287515,-0.7914599497896986,0.7436440677966102,0.9474178719333929,1.0,3/12,21.62%,TCF7L2;CCDC39;ZIC3
prerank,nucleotide biosynthetic process (GO:0009165),0.35265159500939003,0.7913467205822776,0.7003205128205128,1.0,1.0,3/18,12.21%,NMNAT2;NMNAT1;PPAT
prerank,glutathione metabolic process (GO:0006749),0.3131922771096376,0.7910865753818688,0.7125171939477304,1.0,1.0,7/38,12.12%,ETHE1;GSTT1;NAT8;GSTP1;OPLAH;GGCT;GSTA4
prerank,B cell differentiation (GO:0030183),0.3030549489704693,0.7908533393007063,0.729693741677763,1.0,1.0,7/46,11.70%,CD79A;ITGB1;HDAC9;ITGA4;ADAM17;TPD52;ZBTB7A
prerank,monoacylglycerol metabolic process (GO:0046462),0.3745077206286617,0.7908000491531437,0.6933797909407665,1.0,1.0,4/13,18.68%,MGLL;DGAT1;PLA2G4A;FAAH
prerank,regulation of acute inflammatory response (GO:0002673),0.3592915907806318,0.790731737283745,0.7163461538461539,1.0,1.0,18/18,64.11%,GSTP1;OSMR;DNASE1L3;C2CD4A;F12;C2CD4B;PLA2G2D;DNASE1;FFAR2;OSM;IL6;CREB3L3;IL4;IL6ST;NLRP3;KLKB1;ADAM8;PTGES
prerank,oligodendrocyte development (GO:0014003),-0.3079699756678337,-0.790729803539422,0.7532467532467533,0.9478506853310004,1.0,3/15,11.80%,PLP1;B4GALT6;EIF2B3
prerank,DNA methylation or demethylation (GO:0044728),-0.2796656151033756,-0.7904557733357169,0.7754569190600522,0.9466441580254931,1.0,11/19,45.30%,KMT2E;PPM1D;TEX15;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,DNA alkylation (GO:0006305),-0.2796656151033756,-0.7904557733357169,0.7754569190600522,0.9466441580254931,1.0,11/19,45.30%,KMT2E;PPM1D;TEX15;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,limb development (GO:0060173),0.3344725771780387,0.7904004339622817,0.6890881913303438,1.0,1.0,2/28,4.94%,MAP3K20;LNPK
prerank,tRNA processing (GO:0008033),0.2927056473723744,0.7900280689149367,0.7378277153558053,1.0,1.0,16/61,19.48%,WDR4;TRDMT1;CDKAL1;TYW5;FTSJ1;TRMT10C;RTCB;DDX1;NSUN2;KARS1;SARS1;FARS2;TRUB1;FAM98B;TRMT6;AARS2
prerank,organelle fusion (GO:0048284),0.35080398543078456,0.7895070120735539,0.709375,1.0,1.0,9/22,21.73%,AFG3L2;OPA1;MIEF2;MIEF1;MFN2;USP30;MFF;MFN1;GDAP1
prerank,positive regulation of mRNA processing (GO:0050685),-0.27173404942822255,-0.7894803397981326,0.760752688172043,0.947480037098367,1.0,6/21,14.86%,TRA2B;CELF4;DAZAP1;SNW1;LEO1;NCBP2
prerank,cellular response to chemical stress (GO:0062197),0.27998727272020707,0.7891636394084227,0.7557339449541285,1.0,1.0,21/96,17.32%,NCF2;ATG7;CAV1;PARP1;PPARGC1A;ADNP2;SRXN1;NUDT2;GSTP1;LONP1;PYROXD1;SIRT2;TXNRD2;LRRK2;PRKAA2;ZFAND1;RAD52;MT3;SOD3;PRDX5;PRDX6
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3209940379670051,0.7890697160851672,0.7085137085137085,1.0,1.0,4/33,8.61%,ANGPT1;SEMA5A;YAP1;PPARA
prerank,fatty acid biosynthetic process (GO:0006633),-0.21461501228525062,-0.7889166712598542,0.883177570093458,0.9476011038928881,1.0,24/63,31.96%,ELOVL7;HACD4;ASAH2;PTGS2;ACLY;ABCD3;EPHX2;ABHD3;ELOVL4;ELOVL6;HACD2;DECR2;ELOVL1;HACD3;FADS1;ACOT7;HPGD;ALOX12;HSD17B8;DEGS1;OXSM;ELOVL5;TECRL;GPX4
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2570048959253549,0.7888347917364789,0.908908908908909,1.0,1.0,55/497,10.28%,PRDM16;HEY2;TBX2;LBH;LIMS1;LIMD1;PDGFB;NAB1;ATP8B1;ID4;LOXL2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;IGFBP5;SAMD4A;GMNN;MRPL13;RBAK;BTG2;NACC2;HDAC9;SET;NR2F2;MTERF3;ATXN1;PIAS4;SUV39H2;MYBBP1A;DAB2IP;ARID5A;TP53;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;L3MBTL2;SOX9;RELA;PLCB1;MAP3K10;DAPK3;CBX4;MTA3;NR1D1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC
prerank,modulation by symbiont of entry into host (GO:0052372),-0.29886764193685394,-0.7885974885144018,0.7592592592592593,0.9472888511044087,1.0,7/16,23.24%,TRIM25;TRIM5;EXOC2;TRIM14;EXOC7;FUCA2;TRIM21
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.38562967233219103,0.7880609744117227,0.7158469945355191,1.0,1.0,4/11,15.39%,SOX9;PDGFA;LRP5;STAT1
prerank,central nervous system development (GO:0007417),0.25955938584369626,0.7878133803177354,0.8413510747185261,1.0,1.0,22/250,10.44%,SOX6;COL4A1;SERPINI1;ZFHX3;PDGFC;CLN5;SLC6A17;GRIN2C;ATXN1;SYNJ2;TPPP;EML1;SOX9;MBP;SLC23A1;CDH2;GSTP1;NR4A2;ADGRL2;COX7B;HAPLN2;SCYL2
prerank,mitochondrion transport along microtubule (GO:0047497),0.3817659535257272,0.7872189435749571,0.7212020033388982,1.0,1.0,6/13,18.34%,MAPT;OPA1;HIF1A;UXT;RHOT1;MAP1S
prerank,vacuolar acidification (GO:0007035),0.34687901041589647,0.7870388079877638,0.7006172839506173,1.0,1.0,3/21,6.33%,CLN5;ATP6V1H;ATP6V0A2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2837483431960761,0.7869498899015087,0.7763313609467456,1.0,1.0,22/86,16.72%,DLC1;PLCE1;MYO9B;KANK1;NUP62;ARHGEF2;GABARAP;DAB2IP;RASGRP1;TGFB2;ARHGAP17;VAV1;DENND1A;MFN2;BCR;PDCD10;FGF10;IRS2;RAF1;JAK2;RALGPS1;SHOC2
prerank,L-amino acid transport (GO:0015807),-0.25440213229638764,-0.7868243088615104,0.7993311036789298,0.9494202551165123,1.0,13/28,33.12%,SLC1A3;SLC3A2;SLC7A5;CTNS;SLC38A5;SLC1A4;SLC36A1;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2
prerank,regulation of neurogenesis (GO:0050767),0.29621654298104205,0.7864820460430554,0.7541401273885351,1.0,1.0,5/55,7.60%,HEY2;HEYL;PRUNE1;YTHDF2;YAP1
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.26324248917673265,-0.7862081023952898,0.7694444444444445,0.9496794437621446,1.0,3/23,5.85%,SLC12A2;SLC12A7;ATP6V0A4
prerank,negative regulation of locomotion (GO:0040013),-0.3216870315131263,-0.7860677053359706,0.728538283062645,0.9491033891418843,1.0,4/12,20.21%,FBLN1;FRMD5;CCDC125;PTPN2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.26690658322188376,-0.7860232088451292,0.7740112994350282,0.9483693487929722,1.0,11/23,31.74%,ELOVL7;FAR2;ACSL3;ACSL4;ELOVL6;HACD2;ELOVL1;ACOT7;ACSL1;ELOVL5;DGAT2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.23564241125326013,-0.7859714601279548,0.8056537102473498,0.9476415874636831,1.0,6/36,11.40%,KIT;GHR;NF2;CENPJ;CYP1B1;HES1
prerank,atrial septum development (GO:0003283),0.36711506684428175,0.7855826635312197,0.6993355481727574,1.0,1.0,2/13,7.87%,HEY2;TGFB2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3913772738634186,0.785554149324519,0.6957328385899815,1.0,1.0,4/11,15.13%,GMNN;TIPIN;ZRANB3;FBXO5
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3124157026047333,-0.7853363270727775,0.781021897810219,0.9479054262860507,1.0,3/13,12.78%,TPST1;BPNT2;ENPP1
prerank,cell part morphogenesis (GO:0032990),-0.313049224056891,-0.7850678217360098,0.7395577395577395,0.9474984337917443,1.0,6/13,22.16%,PID1;FIS1;PNPT1;CSPG5;NUBPL;SLIRP
prerank,regulation of cell size (GO:0008361),-0.2656764626828054,-0.7847754792956596,0.7819148936170213,0.9471643292815348,1.0,4/23,8.64%,DEPTOR;PRR16;VAV2;RDX
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.27438838097405194,-0.7843434301148204,0.7560975609756098,0.9470401814852509,1.0,4/20,8.42%,FKBP5;CWC27;PPIL2;FKBP1A
prerank,vasculogenesis (GO:0001570),0.32594582488153323,0.7841977563487562,0.7177304964539007,1.0,1.0,5/32,10.07%,HEY2;HAS2;CAV1;VEGFA;PDGFRB
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2614749668408478,0.7840661397326963,0.8412197686645636,1.0,1.0,27/208,11.69%,FLNA;NR1H4;MYD88;RORA;ROR1;NUP62;CARD19;MTDH;DAB2IP;PPM1A;TRAF3;GOLT1B;TIFA;RELA;TNIP1;TRIM68;OTUD7A;GSTP1;NR1D1;EDAR;TRAF5;PELI2;DDX1;ZDHHC17;RHOH;ZFAND6;HTR2B
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.352515795896318,0.783915889360429,0.7026578073089701,1.0,1.0,3/18,13.21%,ANXA1;HNRNPU;ZFP36L1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.38632263737899697,0.7835569416129936,0.6931216931216931,1.0,1.0,3/12,10.21%,HSD17B4;FADS2;SCP2
prerank,regulation of DNA recombination (GO:0000018),0.3204927506469995,0.7832626975177542,0.726207906295754,1.0,1.0,8/32,16.74%,H1-0;RAD51AP1;ZCWPW1;CHEK1;KPNA2;ZRANB3;SIRT6;MSH2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3047552099693967,-0.7827852587409468,0.7551020408163265,0.948612952692723,1.0,6/15,20.21%,METTL3;SAMHD1;STAT2;NLRC5;YTHDF3;PTPN2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.29082428405231026,0.7822557772178869,0.7380952380952381,1.0,1.0,14/65,17.61%,CHMP4C;FHL1;PABIR1;PSMC6;CHEK1;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14;VPS4A
prerank,dendrite morphogenesis (GO:0048813),0.3162679095435948,0.7818204334422573,0.7191011235955056,1.0,1.0,4/35,5.32%,SDC2;DOCK10;KLF7;MEF2A
prerank,regulation of macromolecule metabolic process (GO:0060255),0.26277889467847626,0.7817572697373797,0.8145766345123259,1.0,1.0,23/170,13.47%,TMPRSS4;CRIP1;ALPK2;CDK6;SLC8A2;SLC8A1;HINFP;SORT1;PRDM1;ATP1B1;PIN1;GDNF;ADNP2;TRIM68;HIF1A;TOB2;ROCK2;ANKRA2;AFF1;PCBP3;ZFP36L1;HMG20A;MKLN1
prerank,B cell mediated immunity (GO:0019724),0.3858514845270228,0.7816910999845579,0.7027522935779816,1.0,1.0,10/10,61.44%,MSH2;CD27;CD70;CD74;CD19;SLA2;FCER1G;CARD9;TLR8;FCGR2B
prerank,regulation of postsynapse organization (GO:0099175),0.3241756410805208,0.7816847951674312,0.7295690936106983,1.0,1.0,8/28,16.45%,PDLIM5;KIF1A;ABHD17B;IL1RAPL1;HOMER1;LRRK2;LZTS3;VPS35
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.29186791390446387,-0.7816493477989704,0.7692307692307693,0.9495949607883621,1.0,9/16,27.73%,KLHL22;PIP4P1;GPR137B;TELO2;RRAGD;GPR137;SIK3;PIH1D1;RRAGA
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.36255768386184145,0.7814758392961535,0.7135678391959799,1.0,1.0,4/16,11.54%,PARP1;NAF1;SLX4;TERF2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3129954514925933,-0.7811509276791311,0.7595238095238095,0.949574994106794,1.0,7/13,26.20%,CD44;MDM2;PTTG1IP;KDM1A;SNAI1;YJU2;TWIST1
prerank,cell-cell junction maintenance (GO:0045217),0.3865508756382519,0.7809215692607621,0.6930320150659134,1.0,1.0,1/11,2.33%,FERMT2
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.32665369037843417,-0.7807951103617898,0.7250554323725056,0.9493423886985879,1.0,3/10,20.55%,HSPA5;HERPUD1;ATF4
prerank,acylglycerol biosynthetic process (GO:0046463),-0.26793194733582065,-0.7805753886834693,0.8220858895705522,0.9488956894782733,1.0,3/23,4.77%,AGMO;LPGAT1;LPIN2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.34037018921251205,-0.7805533136248157,0.7368421052631579,0.9481297818596139,1.0,4/10,29.28%,STOML2;CDC7;DBF4;ATRX
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3636368665142856,0.7803600856597159,0.7157360406091371,1.0,1.0,2/15,6.51%,FGF1;VEGFA
prerank,protein localization to microtubule organizing center (GO:1905508),0.3575768414629539,0.7800453505583076,0.7021630615640599,1.0,1.0,4/15,11.88%,PIBF1;CEP192;C2CD3;NEDD1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2727479350296715,-0.7798905630463813,0.7973333333333333,0.9483949614779416,1.0,6/21,19.45%,CDC14B;RAB1A;UBE2S;RPS7;RPL11;BTRC
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3122483451515892,0.7797512512253226,0.7189189189189189,1.0,1.0,8/40,12.48%,PMAIP1;FXN;TP53;OPA1;HRK;DNM1L;GPER1;CLU
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2975632676435008,-0.7795491292123081,0.7774936061381074,0.9481362760398192,1.0,7/15,35.60%,ANAPC1;CDC23;NEK6;CDC16;CDC27;RIOK2;TACC3
prerank,cellular response to lectin (GO:1990858),-0.19139035567157867,-0.7792864096063106,0.968503937007874,0.9469407203807225,1.0,35/104,33.33%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.19139035567157867,-0.7792864096063106,0.968503937007874,0.9469407203807225,1.0,35/104,33.33%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.1902570156517559,-0.7791074666665431,0.9699248120300752,0.9464337850776237,1.0,35/105,33.33%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3055464325014697,0.7790184113697004,0.7357237715803453,1.0,1.0,9/43,10.70%,PDGFB;TERT;TP53;SOX9;TGFB2;RELA;PPARA;HIF1A;TEAD1
prerank,positive regulation of cell growth (GO:0030307),0.27697189728784527,0.7789559634685183,0.7745664739884393,1.0,1.0,23/96,17.45%,AKAP6;IL2;NTN1;PABIR1;FXN;BCL2;MAPT;TGFB2;ADNP2;ADAM17;ITSN2;HDGFL2;CEP43;N6AMT1;HYAL1;SMURF1;INO80;MAP3K13;DDX49;S100A8;S100A9;EIF4G2;RASAL1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.26614382030568945,0.778653721235343,0.8077777777777778,1.0,1.0,14/136,9.69%,FLNA;TMIGD3;HEYL;PTGIS;HAVCR2;SETD6;TAF1;DAB2IP;CD200;TRAF3;ZNF431;MAP3K10;PAXIP1;NFKBIE
prerank,glycerolipid catabolic process (GO:0046503),-0.27572801214496323,-0.7776829143653248,0.8057742782152231,0.9478229166359816,1.0,9/19,30.49%,GDPD1;ABHD12;GDE1;GPCPD1;PNPLA6;ABHD6;LYPLA2;ENPP6;SMPD4
prerank,positive regulation of cell cycle (GO:0045787),0.2888896929064874,0.777650143327419,0.7797029702970297,1.0,1.0,15/62,15.22%,PDGFB;CCND2;EIF4EBP1;USP2;DUSP3;CHEK1;TGFB2;CCND1;ADAM17;PKN2;CITED2;MAPRE3;EIF4E;PRKCA;SRPK2
prerank,DNA conformation change (GO:0071103),-0.28785454070729244,-0.7775587953071881,0.7736842105263158,0.9472120470503284,1.0,9/17,34.32%,HMGB1;TOP1;HHEX;HMGB2;TOP3B;TOP1MT;NAA10;TOP2A;ERCC3
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2816471910393525,0.7773537571097763,0.7817319098457889,1.0,1.0,19/76,17.99%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;FBXW7;RNF180;SIRT2;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;PTEN;HSPBP1;SMURF1;RCHY1;PIAS1
prerank,negative regulation of endocytosis (GO:0045806),0.3413982992856155,0.777208922889549,0.7236421725239617,1.0,1.0,3/24,8.35%,PACSIN3;CAV1;CD300A
prerank,cellular response to amino acid stimulus (GO:0071230),0.3136433343211716,0.7768987054171423,0.7196531791907514,1.0,1.0,8/33,14.48%,LARS1;CASTOR1;CPEB1;CAPN2;RRAGB;SH3BP4;CPEB3;CASTOR2
prerank,positive regulation of DNA replication (GO:0045740),-0.2980623155463046,-0.7762234390588799,0.7901234567901234,0.9484269074208862,1.0,3/16,4.79%,GLI2;EGFR;STN1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.37339037172343603,0.7760418530467074,0.7024029574861368,1.0,1.0,3/11,13.21%,PAPOLA;AHCYL1;ZFP36L1
prerank,positive regulation of cellular senescence (GO:2000774),0.39067233440570887,0.7760219482632043,0.68,1.0,1.0,1/10,3.13%,CGAS
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3205615657372196,0.775603875937684,0.733142037302726,1.0,1.0,6/27,12.56%,CPA4;NAT8;MSL3;KAT7;RUVBL1;MORF4L1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2845974810397278,0.775437846025564,0.7720588235294118,1.0,1.0,17/69,15.35%,PLCE1;PLCB4;PLCL1;KCNH1;IRS1;PLCB1;PLCD1;SIRT2;PDGFRB;HTR2B;TPTE;ZFP36L1;PIK3C3;PLEKHA1;IRS2;PITPNM2;PTEN
prerank,positive regulation of epithelial cell migration (GO:0010634),0.2728373328765961,0.775003043010849,0.8067226890756303,1.0,1.0,14/92,10.88%,ANGPT1;FGF1;ANGPT4;CLASP2;MAPRE2;RRAS;VEGFA;ITGB3;SOX9;TGFB2;RIN2;HIF1A;DOCK1;ROCK2
prerank,DNA methylation (GO:0006306),-0.2610521402691016,-0.774856814933365,0.8199445983379502,0.9497534904414586,1.0,13/23,45.30%,KMT2E;PPM1D;PICK1;TEX15;ZFP57;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,GPI anchor biosynthetic process (GO:0006506),0.31760460531476825,0.7747658428366639,0.717037037037037,1.0,1.0,12/30,23.15%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2;PGAP4;PIGK;PIGZ;GPAA1;PIGS;PIGM
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3176013142253695,0.774361280071552,0.7395079594790159,1.0,1.0,2/32,4.35%,MEF2C;RIMS3
prerank,membrane organization (GO:0061024),0.2572117586940993,0.774337637310865,0.8537344398340249,1.0,1.0,38/227,13.44%,TRDN;CHMP4C;FER1L5;HIP1;DYSF;PACSIN2;ITSN1;FZD4;ACTG1;ACTB;ACTR3;TTPA;SYNJ2;EPN2;CHMP5;CORO1C;AREG;IGF2R;OPA1;SUN2;LPCAT3;GCA;STX18;NSFL1C;HBEGF;DNM1L;STAM2;TLCD2;MFN2;OSBPL2;CHMP2B;DMPK;SNX9;A4GALT;FNBP1;GLTP;LDLRAP1;CHMP2A
prerank,energy reserve metabolic process (GO:0006112),0.34083784429856795,0.7742987780038851,0.7250409165302782,1.0,1.0,2/19,4.84%,PYGM;GFPT1
prerank,translational elongation (GO:0006414),0.27112821322923053,0.7742836034425149,0.799081515499426,1.0,1.0,27/101,19.19%,EEFSEC;MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42;EEF2K;GTPBP2;MRPL14;MRPL4;EEF2;MRPS21;MRPL40;MRPL22;MRPL50
prerank,organelle disassembly (GO:1903008),-0.24451621319562822,-0.7742647116013992,0.8806451612903226,0.9498848354246547,1.0,12/33,25.86%,RB1CC1;GBF1;STX5;RETREG1;TEX264;ATG2B;ATG2A;KIF9;MTIF3;PLK5;ULK2;UBA5
prerank,cholesterol transport (GO:0030301),0.300696114948492,0.7738738743900728,0.7276422764227642,1.0,1.0,10/45,17.73%,CD36;CAV1;STX12;ABCG1;OSBPL2;CLU;LDLRAP1;OSBPL5;VPS4A;LIMA1
prerank,negative regulation of cell projection organization (GO:0031345),-0.2230269624581488,-0.7735106765818154,0.8554216867469879,0.9501976754163064,1.0,11/48,17.54%,EFNB2;LPAR1;APOE;EPHA4;SEMA3A;SPRY2;DPYSL3;RAB29;CBFA2T2;HDAC2;PRAG1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.23777674372229315,-0.7734970832924944,0.8350877192982457,0.9494285073662275,1.0,9/35,18.11%,ATR;TNKS2;XRCC5;CTNNB1;FBXO4;MAP3K4;CCT8;CCT4;ATM
prerank,macroautophagy (GO:0016236),0.26724834988907137,0.7730280373691872,0.8043230944254836,1.0,1.0,32/118,20.61%,DYNLL1;PRKAB2;CHMP4C;PIP4K2A;MTERF3;LIX1L;ATG7;GABARAP;LIX1;VDAC1;MTMR14;STAM2;MFN2;CHMP2B;TSG101;VPS36;PIK3C3;CHMP2A;PRKAA2;STAM;ATG13;TOMM5;VPS4A;MTMR3;FUNDC1;TOMM7;ULK1;ATG10;VPS37A;PRKAB1;MFN1;LAMP2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3456701469283718,0.773005259463892,0.704,1.0,1.0,3/18,8.66%,MEF2C;ITGA4;ADAM17
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3168678098409115,-0.7729245594558817,0.7545871559633027,0.9495469774785822,1.0,3/12,16.90%,CENPC;RMDN1;MAD1L1
prerank,response to lipopolysaccharide (GO:0032496),0.26388987787630364,0.7721190508454262,0.8304347826086956,1.0,1.0,15/138,9.80%,MEF2C;MYD88;VIM;UPF1;CD14;TNFRSF11A;DAB2IP;CHMP5;MAPKAPK2;NFKBIB;RELA;ADAM17;GSTP1;NR1D1;AXL
prerank,histone deacetylation (GO:0016575),0.2968118758672462,0.7714751626177778,0.7486559139784946,1.0,1.0,15/43,19.60%,HDAC9;SFPQ;MSL3;MTA3;SIRT2;MIDEAS;BAZ2A;MORF4L1;MTA1;SIN3A;SIRT6;HDAC1;RBM14;HDAC6;SMARCAD1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25564693416866174,0.77076067173408,0.8633093525179856,1.0,1.0,53/241,16.33%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;SF3B3;SRSF4;PAPOLA;SNRPN;GPKOW;FUS;PPIL1;PPIE;ZMAT5;RBM19;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;SF3A3;HNRNPC;PSPC1;RBM6;SRRM1;SF3B1;SF3B2;ZCRB1;POLR2J;PPWD1;SYNCRIP;PDCD7;CWC22;PPIL3;SNRPB2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,stem cell development (GO:0048864),0.35719878740622535,0.7707294500281306,0.7309644670050761,1.0,1.0,3/16,8.71%,TAPT1;SNAI2;CDH2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2959584195974272,-0.7706374908716521,0.7857142857142857,0.9522669128454818,1.0,4/15,16.41%,GGACT;ALDH4A1;ABHD12;HOGA1
prerank,immunoglobulin mediated immune response (GO:0016064),0.3858514845270228,0.7703058443255468,0.719626168224299,1.0,1.0,10/10,61.44%,CD27;ZP3;CD74;GAPT;CD19;FCER1G;CARD9;TLR8;CD81;FCGR2B
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.22652282427704118,-0.7701818886578484,0.8694029850746269,0.9521495388125217,1.0,14/42,23.79%,SMARCA2;RBBP4;CECR2;SMARCA1;ACTR8;CHD3;ACTR6;MTA2;HDAC2;ZNHIT1;SRCAP;ACTR5;SMARCD2;GATAD2B
prerank,mitochondrial translational termination (GO:0070126),0.2716139278760205,0.7700644743451684,0.7922987164527421,1.0,1.0,28/88,22.05%,MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;MRPL42;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,DNA geometric change (GO:0032392),-0.2590132209775612,-0.7698636257949016,0.7938718662952646,0.9518248504969155,1.0,5/24,12.83%,HMGB1;MRE11;RAD50;BLM;NBN
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.32573073601437547,0.7697394732793456,0.7477477477477478,1.0,1.0,5/28,6.83%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.37151699542231625,0.7689377032606592,0.6898395721925134,1.0,1.0,3/12,11.20%,CSGALNACT1;GFPT1;PARG
prerank,regulation of macrophage activation (GO:0043030),-0.24953507237621242,-0.7687531188884926,0.8295081967213115,0.952618948764293,1.0,9/30,22.93%,IL31RA;LBP;WNT5A;IL33;ZC3H12A;GPR137B;SHPK;HSPD1;SPHK1
prerank,protein targeting (GO:0006605),0.2616794505389447,0.7682944752229839,0.8164627363737486,1.0,1.0,37/118,22.34%,AKAP6;ZFAND2B;GOLGA7B;NACA;GABARAP;ZDHHC2;TRAK1;ZDHHC1;ZDHHC14;PEX19;LONP2;MFN2;ZFAND6;HPS4;AP1S3;TOMM5;AP4E1;ZDHHC4;BCAP31;MFF;TOMM7;ZDHHC3;RTP4;VPS37A;SPCS3;PARD3;SRP14;PEX1;MYO1C;LAMP2;TIMM9;CACNG3;TIMM22;SEC61G;GDAP1;PIKFYVE;TOMM22
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3186297133326656,0.7678732496577111,0.7288629737609329,1.0,1.0,4/30,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,regulation of cellular catabolic process (GO:0031329),0.28755697643271766,0.7674653496046225,0.749379652605459,1.0,1.0,20/62,19.82%,ROCK1;ITPR1;PIP4K2A;MAPT;DAPK3;RRAGB;LONP2;BOK;USP13;LRRK2;RAB8A;WDR41;DAPK2;MTMR3;DDIT3;HDAC6;KAT8;ABL1;PIK3R2;DCAF12
prerank,tube closure (GO:0060606),0.31287532013239583,0.7674340895851026,0.737151248164464,1.0,1.0,3/31,9.19%,DLC1;TGFB2;SKI
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3274572691099067,-0.7670449481470832,0.7731277533039648,0.9544779819189269,1.0,2/10,5.68%,LGALS9;CD55
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3360006942286395,0.7667170916879955,0.7534039334341907,1.0,1.0,2/22,6.74%,FZD5;IL12RB1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.2819151735285541,-0.7666576251832444,0.7803617571059431,0.9542816584507564,1.0,4/17,13.08%,NSA2;PRKDC;C1D;URB1
prerank,sensory perception (GO:0007600),0.29277996282310703,0.7658345061716886,0.7611548556430446,1.0,1.0,5/45,12.39%,ASIC3;TRPV2;NTSR2;KCNA2;CHRNA7
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3085291377810527,0.7657328477507146,0.7595628415300546,1.0,1.0,12/42,16.16%,NARS2;HARS2;LARS1;IARS2;AIMP1;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.2907624421467549,0.7655988962643384,0.764404609475032,1.0,1.0,5/55,5.99%,SDC2;CSPG4;BGN;GPC4;OGN
prerank,snRNA processing (GO:0016180),-0.2882685526148211,-0.7654195603027389,0.783375314861461,0.955308936355224,1.0,6/16,28.47%,INTS6;INTS3;INTS2;INTS11;INTS14;TOE1
prerank,regulation of hormone secretion (GO:0046883),0.3610883680641318,0.7654024932329058,0.7098976109215017,1.0,1.0,1/15,2.79%,ANXA1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.29571870791379495,0.7652272246606332,0.7350543478260869,1.0,1.0,6/50,9.53%,CCNA2;CCND2;ACTB;CCND1;CCNT1;CDK7
prerank,mammary gland development (GO:0030879),0.33213213857877943,0.7650755921369814,0.7353383458646616,1.0,1.0,4/21,11.61%,TGFB3;CAV1;VEGFA;ARHGAP35
prerank,import into nucleus (GO:0051170),-0.20226801895408675,-0.7648665346963296,0.9096385542168675,0.9553668855953826,1.0,22/73,23.85%,APPL2;E2F3;FAM53A;NUP88;NUTF2;IPO8;PTTG1IP;GEMIN8;APPL1;NUP50;SNRPD1;AKT1;EIF4ENIF1;GEMIN7;SMN1;NUP85;IPO11;NXT2;NUP214;RAN;HTATIP2;IPO13
prerank,primary neural tube formation (GO:0014020),0.31540648927940107,0.7647300748737688,0.7469879518072289,1.0,1.0,3/30,9.19%,DLC1;TGFB2;SKI
prerank,"DNA-templated transcription, termination (GO:0006353)",0.27891172198495884,0.7642943775342504,0.7760097919216646,1.0,1.0,8/68,9.61%,CAVIN1;POLR2L;GTF2H4;WDR33;PCF11;PAPOLA;CDK7;POLR1E
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.3183880494697035,-0.7640433128346796,0.7717391304347826,0.9557721273212941,1.0,2/11,8.19%,NEDD4L;COMMD1
prerank,mammary gland epithelium development (GO:0061180),-0.29040113137813844,-0.7637878822248633,0.7942583732057417,0.9553974314759756,1.0,1/14,1.10%,WNT4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.2668711525362034,-0.7636849263974304,0.7983425414364641,0.9547546993331196,1.0,3/22,8.22%,BMP7;WNK1;CD44
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.35526827010199397,0.7634140001729871,0.7226890756302521,1.0,1.0,2/15,11.57%,PLA2G3;ABCG1
prerank,anterograde axonal transport (GO:0008089),0.30293239829645313,0.763360495003152,0.7632311977715878,1.0,1.0,10/37,17.51%,KIF3B;KIF1A;KIF5B;TRAK1;KIF1C;KIF5C;KIF5A;AP3B2;BLOC1S5;MAP1A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.31159698101910477,0.7632491025472372,0.7323943661971831,1.0,1.0,3/31,4.59%,CDK6;FHL1;JADE1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3268588963793847,0.7632178410167135,0.716374269005848,1.0,1.0,5/23,15.40%,SOCS5;SOCS4;CAV1;TSG101;CBLB
prerank,regulation of immune effector process (GO:0002697),-0.22652323271369323,-0.7631223310095843,0.8589211618257261,0.9547680138436162,1.0,18/41,40.49%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;CR1L;C1QC;C1QA;CFHR2;C2;CR2;C3;C3AR1;C6;FCGR2B;C7;CD81
prerank,positive regulation of signaling receptor activity (GO:2000273),0.309963795604576,0.7629317192768529,0.723943661971831,1.0,1.0,7/36,10.49%,ITGB1;TAF1;FBXW7;AREG;ADAM17;HIF1A;HBEGF
prerank,negative regulation of T cell activation (GO:0050868),0.3068097131894098,0.7628266891380843,0.7751060820367751,1.0,1.0,5/35,10.87%,LAX1;HAVCR2;DUSP3;PAG1;TNFRSF21
prerank,regulation of complement activation (GO:0030449),-0.22768721364555028,-0.7627067256868697,0.8669354838709677,0.9545901436713348,1.0,11/40,27.53%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;CR1L;C1QC;C1QA;CFHR2;C2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.35081890343577765,0.7624794820583396,0.717687074829932,1.0,1.0,3/15,7.69%,VEGFA;GDNF;SOX9
prerank,positive regulation of neuron migration (GO:2001224),0.3732195992999797,0.761696826535363,0.7376760563380281,1.0,1.0,3/11,12.58%,ARHGEF2;DAB2IP;KIF20B
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3214592881818913,0.760858962955658,0.7515060240963856,1.0,1.0,4/25,12.92%,AMPD1;AMPD2;PPAT;GMPR
prerank,axonal transport (GO:0098930),0.30313345804713954,0.7601815691980364,0.747612551159618,1.0,1.0,10/36,17.38%,DST;KIF3B;KIF1A;MAPT;OPA1;HIF1A;FBXW11;AP3B2;BLOC1S5;DCTN1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.2514881461006282,-0.7601631603979857,0.8354037267080745,0.9574725381549528,1.0,14/26,31.21%,TET3;CTR9;TET2;OGT;SETD5;ETFBKMT;SETD1A;SUV39H1;PRDM9;EEF2KMT;KMT2A;BEND3;SMYD5;ANTKMT
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3118717552189862,-0.7597369936356441,0.7850467289719626,0.9565197413907076,1.0,3/11,16.59%,CCT8;CCT4;LARP7
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3118717552189862,-0.7597369936356441,0.7850467289719626,0.9565197413907076,1.0,3/11,16.59%,CCT8;CCT4;LARP7
prerank,regulation of mRNA catabolic process (GO:0061013),0.2605060067019644,0.7595426628211779,0.8272827282728272,1.0,1.0,23/121,16.91%,RBM24;VIM;SAMD4A;PARN;SET;UPF1;PSMC6;MAPKAPK2;YTHDF2;PSME4;PSMB1;PSMD5;PRKCD;DCP1A;CNOT7;PSMB2;ZFP36L1;PSMB7;PSMD3;PRKCA;PSMA2;XPO1;PSMD14
prerank,regulation of tau-protein kinase activity (GO:1902947),0.3751593684992593,0.7593324264750622,0.6791044776119403,1.0,1.0,3/10,18.46%,RB1;CLU;EGR1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.32516036864876724,0.7592300150728704,0.7288135593220338,1.0,1.0,1/23,1.50%,PMAIP1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.2756915152024384,0.7591614668820266,0.8133174791914387,1.0,1.0,14/87,14.36%,FGF1;POLR2L;POLR2I;NR4A1;CCL5;POLR2G;FLRT1;GALNT3;POLR2J;ZFP36L1;FGF10;MAPK1;RAB14;HYAL1
prerank,phospholipid metabolic process (GO:0006644),0.2762537623348713,0.7590559591434933,0.7843373493975904,1.0,1.0,11/71,15.01%,PLA2G3;PIP4K2A;LPL;PLPPR1;AGPAT3;PLCD1;PCYT2;PLB1;PNPLA3;PLA2G4A;PLA2G4C
prerank,regulation of cellular response to stress (GO:0080135),0.262391156620126,0.7589359798078957,0.8156996587030717,1.0,1.0,21/115,14.20%,CAMK2G;CAMK2D;NUP62;ALOX5;SLC38A2;MAPT;MAPKAPK2;NUAK1;SEC13;NUP153;BAG3;AMFR;NUP107;AAAS;ROCK2;ATF3;BAG2;NUP98;MAPK1;NUP37;MCL1
prerank,positive regulation of phagocytosis (GO:0050766),0.28962683183391436,0.7588415296621268,0.7815013404825737,1.0,1.0,3/47,5.29%,MERTK;ANO6;MYO18A
prerank,response to growth factor (GO:0070848),0.2956189875235027,0.7582532053943408,0.7608695652173914,1.0,1.0,13/41,20.78%,PDGFB;ACVR2A;BMPR1A;EPHA2;ACVR1B;BMPR1B;CPNE3;URI1;NOS1;HDAC6;SHC1;ACVR1;ERBB2
prerank,neuron projection development (GO:0031175),0.25615670689755776,0.7582472978124075,0.8637339055793991,1.0,1.0,30/168,15.43%,NTF3;ROCK1;FRY;PLXNB1;DOCK10;BTG2;MAPT;DAB2IP;GDNF;HDGFL3;NEDD4;ERCC6;DICER1;ATCAY;SAMD14;RB1;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;MAP4;EPHB1;STMN2;LRRK2;ANKRD27;PPP1R9A;CNTNAP1;PTEN;DNM2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.25099865905533403,0.7579766626405017,0.9007164790174002,1.0,1.0,58/264,16.33%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;CLNS1A;SF3B3;SRSF4;PAPOLA;SNRPN;GPKOW;PRMT7;FUS;PPIL1;PPIE;ZMAT5;RBM19;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;DDX1;SF3A3;HNRNPC;PSPC1;RBM6;TGS1;SRRM1;SF3B1;SF3B2;ZCRB1;POLR2J;PPWD1;SYNCRIP;PDCD7;CWC22;PPIL3;SNRPB2;SRPK2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3215553566678747,-0.7579682219672733,0.7846153846153846,0.958270632837562,1.0,3/10,16.77%,MYO9A;OPHN1;CDC42
prerank,epidermal cell differentiation (GO:0009913),0.30305203510999895,0.7576550448518106,0.7516688918558078,1.0,1.0,5/41,12.31%,ANXA1;JAG1;MED1;EPHA2;BCR
prerank,electron transport chain (GO:0022900),0.34461820659460035,0.7568847220841849,0.7081967213114754,1.0,1.0,5/15,16.07%,PPARGC1A;ETFA;SDHA;ENOX2;UQCRFS1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.32563171924657713,0.7568385536138833,0.740909090909091,1.0,1.0,1/22,1.43%,ROCK1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2169140102394957,-0.756669976788792,0.9227467811158798,0.9593329000953749,1.0,5/49,5.31%,HMGB1;LBP;F3;NOD1;LGALS9
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.36379636235565294,0.7565531655456678,0.7130434782608696,1.0,1.0,2/13,9.25%,CABP1;NUP153
prerank,histone H3 deacetylation (GO:0070932),0.34967462445144326,0.7563785008204247,0.7322695035460993,1.0,1.0,6/15,19.60%,HDAC9;SFPQ;SIRT2;SIRT6;HDAC1;SMARCAD1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3449146258479189,0.7560690049026835,0.7508710801393729,1.0,1.0,2/16,6.87%,FGF1;GDNF
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.24666123107064958,-0.7555976089625385,0.8244047619047619,0.960079946074835,1.0,10/26,32.14%,CUL3;CDC23;DUSP1;NEK6;ANAPC4;NSMCE2;ANAPC15;CDC16;CDC27;RIOK2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.318880935098687,-0.7554222674460808,0.8062953995157385,0.9595515759432678,1.0,6/11,35.70%,UQCRC1;UQCRC2;UQCR11;CYC1;UQCC3;CYCS
prerank,GPI anchor metabolic process (GO:0006505),0.3134224438335259,0.7553409882016279,0.7230538922155688,1.0,1.0,8/26,20.85%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2;PGAP4;PIGZ
prerank,sister chromatid segregation (GO:0000819),0.3096517076247386,0.7548797349213378,0.7553956834532374,1.0,1.0,9/31,17.21%,ZWINT;WRAP73;TOP2B;RB1;KIF18A;KNSTRN;INO80;DSN1;CENPK
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.34266080750248185,0.7545950249885379,0.7492012779552716,1.0,1.0,5/18,16.35%,PLCB1;HRH3;AGRN;GNAQ;RGS10
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.34324688390046204,0.7531498345319607,0.7393364928909952,1.0,1.0,7/18,17.91%,RELA;ROCK2;ABCG1;CHRNA7;CLU;SP1;LRRTM3
prerank,inositol lipid-mediated signaling (GO:0048017),0.28728064628860034,0.7526584553128538,0.7842377260981912,1.0,1.0,8/50,10.07%,PLCE1;PLCB4;PLCL1;KCNH1;IRS1;PLCB1;PLCD1;PDGFRB
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.31898102297048136,0.7523250075057749,0.7923186344238976,1.0,1.0,3/31,6.43%,PMAIP1;BCL2;TP53
prerank,cellular biogenic amine catabolic process (GO:0042402),0.3725312494676865,0.7522584034809446,0.7317073170731707,1.0,1.0,3/10,14.00%,SLC44A1;SARDH;COMT
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.26148191858649306,0.752208098213676,0.803448275862069,1.0,1.0,27/87,21.65%,NDUFS1;NDUFA11;NDUFA2;SDHAF2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;SDHAF3;NDUFA1;LYRM7;NDUFAF2;UQCRFS1;NDUFAF1;SCO1;NDUFV3;UQCC2;NDUFS4;SLC25A33;COA5;OXA1L;NDUFA3;NDUFAF6
prerank,adrenergic receptor signaling pathway (GO:0071875),0.32506652762551136,0.7514057465233468,0.7248764415156508,1.0,1.0,2/20,3.81%,ADRA1D;ADCY9
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3017431212356839,0.7512713901135607,0.7676056338028169,1.0,1.0,5/38,6.83%,PDGFB;DOK7;CAV1;RAP2C;PTPN1
prerank,cellular response to amyloid-beta (GO:1904646),0.29802129234299707,0.7508741122184254,0.7606602475928473,1.0,1.0,2/35,1.73%,CACNA2D1;CD36
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2759192580760019,0.7507384638402883,0.8014796547472256,1.0,1.0,16/74,16.91%,LIMD1;CUL2;PSMC6;ELOC;VEGFA;HIF1A;PSME4;SIRT2;PSMB1;PSMD5;PSMB2;CITED2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.32460522292660243,-0.7506832891588269,0.7816091954022989,0.9646516959962311,1.0,1/10,2.40%,WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.32460522292660243,-0.7506832891588269,0.7816091954022989,0.9646516959962311,1.0,1/10,2.40%,WNK1
prerank,protein-containing complex assembly (GO:0065003),0.2498081711607593,0.7504954949646105,0.8838643371017472,1.0,1.0,37/259,14.40%,DMD;TCAP;PDE4DIP;FERMT2;ANO6;SH3BGR;TBC1D20;SKAP2;CNIH2;AFG3L2;TERT;TP53;LAMC1;AREG;PPARGC1A;MDN1;YAP1;OPA1;SOX9;ADD2;KMT2D;AMER1;SEC13;MAGI1;TEAD1;DNM1L;KIFAP3;BOK;RUVBL1;NSF;SNX9;SEC24A;DMTN;KPNA3;SEC24C;EPRS1;LRRK2
prerank,arachidonic acid metabolic process (GO:0019369),0.30068400653627103,0.7503184478353004,0.7718309859154929,1.0,1.0,8/35,16.24%,PTGIS;ALOX5;TBXAS1;CBR1;MGLL;PLA2G4A;PLA2G4C;EPHX1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.29566691450956956,-0.7502588987109593,0.8106235565819861,0.9644371848154997,1.0,10/13,49.87%,HES1;MGAT5;EGF;CRLF2;JAK3;PTPRT;PIGU;TSLP;IL7R;DOT1L
prerank,melanosome organization (GO:0032438),-0.24163896459215323,-0.7501662180735984,0.8483870967741935,0.9637542641050099,1.0,9/26,31.65%,SHROOM2;DTNBP1;AP1M1;RAB29;AP1G1;BLOC1S6;RAB32;BLOC1S2;TRAPPC6A
prerank,mRNA processing (GO:0006397),0.2472899069842149,0.7499539847080184,0.9270298047276464,1.0,1.0,62/287,16.33%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;GTF2H4;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;PPARGC1A;CELF1;SF3B3;SRSF4;PAPOLA;SNRPN;PRPF18;GPKOW;FUS;PPIL1;PPIE;ZC3H11A;ZMAT5;RBM19;CDK7;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;THOC7;SF3A3;HNRNPC;PSPC1;RBM6;SRRM1;SF3B1;SF3B2;ZCRB1;POLR2J;PPWD1;SON;SYNCRIP;PDCD7;CWC22;PRKACA;PPIL3;SNRPB2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,regulation of mitotic nuclear division (GO:0007088),0.2859877600372473,0.7496163089878252,0.7913950456323338,1.0,1.0,12/55,15.42%,PDGFB;NUP62;PIN1;CUL9;CHEK1;DAPK3;TOM1L2;PDGFRB;LRP5;KIF20B;FBXO5;CAV2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2856210227857667,-0.7493105942545422,0.805045871559633,0.9641212416753916,1.0,6/14,17.30%,ADAM10;APH1A;NCSTN;CLN3;APH1B;PSEN2
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.2759610347499963,-0.7491843601253443,0.8224543080939948,0.9635082087575525,1.0,3/17,6.96%,PID1;NUPR1;HDAC4
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3005224549642622,0.7488174940200694,0.7815934065934066,1.0,1.0,10/38,18.34%,FZD5;SAE1;FBXW7;SREBF2;HPS4;LRRK2;ATG13;LEPROT;USP36;TOMM7
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.23130865403756445,-0.7484754760290785,0.867741935483871,0.9637041332735755,1.0,14/33,28.60%,PABPN1;SLBP;SETX;MAZ;NCBP2;CPSF2;SCAF8;CSTF2T;SSU72;CPSF4;CSTF2;CPSF1;LSM11;CLP1
prerank,alpha-amino acid metabolic process (GO:1901605),0.2888210802592747,0.7484094451968706,0.7836021505376344,1.0,1.0,8/45,11.00%,RIMKLA;KMO;NAT8L;GOT1;GOT2;THAP4;GLS2;GLS
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.36681930936394547,0.7483161924930858,0.7346221441124781,1.0,1.0,1/13,1.50%,PMAIP1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.28849364529833843,-0.7477208641390046,0.8195488721804511,0.9639344182549544,1.0,3/15,13.82%,EGFR;PTK2B;KDR
prerank,prostaglandin biosynthetic process (GO:0001516),0.34231313503799204,0.7474695350065004,0.7277070063694268,1.0,1.0,5/18,17.15%,PTGIS;TBXAS1;CBR1;PLA2G4A;MIF
prerank,peroxisomal membrane transport (GO:0015919),-0.2494381158646935,-0.7474484354917182,0.8233532934131736,0.963517479705015,1.0,9/27,21.52%,PEX14;SLC25A17;ALDH3A2;PEX5;ACBD5;ABCD3;FIS1;PXMP2;PEX13
prerank,signal peptide processing (GO:0006465),0.3579032795735817,0.7472111174625334,0.7304347826086957,1.0,1.0,1/11,2.22%,CLN5
prerank,regulation of chromatin binding (GO:0035561),-0.3244430988534603,-0.7469361811694875,0.801255230125523,0.9634551585813678,1.0,4/10,17.71%,BTAF1;MED25;DTX3L;KDM4D
prerank,indolalkylamine catabolic process (GO:0046218),0.36795570466029937,0.7462166505875488,0.7341269841269841,1.0,1.0,1/10,6.79%,KMO
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2640824004407607,-0.7459964801726475,0.8235294117647058,0.9639272551507462,1.0,11/20,38.59%,GATM;PLOD2;PTDSS2;MTHFS;FPGS;GCLC;GCLM;PTDSS1;GAMT;PLSCR1;GGT1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.28428449517158644,0.745918099986504,0.7933673469387755,1.0,1.0,6/56,7.82%,CD36;MYD88;CD14;MAPKAPK2;TRAF3;TIFA
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.2751831150188579,-0.7458167587582288,0.8329177057356608,0.9633845932257652,1.0,1/15,1.06%,MOXD1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3388513483905228,0.7453462071228306,0.7546218487394958,1.0,1.0,3/17,11.59%,ATP5MF;ATP5MC1;ATP5MG
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3432003457273111,0.7452540854153523,0.7615780445969125,1.0,1.0,3/16,11.59%,ATP5MF;ATP5MC1;ATP5MG
prerank,response to insulin (GO:0032868),0.2669410582216743,0.7451401235136962,0.8532675709001233,1.0,1.0,8/80,7.78%,SLC2A4;SORT1;HDAC9;IRS1;SORBS1;CPEB1;PARP1;GOT1
prerank,regulation of viral life cycle (GO:1903900),0.32780773186534795,0.7450220847100865,0.7729393468118196,1.0,1.0,5/21,12.05%,TRIM68;AXL;NECTIN2;TSG101;KPNA2
prerank,ceramide transport (GO:0035627),-0.30995823068007794,-0.7450195972086928,0.7962085308056872,0.963686158394153,1.0,6/12,22.21%,PLTP;SGPP1;CERT1;PLEKHA3;PSAP;ABCA2
prerank,regulation of lamellipodium organization (GO:1902743),-0.2847072155308777,-0.7450123593516723,0.7949308755760369,0.9629106641029785,1.0,4/14,22.70%,PDPN;CD44;CDC42;CARMIL1
prerank,positive regulation of protein metabolic process (GO:0051247),0.25724266794233985,0.7448578049000469,0.8428899082568807,1.0,1.0,7/110,7.38%,AGTR1;NKD1;OAZ2;ATG7;DAB2IP;NEDD4;RASGRP1
prerank,rRNA 3'-end processing (GO:0031125),-0.31812868541050077,-0.7446809576113509,0.8056206088992974,0.962538738213279,1.0,6/10,25.11%,ERI3;EXOSC9;RPS21;EXOSC2;EXOSC7;EXOSC3
prerank,regulation of microtubule polymerization (GO:0031113),0.29867007311417704,0.7445577142941183,0.779373368146214,1.0,1.0,13/40,20.87%,PRUNE1;DYRK1A;MAPT;TOGARAM1;TBCD;CLIP3;CLASP1;STMN2;MAPRE3;DCTN1;ABL1;CAMSAP1;MAPRE1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.31723911050400483,0.7441731576972456,0.7611275964391692,1.0,1.0,3/24,6.59%,TTLL7;CEP41;PARP1
prerank,protein import into nucleus (GO:0006606),0.271122515939899,0.7441616094060418,0.8292383292383292,1.0,1.0,24/66,20.77%,NUP62;KPNA4;RANBP17;SPRN;SEC13;NUP153;PPP1R10;NUP107;RANBP6;KPNA2;TNPO3;KPNA3;FAM53B;IPO4;IPO7;CBLB;FAM53C;STAT3;NUP54;NUP133;PHB2;IPO9;HIKESHI;TPR
prerank,neuron differentiation (GO:0030182),0.2544690539628335,0.744005145372672,0.8704883227176221,1.0,1.0,17/165,11.34%,MEF2C;FZD5;IRX5;FZD4;FZD8;ITM2C;VEGFA;PIN1;ERCC6;TGFB2;ADNP2;MAP2K1;NR4A2;BRSK1;HS6ST1;RUNX1;IL1RAPL1
prerank,negative regulation of kinase activity (GO:0033673),-0.2047803843447596,-0.7438421103580961,0.9215686274509803,0.9628881104186374,1.0,16/62,20.36%,PRKAG2;NF1;DEPTOR;PDPK1;DTNBP1;PYDC1;WWTR1;PPM1F;TAB1;SNCA;AKT1;ITGB1BP1;TRIB1;PARK7;QARS1;CEACAM1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.260840790176065,0.7438374388652873,0.8065650644783119,1.0,1.0,18/91,16.60%,HIP1;PLA2G3;CDH13;PACSIN3;PACSIN2;PTPN1;RAB3A;DENND10;MAP2K1;MBTPS1;NSF;PACSIN1;MAPK1;LRRK2;SNX17;RAB8B;STON1;RAB8A
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.31860189855864846,-0.7436544674683926,0.7957894736842105,0.9607782698151385,1.0,5/10,27.82%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,t-circle formation (GO:0090656),-0.31860189855864846,-0.7436544674683926,0.7957894736842105,0.9607782698151385,1.0,5/10,27.82%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.31860189855864846,-0.7436544674683926,0.7957894736842105,0.9607782698151385,1.0,5/10,27.82%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,lymphocyte chemotaxis (GO:0048247),0.2990858197785669,0.7436384335357528,0.7882513661202186,1.0,1.0,6/34,18.78%,CYP7B1;CCL5;CCL14;GAS6;CCL25;CCL19
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.28794793404841856,-0.7433979951806813,0.8132387706855791,0.9603456585470675,1.0,6/13,26.49%,PRR5L;GTPBP1;PNPT1;ZC3H12A;ZC3HAV1;MOV10
prerank,response to steroid hormone (GO:0048545),0.30653601200532454,0.7429594671491881,0.7957446808510639,1.0,1.0,6/31,7.87%,TGFB3;CAV1;AR;MED1;YAP1;TGFB2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.34500248266680494,0.7423706071779451,0.7452339688041595,1.0,1.0,3/14,11.71%,MYD88;MAPKAPK2;HNRNPC
prerank,maintenance of protein localization in organelle (GO:0072595),0.3331728860807767,0.7420465604117493,0.7678855325914149,1.0,1.0,4/19,10.29%,HK2;TAPT1;TAF8;HNRNPU
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.28830900889521155,-0.741962286753064,0.8084632516703786,0.9614493927201926,1.0,5/13,33.54%,PDE8A;PARK7;RACK1;HGF;GPR37
prerank,maintenance of protein location in nucleus (GO:0051457),0.3278017932391547,0.7415111312921515,0.749611197511664,1.0,1.0,4/20,10.29%,SYNE1;TAF8;SUN2;HNRNPU
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2796813581880916,0.7413710175160898,0.8152454780361758,1.0,1.0,3/57,2.85%,MAP3K5;PMAIP1;ASPH
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27169686383821745,-0.7411436677877714,0.8150134048257373,0.961800808313135,1.0,7/18,30.44%,PRKN;AKT1;PARK7;MAPK7;BAG5;HTRA2;PPIA
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.28616228850289144,0.7410234642341446,0.7740693196405648,1.0,1.0,8/45,15.91%,CAMK2G;CAMK2D;TRIM68;PRKCD;GBP2;OASL;STAT1;JAK2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.3517765486792074,0.7400799875373043,0.7588028169014085,1.0,1.0,5/12,20.64%,OPLAH;GGCT;CHAC2;CNDP2;HAGH
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.26712023471570806,0.7395968551152915,0.8253968253968254,1.0,1.0,14/69,16.48%,POLR2L;POLR2I;ELL;POLR2G;TAF8;CCNT1;CDK7;INTS5;POLR2J;INTS12;INTS7;TAF11;SP1;INTS1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.31121649910546656,-0.7395870450505642,0.8161434977578476,0.963067177184435,1.0,5/11,29.14%,ARRB1;GRK2;GTF2H2;ADM;ADRB2
prerank,cellular response to insulin stimulus (GO:0032869),0.2509727069115487,0.7388134617655638,0.8539576365663322,1.0,1.0,22/124,15.72%,SLC2A4;PDK4;BCAR3;HDAC9;RARRES2;ATP6V1H;IRS1;SORBS1;ATP6V0A2;CPEB1;PARP1;GOT1;ATP6V1C1;SLC39A14;ATP6V0D2;ZFP36L1;PDK2;EPRS1;IRS2;RAB8B;CAV2;NAMPT
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.27672647596705846,-0.7387008184891145,0.8004750593824228,0.9634471491440219,1.0,5/17,19.05%,EMC2;SGTA;EMC3;EMC8;MMGT1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.31841304367991,0.7385880622996435,0.7710487444608567,1.0,1.0,3/24,7.09%,PLCE1;ACTR3;CYFIP1
prerank,phagosome acidification (GO:0090383),0.3134302810222955,0.738538674837403,0.7651515151515151,1.0,1.0,12/26,25.66%,ATP6V1H;ATP6V0A2;ATP6V1C1;ATP6V0D2;RAB38;ATP6V0C;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,regulation of viral genome replication (GO:0045069),-0.2049345879555775,-0.738064390593242,0.9393939393939394,0.9635015569290398,1.0,14/56,18.26%,DDX3X;STAU1;PARP10;PABPC1;DDB1;IFIT1;ADAR;BST2;PPIH;IFITM1;OAS2;SHFL;IFITM3;SRPK1
prerank,clathrin coat assembly (GO:0048268),0.3403133924149033,0.737983499897248,0.7539267015706806,1.0,1.0,1/15,1.87%,HIP1
prerank,erythrocyte development (GO:0048821),0.38390765707861696,0.7378241934030718,0.7750439367311072,1.0,1.0,3/10,12.99%,MED1;ZBTB7A;DMTN
prerank,protein stabilization (GO:0050821),0.25188347749031637,0.7376848233864457,0.8741935483870967,1.0,1.0,30/168,15.52%,FLNA;HIP1;CRTAP;TSPAN1;USP2;TESC;ATP1B1;TAF1;FBXW7;PIN1;PPARGC1A;CDK7;RPL5;BAG3;PARVA;STX12;PEX19;CCT3;PRKCD;USP13;TMEM88;CLU;PDCD10;HPS4;BAG2;MUL1;GNAQ;DVL1;PTEN;FLOT1
prerank,negative regulation of histone modification (GO:0031057),-0.285096252990114,-0.7375438224329712,0.8170731707317073,0.9633783421445137,1.0,10/14,39.19%,NOC2L;SNCA;TAF7;TWIST1;JARID2;PRMT6;BRCA1;AASS;THAP7;SPHK2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.35411830249076703,0.7374317889680905,0.7447916666666666,1.0,1.0,6/13,19.62%,ALOX5;LPCAT3;CLU;EIF2AK3;NR1H3;WFS1
prerank,replicative senescence (GO:0090399),0.35861848597921797,0.7370777869600617,0.7562724014336918,1.0,1.0,3/12,7.53%,TERT;TP53;CHEK1
prerank,microtubule-based transport (GO:0099111),-0.28744363847311205,-0.7368802211880738,0.8033573141486811,0.9634203856563018,1.0,9/13,49.58%,DYNC1I1;SPEF2;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,error-free translesion synthesis (GO:0070987),-0.257101811943881,-0.7367750226333438,0.8277777777777777,0.9627865395881562,1.0,10/22,37.17%,UFD1;UBC;REV1;UBB;RPA3;RFC3;RPA2;RPA1;RFC1;RFC4
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3308794244861576,0.7367529155046808,0.747557003257329,1.0,1.0,2/17,5.51%,HAVCR2;PRKCQ
prerank,positive regulation of catalytic activity (GO:0043085),-0.21782520463456387,-0.7366937543363722,0.9084745762711864,0.9621347706670643,1.0,11/37,21.25%,MAPK14;XRCC5;STX4;IGF2;ABL2;APH1A;NCSTN;CHTOP;PSEN2;MSH6;FGFR4
prerank,negative regulation of myoblast differentiation (GO:0045662),0.35038626047355415,0.7365403709298736,0.7487520798668885,1.0,1.0,2/13,7.69%,ANKRD2;SOX9
prerank,positive regulation of cell death (GO:0010942),0.27646949155089734,0.7364965834239359,0.8037037037037037,1.0,1.0,5/59,7.57%,MAP3K5;CD36;MAPT;HEBP2;CELF1
prerank,regulation of protein polymerization (GO:0032271),-0.2274065064664893,-0.7363260063122286,0.9094076655052264,0.9618105340580754,1.0,9/35,20.23%,ARHGAP28;RASA1;PFN2;PFN1;DBN1;TTBK1;TPPP3;ARL2;GBA2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3188660557122296,-0.7357924365902232,0.8079625292740047,0.9617496876560843,1.0,1/10,4.15%,LPGAT1
prerank,negative regulation of secretion by cell (GO:1903531),0.28907429575938776,0.7355757932459157,0.780952380952381,1.0,1.0,5/38,11.34%,HTR1B;ANXA1;DPH3;HRH3;IL1RAPL1
prerank,inorganic anion transport (GO:0015698),0.27993837176970304,0.7353890192321749,0.8025157232704403,1.0,1.0,6/53,9.11%,ANO1;ANO6;CLCN6;TTYH1;ANO10;XPR1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.30289529115439107,0.7353838692291662,0.7983074753173484,1.0,1.0,6/33,8.66%,CCND2;ANXA1;FAM83D;PLCB1;CCND1;ADAM17
prerank,canonical Wnt signaling pathway (GO:0060070),0.27304925341032804,0.7350340429146746,0.811965811965812,1.0,1.0,18/68,18.17%,FZD5;FZD4;FZD8;CAV1;FZD9;AMER1;PPP1CA;NR4A2;SCYL2;LRP5;CSNK1E;LRRK2;DVL1;CSNK1A1;PTEN;RYK;WNT5B;TCF7
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2659645565029107,0.7348414006004461,0.8091697645600991,1.0,1.0,18/70,17.40%,SORT1;BCL2;GABARAP;DAB2IP;BCL2L2;TGFB2;BAG3;DEDD2;CASP8AP2;BOK;ACVR1B;DIABLO;DEDD;TNFRSF10B;MCL1;JAK2;FGFR3;TNFSF12
prerank,epidermis development (GO:0008544),-0.1973618379840519,-0.7343165782692234,0.949238578680203,0.9628879108635879,1.0,14/56,26.35%,SVEP1;EMP1;ALDH3A2;LAMA3;FGFR2;CRABP2;SCEL;HDAC2;GATA6;PTHLH;FGF7;YBX1;EDA2R;LAMC2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2492222918973962,0.7341515400627395,0.8728448275862069,1.0,1.0,21/161,10.86%,TMEM131L;NKD1;LIMD1;FZD4;RBMS3;JADE1;TBX18;SDHAF2;CAV1;PSMC6;DAB2IP;IGFBP4;SOX9;SNAI2;AMER1;PSME4;AMFR;PSMB1;SCYL2;PSMD5;LMBR1L
prerank,polarized epithelial cell differentiation (GO:0030859),-0.28604725555857546,-0.73397540550606,0.8416075650118203,0.9625478011829718,1.0,11/13,52.41%,MYO9A;OPHN1;CDC42;SCRIB;SH3BP1;CAMSAP3;MSN;EZR;RHOA;SYNE4;ZDHHC7
prerank,negative regulation of DNA replication (GO:0008156),-0.2917600802760212,-0.7338310118755385,0.8132678132678133,0.9619601472954391,1.0,2/13,5.08%,ATR;PDS5A
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.2699611413978608,-0.7336963261899054,0.839541547277937,0.9613281913094196,1.0,5/18,22.21%,APOE;RDX;PTTG1IP;DACT1;ABCA2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.26691544673441425,-0.7336325271014487,0.8661202185792349,0.960643563306252,1.0,3/18,8.49%,PTPN11;CTR9;IL6R
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3505934677254774,0.7336069173729473,0.7623762376237624,1.0,1.0,2/13,11.12%,CBFB;RUNX1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.26594490451717445,-0.7334609463977081,0.8494623655913979,0.9601011854348876,1.0,3/17,18.91%,LPGAT1;PLAAT3;PLA2G12A
prerank,cytokine-mediated signaling pathway (GO:0019221),0.23777248572912227,0.7332785946709035,0.9658634538152611,1.0,1.0,54/532,10.79%,CAMK2G;LIFR;ACTN4;CD36;LAMA5;LIMS1;MYD88;PDGFB;CNN2;RORA;VIM;CRLF1;ANXA1;GREM2;SOCS5;CAMK2D;IL2;TNFSF13B;LCP1;ITGB1;CCL5;IL12RB2;ALOX5;BCL2;SOCS6;IRS1;TNFRSF11A;PSMC6;TP53;VEGFA;IL10RA;IL12RB1;TRAF3;YAP1;IL22;RELA;PLCB1;TRIM68;CCND1;ADAM17;PAK2;SLA;INPPL1;HIF1A;PSME4;EDAR;TRAF5;PSMB1;IL13RA1;CCL14;PELI2;PSMD5;EIF5A;VAV1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.23307190069634873,-0.7332386795949871,0.8741935483870967,0.959633956369979,1.0,10/30,26.20%,BCL2L1;CD44;MDM2;THOC5;PTTG1IP;KDM1A;TRIM32;SNAI1;YJU2;TWIST1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2889559226080446,0.733234888621902,0.7643142476697736,1.0,1.0,6/46,9.23%,CNN2;LCP1;IL12RB2;IL12RB1;PLCB1;PAK2
prerank,negative regulation of potassium ion transport (GO:0043267),-0.2950832758831412,-0.7324391010644887,0.8364928909952607,0.9598815246446135,1.0,2/13,5.65%,NEDD4L;PTK2B
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2781811564881311,-0.7315944157917331,0.8329466357308585,0.960123065626093,1.0,11/15,38.14%,ZBTB8OS;ERN1;TSEN34;CPSF4;CSTF2;CPSF1;CLP1;TRPT1;TSEN54;TSEN15;RTRAF
prerank,response to sterol (GO:0036314),0.3503470027101641,0.7315874016922169,0.7409326424870466,1.0,1.0,1/11,2.57%,RORA
prerank,quinone biosynthetic process (GO:1901663),-0.28540939855196945,-0.731586784918624,0.8192488262910798,0.9593652027572986,1.0,3/14,6.22%,COQ10B;COQ8B;COQ5
prerank,negative regulation of response to stimulus (GO:0048585),0.27188828603688936,0.7315792171253851,0.8296296296296296,1.0,1.0,17/60,19.69%,CDK6;SOCS5;ALOX5;KLF7;TERT;PTPN1;LPCAT3;TERF2;COL3A1;CLU;FBXO5;ADRA2A;NR1H3;HHIP;ACVR1;WFS1;VPS13C
prerank,regulation of protein targeting to membrane (GO:0090313),0.3118061848532159,0.7314759899394692,0.7868613138686131,1.0,1.0,10/28,22.50%,KCNB1;MIEF2;MIEF1;DMTN;MTCL1;SLC51B;MFF;MYO1C;ERBB2;PDZK1
prerank,regulation of secretion (GO:0051046),-0.2859012905909436,-0.7312519808307714,0.8226950354609929,0.9590143966027053,1.0,4/13,18.57%,ACSL3;MYO6;OAS2;KCNQ1
prerank,cytosolic transport (GO:0016482),0.25695946156920196,0.731024751021165,0.8432494279176201,1.0,1.0,24/108,17.40%,MYO1D;CLN5;HOOK2;SORT1;RHOBTB3;VPS26A;EVI5;WASHC1;VPS26B;ANKFY1;HOOK1;AKTIP;PLEKHJ1;TMEM87A;PIK3C3;VPS50;RAB14;ANKRD27;SNX1;SPAG9;VPS35;CORO7;DCTN1;VPS51
prerank,positive regulation of translational initiation (GO:0045948),0.3275219535677204,0.7309601905887667,0.7567567567567568,1.0,1.0,3/18,6.98%,CCL5;POLR2G;YTHDF2
prerank,regulation of cellular senescence (GO:2000772),0.30199796458673245,0.7306853078544568,0.7856115107913669,1.0,1.0,5/28,11.54%,CDK6;CGAS;TERT;NUAK1;TERF2
prerank,snRNA transcription (GO:0009301),0.2625810039350327,0.7306550689619417,0.8361650485436893,1.0,1.0,14/70,16.48%,POLR2L;POLR2I;ELL;POLR2G;TAF8;CCNT1;CDK7;INTS5;POLR2J;INTS12;INTS7;TAF11;SP1;INTS1
prerank,glycolipid biosynthetic process (GO:0009247),0.29066919238153865,0.7305518980759226,0.8081805359661495,1.0,1.0,10/38,17.31%,LARGE1;PIGN;PIGA;ST8SIA5;A4GALT;ST3GAL2;PIGH;PIGB;PIGP;DPM2
prerank,cellular response to interleukin-2 (GO:0071352),0.3491857610732115,0.7304632319052528,0.7535714285714286,1.0,1.0,1/11,3.19%,IL2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.3491857610732115,0.7304632319052528,0.7535714285714286,1.0,1.0,1/11,3.19%,IL2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.19602801123372654,-0.7299024208817174,0.9438202247191011,0.9598573191069718,1.0,29/70,32.63%,ITCH;PRKDC;PUS7;PSMD7;PSMD9;PSMD13;METTL3;PSMB3;PSMC5;PSMA5;PSMA1;PSMC2;N4BP2L2;SETD1A;LMO2;PSME3;PSMC4;TAL1;PSMB6;PSMB10;PSMA4;KMT2A;PSME1;PSMF1;PSMB9;LDB1;PSME2;TCF3;PSMA8
prerank,regulation of erythrocyte differentiation (GO:0045646),0.30008518732428496,0.7289382286776659,0.8073654390934845,1.0,1.0,9/35,16.03%,CDK6;ACVR2A;MED1;ANKRD54;HIF1A;ACVR1B;ZFP36L1;STAT1;STAT3
prerank,membrane raft organization (GO:0031579),0.3388647160343617,0.7289058799814472,0.7716814159292036,1.0,1.0,5/15,15.80%,FA2H;YJEFN3;NAXE;FLOT1;RFTN1
prerank,cilium organization (GO:0044782),0.2434169983616286,0.7286413505241641,0.9041095890410958,1.0,1.0,20/210,11.50%,FLNA;DYNLL1;PLA2G3;KIF27;ARMC2;EHD2;CEP41;KIF3B;ACTR3;CEP290;IFT43;IFT81;PIBF1;BBIP1;IQCB1;PARVA;EXOC6;RAB11FIP3;FHDC1;KIFAP3
prerank,lysosome localization (GO:0032418),0.28881522874977344,0.7284064515403473,0.8052851182197497,1.0,1.0,4/37,7.79%,MYH9;MILR1;RAB3A;KIF5B
prerank,icosanoid secretion (GO:0032309),0.3557480699670196,0.7279706845932639,0.7561436672967864,1.0,1.0,1/12,2.79%,ANXA1
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.23486824188729,-0.7278072521380857,0.8745874587458746,0.9616674669703883,1.0,11/30,24.99%,LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK
prerank,negative regulation of cellular senescence (GO:2000773),0.34173378304401697,0.7273980420802484,0.7639123102866779,1.0,1.0,4/13,15.13%,CDK6;TERT;TERF2;FBXO5
prerank,regulation of cellular protein localization (GO:1903827),0.2811759905479026,0.7273939044712672,0.816622691292876,1.0,1.0,11/45,15.59%,LCP1;GPC4;MAPT;PARP1;PIN1;PTPN1;CEP72;CSNK1E;PRKAA2;DVL1;CCDC66
prerank,negative regulation of programmed cell death (GO:0043069),0.24033879293660312,0.7272433022744313,0.950354609929078,1.0,1.0,36/355,10.10%,FLNA;NAA38;ANGPT1;NR1H4;ANGPT4;MYD88;TCIM;CCND2;ANXA1;IL2;NUP62;ARHGAP10;ATAD3A;FXN;BCL2;MYO18A;MTDH;TP53;VEGFA;GDNF;PA2G4;MED1;BCL2L2;NAT8;OPA1;SOX9;RELA;API5;CBX4;VDAC1;TNFAIP8;GSTP1;PAK2;BAG3;AXL;FAIM2
prerank,positive regulation of macrophage migration (GO:1905523),0.32133030002631846,0.727073861052548,0.7853736089030207,1.0,1.0,2/19,5.41%,CCL5;RARRES2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.26202171734046314,0.7267423423903511,0.8456140350877193,1.0,1.0,22/84,15.98%,RBM24;KHDRBS3;U2AF2;CIRBP;CELF1;RBMXL1;SRSF4;MBNL2;RBM8A;MBNL1;HNRNPU;SRSF10;RBM3;ZBTB7A;RBM25;SON;NUP98;CWC22;SRPK2;RBM15;SF1;PUF60
prerank,regulation of cell aging (GO:0090342),-0.2992988812224715,-0.7263194159777707,0.8094170403587444,0.962681803663431,1.0,4/11,19.69%,RSL1D1;NEK6;PNPT1;NEK4
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.24134840266275775,-0.7261712096280052,0.8664596273291926,0.9621052417350819,1.0,16/26,42.48%,EPHA4;APH1A;LYN;NCSTN;APH1B;TTBK1;PSME3;PSENEN;PSME1;PSME2;PYCARD;GRIN1;AGER;AIM2;FYN;GRIN2B
prerank,glycoprotein catabolic process (GO:0006516),-0.26843880508106616,-0.7260381514588007,0.8341708542713567,0.9615034531143195,1.0,6/17,27.90%,NGLY1;CTSL;ADAMTS9;FBXO17;STT3B;FBXO44
prerank,oxoacid metabolic process (GO:0043436),-0.23973696924524895,-0.7260154801754466,0.8647798742138365,0.9607720188315072,1.0,5/27,12.78%,TPST1;BPNT2;PPA1;PPA2;ENPP1
prerank,positive regulation of RNA splicing (GO:0033120),0.29815379526676244,0.7257441982482229,0.792507204610951,1.0,1.0,7/29,14.03%,SLC38A2;DYRK1A;U2AF2;CIRBP;RBMXL1;RBM3;NUP98
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.25324348756498755,0.7253893434361954,0.8373983739837398,1.0,1.0,34/95,23.07%,DYNLL1;CEP41;HAUS8;CEP290;RPGRIP1L;IQCB1;CEP192;DYNC1I2;C2CD3;NEDD1;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;PLK4;DCTN1;HAUS4;CEP135;CKAP5;ACTR1A;SFI1;MAPRE1;NPHP4;ODF2;PPP2R1A;NINL;TUBA4A;CEP63;YWHAG;NDE1
prerank,regulation of macrophage differentiation (GO:0045649),-0.27150701380255715,-0.7253357978659403,0.835,0.9608331026132282,1.0,5/15,32.49%,CASP8;HSF1;PTPN2;C1QC;INHA
prerank,negative regulation of cell aging (GO:0090344),0.33238983898100777,0.725187381045848,0.7609756097560976,1.0,1.0,5/16,17.15%,CDK6;TERT;TERF2;FBXO5;MIF
prerank,negative regulation of cellular catabolic process (GO:0031330),0.26364128794629055,0.7250572883861742,0.8222222222222222,1.0,1.0,14/63,17.27%,ROCK1;BCL2;DAB2IP;IL10RA;TIMP4;WASHC1;SIRT2;HTR2B;MCL1;EIF4E;STAT3;MT3;WDR6;EIF4G2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3228918925791494,0.7247636796115863,0.7683881064162754,1.0,1.0,3/20,7.52%,CCL5;RPGRIP1L;PLEK
prerank,DNA replication initiation (GO:0006270),-0.22327405478331325,-0.7242497503266084,0.8801369863013698,0.9613821289466616,1.0,23/37,41.93%,ORC6;ORC5;POLE4;POLE2;CDC7;CDK2;ORC4;DBF4;POLA2;RPA3;ORC1;CDC34;PRIM1;MCM8;RPA2;CDC45;RPA1;POLE;MCM3;POLE3;POLA1;MCM5;MCM10
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3093785598619262,-0.7235887241613285,0.8068181818181818,0.961410992662252,1.0,3/10,17.41%,CCT8;CCT4;WRAP53
prerank,regulation of protein localization to membrane (GO:1905475),0.3022232399586876,0.7232535005546882,0.7901785714285714,1.0,1.0,5/28,7.14%,SLC5A3;ACTB;GPC4;ZDHHC2;AR
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.26648755032517946,0.7223350615816586,0.8367593712212817,1.0,1.0,19/78,17.99%,KLHL40;SOCS5;PABIR1;GABARAP;CAV1;TAF1;RNF180;SIRT2;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;HSPBP1;SIRT6;BCAP31;RCHY1;PIAS1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3016045043744615,-0.7221769692832865,0.8296460176991151,0.9623576242656592,1.0,1/11,3.96%,LDLR
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.2907546292268725,-0.7220216130905263,0.8581730769230769,0.9617677758734418,1.0,2/13,9.32%,PID1;NOS3
prerank,cilium assembly (GO:0060271),0.23717246472289652,0.7219725314406282,0.9432989690721649,1.0,1.0,45/297,15.88%,FLNA;DYNLL1;PLA2G3;KIF27;EHD2;CEP41;HAUS8;DYNLRB1;RSPH1;KIF3B;ACTR3;TBC1D32;CEP290;RPGRIP1L;IFT43;IFT81;PIBF1;TOGARAM1;BBIP1;IQCB1;PARVA;CEP192;EXOC6;RAB11FIP3;DYNC1I2;FHDC1;KIFAP3;C2CD3;NEDD1;STK36;CLASP1;CEP72;SPATA6;CEP43;FOXJ1;CSNK1E;DCTN3;TTC39C;HAUS7;HAUS2;PRKACA;RAB8B;CCDC66;CFAP43;RFX3
prerank,carnitine metabolic process (GO:0009437),0.34361369542625875,0.7219578874056605,0.7419928825622776,1.0,1.0,5/12,20.86%,CPT1B;CRAT;CPT1A;TMLHE;ACADM
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.18967292565992575,-0.7218764364868657,0.9659090909090909,0.9612039248968322,1.0,29/73,32.63%,ITCH;PRKDC;PUS7;PSMD7;PSMD9;PSMD13;METTL3;METTL14;PSMB3;PSMC5;PSMA5;PSMA1;PSMC2;SETD1A;LMO2;PSME3;PSMC4;TAL1;PSMB6;PSMB10;PSMA4;KMT2A;PSME1;PSMF1;PSMB9;LDB1;PSME2;TCF3;PSMA8
prerank,RNA biosynthetic process (GO:0032774),-0.22415223536798712,-0.7216783706866643,0.9006622516556292,0.9606919856802677,1.0,11/31,30.66%,POLR2A;SETX;TTF1;TAF12;TAF13;SMN1;TAF7;TAF5;POLA2;NCOA6;PRIM1
prerank,positive regulation of cell aging (GO:0090343),0.3617916588935384,0.7213008945102203,0.7676950998185118,1.0,1.0,1/11,3.13%,CGAS
prerank,regulation of response to oxidative stress (GO:1902882),0.35280274892667296,0.7210624601278681,0.7685009487666035,1.0,1.0,2/11,7.23%,ALOX5;HEBP2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.27939497210306624,-0.7210531286611565,0.8286445012787724,0.9606897616685929,1.0,4/13,20.57%,MPDU1;ALG14;ALG1;ALG12
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.2769500025038402,-0.7206681851804839,0.8258823529411765,0.9604004046139936,1.0,5/14,22.41%,PKD2;NFKBIA;G3BP2;MDFI;KEAP1
prerank,peptidyl-methionine modification (GO:0018206),0.3596402082698635,0.7204422368213486,0.7986230636833046,1.0,1.0,2/12,8.21%,NAA25;NAA20
prerank,amyloid-beta metabolic process (GO:0050435),0.32562374148419726,0.7200231919916957,0.7885906040268457,1.0,1.0,3/16,7.64%,DYRK1A;APEH;NAT8
prerank,ubiquinone biosynthetic process (GO:0006744),-0.2775394289947948,-0.719737040637999,0.828978622327791,0.9607760250183442,1.0,3/15,6.22%,COQ10B;COQ8B;COQ5
prerank,amino acid transmembrane transport (GO:0003333),0.28212925764024727,0.719654853843185,0.812987012987013,1.0,1.0,1/45,0.33%,SLC38A11
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.27216851133726944,-0.7192923608173043,0.8537170263788969,0.9605767594069056,1.0,7/15,27.01%,RNF213;SFRP4;GPC3;DACT1;RSPO3;ZNRF3;TIAM1
prerank,rRNA catabolic process (GO:0016075),-0.26543515124045797,-0.7192568031418176,0.8461538461538461,0.959871417380017,1.0,7/16,27.19%,TRIR;DIS3;EXOSC9;EXOSC2;EXOSC7;EXOSC3;EXOSC5
prerank,non-motile cilium assembly (GO:1905515),0.29295827217620846,0.7181774367977776,0.7776203966005666,1.0,1.0,5/30,7.53%,TBC1D32;CEP290;RPGRIP1L;PIBF1;TOGARAM1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.3308596113738071,0.718022250516854,0.7864406779661017,1.0,1.0,4/15,17.47%,PPARGC1A;PPARA;MLXIPL;NR1H3
prerank,regulation of exit from mitosis (GO:0007096),-0.21305363009003236,-0.7180066531382239,0.8913043478260869,0.9604810984311393,1.0,9/38,17.58%,CDC14B;ANAPC1;CDC23;UBC;RGCC;BUB3;CDC26;UBE2S;ANAPC4
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3375837434661526,0.7179436188124573,0.7823240589198036,1.0,1.0,3/14,14.62%,DAB2IP;PTPN1;UFL1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.2954450656492369,0.7175201871985389,0.7842261904761905,1.0,1.0,4/29,7.06%,SLC8A2;SHISA9;ZDHHC2;RAB3A
prerank,hemidesmosome assembly (GO:0031581),0.35230159525075483,0.7173541125834588,0.7662565905096661,1.0,1.0,2/11,6.91%,DST;LAMC1
prerank,bone morphogenesis (GO:0060349),0.33599702235422946,0.7160217971317537,0.7618213660245184,1.0,1.0,5/14,17.16%,OSR2;SKI;LRP5;BMPR1B;FGFR3
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.29511170761186123,0.7159768198301488,0.7962697274031564,1.0,1.0,8/31,17.16%,WDR1;LIN7C;RAP2A;MTCL1;PARD3B;ANK1;LIN7A;MARK2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3365041728005353,0.715428734573346,0.7834179357021996,1.0,1.0,3/16,12.48%,NACC2;SNAI2;CLU
prerank,copper ion transport (GO:0006825),-0.29609674369724603,-0.7148434016109931,0.8390804597701149,0.9634425062568039,1.0,4/11,22.58%,STEAP3;ATOX1;STEAP2;SLC31A1
prerank,ubiquinone metabolic process (GO:0006743),-0.2730418930591761,-0.7145286313463142,0.8238095238095238,0.9630537106179411,1.0,9/15,33.69%,COQ10B;COQ8B;COQ5;AIFM2;COQ3;FDXR;UBIAD1;COQ6;COQ7
prerank,nucleoside salvage (GO:0043174),-0.3029972277717603,-0.7143583406931847,0.8075221238938053,0.9625006321694802,1.0,2/10,11.74%,UPP2;HPRT1
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.2615574712842176,-0.7142560651879912,0.8586956521739131,0.9618664971566055,1.0,4/19,21.36%,DDX3X;CHUK;TLR3;HSPD1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.35714905778088435,0.7140006764330332,0.7639405204460966,1.0,1.0,4/10,19.48%,PRMT7;PCGF5;PCGF3;DNMT3A
prerank,regulation of secretion by cell (GO:1903530),0.26819100720297073,0.7132751254991272,0.8303341902313625,1.0,1.0,2/54,2.79%,MEF2C;ANXA1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3188971188808078,0.7132574865602586,0.7809364548494984,1.0,1.0,5/18,13.01%,CLASP2;EMILIN1;RUNX1;RB1;CLASP1
prerank,negative regulation by host of viral transcription (GO:0043922),0.33601854017248206,0.7128042675844481,0.7708333333333334,1.0,1.0,1/12,3.64%,CCL5
prerank,protein localization to centrosome (GO:0071539),0.3236662118696071,0.7125644412589952,0.7732463295269169,1.0,1.0,4/17,11.88%,PIBF1;CEP192;C2CD3;NEDD1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.23347385966576453,0.7124816204492376,0.9442755825734549,1.0,1.0,43/306,13.20%,RPL3L;POLR2L;POLR2I;LARGE1;MLF1;EEFSEC;MRPL36;BRIP1;EXT2;MRPL13;PWP1;SET;HARS2;UPF1;MEF2A;POLR2G;TERT;TIPIN;RPL8;CHEK1;RAD9A;NFKBIB;MRPL43;TNIP1;NR4A2;MRPL51;KAT7;RPL5;MRPL23;RPS23;RHNO1;POLD1;GSPT1;PTMS;BAZ2A;MRPL9;TSFM;ORC2;RMI2;POLR2J;ST3GAL2;MRPL42;EEF2K
prerank,cellular response to interleukin-1 (GO:0071347),0.24392974576525533,0.7123206644862989,0.8902305159165752,1.0,1.0,31/143,19.25%,MYD88;CCL5;PTGIS;UPF1;HAS2;PSMC6;DAB2IP;SOX9;RELA;PLCB1;NR1D1;HIF1A;PSME4;PSMB1;CCL14;PELI2;PSMD5;FBXW11;GBP2;PSMB2;HYAL1;PSMB7;PSMD3;PSMA2;PSMD14;IL1R1;CCL25;EGR1;CD47;CCL19;RPS27A
prerank,positive regulation of JNK cascade (GO:0046330),0.25889387784910534,0.7118683637698165,0.8278388278388278,1.0,1.0,9/70,10.28%,MAP3K5;MFHAS1;DAB2IP;TRAF3;RASGRP1;PLCB1;MAP3K10;EDAR;TRAF5
prerank,cellular response to pH (GO:0071467),0.3224616917037913,0.7118294186122425,0.7792,1.0,1.0,3/17,14.36%,PKD1L3;IMPACT;HYAL1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3264450576209057,0.7117749666145738,0.778534923339012,1.0,1.0,5/15,16.49%,OSR2;CELF1;TGFB2;RICTOR;UBR3
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28892440774706596,0.7116145511060267,0.8033707865168539,1.0,1.0,6/35,11.83%,MUTYH;PARP1;MBD4;PARG;POLD1;POLG
prerank,regulation of ATP metabolic process (GO:1903578),0.27244281910117685,0.7115487116314252,0.8189987163029525,1.0,1.0,17/54,20.77%,NUP62;COX7A2L;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;UQCC2;SLC25A33;TPR
prerank,cellular biogenic amine metabolic process (GO:0006576),0.34143734381501084,0.7113246486215121,0.7948717948717948,1.0,1.0,2/12,10.82%,OAZ2;SMS
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.25703407544158563,-0.7104383351727832,0.8733153638814016,0.9654328819097977,1.0,5/19,19.26%,CAT;GPX1;ACOX1;PRDX4;PARK7
prerank,glycerol metabolic process (GO:0006071),-0.3063686013019783,-0.7103355825847772,0.8325991189427313,0.9647974489408272,1.0,6/10,32.71%,GK5;COQ3;PGP;GK;TPI1;ANGPTL3
prerank,regulation of histone deacetylation (GO:0031063),0.33577808717479585,0.7090100268805368,0.7939609236234458,1.0,1.0,1/13,3.16%,CAMK2D
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2604648080610204,0.7086492064175143,0.8531211750305998,1.0,1.0,12/67,13.34%,TBC1D1;ATP8B1;TBC1D20;CAV1;RABGAP1;EVI5;EPHA2;GAP43;MYO10;TRPM2;DMTN;CAPZB
prerank,myelin maintenance (GO:0043217),0.353849209046784,0.707808432252368,0.7838827838827839,1.0,1.0,2/10,15.35%,CLU;PTEN
prerank,negative regulation of biosynthetic process (GO:0009890),0.32505768633372906,0.7078018205299677,0.7555555555555555,1.0,1.0,4/16,10.85%,EMILIN1;PPARA;GSTP1;GPER1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.270555694842661,-0.7077210106266425,0.8698630136986302,0.9669381259792513,1.0,4/15,15.58%,SDCBP;VPS4B;SDC4;HGS
prerank,positive regulation of cell cycle process (GO:0090068),0.2495596346349828,0.7075209969496101,0.8648018648018648,1.0,1.0,11/91,12.58%,MAP3K20;PDGFB;NUP62;PKN2;SIRT2;PDGFRB;NSFL1C;RHNO1;LRP5;CEP120;KIF20B
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2652226891335663,-0.7069734127588655,0.8450704225352113,0.9670163957958007,1.0,6/15,25.14%,LEF1;SNW1;EP300;CHD1;NUCKS1;TFAP4
prerank,cristae formation (GO:0042407),0.29637094007881676,0.7067870868513318,0.8040435458786936,1.0,1.0,8/27,18.79%,ATP5MF;AFG3L2;DNAJC11;ATP5MC1;ATP5MG;IMMT;APOOL;ATP5F1D
prerank,regulation of double-strand break repair (GO:2000779),0.2771852159165002,0.7066297228136529,0.8394062078272605,1.0,1.0,5/39,8.54%,UBR5;RAD51AP1;ZCWPW1;CHEK1;SPIRE1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3342533999132646,0.7064519642545347,0.7901023890784983,1.0,1.0,1/12,2.22%,CLN5
prerank,lymphocyte mediated immunity (GO:0002449),0.3480575920958173,0.7061767532491051,0.7799295774647887,1.0,1.0,1/12,3.14%,JAG1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.2874187689767701,0.7059592208082673,0.8077455048409405,1.0,1.0,6/31,15.35%,PDLIM5;KIF1A;CUX2;LRRK2;LZTS3;PTEN
prerank,response to cytokine (GO:0034097),0.2424380086644534,0.7059487228626238,0.8938053097345132,1.0,1.0,13/141,8.40%,AKAP6;LIFR;ITIH4;MYD88;ANXA1;BCL2;PTPN18;MAP4K3;TNFRSF11A;MAPKAPK2;TIMP4;RELA;DDOST
prerank,prostaglandin metabolic process (GO:0006693),0.3037181173337592,0.7054899779090533,0.7850746268656716,1.0,1.0,6/26,17.15%,PTGIS;TBXAS1;GSTP1;PTGR1;PLA2G4A;MIF
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3086910259761816,0.705079888529123,0.8159126365054602,1.0,1.0,4/23,8.66%,ZEB2;TGFB1I1;SLC2A10;ADAM17
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3086910259761816,0.705079888529123,0.8159126365054602,1.0,1.0,4/23,8.66%,ZEB2;TGFB1I1;SLC2A10;ADAM17
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2529360857305084,0.7049412041424676,0.8657243816254417,1.0,1.0,20/83,19.58%,CDK6;HINFP;EIF4EBP1;CUL2;CCND1;CDK7;CRLF3;CDK18;RB1;GSPT1;ACVR1B;CDK15;EIF4E;FBXO5;CDK14;BRD4;CUL5;MNAT1;CACUL1;ACVR1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2244450695615116,-0.7041758450134263,0.9060402684563759,0.9693793995594909,1.0,11/28,36.24%,PRKDC;CYRIB;XRCC6;SIRPA;NCKAP1L;HSPD1;THY1;TYROBP;SH3KBP1;NOD2;PYCARD
prerank,DNA modification (GO:0006304),0.30581459152364465,0.7037106238058868,0.8053491827637445,1.0,1.0,4/22,11.54%,MUTYH;PARP1;MBD4;TERF2
prerank,glycerophospholipid metabolic process (GO:0006650),0.25568703224044786,0.7025758950995564,0.8647342995169082,1.0,1.0,17/75,17.32%,PLA2G3;PIGN;PIGA;ABCA3;PLEK;PLCB1;PLCD1;PDGFRB;CPNE3;PNPLA3;PLA2G4A;PIGH;PLA2G4C;PIGB;PIGP;DPM2;PRDX6
prerank,cholesterol biosynthetic process (GO:0006695),-0.22561422133764608,-0.7023046298901019,0.9166666666666666,0.9706576556105707,1.0,16/31,35.78%,LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK;INSIG2;EBP;SC5D;TM7SF2;DHCR7
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.28843990208204195,-0.7021679897355106,0.8558758314855875,0.9700545033528412,1.0,1/12,3.27%,IL18
prerank,regulation of protein binding (GO:0043393),0.24469279920748158,0.7021253469888662,0.8689809630459127,1.0,1.0,22/114,15.52%,XIRP1;ROCK1;PDGFB;ACTB;CAV1;TAF1;TERT;PIN1;ADD2;PRMT7;PPP1CA;AMFR;PSME3IP1;PRKCD;AKTIP;BAG2;LDLRAP1;CSNK1E;LRRK2;DVL1;PRKACA;FLOT1
prerank,mitotic recombination (GO:0006312),-0.26476344841740423,-0.7016898946417481,0.8391959798994975,0.9697660437372865,1.0,5/15,24.52%,RAD50;SMC5;TPRKB;NSMCE2;ERCC1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.25936695507841573,0.7010785467805897,0.8634146341463415,1.0,1.0,16/70,20.65%,PLA2G3;SLC44A5;STARD7;ABCA3;SLC44A1;LPCAT3;PLB1;PLA2G4A;CHKB;PLA2G4C;NR1H3;SLC44A2;MBOAT7;CHPT1;LPCAT1;PLA2G15
prerank,cellular response to interleukin-12 (GO:0071349),0.2739944223152177,0.70103611704999,0.8058510638297872,1.0,1.0,6/48,9.23%,CNN2;LCP1;IL12RB2;IL12RB1;PLCB1;PAK2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.2828112875527041,-0.7009807809476764,0.8314855875831486,0.9697851461352436,1.0,2/12,8.22%,BMP7;CD44
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2832217898424835,0.700687133457704,0.8249299719887955,1.0,1.0,7/32,17.52%,HINFP;CDK18;RB1;CDK15;FBXO5;CDK14;BRD4
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.260094862395321,-0.7003026139210452,0.8552971576227391,0.9697402863401765,1.0,5/18,17.83%,SPTBN1;APPL1;CLN3;VAMP8;STX8
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.32181887969133827,0.7002409447193826,0.7928802588996764,1.0,1.0,6/17,20.68%,COX7A2L;COX8A;COX7B;COX6C;COX5B;COX6A1
prerank,regulation of chromosome organization (GO:0033044),0.3034776605048719,0.700023281266489,0.8080495356037152,1.0,1.0,5/22,12.83%,UPF1;MAPT;RB1;TERF2;RMI2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.24822516122930077,0.6998119953271974,0.8795749704840614,1.0,1.0,15/93,12.85%,MAP3K5;MFHAS1;DAB2IP;ARL6IP5;VEGFA;TRAF3;RASGRP1;TGFB2;PLCB1;MAP3K10;EDAR;TRAF5;EIF2AK2;PDCD10;TAOK3
prerank,cellular response to cytokine stimulus (GO:0071345),0.2278462814110613,0.6994472574440869,0.967644084934277,1.0,1.0,47/416,11.47%,AKAP6;LIFR;CD36;LAMA5;DOCK8;RORA;VIM;CRLF1;ANXA1;GREM2;SOCS5;IL2;ITGB1;CCL5;IL12RB2;PTGIS;ALOX5;BCL2;PTPN18;UPF1;SOCS6;ARHGEF2;HAS2;DAB2IP;TP53;VEGFA;IL10RA;IL12RB1;SOX9;IL22;RELA;DAPK3;CCND1;NR1D1;SLA;INPPL1;HIF1A;AXL;NPR2;HNRNPU;IL13RA1;CCL14;VAV1;GPER1;TNFRSF21;IL1RAPL1;ZFAND6
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.31320047443438365,0.699391135878931,0.7958860759493671,1.0,1.0,4/19,11.71%,NAT10;HNRNPU;TERF2;HNRNPC
prerank,proton transmembrane transport (GO:1902600),0.28413853015013646,0.6990188004104397,0.8463648834019204,1.0,1.0,3/36,5.57%,ATP5MF;UCP3;ATP6V1H
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.331832276897815,0.6975506713515564,0.7946902654867256,1.0,1.0,4/13,15.72%,PTGIS;NAXE;NNMT;NAMPT
prerank,peptide biosynthetic process (GO:0043043),0.23778156673459866,0.6974302277689755,0.9193899782135077,1.0,1.0,15/153,11.93%,DMD;RPL3L;CARNS1;MRPL36;MRPL13;HARS2;RPL8;MRPL43;TNIP1;MRPL51;RPL5;MRPL23;RPS23;GSPT1;MRPL9
prerank,exit from mitosis (GO:0010458),-0.27923018082701256,-0.6971143055030643,0.864367816091954,0.9724223898813578,1.0,3/12,8.54%,EPS8;SPAST;SIRT7
prerank,negative regulation of DNA binding (GO:0043392),0.2887117832999483,0.6969661607939874,0.8290468986384266,1.0,1.0,1/28,1.06%,HEY2
prerank,positive regulation of proteolysis (GO:0045862),0.25963171933069934,0.696768524124078,0.8767123287671232,1.0,1.0,9/55,13.18%,ANGPTL8;PACSIN3;ASPH;TNIP1;IST1;FBXW11;SNX9;PERP;BAG2
prerank,histone H4 acetylation (GO:0043967),0.26929267761468273,0.6966941402117213,0.8115942028985508,1.0,1.0,15/47,19.06%,MCRS1;JADE1;MSL3;KAT7;KANSL3;HAT1;RUVBL1;JADE3;MORF4L1;KANSL1;MSL1;ZZZ3;TADA3;ACTL6A;KAT8
prerank,positive regulation of catabolic process (GO:0009896),0.25530406956468527,0.6963628306007931,0.8754716981132076,1.0,1.0,5/65,7.03%,NKD1;OAZ2;ATG7;DAB2IP;NEDD4
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.30029425268780635,0.6960422488748418,0.8055555555555556,1.0,1.0,7/25,16.03%,ACVR2A;MED1;ANKRD54;HIF1A;ACVR1B;STAT1;STAT3
prerank,regulation of regulated secretory pathway (GO:1903305),0.28490906839566066,0.6959701626891877,0.8207681365576103,1.0,1.0,4/34,7.06%,UNC13D;RIMS3;SYT10;RAB3A
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.30056341284575205,-0.6959173822377474,0.8555798687089715,0.9729400298130948,1.0,2/10,12.02%,CRY1;THOC5
prerank,protein kinase B signaling (GO:0043491),0.2990203674965657,0.6959015416666968,0.8149300155520995,1.0,1.0,8/23,16.65%,CCL5;EPHA2;THEM4;SIRT2;ZFP36L1;GAS6;PTEN;MT3
prerank,"transcription, DNA-templated (GO:0006351)",0.23523468976351525,0.6958737212018674,0.9324181626187962,1.0,1.0,27/207,13.04%,SOX5;POLR2L;POLR2I;MLF1;PWP1;GTF2H4;GTF3C4;ELL;CBFB;MEF2A;POLR2G;TAF1;ELOC;TP53;PARP1;ERCC6;NFKBIB;CCNT1;NR4A2;CDK7;NAT14;TFB2M;BAZ2A;NFX1;NELFB;SMARCA5;POLR2J
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.2988202250321894,-0.6956498488446805,0.8459869848156182,0.971705766300078,1.0,4/10,29.63%,AP2S1;AP2A2;CLTA;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.2988202250321894,-0.6956498488446805,0.8459869848156182,0.971705766300078,1.0,4/10,29.63%,AP2S1;AP2A2;CLTA;AP2M1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.25327358907532704,0.6955718371235297,0.8521303258145363,1.0,1.0,10/71,12.63%,PMAIP1;CHMP4C;SOCS6;UBE2W;OTUD7A;LONP1;CAPN2;NR1D1;RSPRY1;DDI2
prerank,negative regulation of signaling (GO:0023057),0.29677386480625545,0.6950679449204128,0.8340943683409436,1.0,1.0,2/25,6.83%,SOCS5;PTPN1
prerank,response to acidic pH (GO:0010447),0.334912319912792,0.694945278739799,0.7797202797202797,1.0,1.0,2/13,8.82%,PKD1L3;IMPACT
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.23409643745507625,0.6944770045301474,0.9080962800875274,1.0,1.0,31/146,17.52%,DYNLL1;FHL1;CEP41;HAUS8;CEP290;PSMC6;TPX2;CCND1;PSME4;CEP192;PSMB1;PSMD5;DYNC1I2;NEDD1;PSMB2;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PSMB7;PSMD3;PRKACA;FBXO5;PLK4;PSMA2;PSMD14;DCTN1;BRD4
prerank,regulation of exocytosis (GO:0017157),0.2725396640223517,0.694410993765792,0.8404825737265416,1.0,1.0,9/46,16.60%,CLASP2;ANXA1;UNC13D;RAB3A;IL1RAPL1;NSF;CLASP1;RAB8B;RAB8A
prerank,cellular response to hydroxyurea (GO:0072711),-0.29450819343298223,-0.6941368820276711,0.8537117903930131,0.9725047972607028,1.0,6/10,41.31%,BLM;FMR1;ATRX;TIMELESS;NSMCE3;DDX11
prerank,rRNA methylation (GO:0031167),-0.23643662979403415,-0.6932856698953561,0.8815426997245179,0.972629865454061,1.0,11/22,35.66%,DIMT1;BUD23;NSUN3;METTL16;FTSJ3;EMG1;METTL15;FBL;MRM2;MRM3;TRMT112
prerank,toll-like receptor signaling pathway (GO:0002224),0.2521303823210276,0.6930752208526169,0.8838028169014085,1.0,1.0,8/84,8.19%,NR1H4;CD36;MYD88;CD14;PIK3AP1;MAPKAPK2;TRAF3;TNIP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.25274292323886705,-0.6929761682220625,0.8775510204081632,0.9721969873272395,1.0,1/16,0.84%,APPL2
prerank,cellular response to radiation (GO:0071478),0.2745986893816614,0.6926785070595124,0.8438761776581427,1.0,1.0,10/40,19.77%,NET1;RAD51AP1;TP53;RAD9A;RHNO1;CLOCK;INTS7;INO80;SWI5;RAD9B
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3178696628827205,0.6925452119929034,0.7802385008517888,1.0,1.0,3/15,7.80%,TIPIN;RAD9A;HUS1B
prerank,positive regulation of bone resorption (GO:0045780),-0.2882596356134849,-0.6922134578968737,0.8489702517162472,0.9721714228453852,1.0,3/11,11.30%,SPP1;ATP6AP1;PLEKHM1
prerank,translation (GO:0006412),0.2311449520003243,0.6921512256308904,0.9348739495798319,1.0,1.0,43/208,16.55%,RPL3L;EEFSEC;MRPL36;MRPL13;HARS2;LARS1;FTSJ1;APEH;GATB;RPL8;ABCE1;MRPL43;TNIP1;IARS2;MRPS28;MRPL51;RPL5;MRPL23;GFM2;RPS23;MRPL16;GSPT1;MRPL47;MRPL9;DRG2;AIMP1;TSFM;MRPL42;EEF2K;IARS1;N6AMT1;RPL15;SARS2;EPRS1;KARS1;LARS2;FASTKD2;RPL22;SARS1;FARS2;ETF1;RPL31;GTPBP2
prerank,receptor internalization (GO:0031623),0.267630577069683,0.6918894924514752,0.8480325644504749,1.0,1.0,6/44,7.16%,CD36;ITGB1;SAG;CAV1;NEDD4;RAMP1
prerank,mRNA metabolic process (GO:0016071),0.24551270456361288,0.6916609786833278,0.8855491329479769,1.0,1.0,20/90,15.97%,HNRNPR;PCF11;U2AF2;TP53;SFPQ;YTHDF2;PPARGC1A;CELF1;SRSF4;DIS3L2;PRPF18;U2AF1;SF3A3;SF3B2;PCBP3;DXO;SON;PRKACA;LSM10;SF3A1
prerank,RNA interference (GO:0016246),0.31881147868952564,0.6912684678021327,0.8,1.0,1.0,7/17,19.66%,TERT;CELF1;DICER1;DROSHA;DHX9;PRKRA;AGO1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2657543322093667,-0.6909489904200262,0.8451443569553806,0.9726701406358078,1.0,7/17,30.44%,UBQLN1;AKT1;P4HB;MAPK7;BAG5;HTRA2;PPIA
prerank,neutral amino acid transport (GO:0015804),0.29239004725527445,0.6908489541591794,0.8166666666666667,1.0,1.0,6/28,14.11%,SLC6A17;SLC38A2;SLC1A5;SLC7A8;SLC6A15;SLC38A1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.26152458070920254,-0.6904835515962185,0.8833746898263027,0.9723814253987482,1.0,2/16,9.41%,PTPN22;AHR
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.23121989791596642,-0.6898094788494736,0.9086021505376344,0.9723114036827898,1.0,10/23,31.96%,ASAH2;PTGS2;EPHX2;ELOVL6;FADS1;GSTM2;ACOT7;HPGD;ALOX12;GPX4
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.29061104259777676,0.6897388696514,0.8450502152080345,1.0,1.0,4/32,8.24%,SLC44A5;STARD7;SLC44A1;LPCAT3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.26980469508487015,-0.6890058189758603,0.8640552995391705,0.9723437437703799,1.0,1/14,3.27%,IL18
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.3352617166629466,0.6884694737671455,0.783303730017762,1.0,1.0,1/11,4.47%,MFHAS1
prerank,regulation of cellular metabolic process (GO:0031323),0.2657557529150068,0.687839222532518,0.8433242506811989,1.0,1.0,9/45,16.45%,ANGPTL8;PDK4;ACACB;PPARA;ABCG1;MKLN1;PDK2;FLOT1;VPS35
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.2856588415002752,-0.6878343186876803,0.8382022471910112,0.9727775036050911,1.0,3/11,17.41%,CCT8;CCT4;WRAP53
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3197846471116623,0.6871043113999189,0.7931623931623931,1.0,1.0,3/15,11.29%,SIRT3;SAMD8;PRKCD
prerank,negative regulation of hydrolase activity (GO:0051346),-0.19441023038887983,-0.6864297959046247,0.9702127659574468,0.9733009498557056,1.0,10/49,18.41%,CPEB2;WNK1;GMIP;GPSM1;RDX;RCC2;SH3RF2;ZCCHC9;LRCH1;ARL2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.33866847891703195,0.686425581414656,0.8028673835125448,1.0,1.0,4/11,20.83%,DCTD;NT5C3A;DCK;CTPS2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3059100654460317,0.6862667536701985,0.8240887480190174,1.0,1.0,4/20,14.20%,BCL2;BCL2L2;BOK;MCL1
prerank,phospholipid homeostasis (GO:0055091),-0.29197802314755444,-0.6862565910158629,0.8612975391498882,0.9727067999003318,1.0,2/11,12.23%,ABCA1;RCN3
prerank,response to amino acid (GO:0043200),0.2771830815766515,0.6861341045990738,0.8217522658610272,1.0,1.0,6/31,12.52%,LARS1;CPEB1;CAPN2;RRAGB;SH3BP4;CPEB3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2629349279153873,0.6856845928867512,0.8483221476510067,1.0,1.0,12/47,14.05%,DAB2IP;ARL6IP5;RASGRP1;TGFB2;MAP2K1;GSTP1;RAP2A;EIF2AK2;PDCD10;TAOK3;EPHB1;MAPK1
prerank,response to tumor necrosis factor (GO:0034612),0.24488371698101727,0.6856165723769576,0.8967517401392111,1.0,1.0,16/91,14.36%,CCL5;ARHGEF2;HAS2;MAP4K3;TNFRSF11A;DAB2IP;RELA;NR1D1;CCL14;GPER1;TNFRSF21;ZFAND6;YTHDC2;GBP2;ZFP36L1;HYAL1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.29483345562310537,0.6853737331215858,0.8366111951588502,1.0,1.0,6/23,17.51%,ITGB1;INSC;NSFL1C;FBXW11;DCTN1;UBXN2B
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3026339991361078,0.6853269684057162,0.8154574132492114,1.0,1.0,2/21,5.41%,CCL5;RARRES2
prerank,nucleotide-excision repair (GO:0006289),0.24438354856148437,0.6850737798039589,0.9030023094688222,1.0,1.0,14/101,11.46%,POLR2L;POLR2I;BRIP1;GTF2H4;POLR2G;TP53;PARP1;ERCC6;HUS1B;SLX4;PPIE;CDK7;POLD1;COPS8
prerank,positive regulation of hormone secretion (GO:0046887),0.31375043351820925,0.6848717660340384,0.8160919540229885,1.0,1.0,1/17,2.32%,PLA2G3
prerank,chromosome organization (GO:0051276),0.2398933111760862,0.6845940448728922,0.897887323943662,1.0,1.0,23/99,21.52%,PADI3;PADI2;GEM;HMGN3;PARP1;TOP2B;COPS8;ZBTB7A;HMG20A;COPS4;CDAN1;CENPW;MSH2;HDAC1;COPS6;HMGN1;ABL1;RPS27A;NUP133;TCF7L1;H3-3A;CENPV;EZH2
prerank,myeloid cell differentiation (GO:0030099),-0.19415247263957747,-0.6845475225518443,0.9661016949152542,0.9735696029318438,1.0,12/47,26.06%,KMT2E;KIT;RPS19;TET2;LYN;HSPA9;SLC25A38;TIRAP;PTPN2;TAL1;UBA5;ZFPM1
prerank,mitotic metaphase plate congression (GO:0007080),0.2621970008781721,0.6840770412506207,0.8577023498694517,1.0,1.0,8/51,14.12%,CHMP4C;NUP62;CHMP5;PIBF1;CENPE;CHMP2B;CHMP2A;KIF18A
prerank,regulation of immune response (GO:0050776),0.23548880949805595,0.6838010850824524,0.9141914191419142,1.0,1.0,12/135,8.35%,FCGR3B;FCGR3A;ITGB1;LAG3;CD276;ELMOD2;CD200R1;CD200;TRAF3;TGFB2;ITGA4;CD300A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.27447459700338056,0.6831059793287453,0.8541374474053296,1.0,1.0,2/37,7.17%,ENTPD1;ENTPD7
prerank,response to amyloid-beta (GO:1904645),0.2637775357933685,0.6828013402519951,0.8755074424898511,1.0,1.0,2/44,1.73%,CACNA2D1;CD36
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2782303912723357,0.6825506799020472,0.8547486033519553,1.0,1.0,14/41,20.77%,NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,cellular iron ion homeostasis (GO:0006879),0.2599587364170963,0.6824144506627429,0.8629242819843342,1.0,1.0,4/55,6.33%,HJV;HMOX2;FXN;ATP6V0A2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.26630815535052454,-0.6823210536256509,0.8630490956072352,0.9749097519402781,1.0,7/14,26.25%,SRSF7;SRSF6;SFSWAP;RBMX;PCBP4;RNPS1;SRSF12
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.27422575107248026,-0.6820846567166502,0.8716814159292036,0.9743823905294204,1.0,3/12,12.80%,GART;HPRT1;PRPSAP2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2306419406746965,0.6820806063123106,0.9204301075268817,1.0,1.0,16/158,11.69%,FLNA;MYD88;ROR1;NUP62;MTDH;PPM1A;GOLT1B;TIFA;RELA;TRIM68;EDAR;TRAF5;PELI2;DDX1;ZDHHC17;HTR2B
prerank,negative regulation of mRNA processing (GO:0050686),-0.26119214695248927,-0.6817574818998525,0.8808290155440415,0.9739359407168577,1.0,7/15,26.25%,SRSF7;SRSF6;SFSWAP;RBMX;PCBP4;RNPS1;SRSF12
prerank,regulation of cholesterol transport (GO:0032374),0.3070406964366944,0.6808445383848087,0.8260188087774295,1.0,1.0,3/20,10.78%,ABCB4;YJEFN3;NAXE
prerank,lysine catabolic process (GO:0006554),0.3272214461019778,0.6805479405069835,0.7862190812720848,1.0,1.0,2/12,7.09%,DLD;DLST
prerank,lysine metabolic process (GO:0006553),0.3272214461019778,0.6805479405069835,0.7862190812720848,1.0,1.0,2/12,7.09%,DLD;DLST
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.24465972753650833,-0.6799388729192757,0.900804289544236,0.9749282790032926,1.0,3/20,8.05%,AGO3;PUM1;TSNAX
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.29828938621298395,0.6799171921727183,0.847457627118644,1.0,1.0,9/24,22.50%,KCNB1;MIEF2;MIEF1;MTCL1;SLC51B;MFF;MYO1C;ERBB2;PDZK1
prerank,keratan sulfate catabolic process (GO:0042340),-0.2776299886162369,-0.6793901192389473,0.8303571428571429,0.9746878944988221,1.0,4/11,19.21%,HEXA;FMOD;GALNS;OMD
prerank,cellular glucose homeostasis (GO:0001678),0.2646777536714422,0.6790189739668082,0.853625170998632,1.0,1.0,10/41,14.88%,HK2;KCNB1;PPARGC1A;NR1D1;HIF1A;SLC39A14;GPER1;GAS6;PRKAA2;PRKACA
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2614716369931461,0.6780793483340561,0.8584656084656085,1.0,1.0,9/51,11.71%,NAT10;PARN;PRKCQ;PKIB;NAF1;HNRNPU;CCT3;TERF2;HNRNPC
prerank,protein modification by small protein conjugation (GO:0032446),0.2192752811856262,0.6777410847442089,0.9688128772635815,1.0,1.0,80/361,19.62%,TRIM54;UBA2;RNF152;TRIM55;TRIM63;DCUN1D2;NUP62;PDZRN3;LMO7;TNFAIP1;ASB2;ASB1;PIAS4;CUL2;RNF7;CNOT4;PEX2;ATG7;CBLL1;PCNP;SAE1;ELOC;FBXW7;UBE2W;NEDD4;UBE2F;CUL9;DCUN1D1;TRIM68;TRPM4;UBE2E1;NUP153;UHRF2;HIF1A;AMFR;TRIM7;NUP107;UBE2D1;AAAS;FBXO32;PIAS2;TRIM35;NFX1;FBXW11;UBA3;MUL1;TRIM28;NUP98;NUP37;TSPAN17;UFL1;UBA1;UBE2K;NUP210;GAN;UBR3;SMURF1;CCNF;RLIM;ANAPC16;PEX10;UBE2A;MIB2;CUL5;ISG15;RCHY1;PIAS1;BCL11A;RNF103;UBR1;ANAPC11;NUP54;RPS27A;SUMO1;TRIM23;UBE2I;NUP160;ATG10;MIB1;NUP133
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.2598569897177504,-0.6777032506826784,0.8850574712643678,0.9755623039498111,1.0,6/14,31.89%,RPL7L1;URB1;RPF2;FTSJ3;PES1;RPL35
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2201923223172823,0.6775707606501531,0.9643947100712106,1.0,1.0,53/336,15.31%,CRIP1;RBM24;DYRK2;CGAS;HINFP;BTG2;MUTYH;GTF2H4;BCL2;UBR5;RAD51AP1;UPF1;TAF1;MAPKAPK2;TP53;PARP1;ZBTB38;MBD4;TDP1;CHEK1;BCL2L2;REXO4;YAP1;RAD9A;CCND1;SLX4;BRSK1;EPHA2;PSME4;STK33;RIF1;FBXO6;POLD1;BOK;AKTIP;NSMCE4A;MACROD1;RMI2;TAOK3;FNIP2;HPF1;BCL6;TRIM28;CSNK1E;SIRT4;ZRANB3;MCL1;ZBTB4;UFL1;UBA1;KMT5B;MAPK12;CHRNA4
prerank,neuron cell-cell adhesion (GO:0007158),0.3095954974023517,0.6771039921981766,0.8083623693379791,1.0,1.0,2/14,8.14%,ASTN2;ASTN1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.29970474655679813,0.6769360996777554,0.8054226475279107,1.0,1.0,3/21,4.84%,NUDT7;NUDT4;NT5C2
prerank,prostanoid biosynthetic process (GO:0046457),0.3207627826504241,0.6763551511224489,0.8127090301003345,1.0,1.0,2/15,4.83%,PTGIS;TBXAS1
prerank,neuron projection fasciculation (GO:0106030),0.33950413277248775,0.6761207782466179,0.8333333333333334,1.0,1.0,2/10,11.61%,SEMA5A;ARHGAP35
prerank,lipid droplet formation (GO:0140042),-0.2914807034968959,-0.6761160952148475,0.8797327394209354,0.976277452497925,1.0,6/10,33.11%,ZFYVE1;CDS1;SQLE;BSCL2;CDS2;FITM2
prerank,regulation of cytoplasmic transport (GO:1903649),0.33115574965849776,0.6755425979370215,0.8139931740614335,1.0,1.0,4/11,14.40%,DENND10;MAP2K1;MAPK1;LRRK2
prerank,positive regulation of telomere capping (GO:1904355),0.31040069005545273,0.6754889494850503,0.8195876288659794,1.0,1.0,3/17,14.05%,PRKCQ;PKIB;MAPK1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.2967691042522066,0.675397609037344,0.8354037267080745,1.0,1.0,3/22,10.73%,PMAIP1;HEXIM1;EIF5A
prerank,regulation of astrocyte differentiation (GO:0048710),0.32784482331482273,0.6750517794805654,0.8166089965397924,1.0,1.0,1/12,3.37%,SERPINE2
prerank,regulation of cell killing (GO:0031341),0.3044080939025562,0.6749956005046247,0.803030303030303,1.0,1.0,2/16,7.87%,CFH;TGFB2
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2372332258071349,-0.6747210156860803,0.9120879120879121,0.9767718355347641,1.0,4/18,18.39%,PRKDC;METTL3;XRCC6;NCKAP1L
prerank,DNA strand elongation (GO:0022616),-0.2517222387948209,-0.6747116484301673,0.9110512129380054,0.9760362109362438,1.0,11/18,38.13%,MRE11;RAD50;NBN;GINS3;DCLRE1B;RFC3;GINS4;POLD3;GINS1;RFC4;MCM3
prerank,extracellular transport (GO:0006858),-0.2628945064886743,-0.6744563207193414,0.8859857482185273,0.9755165710669144,1.0,9/13,49.58%,SPEF2;ARRDC1;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.248672791344751,0.6744374747941606,0.9016990291262136,1.0,1.0,10/72,14.15%,FGF1;POLR2L;POLR2I;POLR2G;FLRT1;GALNT3;POLR2J;FGF10;MAPK1;RAB14
prerank,negative regulation of T cell differentiation (GO:0045581),0.33445621171416584,0.674383953697284,0.7873873873873873,1.0,1.0,2/10,13.53%,LAG3;FOXJ1
prerank,T cell activation (GO:0042110),0.24568801975554863,0.6740629707571568,0.8771929824561403,1.0,1.0,10/69,13.45%,PPP3CA;IL2;LCP1;CD276;RASGRP1;DDOST;LMBR1L;RHOH;PPP3CB;NCK2
prerank,ether lipid biosynthetic process (GO:0008611),0.33416925307335904,0.6739780984972216,0.8085106382978723,1.0,1.0,4/10,20.01%,PEDS1;PLA2G4A;PLA2G4C;CHPT1
prerank,mRNA transport (GO:0051028),0.23726846306296395,0.6739757754344584,0.9205607476635514,1.0,1.0,23/101,16.21%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;KIF5C;DDX25;THOC7;SRRM1;ZFP36L1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,regulation of phosphorylation (GO:0042325),0.2371659595188409,0.6735559427650407,0.9230769230769231,1.0,1.0,19/120,14.16%,DYNLL1;ROCK1;CCL5;NUP62;DSCAM;PIN1;CORO1C;AR;SEC13;NUP153;HIF1A;SIRT2;NUP107;AAAS;ZBTB7A;FNIP2;PLXNB2;NUP98;NUP37
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.31847060026012014,0.6734326048178706,0.830155979202773,1.0,1.0,3/14,10.21%,HSD17B4;CRAT;SCP2
prerank,transcription preinitiation complex assembly (GO:0070897),0.32674846873817115,0.6732407249740725,0.8073217726396917,1.0,1.0,3/12,15.90%,TAF1;POLR1E;TAF11
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2951429764418395,0.6729546140809056,0.8125,1.0,1.0,5/20,16.35%,PLCB1;AGRN;CHRNA7;GNAQ;RGS10
prerank,protein import into peroxisome matrix (GO:0016558),0.32437061365133274,0.6725448499258331,0.8156934306569343,1.0,1.0,5/12,20.11%,PEX2;PEX5L;PEX10;PEX26;PEX1
prerank,tryptophan metabolic process (GO:0006568),0.3282099927164229,0.6724305008977797,0.8282442748091603,1.0,1.0,1/11,6.79%,KMO
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.28814542789731246,-0.6717390487829837,0.8681318681318682,0.9771349158424293,1.0,3/10,17.57%,CORO2B;PPM1F;SNX3
prerank,regulation of lamellipodium assembly (GO:0010591),0.273912006240738,0.6712002949320076,0.8669467787114846,1.0,1.0,6/34,13.34%,PLCE1;ACTR3;CYFIP1;EPHA2;DMTN;CAPZB
prerank,regulation of urine volume (GO:0035809),0.3374982869670955,0.6707238527385107,0.8142076502732241,1.0,1.0,2/10,9.47%,HAS2;ADCY6
prerank,insulin receptor signaling pathway (GO:0008286),0.24492678043888627,0.670547447826734,0.8959899749373433,1.0,1.0,14/69,15.72%,PDK4;BCAR3;RARRES2;ATP6V1H;IRS1;SORBS1;ATP6V0A2;ATP6V1C1;SLC39A14;ATP6V0D2;PDK2;IRS2;CAV2;NAMPT
prerank,regulation of RNA splicing (GO:0043484),0.247930555131029,0.6703283553440483,0.897908979089791,1.0,1.0,15/69,15.55%,KHDRBS3;RBM38;SLC38A2;DYRK1A;U2AF2;CELF1;MBNL2;FUS;PTBP2;MBNL1;SRSF10;SON;CWC22;SRPK2;SF1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.284513970614923,0.6697211505319257,0.8386627906976745,1.0,1.0,6/27,16.20%,DCTD;AK7;NUDT13;AK2;CMPK1;GLRX
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2512435237149133,0.6685757698949564,0.8946716232961586,1.0,1.0,12/60,13.54%,HEY2;CBFB;TP53;MED1;MED12;SOX9;RELA;CCND1;PAXIP1;MED14;MED8;TRIM28
prerank,negative regulation of B cell proliferation (GO:0030889),0.3312029708541455,0.6677383975573958,0.833648393194707,1.0,1.0,2/11,10.87%,CD300A;TNFRSF21
prerank,regulation of viral release from host cell (GO:1902186),-0.23166694229465296,-0.6676752504655692,0.8929577464788733,0.979950444990532,1.0,7/21,25.85%,PML;TRIM25;DDB1;TRIM5;MID2;TRIM21;TRIM32
prerank,protein autophosphorylation (GO:0046777),0.2264497414069582,0.6674287652087775,0.9342105263157895,1.0,1.0,25/157,14.40%,MYLK2;CAMK2D;MUSK;CAMKK2;PEAK1;DYRK1A;TAF1;MAPKAPK2;STK26;MAP3K10;WNK2;DAPK3;PAK2;STK33;STK24;PDGFRB;EIF2AK2;ACVR1B;CDK12;TNIK;TAOK3;EEF2K;STK10;EPHB1;LRRK2
prerank,nuclear pore organization (GO:0006999),0.3190684551123095,0.6668246058457076,0.810671256454389,1.0,1.0,6/14,20.77%,NUP153;NUP107;NUP98;NUP54;NUP133;TPR
prerank,tRNA modification (GO:0006400),0.247794359854333,0.6665034060996722,0.8890258939580764,1.0,1.0,5/62,5.50%,WDR4;TRDMT1;CDKAL1;TYW5;FTSJ1
prerank,regulation of mRNA processing (GO:0050684),0.2722000148867346,0.6661306750675855,0.8527245949926362,1.0,1.0,10/32,16.81%,KHDRBS3;PAPOLA;AHCYL1;SRSF10;ZFP36L1;SON;CWC22;SRPK2;SF1;DHX9
prerank,negative regulation of protein processing (GO:0010955),0.3192203783614835,0.6659654445091507,0.8330241187384044,1.0,1.0,1/12,3.37%,SERPINE2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.24352519916376753,-0.6659306793794095,0.9053708439897699,0.9806465081427622,1.0,6/18,21.97%,ELOVL7;ACSL3;ACSL4;ELOVL6;HACD2;ELOVL1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2432807952823939,0.6652550447091572,0.894478527607362,1.0,1.0,6/69,7.38%,FZD5;LPL;HAVCR2;CD14;ARHGEF2;RASGRP1
prerank,regulation of adaptive immune response (GO:0002819),-0.24022437355841586,-0.6649056811077535,0.9106280193236715,0.9807479607978296,1.0,11/18,48.83%,ADCY7;AHR;SKAP1;PYCARD;IRF1;FCGR2B;IRF7;FADD;IL4I1;SASH3;IL6ST
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3352717406579399,0.6643172011472782,0.8403041825095057,1.0,1.0,3/10,18.07%,SIRT3;PRKCD;SMPD2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3352717406579399,0.6643172011472782,0.8403041825095057,1.0,1.0,3/10,18.07%,SIRT3;PRKCD;SMPD2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.22446846577423268,0.6636967324498823,0.95,1.0,1.0,28/148,17.55%,PRKAB2;DYRK2;PIP4K2A;BRIP1;PRDM1;USP2;TAF1;TP53;HEXIM1;PIN1;TPX2;CHEK1;RAD9A;NUAK1;RPL5;PRR5;RHNO1;RICTOR;RMI2;CHD4;SGK1;PRKAA2;PPP2R5C;TAF11;HIPK2;BOP1;BRD7;HDAC1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3187536317662645,0.6629911146446172,0.8290155440414507,1.0,1.0,3/12,11.09%,LPCAT3;MBTPS1;SREBF2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.33008032490376793,0.662622321241343,0.8247232472324724,1.0,1.0,2/10,7.53%,SMARCB1;CHEK1
prerank,peroxisome organization (GO:0007031),0.27777027324833636,0.66240576499624,0.8624813153961136,1.0,1.0,9/25,20.35%,PEX2;ABCD4;DNM1L;PEX19;LONP2;PEX10;MFF;PEX1;PEX3
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.25351268413360395,-0.6621703205315433,0.9197994987468672,0.9822852019853814,1.0,5/14,24.61%,MYO9A;OPHN1;CDC42;FSCN1;SCRIB
prerank,regulation of T cell proliferation (GO:0042129),0.24484109239830137,0.6614443439405998,0.9080459770114943,1.0,1.0,3/61,4.17%,ANXA1;CCL5;CD276
prerank,cellular response to interferon-gamma (GO:0071346),0.2390854482336366,0.6612094605613273,0.9133489461358314,1.0,1.0,18/88,18.78%,CAMK2G;CAMK2D;CCL5;IL12RB1;DAPK3;TRIM68;CCL14;PRKCD;GBP2;OASL;SYNCRIP;EPRS1;STAT1;JAK2;IRF3;CCL25;CD47;CCL19
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.248052360117468,0.6605276874083621,0.9031007751937985,1.0,1.0,5/57,9.98%,MEF2C;SHISA9;CNIH2;GSG1L;ACTN2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.2726730190103417,0.6605163145750338,0.8439306358381503,1.0,1.0,2/29,3.64%,ANO6;CCL5
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.2685634809486208,-0.6604660401112334,0.8875878220140515,0.9830019822912958,1.0,1/12,3.27%,IL18
prerank,positive regulation of histone deacetylation (GO:0031065),-0.2689416975875736,-0.6603589464996861,0.9016018306636155,0.982347136061255,1.0,6/12,32.40%,AKAP8;AKAP8L;PRKD2;ZBTB7B;SAP30BP;APLNR
prerank,inner dynein arm assembly (GO:0036159),-0.2782766393583196,-0.6597041758889186,0.8853932584269663,0.9821666891336468,1.0,2/11,13.44%,DNAAF5;CCDC39
prerank,RNA polyadenylation (GO:0043631),0.2811657109137382,0.659213649737845,0.8558421851289834,1.0,1.0,4/26,9.42%,WDR33;PCF11;PAPOLA;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),0.2811657109137382,0.659213649737845,0.8558421851289834,1.0,1.0,4/26,9.42%,WDR33;PCF11;PAPOLA;AHCYL1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.23753980475039072,0.6586661829318972,0.9139908256880734,1.0,1.0,11/80,12.25%,CDC42EP3;PLCE1;TGFB3;ACTR3;TAPT1;CYFIP1;WASHC1;ANLN;AGRN;ARHGAP35;CEP120
prerank,regulation of cell death (GO:0010941),0.23543175337417493,0.6581622790035017,0.9134502923976608,1.0,1.0,20/94,17.67%,CD36;CCN1;FERMT2;CCL5;CELF1;ADNP2;IMPACT;HTR2B;CHRNA7;CLU;SARM1;CHMP2A;EPHB1;LRRK2;SNCG;DHCR24;VPS35;MT3;FAF1;SNCB
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.274499330963795,0.6574858613399455,0.8689248895434463,1.0,1.0,7/26,14.87%,EIF4EBP1;USP2;DUSP3;PKN2;PPP1R10;EIF4E;PRKCA
prerank,negative regulation of interferon-beta production (GO:0032688),-0.28210491546946326,-0.6572858270658745,0.8869936034115139,0.9834287921556975,1.0,3/10,15.75%,PPM1B;SIRPA;RELB
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.26507483695141626,0.6572125618991727,0.8587896253602305,1.0,1.0,11/38,18.19%,CENPP;CENPO;HAT1;RUVBL1;ITGB3BP;SMARCA5;CABIN1;IPO4;CENPW;CENPK;RSF1
prerank,histone modification (GO:0016570),0.23028630805542535,0.6571758623915646,0.9179954441913439,1.0,1.0,28/109,19.74%,PADI3;CCNA2;PADI2;HDAC9;CPA4;MSL3;PRMT7;NSD3;MTA3;SIRT2;MIDEAS;PRKCD;BAZ2A;RUVBL1;MORF4L1;MTA1;UFL1;SIN3A;MT3;USP36;HDAC1;UBE2A;ATXN7L3;RBM14;HDAC6;KAT8;KDM4A;PRMT1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2099788250406021,-0.6570016657598347,0.9357142857142857,0.9829536994150242,1.0,6/28,19.26%,OCLN;SLAIN2;NAV3;GIT1;ARL2;MECP2
prerank,RNA export from nucleus (GO:0006405),0.23120259899671608,0.6567198309950942,0.9273356401384083,1.0,1.0,22/100,16.21%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;XPO5;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.22799310582120882,0.6566957500466527,0.9350797266514806,1.0,1.0,14/108,13.74%,DLC1;MAP3K5;PMAIP1;HIP1;MAPT;ARL6IP5;RPS27L;ATP2A3;GPER1;CASP8AP2;BOK;DIABLO;MUL1;TNFRSF10B
prerank,sulfur compound biosynthetic process (GO:0044272),0.23189037015511604,0.6564367240682907,0.9276546091015169,1.0,1.0,17/104,13.28%,ANGPT1;CSPG4;CHSY3;CSGALNACT1;BGN;CHST5;OGN;GSTT1;GSTP1;CHST3;OPLAH;GGCT;ESD;CHST1;GSTA4;ST3GAL2;MAT2A
prerank,negative regulation of glycolytic process (GO:0045820),0.32917820032998013,0.656416183860233,0.8357664233576643,1.0,1.0,2/10,8.61%,PFKFB1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.32917820032998013,0.656416183860233,0.8357664233576643,1.0,1.0,2/10,8.61%,PFKFB1;PPARA
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2608093463435641,0.656321634158991,0.8857142857142857,1.0,1.0,2/42,3.64%,THPO;CCL5
prerank,response to estradiol (GO:0032355),0.2736632299690691,0.6545937746059504,0.8690807799442897,1.0,1.0,2/31,3.69%,ANXA1;STRN3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.28386684432284365,0.6540429536828489,0.8631578947368421,1.0,1.0,3/27,7.72%,PMAIP1;DYRK1A;SNAI2
prerank,regulation of cell projection organization (GO:0031344),-0.26422755497873557,-0.6534164682615454,0.9254079254079254,0.9850416776275234,1.0,6/13,28.18%,SEMA4D;MYO9A;SPRY2;MFSD2A;MOV10;NTNG1
prerank,protein localization to vacuole (GO:0072665),0.3104288181833517,0.65317570213506,0.8273381294964028,1.0,1.0,2/13,10.84%,KPTN;SH3BP4
prerank,JNK cascade (GO:0007254),0.2572675378205822,0.6529866070717477,0.9058171745152355,1.0,1.0,3/40,8.12%,MAP3K5;MAP4K3;MAP3K10
prerank,lipid catabolic process (GO:0016042),0.28966866721681817,0.65279454438627,0.8311258278145696,1.0,1.0,2/18,9.92%,LPL;SIRT2
prerank,cellular response to light stimulus (GO:0071482),0.24497698956121303,0.6527360864270719,0.9044665012406948,1.0,1.0,15/66,21.00%,SAG;TAF1;TP53;PARP1;NEDD4;RHNO1;POLD1;PRKCD;INO80;EIF2AK4;USP28;N4BP1;EIF2S1;YY1;GNB1
prerank,regulation of actin nucleation (GO:0051125),-0.27027822777671867,-0.6526363052080542,0.8725490196078431,0.9849724181063712,1.0,10/12,48.40%,ARFIP2;PICK1;ARPIN;GSN;ARFIP1;WASHC5;CORO1B;CORO1A;SCIN;ARF1
prerank,nuclear membrane reassembly (GO:0031468),0.2470914763254057,0.652484010166572,0.8988476312419974,1.0,1.0,17/54,19.62%,CHMP4C;SEC13;IST1;SIRT2;NSFL1C;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;UBXN2B;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,regulation of response to stress (GO:0080134),0.3278194511549777,0.6523900087657406,0.8468992248062015,1.0,1.0,1/10,5.19%,SLC38A2
prerank,granulocyte chemotaxis (GO:0071621),0.24423146778563742,0.6523368656184986,0.8933500627352572,1.0,1.0,9/55,18.78%,ANXA1;CCL5;TGFB2;CCL14;S100A8;S100A9;CCL25;SCG2;CCL19
prerank,coenzyme A metabolic process (GO:0015936),-0.2527522417760242,-0.6521112188529484,0.9022556390977443,0.9846701078592917,1.0,7/14,27.02%,PPCDC;PANK1;ACLY;CROT;DCAKD;ACOT7;PPCS
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.23371762052016243,-0.6520785711767801,0.8853658536585366,0.9824727264447299,1.0,5/20,18.11%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.23371762052016243,-0.6520785711767801,0.8853658536585366,0.9824727264447299,1.0,5/20,18.11%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.23371762052016243,-0.6520785711767801,0.8853658536585366,0.9824727264447299,1.0,5/20,18.11%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,regulation of lipid kinase activity (GO:0043550),-0.2691825765749417,-0.6520435523609692,0.8883374689826302,0.9817657388975415,1.0,2/11,7.75%,PIK3R3;WDR91
prerank,glycolipid metabolic process (GO:0006664),0.25025450987840403,0.6517180984876491,0.9073107049608355,1.0,1.0,9/47,14.96%,ESYT2;NEU3;GLA;SUMF1;GM2A;ST3GAL2;GLTP;GLB1;CTSA
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3250301760058741,0.6516305992744047,0.8439716312056738,1.0,1.0,3/10,14.05%,MAP2K1;GSTP1;MAPK1
prerank,positive regulation of cytokine production (GO:0001819),0.21407831976349911,0.6514193815740297,0.9787018255578094,1.0,1.0,29/292,11.19%,NR1H4;POLR2L;MYD88;FZD5;RORA;ANXA1;CGAS;IL2;LPL;IL12RB2;CD276;HAVCR2;CD14;ARHGEF2;PRKCQ;IL12RB1;CD200;PIBF1;RASGRP1;MBP;RELA;PLCB1;ADAM17;LRRFIP1;HIF1A;EIF2AK2;ROCK2;RUNX1;PDE4D
prerank,maturation of LSU-rRNA (GO:0000470),-0.21317235025979783,-0.6509354661187782,0.9323943661971831,0.981879418995664,1.0,8/26,23.46%,NSA2;RSL1D1;RPL7L1;URB1;MRPL1;RPF2;FTSJ3;RPL10A
prerank,positive regulation of synaptic transmission (GO:0050806),0.23542856195041967,0.6503426806840317,0.9207920792079208,1.0,1.0,5/72,5.88%,CRHR2;SLC8A2;GRIN2C;RIMS3;ZDHHC2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2665332076527623,0.6502272369657662,0.8656294200848657,1.0,1.0,4/31,7.97%,DCUN1D2;FBXW7;PIN1;DCUN1D1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.23485889250165592,0.6500249448816389,0.9118357487922706,1.0,1.0,6/73,7.38%,FZD5;LPL;HAVCR2;CD14;ARHGEF2;RASGRP1
prerank,regulation of mononuclear cell migration (GO:0071675),0.281164576139758,0.6498786296204694,0.8763197586726998,1.0,1.0,4/23,14.05%,CCL5;RARRES2;STK10;MAPK1
prerank,Golgi localization (GO:0051645),0.3207859473337919,0.6498189169167793,0.8446771378708552,1.0,1.0,2/11,12.64%,ARHGAP21;PDCD10
prerank,RNA methylation (GO:0001510),0.24012540750187392,0.6495348144100089,0.9180327868852459,1.0,1.0,11/60,15.34%,TRDMT1;FTSJ1;TRMT10C;CBLL1;TFB2M;ZCCHC4;TGS1;METTL6;NSUN2;TRMT44;RBM15
prerank,positive regulation of viral genome replication (GO:0045070),0.26828527471924923,0.6493403629616183,0.8739495798319328,1.0,1.0,6/29,11.81%,CCL5;PPARA;PPIE;PKN2;TOP2B;CNOT7
prerank,tryptophan catabolic process (GO:0006569),0.3156291188353527,0.6493061115203532,0.8400770712909441,1.0,1.0,1/11,6.79%,KMO
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.3120399909651718,0.6487397879380926,0.8214904679376083,1.0,1.0,4/11,20.68%,CAV1;ACTN2;KCNH2;CAB39
prerank,protein acylation (GO:0043543),0.2542322675050381,0.648538904378289,0.8913963328631875,1.0,1.0,11/38,18.77%,NAT10;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;CLOCK;ZDHHC13;ZDHHC5;ZDHHC8;ZDHHC3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2500383127757766,0.648477610345335,0.9087353324641461,1.0,1.0,13/50,19.26%,KLHL40;U2AF2;CAV1;TAF1;BAG2;ADGRB1;UFL1;FBXO5;USP4;ISG15;N4BP1;ABL1;SENP2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.31728705934785295,0.6482739922946976,0.8302238805970149,1.0,1.0,2/10,12.52%,CPEB1;CPEB3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.24069264179450878,-0.6481111469768961,0.9252577319587629,0.983353799876139,1.0,6/17,27.65%,PTPN22;PTPN2;CEACAM1;THY1;LAPTM5;PTPRJ
prerank,protein catabolic process (GO:0030163),0.2369047275963289,0.6475200000314831,0.9084065244667503,1.0,1.0,6/59,10.11%,PMAIP1;CLN5;SOCS6;DAB2IP;NR1D1;FBXO6
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.26215443675375155,0.6474609422293276,0.8933518005540166,1.0,1.0,14/41,20.77%,NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,Golgi to lysosome transport (GO:0090160),0.31041858710321346,0.6473066972570688,0.8467023172905526,1.0,1.0,2/11,9.54%,SORT1;ANKFY1
prerank,inner mitochondrial membrane organization (GO:0007007),0.24926808335457717,0.647219057990028,0.8905608755129959,1.0,1.0,8/47,11.59%,ATP5MF;AFG3L2;OPA1;MTX1;DNAJC11;TIMM29;ATP5MC1;ATP5MG
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.2060311726903376,-0.6465574512343516,0.9510703363914373,0.9837941789212477,1.0,8/31,26.29%,LYN;CEBPB;SDC4;ATM;CD80;CD274;CD86;SOX11
prerank,regulation of B cell apoptotic process (GO:0002902),0.31244776513164485,0.6465514617917173,0.8477064220183487,1.0,1.0,3/12,14.92%,IL2;BCL6;IRS2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.22863663022437036,0.6461556693306618,0.9414519906323185,1.0,1.0,21/96,16.21%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.29104086781228217,0.6459717773816447,0.8685524126455907,1.0,1.0,1/18,3.83%,LAX1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3080457620730711,0.6459144511680702,0.8608247422680413,1.0,1.0,1/13,2.85%,ASPH
prerank,regulation of cell cycle (GO:0051726),0.2152926256370148,0.6456480642313427,0.9712230215827338,1.0,1.0,49/271,17.53%,MAP3K20;CDK6;FBXL22;TRNP1;MLF1;NR4A1;GMNN;MYBBP1A;JUND;DAB2IP;RPS6KA2;TP53;CHEK1;FZD9;SOX9;TGFB2;DAPK3;LIN37;WHAMM;CCND1;MAP2K1;UHRF2;CDK7;CRLF3;SIRT2;HNRNPU;BRINP1;GPER1;RB1;MFN2;LIN9;CITED2;KIF20B;FGF10;SON;PRKACA;MLXIPL;DHCR24;FBXO5;SRPK2;MAPK12;STAT3;HIPK2;TTC28;WDR6;MIF;EIF4G2;BOP1;MASTL
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.2740374828718785,0.645058059469379,0.8783783783783784,1.0,1.0,8/24,19.62%,ALOX5;OPA1;LPCAT3;CLU;LRRK2;NR1H3;CREB3;WFS1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.246572298551603,-0.6443295873492955,0.9230769230769231,0.9846965377146356,1.0,3/15,14.80%,TCF7L2;CAMK1;EMD
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3010339682767822,0.644124573535269,0.8625827814569537,1.0,1.0,3/15,11.98%,NAF1;CCT3;RUVBL1
prerank,protein targeting to mitochondrion (GO:0006626),-0.17910903011435222,-0.6440842479978358,0.9883720930232558,0.9841287776247699,1.0,17/52,30.42%,HSPA4;FBXO7;TIMM44;DNAJC19;FIS1;SAMM50;TOMM34;AIFM1;TIMM17B;HSPD1;IMMP2L;TOMM70;TIMM21;TIMM23;TIMM10B;TIMM8B;GRPEL1
prerank,integrated stress response signaling (GO:0140467),0.301103907659649,0.6431638483079668,0.8547008547008547,1.0,1.0,6/14,22.56%,IMPACT;EIF2AK3;EIF2AK4;DDIT3;EIF2S1;QRICH1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.30997719685177455,0.6428892400054519,0.8397212543554007,1.0,1.0,3/13,14.40%,ENTPD7;OPA1;LRRK2
prerank,regulation of cellular pH (GO:0030641),0.27357674866898773,0.6428816936704428,0.9008746355685131,1.0,1.0,4/29,8.17%,SLC4A8;SLC4A3;SLC4A7;SLC9A8
prerank,smoothened signaling pathway (GO:0007224),0.25823199914516887,0.6428088879427379,0.8755304101838756,1.0,1.0,6/32,17.80%,DYRK2;MAP3K10;DISP2;STK36;HIPK2;IFT27
prerank,vesicle organization (GO:0016050),0.2480051144690395,0.64256236105399,0.9006711409395973,1.0,1.0,8/46,12.42%,HOOK2;SORT1;CAV1;HOOK1;CHMP2B;USP50;AKTIP;PLEKHJ1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.22036552403545726,-0.6422812722363047,0.9380053908355795,0.984715414431797,1.0,7/23,24.54%,COPS2;DDB1;UBC;XPA;COPS7B;UBB;RAD23B
prerank,iron ion homeostasis (GO:0055072),0.24320146697246842,0.6422763528203028,0.9176470588235294,1.0,1.0,4/58,6.33%,HJV;HMOX2;FXN;ATP6V0A2
prerank,androgen receptor signaling pathway (GO:0030521),0.3154786883952719,0.6422645169475824,0.833916083916084,1.0,1.0,2/11,7.14%,ARID1A;AR
prerank,DNA repair (GO:0006281),0.21137130773110258,0.64224702694306,0.9804526748971193,1.0,1.0,53/284,16.89%,HINFP;BRIP1;BTG2;MUTYH;RAD51AP2;GTF2H4;WDR33;RAD51AP1;UPF1;PIAS4;FAAP24;MLH3;TP53;PARP1;WRNIP1;MBD4;TDP1;CHEK1;REXO4;RAD9A;ERCC6;HUS1B;FTO;TENT4A;SLX4;USP1;FANCB;PSME4;FAAP100;FBXO6;RHNO1;DDX1;POLD1;KPNA2;FANCE;NSMCE4A;SMARCA5;RMI2;HPF1;TRIM28;CSNK1E;ZRANB3;MTA1;EXD2;KMT5B;CHRNA4;BABAM1;MAD2L2;RAD52;MGME1;RAD21;MSH2;INO80
prerank,regulation of tumor necrosis factor production (GO:0032680),0.22118795570066752,0.6409564479107307,0.9497206703910615,1.0,1.0,10/112,8.98%,NR1H4;FZD5;LPL;HAVCR2;CD14;ARHGEF2;MAPKAPK2;RASGRP1;DICER1;GSTP1
prerank,synaptic vesicle localization (GO:0097479),0.3106541992329667,0.6404952895840794,0.8658536585365854,1.0,1.0,6/13,21.96%,KIF5B;KIF5C;KIF5A;DNM2;SNAPIN;SYNJ1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.23666671805062253,0.6401953257694609,0.9132075471698113,1.0,1.0,14/64,18.68%,ALOX5;HSD17B4;ACSL5;FADS2;GSTP1;MGLL;SCP2;PNPLA3;CPT1A;PLA2G4A;PLA2G4C;EPHX1;ACSBG1;FAAH
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.2838516736798301,0.6401019833927166,0.8744038155802861,1.0,1.0,4/18,17.44%,KCNB1;IRS1;SIRT4;ADRA2A
prerank,response to leucine (GO:0043201),-0.274901316663945,-0.6395223741927144,0.8898876404494382,0.9852077935945305,1.0,5/10,29.68%,UBR2;KLHL22;RRAGD;SESN2;RPTOR
prerank,cellular response to leucine (GO:0071233),-0.274901316663945,-0.6395223741927144,0.8898876404494382,0.9852077935945305,1.0,5/10,29.68%,UBR2;KLHL22;RRAGD;SESN2;RPTOR
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3086716209282887,0.6394802792125075,0.846286701208981,1.0,1.0,3/12,14.31%,LPCAT3;DGAT1;MTTP
prerank,cellular response to superoxide (GO:0071451),-0.2755651130749408,-0.6390797665192561,0.8920704845814978,0.9847809361634068,1.0,6/10,42.22%,NOS3;ADPRS;PRDX1;PRDX2;ATP7A;SOD1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21637257792533973,0.6387949905298838,0.9496248660235799,1.0,1.0,27/163,16.91%,MEF2C;CD79A;LAX1;CD276;BCL2;FYB2;PRKCQ;PSMC6;LCP2;RELA;PAK2;PSME4;PAG1;PSMB1;PSMD5;TNFRSF21;PDE4D;FBXW11;PSMB2;PLEKHA1;PSMB7;PSMD3;PRAM1;RFTN1;PSMA2;VAV3;PSMD14
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.30169404242475895,0.6387605750372287,0.8274111675126904,1.0,1.0,3/13,8.05%,SLC2A10;RAMP1;PLCB1
prerank,protein acetylation (GO:0006473),0.25978166942615183,0.6386192196577506,0.8766519823788547,1.0,1.0,5/30,14.99%,NAT10;MAPT;HAT1;CLOCK;NAA35
prerank,"base-excision repair, AP site formation (GO:0006285)",0.2875271006388829,0.6382012577659173,0.8906497622820919,1.0,1.0,3/17,11.54%,MUTYH;MBD4;TERF2
prerank,negative regulation of histone acetylation (GO:0035067),0.3101295418337148,0.6378128470325789,0.838475499092559,1.0,1.0,1/11,4.30%,SET
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2457221652387968,0.6376048514673736,0.923784494086728,1.0,1.0,10/45,13.21%,BTG2;CHEK1;HECA;BTG1;TOM1L2;ZWINT;BRINP1;TRIM35;BCL6;ZFP36L1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.26268945557299955,0.636723144178594,0.8913362701908958,1.0,1.0,7/28,16.56%,PSMC6;DAB2IP;FBXW7;CLU;BAG2;PTEN;SMURF1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.25971975454924523,-0.6363532256763265,0.9011764705882352,0.9859750492220988,1.0,6/12,34.92%,PLK2;CHFR;ZWILCH;WEE1;NABP1;BUB1B
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.28230524006958324,0.6350797355431875,0.8525835866261399,1.0,1.0,7/22,17.91%,RELA;ROCK2;ABCG1;CHRNA7;CLU;SP1;LRRTM3
prerank,dendritic spine morphogenesis (GO:0060997),0.296347573336894,0.634936227354381,0.8688811188811189,1.0,1.0,3/15,15.35%,DOCK10;EPHB1;PTEN
prerank,nucleosome assembly (GO:0006334),0.25724111326786353,0.6345568920730862,0.8822674418604651,1.0,1.0,10/31,19.31%,CHAF1B;SOX9;HAT1;SMARCA5;CABIN1;IPO4;RSF1;NAP1L4;NAP1L2;BRD2
prerank,RNA transport (GO:0050658),0.22865838892939047,0.6339325597363951,0.9296116504854369,1.0,1.0,16/71,15.80%,NUP62;ATXN2;U2AF2;SRSF4;ZC3H11A;NUP153;RBM8A;U2AF1;KIF5C;THOC7;SRRM1;XPO5;ZFP36L1;EIF4E;FLOT1;RFTN1
prerank,peptidyl-proline modification (GO:0018208),0.2685678227560851,0.6334526622012014,0.8832565284178188,1.0,1.0,7/25,17.35%,P3H2;PIN1;PPIL1;PPIE;PPWD1;PPIL3;FKBP4
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.30890699292238694,0.6325757034648726,0.8598949211908932,1.0,1.0,1/11,4.25%,PARN
prerank,lipid biosynthetic process (GO:0008610),0.23024893507995325,0.6324026962660017,0.9386281588447654,1.0,1.0,10/77,12.03%,LPL;ALOX5;ACSL5;PDSS2;AGPAT3;MVD;PCYT2;SCP2;NDUFAB1;PDSS1
prerank,regulation of mRNA metabolic process (GO:1903311),-0.2650038363739402,-0.6317663783081883,0.9128440366972477,0.988324532350123,1.0,2/11,18.26%,SAFB2;SRPK1
prerank,autophagosome assembly (GO:0000045),0.24446874257005216,0.6313727154923716,0.9197930142302717,1.0,1.0,12/52,17.51%,ATP2A2;ATG16L2;ATG7;GABARAP;NSFL1C;STX12;MFN2;WDR45;PIK3C3;ATG13;SMURF1;UBXN2B
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.3112984222598944,0.6312933008393125,0.8678899082568807,1.0,1.0,2/10,10.08%,LIN7C;ARHGAP12
prerank,mismatch repair (GO:0006298),0.26311981264510803,0.631203433702635,0.8942028985507247,1.0,1.0,6/27,19.08%,MUTYH;MLH3;POLD1;MSH5;MSH2;ABL1
prerank,positive regulation of protein catabolic process (GO:0045732),0.2238462911576745,0.6303628130599657,0.9490521327014217,1.0,1.0,15/84,17.44%,NKD1;OAZ2;PACSIN3;ATG7;DAB2IP;NEDD4;AMER1;NSF;SNX9;VGLL4;VPS35;SMURF1;FAF1;TNFSF12;ADRA2A
prerank,establishment of epithelial cell polarity (GO:0090162),-0.22734113658611643,-0.6301218038055554,0.9423076923076923,0.9887109662717192,1.0,5/19,16.77%,GOLPH3;MYO9A;OPHN1;CYTH1;CDC42
prerank,sodium ion import across plasma membrane (GO:0098719),0.2889703426408293,0.6294845689506487,0.868020304568528,1.0,1.0,3/17,12.68%,SLC8A1;TRPM4;HCN2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.25481375417010255,-0.6289947224267193,0.9064748201438849,0.9886968029442086,1.0,1/12,4.18%,RBP4
prerank,protein localization to lysosome (GO:0061462),-0.20792747823755925,-0.6278655606849151,0.9583333333333334,0.9886861593426781,1.0,10/28,26.68%,SCARB2;GCC2;RTN4;AP3M1;HGS;LMBRD1;M6PR;GLMP;NCOA4;LAPTM5
prerank,sensory perception of smell (GO:0007608),0.30636708914093014,0.6278156431582775,0.8807339449541285,1.0,1.0,1/11,4.63%,SYT10
prerank,positive regulation of lipid localization (GO:1905954),0.309090705464407,0.6276686195566705,0.8641975308641975,1.0,1.0,1/11,3.34%,LPL
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3063399511453703,0.6272812479745261,0.8645640074211502,1.0,1.0,1/11,4.50%,BCL2
prerank,positive regulation of exocytosis (GO:0045921),0.25937402178179303,0.6272370988295438,0.9114658925979681,1.0,1.0,7/35,15.02%,CLASP2;UNC13D;RAB3A;TSG101;CLASP1;CHMP2A;STAM
prerank,base-excision repair (GO:0006284),0.2421045061565867,0.6269569984696018,0.913563829787234,1.0,1.0,7/48,11.83%,MUTYH;PARP1;MBD4;ERCC6;PARG;POLD1;POLG
prerank,neuron apoptotic process (GO:0051402),0.2801421581335244,0.6263626067762066,0.8751974723538705,1.0,1.0,4/19,12.40%,BCL2;TRPC5;TNFRSF21;DIABLO
prerank,regulation of DNA metabolic process (GO:0051052),0.2423115249882917,0.6262187827789054,0.9214380825565912,1.0,1.0,8/44,12.05%,UPF1;WRNIP1;USP1;KAT7;PDGFA;PARG;TERF2;KPNA2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.21648285824552632,0.6257510595531424,0.9565701559020044,1.0,1.0,20/132,12.81%,RPL3L;DENR;DDX23;TXNL4A;RPS27L;NLE1;CLNS1A;MDN1;CELF1;DICER1;NAF1;EIF2D;PRPF18;PWP2;PRMT7;RPL5;SRSF10;DDX1;TGS1;SF3B1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.31229961562739306,0.6252531546528252,0.8610603290676416,1.0,1.0,1/10,5.78%,MTHFD2L
prerank,regulation of cellular amine metabolic process (GO:0033238),0.23959847082809085,0.6249643079772598,0.9003880983182406,1.0,1.0,10/50,16.91%,OAZ2;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,glycine metabolic process (GO:0006544),0.3040694671869275,0.6245421681009588,0.8865979381443299,1.0,1.0,1/12,6.01%,DLD
prerank,calcium-ion regulated exocytosis (GO:0017156),0.2627537582826942,0.6242879065518567,0.8862275449101796,1.0,1.0,3/27,7.97%,RIMS3;SYT10;ARHGAP17
prerank,pre-replicative complex assembly (GO:0036388),-0.16761845642101317,-0.6241218938644959,0.9946808510638298,0.9903484158941062,1.0,24/64,32.63%,PSMD7;PSMD9;PSMD13;PSMB3;ORC6;UBC;ORC5;PSMC5;PSMA5;PSMA1;PSMC2;PSME3;UBB;PSMC4;PSMB6;ORC4;PSMB10;PSMA4;PSME1;ORC1;PSMF1;PSMB9;PSME2;PSMA8
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2280170148193525,-0.6236393545758154,0.93,0.9899383036720113,1.0,8/17,41.88%,IK;BUB3;ZWILCH;BOD1;KNL1;TTK;SPDL1;CENPA
prerank,regulation of chromosome segregation (GO:0051983),-0.23444034210344072,-0.6232017724414594,0.9333333333333333,0.9894816715811757,1.0,4/16,25.48%,PUM1;SMC5;CSNK2A1;CSNK2A2
prerank,maturation of SSU-rRNA (GO:0030490),0.24859247355048275,0.6225151837833494,0.9015256588072122,1.0,1.0,4/34,8.69%,NAT10;NOB1;WDR46;PWP2
prerank,cellular response to sterol (GO:0036315),0.29852655987134336,0.6224252681552231,0.8724137931034482,1.0,1.0,1/13,2.57%,RORA
prerank,regulation of keratinocyte proliferation (GO:0010837),0.26972042985810013,0.6219399211656333,0.8730407523510971,1.0,1.0,5/22,13.32%,AREG;MED1;SNAI2;ZFP36L1;FGF10
prerank,piRNA metabolic process (GO:0034587),-0.22466493963622997,-0.6214940403150248,0.9410112359550562,0.9898123356342116,1.0,17/19,64.22%,TEX15;TDRKH;EXD1;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,phosphate ion transmembrane transport (GO:0035435),0.2966332484880818,0.6212601397455361,0.8601398601398601,1.0,1.0,2/12,9.11%,SLC20A2;XPR1
prerank,cell proliferation in forebrain (GO:0021846),0.3090150289610555,0.6210704639485669,0.863013698630137,1.0,1.0,3/10,13.56%,AKNA;CEP120;NUMBL
prerank,phospholipid biosynthetic process (GO:0008654),0.24765687042157192,0.619940887378453,0.9298737727910238,1.0,1.0,8/36,13.24%,IDI1;DHDDS;AGPAT3;MVD;PCYT2;SAMD8;SRD5A3;CPNE3
prerank,phosphate ion transport (GO:0006817),0.28301974744406133,0.6195891072246357,0.8962108731466227,1.0,1.0,2/16,9.11%,SLC20A2;XPR1
prerank,lipoprotein biosynthetic process (GO:0042158),0.30532701009683466,0.6186188884879426,0.8692449355432781,1.0,1.0,3/11,13.35%,ATG7;WDR45;PIK3C3
prerank,nuclear migration (GO:0007097),0.2959589192549304,0.6185777983414267,0.863481228668942,1.0,1.0,4/13,12.25%,SYNE2;SUN2;FBXW11;CEP120
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.24218995562726278,-0.6183448258051968,0.9328703703703703,0.9909782209176515,1.0,10/14,38.14%,ZBTB8OS;TSEN34;CPSF4;CSTF2;CPSF1;CLP1;TRPT1;TSEN54;TSEN15;RTRAF
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.27364065385797665,0.6179135242110164,0.8761755485893417,1.0,1.0,1/19,2.09%,PDGFB
prerank,TOR signaling (GO:0031929),-0.20162843587349935,-0.6173745920469529,0.9561643835616438,0.9908231278924576,1.0,7/26,21.14%,SMG1;NPRL3;PRR5L;AKT1;RPS6KB2;MAPKAP1;SYAP1
prerank,retinol metabolic process (GO:0042572),-0.24014587244946184,-0.6173123872934181,0.9176755447941889,0.9901313800570596,1.0,2/14,8.42%,RBP4;CYP1B1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2498961851425078,0.6171824559104401,0.8867647058823529,1.0,1.0,7/33,13.72%,RIMKLA;ART4;GOT1;GOT2;GLS2;GLS;SIRT4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.19661011126385974,-0.6162263689768419,0.968944099378882,0.9900597443769713,1.0,6/28,20.23%,ARHGAP28;RASA1;PFN2;PFN1;DBN1;GBA2
prerank,lymphocyte migration (GO:0072676),0.2529235634704149,0.6162067791369835,0.9094707520891365,1.0,1.0,5/32,19.67%,CCL5;CCL14;CCL25;CCL19;RET
prerank,mRNA methylation (GO:0080009),0.287748936461134,0.6160201774580203,0.8828522920203735,1.0,1.0,3/15,13.20%,TRMT10C;CBLL1;NSUN2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.28606150775052447,0.6157666786230609,0.8672131147540983,1.0,1.0,1/15,2.95%,FAM83D
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.26292640591894856,-0.6151197393410921,0.9222462203023758,0.9899743124538144,1.0,5/10,36.80%,KDM1A;ATRX;JARID2;BRCA1;DNMT3B
prerank,mRNA export from nucleus (GO:0006406),0.21490954567821552,0.6147849151201421,0.9642445213379469,1.0,1.0,21/102,16.21%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.18843466524531854,-0.614734739502037,0.9721254355400697,0.9894878848814986,1.0,21/36,44.95%,WNT5A;PRKN;IRGM;PARP14;NLRC5;CASP4;AGPAT1;LAPTM5;AGPAT2;EDN1;TRIM6;HSPA1A;ZBP1;TXK;CASP1;IL7;CXCR4;CD300LF;PARP9;FADD;C1QTNF4
prerank,tricarboxylic acid metabolic process (GO:0072350),0.30157287736846927,0.6137969144420037,0.8803418803418803,1.0,1.0,4/12,15.82%,ACO2;IDH3A;SIRT4;IREB2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.2819567426701925,0.6136319571787117,0.8924914675767918,1.0,1.0,5/16,17.32%,CIRBP;RBMXL1;RBM3;NUP98;PRDX6
prerank,regulation of proteolysis (GO:0030162),0.2396866897631278,0.6128793902346801,0.9274406332453826,1.0,1.0,8/48,13.12%,ASPH;SERPINE2;CAV1;TRAF3;IST1;FBXW11;DNAJC1;PERP
prerank,serine family amino acid metabolic process (GO:0009069),0.2848684634492392,0.6127342080422822,0.8968386023294509,1.0,1.0,2/16,9.30%,SEPHS2;SEPSECS
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.31029877817118146,0.6126000432563762,0.8474870017331022,1.0,1.0,2/10,8.82%,CAV1;IMPACT
prerank,ribosomal large subunit biogenesis (GO:0042273),0.23111053323995273,0.6124256597884618,0.9369369369369369,1.0,1.0,6/54,9.57%,RPL3L;RRP15;RPF1;NLE1;MDN1;RPL5
prerank,response to ionizing radiation (GO:0010212),0.22338666949186062,0.6123808527523209,0.9433497536945813,1.0,1.0,18/70,19.77%,ANXA1;NET1;RAD51AP1;TP53;RAD9A;BRSK1;PAXIP1;RHNO1;CLOCK;MTA1;INTS7;BABAM1;MSH2;INO80;USP28;MEN1;SWI5;RAD9B
prerank,positive regulation of lipid storage (GO:0010884),0.2708234880243698,0.6111006432429531,0.8799368088467614,1.0,1.0,3/21,13.43%,LPL;SREBF2;OSBPL11
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.264016267229772,-0.6105498332453361,0.9273127753303965,0.9911173560349631,1.0,2/10,13.82%,IL33;KDR
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2560135594093774,0.6105075690034059,0.8989751098096632,1.0,1.0,3/27,7.82%,PARN;PCF11;DICER1
prerank,regulation of interferon-alpha production (GO:0032647),0.2616047894337068,0.610411598026134,0.904833836858006,1.0,1.0,9/23,25.11%,PTPRS;HAVCR2;STAT1;DHX9;IRF3;TLR7;TBK1;SETD2;IFIH1
prerank,RNA 3'-end processing (GO:0031123),0.22177213363761447,0.6102627273588038,0.947565543071161,1.0,1.0,11/69,12.23%,WDR33;PCF11;U2AF2;SRSF4;PAPOLA;TENT4A;ZC3H11A;RBM8A;U2AF1;THOC7;SRRM1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.25597309995438083,0.6100023331798528,0.8938053097345132,1.0,1.0,8/29,18.19%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,CENP-A containing chromatin organization (GO:0061641),0.25597309995438083,0.6100023331798528,0.8938053097345132,1.0,1.0,8/29,18.19%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.22390632127046384,0.6099229024612925,0.9632802937576499,1.0,1.0,20/73,22.85%,POLR2L;ACTB;MYBBP1A;ERCC6;PRMT7;POLR1E;POLR1H;SMARCA5;SF3B1;MTA1;TFAP2C;TAF1A;HDAC6;DNMT3A;MYO1C;H3-3A;EZH2;CTCF;RBBP7;KAT2B
prerank,transferrin transport (GO:0033572),0.24620384011385532,0.6095129056066529,0.9040902679830748,1.0,1.0,8/33,19.28%,ATP6V1H;ATP6V0A2;ARHGAP1;ATP6V1C1;ATP6V0D2;DNM2;ATP6V0C;CLTC
prerank,dopaminergic neuron differentiation (GO:0071542),0.2730391083168383,0.6083934128826137,0.8929133858267716,1.0,1.0,2/19,9.10%,VEGFA;NR4A2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.24994599508088913,0.6082302145782542,0.9138686131386862,1.0,1.0,7/33,13.96%,FXN;MAPT;FZD9;OPA1;CLU;MUL1;ADCK1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2242655228444918,0.6081924990735603,0.9572649572649573,1.0,1.0,9/72,11.46%,POLR2L;POLR2I;GTF2H4;POLR2G;ERCC6;PPIE;CDK7;POLD1;COPS8
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.2933148123252245,0.6078745126747821,0.8933823529411765,1.0,1.0,1/12,4.50%,BCL2
prerank,modulation by host of symbiont process (GO:0051851),-0.18891002139283097,-0.6076304148790459,0.9735099337748344,0.9920135896674922,1.0,6/31,15.28%,LEF1;NAPEPLD;SNW1;TARDBP;EP300;CHD1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.26741500440926474,0.6073469856599686,0.8929110105580694,1.0,1.0,1/21,3.22%,HK2
prerank,positive regulation of histone acetylation (GO:0035066),0.25808622103828216,0.6064856493230778,0.9095092024539877,1.0,1.0,4/23,9.42%,SMARCB1;PPARGC1A;KAT7;PAXIP1
prerank,chromatin remodeling (GO:0006338),0.21168790466874726,0.6058372418791612,0.9623717217787914,1.0,1.0,16/100,13.23%,SMARCD3;CHRAC1;ARID1A;ACTB;SUV39H2;SMARCB1;INO80C;ERCC6;SOX9;RB1;BAZ2A;ZBTB7A;HNRNPC;RUVBL1;SMARCA5;CHD4
prerank,regulation of oxidoreductase activity (GO:0051341),0.293733928794195,0.6056666238690471,0.8809946714031972,1.0,1.0,5/13,21.25%,SIRT4;MT3;HDAC6;ABL1;OXA1L
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2156786150852215,0.6054395315304448,0.9611428571428572,1.0,1.0,27/100,20.16%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;RNF180;GNA12;SIRT2;EIF3H;CLU;BAG2;CSNK1E;LRRK2;DVL1;UFL1;CSNK1A1;HSPBP1;XPO1;MAP1A;RCHY1;PIAS1;N4BP1;DESI1;UCHL5;SUMO1;FHIT;FOXF2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.2461089652986173,0.604892983825727,0.9251412429378532,1.0,1.0,5/33,13.68%,DUSP3;RELA;CD300A;NECTIN2;DGKZ
prerank,interstrand cross-link repair (GO:0036297),0.2305957854813658,0.6047796340132585,0.9373401534526854,1.0,1.0,8/53,12.18%,RAD51AP2;RAD51AP1;FAAP24;SLX4;USP1;FANCB;FAAP100;FANCE
prerank,regulation of cell division (GO:0051302),0.2163015323224607,0.6047429963762049,0.949569495694957,1.0,1.0,10/72,13.35%,FGF1;EFHC1;PIN1;CALM1;INSC;SIRT2;RAB11FIP3;RAB11FIP4;HTR2B;PIK3C3
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.26334967961244604,-0.6047367953653865,0.919908466819222,0.9928651896454119,1.0,4/10,35.63%,DNAJB2;DNAJA4;DNAJB1;HSPA1A
prerank,defense response to bacterium (GO:0042742),0.2094964651767318,0.6041632076978952,0.9720605355064028,1.0,1.0,18/105,17.92%,MYD88;DMBT1;RARRES2;LYST;MBL2;ADAM17;LPO;PRKCD;GBP2;DROSHA;CFP;ADGRB1;RNASE3;MR1;MPEG1;S100A8;S100A9;ISG15
prerank,endosome organization (GO:0007032),0.2381978539671559,0.602843199120504,0.9278779472954231,1.0,1.0,7/41,12.42%,HOOK2;CORO1C;HOOK1;CHMP2B;USP50;AKTIP;PLEKHJ1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2152130639941626,0.6028022917261666,0.9672514619883041,1.0,1.0,18/87,17.49%,CDK6;FHL1;JADE1;PSMC6;PSME4;PSMB1;PSMD5;RB1;PSMB2;ZFP36L1;PSMB7;PSMD3;FBXO5;PTEN;PSMA2;CDK2AP2;PSMD14;BRD7
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.24123305934956368,-0.6022415791790904,0.9498861047835991,0.9934913279117114,1.0,5/12,32.47%,UPP2;DHODH;UMPS;CDA;CAD
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.23058158028408576,-0.6022398664607201,0.9433962264150944,0.9927618922818202,1.0,2/15,8.95%,LDLR;SIK1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.23958079552390013,0.6012353758138107,0.9296551724137931,1.0,1.0,10/38,18.01%,PHLDA3;PPARA;EPHA2;THEM4;GPER1;MUL1;PLEKHA1;PTEN;PPP2R5C;DDIT3
prerank,determination of bilateral symmetry (GO:0009855),0.2568486556646298,0.6007816920510544,0.9074626865671642,1.0,1.0,5/25,17.67%,KIF3B;DNAH11;CITED2;FOXJ1;GALNT11
prerank,positive regulation of chromatin organization (GO:1905269),-0.24836092097082765,-0.6005144310444606,0.9402298850574713,0.9929515266937927,1.0,6/12,33.65%,TERF2IP;MIER1;TAL1;TINF2;ATRX;ACD
prerank,I-kappaB phosphorylation (GO:0007252),-0.25963833401089875,-0.6000978221926131,0.9264069264069265,0.9924680040605872,1.0,4/10,26.15%,CHUK;TLR3;PRDX4;ERC1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.19983163674246435,0.5992592076350374,0.986272439281943,1.0,1.0,57/185,23.07%,DYNLL1;CEP41;HAUS8;CEP290;ANAPC10;PSMC6;TPX2;UBE2E1;ANLN;PSME4;CEP192;SIRT2;CENPE;PSMB1;PSMD5;UBE2D1;DYNC1I2;NEDD1;PSMB2;CLASP1;CEP72;ZFP36L1;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PSMB7;PSMD3;PRKACA;FBXO5;PLK4;PSMA2;INO80;PSMD14;ANAPC16;DCTN1;ANAPC5;HAUS4;ANAPC11;CEP135;RPS27A;CKAP5;ACTR1A;SFI1;MAPRE1;ODF2;ZFP36L2;PPP2R1A;ZW10;NINL;TUBA4A;CEP63;YWHAG;PSMA7;CDC14A;NDE1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.23877230625558615,0.5989039160813228,0.918774966711052,1.0,1.0,4/37,9.58%,MYD88;ALOX5;PPARA;HIF1A
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.2534610249599474,-0.5988275697318179,0.9281045751633987,0.9923554769329047,1.0,1/10,2.79%,PRKCH
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.17398694586833013,-0.5985437144034507,0.9800796812749004,0.9917670100900637,1.0,22/46,40.54%,FBXO7;TIMM44;DNAJC19;FIS1;AKT1;TOMM34;AIFM1;TIMM17B;HSPD1;TOMM70;TIMM21;TIMM23;TIMM10B;TIMM8B;GRPEL1;DNLZ;TOMM40L;TOMM40;RALA;TIMM50;GRPEL2;TIMM10
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2227019405916522,0.5981062167188433,0.9525032092426188,1.0,1.0,10/56,13.93%,ROCK1;EFHC1;SPIRE1;ANLN;IST1;SNX18;ROCK2;SNX9;SON;DCTN3
prerank,synaptonemal complex organization (GO:0070193),0.2731382644731886,0.597962070308561,0.9020866773675762,1.0,1.0,15/15,72.71%,SYCP2;RAD21;SYCE3;SYCE1;SYCP1;HORMAD1;RAD21L1;STAG3;TEX12;SYCE2;TRIP13;REC8;BAG6;TEX11;P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.2731382644731886,0.597962070308561,0.9020866773675762,1.0,1.0,15/15,72.71%,SYCP2;RAD21;SYCE3;SYCE1;SYCP1;HORMAD1;RAD21L1;STAG3;TEX12;SYCE2;TRIP13;REC8;BAG6;TEX11;P3H4
prerank,chromatin assembly (GO:0031497),0.23572666986796836,0.5976784637815865,0.9258741258741259,1.0,1.0,10/38,19.31%,H1-0;CHAF1B;TP53;SOX9;SMARCA5;CDAN1;RSF1;NAP1L4;NAP1L2;BRD2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.2496912341667109,-0.5976174368156019,0.9336283185840708,0.9915112269098525,1.0,3/11,19.65%,NF2;HGS;BCL3
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.26515887664474824,-0.5968138236660193,0.9453781512605042,0.9912118940785423,1.0,5/10,32.43%,GNB5;FMR1;DRD2;CALM3;CBARP
prerank,negative regulation of cell death (GO:0060548),0.21565246201047528,0.5963225874219417,0.9730994152046784,1.0,1.0,9/88,8.82%,CCN1;FERMT2;NUP62;INPP5A;CD200R1;CD200;PPARGC1A;ADNP2;IMPACT
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2482608765521641,0.5960173868459585,0.9314868804664723,1.0,1.0,1/30,1.15%,KLHL40
prerank,microglial cell activation (GO:0001774),-0.208995466135235,-0.5955879159945802,0.9556213017751479,0.9910971708034914,1.0,4/21,16.88%,APP;CX3CL1;SNCA;GRN
prerank,regulation of isotype switching (GO:0045191),0.2781839345145063,0.5955251271665188,0.8777589134125636,1.0,1.0,4/14,16.17%,PAXIP1;RIF1;KMT5B;MAD2L2
prerank,positive regulation of transport (GO:0051050),0.2109209725876809,0.5953990423801266,0.9660818713450292,1.0,1.0,5/85,5.85%,MERTK;KCTD7;ANXA1;ACTB;CBLL1
prerank,glutamate metabolic process (GO:0006536),0.25884786263466086,0.5946547962150449,0.9144295302013423,1.0,1.0,4/19,11.00%,GOT1;GOT2;GLS2;GLS
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.22552613306185287,0.5942957472458578,0.9347826086956522,1.0,1.0,10/53,16.91%,OAZ2;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.23221640179822015,-0.5942467857674183,0.9481132075471698,0.990988634936448,1.0,9/14,36.77%,ENPP3;ENPP1;ITPA;AK4;SMPDL3A;AK1;NME2;AK5;AK3
prerank,DNA catabolic process (GO:0006308),0.29393356940857107,0.5942447611610105,0.8808193668528864,1.0,1.0,2/11,13.69%,REXO4;DNASE1L1
prerank,rRNA modification (GO:0000154),0.2574734617661492,0.5938443245689817,0.9273301737756714,1.0,1.0,3/21,11.54%,NAT10;TFB2M;ZCCHC4
prerank,negative regulation of B cell activation (GO:0050869),0.2617869225763627,0.5935400804965548,0.9138755980861244,1.0,1.0,4/21,13.53%,CD300A;SAMSN1;TNFRSF21;FOXJ1
prerank,receptor metabolic process (GO:0043112),0.22591533234348826,0.5929334084427248,0.9453836150845254,1.0,1.0,5/53,7.16%,CD36;ITGB1;CAV1;NEDD4;RAMP1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.17992262452513463,-0.5917738199969095,0.9921875,0.9914586083984822,1.0,14/38,30.45%,GEMIN8;SART3;SNRPD1;GEMIN7;SMN1;PRPF19;LSM2;AAR2;PRPF31;PRPF8;SRSF12;PRPF3;SART1;DDX20
prerank,protein alkylation (GO:0008213),0.25546070404071886,0.5916864108712415,0.9126506024096386,1.0,1.0,9/22,19.74%,METTL22;GSPT1;VCPKMT;EEF1AKMT2;ETF1;FAM98B;PCMT1;SNRPD3;PRMT1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.2163113961564103,-0.5915374015797716,0.9564032697547684,0.9908424542170324,1.0,1/17,1.61%,CADM1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2601694258394379,0.5900635720528459,0.9086687306501547,1.0,1.0,4/21,10.59%,MED1;MED12;PAXIP1;MED14
prerank,T cell differentiation (GO:0030217),0.23408181018236385,0.5900276932559951,0.9447674418604651,1.0,1.0,6/40,13.21%,ANXA1;IL2;ADAM17;LMBR1L;RHOH;ZFP36L1
prerank,regulation of protein transport (GO:0051223),0.2499392991453535,0.5896433615985842,0.9081481481481481,1.0,1.0,3/27,12.06%,LCP1;PTPN1;DNAJC1
prerank,nuclear pore complex assembly (GO:0051292),0.29858214598679805,0.5891669962834392,0.8789571694599627,1.0,1.0,3/10,14.03%,NUP153;NUP107;NUP98
prerank,intracellular protein transmembrane transport (GO:0065002),0.22788219493777973,0.588585034355586,0.9489932885906041,1.0,1.0,3/42,5.39%,ZFAND2B;RTN2;PEX2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.21984235764060903,-0.5884516745437427,0.9568733153638814,0.9915649922249643,1.0,1/16,1.61%,CADM1
prerank,cellular response to chemokine (GO:1990869),0.22917310837975258,0.5884043098960503,0.951885565669701,1.0,1.0,2/46,3.64%,DOCK8;CCL5
prerank,regulation of intracellular pH (GO:0051453),0.2431285748346726,0.5883794317777274,0.9445214979195562,1.0,1.0,4/34,8.17%,SLC4A8;SLC4A3;SLC4A7;SLC9A8
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24386895713121587,0.5881504794303701,0.9247787610619469,1.0,1.0,5/31,16.17%,IL2;PAXIP1;RIF1;KMT5B;MAD2L2
prerank,chromatin remodeling at centromere (GO:0031055),0.24345496507870085,0.5875770751009732,0.9105571847507331,1.0,1.0,8/31,18.19%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2319762165375123,0.5874334552943914,0.941908713692946,1.0,1.0,9/40,15.13%,MAPT;WRNIP1;USP1;PARG;PRKCD;NSMCE4A;MCL1;FEM1B;FBXO5
prerank,response to light stimulus (GO:0009416),0.22116947548909152,0.5872399773872478,0.9580602883355177,1.0,1.0,12/55,18.64%,MAP4K3;CIRBP;CPT1B;ERCC6;BRSK1;USP1;POLD1;ZRANB3;CLOCK;SPRTN;UBE2A;MEN1
prerank,autophagosome organization (GO:1905037),0.22913196838642616,0.587040361149467,0.951948051948052,1.0,1.0,8/50,13.35%,ATP2A2;ATG16L2;ATG7;GABARAP;NSFL1C;STX12;WDR45;PIK3C3
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2635189204195033,0.5867039753410945,0.9207119741100324,1.0,1.0,6/20,16.70%,BBS12;LONP1;CLU;HOPX;PTGES3L;NDUFAF1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.2387648836216493,0.5859286808199013,0.9388335704125178,1.0,1.0,5/34,11.25%,PDGFB;NUP62;PDGFRB;RB1;LRP5
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2888937249513823,0.585518842411845,0.8807339449541285,1.0,1.0,3/10,18.79%,ATP5MC1;ATP5MG;ATP5F1D
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.24705323981978403,-0.5852716912992035,0.9301801801801802,0.9922710437517483,1.0,4/10,24.68%,MTMR4;DNAJC19;MFSD2A;MTMR2
prerank,microtubule depolymerization (GO:0007019),0.2643947640479958,0.5848732924275228,0.9233278955954323,1.0,1.0,5/17,20.56%,KIF2A;KIF18A;STMN2;CKAP5;STMN3
prerank,intracellular pH reduction (GO:0051452),0.23818640184715772,0.5845612812295313,0.94,1.0,1.0,13/33,25.66%,ATP6V1H;ATP6V0A2;ATP6V1C1;ATP6V0D2;RAB38;ATP6V0C;DMXL1;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2089789363549528,-0.5843046409615864,0.958974358974359,0.9920026723932236,1.0,5/21,18.11%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2252371065923332,0.5841279887585523,0.9603174603174603,1.0,1.0,15/51,19.62%,CHMP4C;SEC13;IST1;SIRT2;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,mitotic nuclear membrane organization (GO:0101024),0.2252371065923332,0.5841279887585523,0.9603174603174603,1.0,1.0,15/51,19.62%,CHMP4C;SEC13;IST1;SIRT2;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.2855101605186481,0.5839564554858252,0.9040139616055847,1.0,1.0,2/12,8.98%,AR;GSTP1
prerank,apoptotic nuclear changes (GO:0030262),0.24831011013847418,0.5836420713677583,0.918722786647315,1.0,1.0,4/24,10.85%,H1-0;DICER1;DEDD2;GPER1
prerank,lipoxygenase pathway (GO:0019372),0.271350688660653,0.5822804054668964,0.9138513513513513,1.0,1.0,1/14,4.29%,ALOX5
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2594842627758219,0.5819118534167669,0.8973063973063973,1.0,1.0,5/18,17.26%,DAB2IP;AMER1;VGLL4;VPS35;FAF1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.2468592114303699,0.5811636273549295,0.9274924471299094,1.0,1.0,6/25,14.55%,KANK1;YAP1;PRKCD;TCHP;CAPZB;ARHGAP24
prerank,rRNA metabolic process (GO:0016072),0.1946488086786355,0.581022670798657,0.9903536977491961,1.0,1.0,36/160,20.31%,NOL6;UTP14A;NOB1;MAPT;WDR46;RPL8;RPF1;WDR36;MDN1;HELQ;PWP2;RPL5;DEDD2;DIS3L;NOP58;TEX10;RPL15;IMP4;LAS1L;PELP1;RPL22;RPL31;DDX49;RPS6;BOP1;RCL1;PDCD11;RPS17;MPHOSPH6;EXOSC10;NIFK;RPS14;EXOSC8;DDX10;WDR43;DHX37
prerank,regulation of aerobic respiration (GO:1903715),0.26486295765286816,0.5805798280482102,0.934453781512605,1.0,1.0,1/15,4.78%,COX7A2L
prerank,positive regulation of protein deacetylation (GO:0090312),-0.22643054894903386,-0.5804649076161882,0.9508196721311475,0.9930284695517712,1.0,8/14,38.77%,AKAP8;AKAP8L;ZBTB7B;SAP30BP;APLNR;BRMS1;ING2;FNTA
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.23363276443708736,-0.5804438579945594,0.9606879606879607,0.9923167277777036,1.0,6/12,35.52%,ESR1;TGFB1;ZC3H12A;ZC3H10;NCOR1;BCDIN3D
prerank,histone H2A monoubiquitination (GO:0035518),0.25847456266851965,0.5781595102824291,0.9102773246329527,1.0,1.0,5/17,19.56%,PCGF6;PCGF5;PCGF3;KDM2B;PCGF2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.2487083083382714,-0.578047116867976,0.9537444933920705,0.9926132056424732,1.0,2/10,11.66%,LGALS9;LYN
prerank,centromere complex assembly (GO:0034508),0.23349499285271558,0.5768585011296484,0.9292649098474342,1.0,1.0,9/36,18.19%,CENPP;CENPO;CENPE;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,positive regulation of isotype switching (GO:0045830),0.2677204925527624,0.5766349538837121,0.893581081081081,1.0,1.0,4/15,16.17%,PAXIP1;RIF1;KMT5B;MAD2L2
prerank,innate immune response in mucosa (GO:0002227),-0.2539258681595654,-0.5765435820429908,0.9662162162162162,0.9925162400385231,1.0,1/10,9.12%,DEFA6
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2569753285668367,0.5745353763004745,0.9228295819935691,1.0,1.0,4/19,15.31%,RAPSN;CHRNA7;CHRFAM7A;CHRNA4
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.272250717282084,0.5743171520305977,0.9262435677530018,1.0,1.0,4/15,15.52%,EHD2;CD53;ADGRB1;FLOT1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.2860701455495938,0.574081821595304,0.9147005444646098,1.0,1.0,3/10,14.40%,BCL2;FZD9;LRRK2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2290521796898048,-0.5734455622528579,0.9685990338164251,0.9930972988279847,1.0,6/13,31.91%,HSPA5;NCK1;DNAJB9;RACK1;PPP1R15B;ATF6B
prerank,innate immune response (GO:0045087),0.19183920402614765,0.5732198405915173,0.9917098445595854,1.0,1.0,14/217,10.11%,NCF2;MYD88;FRK;ATAD3A;MFHAS1;DMBT1;RARRES2;MBL2;TIFA;RELA;TRIM68;SLA;MASP2;ZDHHC1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.2003835308027362,-0.573169938756516,0.9638888888888889,0.9924848266764144,1.0,3/20,12.07%,ARRB1;TADA2A;SOX4
prerank,protein modification by small protein removal (GO:0070646),0.18927080442448904,0.5728312640049824,0.9989711934156379,1.0,1.0,61/252,19.33%,CCNA2;ADRM1;MCRS1;USP2;ACTB;ASXL1;MBD5;PSMC6;TP53;AR;TRAF3;INO80C;OTUD6B;TNIP1;OTUD7A;USP1;HIF1A;PSME4;PSMB1;PSMD5;UBE2D1;STAM2;NFRKB;OTUD4;COPS8;USP13;RUVBL1;USP50;PSMB2;WDR20;SENP6;USP35;USP20;JOSD1;USP30;PSMB7;PSMD3;USP42;COPS4;STAM;USP4;PTEN;BABAM1;ABRAXAS2;RHOT1;PSMA2;INO80;PSMD14;USP36;MBD6;TADA3;USP28;COPS6;INO80D;ACTL6A;DESI2;DESI1;UCHL5;RPS27A;SENP2;SMAD1
prerank,nuclear body organization (GO:0030575),0.2815698549436006,0.5726083123866137,0.9084380610412927,1.0,1.0,7/12,23.06%,USP50;SRPK2;HIPK2;HABP4;SERBP1;ETS1;ZPR1
prerank,response to nitric oxide (GO:0071731),0.2693717843573827,0.5723359064894987,0.8991150442477877,1.0,1.0,1/13,3.85%,GUCY1B1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.2118857288620915,-0.5722760533753638,0.957286432160804,0.9921341127583364,1.0,14/16,59.16%,CD274;TYROBP;TRIB2;JAK3;FCGR2B;DLL1;AGER;LILRB1;VSIR;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,cellular response to oxygen levels (GO:0071453),-0.24785461282832888,-0.5710973629901475,0.9539473684210527,0.9918989133347967,1.0,5/10,27.11%,ATP6AP1;ATP6V1G1;PICK1;ATP6V0D1;TMEM199
prerank,regulation of mitotic cell cycle (GO:0007346),0.19253095581174523,0.5707223306835463,0.9924892703862661,1.0,1.0,35/171,17.96%,BTG2;EIF4EBP1;USP2;ANAPC10;PSMC6;DUSP3;PIN1;CUL9;HECA;BTG1;DAPK3;UBE2E1;PKN2;PSME4;HNRNPU;PSMB1;PSMD5;BRINP1;UBE2D1;RB1;TRIM35;PSMB2;KIF20B;PSMB7;PSMD3;EIF4E;PRKCA;FBXO5;CAV2;PSMA2;TTC28;PSMD14;ANAPC16;ANAPC5;BRINP2
prerank,cilium-dependent cell motility (GO:0060285),0.24574665374786986,0.5705627353496713,0.9462025316455697,1.0,1.0,2/22,6.38%,DNAH17;EFHC1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.2761056220616039,0.57026102532898,0.9121863799283154,1.0,1.0,2/10,10.22%,GNE;ST6GAL1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.27741745983725885,0.5696213657329523,0.8957597173144877,1.0,1.0,3/10,19.53%,NAF1;RUVBL1;ZNHIT6
prerank,response to UV (GO:0009411),0.20583589055407348,0.5694615508661152,0.9859154929577465,1.0,1.0,23/95,18.99%,MAP4K3;TAF1;TP53;PARP1;CIRBP;NEDD4;ERCC6;RELA;CCND1;BRSK1;USP1;RHNO1;POLD1;PRKCD;ZRANB3;MSH2;INO80;SPRTN;EIF2AK4;UBE2A;USP28;MEN1;N4BP1
prerank,macromolecule catabolic process (GO:0009057),0.2408677933027399,0.5693804918248025,0.9477611940298507,1.0,1.0,2/26,7.03%,CLN5;NEDD4
prerank,regulation of B cell differentiation (GO:0045577),-0.20510462696401127,-0.5689834773131134,0.9665809768637532,0.9919960570920927,1.0,10/17,48.04%,NCKAP1L;PPP2R3C;MMP14;SYK;INHA;BTK;XBP1;SFRP1;IL4I1;IKZF3
prerank,regulation of synapse maturation (GO:0090128),-0.24418742246528835,-0.5678453234397579,0.9472527472527472,0.9916906908898722,1.0,4/10,27.90%,NRXN1;ARHGEF15;YWHAZ;RELN
prerank,ncRNA catabolic process (GO:0034661),0.23633576985348587,0.5674940926267716,0.9335260115606936,1.0,1.0,4/28,10.67%,PARN;DIS3L2;DEDD2;DIS3L
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.25802265110781797,0.5666618778352677,0.9266211604095563,1.0,1.0,5/15,19.08%,RPL5;BAG2;FBXO5;MAD2L2;ABL1
prerank,regulation of cell cycle process (GO:0010564),0.19811154426696714,0.5665117738197349,0.985244040862656,1.0,1.0,20/104,16.69%,TIPIN;PIN1;YTHDF2;CALM1;CUL9;CHEK1;SOX9;DAPK3;RAB11FIP3;RAB11FIP4;GPER1;CEP85;KIF20B;RMI2;PIK3C3;KNSTRN;FBXO5;CAV2;PLK4;MAP9
prerank,regulation of phosphatase activity (GO:0010921),0.24525070339249358,0.5664779235330898,0.9365558912386707,1.0,1.0,1/24,2.47%,PPP1R26
prerank,pseudouridine synthesis (GO:0001522),-0.2154606884004081,-0.566088011997569,0.9600997506234414,0.9916067814755479,1.0,6/13,37.58%,PUS7;PUS3;GAR1;NOP10;PUS1;NHP2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.22890947833307207,0.5655409193449277,0.9572039942938659,1.0,1.0,4/36,11.91%,KLHL40;F8A1;PSME3IP1;EIF3H
prerank,motile cilium assembly (GO:0044458),-0.22820512960881556,-0.5648964081839541,0.9641255605381166,0.9913386625758538,1.0,2/12,18.72%,CCDC39;E2F4
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.20277144458270877,0.5644323929846516,0.9798099762470309,1.0,1.0,17/88,17.83%,FBXL22;CUL2;PSMC6;FBXW7;FBXL18;PSME4;FBXO6;PSMB1;PSMD5;FBXW11;PSMB2;PSMB7;PSMD3;PSMA2;CCNF;PSMD14;CUL5
prerank,response to axon injury (GO:0048678),-0.2047864031986708,-0.5633681168697459,0.9564102564102565,0.9911727904809209,1.0,11/18,42.78%,APOD;MAPK8IP3;DPYSL3;FLRT3;MORN4;MTR;TYROBP;P2RY12;SOD1;TREM2;DHFR
prerank,DNA duplex unwinding (GO:0032508),0.21507166726809485,0.5620133779437093,0.9654255319148937,1.0,1.0,5/50,11.07%,ANXA1;GTF2H4;PARP1;MCMDC2;DDX1
prerank,ceramide catabolic process (GO:0046514),0.26367210479400705,0.5617321537027254,0.9290540540540541,1.0,1.0,3/14,12.91%,NEU3;GLA;GM2A
prerank,regulation of immunoglobulin production (GO:0002637),0.2412363090839912,0.5616299655399957,0.9360374414976599,1.0,1.0,1/23,3.19%,IL2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.20614105330281085,-0.5613914438476545,0.9657894736842105,0.9911488109822606,1.0,7/17,32.00%,WASF2;ARFIP2;PICK1;ABI2;CTNNA2;ARFIP1;GMFB
prerank,glial cell development (GO:0021782),0.23483922838935992,0.5613747952534607,0.9455081001472754,1.0,1.0,6/25,17.14%,CDK6;TPPP;NRROS;SOX10;MT3;S100A9
prerank,regulation of sister chromatid cohesion (GO:0007063),0.27291191985042396,0.559319348046643,0.9263351749539595,1.0,1.0,4/12,22.01%,RB1;RAD21;WAPL;CTCF
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2570746696730044,0.5591428947787792,0.9353233830845771,1.0,1.0,3/16,14.99%,NAA25;NAA20;NAA35
prerank,negative regulation of viral process (GO:0048525),0.20862491243627784,0.5574430643095853,0.96248382923674,1.0,1.0,13/57,19.47%,CCL5;HEXIM1;MBL2;TNIP1;EIF2AK2;TRIM35;OASL;TRIM28;SRPK2;STAT1;ISG15;N4BP1;ILF3
prerank,DNA metabolic process (GO:0006259),0.18274466290622746,0.5555656887894935,1.0,1.0,1.0,41/270,15.31%,HINFP;GMNN;BTG2;MUTYH;GTF2H4;DDX23;RAD51AP1;UPF1;SMARCB1;TERT;PARP1;PRIM2;MBD4;TDP1;CHEK1;REXO4;RAD9A;HUS1B;SLX4;LONP1;UHRF2;PSME4;RIF1;FBXO6;TOP2B;PARG;POLD1;TERF2;POLG;KPNA2;ORC2;NSMCE4A;RMI2;TRIM28;CSNK1E;DNASE1L1;ZRANB3;EXD2;KMT5B;SRPK2;CHRNA4
prerank,response to organophosphorus (GO:0046683),-0.21043668059263604,-0.55482811378844,0.9678899082568807,0.9927573741531709,1.0,5/16,32.26%,DGKQ;TRIM16;TYMS;RFC3;VGF
prerank,serine family amino acid catabolic process (GO:0009071),0.2826601128485629,0.5545581449081355,0.9283276450511946,1.0,1.0,1/10,6.01%,DLD
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.2311282474948647,-0.5539183364281922,0.9650655021834061,0.992370618182672,1.0,3/11,16.92%,CAT;GPX1;PRDX4
prerank,positive regulation of nervous system process (GO:0031646),0.25573282576058876,0.5536699525293772,0.9399656946826758,1.0,1.0,3/18,11.93%,TPPP;DICER1;ATPSCKMT
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.27392435725528086,0.5536697528780454,0.9165085388994307,1.0,1.0,2/10,14.40%,STK26;LRRK2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.24550911973020845,0.5533824343615892,0.9382716049382716,1.0,1.0,7/21,19.21%,TTC23;STK36;TUBD1;RAB34;KIF7;DLG5;UCHL5
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2440326967447512,0.5522390737742562,0.9385826771653544,1.0,1.0,2/23,7.03%,SAG;CALM1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.23244053809193205,-0.5518456083267846,0.9588100686498856,0.9923695290004458,1.0,4/11,20.55%,HSPA5;CEBPB;CREB3L1;ATF4
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2618375787287518,0.5512940169714771,0.9408695652173913,1.0,1.0,2/12,9.70%,HUS1B;STK33
prerank,negative regulation of protein kinase activity (GO:0006469),0.19805158461977562,0.5511328513451549,0.9878934624697336,1.0,1.0,15/88,14.52%,SLC8A1;PPM1E;CAV1;DAB2IP;DUSP3;PTPN1;CORO1C;GSTP1;PAK2;RB1;LRP5;CEP85;CEP43;GNAQ;DVL1
prerank,microtubule bundle formation (GO:0001578),0.21817712964875466,0.5500042212098508,0.9720744680851063,1.0,1.0,8/42,15.59%,RSPH1;TPPP;TOGARAM1;AAAS;CLASP1;FOXJ1;MTCL1;CCDC66
prerank,mitochondrial transport (GO:0006839),0.20695867109928137,0.5498466680648465,0.9804432855280313,1.0,1.0,14/53,22.51%,PMAIP1;BCL2;MFN2;TOMM5;BCAP31;MFF;TOMM7;SLC25A16;TIMM9;TIMM22;OXA1L;GDAP1;TOMM22;STARD3
prerank,DNA replication (GO:0006260),0.1905180930638328,0.5467913794682011,0.9897843359818388,1.0,1.0,15/105,13.94%,BRIP1;SET;UPF1;TIPIN;WRNIP1;CHEK1;RAD9A;KAT7;RHNO1;POLD1;PTMS;POLG;ORC2;RMI2;NT5M
prerank,positive regulation of cellular protein localization (GO:1903829),0.20111899575033929,0.5445348844010166,0.9806763285024155,1.0,1.0,7/69,11.10%,FERMT2;SLC5A3;NUP62;MAPT;YAP1;KAT7;GPD1L
prerank,folic acid-containing compound metabolic process (GO:0006760),0.24374801197259877,0.543063752388052,0.9369085173501577,1.0,1.0,2/19,8.66%,MTHFD2L;ALDH1L2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.24717795091772826,0.5426365273699617,0.9448946515397083,1.0,1.0,2/17,7.87%,CCL5;TGFB2
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2275539365566268,-0.5425551408189836,0.9632829373650108,0.9944643100516958,1.0,3/11,20.11%,RBBP4;ASF1A;HIRA
prerank,ribosome biogenesis (GO:0042254),0.17932618503926134,0.5421020387004701,1.0,1.0,1.0,42/187,20.45%,NOL6;MRPL36;UTP14A;NOB1;WDR46;RPL8;RPF1;ABCE1;WDR36;MDN1;NAF1;HELQ;PWP2;RPL5;NOP58;LSG1;TEX10;RPL15;IMP4;LAS1L;PELP1;RPL22;RPL31;GTF3A;XPO1;DDX49;RPS6;BOP1;RCL1;PDCD11;RPS17;DHX29;MPHOSPH6;MRPL22;EXOSC10;RPS14;MALSU1;EXOSC8;DDX10;WDR43;DHX37;EIF2A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.23486799361990401,0.5418921617947299,0.9556213017751479,1.0,1.0,3/26,13.16%,LARGE1;TNIP1;ST3GAL2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.22732183546282175,0.5408673165019126,0.9536516853932584,1.0,1.0,3/31,10.21%,ALOX5;MOCS1;SCP2
prerank,positive regulation of cell communication (GO:0010647),-0.17626498564503823,-0.539601181869388,0.9905362776025236,0.9945876528705074,1.0,7/28,26.30%,SYT1;WLS;RIMS2;CD80;NMU;SOX11;EDN3
prerank,GTP metabolic process (GO:0046039),0.25374839748666755,0.5384899685803091,0.9375,1.0,1.0,3/15,14.40%,ENTPD7;OPA1;LRRK2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.21351640677063488,-0.5384665051573091,0.9719626168224299,0.9941880251826347,1.0,5/13,32.45%,IL18;LAMP1;ZBTB1;AP1G1;TYROBP
prerank,regulation of TOR signaling (GO:0032006),0.19425103712553327,0.5379003196081674,0.9885057471264368,1.0,1.0,12/67,15.38%,FAM83D;LARS1;GNA12;SEC13;RRAGB;EPM2A;NPRL2;SH3BP4;RICTOR;GAS6;PRKAA2;ITFG2
prerank,protein targeting to peroxisome (GO:0006625),0.22316438323066196,0.5376814682590053,0.961764705882353,1.0,1.0,11/29,21.73%,PEX2;ATAD1;PEX19;LONP2;ZFAND6;RAB8B;PEX10;PEX26;PEX1;PEX3;GDAP1
prerank,mitotic cytokinesis (GO:0000281),0.20728020277839793,0.5371928976774127,0.977088948787062,1.0,1.0,7/47,13.64%,ROCK1;EFHC1;ANLN;SNX18;ROCK2;SNX9;SON
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.20632245391784082,0.536760802680857,0.9701897018970189,1.0,1.0,5/44,11.79%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,regulation of rRNA processing (GO:2000232),-0.2011947361157671,-0.5356379118274854,0.979381443298969,0.9943392403074736,1.0,7/16,35.66%,SIRT7;DIMT1;BUD23;HEATR1;RIOK2;NUDT16;TRMT112
prerank,male meiosis I (GO:0007141),0.24695694854674033,0.5350252804208117,0.9516666666666667,1.0,1.0,1/16,5.67%,FOXJ3
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.24828403863329387,0.5345362395747814,0.9406099518459069,1.0,1.0,4/15,15.60%,CNOT7;CPEB3;ZFP36L1;NANOS1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.24828403863329387,0.5345362395747814,0.9406099518459069,1.0,1.0,4/15,15.60%,CNOT7;CPEB3;ZFP36L1;NANOS1
prerank,steroid catabolic process (GO:0006706),-0.2294044338762235,-0.534129694187509,0.9704641350210971,0.9940575908087843,1.0,3/10,34.37%,SPP1;HSD17B11;HSD11B1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.23630945428815692,0.5338576546222863,0.947452229299363,1.0,1.0,8/19,22.50%,FOXJ1;MTCL1;PARD3B;CLIC4;MARK2;PARD3;PATJ;ERBIN
prerank,protein deneddylation (GO:0000338),-0.22984322023350845,-0.5333671011531051,0.9623430962343096,0.9935774516025268,1.0,4/10,30.04%,COPS2;COPS7B;TOR1A;GPS1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.248292808486986,0.5333086391681976,0.9506802721088435,1.0,1.0,1/14,7.28%,PIBF1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.19867735203234457,0.5327085433216548,0.9826946847960445,1.0,1.0,11/62,15.30%,BCL2;ARHGEF2;BCL2L2;OPA1;SNAI2;NDUFS3;RTKN2;CLU;MCL1;LRRK2;URI1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.23560034637261149,0.5324024269581883,0.9581993569131833,1.0,1.0,5/20,14.39%,RELA;ADAM17;MBTPS1;HM13;SPPL2B
prerank,peptidyl-lysine acetylation (GO:0018394),0.2677068053021798,0.5296060680478711,0.9470802919708029,1.0,1.0,3/10,22.85%,KAT7;ESCO1;KAT2B
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.2501818319562454,0.5290372468161102,0.9417808219178082,1.0,1.0,1/15,4.94%,LNPK
prerank,cellular response to UV-A (GO:0071492),-0.2144659438084046,-0.5282925830411962,0.9741784037558685,0.9941338593099975,1.0,6/11,45.25%,MMP2;MMP1;MME;OPN3;TIMP1;MMP3
prerank,recombinational repair (GO:0000725),0.1899143444393116,0.526625067702908,0.9879951980792316,1.0,1.0,15/77,17.43%,RAD51AP2;RAD51AP1;PARP1;SFPQ;HUS1B;SLX4;HELQ;SFR1;RHNO1;MORF4L1;EXD2;RAD52;INO80;PSMD14;REV3L
prerank,"phototransduction, visible light (GO:0007603)",0.24906674651319888,0.5265918712105816,0.9456140350877194,1.0,1.0,2/14,13.95%,SAG;GNAQ
prerank,prostanoid metabolic process (GO:0006692),0.2529545876607577,0.5245651809899967,0.944153577661431,1.0,1.0,2/13,10.97%,GSTP1;PTGR1
prerank,mRNA modification (GO:0016556),0.23109281826160213,0.5221957275612316,0.9542682926829268,1.0,1.0,6/22,19.05%,TRMT10C;CBLL1;NSUN2;TRUB1;TRUB2;TRMT6
prerank,nuclear envelope organization (GO:0006998),-0.18428619198628154,-0.5216200050336082,0.9869791666666666,0.9950580760738241,1.0,8/20,31.65%,TOR1AIP1;EMD;LEMD2;TMEM43;TOR1A;REEP3;NUP155;NEMP1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.2504766470705399,0.5216146238257758,0.9316987740805605,1.0,1.0,3/13,15.91%,GSTP1;NAMPT;JAK2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.22598655617723812,0.5206935629187445,0.9532163742690059,1.0,1.0,5/26,17.38%,MAPT;TOGARAM1;CLASP1;STMN2;DCTN1
prerank,folic acid metabolic process (GO:0046655),0.23679745787526899,0.5197222589573083,0.948220064724919,1.0,1.0,2/18,8.66%,MTHFD2L;ALDH1L2
prerank,central nervous system neuron differentiation (GO:0021953),0.21699691171411659,0.5195523211211546,0.9732016925246827,1.0,1.0,8/33,19.42%,MAPT;NR4A2;FAIM2;SIN3A;RYK;NPY;MDGA1;AGTPBP1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.19753119291498394,0.519448126469639,0.9848484848484849,1.0,1.0,14/53,20.16%,PSMC6;DAB2IP;FBXW7;F8A1;GNA12;PSME3IP1;BAG2;UFL1;PRKACA;XPO1;PSMD14;DESI1;UCHL5;FOXF2
prerank,neuron projection organization (GO:0106027),0.24004821946876914,0.518526814640172,0.9509632224168126,1.0,1.0,5/15,17.51%,CHRNA7;ATP1A3;PLS1;DCTN1;MAP1A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.22461601316670815,0.5181511558716987,0.9626168224299065,1.0,1.0,3/24,12.48%,BCL2;SNAI2;CLU
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2253317567025995,0.5178423028463743,0.9720496894409938,1.0,1.0,5/22,16.30%,PSME4;PSMB1;PSMB2;PSMB7;PSMA2
prerank,protein localization to phagophore assembly site (GO:0034497),0.25668446565412983,0.517651588464154,0.949814126394052,1.0,1.0,3/11,15.66%,MFN2;WDR45;ATG13
prerank,response to nutrient levels (GO:0031667),0.2349805705684144,0.5167724838570905,0.9418604651162791,1.0,1.0,3/17,18.88%,KCNB1;PRKAA2;ULK1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2573492397121484,0.5167185217115601,0.9562841530054644,1.0,1.0,2/10,14.07%,THAP4;QDPR
prerank,regulation of phosphate metabolic process (GO:0019220),-0.19583350193468238,-0.5156560484295554,0.9799498746867168,0.9956630902935849,1.0,7/16,40.24%,IGBP1;SMG6;SRPX2;CD24;PSEN1;TIGAR;IKBKB
prerank,protein K63-linked deubiquitination (GO:0070536),0.2110260215042185,0.5147084595425927,0.98,1.0,1.0,8/31,16.91%,OTUD7A;OTUD4;USP13;USP50;USP20;BABAM1;ABRAXAS2;PSMD14
prerank,neutrophil migration (GO:1990266),-0.13785878659401812,-0.512316689802331,1.0,0.9956798291321525,1.0,4/58,8.21%,PECAM1;CXADR;GBF1;BSG
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17879646427185877,0.5117218889017923,0.9919724770642202,1.0,1.0,22/95,20.91%,RAD51AP2;RAD51AP1;PARP1;SFPQ;HUS1B;SLX4;HELQ;FANCB;SFR1;MCMDC2;MORF4L1;EXD2;RAD52;RAD21;INO80;PSMD14;REV3L;RAD54B;SWI5;YY1;MCM4;RAD51D
prerank,water-soluble vitamin metabolic process (GO:0006767),0.18993973731829508,0.5110810622979921,0.9855595667870036,1.0,1.0,7/68,9.20%,MCCC2;MTHFD2L;SLC23A2;SLC23A1;ALDH1L2;ABCD4;AASDHPPT
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.19818672057236272,0.5084285083517577,0.9920948616600791,1.0,1.0,12/45,21.35%,GCNT2;ATXN2;CYFIP1;DDX25;RBM3;EIF4E;NANOS1;METAP1;YTHDC1;EIF2A;LARP1;RPL10
prerank,homocysteine metabolic process (GO:0050667),0.2542772219173236,0.5070310410387092,0.9566787003610109,1.0,1.0,1/11,5.95%,BLMH
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.23115540310185884,0.5065761492009495,0.9740061162079511,1.0,1.0,3/18,13.52%,FZD9;BOK;MUL1
prerank,homologous chromosome segregation (GO:0045143),-0.17838417952832972,-0.5063247193501694,0.9892183288409704,0.996158413199063,1.0,2/20,8.54%,CENPC;SIRT7
prerank,antibacterial humoral response (GO:0019731),0.23358056234162464,0.5057039060153857,0.9635416666666666,1.0,1.0,1/16,5.11%,DMBT1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22829447734840505,0.5043374129736816,0.9717425431711146,1.0,1.0,2/19,7.14%,ELL;AR
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.24419334588826133,0.5041437869643844,0.9501845018450185,1.0,1.0,11/11,75.60%,TIMM29;TIMM9;TIMM22;ROMO1;TIMM13;AGK;TIMM10;NDUFA13;TIMM8B;TIMM10B;TOMM70
prerank,renal absorption (GO:0070293),0.24765224344457637,0.5034257654046234,0.950354609929078,1.0,1.0,3/10,18.13%,HAS2;SGK1;SLC15A2
prerank,regulation of cytokine production (GO:0001817),0.17350480774165367,0.5015472233629067,1.0,1.0,1.0,9/126,7.87%,ANXA1;HDAC9;CD276;ALOX5;ASB1;MAPKAPK2;TRAF3;SNAI2;ATP2B1
prerank,negative regulation of phosphatase activity (GO:0010923),0.20835398840620317,0.5013865897276893,0.9658246656760773,1.0,1.0,2/25,7.87%,PPP1R26;TGFB2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.24875418249991788,0.5011640760344341,0.9485294117647058,1.0,1.0,2/10,11.54%,RIF1;TERF2
prerank,regulation of lipid catabolic process (GO:0050994),0.22311753645147064,0.5011164388917909,0.9666136724960255,1.0,1.0,2/19,10.91%,RARRES2;LONP2
prerank,tRNA metabolic process (GO:0006399),0.22740490606442862,0.5008629054364554,0.9686985172981878,1.0,1.0,4/17,16.16%,DTD1;KARS1;SARS1;FARS2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2334735388285516,0.5006476652647495,0.9553571428571429,1.0,1.0,12/12,76.67%,MCMDC2;MCM4;MCM7;MCM2;MCM6;GINS2;MCM5;MCM3;CDC45;GINS4;MUS81;CDC7
prerank,regulation of transferase activity (GO:0051338),0.22409123317101376,0.4998180638507201,0.9706840390879479,1.0,1.0,5/17,21.44%,FEM1A;FEM1B;PPP1R3F;HMBOX1;EMP2
prerank,positive regulation of immune response (GO:0050778),0.18383018458845293,0.49918633948480173,0.9950124688279302,1.0,1.0,4/64,7.87%,IL2;CCL5;IL12RB1;TGFB2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.21275609364717213,-0.49872532339872233,0.9956236323851203,0.9968519806344245,1.0,2/10,15.43%,OS9;INSIG1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.21409337367774117,0.4973799554077839,0.9719626168224299,1.0,1.0,3/23,7.69%,VEGFA;GDNF;SOX9
prerank,histone H2A acetylation (GO:0043968),0.22577044238776722,0.4948397406273152,0.956953642384106,1.0,1.0,3/16,12.56%,MSL3;RUVBL1;MORF4L1
prerank,positive regulation of response to stimulus (GO:0048584),0.19342566608579073,0.4946797074550871,0.9919246298788694,1.0,1.0,5/40,12.71%,CGAS;TGFB2;PRKCD;HOMER1;NSMCE4A
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.21448639203750403,0.4940670512465057,0.9794628751974723,1.0,1.0,3/21,12.79%,MFHAS1;ENSA;ARPP19
prerank,axoneme assembly (GO:0035082),0.2063444820821383,0.49350977772132965,0.9762237762237762,1.0,1.0,4/31,16.17%,RSPH1;TOGARAM1;FOXJ1;DNAI4
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.23118837889137045,0.49248519857515305,0.9509001636661211,1.0,1.0,2/14,11.86%,RELA;NECTIN2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.21388647999778287,0.4920479845483304,0.9774096385542169,1.0,1.0,2/24,4.89%,FXN;SUCLA2
prerank,central nervous system neuron development (GO:0021954),0.23192849149313893,0.4917452607577405,0.9675324675324676,1.0,1.0,4/15,18.54%,MAPT;ARHGAP35;PTEN;NPY
prerank,glial cell differentiation (GO:0010001),0.20262983910588167,0.4914949755369562,0.9909638554216867,1.0,1.0,7/28,18.81%,TPPP;SOX9;CDH2;FGF10;STAT3;SOX10;METRN
prerank,histone exchange (GO:0043486),0.19841637313582358,0.49107998398306224,0.9887640449438202,1.0,1.0,9/37,18.58%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1;VPS72
prerank,mitotic DNA replication (GO:1902969),-0.2092184968461332,-0.49053859924744214,0.9782135076252724,0.9975185652208658,1.0,6/10,41.60%,GINS3;LIG1;CDC45;GINS1;MCM3;POLA1
prerank,cellular response to inorganic substance (GO:0071241),-0.17167236832277782,-0.49002978969032424,0.9918478260869565,0.9969012692759067,1.0,8/21,32.08%,FOXO1;KCNC2;BLM;FMR1;CDK2;ATRX;TIMELESS;MTR
prerank,modulation by host of viral genome replication (GO:0044827),0.23844008008917333,0.4894070878591418,0.9681978798586572,1.0,1.0,3/13,17.63%,TBC1D20;YTHDC2;EIF2AK4
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.23975146309300438,0.48714303085575206,0.972875226039783,1.0,1.0,1/11,5.83%,ATP1B1
prerank,regulation of neuron projection arborization (GO:0150011),0.22462686377398172,0.48672835685632965,0.9630872483221476,1.0,1.0,1/15,3.34%,FZD4
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.21145773269044604,0.4844740863406063,0.9619047619047619,1.0,1.0,3/22,13.68%,DUSP3;CD300A;DGKZ
prerank,sensory perception of pain (GO:0019233),-0.16666167478430116,-0.4782621405863209,0.9973190348525469,0.9979185686366319,1.0,12/21,48.70%,RETREG1;SCN9A;MME;PTGES;TRPA1;CCR2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;PROK2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.18564597506757913,-0.474987828513888,0.9832134292565947,0.9976365773880538,1.0,6/13,33.01%,UPP2;SMUG1;DUT;OGG1;TDG;NEIL1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.21876921017912018,0.4749152746995501,0.9818181818181818,1.0,1.0,3/17,12.99%,CALM1;SIRT2;DMTN
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.2251854200065717,0.47491296006684147,0.9650959860383944,1.0,1.0,4/13,21.01%,AXL;GAS6;DHX9;TRIM44
prerank,regulation of oxidative phosphorylation (GO:0002082),0.2132252556668272,0.4738263000397799,0.9737704918032787,1.0,1.0,4/16,20.51%,COX7A2L;MLXIPL;UQCC2;SLC25A33
prerank,regulation of B cell activation (GO:0050864),0.19563134103996263,0.4731790920328591,0.9742813918305597,1.0,1.0,3/25,13.53%,SAMSN1;ZFP36L1;FOXJ1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.17934313227260062,0.47248533793500647,0.9961538461538462,1.0,1.0,10/55,16.91%,FHL1;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,cell junction maintenance (GO:0034331),-0.18157667664325053,-0.4710581679465552,0.993006993006993,0.9973842529205968,1.0,7/14,42.00%,NLGN2;CLDN1;CHCHD10;CSF1R;F2R;CBLN1;PRTN3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.20407999565923293,0.46634299279270536,0.982484076433121,1.0,1.0,7/22,19.70%,NEDD4;TSG101;VPS36;STAM;VPS4A;TOM1L1;VPS37A
prerank,pigment granule transport (GO:0051904),0.20409414313219446,0.4607315739902419,0.9769357495881383,1.0,1.0,6/18,24.21%,MREG;BLOC1S5;MLPH;BBS5;MYO5A;BBS7
prerank,melanosome transport (GO:0032402),0.20409414313219446,0.4607315739902419,0.9769357495881383,1.0,1.0,6/18,24.21%,MREG;BLOC1S5;MLPH;BBS5;MYO5A;BBS7
prerank,negative regulation of centrosome duplication (GO:0010826),0.22359060016636062,0.45706806929010213,0.978494623655914,1.0,1.0,5/11,24.77%,CCNF;RBM14;CENATAC;KAT2B;TRIM37
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.19431543119548933,0.45620978543761126,0.9956076134699854,1.0,1.0,4/29,19.08%,ZCWPW1;SYCP2;RAD21;TERB1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.1946710350988209,-0.4548159673699085,1.0,0.998464221523137,1.0,7/10,59.16%,NCKAP1L;TLR4;VSIR;IL12A;PRNP;FOXP3;IL12B
prerank,response to hydroxyurea (GO:0072710),0.2231718332527192,0.45448821527436856,0.9835466179159049,1.0,1.0,2/11,12.63%,KAT7;DDI2
prerank,cilium movement (GO:0003341),-0.13016359634985306,-0.454178881679039,1.0,0.997805022777539,1.0,31/48,50.91%,DNAAF5;ODAD1;CCDC39;DNHD1;SPEF2;GAS8;CFAP61;DNAH5;CFAP70;CFAP251;CFAP53;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;SPA17;DNAH9;DNAAF2;ODAD4;TEKT2;CFAP100;CFAP206;RSPH9;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5
prerank,regulation of response to interferon-gamma (GO:0060330),0.2074812900689399,0.4503202425997677,0.9772727272727273,1.0,1.0,4/14,19.26%,STAT1;JAK2;PIAS1;SUMO1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.1853658267642585,0.44866650730135504,0.9957081545064378,1.0,1.0,5/33,17.00%,TESC;RUNX1;ZFP36L1;PRKCA;ACIN1
prerank,pinocytosis (GO:0006907),0.22486114533328821,0.44780401335982256,0.9805996472663139,1.0,1.0,2/10,14.69%,MAPKAPK2;RAB34
prerank,negative regulation of cholesterol transport (GO:0032375),0.22625134991294943,0.4457241642634154,0.9684601113172542,1.0,1.0,1/10,11.09%,SREBF2
prerank,mitochondrial transcription (GO:0006390),0.22443172200366773,0.4454782605331292,0.9731800766283525,1.0,1.0,4/10,22.80%,TFB2M;TEFM;SLC25A33;TFAM
prerank,mesoderm development (GO:0007498),0.20137370507533306,0.4443429498158254,0.9823434991974318,1.0,1.0,4/18,17.55%,VEGFA;IKZF1;JAK2;GDF11
prerank,DNA-dependent DNA replication (GO:0006261),0.15362667518371323,0.44373679968858254,1.0,1.0,1.0,20/128,17.43%,GMNN;DDX23;PSMC6;WRNIP1;PRIM2;PSME4;PSMB1;MCMDC2;PSMD5;POLD1;POLG;PSMB2;ORC2;PSMB7;PSMD3;SRPK2;PSMA2;MGME1;PSMD14;REV3L
prerank,response to hexose (GO:0009746),0.18766213270047455,0.44345355327115127,0.9882005899705014,1.0,1.0,1/25,3.34%,LPL
prerank,outer dynein arm assembly (GO:0036158),0.20602187646806808,0.44311444345468565,0.9717607973421927,1.0,1.0,1/15,5.18%,DNAH17
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.1985455190747349,0.4362716856999707,0.9802955665024631,1.0,1.0,2/16,15.26%,IL12RB1;STX7
prerank,regulation of cilium movement (GO:0003352),0.21524074157602682,0.4360354039522139,0.9840425531914894,1.0,1.0,2/10,15.78%,DNAH11;CFAP43
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.18179743538862658,0.4348034231220468,0.9928366762177651,1.0,1.0,4/29,15.26%,IL12RB1;RASGRP1;NECTIN2;STX7
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.20761568389041307,0.4335721894889323,0.9861111111111112,1.0,1.0,1/12,7.28%,PIBF1
prerank,cell differentiation in hindbrain (GO:0021533),-0.1835145049335149,-0.4310180601636956,0.9928400954653938,0.9989799551732143,1.0,7/11,46.94%,OPHN1;GRID2;ATP7A;LHX1;CBLN1;CEND1;NOG
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.20146295509003426,0.42754030253058284,0.9892086330935251,1.0,1.0,4/13,22.00%,EDEM2;SLC51B;BCAP31;SEC16A
prerank,determination of left/right symmetry (GO:0007368),0.1695762479273152,0.4240203720195174,1.0,1.0,1.0,7/37,17.67%,KIF3B;DNAH11;CITED2;FOXJ1;RFX3;DAND5;GALNT11
prerank,phagosome-lysosome fusion (GO:0090385),-0.182144541040018,-0.4223177927887515,0.9934782608695653,0.9987607470274047,1.0,3/10,29.85%,CLN3;SYT7;RAB39A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.188618529826329,0.4205108108338588,0.9903691813804173,1.0,1.0,3/17,16.03%,IRS1;IRS2;STAT3
prerank,cellular response to interleukin-7 (GO:0098761),0.188618529826329,0.4205108108338588,0.9903691813804173,1.0,1.0,3/17,16.03%,IRS1;IRS2;STAT3
prerank,B cell activation involved in immune response (GO:0002312),0.19914615770969338,0.41731428669300796,0.9861111111111112,1.0,1.0,13/13,80.10%,CD180;MSH2;RNF168;CD40LG;GPR183;GAPT;CD19;RNF8;FCGR2B;LIG4;BATF;EXOSC3;MSH6
prerank,regulation of centriole replication (GO:0046599),0.189613447215778,0.4158983330827868,0.9852216748768473,1.0,1.0,4/18,18.50%,NUP62;PLK4;RBM14;CEP295
prerank,axonemal dynein complex assembly (GO:0070286),0.17250197876710022,0.41253339589131466,0.9942279942279942,1.0,1.0,2/28,8.55%,DNAH17;CFAP73
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.17216191960580224,-0.41130039596924867,1.0,0.9985918426863308,1.0,6/11,52.31%,HDAC2;TAF7;CIITA;XBP1;PF4;IL4
prerank,phagolysosome assembly (GO:0001845),0.19779593593012534,0.4084296476273003,0.9926605504587156,1.0,1.0,6/12,25.66%,RAB14;RAB34;PIKFYVE;ARL8B;RAB7B;RAB7A
prerank,lipid droplet organization (GO:0034389),0.17605276977586806,0.40544798929921855,0.9984520123839009,1.0,1.0,3/22,15.01%,AUP1;PNPLA3;PLA2G4C
prerank,neutrophil chemotaxis (GO:0030593),0.15128393918161126,0.4029410109546162,0.9974811083123426,1.0,1.0,10/53,22.41%,CCL5;TGFB2;CCL14;S100A8;S100A9;CCL25;CCL19;PIKFYVE;PPIB;CCL13
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.19710270952194617,0.39765650808498704,0.9963636363636363,1.0,1.0,2/10,14.83%,SIRT2;KNSTRN
prerank,receptor recycling (GO:0001881),0.1915134015441592,0.38510157567905995,0.9946140035906643,1.0,1.0,10/10,80.86%,PLEKHJ1;ARFGEF2;NSG1;RAB11B;LMTK2;SORL1;PHETA2;REP15;PHETA1;EHD3
prerank,nuclear transport (GO:0051169),0.17317502869754503,0.3780932922524209,0.9949066213921901,1.0,1.0,5/16,23.14%,AAAS;NUP98;XPO1;ANP32A;RBM15B
prerank,nucleocytoplasmic transport (GO:0006913),0.14718983905737937,0.3736383368912056,1.0,1.0,1.0,9/40,21.69%,ATXN1;AAAS;LSG1;NUP98;XPO1;SNRPD3;GEMIN6;SNUPN;ANP32A
prerank,tRNA wobble uridine modification (GO:0002098),0.1692337388549465,0.3646849750565781,0.9949238578680203,1.0,1.0,2/14,15.86%,DPH3;ELP3
prerank,dendritic cell differentiation (GO:0097028),0.15786826331495235,0.3632469323494266,0.996969696969697,1.0,1.0,3/22,13.58%,AXL;TRPM2;GAS6
prerank,tetrapyrrole metabolic process (GO:0033013),0.161715757080952,0.35247330640668184,0.998389694041868,1.0,1.0,18/18,83.85%,ABCD4;MMAB;MMAA;ABCC1;MMACHC;CBLIF;CTRC;AMN;TCN1;MTRR;TCN2;ABCB6;MMADHC;CD320;MTR;MMUT;CUBN;LMBRD1
prerank,tRNA wobble base modification (GO:0002097),0.16422570025627464,0.35126643319125367,1.0,1.0,1.0,2/14,15.86%,DPH3;ELP3
prerank,cobalamin metabolic process (GO:0009235),0.16170560160763622,0.34801806601089325,0.9983739837398374,1.0,1.0,17/17,83.85%,ABCD4;MMAB;MMAA;ABCC1;MMACHC;CBLIF;CTRC;AMN;TCN1;MTRR;TCN2;MMADHC;CD320;MTR;MMUT;CUBN;LMBRD1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.1580874050448557,0.34563299994344565,0.9983471074380166,0.9996457151933033,1.0,15/16,65.45%,MCMDC2;MCM4;MCM7;MCM2;PURA;SSBP1;RECQL;MCM6;RECQL5;RECQL4;HMGA1;WRN;TWNK;RPA1;RAD51
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.12611075218773868,0.30397072063177866,1.0,0.9998812894156237,1.0,7/32,23.17%,FAM3A;RNASE3;S100A9;RPL30;ROMO1;CCL13;GAPDH
